Name,Term,ES,NES,NOM p-val,FDR q-val,FWER p-val,Tag %,Gene %,Lead_genes
prerank,PanglaoDB_Augmented_2021__Podocytes,-0.6237402107286237,-1.8284875206412263,0.0,1.0,0.64,18/165,5.78%,PLEKHH2;ITGB5;GOLIM4;TRIB2;IQGAP2;LAMB2;SRGAP1;CDH13;RND3;UNC13B;PROS1;KITLG;NFIB;EHD4;RASSF8;WWTR1;COL4A3;NPHS1
prerank,GO_Biological_Process_2021__regulation of response to cytokine stimulus (GO:0060759),-0.8270185862420776,-1.808523016036904,0.0,1.0,0.73,5/17,7.73%,RUNX1;IFIH1;APOA1;MAPK7;CBFB
prerank,GO_Biological_Process_2021__negative regulation of protein depolymerization (GO:1901880),-0.8153468442660406,-1.8084008438593,0.0,1.0,0.73,1/24,0.03%,PLEKHH2
prerank,PanglaoDB_Augmented_2021__Parathyroid Chief Cells,-0.6918621746031228,-1.7990232590890056,0.0,1.0,0.8,7/77,0.73%,GEM;SPRED2;GPC4;CAMK1G;TRPC7;NPNT;KCNIP1
prerank,GO_Biological_Process_2021__regulation of actin filament depolymerization (GO:0030834),-0.9628998079791016,-1.7791889917190713,0.0,1.0,0.88,2/9,1.47%,PLEKHH2;F2RL1
prerank,GO_Biological_Process_2021__fatty acid biosynthetic process (GO:0006633),-0.7363383901268531,-1.759669441274694,0.0,1.0,0.94,7/60,4.77%,CYP1A2;DECR2;ABHD1;ELOVL6;MLYCD;LTC4S;CYP2D6
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation (GO:0035335),-0.7717307153900131,-1.7562786534113706,0.027777777777777776,1.0,0.95,7/33,3.69%,DUSP4;DUSP5;UBASH3B;PTPRT;PTPRB;PTPN9;DUSP2
prerank,GO_Biological_Process_2021__lipid catabolic process (GO:0016042),-0.8813927551752662,-1.7542695875695689,0.0,1.0,0.97,2/18,0.42%,CYP1A2;GLYATL2
prerank,GO_Biological_Process_2021__long-chain fatty acid biosynthetic process (GO:0042759),-0.8605821884912987,-1.7381862869085243,0.0,1.0,0.98,4/25,4.77%,CYP1A2;ELOVL6;LTC4S;CYP2D6
prerank,GO_Biological_Process_2021__negative regulation of actin filament depolymerization (GO:0030835),-0.9951194667043303,-1.729835252117431,0.0,1.0,0.98,1/6,0.03%,PLEKHH2
prerank,GO_Biological_Process_2021__amyloid fibril formation (GO:1990000),0.8074369721072315,1.7268479734204618,0.0,0.4171305829526722,0.38,6/40,8.26%,SERF1A;CALB1;HSPG2;H3-3A;MFGE8;SIAH1
prerank,GO_Biological_Process_2021__regulation of protein deacetylation (GO:0090311),-0.9812590319530234,-1.7211338827376435,0.0,1.0,0.98,3/8,0.88%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__long-chain fatty acid metabolic process (GO:0001676),-0.6620103089729948,-1.7023879510734639,0.0,1.0,1.0,7/67,4.98%,CYP1A2;GLYATL2;ELOVL6;CYP4Z1;LTC4S;CYP2D6;ACOT1
prerank,GO_Biological_Process_2021__central nervous system neuron development (GO:0021954),0.9682552225722224,1.6960292900186378,0.0,0.48402888399225175,0.59,1/13,0.04%,NPY
prerank,GO_Biological_Process_2021__myeloid cell development (GO:0061515),-0.7960985001854664,-1.693853937388098,0.0,1.0,1.0,4/15,7.25%,KIT;ALAS1;LYAR;FOXP1
prerank,GO_Biological_Process_2021__regulation of dendrite development (GO:0050773),-0.7250876657273087,-1.6892831574151537,0.02702702702702703,1.0,1.0,8/36,10.65%,ALK;BMP7;MARK1;KNDC1;VLDLR;LRP8;COBL;NSMF
prerank,GO_Biological_Process_2021__monocarboxylic acid metabolic process (GO:0032787),-0.658003745365677,-1.6845758887543885,0.0,1.0,1.0,12/105,8.42%,CYP1A2;PER2;LDHC;AOAH;IGF1;ACOT1;ALDH1A2;ACOT11;ALDH1A3;CROT;ACSF3;MTHFS
prerank,GO_Biological_Process_2021__negative regulation of cytoskeleton organization (GO:0051494),-0.7359850093714069,-1.6815273084508584,0.041666666666666664,1.0,1.0,1/29,0.03%,PLEKHH2
prerank,GO_Biological_Process_2021__regulation of cellular component movement (GO:0051270),-0.6573475240182696,-1.6789546238427113,0.037037037037037035,1.0,1.0,7/48,7.44%,NRG1;PRAG1;BTC;EREG;PDPN;IGBP1;ETS1
prerank,GO_Biological_Process_2021__steroid catabolic process (GO:0006706),-0.9332640679206019,-1.6767253615292277,0.0,1.0,1.0,1/10,0.01%,CYP1A2
prerank,PanglaoDB_Augmented_2021__Neural Stem/Precursor Cells,-0.5737396661119466,-1.6714454148616562,0.0,1.0,1.0,29/124,14.98%,PLEKHH2;KCNIP1;CACNG4;PCDH19;RND3;ASCL1;ID4;RHBDL3;POU3F4;ARX;ADGRA1;NYAP1;ZNF536;RGS8;MAPK4;PHF21B;DLX5;APOE;STMN2;ELAVL3;PLPPR5;ARNT2;GRIA2;DNER;RBM3;DLX2;SRRM3;MSI1;SEMA5B
prerank,GO_Biological_Process_2021__manganese ion transport (GO:0006828),-0.8646392687363991,-1.6690255328789128,0.0,1.0,1.0,2/14,0.58%,TRPC3;TRPC7
prerank,GO_Biological_Process_2021__neuromuscular process (GO:0050905),-0.8680882702997562,-1.668710451491131,0.0,0.9900556650964952,1.0,3/10,7.61%,GCH1;TPP1;SHANK1
prerank,GO_Biological_Process_2021__blood vessel endothelial cell migration (GO:0043534),-0.7687356539631895,-1.6610659053100807,0.058823529411764705,1.0,1.0,2/18,1.73%,KDR;GREM1
prerank,GO_Biological_Process_2021__regulation of synapse organization (GO:0050807),-0.7224974736868125,-1.6536002957336944,0.0,1.0,1.0,4/23,13.59%,MDGA1;ABHD17A;CTNNA2;GRIPAP1
prerank,GO_Biological_Process_2021__cell migration involved in sprouting angiogenesis (GO:0002042),-0.789893127362859,-1.64917368748801,0.029411764705882353,1.0,1.0,2/16,1.73%,KDR;GREM1
prerank,GO_Biological_Process_2021__drug catabolic process (GO:0042737),-0.9478124994899042,-1.6453904335595506,0.0,1.0,1.0,1/11,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__exogenous drug catabolic process (GO:0042738),-0.9531796363653098,-1.6405481607276178,0.0,1.0,1.0,1/10,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial cell proliferation (GO:1905564),-0.7897823975592486,-1.6384683265377107,0.05555555555555555,1.0,1.0,2/12,3.98%,ITGA4;APLN
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 4 signaling pathway (GO:0034143),-0.8118689645436639,-1.63547911437378,0.05405405405405406,1.0,1.0,2/15,1.47%,RAB7B;F2RL1
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via STAT (GO:1904893),-0.9028987562296186,-1.6337581662206648,0.0,1.0,1.0,1/7,0.93%,PTPRT
prerank,GO_Biological_Process_2021__organic cyclic compound catabolic process (GO:1901361),-0.9677268992016049,-1.633590008286581,0.020833333333333332,0.9711942656461822,1.0,1/8,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__primary alcohol metabolic process (GO:0034308),-0.7849307943573283,-1.6335249497819242,0.030303030303030304,0.9403201186180556,1.0,4/21,4.77%,CYP1A2;RBP4;IGF1;CYP2D6
prerank,GO_Biological_Process_2021__positive regulation of striated muscle cell differentiation (GO:0051155),-0.7899260106724256,-1.6332474009529652,0.05714285714285714,0.9166614961945326,1.0,4/19,4.56%,NRG1;GREM1;IGF1;MAML1
prerank,GO_Biological_Process_2021__carboxylic acid metabolic process (GO:0019752),-0.7719248634367537,-1.6331503641822886,0.0,0.8897381604173803,1.0,3/27,3.19%,CYP1A2;ST3GAL1;CYB5A
prerank,GO_Biological_Process_2021__regulation of cell morphogenesis (GO:0022604),-0.6788398483281021,-1.6314530879762443,0.05405405405405406,0.880981735890949,1.0,5/30,6.60%,NTNG1;CLDN4;WTIP;PDPN;ZMYM6
prerank,GO_Biological_Process_2021__aflatoxin metabolic process (GO:0046222),-0.9449788521052737,-1.6299827200219383,0.0,0.8217416667315793,1.0,1/9,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__mycotoxin metabolic process (GO:0043385),-0.9449788521052737,-1.6299827200219383,0.0,0.8217416667315793,1.0,1/9,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__organic heteropentacyclic compound metabolic process (GO:1901376),-0.9449788521052737,-1.6299827200219383,0.0,0.8217416667315793,1.0,1/9,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0016339),-0.697224066052242,-1.6249518473514812,0.04,0.8438877680639617,1.0,6/29,10.92%,SELP;CDH13;CDH6;CDHR3;CDH20;PCDHB4
prerank,GO_Biological_Process_2021__stress fiber assembly (GO:0043149),-0.7936871892003423,-1.6245555299079653,0.034482758620689655,0.8059220919930401,1.0,5/15,11.68%,ITGB5;PDLIM1;KCTD13;FHDC1;PHACTR1
prerank,GO_Biological_Process_2021__contractile actin filament bundle assembly (GO:0030038),-0.7936871892003423,-1.6245555299079653,0.034482758620689655,0.8059220919930401,1.0,5/15,11.68%,ITGB5;PDLIM1;KCTD13;FHDC1;PHACTR1
prerank,GO_Biological_Process_2021__wound healing (GO:0042060),-0.6371785192803787,-1.6221640124749102,0.058823529411764705,0.805518129636095,1.0,11/50,11.83%,NRG1;AHNAK2;EREG;IGF1;CFLAR;TGFB2;FGF1;PDGFRA;DYSF;SCARB1;NOG
prerank,GO_Biological_Process_2021__white fat cell differentiation (GO:0050872),-0.9383561803813301,-1.6209567821765132,0.0,0.7950650408859651,1.0,1/6,0.17%,PER2
prerank,GO_Biological_Process_2021__snoRNA localization (GO:0048254),-0.9173875269220926,-1.6204180390901795,0.0,0.7805088421046884,1.0,1/6,3.71%,ZNHIT6
prerank,PanglaoDB_Augmented_2021__Hepatocytes,-0.5994921715904984,-1.620337003357762,0.0,0.7643717897584744,1.0,6/105,2.43%,CYP1A2;F11;PAH;FGFR4;RND3;RBP4
prerank,GO_Biological_Process_2021__protein dephosphorylation (GO:0006470),-0.6041633872283498,-1.6180566204576428,0.0,0.7630476475130141,1.0,26/127,14.55%,DUSP4;DUSP5;UBASH3B;PTPN3;PTPRT;EYA4;PTPRB;PTPN9;CDC14B;PPP2R3B;DUSP2;PPEF1;PTPRH;PPM1G;DUSP12;PGP;TIMM50;PTPRS;DUSP10;PPP1CA;PPP2R1B;PTPRO;DUSP6;PPM1M;PTPN1;SSH1
prerank,GO_Biological_Process_2021__regulation of granulocyte differentiation (GO:0030852),-0.9099708079612137,-1.6178453035801859,0.0,0.7486046541849004,1.0,2/7,1.60%,LEF1;RUNX1
prerank,GO_Biological_Process_2021__protein destabilization (GO:0031648),0.7975353867653208,1.6145493822622403,0.0,1.0,0.98,1/30,0.02%,SERF1A
prerank,GO_Biological_Process_2021__glucan biosynthetic process (GO:0009250),-0.9045987452859618,-1.6138282630093057,0.0,0.7411993004629185,1.0,1/11,0.17%,PER2
prerank,GO_Biological_Process_2021__glycogen biosynthetic process (GO:0005978),-0.9045987452859618,-1.6138282630093057,0.0,0.7411993004629185,1.0,1/11,0.17%,PER2
prerank,GO_Biological_Process_2021__basement membrane assembly (GO:0070831),-0.9274330866233369,-1.6134687958199536,0.023255813953488372,0.7277987891605228,1.0,3/8,3.47%,LAMB2;LAMB3;NTNG1
prerank,GO_Biological_Process_2021__steroid metabolic process (GO:0008202),-0.7261149464528072,-1.612698708601784,0.03571428571428571,0.7169076973986187,1.0,1/57,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__ERK1 and ERK2 cascade (GO:0070371),-0.7678106671799669,-1.6088963499434539,0.0,0.7307657128457002,1.0,3/17,7.04%,KDR;IGF1;APOA1
prerank,GO_Biological_Process_2021__inositol phosphate-mediated signaling (GO:0048016),-0.8226089120118008,-1.608353773866933,0.0,0.720778595610472,1.0,2/15,2.89%,HRH1;NFATC1
prerank,GO_Biological_Process_2021__medium-chain fatty acid catabolic process (GO:0051793),-0.9708419740314914,-1.605370108598427,0.0196078431372549,0.7260619287493709,1.0,2/5,0.90%,GLYATL2;ABHD1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell differentiation (GO:1905063),-0.9014508064194718,-1.5992005364687611,0.02702702702702703,0.7569917138025933,1.0,2/7,2.89%,KIT;NFATC1
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell differentiation (GO:0051152),-0.8988403332877967,-1.5927693589043925,0.058823529411764705,0.7955104896597837,1.0,2/5,6.55%,KIT;OLFM2
prerank,GO_Biological_Process_2021__ERBB2 signaling pathway (GO:0038128),-0.6668528676966359,-1.588692312043496,0.02702702702702703,0.8132719967610447,1.0,3/28,3.11%,NRG1;BTC;EREG
prerank,GO_Biological_Process_2021__protein side chain deglutamylation (GO:0035610),-0.9181532324733829,-1.585107137212385,0.022727272727272728,0.8284319481360503,1.0,1/5,3.77%,AGBL1
prerank,GO_Biological_Process_2021__axonal fasciculation (GO:0007413),-0.7977077048376932,-1.5804312585860854,0.02631578947368421,0.8581369681188804,1.0,3/12,3.29%,EPHA3;EPHB2;AMIGO1
prerank,GO_Biological_Process_2021__prostaglandin biosynthetic process (GO:0001516),0.8355675859042616,1.5752681423187347,0.031746031746031744,1.0,1.0,3/15,2.65%,PTGES;PTGIS;HPGDS
prerank,GO_Biological_Process_2021__DNA dealkylation (GO:0035510),-0.8549365775451614,-1.574765615144236,0.0,0.8793372366506192,1.0,3/10,4.77%,ALKBH2;ALKBH3;MGMT
prerank,GO_Biological_Process_2021__DNA dealkylation involved in DNA repair (GO:0006307),-0.8549365775451614,-1.574765615144236,0.0,0.8793372366506192,1.0,3/10,4.77%,ALKBH2;ALKBH3;MGMT
prerank,GO_Biological_Process_2021__cellular amide metabolic process (GO:0043603),-0.5959008679552427,-1.5728139642774785,0.0,0.8804040429493812,1.0,13/90,9.50%,PM20D1;CPXM2;ST3GAL1;MLYCD;ACOT1;SLC19A1;MTHFD2;ACOT11;DHFR;ACOT8;MTHFS;SMPD3;MME
prerank,GO_Biological_Process_2021__regulation of vascular endothelial cell proliferation (GO:1905562),-0.7543833389399437,-1.569504791400162,0.029411764705882353,0.8962141942921603,1.0,3/16,5.51%,ITGA4;APLN;COL4A3
prerank,GO_Biological_Process_2021__regulation of leukocyte tethering or rolling (GO:1903236),-0.9856218020999681,-1.5683729232540415,0.0,0.8913857106767088,1.0,2/5,0.60%,CCL28;SELP
prerank,GO_Biological_Process_2021__regulation of complement activation (GO:0030449),0.7228101882080307,1.5677646783062873,0.0,1.0,1.0,2/27,0.23%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__epithelial cell-cell adhesion (GO:0090136),-0.876671912316793,-1.5662963563370371,0.04878048780487805,0.8948571982312316,1.0,3/11,6.07%,ITGB5;KIT;SERPINB8
prerank,GO_Biological_Process_2021__positive regulation of signaling receptor activity (GO:2000273),-0.6703358277124494,-1.564840698767384,0.0,0.894752158101183,1.0,7/25,11.13%,BTC;GREM1;EPHB2;EREG;HDAC1;TAF1;NRP1
prerank,GO_Biological_Process_2021__prostanoid biosynthetic process (GO:0046457),0.857614163894032,1.564634811497167,0.01639344262295082,1.0,1.0,2/11,1.29%,PTGES;PTGIS
prerank,GO_Biological_Process_2021__positive regulation of granulocyte differentiation (GO:0030854),-0.9124352730242742,-1.562563404852834,0.0,0.9010574409027671,1.0,2/5,1.60%,LEF1;RUNX1
prerank,GO_Biological_Process_2021__intermediate filament organization (GO:0045109),-0.8157556042001363,-1.562545947269114,0.058823529411764705,0.8878192060799533,1.0,2/12,0.68%,TCHH;PKP2
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell periphery (GO:1904377),-0.6480866753827713,-1.561615867833495,0.08571428571428572,0.881603605351578,1.0,7/45,7.58%,STAC;EPHA3;PTPN9;EPHB2;ZDHHC5;NUMA1;RANGRF
prerank,GO_Biological_Process_2021__actin cytoskeleton reorganization (GO:0031532),-0.6512862643755107,-1.5589313803344644,0.0,0.8912981596967445,1.0,8/51,12.57%,NRK;KIT;EFS;CDC42BPB;NRP1;PHACTR1;PARVA;THSD7A
prerank,GO_Biological_Process_2021__response to muscle stretch (GO:0035994),0.8703747516684852,1.5557385489873976,0.015384615384615385,1.0,1.0,2/13,1.71%,CSRP3;CAV3
prerank,GO_Biological_Process_2021__regulation of immune effector process (GO:0002697),0.72145030211347,1.5548669732397344,0.0,1.0,1.0,2/28,0.23%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__negative regulation of endocytosis (GO:0045806),-0.7476945076066194,-1.5544279848160951,0.0625,0.9158182708187512,1.0,2/17,7.05%,EPHA3;MCTP1
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication (GO:0090329),0.8829914102752715,1.5535411568844961,0.03125,1.0,1.0,2/10,2.48%,TICRR;GMNN
prerank,GO_Biological_Process_2021__regulation of lens fiber cell differentiation (GO:1902746),-0.9626093048751795,-1.5530657664258627,0.045454545454545456,0.9154268809449388,1.0,3/6,0.88%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__medium-chain fatty acid metabolic process (GO:0051791),-0.8962371582038668,-1.5523749089085392,0.0,0.9089773777203726,1.0,4/11,8.04%,GLYATL2;ABHD1;CYP4Z1;CROT
prerank,GO_Biological_Process_2021__regulation of long-term synaptic depression (GO:1900452),0.8928181414035324,1.551966782876052,0.0,1.0,1.0,1/8,1.74%,AGER
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion involved in gastrulation (GO:0070587),-0.8868949614516346,-1.5501657616660405,0.02564102564102564,0.9047920530771909,1.0,2/6,7.26%,APOA1;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of heterotypic cell-cell adhesion (GO:0034115),-0.8868949614516346,-1.5501657616660405,0.02564102564102564,0.9047920530771909,1.0,2/6,7.26%,APOA1;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of DNA binding (GO:0043392),-0.7244286916826415,-1.5490904755627986,0.0,0.902125297552332,1.0,5/23,9.95%,PER2;LEF1;TFAP4;HMGA2;IFI16
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell differentiation (GO:0030857),-0.9284983715963107,-1.5457499415275857,0.0,0.9184466433962062,1.0,3/8,0.88%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__epithelial cell morphogenesis (GO:0003382),-0.7636302552971719,-1.545249381563411,0.05555555555555555,0.9105461099888998,1.0,4/13,12.85%,COL15A1;SIPA1L3;COL18A1;RILPL1
prerank,GO_Biological_Process_2021__membrane lipid catabolic process (GO:0046466),0.906135479920171,1.5444550019257979,0.0,1.0,1.0,2/8,4.87%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__bone cell development (GO:0098751),-0.9049038519298713,-1.5401076327119976,0.0,0.9451352776840335,1.0,2/8,7.25%,KIT;FOXP1
prerank,GO_Biological_Process_2021__retinol metabolic process (GO:0042572),-0.8140846462039518,-1.5397044489239602,0.024390243902439025,0.9358479402021321,1.0,2/12,2.43%,CYP1A2;RBP4
prerank,GO_Biological_Process_2021__negative regulation of bone mineralization (GO:0030502),-0.7973574184286771,-1.5391334951780218,0.027777777777777776,0.9287309459762385,1.0,2/9,3.63%,GREM1;SRGN
prerank,GO_Biological_Process_2021__regulation of cell development (GO:0060284),-0.7110814115346599,-1.538931249092732,0.03225806451612903,0.919353384831977,1.0,2/27,2.83%,PER2;ASCL1
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium morphogenesis (GO:2000394),0.9739294073555316,1.5387738004196487,0.0,1.0,1.0,2/7,1.75%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__rRNA base methylation (GO:0070475),-0.9324343246248142,-1.5383336762321718,0.05,0.9134706233218544,1.0,1/6,1.48%,BUD23
prerank,GO_Biological_Process_2021__regulation of fibrinolysis (GO:0051917),-0.9058423719430854,-1.536959211459235,0.025,0.912824449236405,1.0,1/8,0.09%,F11
prerank,GO_Biological_Process_2021__positive regulation of Rho protein signal transduction (GO:0035025),-0.7127847595307777,-1.5363919987920138,0.034482758620689655,0.906823866810417,1.0,5/23,7.04%,P2RY10;PRAG1;F2RL1;RTN4R;APOA1
prerank,GO_Biological_Process_2021__mRNA methylation (GO:0080009),-0.757868665630793,-1.5324168677673244,0.0,0.9321408635186869,1.0,3/15,11.29%,METTL8;TRMT10C;TRMT61A
prerank,GO_Biological_Process_2021__regulation of voltage-gated calcium channel activity (GO:1901385),-0.7354324661347138,-1.5310048051483025,0.02857142857142857,0.9314640381522351,1.0,3/20,4.99%,STAC;CBARP;DRD4
prerank,GO_Biological_Process_2021__detection of muscle stretch (GO:0035995),0.9194112999898694,1.5292151423024871,0.0,1.0,1.0,2/7,1.71%,CSRP3;CAV3
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 9 signaling pathway (GO:0034163),-0.8492260271467361,-1.5288256394550122,0.06666666666666667,0.9387417338394775,1.0,3/8,10.87%,RAB7B;GRAMD4;PTPRS
prerank,GO_Biological_Process_2021__regulation of tau-protein kinase activity (GO:1902947),-0.8557610936041175,-1.528531749556116,0.05263157894736842,0.930476891598277,1.0,3/8,11.39%,C5AR1;SORL1;CLU
prerank,GO_Biological_Process_2021__negative regulation of lipid catabolic process (GO:0050995),-0.8134517886978156,-1.5279944848712472,0.10526315789473684,0.9250902147126352,1.0,4/10,10.04%,ALK;PLIN5;CIDEA;SORL1
prerank,GO_Biological_Process_2021__negative regulation of supramolecular fiber organization (GO:1902904),-0.6104120904679975,-1.5276082258453738,0.0,0.9173173381534736,1.0,1/66,0.03%,PLEKHH2
prerank,GO_Biological_Process_2021__regulation of epithelial cell differentiation (GO:0030856),0.9049958531488572,1.5256863983389448,0.014084507042253521,1.0,1.0,1/11,0.28%,APOLD1
prerank,GO_Biological_Process_2021__peptidyl-threonine dephosphorylation (GO:0035970),-0.729566785251774,-1.5247860106946327,0.09375,0.931865691977134,1.0,3/20,3.69%,DUSP4;DUSP5;DUSP2
prerank,GO_Biological_Process_2021__cellular nitrogen compound biosynthetic process (GO:0044271),-0.7004394826383875,-1.5223690480095253,0.0,0.9405820655016585,1.0,5/27,9.46%,PM20D1;GCH1;SPHK2;SPTLC1;GCHFR
prerank,GO_Biological_Process_2021__regulation of DNA-templated transcription in response to stress (GO:0043620),-0.8664066971684138,-1.5222420769057667,0.02,0.9318323806034503,1.0,3/8,8.24%,RGS14;TCIM;INO80
prerank,GO_Biological_Process_2021__tetrahydrofolate metabolic process (GO:0046653),-0.8033694432142147,-1.5216210847235017,0.06382978723404255,0.9259680372981464,1.0,7/11,15.78%,TYMS;MTHFD2;DHFR;MTHFS;MTHFD2L;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__cellular response to osmotic stress (GO:0071470),0.8344829041597313,1.5210474505443536,0.03636363636363636,1.0,1.0,4/16,10.02%,MYLK;RCSD1;YBX3;LRRC8D
prerank,GO_Biological_Process_2021__medium-chain fatty acid biosynthetic process (GO:0051792),-0.9635440860487733,-1.5167983327837289,0.02564102564102564,0.9599918873624321,1.0,1/5,0.90%,ABHD1
prerank,GO_Biological_Process_2021__aorta development (GO:0035904),0.8326466743939022,1.5147065679046683,0.014084507042253521,1.0,1.0,3/11,8.52%,PDGFRB;ADAMTS9;TBX1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-mediated signaling (GO:0106058),-0.8863050991734519,-1.5143180390759015,0.0,0.9590893949493219,1.0,2/8,3.96%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__positive regulation of calcineurin-NFAT signaling cascade (GO:0070886),-0.8863050991734519,-1.5143180390759015,0.0,0.9590893949493219,1.0,2/8,3.96%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__catecholamine biosynthetic process (GO:0042423),-0.8462568098295657,-1.5141749560189401,0.0,0.9503096047398368,1.0,3/7,5.75%,PAH;GCH1;TGFB2
prerank,GO_Biological_Process_2021__cellular response to histamine (GO:0071420),-0.9521537896373795,-1.5132925247631503,0.0,0.9476871812670963,1.0,1/6,1.00%,HRH1
prerank,GO_Biological_Process_2021__regulation of humoral immune response (GO:0002920),0.7083274183341592,1.5128462120936566,0.0,1.0,1.0,2/29,0.23%,C3AR1;C4BPB
prerank,GO_Biological_Process_2021__organophosphate ester transport (GO:0015748),-0.7042856336281367,-1.5126361009960754,0.07407407407407407,0.9437076354863847,1.0,6/23,12.08%,PRELID2;TRIAP1;PITPNC1;SCARB1;PITPNM1;PITPNA
prerank,GO_Biological_Process_2021__positive regulation of dendrite development (GO:1900006),-0.8419713231971966,-1.512232994210953,0.09090909090909091,0.937015663330191,1.0,5/9,10.64%,ALK;BMP7;VLDLR;LRP8;COBL
prerank,GO_Biological_Process_2021__aorta morphogenesis (GO:0035909),0.8746254644601792,1.5117617263557694,0.0,1.0,1.0,4/12,8.52%,MYLK;PDGFRB;ADAMTS9;TBX1
prerank,GO_Biological_Process_2021__cell-cell adhesion via plasma-membrane adhesion molecules (GO:0098742),-0.5228010095474064,-1.5113437931831717,0.045454545454545456,0.9365354077071314,1.0,23/128,10.92%,GPC4;SELP;PTPRT;IGSF11;CDH13;CDH26;CDH6;AMIGO1;NTNG1;CNTN6;CLDN4;SDK1;LRFN4;TGFB2;DSCAML1;CDHR3;TENM4;FGFRL1;ADGRL1;CDH20;CDH1;PTPRS;PCDHB4
prerank,GO_Biological_Process_2021__positive regulation of signaling (GO:0023056),-0.681454888831152,-1.5111740480161142,0.0,0.927990237060431,1.0,7/30,7.50%,NMB;CLSTN2;HCRT;PTPN23;ECE1;NMU;KCTD13
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated calcium channel activity (GO:1901387),-0.914227416278326,-1.5106284674329313,0.0,0.9236754661687413,1.0,2/7,2.68%,STAC;CACNA2D1
prerank,GO_Biological_Process_2021__sphingolipid catabolic process (GO:0030149),0.8146798703983493,1.5106022127525924,0.014084507042253521,1.0,1.0,1/15,0.36%,ENPP2
prerank,GO_Biological_Process_2021__regulation of steroid biosynthetic process (GO:0050810),-0.8299272349313851,-1.5105977781797997,0.027777777777777776,0.9154155363109152,1.0,3/10,9.78%,FGFR4;NR1H4;AKR1C3
prerank,GO_Biological_Process_2021__response to organophosphorus (GO:0046683),-0.7646953039257159,-1.5102894698719738,0.08888888888888889,0.9082423028128578,1.0,3/14,5.43%,TRPC3;TYMS;VGF
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte migration (GO:2000403),0.9239232174548857,1.5100482397586483,0.0,1.0,1.0,2/7,5.30%,CCL5;DOCK8
prerank,GO_Biological_Process_2021__maintenance of blood-brain barrier (GO:0035633),0.7750516413551256,1.5088603668703713,0.016129032258064516,1.0,1.0,3/24,8.64%,LAMA2;TJP3;F11R
prerank,GO_Biological_Process_2021__positive regulation of miRNA metabolic process (GO:2000630),-0.7892035054365423,-1.5075946253542367,0.0625,0.9220173711402994,1.0,2/6,15.85%,LIN28B;PNPT1
prerank,GO_Biological_Process_2021__megakaryocyte development (GO:0035855),-0.9825171322762201,-1.507527933155689,0.0,0.9145242997611674,1.0,1/5,0.36%,KIT
prerank,GO_Biological_Process_2021__monovalent inorganic anion homeostasis (GO:0055083),0.9002425796036453,1.506856994949607,0.0,1.0,1.0,2/10,0.63%,CA12;SLC12A7
prerank,GO_Biological_Process_2021__chloride ion homeostasis (GO:0055064),0.9002425796036453,1.506856994949607,0.0,1.0,1.0,2/10,0.63%,CA12;SLC12A7
prerank,GO_Biological_Process_2021__negative regulation of transport (GO:0051051),-0.6318535249342757,-1.5066309775122966,0.027777777777777776,0.9128587264079573,1.0,5/39,9.91%,NRG1;EPHA3;MCTP1;RAB7A;DYSF
prerank,GO_Biological_Process_2021__rRNA methylation (GO:0031167),-0.7167523777051079,-1.5062690154396325,0.0625,0.9075072950661384,1.0,3/19,6.64%,BUD23;MTERF4;FBLL1
prerank,GO_Biological_Process_2021__cyclooxygenase pathway (GO:0019371),0.8883182489953351,1.505965703741871,0.015384615384615385,1.0,1.0,3/9,2.65%,PTGES;PTGIS;HPGDS
prerank,GO_Biological_Process_2021__glycerolipid metabolic process (GO:0046486),-0.8070146989661104,-1.5051033648932355,0.06060606060606061,0.9064429017354371,1.0,3/10,9.68%,DGKB;GAL3ST1;PGP
prerank,GO_Biological_Process_2021__neurotransmitter receptor diffusion trapping (GO:0099628),-0.855029576334394,-1.504984428052797,0.024390243902439025,0.8911481091971598,1.0,3/8,3.25%,CACNG4;CACNG5;CACNG3
prerank,GO_Biological_Process_2021__postsynaptic neurotransmitter receptor diffusion trapping (GO:0098970),-0.855029576334394,-1.504984428052797,0.024390243902439025,0.8911481091971598,1.0,3/8,3.25%,CACNG4;CACNG5;CACNG3
prerank,GO_Biological_Process_2021__histone H3 deacetylation (GO:0070932),-0.7668982052919506,-1.5049323795989473,0.0625,0.8834546670794149,1.0,2/14,5.87%,PER2;HDAC1
prerank,GO_Biological_Process_2021__macromolecule modification (GO:0043412),-0.8255417324162422,-1.5038887627996447,0.027777777777777776,0.8837395917598251,1.0,2/8,10.06%,ST3GAL1;ST3GAL2
prerank,GO_Biological_Process_2021__nucleobase-containing compound biosynthetic process (GO:0034654),-0.7388073150016732,-1.503869541993764,0.13157894736842105,0.8762426617254666,1.0,8/16,14.18%,APRT;TYMS;GMPR;PNP;POLL;POLD3;ADA;ADK
prerank,GO_Biological_Process_2021__left/right pattern formation (GO:0060972),-0.9620459124967843,-1.5035341171032237,0.0,0.8722472161163037,1.0,1/6,0.40%,PKD1L1
prerank,GO_Biological_Process_2021__vascular associated smooth muscle contraction (GO:0014829),0.9279964599475493,1.502446829002381,0.0,1.0,1.0,1/6,2.82%,ACTA2
prerank,GO_Biological_Process_2021__endoderm formation (GO:0001706),-0.6535453502455101,-1.5018881964472057,0.0625,0.8764424401670363,1.0,6/27,3.69%,DUSP4;ITGB5;DUSP5;ITGA4;LAMB3;DUSP2
prerank,GO_Biological_Process_2021__positive regulation of pseudopodium assembly (GO:0031274),-0.8498581098059265,-1.501703233129811,0.07317073170731707,0.8628922442473215,1.0,1/7,1.47%,F2RL1
prerank,GO_Biological_Process_2021__regulation of pseudopodium assembly (GO:0031272),-0.8498581098059265,-1.501703233129811,0.07317073170731707,0.8628922442473215,1.0,1/7,1.47%,F2RL1
prerank,GO_Biological_Process_2021__regulation of calcineurin-NFAT signaling cascade (GO:0070884),-0.7289690657781213,-1.5015790637905595,0.027777777777777776,0.8568093444598917,1.0,4/18,3.96%,LMCD1;HOMER2;FHL2;IGF1
prerank,GO_Biological_Process_2021__regulation of sarcomere organization (GO:0060297),0.9608369574186765,1.5010154853051323,0.0,1.0,1.0,1/5,1.71%,CAV3
prerank,GO_Biological_Process_2021__synaptic vesicle docking (GO:0016081),-0.8339168105301082,-1.4981044777705879,0.04878048780487805,0.8792486570662457,1.0,2/6,3.08%,UNC13B;UNC13C
prerank,GO_Biological_Process_2021__endoderm development (GO:0007492),-0.9537585148948504,-1.4971725414961197,0.0,0.8770280617591457,1.0,3/7,3.69%,DUSP4;DUSP5;DUSP2
prerank,GO_Biological_Process_2021__estrogen metabolic process (GO:0008210),-0.7952602585217993,-1.4969713491458272,0.06818181818181818,0.8714330306245182,1.0,1/14,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of dendrite morphogenesis (GO:0050775),-0.6788025931419414,-1.496592108673213,0.05714285714285714,0.8663785826368207,1.0,5/18,20.54%,FBXW8;LRP8;RELN;DBNL;CUX1
prerank,GO_Biological_Process_2021__late endosome to Golgi transport (GO:0034499),-0.919745523166503,-1.4948268621132528,0.029411764705882353,0.8720320801612632,1.0,1/5,0.33%,RAB7B
prerank,GO_Biological_Process_2021__hypotonic response (GO:0006971),0.9857894868458953,1.494119612807902,0.015873015873015872,1.0,1.0,1/5,0.75%,MYLK
prerank,GO_Biological_Process_2021__cellular response to angiotensin (GO:1904385),-0.8824974521976069,-1.4918900989123982,0.07317073170731707,0.8860317729281821,1.0,3/7,9.75%,CA2;PRKCD;SLC30A10
prerank,GO_Biological_Process_2021__regulation of platelet activation (GO:0010543),-0.7964967672570251,-1.491524512222223,0.07894736842105263,0.8812019813249219,1.0,2/16,0.85%,SELP;CELA2A
prerank,GO_Biological_Process_2021__regulation of coagulation (GO:0050818),-0.8283007417794792,-1.4905647156964705,0.02631578947368421,0.8823475990473691,1.0,3/7,7.75%,F2RL1;EPHB2;HS3ST5
prerank,GO_Biological_Process_2021__branching involved in ureteric bud morphogenesis (GO:0001658),-0.8733729086985422,-1.4891505856261606,0.023255813953488372,0.8869453045646726,1.0,2/8,5.79%,NPNT;FGF1
prerank,GO_Biological_Process_2021__positive regulation of cation channel activity (GO:2001259),-0.6974311822632061,-1.4885530513941216,0.0,0.8841559601607241,1.0,3/28,3.58%,STAC;EPHB2;LRRC55
prerank,GO_Biological_Process_2021__negative regulation of hematopoietic progenitor cell differentiation (GO:1901533),-0.8922902140399038,-1.4872380451065519,0.1,0.8862142334738164,1.0,1/5,0.81%,MYB
prerank,GO_Biological_Process_2021__response to cadmium ion (GO:0046686),-0.6804236705129257,-1.4868554544788588,0.10344827586206896,0.8829424170475184,1.0,5/19,14.83%,MT1E;FOS;AKR1C3;EGFR;HSF1
prerank,GO_Biological_Process_2021__positive regulation of Ras protein signal transduction (GO:0046579),-0.6229290922440727,-1.4867429587319734,0.05,0.8774052130228545,1.0,9/51,7.57%,P2RY10;PRAG1;F2RL1;IGF1;RASGRF1;RASGRP1;RTN4R;APOA1;MMD2
prerank,GO_Biological_Process_2021__ureteric bud morphogenesis (GO:0060675),-0.9104379316123948,-1.486649153429302,0.0,0.8719500416504078,1.0,1/7,0.67%,NPNT
prerank,GO_Biological_Process_2021__cell differentiation in spinal cord (GO:0021515),-0.8460011581399721,-1.485306611043353,0.05555555555555555,0.8756958454756033,1.0,2/7,0.92%,MDGA1;SOX13
prerank,GO_Biological_Process_2021__arachidonic acid metabolic process (GO:0019369),-0.6555718027238553,-1.4852547712717883,0.05714285714285714,0.8697154585093364,1.0,1/34,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of bile acid biosynthetic process (GO:0070857),-0.7704940343285918,-1.4847910018635564,0.03333333333333333,0.866375314066902,1.0,2/7,7.93%,FGFR4;NR1H4
prerank,GO_Biological_Process_2021__phagosome-lysosome fusion (GO:0090385),-0.8537992648314593,-1.4846176224400456,0.05405405405405406,0.8625761894087383,1.0,2/8,7.58%,RAB7B;RAB7A
prerank,GO_Biological_Process_2021__striated muscle cell differentiation (GO:0051146),-0.7828647008996895,-1.4843879713317243,0.02702702702702703,0.857723818063428,1.0,1/15,0.71%,NRG1
prerank,GO_Biological_Process_2021__alkaloid metabolic process (GO:0009820),-0.9717904407263191,-1.4833090530864657,0.0,0.858438600408009,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__positive regulation of neuron projection development (GO:0010976),-0.5321095542986971,-1.4832939830027378,0.0,0.8524925236993206,1.0,16/80,13.92%,ALK;ROR2;BMP7;EPHA3;ITGA6;ARSB;TOX;VLDLR;LRP8;COBL;APOE;STMN2;MDK;PLPPR5;P3H1;GPC2
prerank,MSigDB_Hallmark_2020__Xenobiotic Metabolism,-0.5299451459134293,-1.4823417161966412,0.0,0.8532338915661041,1.0,13/160,5.01%,CYP1A2;F11;PAPSS2;CA2;IL1R1;RBP4;ATOH8;PROS1;CYB5A;IGF1;SLC35B1;GCH1;ALAS1
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception of sound (GO:0050910),-0.80355882359752,-1.4809847172673876,0.10810810810810811,0.8566079078646329,1.0,2/9,8.02%,KIT;COL11A1
prerank,GO_Biological_Process_2021__postsynaptic membrane organization (GO:0001941),0.7887458770537562,1.480317215369001,0.04838709677419355,1.0,1.0,2/19,1.26%,LRP4;CHRNB1
prerank,GO_Biological_Process_2021__negative regulation of lens fiber cell differentiation (GO:1902747),-0.9626385221085825,-1.4800717243702193,0.02040816326530612,0.8565329737859478,1.0,3/5,0.88%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__positive regulation of cell communication (GO:0010647),-0.7286222269409723,-1.4792563037969564,0.0,0.8571348878071064,1.0,6/23,7.50%,NMB;CLSTN2;HCRT;PTPN23;NMU;KCTD13
prerank,GO_Biological_Process_2021__regulation of plasminogen activation (GO:0010755),-0.7993641085756611,-1.4789115832591444,0.07894736842105263,0.8530300432637695,1.0,3/10,7.08%,MELTF;RUNX1;SERPINF2
prerank,GO_Biological_Process_2021__sequestering of extracellular ligand from receptor (GO:0035581),-0.7769944927032999,-1.4784054071690105,0.04878048780487805,0.8501235648175797,1.0,5/11,13.46%,LTBP1;GREM1;CHRDL1;NOG;NBL1
prerank,GO_Biological_Process_2021__tetrahydrobiopterin metabolic process (GO:0046146),-0.8053710259098481,-1.478315401733834,0.05,0.8450802519961179,1.0,5/10,12.71%,PRKG2;GCH1;DHFR;GCHFR;PTS
prerank,GO_Biological_Process_2021__neurotransmitter biosynthetic process (GO:0042136),-0.8778426255690435,-1.4772444800746345,0.0,0.8451786381443409,1.0,3/9,7.90%,PAH;SLC22A2;SLC6A4
prerank,GO_Biological_Process_2021__error-prone translesion synthesis (GO:0042276),0.7787560969023635,1.477201143820011,0.0,1.0,1.0,4/21,13.59%,RFC5;POLE2;PCNA;RPA3
prerank,GO_Biological_Process_2021__regulation of AMPA receptor activity (GO:2000311),-0.7155153161284634,-1.475199340499491,0.025,0.8541438816849997,1.0,9/23,16.42%,CACNG4;CACNG5;CACNG3;GSG1L;SHANK1;CNIH3;CNIH2;NLGN3;RELN
prerank,GO_Biological_Process_2021__sensory perception of pain (GO:0019233),0.7972078093287798,1.4743833175884271,0.0,1.0,1.0,4/15,5.47%,PTGES;TRPA1;OPRK1;SCN9A
prerank,GO_Biological_Process_2021__ureteric bud development (GO:0001657),-0.8392930366842863,-1.473680224761003,0.023809523809523808,0.8621565472187529,1.0,2/9,0.88%,NPNT;BMP7
prerank,GO_Biological_Process_2021__phosphatidylcholine catabolic process (GO:0034638),0.9343874222502414,1.4732944935039958,0.01818181818181818,1.0,1.0,3/8,3.22%,ENPP2;PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__epoxygenase P450 pathway (GO:0019373),-0.95999379886547,-1.4723966621481959,0.0,0.8661029332403464,1.0,1/6,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__amide biosynthetic process (GO:0043604),-0.6422214376671751,-1.4718691120426874,0.03225806451612903,0.8633163358881487,1.0,2/44,2.90%,PM20D1;SPTSSB
prerank,GO_Biological_Process_2021__positive regulation of triglyceride metabolic process (GO:0090208),-0.7137584763483317,-1.4707359481903117,0.04,0.8667496180414591,1.0,5/14,18.50%,PLIN5;APOA1;SCARB1;PNPLA2;NR1H2
prerank,GO_Biological_Process_2021__dopamine uptake (GO:0090494),-0.8592485284823375,-1.4704852248136566,0.13953488372093023,0.8635428153753641,1.0,5/6,12.86%,SLC22A2;SLC29A4;SLC22A3;SLC6A2;SLC22A1
prerank,GO_Biological_Process_2021__positive regulation by host of viral transcription (GO:0043923),-0.7754157116390533,-1.4702122266707158,0.08571428571428572,0.8589403584477666,1.0,5/16,9.54%,LEF1;RRP1B;TFAP4;TAF11;SMARCA4
prerank,GO_Biological_Process_2021__mesonephros development (GO:0001823),-0.9110438771093279,-1.46956877706586,0.05,0.8581431207630419,1.0,2/5,5.79%,BMP7;FGF1
prerank,GO_Biological_Process_2021__histone deacetylation (GO:0016575),-0.5872413846768137,-1.4662476932826771,0.0,0.8747317522551944,1.0,5/44,5.87%,PER2;TBL1Y;PRDM5;HDAC5;HDAC1
prerank,GO_Biological_Process_2021__blood vessel diameter maintenance (GO:0097746),-0.6839510736140624,-1.4659692495633014,0.06060606060606061,0.8712028386225595,1.0,5/26,7.24%,PER2;F2RL1;ECE1;SERPINF2;ACE2
prerank,GO_Biological_Process_2021__positive regulation of DNA-dependent DNA replication (GO:2000105),-0.8549945854079439,-1.465624166734808,0.06521739130434782,0.8679804153662478,1.0,3/9,8.39%,DBF4B;INO80;WIZ
prerank,GO_Biological_Process_2021__regulation of lamellipodium morphogenesis (GO:2000392),0.8911795469880354,1.4651067822029056,0.03076923076923077,1.0,1.0,2/10,1.75%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__forebrain neuron differentiation (GO:0021879),0.9125955629628955,1.4629283027466287,0.015384615384615385,1.0,1.0,1/7,4.82%,INHBA
prerank,GO_Biological_Process_2021__glycerol ether biosynthetic process (GO:0046504),-0.9040217395304294,-1.4607130625410274,0.07317073170731707,0.8945153448889303,1.0,1/5,1.59%,PEX7
prerank,GO_Biological_Process_2021__cellular lipid biosynthetic process (GO:0097384),-0.9040217395304294,-1.4607130625410274,0.07317073170731707,0.8945153448889303,1.0,1/5,1.59%,PEX7
prerank,GO_Biological_Process_2021__renal filtration (GO:0097205),-0.8449629874457172,-1.4601270170359226,0.023255813953488372,0.8931865560369505,1.0,1/8,0.95%,SULF2
prerank,GO_Biological_Process_2021__postsynaptic membrane assembly (GO:0097104),0.8498586857072191,1.4599212971068396,0.014492753623188406,1.0,1.0,1/9,0.45%,LRP4
prerank,GO_Biological_Process_2021__positive regulation of protein localization to plasma membrane (GO:1903078),-0.6526203890707957,-1.4597523363179787,0.037037037037037035,0.8909341598648929,1.0,6/45,7.58%,STAC;EPHA3;PTPN9;EPHB2;ZDHHC5;RANGRF
prerank,GO_Biological_Process_2021__leukocyte tethering or rolling (GO:0050901),-0.8075138813904396,-1.457099996818466,0.08333333333333333,0.905097284131241,1.0,2/12,1.19%,SELP;ITGA4
prerank,GO_Biological_Process_2021__chondrocyte development (GO:0002063),-0.917747536333662,-1.4566668471188025,0.0975609756097561,0.9031381627816196,1.0,1/6,0.95%,SULF2
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by integrin (GO:0033631),-0.9514985080427174,-1.4563440053002736,0.0,0.8992725947884945,1.0,2/5,1.19%,NPNT;ITGA4
prerank,GO_Biological_Process_2021__posttranslational protein targeting to endoplasmic reticulum membrane (GO:0006620),0.8300851021387378,1.4562200292433933,0.03508771929824561,1.0,1.0,2/11,7.54%,CHMP4B;HSPA5
prerank,GO_Biological_Process_2021__regulation of triglyceride catabolic process (GO:0010896),-0.822349083043133,-1.4562019790864968,0.05128205128205128,0.8949523338328884,1.0,4/7,14.45%,PLIN5;APOA1;SORL1;PNPLA2
prerank,GO_Biological_Process_2021__positive regulation of vasculogenesis (GO:2001214),-0.8702585917163292,-1.4555461122607993,0.07894736842105263,0.8937507888158626,1.0,2/7,6.17%,KDR;RIN2
prerank,GO_Biological_Process_2021__regulation of striated muscle cell differentiation (GO:0051153),-0.85582443380528,-1.4555086489622133,0.04878048780487805,0.8887714691346164,1.0,2/6,3.60%,NRG1;HDAC5
prerank,GO_Biological_Process_2021__positive regulation of mononuclear cell migration (GO:0071677),0.7373709380804536,1.4554912331125789,0.1016949152542373,1.0,1.0,3/17,3.22%,AGER;CCL5;PLA2G7
prerank,GO_Biological_Process_2021__muscle tissue morphogenesis (GO:0060415),0.8488429876068395,1.455066275434693,0.030303030303030304,1.0,1.0,5/11,8.52%,MYLK;NOTCH1;ZFPM1;ACTC1;TBX1
prerank,GO_Biological_Process_2021__embryonic appendage morphogenesis (GO:0035113),-0.7877327000290549,-1.4537544539891418,0.18181818181818182,0.8968803830316788,1.0,3/9,8.78%,TGFB2;PTCH1;MYH3
prerank,GO_Biological_Process_2021__response to angiotensin (GO:1990776),-0.8726367314440299,-1.453038764666676,0.06818181818181818,0.8957700073419739,1.0,2/6,9.75%,PRKCD;SLC30A10
prerank,GO_Biological_Process_2021__cardiac muscle cell differentiation (GO:0055007),-0.7201301157324242,-1.4529655854726122,0.07692307692307693,0.8913509921846541,1.0,2/17,3.82%,NRG1;MYH11
prerank,GO_Biological_Process_2021__tachykinin receptor signaling pathway (GO:0007217),-0.8811023014295485,-1.4511227338444368,0.023255813953488372,0.8977757648677046,1.0,2/6,4.80%,TACR1;GRK5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy in response to stress (GO:1903242),-0.9341704254183593,-1.450918030762045,0.07317073170731707,0.8942765511780307,1.0,1/5,0.13%,TRPC3
prerank,GO_Biological_Process_2021__mRNA transcription (GO:0009299),-0.7872826715374033,-1.4507535392514255,0.06666666666666667,0.8909761501602655,1.0,4/11,14.83%,EREG;C5AR1;TFCP2;HSF1
prerank,GO_Biological_Process_2021__lamellipodium assembly (GO:0030032),-0.7031769758914151,-1.4500197191367281,0.05128205128205128,0.8920682476235092,1.0,3/23,2.59%,KIT;CDH13;ARFIP2
prerank,GO_Biological_Process_2021__purinergic nucleotide receptor signaling pathway (GO:0035590),0.8482516277956696,1.4492457367832157,0.015873015873015872,1.0,1.0,1/15,0.10%,C3AR1
prerank,GO_Biological_Process_2021__regulation of interleukin-5 production (GO:0032674),-0.8427369094535819,-1.4487297101660466,0.07142857142857142,0.896061780800278,1.0,1/6,1.33%,LEF1
prerank,GO_Biological_Process_2021__cell differentiation in hindbrain (GO:0021533),-0.7982854914835399,-1.4486142079781976,0.10526315789473684,0.89171013569691,1.0,2/9,11.83%,KNDC1;NOG
prerank,GO_Biological_Process_2021__mesonephric tubule development (GO:0072164),-0.8604689176562701,-1.44810633612103,0.05128205128205128,0.8899765107413715,1.0,2/8,0.88%,NPNT;BMP7
prerank,GO_Biological_Process_2021__lipid phosphorylation (GO:0046834),-0.7692532942357119,-1.4470505915091765,0.1,0.8915147922497332,1.0,3/10,10.31%,DGKB;DGKD;DGKH
prerank,GO_Biological_Process_2021__positive regulation of behavior (GO:0048520),-0.8130072635901857,-1.4468254901121895,0.16666666666666666,0.8881066155036191,1.0,4/7,17.10%,CRH;NR4A3;CFAP20;SGIP1
prerank,GO_Biological_Process_2021__protein autoprocessing (GO:0016540),-0.804339269295981,-1.4459059847899554,0.0851063829787234,0.8885658395303581,1.0,2/9,3.44%,MYRFL;KLK6
prerank,GO_Biological_Process_2021__regulation of DNA-dependent DNA replication initiation (GO:0030174),0.9388565210049096,1.4455348953234002,0.0,1.0,1.0,1/5,0.75%,TICRR
prerank,GO_Biological_Process_2021__response to histamine (GO:0034776),-0.7773105510096173,-1.4450442278207685,0.11904761904761904,0.8904677662579479,1.0,2/9,4.99%,HRH1;DRD4
prerank,GO_Biological_Process_2021__protein homotrimerization (GO:0070207),0.8620543791870628,1.4444306074433033,0.045454545454545456,1.0,1.0,1/9,0.38%,STEAP4
prerank,GO_Biological_Process_2021__protein trimerization (GO:0070206),0.8620543791870628,1.4444306074433033,0.045454545454545456,1.0,1.0,1/9,0.38%,STEAP4
prerank,GO_Biological_Process_2021__peptidyl-tyrosine dephosphorylation involved in inactivation of protein kinase activity (GO:1990264),-0.8459403349770767,-1.4443673722120625,0.02631578947368421,0.8900757409065976,1.0,5/7,14.52%,PTPRT;PTPRB;DUSP10;PTPRO;PTPN1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid biosynthetic process (GO:0045723),-0.708216082066436,-1.442431104607257,0.075,0.8964719388193418,1.0,5/10,19.94%,APOA1;ABCD1;SLC45A3;NR1H2;ABCD2
prerank,GO_Biological_Process_2021__membrane protein ectodomain proteolysis (GO:0006509),-0.6470614368091901,-1.4419647059590577,0.08571428571428572,0.8949274893271802,1.0,4/18,12.45%,ADAM19;NCSTN;RBMX;HM13
prerank,GO_Biological_Process_2021__negative regulation of bone remodeling (GO:0046851),-0.8709390505399497,-1.441735550547547,0.10526315789473684,0.891758612998779,1.0,3/6,4.71%,UBASH3B;GREM1;SFRP1
prerank,GO_Biological_Process_2021__regulation of focal adhesion assembly (GO:0051893),-0.6047888212840637,-1.4415682080469034,0.02564102564102564,0.8885489053276546,1.0,3/50,4.71%,KDR;EPHA3;SFRP1
prerank,GO_Biological_Process_2021__lysosome localization (GO:0032418),-0.6253344352780174,-1.4412709671517778,0.027777777777777776,0.8855204061952249,1.0,7/30,16.57%,KIT;HPS6;BORCS6;NR4A3;PLEKHM2;S100A13;PIP4P1
prerank,GO_Biological_Process_2021__negative regulation of hippo signaling (GO:0035331),-0.789294918183866,-1.4409887913883408,0.11764705882352941,0.8826702842180734,1.0,8/12,17.51%,WTIP;SHANK2;MAP2K3;DLG5;WWC3;VGLL4;WWC1;MARK3
prerank,GO_Biological_Process_2021__low-density lipoprotein particle receptor catabolic process (GO:0032802),-0.7851628493470707,-1.4401115668469577,0.06976744186046512,0.8793832535660335,1.0,2/9,6.89%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__low-density lipoprotein receptor particle metabolic process (GO:0032799),-0.7851628493470707,-1.4401115668469577,0.06976744186046512,0.8793832535660335,1.0,2/9,6.89%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__regulation of viral life cycle (GO:1903900),0.7702747282210974,1.4396965929346606,0.04411764705882353,1.0,1.0,3/18,1.82%,TRIM22;TRIM5;TRIML2
prerank,GO_Biological_Process_2021__cardiac muscle contraction (GO:0060048),0.7074162070761568,1.4395755396339514,0.05194805194805195,1.0,1.0,7/23,18.82%,CSRP3;SCN4B;MYBPC3;ATP1B1;CAMK2D;KCNQ1;TTN
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein kinase activity (GO:1904029),0.6774478700902355,1.439458844497415,0.06493506493506493,1.0,1.0,10/49,11.05%,CCNG2;CDKN2D;CCND2;CCNE1;CCNB3;CDKN1B;CDC25A;CCNE2;CDK5R1;CDC6
prerank,GO_Biological_Process_2021__glomerular filtration (GO:0003094),-0.8632919471936338,-1.4394210921862733,0.022727272727272728,0.8786324512619066,1.0,1/7,0.95%,SULF2
prerank,GO_Biological_Process_2021__negative regulation of metallopeptidase activity (GO:1905049),0.9430282428386838,1.4393277004785232,0.015873015873015872,1.0,1.0,2/5,3.88%,TIMP3;TIMP2
prerank,GO_Biological_Process_2021__branching morphogenesis of an epithelial tube (GO:0048754),-0.6453781938895164,-1.4387721290958497,0.0975609756097561,0.8778173933293816,1.0,2/27,0.77%,NPNT;KDR
prerank,GO_Biological_Process_2021__melanosome organization (GO:0032438),-0.715621768443722,-1.4383547837749848,0.11764705882352941,0.875007159245516,1.0,2/20,4.31%,RAB32;BLOC1S4
prerank,GO_Biological_Process_2021__respiratory chain complex III assembly (GO:0017062),-0.8183544956907545,-1.436970861541133,0.044444444444444446,0.875633866861018,1.0,1/8,5.68%,SLC25A33
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex III assembly (GO:0034551),-0.8183544956907545,-1.436970861541133,0.044444444444444446,0.875633866861018,1.0,1/8,5.68%,SLC25A33
prerank,PanglaoDB_Augmented_2021__His Bundle Cells,-0.5322338473833222,-1.436537986169685,0.07692307692307693,0.8738634034649503,1.0,12/93,4.80%,PDE10A;FBXL7;RNF150;LAMA4;SLC16A2;CACNA2D1;PCDH18;ZNF462;NTM;SFRP1;RASSF8;WWTR1
prerank,GO_Biological_Process_2021__catecholamine uptake (GO:0090493),-0.8716361802594782,-1.4364577378056558,0.11627906976744186,0.8656299749486909,1.0,5/5,12.86%,SLC22A2;SLC29A4;SLC22A3;SLC6A2;SLC22A1
prerank,GO_Biological_Process_2021__norepinephrine transport (GO:0015874),-0.8716361802594782,-1.4364577378056558,0.11627906976744186,0.8656299749486909,1.0,5/5,12.86%,SLC22A2;SLC29A4;SLC22A3;SLC6A2;SLC22A1
prerank,GO_Biological_Process_2021__monocyte activation (GO:0042117),-0.7464773056199054,-1.4357630497668763,0.06060606060606061,0.8661569397835428,1.0,5/10,16.00%,AZU1;FOXP1;DYSF;SPACA3;FER1L5
prerank,GO_Biological_Process_2021__heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules (GO:0007157),-0.5996770904745249,-1.435414567381742,0.0,0.8637766808135494,1.0,4/30,7.76%,SELP;AMIGO1;TENM4;ADGRL1
prerank,GO_Biological_Process_2021__insulin secretion (GO:0030073),0.8699495416204323,1.4343303667592453,0.0,1.0,1.0,1/12,3.74%,SLC30A8
prerank,GO_Biological_Process_2021__positive regulation of organelle organization (GO:0010638),0.7417313346886346,1.4337756064496636,0.014285714285714285,1.0,1.0,3/28,8.34%,SHCBP1L;LMAN1;PPARGC1A
prerank,GO_Biological_Process_2021__intestinal epithelial cell differentiation (GO:0060575),0.9650471086367585,1.4330181762187317,0.0,1.0,1.0,1/5,0.04%,NPY
prerank,GO_Biological_Process_2021__ribosomal small subunit export from nucleus (GO:0000056),-0.8907618130429948,-1.4320702544679267,0.029411764705882353,0.8795721651135237,1.0,1/7,3.82%,NOP9
prerank,GO_Biological_Process_2021__gluconeogenesis (GO:0006094),-0.619855373802165,-1.4317980449024363,0.12121212121212122,0.877423596064438,1.0,4/33,2.99%,PER2;G6PC3;RBP4;SLC37A4
prerank,GO_Biological_Process_2021__sialylation (GO:0097503),-0.8723794509279614,-1.4311406338962374,0.0,0.8769981663025727,1.0,3/6,10.06%,ST6GALNAC2;ST3GAL1;ST3GAL2
prerank,GO_Biological_Process_2021__collagen-activated tyrosine kinase receptor signaling pathway (GO:0038063),-0.8331937492876558,-1.4310082625367144,0.12195121951219512,0.8738661141779838,1.0,1/5,0.56%,UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of neural precursor cell proliferation (GO:2000178),-0.8673750898641679,-1.4305622030216265,0.06976744186046512,0.8725850104464766,1.0,2/7,11.09%,SLC16A2;SIRT2
prerank,GO_Biological_Process_2021__regulation of sterol biosynthetic process (GO:0106118),0.8153922421278413,1.4304637818292603,0.01639344262295082,1.0,1.0,1/9,4.62%,LPCAT3
prerank,GO_Biological_Process_2021__autophagosome-lysosome fusion (GO:0061909),-0.851354947519805,-1.4300250770735115,0.02702702702702703,0.8721886991365326,1.0,1/8,1.38%,RUBCNL
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transporter activity (GO:1901017),0.8761015065906744,1.429877689717053,0.04081632653061224,1.0,1.0,1/7,1.71%,CAV3
prerank,GO_Biological_Process_2021__antimicrobial humoral immune response mediated by antimicrobial peptide (GO:0061844),0.8272680456241254,1.429235420267352,0.07246376811594203,1.0,1.0,1/12,0.21%,GNLY
prerank,PanglaoDB_Augmented_2021__Noradrenergic Neurons,-0.6183646899378891,-1.4289674437195867,0.034482758620689655,0.8751363594442791,1.0,5/33,2.43%,F11;PAH;RIMBP2;SLC39A11;RBP4
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate junction organization (GO:0150117),-0.7155220966654909,-1.428739444032155,0.07894736842105263,0.8724046306886901,1.0,3/21,11.13%,KDR;SFRP1;NRP1
prerank,GO_Biological_Process_2021__protein sialylation (GO:1990743),-0.8735436163573517,-1.4286037519086179,0.02857142857142857,0.8695000208729524,1.0,3/5,10.06%,ST6GALNAC2;ST3GAL1;ST3GAL2
prerank,GO_Biological_Process_2021__phosphatidylcholine metabolic process (GO:0046470),0.6579686576885664,1.428497256885763,0.02857142857142857,1.0,1.0,4/53,4.62%,ENPP2;PLA2G10;PLA2G7;LPCAT3
prerank,GO_Biological_Process_2021__glycerophospholipid catabolic process (GO:0046475),0.7549351821657772,1.4278249978583533,0.08571428571428572,1.0,1.0,3/20,3.22%,ENPP2;PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__calcineurin-NFAT signaling cascade (GO:0033173),-0.7636626563813289,-1.4272116609070795,0.0975609756097561,0.8718359161955603,1.0,1/8,2.89%,NFATC1
prerank,GO_Biological_Process_2021__calcineurin-mediated signaling (GO:0097720),-0.7636626563813289,-1.4272116609070795,0.0975609756097561,0.8718359161955603,1.0,1/8,2.89%,NFATC1
prerank,GO_Biological_Process_2021__postsynapse assembly (GO:0099068),0.8325773315315786,1.4271051942914406,0.015384615384615385,1.0,1.0,1/11,0.45%,LRP4
prerank,GO_Biological_Process_2021__double-strand break repair via classical nonhomologous end joining (GO:0097680),-0.8113484929819177,-1.4268751204836903,0.15789473684210525,0.8698878918093594,1.0,3/6,9.75%,ERCC8;ZBTB7A;XRCC6
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome assembly (GO:0006336),0.7275160927633035,1.4248427049223789,0.058823529411764705,1.0,1.0,5/33,4.61%,CENPO;CENPI;H3-3A;CENPK;KNL1
prerank,GO_Biological_Process_2021__positive regulation of catalytic activity (GO:0043085),-0.584491636174849,-1.4248169941041775,0.05555555555555555,0.8809492573016073,1.0,6/30,10.42%,FGFR4;XRCC4;CHTOP;APOA1;NCSTN;B3GAT3
prerank,GO_Biological_Process_2021__selenocysteine incorporation (GO:0001514),-0.7789122420174435,-1.4242677263749726,0.07317073170731707,0.8754142531399305,1.0,4/7,20.65%,EEFSEC;SECISBP2;DIO2;TRNAU1AP
prerank,GO_Biological_Process_2021__translational readthrough (GO:0006451),-0.7789122420174435,-1.4242677263749726,0.07317073170731707,0.8754142531399305,1.0,4/7,20.65%,EEFSEC;SECISBP2;DIO2;TRNAU1AP
prerank,GO_Biological_Process_2021__platelet activating factor metabolic process (GO:0046469),0.8927031369429529,1.423584598773826,0.0,1.0,1.0,2/8,3.22%,PLA2G10;PLA2G7
prerank,GO_Biological_Process_2021__negative regulation of glucose import (GO:0046325),-0.8350998381287649,-1.4231908660722032,0.058823529411764705,0.8797003079114714,1.0,1/7,1.84%,PID1
prerank,PanglaoDB_Augmented_2021__Delta Cells,-0.5286457009001272,-1.4223123089092833,0.0,0.8804395932842468,1.0,21/106,13.06%,ETV1;KCNIP1;RIMBP2;PTPRT;UNC5B;RBP4;SST;SLC6A1;ADGRA1;MAPK4;RAB3C;TMEM196;POU3F1;GAD2;LCORL;STMN2;SCG2;RGS7BP;KCNB2;NPTX2;GRIA2
prerank,GO_Biological_Process_2021__SCF complex assembly (GO:0010265),-0.8655913383700911,-1.4221369475741759,0.02564102564102564,0.877680038574457,1.0,1/6,0.66%,FBXL7
prerank,GO_Biological_Process_2021__presynaptic membrane assembly (GO:0097105),0.8351519124815563,1.4220842946894365,0.043478260869565216,1.0,1.0,1/10,0.45%,LRP4
prerank,GO_Biological_Process_2021__central nervous system projection neuron axonogenesis (GO:0021952),-0.7395849751982647,-1.4212343168858845,0.06896551724137931,0.8798123610307531,1.0,2/12,3.62%,EPHB2;NFIB
prerank,GO_Biological_Process_2021__commissural neuron axon guidance (GO:0071679),-0.852622118998496,-1.4211202118336557,0.027777777777777776,0.876891463545741,1.0,3/7,11.13%,EPHB2;NFIB;NRP1
prerank,GO_Biological_Process_2021__prostaglandin metabolic process (GO:0006693),0.7102641042662252,1.4199856276485945,0.09090909090909091,1.0,1.0,3/21,2.65%,PTGES;PTGIS;HPGDS
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis (GO:2001028),-0.7475201942653822,-1.4196178080019959,0.12195121951219512,0.8828298397991292,1.0,3/14,11.72%,KDR;HSPB1;SMOC2
prerank,GO_Biological_Process_2021__intra-Golgi vesicle-mediated transport (GO:0006891),0.6973830180993682,1.4189709461512579,0.057971014492753624,1.0,1.0,1/28,0.22%,RAB6C
prerank,GO_Biological_Process_2021__regulation of keratinocyte differentiation (GO:0045616),-0.6566803114875086,-1.418849398820986,0.10526315789473684,0.8836012922029788,1.0,4/22,7.73%,RUNX1;NUMA1;CBFB;MACROH2A2
prerank,GO_Biological_Process_2021__positive regulation of myotube differentiation (GO:0010831),-0.8059529701702757,-1.418411632488199,0.09090909090909091,0.8818821225108906,1.0,2/5,16.75%,MAML1;ATP11A
prerank,GO_Biological_Process_2021__cellular nitrogen compound catabolic process (GO:0044270),-0.87897151122278,-1.417486381404191,0.10204081632653061,0.883763783477973,1.0,1/7,0.03%,PM20D1
prerank,GO_Biological_Process_2021__positive regulation of execution phase of apoptosis (GO:1900119),0.8757623344055127,1.4174345680130107,0.07142857142857142,1.0,1.0,2/7,4.57%,PTGIS;BOK
prerank,GO_Biological_Process_2021__establishment of protein localization to chromosome (GO:0070199),-0.745401856138322,-1.4173398401603463,0.08333333333333333,0.8811356191635937,1.0,5/10,22.04%,BRCA2;MACROH2A2;LRWD1;MACROH2A1;RUVBL2
prerank,GO_Biological_Process_2021__regulation of viral entry into host cell (GO:0046596),0.744342010356217,1.4169750931916578,0.056338028169014086,1.0,1.0,4/22,2.19%,TRIM22;TRIM5;TRIML2;CD4
prerank,GO_Biological_Process_2021__negative regulation of transcription regulatory region DNA binding (GO:2000678),-0.8081921448769503,-1.416609506229342,0.075,0.8820848782384996,1.0,1/11,0.17%,PER2
prerank,GO_Biological_Process_2021__rRNA modification (GO:0000154),-0.7274369969644433,-1.4162131525174992,0.07142857142857142,0.8806461238010858,1.0,3/20,6.64%,BUD23;MTERF4;FBLL1
prerank,GO_Biological_Process_2021__terpenoid metabolic process (GO:0006721),-0.9735480962638894,-1.4153568198379558,0.0,0.8808602211687573,1.0,1/5,0.01%,CYP1A2
prerank,GO_Biological_Process_2021__regulation of peptide hormone secretion (GO:0090276),-0.5699226745096605,-1.4135143637277479,0.038461538461538464,0.8873641271792921,1.0,5/51,5.96%,PER2;CELA2A;GLP1R;ITPR2;CACNA1A
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by cadherin (GO:2000049),-0.877216537159595,-1.4127206401810195,0.058823529411764705,0.8887524465870129,1.0,2/7,7.08%,ADAM19;SERPINF2
prerank,GO_Biological_Process_2021__negative regulation of RNA splicing (GO:0033119),-0.6766898500338003,-1.4095978477473325,0.15384615384615385,0.9058441651353268,1.0,9/18,16.93%,SFSWAP;PTBP3;RBMX;U2AF2;SRSF7;PTBP1;RPS26;PCBP4;PTBP2
prerank,GO_Biological_Process_2021__calcium ion homeostasis (GO:0055074),0.626374297888086,1.4094727949940196,0.0,1.0,1.0,19/68,17.88%,CSRP3;TRPV6;WFS1;CCL5;GCM2;CALCB;ELANE;TMEM203;VAPB;SLC24A4;FAM20A;SLC24A2;SLC24A1;DRD3;ATP1B1;HTR2B;CHRNA7;NPTN;TRDN
prerank,GO_Biological_Process_2021__immune response-regulating cell surface receptor signaling pathway (GO:0002768),-0.8705268904932664,-1.4093916378795777,0.047619047619047616,0.9034990317845685,1.0,1/6,0.36%,KIT
prerank,GO_Biological_Process_2021__leukocyte adhesion to vascular endothelial cell (GO:0061756),-0.8015256798004078,-1.407790165989754,0.058823529411764705,0.9090244625388871,1.0,2/13,1.19%,SELP;ITGA4
prerank,GO_Biological_Process_2021__retinoid metabolic process (GO:0001523),-0.5791894553034815,-1.4076759949810678,0.09090909090909091,0.9058565143161054,1.0,4/53,3.27%,CYP1A2;GPC4;RBP4;SDC4
prerank,GO_Biological_Process_2021__protein processing (GO:0016485),-0.5527196817441293,-1.4075425589133177,0.037037037037037035,0.9027740539770882,1.0,15/72,12.45%,ADAM19;MYRFL;PRSS12;ADAMTS3;TYSND1;CPXM2;KLK6;SRGN;PTCH1;ECE1;NCSTN;MME;EEF1AKMT4-ECE2;RCE1;HM13
prerank,GO_Biological_Process_2021__regulation of bile acid metabolic process (GO:1904251),-0.8987785102744525,-1.406875012113088,0.06896551724137931,0.9020078333208797,1.0,2/5,7.93%,FGFR4;NR1H4
prerank,GO_Biological_Process_2021__modulation by symbiont of entry into host (GO:0052372),0.8027413901618452,1.4058697449748896,0.04411764705882353,1.0,1.0,3/13,1.82%,TRIM22;TRIM5;TRIML2
prerank,GO_Biological_Process_2021__cellular response to cadmium ion (GO:0071276),-0.6805063728439316,-1.405769030493096,0.11538461538461539,0.9043478572843722,1.0,5/18,14.83%,MT1E;FOS;AKR1C3;EGFR;HSF1
prerank,PanglaoDB_Augmented_2021__Platelets,0.5962743951305554,1.4050287693102506,0.013333333333333334,1.0,1.0,17/110,8.88%,TUBB1;C3AR1;NOX5;CCL5;FGL2;HCK;CD300LF;PREX1;ACKR3;SLC26A4;CDKN2D;THEMIS2;P2RY12;GMFG;ALOX12;F11R;HLA-A
prerank,GO_Biological_Process_2021__mast cell mediated immunity (GO:0002448),-0.8545408308935718,-1.4037751228529456,0.06666666666666667,0.9123184746618138,1.0,1/6,0.36%,KIT
prerank,GO_Biological_Process_2021__transition metal ion transport (GO:0000041),-0.6314804207392459,-1.4032430391123472,0.034482758620689655,0.9112904079569916,1.0,3/33,1.24%,TRPC3;TRPC7;MELTF
prerank,GO_Biological_Process_2021__regulation of meiotic nuclear division (GO:0040020),0.9077049879635762,1.4032090658840815,0.046153846153846156,1.0,1.0,1/6,0.18%,WEE2
prerank,GO_Biological_Process_2021__regulation of pri-miRNA transcription by RNA polymerase II (GO:1902893),-0.5563579267281972,-1.4027698014481316,0.15151515151515152,0.91113730744079,1.0,8/32,9.54%,ATOH8;FOS;NFIB;APLN;TGFB2;ETS1;STAT3;SMARCA4
prerank,GO_Biological_Process_2021__negative regulation of glucose transmembrane transport (GO:0010829),-0.7674299638004161,-1.4027033358054326,0.06,0.9077060471609146,1.0,3/9,15.08%,PID1;LEP;PRKCB
prerank,GO_Biological_Process_2021__positive regulation of cell migration involved in sprouting angiogenesis (GO:0090050),-0.7301207353794575,-1.4024210073085603,0.2222222222222222,0.9056778743084449,1.0,2/13,6.70%,KDR;RHOJ
prerank,GO_Biological_Process_2021__immune response-activating cell surface receptor signaling pathway (GO:0002429),0.7807186954459894,1.4021803952099392,0.05333333333333334,1.0,1.0,1/14,0.10%,C3AR1
prerank,GO_Biological_Process_2021__oligosaccharide-lipid intermediate biosynthetic process (GO:0006490),-0.7113201200518566,-1.4016447511939003,0.11538461538461539,0.9069760471912455,1.0,3/12,10.92%,ALG8;ALG12;MPDU1
prerank,GO_Biological_Process_2021__neuromuscular process controlling balance (GO:0050885),-0.7799227864691665,-1.4011607513187938,0.20512820512820512,0.9066154625288083,1.0,2/8,7.61%,TPP1;SHANK1
prerank,GO_Biological_Process_2021__DNA ligation involved in DNA repair (GO:0051103),-0.8232265435498398,-1.4003770975009229,0.07692307692307693,0.9078994429056413,1.0,1/5,3.73%,XRCC4
prerank,GO_Biological_Process_2021__retinal metabolic process (GO:0042574),0.7737790075070394,1.4001696944609932,0.09615384615384616,1.0,1.0,3/13,4.87%,RDH10;BCO1;CYP1B1
prerank,GO_Biological_Process_2021__positive regulation of T cell apoptotic process (GO:0070234),0.8334609273113207,1.4000902738025314,0.03571428571428571,1.0,1.0,2/7,8.00%,CCL5;IDO1
prerank,GO_Biological_Process_2021__regulation of bone remodeling (GO:0046850),-0.8202101740239491,-1.3998076997615294,0.06976744186046512,0.9072561351821608,1.0,4/7,14.61%,GREM1;SFRP1;MDK;LEP
prerank,GO_Biological_Process_2021__negative regulation of mRNA processing (GO:0050686),-0.6820978218145307,-1.3993998665442706,0.08823529411764706,0.9072356935979782,1.0,6/14,16.17%,SFSWAP;RBMX;U2AF2;SRSF7;PTBP1;PCBP4
prerank,GO_Biological_Process_2021__positive regulation of glial cell migration (GO:1903977),0.8912990256326818,1.3993966070875998,0.03225806451612903,1.0,1.0,1/5,6.37%,P2RY12
prerank,GO_Biological_Process_2021__regulation of alcohol biosynthetic process (GO:1902930),0.784388442306055,1.3984946887347727,0.0,1.0,1.0,1/12,4.62%,LPCAT3
prerank,GO_Biological_Process_2021__cellular hypotonic response (GO:0071476),0.9759506521441985,1.3983790343174407,0.0,1.0,1.0,1/5,0.75%,MYLK
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type peptidase activity (GO:1905247),0.8761594123095333,1.3979506574385108,0.0967741935483871,1.0,1.0,1/8,1.74%,AGER
prerank,GO_Biological_Process_2021__desmosome organization (GO:0002934),-0.8911740672191388,-1.3974922665817884,0.045454545454545456,0.9159413285850344,1.0,1/5,0.68%,PKP2
prerank,GO_Biological_Process_2021__regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000341),-0.7829373601497851,-1.396149641509009,0.14285714285714285,0.9210124316846342,1.0,2/10,7.25%,F2RL1;FOXP1
prerank,GO_Biological_Process_2021__response to misfolded protein (GO:0051788),-0.7971355933367321,-1.3952566125175692,0.1,0.9234353439512057,1.0,2/7,11.39%,DNAJB12;CLU
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell chemotaxis by VEGF-activated vascular endothelial growth factor receptor signaling pathway (GO:0038033),-0.9197763466051756,-1.3951160067677655,0.02564102564102564,0.9204773563015582,1.0,2/5,7.27%,KDR;HSPB1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 3 signaling pathway (GO:0034139),-0.9093538047305215,-1.3949440731735994,0.125,0.9180930915153552,1.0,1/5,1.47%,F2RL1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte adhesion to vascular endothelial cell (GO:1904996),-0.8413810571789156,-1.3944605308601488,0.0625,0.9184697369170324,1.0,3/11,12.12%,SELP;ETS1;MDK
prerank,GO_Biological_Process_2021__positive regulation of membrane depolarization (GO:1904181),-0.8627026983873558,-1.3938151530781182,0.10526315789473684,0.9186249244818864,1.0,1/6,0.77%,KDR
prerank,GO_Biological_Process_2021__positive regulation of T cell migration (GO:2000406),0.7771795227105124,1.3932350984886912,0.07246376811594203,1.0,1.0,2/13,5.30%,CCL5;DOCK8
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-threonine phosphorylation (GO:0010801),-0.7587682857707333,-1.3932130490218058,0.15789473684210525,0.9184523721943263,1.0,3/16,0.88%,SPRED2;SPRED3;SPRED1
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, GABAergic (GO:0032230)",-0.8597131361063497,-1.3929985815205008,0.125,0.9158957197625658,1.0,1/5,6.08%,ZDHHC3
prerank,GO_Biological_Process_2021__regulation of hepatocyte proliferation (GO:2000345),-0.7434433189121136,-1.3915700568704958,0.11764705882352941,0.9205955353254938,1.0,1/6,12.12%,MDK
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting serotonin receptor signaling pathway (GO:0007198),-0.9128261674488999,-1.391429760099363,0.0,0.9178350176671506,1.0,1/5,0.27%,HTR1F
prerank,GO_Biological_Process_2021__negative regulation of catalytic activity (GO:0043086),0.7308803481664231,1.3912691594964166,0.10606060606060606,1.0,1.0,6/22,20.46%,NES;NOTCH1;ATP5IF1;TMBIM1;PLN;IFIT1
prerank,"GO_Biological_Process_2021__negative regulation of mRNA splicing, via spliceosome (GO:0048025)",-0.7004965809873579,-1.3912070065851454,0.15151515151515152,0.9160066219383854,1.0,6/13,16.17%,SFSWAP;RBMX;U2AF2;SRSF7;PTBP1;PCBP4
prerank,GO_Biological_Process_2021__positive regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902961),0.8993211240404374,1.3904462840912275,0.06153846153846154,1.0,1.0,1/7,1.74%,AGER
prerank,GO_Biological_Process_2021__negative regulation of androgen receptor signaling pathway (GO:0060766),-0.7914670267472903,-1.3898959940328686,0.14285714285714285,0.9205458247573244,1.0,5/10,9.54%,SFRP1;HDAC1;FOXP1;ZBTB7A;SMARCA4
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell activation (GO:2000516)",0.8727062711813797,1.389555037378665,0.03333333333333333,1.0,1.0,1/8,2.52%,ZBTB7B
prerank,GO_Biological_Process_2021__scaRNA localization to Cajal body (GO:0090666),0.9496239094573591,1.3885060779782363,0.05172413793103448,1.0,1.0,1/5,2.97%,TCP1
prerank,GO_Biological_Process_2021__RNA localization to Cajal body (GO:0090670),0.9496239094573591,1.3885060779782363,0.05172413793103448,1.0,1.0,1/5,2.97%,TCP1
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid separation (GO:0010965),-0.6441217173714628,-1.3884914108948243,0.1,0.9254763002425132,1.0,4/14,10.85%,NEK6;PTTG1;TPR;CDC23
prerank,GO_Biological_Process_2021__regulation of protein modification process (GO:0031399),-0.5888955533647494,-1.3881783959281773,0.12903225806451613,0.9235868075093746,1.0,7/43,7.27%,SPRED2;SPRED3;SPRED1;RABL3;PUM3;ATG10;HSPB1
prerank,GO_Biological_Process_2021__regulation of positive chemotaxis (GO:0050926),-0.8595407174678624,-1.3881316030596367,0.14285714285714285,0.9204444383675624,1.0,3/7,1.54%,KDR;F2RL1;CDH13
prerank,GO_Biological_Process_2021__regulation of acute inflammatory response (GO:0002673),0.8277481667074977,1.387742698608316,0.03278688524590164,1.0,1.0,2/9,6.60%,PTGES;OSMR
prerank,GO_Biological_Process_2021__positive regulation of mesenchymal cell proliferation (GO:0002053),0.8115012043536687,1.3875317898290565,0.07462686567164178,1.0,1.0,3/9,11.22%,TBX1;STAT1;FGFR2
prerank,GO_Biological_Process_2021__CENP-A containing chromatin organization (GO:0061641),0.7281808201827518,1.387374791789213,0.07352941176470588,1.0,1.0,6/26,15.28%,CENPO;CENPI;CENPK;KNL1;CENPU;CENPL
prerank,GO_Biological_Process_2021__CENP-A containing nucleosome assembly (GO:0034080),0.7281808201827518,1.387374791789213,0.07352941176470588,1.0,1.0,6/26,15.28%,CENPO;CENPI;CENPK;KNL1;CENPU;CENPL
prerank,GO_Biological_Process_2021__amyloid precursor protein catabolic process (GO:0042987),-0.7439093469181159,-1.387324003528234,0.07142857142857142,0.921796173326852,1.0,2/12,8.36%,ADAM19;NCSTN
prerank,GO_Biological_Process_2021__mitotic cell cycle checkpoint signaling (GO:0007093),0.7360569699379808,1.387296993380686,0.11290322580645161,1.0,1.0,1/16,0.18%,WEE2
prerank,GO_Biological_Process_2021__endothelial cell morphogenesis (GO:0001886),-0.8532503614737783,-1.3871239277336305,0.047619047619047616,0.9189458261602721,1.0,2/5,8.80%,COL15A1;COL18A1
prerank,GO_Biological_Process_2021__regulation of mRNA metabolic process (GO:1903311),-0.686415948819239,-1.3869393526987785,0.08571428571428572,0.9161165926764074,1.0,3/12,8.15%,SRPK3;PTCD2;IWS1
prerank,GO_Biological_Process_2021__regulation of nuclear cell cycle DNA replication (GO:0033262),-0.8023047827743481,-1.3868663284612233,0.11363636363636363,0.913360252826277,1.0,3/8,8.39%,DBF4B;INO80;WIZ
prerank,GO_Biological_Process_2021__L-arginine transmembrane transport (GO:1903400),-0.8301518973114647,-1.3864220533408715,0.16666666666666666,0.9123343211976563,1.0,4/6,11.69%,SLC22A2;SLC25A29;SLC7A1;SLC7A2
prerank,GO_Biological_Process_2021__cardiac myofibril assembly (GO:0055003),0.7647301394368861,1.3861532933992986,0.08695652173913043,1.0,1.0,3/13,6.44%,CSRP3;PDGFRB;ACTC1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell surface (GO:2000009),0.8113042643338751,1.3860453657761855,0.09090909090909091,1.0,1.0,1/8,1.71%,CAV3
prerank,GO_Biological_Process_2021__proteoglycan metabolic process (GO:0006029),-0.6958669173443798,-1.3858367635475044,0.058823529411764705,0.9115740686977117,1.0,5/23,5.93%,SULF2;CHST8;HS3ST4;IGF1;GAL3ST4
prerank,GO_Biological_Process_2021__cardiocyte differentiation (GO:0035051),-0.7991804676577531,-1.3857689022665929,0.02564102564102564,0.9087101537388452,1.0,3/9,11.65%,NRG1;TGFB2;EEF1AKMT4-ECE2
prerank,PanglaoDB_Augmented_2021__Red Pulp Macrophages,0.6665239915461174,1.3855939325590672,0.03125,1.0,1.0,18/39,19.74%,C3AR1;MS4A6A;FGL2;HCK;CD300LF;CD14;SIGLEC1;C1QA;MYO1F;ADGRE1;IGSF6;SLC7A7;SLC40A1;AQP9;TBXAS1;LY86;WDFY4;TLR2
prerank,GO_Biological_Process_2021__centromere complex assembly (GO:0034508),0.6950589128568534,1.38513511211589,0.06666666666666667,1.0,1.0,8/32,20.58%,CENPO;CENPI;CENPK;KNL1;CENPU;CENPL;HELLS;OIP5
prerank,GO_Biological_Process_2021__tetrahydrofolate interconversion (GO:0035999),-0.8097037333420364,-1.3844717750652438,0.13953488372093023,0.914375749036139,1.0,6/9,15.78%,TYMS;MTHFD2;MTHFS;MTHFD2L;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid transport (GO:0015812),-0.8956953808920909,-1.3844589218932093,0.13513513513513514,0.9112160076386268,1.0,2/5,5.33%,SLC6A11;SLC6A1
prerank,GO_Biological_Process_2021__peptidyl-lysine monomethylation (GO:0018026),-0.7408569527101506,-1.3831438783250647,0.14285714285714285,0.9164754404849671,1.0,4/11,20.55%,SMYD2;EHMT1;KMT5A;SETD2
prerank,GO_Biological_Process_2021__thyroid hormone transport (GO:0070327),-0.8206526698130827,-1.3831072279116696,0.058823529411764705,0.9136351021018136,1.0,1/6,1.96%,SLC16A2
prerank,GO_Biological_Process_2021__hormone transport (GO:0009914),-0.7909031153998385,-1.3823992694266756,0.12121212121212122,0.9150589935745874,1.0,3/8,15.27%,SLC16A2;SLC22A9;SLCO1C1
prerank,GO_Biological_Process_2021__regulation of plasma membrane organization (GO:1903729),0.891227533246157,1.3822200566742509,0.07017543859649122,1.0,1.0,1/5,0.57%,NOX5
prerank,GO_Biological_Process_2021__negative regulation of dendritic spine development (GO:0061000),-0.7549184265792307,-1.3820831731297616,0.18421052631578946,0.9137039146526129,1.0,2/7,10.87%,GRIN3A;PTPRS
prerank,GO_Biological_Process_2021__piRNA metabolic process (GO:0034587),0.7378509407302835,1.3820640765033383,0.056338028169014086,1.0,1.0,3/16,4.26%,TDRD1;TDRD9;HENMT1
prerank,GO_Biological_Process_2021__regulation of lipid catabolic process (GO:0050994),-0.6839050459341466,-1.3814996331358298,0.08108108108108109,0.9133617336428413,1.0,4/11,10.44%,ALK;TYSND1;CIDEA;ABCD1
prerank,GO_Biological_Process_2021__regulation of extent of cell growth (GO:0061387),-0.7329893277010684,-1.3813363191273051,0.10869565217391304,0.9110725730544299,1.0,4/8,19.96%,APOE;DNM2;SIN3A;NRCAM
prerank,GO_Biological_Process_2021__DNA unwinding involved in DNA replication (GO:0006268),0.7196915733908056,1.381225293672043,0.07352941176470588,1.0,1.0,6/16,22.06%,MCM2;MCMDC2;RECQL;PURA;RECQL4;MCM6
prerank,GO_Biological_Process_2021__cerebellar granule cell differentiation (GO:0021707),-0.8626404347239907,-1.38050965698801,0.125,0.9129834752724295,1.0,1/5,5.68%,KNDC1
prerank,GO_Biological_Process_2021__detection of visible light (GO:0009584),0.8189800617044447,1.3804289491908928,0.09090909090909091,1.0,1.0,5/12,15.18%,RP1;CNGB1;GNAT2;CACNA2D4;PDE6B
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001240),-0.7074369621587764,-1.3802942414589066,0.08571428571428572,0.9079614151571113,1.0,4/14,7.26%,UNC5B;EYA4;BCL2;MAPK7
prerank,GO_Biological_Process_2021__negative regulation of signal transduction in absence of ligand (GO:1901099),-0.7074369621587764,-1.3802942414589066,0.08571428571428572,0.9079614151571113,1.0,4/14,7.26%,UNC5B;EYA4;BCL2;MAPK7
prerank,GO_Biological_Process_2021__cobalamin transport (GO:0015889),0.8792817967407041,1.380189481035607,0.046153846153846156,1.0,1.0,3/6,9.38%,AMN;CBLIF;TCN2
prerank,"GO_Biological_Process_2021__negative regulation of complement activation, classical pathway (GO:0045959)",0.9006251529685759,1.3797587168748244,0.0,1.0,1.0,1/7,0.23%,C4BPB
prerank,"GO_Biological_Process_2021__regulation of complement activation, classical pathway (GO:0030450)",0.9006251529685759,1.3797587168748244,0.0,1.0,1.0,1/7,0.23%,C4BPB
prerank,GO_Biological_Process_2021__negative regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002924),0.9006251529685759,1.3797587168748244,0.0,1.0,1.0,1/7,0.23%,C4BPB
prerank,GO_Biological_Process_2021__branching involved in blood vessel morphogenesis (GO:0001569),-0.7327702125221316,-1.37961839965877,0.12195121951219512,0.9083845803751653,1.0,1/11,0.77%,KDR
prerank,GO_Biological_Process_2021__regulation of peptidyl-threonine phosphorylation (GO:0010799),-0.675281420009703,-1.3792538711077016,0.09090909090909091,0.9072331498468355,1.0,4/35,0.88%,SPRED2;SPRED3;BMP7;SPRED1
prerank,GO_Biological_Process_2021__cellular senescence (GO:0090398),-0.6299745997768283,-1.3783473875126662,0.02857142857142857,0.9095646988776332,1.0,6/23,16.82%,ECRG4;PRKCD;ID2;HMGA2;PML;ULK3
prerank,GO_Biological_Process_2021__protein maturation (GO:0051604),-0.5226853069404814,-1.3782837749043293,0.1,0.9067100606346156,1.0,17/76,15.51%,ADAM19;ADAMTS3;TYSND1;CPXM2;LMF2;SRGN;PTCH1;ECE1;LMF1;NCSTN;MME;SORL1;EEF1AKMT4-ECE2;DNAJB11;TASP1;METAP2;TSPAN32
prerank,"GO_Biological_Process_2021__negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515)",-0.8298287406844309,-1.3772681858956277,0.0975609756097561,0.9097078162171035,1.0,3/6,7.73%,RUNX1;TARM1;CBFB
prerank,GO_Biological_Process_2021__regulation of neurotransmitter receptor activity (GO:0099601),-0.5509060885142774,-1.3771029287437335,0.03125,0.907453571968717,1.0,18/56,17.37%,CACNG4;CACNG5;CACNG3;CRH;GSG1L;SHANK1;CNIH3;NPTXR;GRIA4;GRIA1;GRIN2A;NPTX2;GRIA2;CNIH2;DLGAP4;RELN;OPRM1;LRRC7
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-NFAT signaling cascade (GO:0070885),-0.7480211770834062,-1.3770065414273467,0.058823529411764705,0.9017885400287148,1.0,2/8,2.15%,HOMER2;FHL2
prerank,GO_Biological_Process_2021__negative regulation of calcineurin-mediated signaling (GO:0106057),-0.7480211770834062,-1.3770065414273467,0.058823529411764705,0.9017885400287148,1.0,2/8,2.15%,HOMER2;FHL2
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion assembly (GO:0051894),-0.7403583088883569,-1.3760529678836284,0.1111111111111111,0.904091025507245,1.0,3/16,11.13%,KDR;SFRP1;NRP1
prerank,GO_Biological_Process_2021__regulation of T cell mediated cytotoxicity (GO:0001914),0.7496123691637355,1.3756822639333335,0.09375,1.0,1.0,4/15,8.88%,AGER;PTPRC;FADD;HLA-A
prerank,GO_Biological_Process_2021__mast cell activation involved in immune response (GO:0002279),-0.8546358986598321,-1.3749719981535984,0.10869565217391304,0.9039825022928587,1.0,1/5,0.36%,KIT
prerank,GO_Biological_Process_2021__mast cell degranulation (GO:0043303),-0.8546358986598321,-1.3749719981535984,0.10869565217391304,0.9039825022928587,1.0,1/5,0.36%,KIT
prerank,GO_Biological_Process_2021__ERBB signaling pathway (GO:0038127),-0.5406259825967136,-1.3740330073865987,0.0625,0.9058272006041564,1.0,5/58,6.26%,SHC3;NRG1;BTC;EREG;DGKD
prerank,GO_Biological_Process_2021__mRNA pseudouridine synthesis (GO:1990481),0.8657413675554753,1.373841473117623,0.07246376811594203,1.0,1.0,1/7,6.27%,TRUB1
prerank,GO_Biological_Process_2021__lamellipodium organization (GO:0097581),-0.6219762600940006,-1.3732483845152252,0.05555555555555555,0.9064769925698871,1.0,3/26,2.59%,KIT;CDH13;ARFIP2
prerank,GO_Biological_Process_2021__presynapse assembly (GO:0099054),0.7542452150232075,1.3731495970499503,0.09859154929577464,1.0,1.0,1/17,0.45%,LRP4
prerank,GO_Biological_Process_2021__cellular response to interferon-gamma (GO:0071346),0.5999225546231287,1.3727102450184923,0.08333333333333333,1.0,1.0,15/63,20.54%,TRIM22;TRIM5;CCL5;HCK;CIITA;HLA-A;STAT1;IRF1;CAMK2D;TRIM25;EPRS1;PTAFR;B2M;TLR2;SP100
prerank,PanglaoDB_Augmented_2021__Plasma Cells,-0.5796138293089544,-1.37249943367475,0.17391304347826086,0.9076410092900838,1.0,2/47,0.17%,CD38;P2RY10
prerank,GO_Biological_Process_2021__sprouting angiogenesis (GO:0002040),-0.5892023405233091,-1.3722462346128512,0.05714285714285714,0.905555253110734,1.0,4/42,1.82%,KDR;CDH13;GREM1;NAXE
prerank,GO_Biological_Process_2021__regulation of centrosome cycle (GO:0046605),0.7345554753029726,1.3719059706055416,0.1044776119402985,1.0,1.0,5/20,12.21%,RAB6C;ATF5;CHMP4B;CHMP2B;CHMP1A
prerank,GO_Biological_Process_2021__base conversion or substitution editing (GO:0016553),-0.8414524529686247,-1.3716483226756928,0.06060606060606061,0.9057311762852808,1.0,2/8,3.44%,APOBEC3H;ADARB2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol dephosphorylation (GO:0060304),-0.8144493460898025,-1.371048491108193,0.06451612903225806,0.9064193542252837,1.0,1/5,8.12%,MTMR9
prerank,GO_Biological_Process_2021__regulation of vasculature development (GO:1901342),-0.6906110746626859,-1.3709321784005442,0.1111111111111111,0.9041721990112996,1.0,5/20,7.53%,TSPAN12;VASH1;SFRP1;ETS1;VASH2
prerank,GO_Biological_Process_2021__replication-born double-strand break repair via sister chromatid exchange (GO:1990414),-0.8334461111466132,-1.3704121613341491,0.14634146341463414,0.9044900380013022,1.0,1/6,1.84%,RAD21L1
prerank,GO_Biological_Process_2021__endothelium development (GO:0003158),-0.8215575902389235,-1.369262525099329,0.2413793103448276,0.9088265356745188,1.0,1/7,0.77%,KDR
prerank,GO_Biological_Process_2021__Golgi ribbon formation (GO:0090161),-0.7044309377784005,-1.3689111284897477,0.13157894736842105,0.9075608972822734,1.0,9/13,27.24%,FHDC1;PRMT5;STX6;TMED5;VTI1A;GCC2;MYO18A;TRIP11;GOLGA2
prerank,GO_Biological_Process_2021__regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0000079),0.6021236223399178,1.3686771270605618,0.060240963855421686,1.0,1.0,12/75,11.05%,CCNG2;SPDYA;PSRC1;CDKN2D;CCND2;CCNE1;CCNB3;CDKN1B;CDC25A;CCNE2;CDK5R1;CDC6
prerank,GO_Biological_Process_2021__proton transmembrane transport (GO:1902600),0.6629935591228987,1.3685057608921138,0.13793103448275862,1.0,1.0,3/22,8.73%,NOX5;ATP12A;SLC36A1
prerank,GO_Biological_Process_2021__cellular response to X-ray (GO:0071481),-0.8051752187241332,-1.3681639662215574,0.18421052631578946,0.9085533076122528,1.0,2/5,16.96%,XRCC6;ATM
prerank,GO_Biological_Process_2021__vasoconstriction (GO:0042310),0.7985878138015042,1.3678677821336185,0.07017543859649122,1.0,1.0,2/8,16.04%,ACTA2;HTR2B
prerank,PanglaoDB_Augmented_2021__Erythroblasts,0.6072916490226559,1.3670370837751669,0.05714285714285714,1.0,1.0,4/70,1.54%,TUBB1;TRIM58;GYPB;RGS10
prerank,GO_Biological_Process_2021__regulation of extracellular matrix disassembly (GO:0010715),-0.7280808468195057,-1.366582588345287,0.08571428571428572,0.9144361592123145,1.0,3/14,6.06%,MELTF;FGFR4;PDPN
prerank,GO_Biological_Process_2021__nicotinamide nucleotide biosynthetic process (GO:0019359),-0.8248962162189617,-1.366316319873019,0.06818181818181818,0.9130734200954427,1.0,1/7,0.71%,NMNAT3
prerank,GO_Biological_Process_2021__negative regulation of ERK1 and ERK2 cascade (GO:0070373),-0.6110861253987491,-1.3661316730017585,0.12121212121212122,0.9112193025679804,1.0,6/40,2.36%,DUSP4;SPRED2;SPRED3;SPRED1;RGS14;EPHB2
prerank,GO_Biological_Process_2021__iron import into cell (GO:0033212),0.9075484796332941,1.3658314829585887,0.046153846153846156,1.0,1.0,1/6,0.57%,NOX5
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium organization (GO:1902745),0.6942602949239207,1.3650610405686574,0.1,1.0,1.0,2/29,1.75%,ENPP2;RREB1
prerank,GO_Biological_Process_2021__regulation of adherens junction organization (GO:1903391),-0.8245811657758919,-1.3650282968737115,0.1282051282051282,0.9142267572813548,1.0,2/5,7.62%,PTPN23;BMP6
prerank,PanglaoDB_Augmented_2021__Spermatocytes,0.7244627810914307,1.3649697864978982,0.014705882352941176,1.0,1.0,6/19,13.86%,TEX101;SYCP3;TDRD5;CAPN1;NOTCH3;SYCP2
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, endonucleolytic (GO:0090502)",-0.7209464179946541,-1.3649498589515208,0.13636363636363635,0.912064578675204,1.0,4/12,17.80%,ZC3H12B;POP1;ZC3H12C;LACTB2
prerank,GO_Biological_Process_2021__chromatin remodeling at centromere (GO:0031055),0.7079532827727938,1.3643722702604357,0.07246376811594203,1.0,1.0,8/28,20.58%,CENPO;CENPI;CENPK;KNL1;CENPU;CENPL;HELLS;OIP5
prerank,GO_Biological_Process_2021__miRNA catabolic process (GO:0010587),-0.7844999370765365,-1.364147431336861,0.19444444444444445,0.9136990895586692,1.0,2/6,13.32%,LIN28B;DIS3L2
prerank,GO_Biological_Process_2021__sensory perception of bitter taste (GO:0050913),-0.7730132872003911,-1.363935609702338,0.2,0.9088822876282446,1.0,5/7,7.81%,RTP5;TAS2R7;TAS2R9;CA6;GNAT3
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of bitter taste (GO:0001580),-0.7730132872003911,-1.363935609702338,0.2,0.9088822876282446,1.0,5/7,7.81%,RTP5;TAS2R7;TAS2R9;CA6;GNAT3
prerank,PanglaoDB_Augmented_2021__Langerhans Cells,0.6098699399589559,1.3639249242407676,0.031746031746031744,1.0,1.0,21/52,19.74%,MS4A6A;FGL2;HCK;CD300LF;HLA-DMA;PTPRC;PIK3R5;HLA-DMB;AHR;TAGAP;CIITA;SIGLEC1;C1QA;MYO1F;IGSF6;EPCAM;LY86;PTAFR;WDFY4;CD74;TLR2
prerank,GO_Biological_Process_2021__negative regulation of cell differentiation (GO:0045596),-0.508912705638543,-1.36388815044168,0.09090909090909091,0.9061398978677843,1.0,19/139,9.02%,SPRED2;SPRED3;PKP2;MYB;TRIB2;BMP7;SPRED1;SINHCAF;GREM1;ASCL1;DTX1;SFRP1;WWTR1;PTCH1;PTHLH;ID2;CRIM1;RORA;ANKRD2
prerank,GO_Biological_Process_2021__serotonin uptake (GO:0051610),-0.8716361802594782,-1.363417280079011,0.08163265306122448,0.9027458633033997,1.0,5/5,12.86%,SLC22A2;SLC6A4;SLC29A4;SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__serotonin transport (GO:0006837),-0.8716361802594782,-1.363417280079011,0.08163265306122448,0.9027458633033997,1.0,5/5,12.86%,SLC22A2;SLC6A4;SLC29A4;SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum unfolded protein response (GO:1900102),0.7780743110603799,1.363397176934054,0.028169014084507043,1.0,1.0,2/13,7.54%,WFS1;HSPA5
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle hypertrophy (GO:0010613),-0.6927338734308368,-1.3633962242618811,0.07894736842105263,0.9000043133104376,1.0,2/16,3.96%,TRPC3;IGF1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell proliferation (GO:0061469),-0.789582926972875,-1.3630476007885572,0.08888888888888889,0.8986013706087681,1.0,4/6,19.25%,NR4A3;NR4A1;SGPP2;NUPR1
prerank,GO_Biological_Process_2021__positive regulation of histone deacetylation (GO:0031065),0.808819843785626,1.362397968579179,0.05,1.0,1.0,2/11,5.70%,ZBTB7B;ING2
prerank,GO_Biological_Process_2021__response to exogenous dsRNA (GO:0043330),-0.6803343792538012,-1.3620188629124228,0.08823529411764706,0.9003688230633282,1.0,4/16,10.40%,STING1;IFIH1;TICAM1;COLEC12
prerank,GO_Biological_Process_2021__regulation of mesenchymal cell proliferation (GO:0010464),0.8150156802113331,1.3618393744977704,0.04918032786885246,1.0,1.0,3/10,11.22%,TBX1;STAT1;FGFR2
prerank,GO_Biological_Process_2021__negative regulation of ERBB signaling pathway (GO:1901185),-0.5933561333791536,-1.3615117795786005,0.1,0.9001116250131524,1.0,4/36,3.11%,PTPN3;BTC;RNF126;EREG
prerank,GO_Biological_Process_2021__MAPK cascade (GO:0000165),-0.4860849529190029,-1.361256618919453,0.0,0.8985904606182307,1.0,22/257,7.45%,NRK;KIT;DUSP5;SHC3;PTPN3;NRG1;KDR;SPRED1;FGFR4;BTC;PRKG2;EREG;KITLG;IGF1;RASGRF1;RASGRP1;MAP3K20;PDE6D;FGF1;FGF13;APOA1;RASA2
prerank,GO_Biological_Process_2021__membrane fusion involved in viral entry into host cell (GO:0039663),0.9066052685386542,1.3611574334073009,0.017857142857142856,1.0,1.0,1/6,2.19%,CD4
prerank,GO_Biological_Process_2021__fusion of virus membrane with host plasma membrane (GO:0019064),0.9066052685386542,1.3611574334073009,0.017857142857142856,1.0,1.0,1/6,2.19%,CD4
prerank,GO_Biological_Process_2021__endothelial cell differentiation (GO:0045446),-0.7151766407523826,-1.3609569524931973,0.2,0.8972092019397058,1.0,1/9,0.77%,KDR
prerank,GO_Biological_Process_2021__cellular response to inorganic substance (GO:0071241),-0.6879205800439743,-1.3605091026511977,0.11627906976744186,0.8972243283877447,1.0,4/14,12.76%,TIMELESS;MTR;DDX11;SPIDR
prerank,GO_Biological_Process_2021__regulation of feeding behavior (GO:0060259),-0.7335631877186913,-1.3604669076738678,0.1111111111111111,0.894688298358553,1.0,5/8,18.35%,STAT3;NR4A3;CFAP20;SGIP1;EIF2AK4
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection morphogenesis (GO:0120039),-0.5596000697891069,-1.3603072838825339,0.16129032258064516,0.8930299020160388,1.0,4/48,4.02%,NRK;BMP7;NYAP2;SGK1
prerank,GO_Biological_Process_2021__dorsal/ventral pattern formation (GO:0009953),-0.7408727182766219,-1.3601059468186574,0.11627906976744186,0.8916394661592884,1.0,8/14,16.38%,GREM1;SFRP1;PTCH1;DSCAML1;NOG;NBL1;ACVR1;FBXL15
prerank,PanglaoDB_Augmented_2021__Oligodendrocyte Progenitor Cells,-0.5146913037480247,-1.359787346964845,0.047619047619047616,0.8908144560556651,1.0,24/118,14.60%,ETV5;SHC3;KCNIP1;ASCL1;NTM;VCAN;TNR;SLC6A1;LHFPL3;ADGRA1;NYAP1;ZNF536;MMD2;MAPK4;PDGFRA;LRRTM3;SYNDIG1;STMN2;ELAVL3;ARNT2;GRIA2;BRINP2;BRINP1;EPN2
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882),0.692538897601518,1.3596382145759278,0.078125,1.0,1.0,7/17,26.97%,FKBP1B;ATP1B1;CAMK2D;CALM3;ATP2A2;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081),-0.6930585638757886,-1.3596235573622504,0.1794871794871795,0.888926589363711,1.0,2/13,4.94%,KIT;TICAM1
prerank,GO_Biological_Process_2021__cell-cell junction maintenance (GO:0045217),-0.8168492784476226,-1.3595830527866088,0.07894736842105263,0.8865816923027757,1.0,2/8,9.47%,F2RL1;CSF1R
prerank,GO_Biological_Process_2021__establishment of protein localization to chromatin (GO:0071169),-0.7704368976152636,-1.3593690369701483,0.15789473684210525,0.8853548018570583,1.0,4/6,22.04%,MACROH2A2;LRWD1;MACROH2A1;RUVBL2
prerank,PanglaoDB_Augmented_2021__Clara Cells,0.6710873320311843,1.3583141563152814,0.05263157894736842,1.0,1.0,14/41,18.52%,STEAP4;ALDH1A1;SMIM22;VWA2;SYT2;AHR;TFCP2L1;SCEL;B3GNT3;MUC4;TMC4;SFTPC;SFTPD;MUC20
prerank,GO_Biological_Process_2021__protein insertion into membrane (GO:0051205),-0.6197491125925323,-1.3579253652688235,0.06451612903225806,0.8920085583389774,1.0,3/24,4.89%,RTP5;CYB5A;EMD
prerank,GO_Biological_Process_2021__regulation of synapse structural plasticity (GO:0051823),-0.803139959979756,-1.357684390506105,0.18181818181818182,0.8907305637228441,1.0,2/5,10.30%,FRMPD4;CTNNA2
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor 4 signaling pathway (GO:0034144),-0.863206009762781,-1.3572891872632653,0.12903225806451613,0.8898388895819362,1.0,1/5,0.33%,RAB7B
prerank,GO_Biological_Process_2021__endothelial cell proliferation (GO:0001935),0.7887533485715772,1.3570956130190777,0.06779661016949153,1.0,1.0,2/11,4.85%,NOX5;LOXL2
prerank,GO_Biological_Process_2021__regulation of stem cell division (GO:2000035),-0.814591488068301,-1.3570810326223797,0.12121212121212122,0.8885749594241045,1.0,2/7,4.08%,CDK2AP2;PRDM15
prerank,GO_Biological_Process_2021__cellular response to brain-derived neurotrophic factor stimulus (GO:1990416),0.8862339120115026,1.357012214940937,0.06666666666666667,1.0,1.0,1/5,6.03%,WASF1
prerank,GO_Biological_Process_2021__regulation of centrosome duplication (GO:0010824),0.7012594163223679,1.3568095030198715,0.09836065573770492,1.0,1.0,5/27,12.21%,RAB6C;CHMP4B;C10ORF90;CHMP2B;CHMP1A
prerank,GO_Biological_Process_2021__negative regulation of osteoblast proliferation (GO:0033689),-0.7999841011700405,-1.3567098050496322,0.18421052631578946,0.8884060330124041,1.0,2/7,4.71%,GREM1;SFRP1
prerank,GO_Biological_Process_2021__protein localization to synapse (GO:0035418),-0.7218884457158993,-1.3565550610778532,0.06666666666666667,0.8863614586805317,1.0,4/11,22.29%,NPHS1;SHANK1;MPP4;BSN
prerank,GO_Biological_Process_2021__detection of light stimulus involved in sensory perception (GO:0050962),0.8822162677068269,1.3563244180995733,0.09230769230769231,1.0,1.0,3/7,8.63%,CNGB1;GNAT2;CACNA2D4
prerank,GO_Biological_Process_2021__detection of light stimulus involved in visual perception (GO:0050908),0.8822162677068269,1.3563244180995733,0.09230769230769231,1.0,1.0,3/7,8.63%,CNGB1;GNAT2;CACNA2D4
prerank,GO_Biological_Process_2021__cell cycle checkpoint signaling (GO:0000075),0.8103552139816734,1.3562579331022535,0.11475409836065574,1.0,1.0,1/9,0.18%,WEE2
prerank,GO_Biological_Process_2021__cellular response to dsRNA (GO:0071359),-0.661631452043267,-1.355916474674016,0.05555555555555555,0.8875722069299444,1.0,2/15,2.42%,STING1;IFIH1
prerank,GO_Biological_Process_2021__heart trabecula morphogenesis (GO:0061384),-0.7090948988603198,-1.3557492494398868,0.15625,0.8859152336119384,1.0,4/14,5.75%,NRG1;BMP7;RBP4;TGFB2
prerank,PanglaoDB_Augmented_2021__Adipocytes,0.5467972354211089,1.3554148510070503,0.09210526315789473,1.0,1.0,22/131,8.75%,OLFML1;STEAP4;LAMA2;PTGES;TIMP3;ACTA2;PDGFRB;AOX1;POSTN;CYP1B1;FBLN5;NQO1;PLSCR4;AGT;SERPINF1;RARRES2;ECM2;ANGPTL2;ADRB1;PPARGC1A;TBX1;F10
prerank,GO_Biological_Process_2021__interferon-gamma-mediated signaling pathway (GO:0060333),0.6381581608549419,1.3552962239755095,0.125,1.0,1.0,12/42,20.54%,TRIM22;TRIM5;HCK;CIITA;HLA-A;STAT1;IRF1;CAMK2D;TRIM25;PTAFR;B2M;SP100
prerank,GO_Biological_Process_2021__microvillus organization (GO:0032528),0.7479413814002656,1.3552232839791054,0.18867924528301888,1.0,1.0,1/12,2.91%,STK26
prerank,GO_Biological_Process_2021__microvillus assembly (GO:0030033),0.7479413814002656,1.3552232839791054,0.18867924528301888,1.0,1.0,1/12,2.91%,STK26
prerank,GO_Biological_Process_2021__regulation of Rho protein signal transduction (GO:0035023),-0.5399354348038522,-1.3551424869531963,0.13793103448275862,0.8857974249105993,1.0,12/59,13.03%,P2RY10;PRAG1;F2RL1;HEG1;RTN4R;APOA1;KCTD13;NRP1;APOE;RIPOR2;GPR35;SYNPO2L
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell proliferation (GO:0001938),-0.5567127894725697,-1.3550019042845651,0.14285714285714285,0.8839080377973003,1.0,11/57,13.57%,KDR;ITGA4;CDH13;APLN;VASH2;VIP;NRP1;HMGB2;MDK;SCG2;NR4A1
prerank,GO_Biological_Process_2021__regulation of protein localization to cell surface (GO:2000008),0.682284820304617,1.354914622802991,0.078125,1.0,1.0,2/27,1.85%,CAV3;TMEM35A
prerank,GO_Biological_Process_2021__phosphatidylcholine acyl-chain remodeling (GO:0036151),0.7212522649806072,1.3548074722323762,0.03389830508474576,1.0,1.0,2/19,4.62%,PLA2G10;LPCAT3
prerank,GO_Biological_Process_2021__histone H3-K4 trimethylation (GO:0080182),-0.7458705317276038,-1.3547673923471117,0.1,0.8830159561090997,1.0,4/12,17.48%,PRDM7;BEND3;WDR82;TET2
prerank,GO_Biological_Process_2021__regulation of cholesterol transport (GO:0032374),-0.6463035244804813,-1.3546792125967715,0.05714285714285714,0.8809817358909492,1.0,3/19,7.04%,NAXE;ABCA13;APOA1
prerank,GO_Biological_Process_2021__microtubule polymerization or depolymerization (GO:0031109),-0.6125012878608888,-1.3540175890217967,0.22580645161290322,0.8816558784366744,1.0,6/20,13.52%,TPPP3;FGF13;MAP7D3;KATNB1;STMN2;KIF24
prerank,GO_Biological_Process_2021__phosphatidylethanolamine acyl-chain remodeling (GO:0036152),0.7899775942478386,1.3539370093884258,0.04838709677419355,1.0,1.0,2/12,4.62%,PLA2G10;LPCAT3
prerank,GO_Biological_Process_2021__phagolysosome assembly (GO:0001845),-0.7165966889390728,-1.3538635955746974,0.07894736842105263,0.8801669550947493,1.0,2/10,7.58%,RAB7B;RAB7A
prerank,GO_Biological_Process_2021__pteridine-containing compound biosynthetic process (GO:0042559),-0.8258321347534359,-1.3532436944616504,0.08695652173913043,0.8808395601641194,1.0,3/5,8.42%,GCH1;DHFR;MTHFS
prerank,GO_Biological_Process_2021__dense core granule cytoskeletal transport (GO:0099519),0.8315818683171801,1.3525587306881275,0.10344827586206896,1.0,1.0,1/7,6.55%,SYT4
prerank,GO_Biological_Process_2021__regulation of extracellular exosome assembly (GO:1903551),-0.8019407795449109,-1.3516857634860875,0.11904761904761904,0.8862878787599934,1.0,2/5,14.88%,SDC4;TSG101
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 4 signaling pathway (GO:0034145),-0.7898875806500473,-1.3515348081622185,0.14285714285714285,0.8845157600463855,1.0,1/7,1.47%,F2RL1
prerank,GO_Biological_Process_2021__positive regulation of protein deacetylation (GO:0090312),0.7849432724732155,1.3514331205966974,0.05084745762711865,1.0,1.0,2/11,5.70%,ZBTB7B;ING2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via nonhomologous end joining (GO:2001034),-0.6715768606044816,-1.3512434869721095,0.08571428571428572,0.8836397836426657,1.0,4/15,17.70%,PNKP;SHLD1;KMT5B;DTX3L
prerank,PanglaoDB_Augmented_2021__Alveolar Macrophages,0.6182050658513862,1.351237417835405,0.04411764705882353,1.0,1.0,6/48,6.60%,C3AR1;MS4A6A;FGL2;HCK;CD300LF;CD14
prerank,GO_Biological_Process_2021__negative regulation of protein ubiquitination (GO:0031397),-0.5378265142861343,-1.3511489399308076,0.04,0.8814837197860437,1.0,10/46,15.26%,PER2;SVBP;LIMK1;TAF1;CHP1;U2AF2;SH3RF2;USP4;SIRT7;IVNS1ABP
prerank,GO_Biological_Process_2021__proteasomal ubiquitin-independent protein catabolic process (GO:0010499),0.7411474784665696,1.3506704655696928,0.0625,1.0,1.0,4/18,15.17%,ENC1;PSMB6;PSMA3;PSMB8
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902253),0.8024634148517702,1.3503649337860846,0.10909090909090909,1.0,1.0,2/8,10.31%,MSX1;RPS7
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:0042771),0.7248774144449147,1.3498477271274065,0.11475409836065574,1.0,1.0,1/19,0.72%,AEN
prerank,GO_Biological_Process_2021__heme catabolic process (GO:0042167),0.8023211395339084,1.349092806628599,0.10294117647058823,1.0,1.0,3/8,4.11%,AMBP;SLCO2B1;ABCC2
prerank,GO_Biological_Process_2021__porphyrin-containing compound catabolic process (GO:0006787),0.8023211395339084,1.349092806628599,0.10294117647058823,1.0,1.0,3/8,4.11%,AMBP;SLCO2B1;ABCC2
prerank,GO_Biological_Process_2021__regulation of dendritic spine development (GO:0060998),-0.6632047557374714,-1.3490822312783093,0.0967741935483871,0.8901919994934454,1.0,10/21,23.76%,GRIN3A;SHANK1;DLG5;PTPRS;APOE;FOXO6;NEURL1;SRGAP2C;KIF1A;PSEN1
prerank,GO_Biological_Process_2021__neutral lipid catabolic process (GO:0046461),-0.8410765705965719,-1.3488296767979857,0.1282051282051282,0.8890678005489849,1.0,1/5,7.07%,LYPLA2
prerank,GO_Biological_Process_2021__anterior/posterior axis specification (GO:0009948),0.8121672237453952,1.3484087109242706,0.058823529411764705,1.0,1.0,2/10,10.36%,WNT8A;RIPPLY2
prerank,GO_Biological_Process_2021__positive regulation of p38MAPK cascade (GO:1900745),0.740868152115497,1.3479009300471883,0.11475409836065574,1.0,1.0,2/18,1.74%,GADD45B;AGER
prerank,GO_Biological_Process_2021__megakaryocyte differentiation (GO:0030219),-0.7277740401404093,-1.3478276098224686,0.1388888888888889,0.892051246515929,1.0,2/9,6.86%,KIT;IL11
prerank,GO_Biological_Process_2021__positive regulation of ceramide biosynthetic process (GO:2000304),-0.8051909702619855,-1.3473037119713287,0.14285714285714285,0.889494593114165,1.0,4/8,16.81%,SPHK2;PRKCD;SMPD3;NSMAF
prerank,GO_Biological_Process_2021__positive regulation of sphingolipid biosynthetic process (GO:0090154),-0.8051909702619855,-1.3473037119713287,0.14285714285714285,0.889494593114165,1.0,4/8,16.81%,SPHK2;PRKCD;SMPD3;NSMAF
prerank,GO_Biological_Process_2021__heart process (GO:0003015),-0.7028725430267553,-1.3468674915127,0.15384615384615385,0.8894510056880855,1.0,2/11,2.44%,NOX4;SGCD
prerank,GO_Biological_Process_2021__peptidyl-arginine modification (GO:0018195),-0.7572612355863175,-1.3465451140903015,0.13636363636363635,0.8885020716029121,1.0,3/10,16.00%,PRMT5;PRMT8;ART4
prerank,GO_Biological_Process_2021__negative regulation of cardiac muscle hypertrophy (GO:0010614),0.767932046487988,1.346535181522319,0.171875,1.0,1.0,2/10,4.13%,CAV3;NOTCH1
prerank,GO_Biological_Process_2021__ammonium transmembrane transport (GO:0072488),0.8797164908970326,1.3460070757464875,0.07017543859649122,1.0,1.0,2/6,10.73%,SLC12A7;RHD
prerank,GO_Biological_Process_2021__neuron migration (GO:0001764),-0.5395577997082239,-1.3457239992207433,0.04,0.8903854183754453,1.0,5/47,6.99%,MDGA1;SH3RF1;MARK1;FGF13;SPOCK1
prerank,GO_Biological_Process_2021__regulation of translational elongation (GO:0006448),0.9037908694525597,1.345655746381511,0.06451612903225806,1.0,1.0,1/5,2.69%,EIF5A2
prerank,GO_Biological_Process_2021__cardiac muscle cell-cardiac muscle cell adhesion (GO:0086042),-0.8654903154565062,-1.345309690032163,0.0975609756097561,0.8903005649194845,1.0,1/6,0.68%,PKP2
prerank,GO_Biological_Process_2021__positive regulation of pri-miRNA transcription by RNA polymerase II (GO:1902895),-0.5869599157725369,-1.3451447178223026,0.13513513513513514,0.888966700544232,1.0,7/24,9.54%,ATOH8;FOS;APLN;TGFB2;ETS1;STAT3;SMARCA4
prerank,GO_Biological_Process_2021__organophosphate catabolic process (GO:0046434),0.8629550084804811,1.345111273300735,0.03278688524590164,1.0,1.0,1/7,0.36%,ENPP2
prerank,GO_Biological_Process_2021__negative regulation of glial cell proliferation (GO:0060253),0.8659674696938693,1.3448166180986607,0.07692307692307693,1.0,1.0,2/5,11.31%,NOTCH1;SOX11
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001267),0.8164872844324622,1.344797598037191,0.07692307692307693,1.0,1.0,2/9,13.26%,FAS;PLAUR
prerank,GO_Biological_Process_2021__dephosphorylation (GO:0016311),-0.5205938158629247,-1.3446454393669174,0.037037037037037035,0.8886136660670652,1.0,29/135,14.85%,DUSP4;DUSP5;PTPN3;PTPRT;PTPRB;PTPN9;CDC14B;PPP2R3B;DUSP2;THNSL2;PPEF1;PTPRH;PNKP;PPM1G;DUSP12;PGP;TIMM50;PTPRS;DUSP10;PPP1CA;DUSP15;PLPPR5;PPP2R1B;PTPRO;DUSP6;PPM1M;PTPN1;SSH1;SGPP2
prerank,GO_Biological_Process_2021__production of siRNA involved in RNA interference (GO:0030422),0.7594180184520152,1.3441459519019152,0.14754098360655737,1.0,1.0,2/8,11.21%,HENMT1;MRPL44
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic translation (GO:2000767),0.8512214440082824,1.343997595335447,0.08064516129032258,1.0,1.0,1/5,7.38%,YBX3
prerank,GO_Biological_Process_2021__homophilic cell adhesion via plasma membrane adhesion molecules (GO:0007156),-0.5248028565109988,-1.3435145955759424,0.04,0.8911360818495379,1.0,7/48,6.48%,PTPRT;IGSF11;CDH13;AMIGO1;CNTN6;SDK1;DSCAML1
prerank,GO_Biological_Process_2021__cell junction maintenance (GO:0034331),-0.7381298225116228,-1.34345318477417,0.14285714285714285,0.8891913239352954,1.0,2/11,9.47%,F2RL1;CSF1R
prerank,PanglaoDB_Augmented_2021__Basophils,0.5575975391788596,1.3431608931534724,0.04411764705882353,1.0,1.0,13/81,10.18%,C3AR1;MS4A6A;P2RY1;CD4;STAB1;FGL2;HCK;CD300LF;CD14;NFIL3;HGF;DNASE2B;SIGLEC1
prerank,GO_Biological_Process_2021__phosphatidylserine metabolic process (GO:0006658),0.7446687335856457,1.3418534993090185,0.06060606060606061,1.0,1.0,3/19,6.20%,PLA2G10;LPCAT3;SERINC1
prerank,GO_Biological_Process_2021__positive regulation of cell activation (GO:0050867),-0.9090377878167422,-1.3413158927867204,0.06976744186046512,0.8966801063299483,1.0,1/5,0.60%,SELP
prerank,GO_Biological_Process_2021__regulation of lymphocyte activation (GO:0051249),0.7896283104306515,1.3412796834227994,0.06451612903225806,1.0,1.0,3/9,6.14%,CD4;CCL5;THEMIS2
prerank,GO_Biological_Process_2021__positive regulation of macrophage derived foam cell differentiation (GO:0010744),0.8246851022817074,1.3412625594486782,0.06060606060606061,1.0,1.0,2/10,6.08%,PLA2G10;AGT
prerank,GO_Biological_Process_2021__tRNA pseudouridine synthesis (GO:0031119),-0.7916233260122671,-1.3409296792326912,0.18421052631578946,0.8968105224899079,1.0,2/6,15.73%,PUSL1;RPUSD4
prerank,GO_Biological_Process_2021__lysine catabolic process (GO:0006554),-0.7206589252404652,-1.3408972459498916,0.125,0.8919748558127186,1.0,3/12,8.93%,AASS;OGDH;HYKK
prerank,GO_Biological_Process_2021__lysine metabolic process (GO:0006553),-0.7206589252404652,-1.3408972459498916,0.125,0.8919748558127186,1.0,3/12,8.93%,AASS;OGDH;HYKK
prerank,GO_Biological_Process_2021__glycogen metabolic process (GO:0005977),-0.6580728945074668,-1.3408294560183103,0.15384615384615385,0.8897485785310345,1.0,1/23,0.17%,PER2
prerank,GO_Biological_Process_2021__positive regulation of cell junction assembly (GO:1901890),-0.5465769594519854,-1.340381395788802,0.029411764705882353,0.889972511660474,1.0,8/45,11.32%,KDR;EPHB2;CLSTN2;SFRP1;ACE2;DLG5;NRP1;SYNDIG1
prerank,GO_Biological_Process_2021__natural killer cell mediated cytotoxicity (GO:0042267),0.8058549595378202,1.33995292071736,0.07692307692307693,1.0,1.0,3/10,9.53%,CLEC2A;CORO1A;TUBB
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transporter activity (GO:1901021),-0.6420710015441237,-1.3398369326935113,0.22,0.8903852067107015,1.0,1/19,0.28%,STAC
prerank,GO_Biological_Process_2021__positive regulation of B cell activation (GO:0050871),-0.5890499719292789,-1.339616656094002,0.06666666666666667,0.8889768819672068,1.0,2/37,2.36%,CD38;EPHB2
prerank,"GO_Biological_Process_2021__CD4-positive, alpha-beta T cell activation (GO:0035710)",-0.8291142229835131,-1.3395623474014458,0.17777777777777778,0.8869714669424758,1.0,1/5,2.66%,CDH26
prerank,GO_Biological_Process_2021__purine deoxyribonucleotide catabolic process (GO:0009155),-0.8311165650989594,-1.3394016791492767,0.20588235294117646,0.8853159775862415,1.0,2/6,6.13%,PNP;SAMHD1
prerank,GO_Biological_Process_2021__nucleotide biosynthetic process (GO:0009165),-0.7195154503483207,-1.339172281051549,0.15625,0.8840452030472206,1.0,3/16,8.67%,NMNAT3;PNP;RRM2
prerank,GO_Biological_Process_2021__regulation of T cell apoptotic process (GO:0070232),0.8229036448550675,1.3386675857016932,0.15517241379310345,1.0,1.0,2/7,8.00%,CCL5;IDO1
prerank,GO_Biological_Process_2021__central nervous system neuron differentiation (GO:0021953),0.6500970992555662,1.3386615799962545,0.10909090909090909,1.0,1.0,1/28,0.04%,NPY
prerank,GO_Biological_Process_2021__neuron projection fasciculation (GO:0106030),-0.69665239972752,-1.3383317800616277,0.15384615384615385,0.8870548865809207,1.0,2/10,3.29%,EPHB2;AMIGO1
prerank,GO_Biological_Process_2021__purine-containing compound salvage (GO:0043101),-0.7341561967239918,-1.3381975494929625,0.13513513513513514,0.8854123496077905,1.0,3/11,3.37%,APRT;GMPR;PNP
prerank,GO_Biological_Process_2021__histone exchange (GO:0043486),0.676168928380419,1.3379148655868627,0.1,1.0,1.0,8/34,15.28%,CENPO;CENPI;CENPK;KNL1;SPTY2D1;CENPU;ACTR6;CENPL
prerank,GO_Biological_Process_2021__cytoskeleton-dependent cytokinesis (GO:0061640),0.6266822576745108,1.3372857769838988,0.0547945205479452,1.0,1.0,7/64,10.92%,NOX5;ROPN1B;RASA1;CHMP4B;SEPTIN14;ANLN;RHOB
prerank,GO_Biological_Process_2021__regulation of response to endoplasmic reticulum stress (GO:1905897),0.7802741382834343,1.3361226036164213,0.07547169811320754,1.0,1.0,2/12,4.62%,WFS1;LPCAT3
prerank,GO_Biological_Process_2021__cellular defense response (GO:0006968),0.711371681072906,1.3360777252503817,0.09375,1.0,1.0,3/20,2.21%,GNLY;ITK;KLRG1
prerank,GO_Biological_Process_2021__protein localization to ciliary membrane (GO:1903441),-0.7465761286813661,-1.3359075752074974,0.17777777777777778,0.8947791218075482,1.0,1/7,2.44%,ARL13B
prerank,GO_Biological_Process_2021__smooth muscle tissue development (GO:0048745),0.8041130878644863,1.3356632817817626,0.13114754098360656,1.0,1.0,1/8,0.75%,MYLK
prerank,GO_Biological_Process_2021__negative regulation of MAPK cascade (GO:0043409),-0.5205510839806302,-1.33543938219013,0.08333333333333333,0.895281998791216,1.0,11/74,6.40%,DUSP4;SPRED2;SPRED3;BMP7;SPRED1;SPRY4;RGS14;EPHB2;PRDM15;PRKCD;IGBP1
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061419),0.9339864096725469,1.335036197721835,0.03278688524590164,1.0,1.0,1/5,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__cell chemotaxis (GO:0060326),-0.5749332808854798,-1.3345254767649006,0.18518518518518517,0.8974885515739585,1.0,14/40,13.57%,KIT;CCL28;LEF1;AZU1;PRKCD;PDGFRA;ACKR2;CXCR5;NRP1;ABCC1;HMGB2;PARVA;ELMO2;NR4A1
prerank,GO_Biological_Process_2021__regulation of anatomical structure morphogenesis (GO:0022603),-0.4882642248882709,-1.3345092050815048,0.07407407407407407,0.8953549182276895,1.0,12/107,7.53%,PID1;TSPAN12;VASH1;LZTS3;CLDN4;WTIP;SFRP1;BCL6;KNDC1;ZMYM6;ETS1;VASH2
prerank,GO_Biological_Process_2021__negative regulation of neurogenesis (GO:0050768),0.6419692759790132,1.3342994928460092,0.09230769230769231,1.0,1.0,5/29,11.77%,LRP4;NOTCH1;OMG;REST;YWHAH
prerank,GO_Biological_Process_2021__chondroitin sulfate catabolic process (GO:0030207),-0.7624006973182924,-1.333503372820244,0.10526315789473684,0.8981401236266262,1.0,2/9,4.76%,VCAN;ARSB
prerank,GO_Biological_Process_2021__mRNA transcription by RNA polymerase II (GO:0042789),-0.7662265582429034,-1.3328166106194297,0.13636363636363635,0.8989602039006713,1.0,2/6,14.26%,C5AR1;TFCP2
prerank,GO_Biological_Process_2021__regulation of protein localization to cell periphery (GO:1904375),0.7336136869329101,1.332375763718028,0.11940298507462686,1.0,1.0,1/16,1.49%,LDLRAP1
prerank,GO_Biological_Process_2021__ether lipid biosynthetic process (GO:0008611),-0.7744445156596811,-1.3321127384484124,0.13953488372093023,0.9001063810742483,1.0,1/9,1.59%,PEX7
prerank,GO_Biological_Process_2021__regulation of T cell migration (GO:2000404),0.7626317135193718,1.3316044649903787,0.16393442622950818,1.0,1.0,2/11,5.30%,CCL5;DOCK8
prerank,GO_Biological_Process_2021__angiotensin-activated signaling pathway (GO:0038166),-0.8536433113496382,-1.3306556037853143,0.11764705882352941,0.905457010298974,1.0,1/5,2.01%,CA2
prerank,GO_Biological_Process_2021__regulation of T cell mediated immunity (GO:0002709),0.8985442389875041,1.330388876305052,0.10344827586206896,1.0,1.0,2/5,9.87%,AGER;WAS
prerank,GO_Biological_Process_2021__adenosine to inosine editing (GO:0006382),-0.7912292229861566,-1.32992764180756,0.20588235294117646,0.9069455914025953,1.0,2/6,12.65%,ADARB2;ADAT2
prerank,GO_Biological_Process_2021__regulation of regulatory T cell differentiation (GO:0045589),-0.6487860005348958,-1.3291813626471367,0.06060606060606061,0.9083172105281028,1.0,6/15,12.12%,RUNX1;SOX12;BCL6;CBFB;DUSP10;MDK
prerank,GO_Biological_Process_2021__negative regulation of cholesterol transport (GO:0032375),0.8387344682162099,1.3283004130005727,0.08771929824561403,1.0,1.0,1/7,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__urate metabolic process (GO:0046415),-0.7859992307928844,-1.327855165993328,0.15789473684210525,0.9116072040705808,1.0,3/7,4.28%,SLC16A9;PNP;SLC2A9
prerank,GO_Biological_Process_2021__TORC1 signaling (GO:0038202),-0.7309591813937533,-1.3275953656125281,0.125,0.9108218781842632,1.0,4/8,21.58%,CARD11;RPTOR;MTOR;LARP1
prerank,GO_Biological_Process_2021__regulation of ribonucleoprotein complex localization (GO:2000197),-0.8133737547864388,-1.3275025079855491,0.0967741935483871,0.9066676483951863,1.0,2/6,8.15%,TPR;IWS1
prerank,GO_Biological_Process_2021__regulation of mRNA export from nucleus (GO:0010793),-0.8133737547864388,-1.3275025079855491,0.0967741935483871,0.9066676483951863,1.0,2/6,8.15%,TPR;IWS1
prerank,GO_Biological_Process_2021__erythrocyte differentiation (GO:0030218),-0.5283521226753145,-1.3272669849204013,0.10344827586206896,0.9055053907430972,1.0,5/36,8.01%,KIT;INHA;ALAS1;LYAR;ID2
prerank,GO_Biological_Process_2021__positive regulation of oxidoreductase activity (GO:0051353),0.7666731328131102,1.3271214864240268,0.14516129032258066,1.0,1.0,2/10,16.88%,AGT;RFK
prerank,GO_Biological_Process_2021__G protein-coupled serotonin receptor signaling pathway (GO:0098664),-0.7994226674549263,-1.3269366683823633,0.20689655172413793,0.9049587858835435,1.0,1/8,0.27%,HTR1F
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transmembrane transport (GO:1904427),0.7564259542371801,1.3264013315533003,0.10606060606060606,1.0,1.0,3/16,11.81%,CALCR;CASQ1;GPER1
prerank,GO_Biological_Process_2021__regulation of vasculogenesis (GO:2001212),-0.8153546215148753,-1.326325212305554,0.1111111111111111,0.9058459919902063,1.0,2/9,6.17%,KDR;RIN2
prerank,GO_Biological_Process_2021__negative regulation of B cell apoptotic process (GO:0002903),-0.8924918571124767,-1.3262637271513145,0.05,0.9039809350314745,1.0,2/6,7.25%,BCL6;FOXP1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for mitochondrial protein translation (GO:0070127),-0.734535659571731,-1.3261128538704186,0.08108108108108109,0.9028016067637229,1.0,6/7,26.56%,WARS2;EARS2;YARS2;GARS1;TARS2;DARS2
prerank,GO_Biological_Process_2021__DNA ligation (GO:0006266),-0.8280179674413132,-1.3258762526716008,0.14705882352941177,0.9018412530631781,1.0,3/6,9.75%,XRCC4;MGMT;XRCC6
prerank,GO_Biological_Process_2021__xylulose 5-phosphate biosynthetic process (GO:1901159),-0.8135038090572837,-1.3256912414030442,0.11904761904761904,0.8959584254010952,1.0,3/5,12.03%,XYLB;SORD;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process (GO:0006064),-0.8135038090572837,-1.3256912414030442,0.11904761904761904,0.8959584254010952,1.0,3/5,12.03%,XYLB;SORD;DCXR
prerank,GO_Biological_Process_2021__glucuronate catabolic process to xylulose 5-phosphate (GO:0019640),-0.8135038090572837,-1.3256912414030442,0.11904761904761904,0.8959584254010952,1.0,3/5,12.03%,XYLB;SORD;DCXR
prerank,GO_Biological_Process_2021__positive regulation of circadian rhythm (GO:0042753),-0.8250679819778552,-1.3256763113342018,0.17777777777777778,0.8938998720681032,1.0,2/6,8.93%,CRH;RORA
prerank,GO_Biological_Process_2021__dosage compensation by inactivation of X chromosome (GO:0009048),0.717925002288748,1.3252903560239895,0.15873015873015872,1.0,1.0,2/12,19.18%,BRCA1;YTHDC1
prerank,GO_Biological_Process_2021__hemidesmosome assembly (GO:0031581),-0.7727111023997284,-1.3249310597803483,0.1388888888888889,0.8949722518161427,1.0,3/9,9.10%,LAMB3;ITGA6;LAMA3
prerank,GO_Biological_Process_2021__Arp2/3 complex-mediated actin nucleation (GO:0034314),-0.6772152522051629,-1.3247207186036971,0.15151515151515152,0.8935559466722015,1.0,2/12,4.11%,IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__vacuolar acidification (GO:0007035),-0.707221248593997,-1.3244141646936407,0.23333333333333334,0.8929491313527548,1.0,2/17,5.88%,ATP6V0D2;CLN6
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan metabolic process (GO:0030201),-0.6469322097563646,-1.324323574843144,0.16666666666666666,0.8910923608500135,1.0,9/21,14.35%,SULF2;HS3ST4;HS3ST3B1;HS3ST5;EXT1;B3GAT3;EXT2;XYLT2;SGSH
prerank,GO_Biological_Process_2021__lipid oxidation (GO:0034440),0.80840650122119,1.3240043214586408,0.08955223880597014,1.0,1.0,5/9,13.88%,PLA2G7;ALOX12;ADIPOR2;PPARGC1A;ACOX1
prerank,GO_Biological_Process_2021__NLS-bearing protein import into nucleus (GO:0006607),0.7276226174323976,1.3237815368793309,0.09090909090909091,1.0,1.0,3/19,8.85%,RGPD3;RGPD4;RGPD1
prerank,GO_Biological_Process_2021__negative regulation of peptidase activity (GO:0010466),0.6329926369279382,1.32377163376306,0.07352941176470588,1.0,1.0,8/36,9.68%,TIMP3;TIMP2;AGT;SERPINA10;SERPINF1;KNG1;SERPINI2;SPOCK3
prerank,GO_Biological_Process_2021__positive regulation of calcium ion import (GO:0090280),0.8509734986403203,1.3233680483860806,0.11475409836065574,1.0,1.0,2/7,3.19%,CALCR;PDGFRB
prerank,GO_Biological_Process_2021__actin nucleation (GO:0045010),-0.6504181993550717,-1.3224569566878766,0.1724137931034483,0.897195271680548,1.0,2/17,4.11%,IQGAP2;ARPC3
prerank,GO_Biological_Process_2021__regulation of hemopoiesis (GO:1903706),-0.7232840125523664,-1.3222460203151878,0.21621621621621623,0.8959605899753847,1.0,3/11,7.73%,GFI1B;RUNX1;CBFB
prerank,"GO_Biological_Process_2021__tRNA splicing, via endonucleolytic cleavage and ligation (GO:0006388)",-0.7081407279171312,-1.321911160223527,0.14634146341463414,0.8954920233056235,1.0,2/15,2.61%,CPSF1;TRPT1
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix organization (GO:1903055),-0.6810691730775684,-1.3212961931767868,0.15151515151515152,0.8961975182438432,1.0,3/15,6.06%,MELTF;RUNX1;PDPN
prerank,"GO_Biological_Process_2021__posttranslational protein targeting to membrane, translocation (GO:0031204)",0.7801954919166013,1.3212773619566778,0.13114754098360656,1.0,1.0,1/7,7.54%,HSPA5
prerank,GO_Biological_Process_2021__positive regulation of cellular component biogenesis (GO:0044089),-0.5340084466826398,-1.3210489389833586,0.07142857142857142,0.8951118234402635,1.0,17/70,14.88%,NRG1;BMP7;BCL2L11;SDC4;TRABD2A;TPR;RAB7A;ERCC1;LIMK1;SMPD3;CLU;SPIDR;SYNPO2L;FAF1;SH3GLB1;SNF8;TSG101
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection organization (GO:0120036),0.5472172966080332,1.3208177940508177,0.05333333333333334,1.0,1.0,5/107,5.82%,NPY;ROPN1B;AGER;PLP1;UNC5A
prerank,GO_Biological_Process_2021__negative regulation of muscle hypertrophy (GO:0014741),0.8189123473428339,1.320804307784134,0.14516129032258066,1.0,1.0,2/7,4.13%,CAV3;NOTCH1
prerank,PanglaoDB_Augmented_2021__Schwann Cells,0.5419553116139814,1.3207757011954406,0.06329113924050633,1.0,1.0,15/125,9.74%,NPY;LRP4;PPP1R1B;CD82;CTHRC1;SOX10;IGFBP5;TST;PLP1;CHST1;SCN4B;AGT;CPE;SCN7A;CNTN2
prerank,GO_Biological_Process_2021__regulation of B cell apoptotic process (GO:0002902),-0.7396078059797503,-1.3206115048333706,0.14285714285714285,0.8950259994762473,1.0,2/7,7.25%,BCL6;FOXP1
prerank,GO_Biological_Process_2021__negative regulation of neuron differentiation (GO:0045665),-0.6784893873567691,-1.3203396923302522,0.14814814814814814,0.8945300375380487,1.0,3/16,4.04%,BMP7;ASCL1;DTX1
prerank,GO_Biological_Process_2021__DNA alkylation (GO:0006305),-0.6783993178008029,-1.319634740952332,0.14705882352941177,0.8932048254826341,1.0,9/17,19.55%,FOS;TEX15;DNMT1;DMAP1;BEND3;EHMT2;GATAD2A;DNMT3B;EHMT1
prerank,GO_Biological_Process_2021__DNA methylation or demethylation (GO:0044728),-0.6783993178008029,-1.319634740952332,0.14705882352941177,0.8932048254826341,1.0,9/17,19.55%,FOS;TEX15;DNMT1;DMAP1;BEND3;EHMT2;GATAD2A;DNMT3B;EHMT1
prerank,GO_Biological_Process_2021__sequestering of BMP from receptor via BMP binding (GO:0038098),-0.7955156075387955,-1.3193342129755339,0.1111111111111111,0.8923432160126078,1.0,4/7,13.46%,GREM1;CHRDL1;NOG;NBL1
prerank,GO_Biological_Process_2021__cellular response to monoamine stimulus (GO:0071868),-0.7725075084430346,-1.319070542267204,0.225,0.8896859199481929,1.0,2/5,11.93%,DRD1;NR4A3
prerank,GO_Biological_Process_2021__response to catecholamine (GO:0071869),-0.7725075084430346,-1.319070542267204,0.225,0.8896859199481929,1.0,2/5,11.93%,DRD1;NR4A3
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell action potential (GO:0098911),-0.7150281115741743,-1.3188875330873668,0.12195121951219512,0.8883330858784794,1.0,1/10,0.68%,PKP2
prerank,GO_Biological_Process_2021__organonitrogen compound catabolic process (GO:1901565),0.574759404992792,1.3182848580586908,0.07246376811594203,1.0,1.0,12/51,14.85%,ENPP2;PLA2G10;PLA2G7;ERAP2;ELANE;TST;SIAH1;LVRN;ENPEP;IL4I1;CLPX;NAALADL1
prerank,GO_Biological_Process_2021__regulation of microtubule-based process (GO:0032886),-0.5891579111021977,-1.3181088560268597,0.16129032258064516,0.8902162747549897,1.0,7/35,11.37%,CDK2AP2;EPHA3;TRIM36;IGBP1;AURKA;TRAF3IP1;MAP10
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta production (GO:0071634),-0.7102502046495055,-1.3177053037108863,0.15151515151515152,0.8898754562723242,1.0,3/12,7.08%,LTBP1;TGFB2;SERPINF2
prerank,GO_Biological_Process_2021__protein localization to centrosome (GO:0071539),-0.7394437274733535,-1.3173998550747283,0.23333333333333334,0.8890675160037343,1.0,8/17,22.06%,NEDD1;CEP83;PCM1;PIBF1;NUDCD3;HOOK3;GOLGB1;CCDC14
prerank,GO_Biological_Process_2021__cellular response to exogenous dsRNA (GO:0071360),-0.688775564444374,-1.3165891468055515,0.027777777777777776,0.8909689790769735,1.0,2/12,2.42%,STING1;IFIH1
prerank,GO_Biological_Process_2021__positive regulation of nervous system process (GO:0031646),-0.7081614192023016,-1.3161574220184558,0.14285714285714285,0.8911619692834667,1.0,3/14,7.21%,UNC13B;HCRT;TENM4
prerank,GO_Biological_Process_2021__regulation of interleukin-13 production (GO:0032656),-0.8021936646136484,-1.3144696154998252,0.15151515151515152,0.897304831450287,1.0,2/8,6.17%,LEF1;SPHK2
prerank,"GO_Biological_Process_2021__protein localization to chromosome, telomeric region (GO:0070198)",-0.6761088590912692,-1.3143545403244516,0.15625,0.8956246887905577,1.0,2/14,6.88%,BRCA2;TPP1
prerank,GO_Biological_Process_2021__death-inducing signaling complex assembly (GO:0071550),0.8542580898127798,1.3142052295794593,0.11666666666666667,1.0,1.0,2/6,10.45%,FADD;CASP8
prerank,GO_Biological_Process_2021__negative regulation of viral release from host cell (GO:1902187),0.7702237243283584,1.313777365968471,0.12727272727272726,1.0,1.0,2/11,4.97%,TRIM5;TRIM32
prerank,GO_Biological_Process_2021__detection of mechanical stimulus involved in sensory perception (GO:0050974),-0.6967453550941967,-1.3136067703097782,0.15625,0.8968311350080107,1.0,2/13,8.02%,KIT;COL11A1
prerank,GO_Biological_Process_2021__neurotransmitter reuptake (GO:0098810),-0.7806614638133973,-1.3135838442972656,0.14893617021276595,0.8948958830264258,1.0,5/8,12.86%,SLC22A2;SLC6A4;SLC29A4;SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transmembrane transport (GO:1901380),0.7918897362801465,1.313489770494405,0.11666666666666667,1.0,1.0,1/8,1.71%,CAV3
prerank,GO_Biological_Process_2021__cilium-dependent cell motility (GO:0060285),0.6854047607257183,1.3134780985082333,0.1388888888888889,1.0,1.0,5/19,13.34%,DNAH3;CFAP54;DNAH8;CCDC39;DNAH7
prerank,PanglaoDB_Augmented_2021__Anterior Pituitary Gland Cells,-0.4799135375910423,-1.3134609243273399,0.1,0.8933648810384255,1.0,19/114,9.66%,CNGA3;RNF150;RIMBP2;PENK;SGCD;CACNA2D1;PCDH18;NTM;SST;SEZ6L2;ZNF385D;ZNF536;COL11A1;GRIA4;RAB3C;FGF14;GRIA1;TMEM196;PDGFRA
prerank,GO_Biological_Process_2021__digestive system development (GO:0055123),-0.7827873159554243,-1.31286848994874,0.1891891891891892,0.8938781585049237,1.0,1/8,0.36%,KIT
prerank,GO_Biological_Process_2021__bleb assembly (GO:0032060),0.8226964007339462,1.3126936903111641,0.03636363636363636,1.0,1.0,1/6,0.75%,MYLK
prerank,GO_Biological_Process_2021__cell junction assembly (GO:0034329),-0.47950338738698217,-1.312155601978842,0.15789473684210525,0.8943890486343686,1.0,14/88,14.91%,PKP2;CDH6;ITGA6;SDK1;SHANK2;CDHR3;CDH20;CDH1;DRD1;PCDHB4;TLN1;FARP1;DNER;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of protein export from nucleus (GO:0046827),-0.7124089443647676,-1.3119444876190116,0.12195121951219512,0.8931315164898721,1.0,4/14,17.64%,TPR;EMD;BAG3;ANP32B
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905007),-0.8254935097693081,-1.3119117449520215,0.15217391304347827,0.8911293403302857,1.0,3/5,16.59%,TGFB2;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__phosphatidylserine acyl-chain remodeling (GO:0036150),0.7914710733659038,1.3115125416706372,0.11290322580645161,1.0,1.0,2/10,4.62%,PLA2G10;LPCAT3
prerank,GO_Biological_Process_2021__synaptic vesicle localization (GO:0097479),-0.724159667195481,-1.310399757224641,0.17142857142857143,0.897372472298195,1.0,5/13,24.86%,SYNDIG1;TMEM230;DNM2;RAB27A;KIF5C
prerank,GO_Biological_Process_2021__pinocytosis (GO:0006907),0.7578812515494645,1.310350388794883,0.109375,1.0,1.0,1/7,4.46%,DOCK2
prerank,GO_Biological_Process_2021__positive regulation of response to DNA damage stimulus (GO:2001022),-0.5496815326681477,-1.3100719046208342,0.11428571428571428,0.897058637615042,1.0,8/48,8.75%,SPRED2;SPRED3;SPRED1;EYA4;PRKCD;BRCC3;ERCC8;HMGA2
prerank,GO_Biological_Process_2021__negative regulation of substrate adhesion-dependent cell spreading (GO:1900025),-0.7562848486838745,-1.3099900181027093,0.11904761904761904,0.893460963415863,1.0,2/11,1.89%,MELTF;SPRY4
prerank,GO_Biological_Process_2021__negative regulation of cell morphogenesis involved in differentiation (GO:0010771),-0.7562848486838745,-1.3099900181027093,0.11904761904761904,0.893460963415863,1.0,2/11,1.89%,MELTF;SPRY4
prerank,GO_Biological_Process_2021__regulation of neuron death (GO:1901214),-0.5483685972341202,-1.309912490645622,0.18518518518518517,0.8917712421849727,1.0,2/71,2.98%,PM20D1;FOS
prerank,GO_Biological_Process_2021__smooth muscle contraction (GO:0006939),0.7168816193185515,1.3096090180970967,0.12121212121212122,1.0,1.0,2/13,2.82%,MYLK;ACTA2
prerank,GO_Biological_Process_2021__response to corticosteroid (GO:0031960),0.8416397274680124,1.30958383909832,0.078125,1.0,1.0,2/6,4.01%,CALCR;GOT1
prerank,GO_Biological_Process_2021__cellular response to laminar fluid shear stress (GO:0071499),-0.7589182369576118,-1.3089086002846737,0.1951219512195122,0.894723441871787,1.0,1/6,7.26%,MAPK7
prerank,GO_Biological_Process_2021__prostaglandin transport (GO:0015732),-0.8290310501955144,-1.3087921280959671,0.16279069767441862,0.8933275209460769,1.0,3/5,14.61%,ABCC4;SLCO3A1;LEP
prerank,GO_Biological_Process_2021__short-chain fatty acid metabolic process (GO:0046459),0.7529205245470072,1.3083135067533245,0.18571428571428572,1.0,1.0,1/9,3.28%,ACOT4
prerank,GO_Biological_Process_2021__histone arginine methylation (GO:0034969),-0.7039507871483979,-1.3082990727762458,0.1875,0.8935397300898311,1.0,3/8,15.90%,NR1H4;PRMT5;PRMT6
prerank,GO_Biological_Process_2021__negative regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045869),-0.7609570164691875,-1.3079314785872687,0.14285714285714285,0.8932395679350009,1.0,2/8,8.75%,APOBEC3H;HMGA2
prerank,GO_Biological_Process_2021__detection of chemical stimulus involved in sensory perception of taste (GO:0050912),-0.7354138838462309,-1.307665115638883,0.20588235294117646,0.8922391676654108,1.0,5/8,7.81%,RTP5;TAS2R7;TAS2R9;CA6;GNAT3
prerank,GO_Biological_Process_2021__cellular response to leptin stimulus (GO:0044320),-0.7268698686345021,-1.30697041909276,0.16666666666666666,0.8935660528767684,1.0,4/8,20.75%,STAT3;NR4A3;LEP;GCK
prerank,GO_Biological_Process_2021__hexose biosynthetic process (GO:0019319),-0.5889374022745913,-1.3066808906272256,0.14285714285714285,0.8926964119465801,1.0,4/36,2.99%,PER2;G6PC3;RBP4;SLC37A4
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte differentiation (GO:0002761),-0.8782400398030219,-1.306307537872019,0.09375,0.8925275459667155,1.0,2/6,7.25%,UBASH3B;FOXP1
prerank,GO_Biological_Process_2021__fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate (GO:0061624),0.8826977910985089,1.306222395446807,0.11666666666666667,1.0,1.0,3/5,10.80%,ALDH1A1;KHK;ALDOB
prerank,GO_Biological_Process_2021__fructose catabolic process (GO:0006001),0.8826977910985089,1.306222395446807,0.11666666666666667,1.0,1.0,3/5,10.80%,ALDH1A1;KHK;ALDOB
prerank,GO_Biological_Process_2021__mitral valve morphogenesis (GO:0003183),0.8214272013121164,1.3057110262982938,0.12698412698412698,1.0,1.0,2/8,6.18%,NOTCH1;ZFPM1
prerank,PanglaoDB_Augmented_2021__Macrophages,0.5495729522305103,1.3054279225210046,0.08571428571428572,1.0,1.0,18/97,8.25%,C3AR1;MS4A6A;CHIT1;SLCO2B1;CCL5;STAB1;FGL2;HPGDS;HCK;CD300LF;PTPRC;PIK3R5;AHR;FMNL1;CD14;NCEH1;TAGAP;CPM
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO:0010881),0.6964603060997085,1.3048600893495261,0.14035087719298245,1.0,1.0,4/14,25.08%,FKBP1B;CAMK2D;CALM3;RYR2
prerank,GO_Biological_Process_2021__nuclear pore complex assembly (GO:0051292),-0.6974516899693819,-1.304746435996934,0.23076923076923078,0.8985223587938901,1.0,1/9,4.10%,TPR
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045737),0.6944520077899954,1.3045847384019753,0.06153846153846154,1.0,1.0,3/17,6.12%,SPDYA;PSRC1;CCND2
prerank,GO_Biological_Process_2021__estrogen biosynthetic process (GO:0006703),0.8115604609968741,1.304483103318362,0.1206896551724138,1.0,1.0,3/5,17.80%,HSD17B2;CYP19A1;HSD17B11
prerank,GO_Biological_Process_2021__steroid hormone biosynthetic process (GO:0120178),0.7177098851134898,1.3042616422440525,0.09230769230769231,1.0,1.0,7/18,20.89%,HSD17B2;CYP19A1;HSD17B6;TSPOAP1;DHCR7;HSD17B11;AKR1B1
prerank,GO_Biological_Process_2021__basement membrane organization (GO:0071711),-0.7112758069981847,-1.304050773314933,0.08571428571428572,0.8995710417811581,1.0,3/14,3.47%,LAMB2;LAMB3;NTNG1
prerank,GO_Biological_Process_2021__peptidyl-lysine deacetylation (GO:0034983),-0.7096588263259048,-1.3040136884028808,0.20512820512820512,0.8977833161397264,1.0,4/8,21.41%,SIRT2;HDAC9;HDAC10;HDAC4
prerank,GO_Biological_Process_2021__phosphatidylinositol acyl-chain remodeling (GO:0036149),0.8032335226680272,1.3038440750037736,0.06557377049180328,1.0,1.0,1/9,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__aggrephagy (GO:0035973),-0.584932756488622,-1.3034958468488973,0.1388888888888889,0.8980755285036037,1.0,5/26,20.09%,ARL13B;PCNT;ACBD5;PRKN;SQSTM1
prerank,PanglaoDB_Augmented_2021__Gamma (PP) Cells,-0.4957279904914076,-1.303454036348729,0.045454545454545456,0.8964243668525219,1.0,23/110,13.91%,ETV1;RIMBP2;PTPRT;PCDH19;NFIB;SST;ID4;SLC6A1;UNC5C;ARX;ADGRA1;SERTM1;MAPK4;FGF14;CMTM8;TMEM196;PCDHB4;STMN2;RGS7BP;THSD7A;GRIA2;SEMA6D;PAX6
prerank,GO_Biological_Process_2021__amino sugar catabolic process (GO:0046348),0.8178742135742064,1.302799037875597,0.13636363636363635,1.0,1.0,1/7,0.86%,ALDH1A1
prerank,GO_Biological_Process_2021__cellular response to drug (GO:0035690),0.6761501812713648,1.3027774279252993,0.16393442622950818,1.0,1.0,4/18,19.45%,KCNE2;REST;KCNQ1;CRHBP
prerank,GO_Biological_Process_2021__collagen-activated signaling pathway (GO:0038065),-0.7047739319080133,-1.302533766703806,0.20930232558139536,0.8984372853187129,1.0,1/7,0.56%,UBASH3B
prerank,GO_Biological_Process_2021__nuclear cell cycle DNA replication initiation (GO:1902315),0.7508501807737312,1.3024760444762913,0.171875,1.0,1.0,2/6,8.15%,MCM2;MCMDC2
prerank,GO_Biological_Process_2021__mitotic DNA replication initiation (GO:1902975),0.7508501807737312,1.3024760444762913,0.171875,1.0,1.0,2/6,8.15%,MCM2;MCMDC2
prerank,GO_Biological_Process_2021__oxoacid metabolic process (GO:0043436),0.7100039956825013,1.3022161995959864,0.12698412698412698,1.0,1.0,5/18,20.67%,SULT2A1;PPA1;DAO;MTARC2;TPST2
prerank,GO_Biological_Process_2021__phospholipid efflux (GO:0033700),-0.8389453255640955,-1.3011552306063907,0.1794871794871795,0.9030920385722476,1.0,2/6,11.15%,APOA1;APOE
prerank,GO_Biological_Process_2021__metanephros development (GO:0001656),-0.6711857880487474,-1.300443239466455,0.25,0.9046146057685359,1.0,2/14,6.06%,BMP7;PTCH1
prerank,GO_Biological_Process_2021__secretory granule organization (GO:0033363),-0.7852785196326607,-1.3000360670619195,0.15,0.9048885530411176,1.0,1/6,3.63%,SRGN
prerank,GO_Biological_Process_2021__negative regulation of activated T cell proliferation (GO:0046007),0.7462331267469358,1.3000142677930973,0.2,1.0,1.0,2/8,9.60%,BTN2A2;PDCD1LG2
prerank,GO_Biological_Process_2021__neurotransmitter uptake (GO:0001504),-0.6396164249273725,-1.2998604496344457,0.125,0.9037981947387268,1.0,3/12,9.16%,SLC22A2;SLC29A4;SLC22A3
prerank,GO_Biological_Process_2021__male meiosis I (GO:0007141),0.7136379194652158,1.2998395800362375,0.11428571428571428,1.0,1.0,7/15,18.09%,TDRD9;ING2;SYCP3;BTBD18;MEIOC;HSF2BP;SLC25A31
prerank,GO_Biological_Process_2021__oxidative RNA demethylation (GO:0035513),-0.8700841471237964,-1.299780530412895,0.08333333333333333,0.9023107673914668,1.0,1/5,2.80%,ALKBH3
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translation (GO:2000765),0.6972912183190584,1.2996883734736155,0.11940298507462686,1.0,1.0,1/13,7.38%,YBX3
prerank,GO_Biological_Process_2021__presynaptic membrane organization (GO:0097090),0.7599090630210175,1.2995860152634136,0.10294117647058823,1.0,1.0,2/11,9.74%,LRP4;CNTN2
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway (GO:2001269),0.813426565709608,1.2992770134884297,0.15789473684210525,1.0,1.0,2/7,11.17%,CASP8;FAS
prerank,GO_Biological_Process_2021__sphingomyelin metabolic process (GO:0006684),-0.7347464961273986,-1.2987657385947664,0.12,0.9049937895063925,1.0,4/9,18.76%,SGMS2;SMPD3;SMPD4;SGMS1
prerank,GO_Biological_Process_2021__negative regulation of cell projection organization (GO:0031345),-0.5607905640392785,-1.298663101456662,0.08571428571428572,0.9036333536242499,1.0,9/44,11.37%,PRAG1;PTPN9;MYLIP;RTN4R;SPOCK1;SPRY3;PTPRS;APOE;STMN2
prerank,GO_Biological_Process_2021__negative regulation of ion transmembrane transporter activity (GO:0032413),0.6917691965313456,1.2984047163612693,0.18333333333333332,1.0,1.0,5/15,17.19%,CAV3;TCAF2;HECW1;CAMK2D;PLN
prerank,GO_Biological_Process_2021__regulation of macrophage derived foam cell differentiation (GO:0010743),0.7108211703633809,1.2983013803150498,0.07462686567164178,1.0,1.0,2/19,6.08%,PLA2G10;AGT
prerank,GO_Biological_Process_2021__L-arginine import across plasma membrane (GO:0097638),-0.8159962449203196,-1.2982365520271126,0.24324324324324326,0.9037836161140089,1.0,3/5,11.69%,SLC22A2;SLC7A1;SLC7A2
prerank,MSigDB_Hallmark_2020__UV Response Dn,-0.46711013343163016,-1.2982328192073724,0.0,0.9018188691224568,1.0,16/131,8.02%,KIT;LTBP1;RUNX1;FHL2;RND3;MT1E;NFIB;BCKDHB;MGMT;GRK5;CACNA1A;VLDLR;RASA2;SFMBT1;SLC7A1;COL11A1
prerank,GO_Biological_Process_2021__regulation of dephosphorylation (GO:0035303),-0.6298259323897835,-1.2978898487471895,0.15151515151515152,0.9013914646096376,1.0,3/14,9.39%,IGBP1;MTMR9;SMG6
prerank,GO_Biological_Process_2021__regulation of cytoplasmic mRNA processing body assembly (GO:0010603),-0.8284656814517173,-1.2977267001975261,0.17142857142857143,0.90014213520314,1.0,1/6,4.87%,NBDY
prerank,GO_Biological_Process_2021__glyceraldehyde-3-phosphate metabolic process (GO:0019682),0.8416832275997005,1.2976308557736274,0.16666666666666666,1.0,1.0,3/7,10.80%,ALDH1A1;KHK;ALDOB
prerank,GO_Biological_Process_2021__xenobiotic catabolic process (GO:0042178),-0.7568052782248154,-1.2975865711207621,0.23809523809523808,0.8986242038287047,1.0,1/6,5.67%,GSTM3
prerank,GO_Biological_Process_2021__carboxylic acid transmembrane transport (GO:1905039),0.6177076353887535,1.297563537655175,0.09090909090909091,1.0,1.0,11/36,17.96%,SLC7A11;SLC38A11;SLC23A1;SLC38A8;ABCB1;SLC36A1;SLC38A2;SLC7A7;SLC38A5;SLC16A1;SLC38A4
prerank,GO_Biological_Process_2021__positive regulation of nuclear cell cycle DNA replication (GO:0010571),-0.866907612010528,-1.2972261683792756,0.1,0.8980545543589046,1.0,3/6,8.39%,DBF4B;INO80;WIZ
prerank,GO_Biological_Process_2021__RNA methylation (GO:0001510),-0.5156247561239402,-1.2971958216025397,0.08333333333333333,0.8962748209922646,1.0,10/56,11.29%,METTL8;BUD23;MTERF4;LCMT2;THADA;FBLL1;TRDMT1;TRMT10C;ALKBH8;TRMT61A
prerank,GO_Biological_Process_2021__negative regulation of systemic arterial blood pressure (GO:0003085),0.8538731079941713,1.296934555807428,0.10144927536231885,1.0,1.0,2/5,8.25%,SOD2;ADRB1
prerank,GO_Biological_Process_2021__cellular divalent inorganic cation homeostasis (GO:0072503),0.5688476451244809,1.2966680752191428,0.0625,1.0,1.0,18/77,17.88%,CSRP3;CCL5;GCM2;CALCB;SLC30A8;ELANE;TMEM203;VAPB;SLC24A4;SLC39A12;SLC24A2;SLC24A1;DRD3;ATP1B1;HTR2B;CHRNA7;NPTN;TRDN
prerank,GO_Biological_Process_2021__positive regulation of cell-matrix adhesion (GO:0001954),-0.6083538310023702,-1.2966399022385884,0.14705882352941177,0.8969830865617237,1.0,6/34,6.17%,CCL28;KDR;CDH13;UTRN;SFRP1;RIN2
prerank,GO_Biological_Process_2021__regulation of proton transport (GO:0010155),-0.7249106588592629,-1.2963984821601349,0.21951219512195122,0.8962998765663976,1.0,1/7,6.17%,SPHK2
prerank,GO_Biological_Process_2021__positive regulation of T cell activation (GO:0050870),0.6065579780507648,1.2963350806989664,0.08955223880597014,1.0,1.0,10/40,12.76%,CCL5;IL15;DOCK8;PTPRC;HLA-DMB;IL7;HLA-A;PDCD1LG2;CD6;RHOH
prerank,GO_Biological_Process_2021__pyrimidine nucleotide metabolic process (GO:0006220),-0.752599527499825,-1.2961510777765157,0.20930232558139536,0.8954689911033782,1.0,2/5,8.94%,ENPP3;CTPS2
prerank,GO_Biological_Process_2021__protein ufmylation (GO:0071569),0.8623119069914121,1.295823968184094,0.03636363636363636,1.0,1.0,1/5,6.84%,UFM1
prerank,GO_Biological_Process_2021__protein polyufmylation (GO:1990564),0.8623119069914121,1.295823968184094,0.03636363636363636,1.0,1.0,1/5,6.84%,UFM1
prerank,GO_Biological_Process_2021__protein K69-linked ufmylation (GO:1990592),0.8623119069914121,1.295823968184094,0.03636363636363636,1.0,1.0,1/5,6.84%,UFM1
prerank,GO_Biological_Process_2021__urogenital system development (GO:0001655),-0.8637257810204775,-1.295574649847857,0.14285714285714285,0.8956635125385476,1.0,2/6,6.25%,EPHB2;AMH
prerank,GO_Biological_Process_2021__enzyme-directed rRNA pseudouridine synthesis (GO:0000455),-0.7840878150903012,-1.2953416886129843,0.3,0.894657571518737,1.0,2/6,15.73%,RPUSD1;RPUSD4
prerank,GO_Biological_Process_2021__positive regulation of monooxygenase activity (GO:0032770),-0.6209575565055713,-1.295322726497139,0.2,0.8929077221925217,1.0,6/17,13.01%,GCH1;S100A1;DHFR;SCARB1;APOE;NOS1AP
prerank,GO_Biological_Process_2021__T-helper 1 type immune response (GO:0042088),-0.7519960281023329,-1.2953115326645384,0.25,0.891045832331466,1.0,1/5,1.33%,LEF1
prerank,GO_Biological_Process_2021__dopamine transport (GO:0015872),-0.7920194697055236,-1.295305062290664,0.21428571428571427,0.8891918151548124,1.0,4/5,12.86%,SLC22A2;SLC29A4;SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase I (GO:0045943),-0.6331142212032118,-1.2951764045874032,0.15151515151515152,0.8875835230763597,1.0,10/21,21.98%,LYAR;NCL;SMARCA4;UBTF;DDX11;SMARCB1;WDR75;MTOR;MARS1;ERBB2
prerank,GO_Biological_Process_2021__negative regulation of cell death (GO:0060548),-0.592338014823758,-1.2945901581576222,0.18181818181818182,0.8880889401265999,1.0,2/69,0.88%,PM20D1;BMP7
prerank,GO_Biological_Process_2021__L-methionine salvage (GO:0071267),-0.795970289807947,-1.2938061217181218,0.16216216216216217,0.8898951981599634,1.0,3/5,15.07%,APIP;MRI1;BHMT2
prerank,GO_Biological_Process_2021__regulation of histone methylation (GO:0031060),-0.649344784964305,-1.2937368619798673,0.18421052631578946,0.8884433002787886,1.0,3/13,10.98%,AASS;CHTOP;TET1
prerank,GO_Biological_Process_2021__ncRNA metabolic process (GO:0034660),0.6244326955883365,1.2935863691646545,0.11594202898550725,1.0,1.0,3/34,4.26%,TDRD1;TDRD9;HENMT1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell apoptotic process (GO:0034391),-0.7771392868615407,-1.2935732207035524,0.23684210526315788,0.8871744108545339,1.0,1/6,3.96%,IGF1
prerank,GO_Biological_Process_2021__endocrine system development (GO:0035270),0.7658897939554988,1.2931455920108443,0.078125,1.0,1.0,3/12,8.52%,HESX1;GCM2;TBX1
prerank,PanglaoDB_Augmented_2021__Osteoblasts,0.5507711016343289,1.2928044765876638,0.0684931506849315,1.0,1.0,21/116,11.81%,OLFML1;CALB1;LRP4;LAMA2;ALPL;TIMP3;ACTA2;HSPG2;PDGFRB;POSTN;ITGA5;IGFBP5;OSMR;ANGPTL2;BMP1;SFRP4;RUNX2;EFEMP1;FAS;FGFR2;GPER1
prerank,GO_Biological_Process_2021__regulation of synapse assembly (GO:0051963),-0.5227481689846987,-1.2926578111072127,0.14285714285714285,0.8889712654540185,1.0,9/45,11.96%,MDGA1;GPC4;EPHB2;CLSTN2;LRFN4;DLG5;EIF4G1;SYNDIG1;LHFPL4
prerank,GO_Biological_Process_2021__cellular metal ion homeostasis (GO:0006875),0.5824642041784363,1.2921144060249623,0.06944444444444445,1.0,1.0,23/75,23.12%,CSRP3;CCL5;GCM2;CALCB;ELANE;TMEM203;VAPB;SLC24A4;ATP12A;SLC24A2;SLC24A1;DRD3;ATP1B1;HTR2B;CHRNA7;NPTN;TRDN;ATP1A1;LETM1;SLC24A5;CALR;ATP2B4;ATP2A2
prerank,GO_Biological_Process_2021__C-terminal protein amino acid modification (GO:0018410),-0.6935193878011593,-1.2918489628326406,0.2413793103448276,0.8899090174813107,1.0,5/11,25.14%,AGBL1;ICMT;LCMT1;TTL;ATG7
prerank,GO_Biological_Process_2021__regulation of nitrogen compound metabolic process (GO:0051171),-0.7879785588613821,-1.2916939069044406,0.20454545454545456,0.888732909916501,1.0,1/6,11.15%,APOE
prerank,GO_Biological_Process_2021__regulation of cell-substrate junction assembly (GO:0090109),-0.6450228239540262,-1.2915652096131487,0.14893617021276595,0.8872107519820618,1.0,1/21,1.35%,EPHA3
prerank,GO_Biological_Process_2021__regulation of cell projection organization (GO:0031344),-0.701851283989172,-1.2911489441621982,0.14583333333333334,0.8874167329183266,1.0,1/10,3.47%,NTNG1
prerank,GO_Biological_Process_2021__histone H2A-K119 monoubiquitination (GO:0036353),-0.7416599526400156,-1.290608393498179,0.24324324324324326,0.8875344926041874,1.0,2/8,12.98%,PCGF1;PCGF6
prerank,GO_Biological_Process_2021__negative regulation of complement activation (GO:0045916),0.7722809774972089,1.2903252317995841,0.13793103448275862,1.0,1.0,1/10,0.23%,C4BPB
prerank,GO_Biological_Process_2021__cellular response to granulocyte macrophage colony-stimulating factor stimulus (GO:0097011),0.8136974474899928,1.2901780021404163,0.10909090909090909,1.0,1.0,2/5,13.16%,CD4;NPR2
prerank,GO_Biological_Process_2021__response to granulocyte macrophage colony-stimulating factor (GO:0097012),0.8136974474899928,1.2901780021404163,0.10909090909090909,1.0,1.0,2/5,13.16%,CD4;NPR2
prerank,GO_Biological_Process_2021__regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090092),0.665646261306776,1.2899869672537703,0.14925373134328357,1.0,1.0,7/27,13.78%,ZNF703;EID2;NREP;SFRP4;SOX11;SMAD7;TGFB1
prerank,GO_Biological_Process_2021__ethanol metabolic process (GO:0006067),0.8406370674955305,1.2898206855037093,0.1206896551724138,1.0,1.0,4/7,14.21%,ALDH1A1;SULT2A1;ADH5;ALDH2
prerank,GO_Biological_Process_2021__determination of bilateral symmetry (GO:0009855),0.6710636837237323,1.2890032649258782,0.15254237288135594,1.0,1.0,5/20,12.32%,NOTCH1;DNAH11;ODAD3;TBX1;ARL6
prerank,GO_Biological_Process_2021__activation of protein kinase B activity (GO:0032148),-0.5705347503104524,-1.2887341031079218,0.15625,0.8944525823927373,1.0,3/27,5.79%,NRG1;IGF1;FGF1
prerank,GO_Biological_Process_2021__ER overload response (GO:0006983),0.7924273694129722,1.2885616960533524,0.14035087719298245,1.0,1.0,1/8,1.71%,WFS1
prerank,GO_Biological_Process_2021__glycine metabolic process (GO:0006544),0.7582394392123717,1.287144798448938,0.2028985507246377,1.0,1.0,2/9,3.87%,SDS;BAAT
prerank,GO_Biological_Process_2021__protein transport to vacuole involved in ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043328),-0.8009837553276873,-1.2869661240470625,0.175,0.8987388544114943,1.0,2/5,14.36%,VPS25;SNF8
prerank,GO_Biological_Process_2021__establishment of protein localization to vacuole (GO:0072666),-0.8009837553276873,-1.2869661240470625,0.175,0.8987388544114943,1.0,2/5,14.36%,VPS25;SNF8
prerank,PanglaoDB_Augmented_2021__Eosinophils,0.5819969015028972,1.286946787348594,0.11764705882352941,1.0,1.0,11/53,9.88%,C3AR1;CCL5;HCK;CD300LF;PTPRC;PIK3R5;GMFG;TAGAP;ARHGAP9;WAS;ARHGAP25
prerank,GO_Biological_Process_2021__T cell apoptotic process (GO:0070231),0.8442764730387575,1.286807211359616,0.1076923076923077,1.0,1.0,2/5,11.17%,GLI3;FAS
prerank,GO_Biological_Process_2021__phosphatidylglycerol acyl-chain remodeling (GO:0036148),0.7891442163507154,1.2865896010501108,0.17142857142857143,1.0,1.0,1/7,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__dendritic cell migration (GO:0036336),0.8094929116253498,1.2863127598439223,0.171875,1.0,1.0,3/7,15.07%,CCL5;EPS8;GPR183
prerank,GO_Biological_Process_2021__positive regulation of protein localization to Cajal body (GO:1904871),0.7670637677435437,1.2861297160638683,0.2222222222222222,1.0,1.0,4/11,21.62%,TCP1;CCT6A;CCT8;CCT7
prerank,GO_Biological_Process_2021__regulation of protein localization to Cajal body (GO:1904869),0.7670637677435437,1.2861297160638683,0.2222222222222222,1.0,1.0,4/11,21.62%,TCP1;CCT6A;CCT8;CCT7
prerank,GO_Biological_Process_2021__diol metabolic process (GO:0034311),-0.6628049803261852,-1.2860654420876025,0.17142857142857143,0.9007677191396475,1.0,6/18,14.85%,PRKG2;GCH1;SPHK2;GCHFR;PTS;SGPP2
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell apoptotic process (GO:0010664),-0.8383990421548254,-1.2856175766552522,0.1935483870967742,0.9008857976867021,1.0,3/5,12.34%,BMP7;MDK;BAG3
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine development (GO:0060999),-0.6204350291482367,-1.28556330116009,0.14285714285714285,0.8993636894986002,1.0,8/21,19.66%,SHANK1;LRP8;DLG5;APOE;RELN;DBNL;FOXO6;NEURL1
prerank,GO_Biological_Process_2021__long-chain fatty acid catabolic process (GO:0042758),-0.8117057905508123,-1.2851461706332812,0.2,0.8991683568176103,1.0,1/5,0.42%,GLYATL2
prerank,GO_Biological_Process_2021__keratan sulfate catabolic process (GO:0042340),0.8170542781998527,1.2849059603519066,0.12280701754385964,1.0,1.0,1/8,0.27%,PRELP
prerank,GO_Biological_Process_2021__negative regulation of endopeptidase activity (GO:0010951),0.6044412564037118,1.2844369443248602,0.10294117647058823,1.0,1.0,8/34,9.68%,TIMP3;TIMP2;AGT;SERPINA10;SERPINF1;KNG1;SERPINI2;SPOCK3
prerank,GO_Biological_Process_2021__positive regulation of macrophage migration (GO:1905523),0.7178712484435514,1.2842863777832234,0.07692307692307693,1.0,1.0,4/17,8.55%,CCL5;P2RY12;RARRES2;CMKLR1
prerank,GO_Biological_Process_2021__exocrine system development (GO:0035272),0.8340573330252172,1.284234779671362,0.1791044776119403,1.0,1.0,2/5,11.22%,IGSF3;FGFR2
prerank,GO_Biological_Process_2021__regulation of hematopoietic progenitor cell differentiation (GO:1901532),-0.564309630903102,-1.2841570076506752,0.2,0.902440445490374,1.0,5/61,8.40%,MYB;RUNX1;KITLG;CBFB;PDCD2
prerank,GO_Biological_Process_2021__homeostasis of number of cells (GO:0048872),0.7678651626607339,1.2838401317788382,0.12698412698412698,1.0,1.0,3/12,4.62%,LRRC19;NOTCH1;LPCAT3
prerank,GO_Biological_Process_2021__DNA methylation (GO:0006306),-0.6557425253109057,-1.2832006585537337,0.1388888888888889,0.9045841836955083,1.0,9/19,19.55%,FOS;TEX15;DNMT1;DMAP1;BEND3;EHMT2;GATAD2A;DNMT3B;EHMT1
prerank,GO_Biological_Process_2021__positive regulation of positive chemotaxis (GO:0050927),-0.6772315370879607,-1.2830457389997199,0.23529411764705882,0.9032666504085468,1.0,4/14,5.70%,KDR;F2RL1;CDH13;AZU1
prerank,GO_Biological_Process_2021__negative regulation of microglial cell activation (GO:1903979),0.8428774132013748,1.2825734786380378,0.13333333333333333,1.0,1.0,1/6,5.48%,PTPRC
prerank,GO_Biological_Process_2021__spermidine metabolic process (GO:0008216),-0.7358847579468929,-1.2825126017459125,0.25,0.9038053920143138,1.0,2/6,16.55%,SRM;HDAC10
prerank,GO_Biological_Process_2021__negative regulation of long-term synaptic potentiation (GO:1900272),0.8171039684408583,1.2814616487653059,0.15384615384615385,1.0,1.0,1/7,1.74%,AGER
prerank,GO_Biological_Process_2021__insulin metabolic process (GO:1901142),-0.8113644644661606,-1.2813314441469437,0.17142857142857143,0.907013325248243,1.0,2/5,9.53%,CELA2A;IDE
prerank,GO_Biological_Process_2021__sulfur compound transport (GO:0072348),0.6870458740724092,1.281008971177796,0.14516129032258066,1.0,1.0,8/24,15.73%,SLC13A4;MGST1;SLC26A4;SLC36A1;LRRC8D;SLC26A7;ABCG2;RACGAP1
prerank,GO_Biological_Process_2021__bundle of His cell to Purkinje myocyte communication (GO:0086069),-0.8655456052426597,-1.2804274929671973,0.1111111111111111,0.907021999249011,1.0,1/5,0.68%,PKP2
prerank,GO_Biological_Process_2021__bundle of His cell-Purkinje myocyte adhesion involved in cell communication (GO:0086073),-0.8655456052426597,-1.2804274929671973,0.1111111111111111,0.907021999249011,1.0,1/5,0.68%,PKP2
prerank,GO_Biological_Process_2021__metal ion homeostasis (GO:0055065),0.6214727008513629,1.279586215518731,0.05405405405405406,1.0,1.0,3/32,1.71%,SLC12A7;TRPV6;WFS1
prerank,"GO_Biological_Process_2021__positive regulation of protein localization to chromosome, telomeric region (GO:1904816)",0.7550903353621822,1.2795250729635084,0.21311475409836064,1.0,1.0,5/12,21.62%,TCP1;CCT6A;CCT8;GNL3;CCT7
prerank,GO_Biological_Process_2021__entry into host (GO:0044409),0.7533128979980965,1.2794343407776478,0.1111111111111111,1.0,1.0,1/10,2.19%,CD4
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle priming (GO:0010807),-0.7851544386288118,-1.279414860518499,0.20833333333333334,0.9095544982429713,1.0,1/5,2.40%,UNC13B
prerank,"GO_Biological_Process_2021__RNA splicing, via endonucleolytic cleavage and ligation (GO:0000394)",-0.6656622688314455,-1.2793435816318823,0.175,0.9079327291553249,1.0,2/16,2.61%,CPSF1;TRPT1
prerank,GO_Biological_Process_2021__regulation of glucagon secretion (GO:0070092),-0.8813410813373231,-1.2791959162905187,0.075,0.9066831910841269,1.0,1/5,4.12%,CRH
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway by p53 class mediator (GO:0072332),0.669052379626843,1.2790593966480182,0.12903225806451613,1.0,1.0,3/31,6.85%,AEN;BOK;HINT1
prerank,GO_Biological_Process_2021__positive regulation of cyclin-dependent protein kinase activity (GO:1904031),0.6828845120177567,1.2773936252769382,0.11290322580645161,1.0,1.0,3/20,6.12%,SPDYA;PSRC1;CCND2
prerank,GO_Biological_Process_2021__regulation of glial cell differentiation (GO:0045685),-0.7575555134936475,-1.277118309184376,0.2631578947368421,0.914536259377473,1.0,3/5,22.44%,OPALIN;SLC45A3;TNFRSF21
prerank,GO_Biological_Process_2021__regulation of actin filament length (GO:0030832),0.8617899052366339,1.2769086072980276,0.16363636363636364,1.0,1.0,3/6,13.50%,WAS;EPS8;BRK1
prerank,GO_Biological_Process_2021__regulation of protein targeting to mitochondrion (GO:1903214),0.6220929225718742,1.2765303687228646,0.15942028985507245,1.0,1.0,7/33,16.73%,LMAN1;ARIH2;HSPA1L;ATP5IF1;RHOU;UBL5;PINK1
prerank,GO_Biological_Process_2021__endothelial tube morphogenesis (GO:0061154),0.807945871004962,1.2762296371733775,0.13559322033898305,1.0,1.0,1/7,10.92%,RHOB
prerank,GO_Biological_Process_2021__regulation of neuronal synaptic plasticity (GO:0048168),-0.5838014996979782,-1.2761118869425068,0.17647058823529413,0.9173699596382062,1.0,4/27,11.15%,EPHB2;MCTP1;NSMF;APOE
prerank,GO_Biological_Process_2021__regulation of histone exchange (GO:1900049),0.7622659129195999,1.275941775643296,0.1111111111111111,1.0,1.0,1/9,3.54%,H3-3A
prerank,GO_Biological_Process_2021__positive regulation of histone exchange (GO:1900051),0.7622659129195999,1.275941775643296,0.1111111111111111,1.0,1.0,1/9,3.54%,H3-3A
prerank,GO_Biological_Process_2021__endosome to pigment granule transport (GO:0043485),-0.8437575214498683,-1.275833296818332,0.16666666666666666,0.9149091275733395,1.0,1/5,1.09%,RAB32
prerank,GO_Biological_Process_2021__endosome to melanosome transport (GO:0035646),-0.8437575214498683,-1.275833296818332,0.16666666666666666,0.9149091275733395,1.0,1/5,1.09%,RAB32
prerank,GO_Biological_Process_2021__substrate-dependent cell migration (GO:0006929),0.6950765773197753,1.2758328875174882,0.22388059701492538,1.0,1.0,4/14,10.53%,PTPRC;P2RY12;ITGA11;VEGFC
prerank,GO_Biological_Process_2021__regulation of cGMP-mediated signaling (GO:0010752),-0.7819092552131736,-1.2751737384282835,0.21428571428571427,0.9158867197667232,1.0,1/6,0.61%,PDE10A
prerank,GO_Biological_Process_2021__regulation of glial cell proliferation (GO:0060251),0.8376540563969092,1.275117826813602,0.13114754098360656,1.0,1.0,2/5,11.31%,NOTCH1;SOX11
prerank,GO_Biological_Process_2021__positive regulation of wound healing (GO:0090303),0.6386445703132559,1.2747422018594654,0.18181818181818182,1.0,1.0,2/28,1.75%,MYLK;RREB1
prerank,GO_Biological_Process_2021__pteridine-containing compound metabolic process (GO:0042558),-0.7199895785129263,-1.274411642663412,0.16666666666666666,0.9179447407940502,1.0,5/12,14.10%,PRKG2;GCH1;GCHFR;PTS;MTHFD1L
prerank,GO_Biological_Process_2021__myotube cell development (GO:0014904),-0.6860183948821639,-1.2740580047315593,0.175,0.9174973883140195,1.0,3/7,9.57%,IGF1;RYR1;SELENON
prerank,GO_Biological_Process_2021__regulation of cellular response to transforming growth factor beta stimulus (GO:1903844),0.7009127367980683,1.2731999905487459,0.14516129032258066,1.0,1.0,6/21,13.78%,ZNF703;EID2;NREP;SOX11;SMAD7;TGFB1
prerank,GO_Biological_Process_2021__cell-cell adhesion mediated by cadherin (GO:0044331),-0.7226238645062767,-1.2731558981338602,0.20689655172413793,0.9196826231493412,1.0,3/6,21.18%,PLEKHA7;CDHR2;MMP24
prerank,GO_Biological_Process_2021__negative regulation of metabolic process (GO:0009892),0.6038381017201189,1.272623208051527,0.17333333333333334,1.0,1.0,10/44,14.07%,ALDH1A1;BTN2A2;IL18R1;NOTCH1;IL15;TLE3;ARRDC3;ACOT13;ACVR2B;PLCL1
prerank,GO_Biological_Process_2021__negative regulation of chemotaxis (GO:0050922),0.6242681572580902,1.2725533131372806,0.12857142857142856,1.0,1.0,6/29,14.43%,SEMA3D;NOTCH1;ELANE;ANGPT2;SEMA3F;SEMA3A
prerank,PanglaoDB_Augmented_2021__Enterocytes,0.527336950699108,1.2712010673608802,0.12195121951219512,1.0,1.0,24/101,17.45%,NR1I3;ANKS4B;SPON2;SLC23A1;ABCC2;SOX10;KLF5;NR5A2;GBA3;GPX2;ACSL5;TRPM6;GIPC2;CA1;KHK;NKD2;ALDOB;ABCG2;UGT2B7;SLC28A2;SLC52A1;SLC40A1;TMC4;DEGS2
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix disassembly (GO:0090091),-0.7785772520523886,-1.2711007162140833,0.1935483870967742,0.9273870169752126,1.0,2/7,6.06%,MELTF;PDPN
prerank,GO_Biological_Process_2021__regulation of osteoclast differentiation (GO:0045670),-0.6760346841751523,-1.270623217932997,0.20588235294117646,0.9276685957890448,1.0,2/16,2.28%,UBASH3B;LRRC17
prerank,GO_Biological_Process_2021__positive regulation of chromatin binding (GO:0035563),0.7626767685952189,1.2701271066759083,0.18461538461538463,1.0,1.0,1/8,2.48%,GMNN
prerank,GO_Biological_Process_2021__regulation of T cell mediated immune response to tumor cell (GO:0002840),0.8158713837565232,1.269742608275007,0.16071428571428573,1.0,1.0,2/5,12.71%,AHR;IL4I1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix assembly (GO:1901201),0.8290660447332778,1.268116519640705,0.21568627450980393,1.0,1.0,4/5,16.59%,NOTCH1;AGT;TGFB1;RGCC
prerank,GO_Biological_Process_2021__sterol biosynthetic process (GO:0016126),0.5969555376007771,1.2679529445657105,0.14285714285714285,1.0,1.0,12/30,19.35%,NSDHL;HMGCR;HMGCS1;G6PD;SQLE;MSMO1;FAXDC2;INSIG2;DHCR7;DHCR24;INSIG1;ACAA2
prerank,GO_Biological_Process_2021__peptidyl-serine phosphorylation (GO:0018105),-0.44666357152965724,-1.267843654222478,0.05263157894736842,0.9377499964974221,1.0,29/148,19.36%,STK32B;CAMK1G;NEK6;SGK1;MARK1;PRKCD;AURKA;PLK2;TAF1;SBK1;CSNK1G2;MAP3K10;PRKCE;MAPK12;MAST2;PRKCB;TLK2;TGFBR1;ULK3;ATM;MAST4;MARK3;LATS1;VRK1;LATS2;MTOR;DMPK;PKN2;STK38
prerank,GO_Biological_Process_2021__glucose metabolic process (GO:0006006),-0.5410763947832699,-1.2676192768529193,0.1,0.9365265180852119,1.0,4/49,2.99%,PER2;G6PC3;RBP4;SLC37A4
prerank,GO_Biological_Process_2021__positive regulation of mRNA 3'-end processing (GO:0031442),0.7186102593647385,1.2671064791631395,0.22580645161290322,1.0,1.0,2/10,6.96%,NCBP1;NCBP2
prerank,GO_Biological_Process_2021__regulation of execution phase of apoptosis (GO:1900117),0.7163637220137997,1.2669256676240024,0.23636363636363636,1.0,1.0,2/11,4.57%,PTGIS;BOK
prerank,GO_Biological_Process_2021__sensory perception of light stimulus (GO:0050953),0.5536150810621018,1.266765146271204,0.12162162162162163,1.0,1.0,14/60,12.27%,RDH10;WFS1;CRYBG3;CRYBB1;TYR;RABGGTB;CNGB1;GNAT2;ARR3;CABP4;GPR179;GUCY2F;EFEMP1;SLC24A1
prerank,GO_Biological_Process_2021__response to X-ray (GO:0010165),-0.7125185111467159,-1.2666909174509786,0.21212121212121213,0.938845439010946,1.0,3/12,9.75%,XRCC4;BRCC3;XRCC6
prerank,GO_Biological_Process_2021__positive regulation of B cell proliferation (GO:0030890),-0.6821360600882403,-1.2666379997634785,0.13793103448275862,0.9371045490775709,1.0,2/20,2.36%,CD38;EPHB2
prerank,GO_Biological_Process_2021__synaptic vesicle transport (GO:0048489),-0.7089520892005539,-1.2664870677862552,0.21212121212121213,0.9361352901471918,1.0,4/11,24.86%,TMEM230;DNM2;RAB27A;KIF5C
prerank,GO_Biological_Process_2021__divalent inorganic cation homeostasis (GO:0072507),0.6541989017593686,1.2662256794436135,0.234375,1.0,1.0,3/18,7.98%,TRPV6;WFS1;FAM20A
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell differentiation (GO:0051151),-0.7322603106688295,-1.2655243513994192,0.16666666666666666,0.9377599011518513,1.0,2/9,3.11%,NFATC1;EREG
prerank,GO_Biological_Process_2021__regulation of barbed-end actin filament capping (GO:2000812),-0.7531131094409764,-1.2652885396545817,0.19047619047619047,0.93701081370406,1.0,4/5,23.20%,CARMIL2;MTPN;CRACD;CARMIL1
prerank,GO_Biological_Process_2021__histone modification (GO:0016570),-0.46065074474811285,-1.2649284622704768,0.13636363636363635,0.9367263220309466,1.0,22/103,18.24%,EYA4;TBL1Y;PRDM5;HDAC5;HDAC1;TAF10;PARP2;PRKCD;INCENP;BAZ1B;SIN3B;SIRT2;USP51;EHMT2;PRMT8;SIRT7;HDAC9;PRMT6;HDAC10;EYA2;SIN3A;CREBBP
prerank,GO_Biological_Process_2021__regulation of viral release from host cell (GO:1902186),0.6467341025788086,1.2649037618230865,0.14285714285714285,1.0,1.0,6/19,17.89%,TRIM5;TRIM32;VPS37B;CHMP2B;CHMP2A;TRIM25
prerank,GO_Biological_Process_2021__positive regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035360),0.8422146364817131,1.2645465552598791,0.12698412698412698,1.0,1.0,2/5,8.65%,PTGIS;LMO3
prerank,GO_Biological_Process_2021__regulation of microtubule cytoskeleton organization (GO:0070507),-0.5566477200593607,-1.2644816411195163,0.14705882352941177,0.9366868887295922,1.0,6/34,11.37%,CDK2AP2;EPHA3;TRIM36;MAPRE1;TRAF3IP1;STMN2
prerank,GO_Biological_Process_2021__beta-catenin destruction complex disassembly (GO:1904886),0.7145554992004246,1.2642526639049594,0.17647058823529413,1.0,1.0,1/16,1.38%,WNT8A
prerank,GO_Biological_Process_2021__negative regulation of locomotion (GO:0040013),0.7299233184423581,1.264187051029511,0.2222222222222222,1.0,1.0,5/11,20.30%,ELANE;SPOCK3;WAS;FBLN1;FRMD5
prerank,GO_Biological_Process_2021__mitotic sister chromatid cohesion (GO:0007064),-0.6760672509611001,-1.264085267513378,0.22857142857142856,0.9362688353855564,1.0,4/13,12.32%,RAD21L1;DSCC1;SMC1A;MAU2
prerank,GO_Biological_Process_2021__cholesterol biosynthetic process (GO:0006695),0.6064364987238133,1.263502891990857,0.17105263157894737,1.0,1.0,11/28,19.35%,NSDHL;HMGCR;HMGCS1;G6PD;SQLE;MSMO1;INSIG2;DHCR7;DHCR24;INSIG1;ACAA2
prerank,GO_Biological_Process_2021__negative regulation of monooxygenase activity (GO:0032769),0.8301342313847673,1.263003611834126,0.15254237288135594,1.0,1.0,1/6,1.71%,CAV3
prerank,GO_Biological_Process_2021__peptidyl-serine modification (GO:0018209),-0.43656734941364794,-1.262269843115679,0.05263157894736842,0.9421441460608494,1.0,30/158,19.36%,STK32B;CAMK1G;NEK6;SGK1;MARK1;PARP2;PRKCD;AURKA;PLK2;TAF1;SBK1;CSNK1G2;MAP3K10;PRKCE;MAPK12;MAST2;PRKCB;TLK2;TGFBR1;ULK3;ATM;MAST4;MARK3;LATS1;VRK1;LATS2;MTOR;DMPK;PKN2;STK38
prerank,GO_Biological_Process_2021__cellular response to platelet-derived growth factor stimulus (GO:0036120),-0.719228032224982,-1.261595250879155,0.1891891891891892,0.9429839839495993,1.0,3/6,20.00%,SYAP1;MARS1;HAS1
prerank,GO_Biological_Process_2021__miRNA metabolic process (GO:0010586),-0.5920441836073478,-1.2615545303621087,0.16129032258064516,0.9413457974280266,1.0,7/19,18.46%,KHSRP;DGCR8;LIN28B;TRIM71;DIS3L2;TARBP2;XPO5
prerank,GO_Biological_Process_2021__regulation of histone phosphorylation (GO:0033127),0.7511952542042537,1.2609448657294169,0.15942028985507245,1.0,1.0,2/9,9.24%,TWIST1;RPS6KA4
prerank,GO_Biological_Process_2021__regulation of cation channel activity (GO:2001257),-0.4963660692117191,-1.2607741135758646,0.07894736842105263,0.9430699725156445,1.0,15/80,9.57%,STAC;CACNG4;CACNG5;CACNG3;CRH;GSG1L;FGF13;SHANK1;CNIH3;GRIA4;KCNE1;FGF14;GRIA1;GRIN2A;SELENON
prerank,GO_Biological_Process_2021__regulation of blood coagulation (GO:0030193),-0.6056938561345748,-1.2607594678655256,0.12195121951219512,0.9415182451343759,1.0,2/19,2.36%,F2RL1;EPHB2
prerank,GO_Biological_Process_2021__positive regulation of cilium-dependent cell motility (GO:2000155),-0.8470427070693809,-1.2607584144397845,0.13636363636363635,0.9362054681445291,1.0,1/5,1.22%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of cilium movement (GO:0003353),-0.8470427070693809,-1.2607584144397845,0.13636363636363635,0.9362054681445291,1.0,1/5,1.22%,TACR1
prerank,GO_Biological_Process_2021__positive regulation of flagellated sperm motility (GO:1902093),-0.8470427070693809,-1.2607584144397845,0.13636363636363635,0.9362054681445291,1.0,1/5,1.22%,TACR1
prerank,GO_Biological_Process_2021__regulation of dendritic cell differentiation (GO:2001198),0.8569457193423153,1.259476081452989,0.1694915254237288,1.0,1.0,1/5,1.74%,AGER
prerank,GO_Biological_Process_2021__regulation of activated T cell proliferation (GO:0046006),0.691179798892908,1.25934014951578,0.14754098360655737,1.0,1.0,6/21,9.60%,BTN2A2;AGER;FADD;IDO1;HHLA2;PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation of leukocyte proliferation (GO:0070664),-0.7519784254986269,-1.2590813003472963,0.275,0.9418326403956583,1.0,2/5,8.37%,GREM1;ENPP3
prerank,GO_Biological_Process_2021__receptor signaling pathway via JAK-STAT (GO:0007259),0.6376350342373256,1.2589632569147506,0.19696969696969696,1.0,1.0,5/22,14.66%,IL15;STAT4;STAT1;STAT5A;STAT6
prerank,MSigDB_Hallmark_2020__KRAS Signaling Up,-0.44507152395458704,-1.2586101929483513,0.07692307692307693,0.9421295002186266,1.0,23/153,8.04%,ETV1;ETV5;TRIB2;BTC;F2RL1;IL1RL2;CA2;PTCD2;EPHB2;RBP4;ZNF277;PRKG2;EREG;PRRX1;ALDH1A2;ANO1;CIDEA;ATG10;ALDH1A3;ETS1;NR1H4;ID2;CROT
prerank,GO_Biological_Process_2021__protein localization to microtubule organizing center (GO:1905508),-0.7332432981626105,-1.2585972661994067,0.16666666666666666,0.9404380671793487,1.0,6/15,22.06%,NEDD1;CEP83;PCM1;PIBF1;HOOK3;CCDC14
prerank,GO_Biological_Process_2021__CD40 signaling pathway (GO:0023035),0.8412505572126336,1.2584936671790594,0.14285714285714285,1.0,1.0,1/5,4.62%,ITGA5
prerank,GO_Biological_Process_2021__positive regulation of transporter activity (GO:0032411),-0.672565327629294,-1.2583016355010623,0.1590909090909091,0.9399959420790363,1.0,1/10,4.02%,SGK1
prerank,GO_Biological_Process_2021__negative regulation of membrane potential (GO:0045837),0.7185356891177435,1.258245930622317,0.2222222222222222,1.0,1.0,2/8,11.15%,BNIP3;RNF122
prerank,GO_Biological_Process_2021__negative regulation of programmed cell death (GO:0043069),-0.39836295877303074,-1.2579141474796665,0.0,0.9399778161820734,1.0,29/286,8.75%,CD38;BCL2A1;KDR;LEF1;HMGN5;GREM1;MIEN1;SH3RF1;FHL2;ASCL1;APIP;NTSR1;IGF1;TRIAP1;TCIM;SFRP1;MGMT;GRK5;AZU1;CFLAR;HDAC1;PDPN;BCL2;HSPB1;PLK2;RAB7A;NR1H4;DCPS;HMGA2
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition (GO:0010717),-0.5176328564434929,-1.2575991810573446,0.2,0.9395908984027821,1.0,10/57,6.06%,SPRED2;SPRED3;SPRED1;LEF1;EPHA3;GREM1;SFRP1;WWTR1;TGFB2;PDPN
prerank,GO_Biological_Process_2021__regulation of protein lipidation (GO:1903059),-0.7924398402657884,-1.2569439245304144,0.3157894736842105,0.9408884939315335,1.0,1/5,2.52%,RABL3
prerank,GO_Biological_Process_2021__regulation of insulin secretion (GO:0050796),-0.4628082142580378,-1.2568494520544227,0.09090909090909091,0.9396088556559378,1.0,8/85,5.96%,PER2;CELA2A;GLP1R;RBP4;ITPR2;SFRP1;EPHA5;CACNA1A
prerank,GO_Biological_Process_2021__tryptophan catabolic process (GO:0006569),0.7089664692984282,1.256662930027012,0.21739130434782608,1.0,1.0,3/10,12.71%,IDO1;ACMSD;IL4I1
prerank,GO_Biological_Process_2021__heterochromatin organization (GO:0070828),0.7236286567700481,1.2565468667844186,0.2222222222222222,1.0,1.0,2/13,4.85%,POLE3;LOXL2
prerank,GO_Biological_Process_2021__positive regulation of chromatin organization (GO:1905269),0.7028656178016703,1.256527020991379,0.15,1.0,1.0,1/12,3.54%,H3-3A
prerank,GO_Biological_Process_2021__positive regulation of cell migration by vascular endothelial growth factor signaling pathway (GO:0038089),-0.6847960774712663,-1.2559388535734914,0.17142857142857143,0.9413207972368778,1.0,2/8,7.27%,KDR;HSPB1
prerank,GO_Biological_Process_2021__macrophage differentiation (GO:0030225),0.7412771422924047,1.2557763594971298,0.234375,1.0,1.0,3/10,10.45%,CD4;IL15;CASP8
prerank,GO_Biological_Process_2021__extracellular matrix assembly (GO:0085029),-0.6819147049985433,-1.255486470108238,0.25,0.9413526846792016,1.0,5/19,4.47%,LAMB2;LAMB3;NTNG1;MYH11;TNXB
prerank,GO_Biological_Process_2021__regulation of chromosome organization (GO:0033044),0.695090423990227,1.2553499853966512,0.171875,1.0,1.0,1/18,1.52%,SHCBP1L
prerank,GO_Biological_Process_2021__nose development (GO:0043584),0.8334393500400404,1.2552466961214905,0.10294117647058823,1.0,1.0,2/6,13.02%,GLI3;SIX4
prerank,GO_Biological_Process_2021__glycosyl compound catabolic process (GO:1901658),0.7847258599782815,1.2550342275838866,0.13559322033898305,1.0,1.0,1/6,6.04%,GBA3
prerank,GO_Biological_Process_2021__glycoside metabolic process (GO:0016137),0.7847258599782815,1.2550342275838866,0.13559322033898305,1.0,1.0,1/6,6.04%,GBA3
prerank,GO_Biological_Process_2021__cerebral cortex neuron differentiation (GO:0021895),-0.8324796828463861,-1.2549556265245398,0.2558139534883721,0.9418543109456956,1.0,2/5,6.35%,ASCL1;TOX
prerank,GO_Biological_Process_2021__receptor internalization (GO:0031623),0.6241564597474858,1.2549002411362988,0.12162162162162163,1.0,1.0,4/38,5.95%,LDLRAP1;CAV3;ACKR3;ARR3
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway (GO:2001237),-0.48590120542135284,-1.2546019511979605,0.07407407407407407,0.9415724353900811,1.0,8/59,7.26%,UNC5B;EYA4;SH3RF1;IGF1;ITGA6;CFLAR;BCL2;MAPK7
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine kinase signaling pathway (GO:0007169),-0.4066904111316647,-1.2545914989005738,0.06666666666666667,0.9398612237155133,1.0,21/331,4.28%,KIT;ALK;SPRED2;SHC3;ROR2;UBASH3B;ATP6V0D2;NRG1;KDR;SPRED1;PTPRT;SULF2;FGFR4;EPHA3;RGS14;EPHB2;SHC4;PDGFD;IGF1;ARPC3;EFS
prerank,GO_Biological_Process_2021__negative regulation of blood coagulation (GO:0030195),-0.5451290935884023,-1.254129567064106,0.25,0.9400513179173167,1.0,1/27,0.09%,F11
prerank,GO_Biological_Process_2021__establishment of protein localization to membrane (GO:0090150),-0.4680083593473054,-1.254122660604711,0.05263157894736842,0.9383232824064393,1.0,2/62,0.55%,FRMPD1;RTP5
prerank,GO_Biological_Process_2021__T cell mediated immunity (GO:0002456),0.6799592153740588,1.2536160650809405,0.2318840579710145,1.0,1.0,2/13,8.88%,CD8A;HLA-A
prerank,GO_Biological_Process_2021__negative regulation of ATP metabolic process (GO:1903579),-0.6707272072075445,-1.253485414021213,0.2222222222222222,0.9395759119690686,1.0,1/14,1.84%,PID1
prerank,GO_Biological_Process_2021__diacylglycerol metabolic process (GO:0046339),-0.5741619207807152,-1.253150512781598,0.23076923076923078,0.9390168111226811,1.0,5/20,14.98%,DGKB;DGKD;DGKH;PNPLA2;MOGAT1
prerank,GO_Biological_Process_2021__maintenance of protein localization in endoplasmic reticulum (GO:0035437),0.709827438057305,1.2528427733189145,0.21428571428571427,1.0,1.0,4/11,19.15%,HSPA5;GPAA1;INSIG2;INSIG1
prerank,GO_Biological_Process_2021__indolalkylamine catabolic process (GO:0046218),0.7200390387518588,1.252730403405799,0.21212121212121213,1.0,1.0,3/9,12.71%,IDO1;ACMSD;IL4I1
prerank,GO_Biological_Process_2021__tryptophan metabolic process (GO:0006568),0.7200390387518588,1.252730403405799,0.21212121212121213,1.0,1.0,3/9,12.71%,IDO1;ACMSD;IL4I1
prerank,PanglaoDB_Augmented_2021__Tuft Cells,0.6123533721100891,1.2526921998458163,0.14705882352941177,1.0,1.0,9/38,9.53%,MS4A6A;FGL2;HCK;CD300LF;PTPRC;CD14;MXD1;NREP;TUBB
prerank,GO_Biological_Process_2021__positive regulation of cell cycle process (GO:0090068),-0.4503870312440215,-1.2524565597482469,0.038461538461538464,0.9400059016257416,1.0,19/75,11.56%,BTC;CDC14B;EREG;IGF1;TPR;DBF4B;MAP3K20;ANKRD31;AURKA;NUMA1;SVIL;NSFL1C;INO80;WIZ;KIF23;CXCR5;SIRT2;MAP10;DDX11
prerank,GO_Biological_Process_2021__positive regulation of blood vessel endothelial cell migration (GO:0043536),-0.5438278103524801,-1.2522544781592098,0.19230769230769232,0.9390622252235554,1.0,5/42,8.52%,KDR;RHOJ;HSPB1;ETS1;MAP2K3
prerank,GO_Biological_Process_2021__positive regulation of insulin receptor signaling pathway (GO:0046628),0.7197813040149416,1.2522440889761093,0.26153846153846155,1.0,1.0,1/9,2.52%,ZBTB7B
prerank,GO_Biological_Process_2021__positive regulation of cellular response to insulin stimulus (GO:1900078),0.7197813040149416,1.2522440889761093,0.26153846153846155,1.0,1.0,1/9,2.52%,ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell migration (GO:0014912),0.7352459684796161,1.2522429005585147,0.23333333333333334,1.0,1.0,2/11,8.41%,IGFBP5;PRKG1
prerank,GO_Biological_Process_2021__calcium import into the mitochondrion (GO:0036444),-0.7147907276534442,-1.2520382206004883,0.2391304347826087,0.9382246875898598,1.0,6/10,21.75%,MCUB;MICU1;MICU2;MCUR1;MCU;SLC25A23
prerank,GO_Biological_Process_2021__regulation of pathway-restricted SMAD protein phosphorylation (GO:0060393),-0.5960919143595722,-1.2520191616906462,0.1724137931034483,0.9365957102002831,1.0,11/37,14.03%,BMP7;BMP3;GREM1;INHA;PMEPA1;TGFB2;BMP6;TGFB3;NOG;LEFTY1;BMPER
prerank,PanglaoDB_Augmented_2021__Crypt Cells,-0.5132657687851044,-1.2518354737676811,0.13043478260869565,0.9356377788305066,1.0,12/86,3.12%,GPC4;NPNT;RIMBP2;BMP7;PTPRT;FREM1;TPPP3;TNFRSF19;PCDH19;EPHB2;MYH14;ZBTB7C
prerank,GO_Biological_Process_2021__phospholipid metabolic process (GO:0006644),0.5672589554017012,1.2514479322709922,0.125,1.0,1.0,2/53,1.60%,ENPP2;PLA2G10
prerank,GO_Biological_Process_2021__regulation of endodeoxyribonuclease activity (GO:0032071),-0.7510740751655545,-1.251387556316201,0.21875,0.9357558177311255,1.0,2/7,11.56%,PRKCD;DDX11
prerank,GO_Biological_Process_2021__negative regulation of reproductive process (GO:2000242),0.7064773812004327,1.2511373791149787,0.16666666666666666,1.0,1.0,1/15,0.18%,WEE2
prerank,GO_Biological_Process_2021__peptide antigen assembly with MHC protein complex (GO:0002501),0.8059813363129222,1.250616297994835,0.2,1.0,1.0,3/5,11.18%,HLA-DMA;HLA-DMB;TAPBPL
prerank,"GO_Biological_Process_2021__positive regulation of synaptic transmission, glutamatergic (GO:0051968)",-0.6151610819042207,-1.2504364508680477,0.15789473684210525,0.9383204242059348,1.0,3/15,3.25%,CACNG4;CACNG5;CACNG3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell apoptotic process (GO:2000352),-0.6086658915440744,-1.250346520951367,0.15384615384615385,0.9370846883137517,1.0,5/15,15.13%,KDR;IL11;MAPK7;SCG2;ANGPT1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle contraction (GO:0014819),0.8026258100693165,1.2502454010391317,0.2465753424657534,1.0,1.0,1/6,1.71%,CAV3
prerank,GO_Biological_Process_2021__folic acid metabolic process (GO:0046655),-0.6592620055399291,-1.2498387040210805,0.14705882352941177,0.9374026634954679,1.0,8/17,16.09%,SLC19A1;MTHFD2;DHFR;MTHFS;MTHFD2L;MTHFD1L;MTHFR;PM20D2
prerank,GO_Biological_Process_2021__positive regulation of monocyte differentiation (GO:0045657),0.764263137166074,1.2493544979691387,0.19298245614035087,1.0,1.0,1/7,2.19%,CD4
prerank,GO_Biological_Process_2021__protein retention in Golgi apparatus (GO:0045053),-0.7605837259230414,-1.249156678909784,0.2571428571428571,0.938429350668759,1.0,1/5,10.04%,SORL1
prerank,PanglaoDB_Augmented_2021__Microglia,0.5295733923088196,1.2489826502023218,0.11428571428571428,1.0,1.0,13/79,6.60%,C3AR1;MS4A6A;IL21R;SLCO2B1;CD4;FGL2;HPGDS;HCK;CD300LF;PTPRC;PIK3R5;P2RY12;CD14
prerank,GO_Biological_Process_2021__ethanol oxidation (GO:0006069),0.8357625849411556,1.2489209301569044,0.2033898305084746,1.0,1.0,3/6,14.21%,ALDH1A1;ADH5;ALDH2
prerank,"GO_Biological_Process_2021__phototransduction, visible light (GO:0007603)",0.7407756049911817,1.2488071511679066,0.15789473684210525,1.0,1.0,4/11,15.18%,RP1;CNGB1;CNGA1;PDE6B
prerank,GO_Biological_Process_2021__prostanoid metabolic process (GO:0006692),0.7284787365795609,1.2486208313482128,0.14516129032258066,1.0,1.0,4/11,13.88%,PTGES;HPGDS;PTGR1;ACOX1
prerank,GO_Biological_Process_2021__negative regulation of phosphoprotein phosphatase activity (GO:0032515),0.7177418131592338,1.248574624550844,0.26229508196721313,1.0,1.0,2/19,6.15%,PPP1R1B;FKBP1B
prerank,GO_Biological_Process_2021__negative regulation of immune system process (GO:0002683),0.743967036940558,1.2485673171981144,0.14516129032258066,1.0,1.0,6/10,21.23%,AMBP;FADD;GPER1;SPINK5;CD200;FCRLB
prerank,PanglaoDB_Augmented_2021__Epsilon Cells,-0.4508015643371679,-1.2480519769448133,0.07692307692307693,0.9408948205508219,1.0,12/80,7.93%,F11;PAH;EYA4;ITGA4;HRH2;RBP4;SPTSSB;AFF3;APOA1;ARX;XYLB;NR1H4
prerank,GO_Biological_Process_2021__dendritic spine morphogenesis (GO:0060997),-0.7103187927934831,-1.2480232617523686,0.14285714285714285,0.9393601958664037,1.0,3/14,7.61%,EPHB2;DOCK10;SHANK1
prerank,PanglaoDB_Augmented_2021__Monocytes,0.5447077632216126,1.2480188378231407,0.2,1.0,1.0,28/78,22.14%,C3AR1;MS4A6A;FGL2;HCK;CD300LF;PTPRC;CD14;IDO1;TAGAP;CMKLR1;IFIT3;MYO1F;ADGRE1;RGS1;IGSF6;FN1;PSAP;AQP9;LY86;PTAFR;TLR2;PLSCR1;IFIT1;NFKBIZ;CX3CR1;NCF2;IFITM3;HK3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA duplex unwinding (GO:0000717)",-0.6179098957144767,-1.2478501912195108,0.2564102564102564,0.9382849486226036,1.0,8/20,22.38%,ERCC2;GTF2H2;CUL4A;DDB2;GTF2H5;ERCC3;XPC;PARP1
prerank,GO_Biological_Process_2021__negative regulation of biomineralization (GO:0110150),0.7930831706991172,1.2475505443144688,0.18867924528301888,1.0,1.0,2/8,13.78%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__chemokine-mediated signaling pathway (GO:0070098),0.7441523243083417,1.2475003258215263,0.1864406779661017,1.0,1.0,2/14,4.76%,CCL5;ACKR3
prerank,GO_Biological_Process_2021__cellular response to UV-B (GO:0071493),-0.7204261072459572,-1.2474099617541616,0.22857142857142856,0.9389251632058337,1.0,2/5,21.51%,MME;STK11
prerank,GO_Biological_Process_2021__glucan catabolic process (GO:0009251),0.6863227350192795,1.247408354161291,0.19642857142857142,1.0,1.0,3/13,15.20%,PHKG1;PHKA1;AGL
prerank,GO_Biological_Process_2021__smooth muscle cell differentiation (GO:0051145),0.753884067385958,1.2472554140050283,0.13793103448275862,1.0,1.0,1/7,3.91%,TMEM204
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221),-0.7700249787808406,-1.2471641875020707,0.26,0.9382816674046549,1.0,1/6,0.72%,PAH
prerank,GO_Biological_Process_2021__negative regulation of cell size (GO:0045792),0.8328814060778938,1.2470813721300777,0.2033898305084746,1.0,1.0,1/5,1.71%,CAV3
prerank,GO_Biological_Process_2021__visual perception (GO:0007601),0.5634644561077533,1.2467709577286001,0.125,1.0,1.0,15/61,12.27%,RDH10;WFS1;CRYBG3;CRYBB1;TYR;RABGGTB;CNGB1;GNAT2;ARR3;CABP4;CACNA2D4;GPR179;GUCY2F;EFEMP1;SLC24A1
prerank,GO_Biological_Process_2021__regulation of protein localization (GO:0032880),0.601435625769693,1.2458197584781603,0.125,1.0,1.0,5/53,5.26%,TRIM22;TRIM5;TRIML2;BORA;SLC26A4
prerank,GO_Biological_Process_2021__androgen metabolic process (GO:0008209),0.6880674587007753,1.2457270531122822,0.125,1.0,1.0,6/13,17.80%,HSD17B10;CYP19A1;UGT2B7;HSD17B6;SPP1;HSD17B11
prerank,GO_Biological_Process_2021__venous blood vessel morphogenesis (GO:0048845),0.8433820841472468,1.2452365896904165,0.2,1.0,1.0,1/5,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleolus (GO:1904749),-0.7500623041744057,-1.2450941142182939,0.2222222222222222,0.9455661620808193,1.0,4/7,18.84%,NVL;POLR1A;NMD3;BYSL
prerank,GO_Biological_Process_2021__positive regulation of T cell chemotaxis (GO:0010820),0.7472713190055784,1.2450408938355393,0.23809523809523808,1.0,1.0,1/8,2.27%,CCL5
prerank,GO_Biological_Process_2021__regulation of T cell chemotaxis (GO:0010819),0.7472713190055784,1.2450408938355393,0.23809523809523808,1.0,1.0,1/8,2.27%,CCL5
prerank,GO_Biological_Process_2021__anion transport (GO:0006820),0.6373224781615123,1.2450278060001454,0.24615384615384617,1.0,1.0,8/27,12.89%,SLC13A4;SLCO2B1;SLC26A4;SLC22A25;SLC17A8;LRRC8D;SLC26A7;ABCG2
prerank,GO_Biological_Process_2021__lipoprotein biosynthetic process (GO:0042158),-0.649114048865207,-1.2449474637302664,0.2,0.9447128622486162,1.0,8/11,25.14%,PORCN;ATG10;APOE;WDR45;WIPI2;ALOX12B;PIK3C3;ATG7
prerank,GO_Biological_Process_2021__positive regulation of triglyceride biosynthetic process (GO:0010867),-0.6620028857598458,-1.2447455577690485,0.3103448275862069,0.9438625883023428,1.0,3/10,18.50%,PLIN5;SCARB1;NR1H2
prerank,GO_Biological_Process_2021__regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547),-0.7934738887879456,-1.2447174962400083,0.23076923076923078,0.9423666721361789,1.0,1/5,1.86%,TSPAN12
prerank,GO_Biological_Process_2021__zymogen activation (GO:0031638),-0.6056093557351196,-1.2444379243360153,0.20588235294117646,0.9418722049864506,1.0,2/25,1.69%,F11;PRSS12
prerank,PanglaoDB_Augmented_2021__Erythroid-like And Erythroid Precursor Cells,0.5680319739668389,1.2441914092645883,0.1232876712328767,1.0,1.0,11/67,11.06%,TUBB1;GYPB;NR1I3;UROD;CD300LF;KCNN4;GMFG;CA1;ARG1;RHD;HEMGN
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K4 methylation (GO:0051571),-0.6548751588067865,-1.2440699636896448,0.2127659574468085,0.9419761257042385,1.0,1/13,0.81%,MYB
prerank,GO_Biological_Process_2021__atrioventricular valve formation (GO:0003190),0.8266293290951561,1.2438870137047684,0.19672131147540983,1.0,1.0,2/6,6.18%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__fibroblast growth factor receptor signaling pathway (GO:0008543),-0.5490239253931958,-1.243862001471328,0.19047619047619047,0.9411118414138722,1.0,15/61,15.37%,SPRED2;SPRED1;FGFR4;FGF1;FIBP;FGFRL1;POLR2G;NOG;TRIM71;GTF2F1;POLR2C;FLRT2;POLR2L;FGFR3;PTBP1
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to telomere (GO:0070203),0.7601197649559148,1.2434649148109012,0.20967741935483872,1.0,1.0,4/11,21.62%,TCP1;CCT6A;CCT8;CCT7
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to telomere (GO:1904851),0.7704170304808299,1.2429261420933764,0.2459016393442623,1.0,1.0,4/10,21.62%,TCP1;CCT6A;CCT8;CCT7
prerank,GO_Biological_Process_2021__glutamine family amino acid catabolic process (GO:0009065),0.7070197434798657,1.2428319231649565,0.2698412698412698,1.0,1.0,4/11,16.34%,ALDH4A1;ARG1;GAD1;DAO
prerank,GO_Biological_Process_2021__negative regulation of protein phosphorylation (GO:0001933),-0.48550828810133473,-1.2427925891859752,0.08333333333333333,0.9441151476004207,1.0,16/135,6.22%,SPRED2;SPRED3;UBASH3B;TRIB2;SPRED1;RASSF2;GREM1;PID1;PRR5L;EPHB2;PRKRIP1;PMEPA1;SFRP1;WWTR1;ZBED3;PRKCD
prerank,GO_Biological_Process_2021__camera-type eye development (GO:0043010),0.722199093713904,1.2426069265921496,0.1509433962264151,1.0,1.0,4/17,10.67%,NES;CYP1B1;LAMA1;EFEMP1
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in immune response (GO:0002720),-0.5572468662045191,-1.2421788366651527,0.2,0.9453026761029452,1.0,3/23,6.17%,KIT;F2RL1;SPHK2
prerank,GO_Biological_Process_2021__double-strand break repair via synthesis-dependent strand annealing (GO:0045003),0.85080775759941,1.2420105894441216,0.2,1.0,1.0,2/5,9.15%,RAD54L;FANCM
prerank,MSigDB_Hallmark_2020__heme Metabolism,0.5062712445622743,1.2419731516785173,0.11764705882352941,1.0,1.0,14/166,12.89%,TRIM58;GYPB;GYPE;SLC7A11;TYR;UROD;LAMP2;CA1;SLC2A1;CLCN3;RHD;IGSF3;MOSPD1;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of signal transduction by p53 class mediator (GO:1901798),-0.6318941724641496,-1.2418159732659808,0.2,0.9454492330056031,1.0,3/18,0.88%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__cellular response to chemokine (GO:1990869),0.7118469931534459,1.2410121926764441,0.16923076923076924,1.0,1.0,3/17,5.30%,CCL5;ACKR3;DOCK8
prerank,GO_Biological_Process_2021__axon ensheathment in central nervous system (GO:0032291),0.772889337234888,1.240984240881395,0.19047619047619047,1.0,1.0,2/6,5.34%,SOX10;PLP1
prerank,GO_Biological_Process_2021__negative regulation of axonogenesis (GO:0050771),0.6391500505869825,1.2407172342014456,0.16981132075471697,1.0,1.0,2/25,5.49%,LRP4;OMG
prerank,GO_Biological_Process_2021__positive regulation of hemoglobin biosynthetic process (GO:0046985),-0.8178316604354963,-1.2395427436992739,0.3023255813953488,0.9533824167314415,1.0,3/5,13.26%,SLC25A37;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__regulation of leukocyte adhesion to vascular endothelial cell (GO:1904994),-0.6931035503622698,-1.2394432095138757,0.17647058823529413,0.952136770336033,1.0,2/10,12.12%,ETS1;MDK
prerank,GO_Biological_Process_2021__ornithine transport (GO:0015822),-0.8419013304008379,-1.2390748011919492,0.1794871794871795,0.9517304015662613,1.0,3/5,11.69%,SLC25A29;SLC7A1;SLC7A2
prerank,GO_Biological_Process_2021__granulocyte differentiation (GO:0030851),-0.6634054618221742,-1.2389929211141144,0.2571428571428571,0.9502223039055295,1.0,1/12,1.33%,LEF1
prerank,GO_Biological_Process_2021__cAMP-mediated signaling (GO:0019933),-0.5841448669009472,-1.2387789609968924,0.15217391304347827,0.9495270092862421,1.0,6/22,13.94%,GLP1R;PDE3A;EPHA5;MAPK7;PDE7A;CAP2
prerank,GO_Biological_Process_2021__positive regulation of protein autophosphorylation (GO:0031954),-0.6223035908227968,-1.2386117350203862,0.16666666666666666,0.9484188265509689,1.0,3/21,2.88%,RASSF2;GREM1;PDGFD
prerank,GO_Biological_Process_2021__amino acid import across plasma membrane (GO:0089718),-0.584719633416917,-1.2382910144235582,0.1891891891891892,0.9477778320737951,1.0,5/20,11.69%,SLC16A2;SLC22A2;SLC6A9;SLC7A1;SLC7A2
prerank,MSigDB_Hallmark_2020__TNF-alpha Signaling via NF-kB,-0.4867170993501226,-1.2382605828566666,0.125,0.9462139448393373,1.0,24/148,8.52%,GEM;DUSP4;BCL2A1;DUSP5;F2RL1;IFIH1;LAMB3;CEBPD;FOS;SDC4;PMEPA1;DUSP2;SGK1;GCH1;BCL6;CFLAR;MARCKS;SERPINB8;IER3;ATF3;IL15RA;PLK2;ID2;MAP2K3
prerank,GO_Biological_Process_2021__positive regulation of phosphoprotein phosphatase activity (GO:0032516),0.7104635745392924,1.2378310831495876,0.25396825396825395,1.0,1.0,2/12,5.48%,PDGFRB;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of nitric-oxide synthase activity (GO:0051000),-0.6412174289951083,-1.2376262753471021,0.28125,0.9470371388744415,1.0,6/13,13.01%,GCH1;S100A1;DHFR;SCARB1;APOE;NOS1AP
prerank,GO_Biological_Process_2021__regulation of protein localization to cilium (GO:1903564),-0.7644705925037724,-1.2374712037121236,0.23529411764705882,0.9462562656097676,1.0,2/5,15.54%,CROCC;ENTR1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte chemotaxis (GO:0140131),0.7306866927692093,1.2374656177413157,0.30158730158730157,1.0,1.0,1/9,2.27%,CCL5
prerank,GO_Biological_Process_2021__secondary alcohol biosynthetic process (GO:1902653),0.6064456441255348,1.237374092533575,0.2054794520547945,1.0,1.0,11/27,19.35%,NSDHL;HMGCR;HMGCS1;G6PD;SQLE;MSMO1;INSIG2;DHCR7;DHCR24;INSIG1;ACAA2
prerank,GO_Biological_Process_2021__cell morphogenesis involved in differentiation (GO:0000904),-0.4995005394022366,-1.2370237711813539,0.15384615384615385,0.9462288780625013,1.0,19/66,19.03%,LAMB2;ITGA4;ARL13B;LAMB3;NTNG1;SIPA1L3;TYRO3;NRP1;ITGA8;PARVA;RILPL1;VAMP3;TBCD;RELN;PXN;PARVG;TEK;FERMT3;LAMC3
prerank,GO_Biological_Process_2021__muscle cell differentiation (GO:0042692),0.6393964533560951,1.2366462548183161,0.1791044776119403,1.0,1.0,3/24,8.52%,CHRNB1;TMEM204;TBX1
prerank,GO_Biological_Process_2021__plasma membrane raft assembly (GO:0044854),0.835879060975649,1.2365055946025505,0.1774193548387097,1.0,1.0,1/5,1.71%,CAV3
prerank,GO_Biological_Process_2021__regulation of protein kinase C signaling (GO:0090036),-0.6576064768774401,-1.2362601938293962,0.21428571428571427,0.9473863009029421,1.0,3/11,14.03%,SPHK2;DGKD;GPD1L
prerank,GO_Biological_Process_2021__PML body organization (GO:0030578),-0.8008563158067483,-1.2361969490394003,0.1951219512195122,0.9460054289454756,1.0,2/5,15.18%,ETS1;PML
prerank,GO_Biological_Process_2021__positive regulation of mRNA catabolic process (GO:0061014),-0.49450987281031233,-1.2361816487353712,0.14285714285714285,0.9444365161020619,1.0,10/42,19.91%,PRR5L;KHSRP;POLR2G;MEX3D;BTG2;ZC3HAV1;PNPT1;CELF1;NANOS3;RC3H1
prerank,GO_Biological_Process_2021__sulfate transport (GO:0008272),0.6942152091314518,1.236164169504387,0.18840579710144928,1.0,1.0,4/12,15.73%,SLC13A4;SLC26A4;SLC26A7;RACGAP1
prerank,GO_Biological_Process_2021__platelet aggregation (GO:0070527),-0.545656759967421,-1.2359669819736288,0.13157894736842105,0.9437148517190336,1.0,6/26,12.12%,UBASH3B;FIBP;HSPB1;TYRO3;PDGFRA;TLN1
prerank,GO_Biological_Process_2021__L-serine metabolic process (GO:0006563),0.7054965229349326,1.2358671952208629,0.13559322033898305,1.0,1.0,1/9,2.53%,SDS
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta2 production (GO:0032909),-0.7105362971781076,-1.235493120503907,0.3023255813953488,0.9438601188669068,1.0,1/6,5.75%,TGFB2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor receptor signaling pathway (GO:0042059),-0.582031099880671,-1.235490346705609,0.24,0.9422549145831196,1.0,5/39,3.11%,PTPN3;BTC;RNF126;VPS25;EREG
prerank,GO_Biological_Process_2021__positive regulation of protein ubiquitination (GO:0031398),0.5348648684222056,1.2354644646624395,0.13333333333333333,1.0,1.0,19/68,26.86%,WFS1;FANCI;PHF23;FANCM;ARRDC3;SMAD7;RIPK2;BRCA1;DERL1;PINK1;DCUN1D1;LRRK2;RCHY1;SPHK1;KDM1A;UBE3A;UBE2D1;LAPTM5;UBQLN1
prerank,GO_Biological_Process_2021__regulation of nuclear division (GO:0051783),0.6735819627799252,1.2350972899168366,0.20588235294117646,1.0,1.0,1/14,2.42%,BORA
prerank,GO_Biological_Process_2021__positive regulation of cation transmembrane transport (GO:1904064),-0.5646162085777003,-1.2349757649518915,0.16666666666666666,0.9432158412677752,1.0,11/38,15.05%,STAC;KCNJ16;AMIGO1;KCNN3;ACE2;KCNE1;KCNN2;NOS1AP;KCNJ6;GABBR2;KCNJ2
prerank,GO_Biological_Process_2021__nucleotide metabolic process (GO:0009117),-0.5894406171269864,-1.234542457288728,0.14285714285714285,0.9431939783386787,1.0,4/22,8.94%,NMNAT3;PNP;ENPP3;CTPS2
prerank,"GO_Biological_Process_2021__establishment of mitochondrion localization, microtubule-mediated (GO:0034643)",-0.6951371273249428,-1.2344411404643831,0.26666666666666666,0.9421943145755953,1.0,2/6,17.12%,UXT;MAP1S
prerank,GO_Biological_Process_2021__negative regulation of stem cell differentiation (GO:2000737),0.7611308461338399,1.2343608082654491,0.15625,1.0,1.0,2/10,9.19%,NOTCH1;REST
prerank,GO_Biological_Process_2021__peptidyl-glutamine methylation (GO:0018364),-0.8111433097768024,-1.2338747027070585,0.2631578947368421,0.9432933359673441,1.0,3/5,18.24%,FBLL1;SIRT7;CREBBP
prerank,GO_Biological_Process_2021__diol biosynthetic process (GO:0034312),-0.6328729109097853,-1.2337279385028157,0.22857142857142856,0.942296876200715,1.0,4/15,8.70%,GCH1;SPHK2;DHFR;SPTLC1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane depolarization (GO:0060373),0.7916244867967994,1.2333746769850424,0.16666666666666666,1.0,1.0,2/5,11.46%,CAV3;SMAD7
prerank,GO_Biological_Process_2021__early endosome to Golgi transport (GO:0034498),0.7394148908647724,1.2330851359499604,0.1935483870967742,1.0,1.0,1/12,2.79%,LMAN1
prerank,GO_Biological_Process_2021__catecholamine metabolic process (GO:0006584),-0.658675448344016,-1.2329823283864318,0.24324324324324326,0.9438191671808948,1.0,3/10,10.32%,PAH;DRD4;DRD1
prerank,GO_Biological_Process_2021__mitotic chromosome condensation (GO:0007076),0.6479811647879268,1.2326674656669492,0.16666666666666666,1.0,1.0,5/22,12.53%,NCAPH2;NCAPG;PHF13;CHMP1A;SMC2
prerank,GO_Biological_Process_2021__anterograde synaptic vesicle transport (GO:0048490),-0.636610447149644,-1.2321899569733656,0.1724137931034483,0.9441759157110998,1.0,2/11,7.29%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__synaptic vesicle transport along microtubule (GO:0099517),-0.636610447149644,-1.2321899569733656,0.1724137931034483,0.9441759157110998,1.0,2/11,7.29%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__regulation of phosphoprotein phosphatase activity (GO:0043666),0.6244040745657835,1.2319270897031103,0.2537313432835821,1.0,1.0,3/30,6.15%,PPP1R1B;PDGFRB;FKBP1B
prerank,GO_Biological_Process_2021__regulation of calcium ion transport (GO:0051924),0.5876545251614044,1.2318525136890686,0.18571428571428572,1.0,1.0,5/41,2.27%,MYLK;WFS1;CAV3;CD4;CCL5
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540),-0.604311230320275,-1.2318323951915162,0.17647058823529413,0.943491595744116,1.0,5/14,10.44%,DECR2;EHHADH;CROT;ACOT8;ABCD1
prerank,GO_Biological_Process_2021__digestive tract development (GO:0048565),0.6287186272821675,1.2316825873795356,0.19402985074626866,1.0,1.0,5/25,11.22%,NPY;GLI3;RARRES2;CCDC39;FGFR2
prerank,GO_Biological_Process_2021__regulation of establishment or maintenance of cell polarity (GO:0032878),-0.5681343282613726,-1.231675867912268,0.16216216216216217,0.9426209931312122,1.0,3/16,18.63%,LLGL2;RIPOR2;TEK
prerank,GO_Biological_Process_2021__foam cell differentiation (GO:0090077),0.7753934144294812,1.23064032915013,0.2777777777777778,1.0,1.0,4/5,21.48%,STAT1;TGFB1;SOAT1;PPARG
prerank,GO_Biological_Process_2021__macrophage derived foam cell differentiation (GO:0010742),0.7753934144294812,1.23064032915013,0.2777777777777778,1.0,1.0,4/5,21.48%,STAT1;TGFB1;SOAT1;PPARG
prerank,GO_Biological_Process_2021__regulation of leukocyte chemotaxis (GO:0002688),-0.6367950336420413,-1.2300469908039289,0.18421052631578946,0.9472127367768276,1.0,1/13,1.47%,F2RL1
prerank,GO_Biological_Process_2021__cellular response to interleukin-21 (GO:0098757),0.802191291778465,1.2299525250573409,0.2,1.0,1.0,3/6,9.09%,IL21R;STAT4;STAT1
prerank,GO_Biological_Process_2021__interleukin-21-mediated signaling pathway (GO:0038114),0.802191291778465,1.2299525250573409,0.2,1.0,1.0,3/6,9.09%,IL21R;STAT4;STAT1
prerank,GO_Biological_Process_2021__regulation of glycoprotein biosynthetic process (GO:0010559),-0.7640193612210475,-1.229889098303627,0.2608695652173913,0.9463388342709123,1.0,3/7,19.05%,IGF1;FKTN;NECAB2
prerank,GO_Biological_Process_2021__cellular response to prostaglandin E stimulus (GO:0071380),-0.7701559288070504,-1.2295717477429424,0.3157894736842105,0.9459603688170289,1.0,1/5,4.71%,SFRP1
prerank,GO_Biological_Process_2021__reverse cholesterol transport (GO:0043691),-0.7151152288893745,-1.2295049721490987,0.23684210526315788,0.9445529096569005,1.0,5/11,17.71%,APOA1;SCARB1;APOE;CLU;LCAT
prerank,GO_Biological_Process_2021__regulation of presynapse organization (GO:0099174),-0.5910370839735929,-1.2292408708351508,0.19444444444444445,0.942405416125783,1.0,3/17,5.65%,MDGA1;GPC4;LRFN4
prerank,GO_Biological_Process_2021__regulation of presynapse assembly (GO:1905606),-0.5910370839735929,-1.2292408708351508,0.19444444444444445,0.942405416125783,1.0,3/17,5.65%,MDGA1;GPC4;LRFN4
prerank,GO_Biological_Process_2021__regulation of inflammatory response to wounding (GO:0106014),-0.8206811814358144,-1.2287484023878574,0.2653061224489796,0.9428281099186522,1.0,2/5,12.12%,SIGLEC10;MDK
prerank,GO_Biological_Process_2021__response to prostaglandin E (GO:0034695),-0.7382460559548092,-1.2286645813730872,0.21621621621621623,0.9417142325882762,1.0,1/6,4.71%,SFRP1
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway (GO:0007197),-0.7104517328326614,-1.2283386798846654,0.20833333333333334,0.9414632365467113,1.0,3/8,20.11%,CHRM5;OPRM1;HRH4
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880),0.6548244274139675,1.2275635429815253,0.2037037037037037,1.0,1.0,6/19,25.08%,FKBP1B;CASQ1;CAMK2D;TRDN;CALM3;RYR2
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in determination of left/right asymmetry (GO:0060287),0.8130585894337814,1.2271952241884152,0.12280701754385964,1.0,1.0,2/7,10.58%,ODAD4;CCDC39
prerank,GO_Biological_Process_2021__establishment of spindle orientation (GO:0051294),-0.5625288287840589,-1.227188150625418,0.21212121212121213,0.9445051557946649,1.0,5/25,10.74%,NUMA1;NSFL1C;CDK5RAP2;KIF25;LLGL2
prerank,GO_Biological_Process_2021__myoblast differentiation (GO:0045445),-0.636113298906237,-1.2270750775565176,0.28205128205128205,0.9435097400816721,1.0,2/14,3.96%,NRG1;IGF1
prerank,GO_Biological_Process_2021__glutamate receptor signaling pathway (GO:0007215),-0.5176950087033814,-1.2268952730902456,0.14814814814814814,0.9427024497680565,1.0,7/35,13.06%,HOMER2;GRIK4;GRIN3A;GRIA4;GRIN2A;GRIN2C;GRIA2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide biosynthetic process (GO:0009220),-0.6775700377657978,-1.2266286492580862,0.19444444444444445,0.942243850448289,1.0,2/7,14.34%,CTPS2;AK5
prerank,GO_Biological_Process_2021__purine-containing compound biosynthetic process (GO:0072522),-0.5618881762312641,-1.2263620835271245,0.17142857142857143,0.9416715888078812,1.0,3/22,3.37%,APRT;GMPR;PNP
prerank,GO_Biological_Process_2021__sulfur amino acid metabolic process (GO:0000096),-0.5814675506335838,-1.225912137776002,0.16216216216216217,0.9419979847963098,1.0,1/19,0.27%,NOX4
prerank,GO_Biological_Process_2021__negative regulation of DNA repair (GO:0045738),0.7504314327278451,1.2256947078177436,0.23529411764705882,1.0,1.0,4/7,19.68%,TWIST1;OTUB1;UBR5;RNF169
prerank,GO_Biological_Process_2021__positive regulation of dendritic spine morphogenesis (GO:0061003),-0.6336689966815549,-1.2256432926187557,0.2777777777777778,0.9415657307057039,1.0,3/9,16.86%,LRP8;RELN;DBNL
prerank,GO_Biological_Process_2021__glycerol ether metabolic process (GO:0006662),0.8049503505350161,1.2249669483234291,0.22950819672131148,1.0,1.0,1/5,7.35%,NCEH1
prerank,GO_Biological_Process_2021__negative regulation of small GTPase mediated signal transduction (GO:0051058),-0.6041280180477394,-1.2248850370307816,0.1956521739130435,0.9433810276233227,1.0,4/19,9.33%,SPRY4;EPHB2;TGFB2;SPRY3
prerank,GO_Biological_Process_2021__negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315),0.7105269182313032,1.2242583185543603,0.24528301886792453,1.0,1.0,3/9,21.68%,FKBP1B;TRDN;CALM3
prerank,GO_Biological_Process_2021__negative regulation of release of sequestered calcium ion into cytosol (GO:0051280),0.7105269182313032,1.2242583185543603,0.24528301886792453,1.0,1.0,3/9,21.68%,FKBP1B;TRDN;CALM3
prerank,GO_Biological_Process_2021__negative regulation of protein activation cascade (GO:2000258),0.7617617220300901,1.2237441190926208,0.24193548387096775,1.0,1.0,5/7,21.79%,F8;F10;A2M;SERPING1;F3
prerank,GO_Biological_Process_2021__regulation of neuron projection arborization (GO:0150011),-0.6425204525718959,-1.2235392950712556,0.19444444444444445,0.9473642817563943,1.0,2/15,9.33%,NTNG1;SPRY3
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in immune response (GO:0002718),-0.7184272599775076,-1.2234083005040544,0.2647058823529412,0.9463086019857346,1.0,3/10,7.04%,F2RL1;SPHK2;APOA1
prerank,GO_Biological_Process_2021__regulation of hair cycle (GO:0042634),0.7612121464812887,1.2224528373768997,0.1875,1.0,1.0,2/6,21.34%,TRPV3;PER1
prerank,GO_Biological_Process_2021__regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091),-0.6966512724780524,-1.2224176725667601,0.1282051282051282,0.9493846931967602,1.0,2/9,8.75%,APOBEC3H;HMGA2
prerank,GO_Biological_Process_2021__renal water homeostasis (GO:0003091),0.6820000410309637,1.2222273834751305,0.17391304347826086,1.0,1.0,3/19,15.80%,WFS1;MYO5B;RAB11A
prerank,GO_Biological_Process_2021__positive regulation of acute inflammatory response (GO:0002675),0.7912378770907095,1.221716870589046,0.18055555555555555,1.0,1.0,2/7,7.52%,OSMR;PTGER3
prerank,PanglaoDB_Augmented_2021__Stromal Cells,-0.4902705840071288,-1.221687263040013,0.06451612903225806,0.9509023671039548,1.0,16/85,6.70%,KIT;TAGLN;COL15A1;ABI3BP;ITGA4;LAMA4;ADAMTS2;SVEP1;COL6A2;SGCD;PCDH18;FNDC1;PRRX1;ADAMTS5;TLR1;RHOJ
prerank,GO_Biological_Process_2021__mitochondrial DNA repair (GO:0043504),0.7767540001894577,1.2216220239575262,0.25,1.0,1.0,1/5,6.49%,MGME1
prerank,GO_Biological_Process_2021__cellular modified amino acid catabolic process (GO:0042219),0.7689673541379816,1.221434779082988,0.208955223880597,1.0,1.0,3/8,11.63%,CHAC2;ALDH4A1;CHAC1
prerank,GO_Biological_Process_2021__negative regulation of cold-induced thermogenesis (GO:0120163),0.5764376965154128,1.2214068135851937,0.20512820512820512,1.0,1.0,9/39,14.07%,ALDH1A1;IL18R1;NOTCH1;IL15;TLE3;ARRDC3;ACOT13;ACVR2B;PLCL1
prerank,GO_Biological_Process_2021__myeloid dendritic cell activation (GO:0001773),0.8082177215920258,1.2213082187284012,0.203125,1.0,1.0,1/6,4.46%,DOCK2
prerank,GO_Biological_Process_2021__photoreceptor cell differentiation (GO:0046530),0.761564335338551,1.2210409151350023,0.23809523809523808,1.0,1.0,1/7,2.48%,RP1
prerank,GO_Biological_Process_2021__positive regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901838),-0.6621579620780518,-1.2209177914945573,0.3,0.9524833503264856,1.0,6/10,19.93%,NCL;SMARCA4;DDX11;SMARCB1;MTOR;MARS1
prerank,GO_Biological_Process_2021__regulation of MAP kinase activity (GO:0043405),-0.4816051868912976,-1.2207628342699535,0.14705882352941177,0.9516986079854612,1.0,11/79,6.22%,KIT;TPD52L1;TRIB2;BMP7;SPRY4;RGS14;PDGFD;RASGRP1;PIK3R6;FGF1;PRKCD
prerank,GO_Biological_Process_2021__positive regulation of voltage-gated potassium channel activity (GO:1903818),-0.6602662503176764,-1.2206701273089924,0.3142857142857143,0.9505311364684237,1.0,2/7,13.01%,LRRC55;NOS1AP
prerank,GO_Biological_Process_2021__regulation of microglial cell activation (GO:1903978),0.7159088738421434,1.2206283383350707,0.208955223880597,1.0,1.0,3/9,21.17%,PTPRC;STAP1;SPHK1
prerank,GO_Biological_Process_2021__regulation of striated muscle contraction (GO:0006942),0.6373332537851941,1.2204527649666232,0.21739130434782608,1.0,1.0,3/19,11.46%,CAV3;MYBPC3;SMAD7
prerank,GO_Biological_Process_2021__regulation of neuron projection development (GO:0010975),-0.4174535929865453,-1.220376481556407,0.1111111111111111,0.9502950597535987,1.0,24/151,13.93%,ROR2;EPHA3;PRAG1;PTPN9;MYLIP;LZTS3;NTNG1;ITGA6;ARSB;MARK1;KNDC1;RTN4R;TOX;SPOCK1;NCS1;CTNNA2;PTPRS;APOE;STMN2;MDK;PLPPR5;P3H1;GPC2;PTPRO
prerank,GO_Biological_Process_2021__T cell receptor signaling pathway (GO:0050852),0.5021417650015966,1.2203604254464793,0.12987012987012986,1.0,1.0,15/124,15.17%,ITK;BTN2A2;CD4;PTPRC;THEMIS2;FYB1;HLA-A;HHLA2;PSMB6;WAS;PLCG2;EIF2B5;RIPK2;PSMA3;PSMB8
prerank,GO_Biological_Process_2021__astrocyte development (GO:0014002),0.7731656103828703,1.220132953636442,0.2909090909090909,1.0,1.0,2/5,17.85%,EIF2B5;CDK6
prerank,GO_Biological_Process_2021__mitotic DNA replication (GO:1902969),0.7006615120937177,1.219955726641366,0.17857142857142858,1.0,1.0,3/9,10.12%,MCM2;MCMDC2;GINS1
prerank,GO_Biological_Process_2021__enzyme linked receptor protein signaling pathway (GO:0007167),-0.4477948662749467,-1.219947518607939,0.10526315789473684,0.9502630431724244,1.0,11/117,2.61%,KIT;ALK;SHC3;ROR2;KDR;PTPRT;FGFR4;EPHA3;GUCY2C;EPHB2;SHC4
prerank,GO_Biological_Process_2021__cellular response to transforming growth factor beta stimulus (GO:0071560),-0.48061321402564305,-1.2196601726719607,0.07407407407407407,0.9499830445874831,1.0,11/92,9.80%,ITGB5;FOS;PDE3A;ZMIZ2;SFRP1;TGFB2;APOA1;MAPK7;GCNT2;CILP;TGFB3
prerank,GO_Biological_Process_2021__epidermal growth factor receptor signaling pathway (GO:0007173),-0.508286877373759,-1.2193505176017574,0.16666666666666666,0.949839043197135,1.0,4/40,6.26%,SHC3;BTC;EREG;DGKD
prerank,GO_Biological_Process_2021__myeloid cell differentiation (GO:0030099),-0.5269093203164563,-1.219245490750261,0.16216216216216217,0.9487512910512238,1.0,3/40,2.39%,KIT;RUNX1;INHA
prerank,GO_Biological_Process_2021__establishment of endothelial intestinal barrier (GO:0090557),0.7296348263838419,1.219165144704175,0.23809523809523808,1.0,1.0,2/10,8.64%,TJP3;F11R
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell migration (GO:0043535),-0.5207374141470237,-1.2187948948048561,0.17142857142857143,0.9491708445186358,1.0,6/45,11.15%,KDR;VASH1;HSPB1;ETS1;MAP2K3;APOE
prerank,GO_Biological_Process_2021__cellular response to estrogen stimulus (GO:0071391),-0.6329696926245598,-1.2183900003656134,0.23529411764705882,0.9491856891674922,1.0,2/14,4.71%,ARID5A;SFRP1
prerank,GO_Biological_Process_2021__cholesterol metabolic process (GO:0008203),0.5453179163905035,1.2182394505505958,0.15942028985507245,1.0,1.0,16/55,20.71%,LDLRAP1;NSDHL;SULT2A1;HMGCR;HMGCS1;G6PD;SQLE;MSMO1;INSIG2;SNX17;DHCR7;DHCR24;INSIG1;ACAA2;ANGPTL3;SOAT1
prerank,GO_Biological_Process_2021__regulation of transcription of nucleolar large rRNA by RNA polymerase I (GO:1901836),-0.6414967958717674,-1.2174365800885227,0.13157894736842105,0.9511917850903343,1.0,9/14,19.93%,MACROH2A2;NCL;SMARCA4;DDX11;SIRT7;SMARCB1;MTOR;MACROH2A1;MARS1
prerank,GO_Biological_Process_2021__thymus development (GO:0048538),0.7712413357022465,1.217099766231375,0.13793103448275862,1.0,1.0,2/8,8.52%,FADD;TBX1
prerank,GO_Biological_Process_2021__protein localization to microtubule end (GO:1905725),-0.7642268309785768,-1.2169448149162725,0.3157894736842105,0.9498990413062157,1.0,3/5,21.94%,MAPRE1;GAS2L2;GAS2L1
prerank,GO_Biological_Process_2021__protein localization to microtubule plus-end (GO:1904825),-0.7642268309785768,-1.2169448149162725,0.3157894736842105,0.9498990413062157,1.0,3/5,21.94%,MAPRE1;GAS2L2;GAS2L1
prerank,GO_Biological_Process_2021__cellular response to nitric oxide (GO:0071732),-0.7539385107714233,-1.2166080247533133,0.23809523809523808,0.9480808621728136,1.0,1/5,10.48%,MTR
prerank,GO_Biological_Process_2021__cellular response to reactive nitrogen species (GO:1902170),-0.7539385107714233,-1.2166080247533133,0.23809523809523808,0.9480808621728136,1.0,1/5,10.48%,MTR
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell migration (GO:0090521),0.7981768878736831,1.2160183857305447,0.2631578947368421,1.0,1.0,2/5,15.29%,ANLN;KANK2
prerank,GO_Biological_Process_2021__lymphocyte migration (GO:0072676),0.7442135855586702,1.2160033750958832,0.288135593220339,1.0,1.0,3/7,23.14%,CCL5;MSN;MSMP
prerank,GO_Biological_Process_2021__polyamine biosynthetic process (GO:0006596),-0.7519079878692814,-1.2158906179517526,0.2631578947368421,0.9492959731748395,1.0,1/6,6.34%,SRM
prerank,GO_Biological_Process_2021__postsynapse organization (GO:0099173),0.7578990988491037,1.2158060447462435,0.25396825396825395,1.0,1.0,3/8,17.34%,CHRNB1;LGMN;CHRNA7
prerank,GO_Biological_Process_2021__nucleotide catabolic process (GO:0009166),-0.709624185093978,-1.2156474039592464,0.30303030303030304,0.9487785441951104,1.0,4/14,10.85%,PNP;ITPA;SAMHD1;DNPH1
prerank,GO_Biological_Process_2021__nucleoside phosphate biosynthetic process (GO:1901293),-0.6774473435710544,-1.2148309382062463,0.3225806451612903,0.9502985406050062,1.0,2/13,3.37%,NMNAT3;PNP
prerank,GO_Biological_Process_2021__neuron fate commitment (GO:0048663),-0.6583761334201984,-1.2146423421304087,0.21875,0.9496486007222736,1.0,4/9,16.59%,ASCL1;ID2;PAX6;TGFBR1
prerank,GO_Biological_Process_2021__forebrain neuron development (GO:0021884),0.8382715200383852,1.214428958119607,0.0967741935483871,1.0,1.0,1/6,11.22%,FGFR2
prerank,GO_Biological_Process_2021__negative regulation of Ras protein signal transduction (GO:0046580),-0.5402207115204337,-1.2143551510898232,0.25806451612903225,0.9490889311225811,1.0,8/32,13.63%,SPRY4;EPHB2;HEG1;TGFB2;KCTD13;SPRY3;RIPOR2;SPRY1
prerank,GO_Biological_Process_2021__response to ionizing radiation (GO:0010212),0.5223880279324083,1.2143056376739205,0.2054794520547945,1.0,1.0,10/66,15.13%,AEN;TICRR;NHEJ1;FIGNL1;RAD9B;INIP;RHOB;EYA1;BRCA1;ECT2
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate catabolic process (GO:0009169),-0.6959770954756491,-1.2142712958000017,0.275,0.9479363478186612,1.0,2/7,11.52%,PNP;PRTFDC1
prerank,GO_Biological_Process_2021__aromatic amino acid family metabolic process (GO:0009072),-0.7302974979701922,-1.2139924949329954,0.27450980392156865,0.9471392036582607,1.0,1/8,0.72%,PAH
prerank,GO_Biological_Process_2021__regulation of ossification (GO:0030278),0.6329388667875355,1.2136906555045723,0.15942028985507245,1.0,1.0,4/28,5.96%,LRP4;NOTCH1;NOTUM;TWIST1
prerank,GO_Biological_Process_2021__response to vitamin (GO:0033273),0.8244751643274892,1.2133261466165242,0.19047619047619047,1.0,1.0,2/5,6.04%,ALPL;CDKN2D
prerank,GO_Biological_Process_2021__cellular response to oxidative stress (GO:0034599),-0.43935989735372466,-1.2131722063918056,0.09523809523809523,0.9486060037175938,1.0,11/103,9.78%,ETV5;NOX4;PRR5L;FOS;GPX7;PRKCD;VKORC1L1;ANKRD2;RBM11;PDGFRA;AKR1C3
prerank,GO_Biological_Process_2021__triglyceride catabolic process (GO:0019433),0.6610853494653767,1.212895135040636,0.2222222222222222,1.0,1.0,4/15,11.88%,LIPH;FABP3;LIPI;PNPLA1
prerank,GO_Biological_Process_2021__positive regulation of synaptic transmission (GO:0050806),-0.455518817878566,-1.212876010003284,0.05263157894736842,0.9484679511056374,1.0,15/64,11.27%,RGS14;CACNG4;EPHB2;CACNG5;CACNG3;CLSTN2;CRHR2;ZDHHC3;SHANK2;NMU;PLK2;KCTD13;GRIN2A;DRD1;GRIN2C
prerank,GO_Biological_Process_2021__regulation of high voltage-gated calcium channel activity (GO:1901841),-0.6742597688411537,-1.2125487155549637,0.21951219512195122,0.9481771130135631,1.0,3/9,13.01%,CACNA2D1;NIPSNAP2;NOS1AP
prerank,GO_Biological_Process_2021__regulation of T cell activation (GO:0050863),0.6054788234668501,1.2124287688526776,0.20588235294117646,1.0,1.0,2/27,2.27%,CD4;CCL5
prerank,GO_Biological_Process_2021__protein localization to cilium (GO:0061512),0.6128958070610235,1.2122647508119768,0.2222222222222222,1.0,1.0,7/30,21.74%,ROPN1B;ODAD4;FSIP2;ARL6;TUB;TULP3;NPHP4
prerank,GO_Biological_Process_2021__UV protection (GO:0009650),-0.8324688558503848,-1.211977209723085,0.2558139534883721,0.9491546977541878,1.0,2/6,8.41%,ERCC2;SDF4
prerank,GO_Biological_Process_2021__fatty acid catabolic process (GO:0009062),-0.48042103928901336,-1.211690697520575,0.1724137931034483,0.9488418770332612,1.0,13/65,14.68%,GLYATL2;ABHD1;EHHADH;NUDT7;CROT;ACOT8;MECR;ABCD1;ACADVL;HADHA;SLC27A2;SLC25A17;PHYH
prerank,GO_Biological_Process_2021__positive regulation of lipid localization (GO:1905954),0.7318650389198659,1.2113153604938947,0.2727272727272727,1.0,1.0,1/8,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__serine transport (GO:0032329),0.8016608303256848,1.2111204817494328,0.08620689655172414,1.0,1.0,3/6,16.48%,SFXN3;SLC38A2;SLC38A5
prerank,GO_Biological_Process_2021__inclusion body assembly (GO:0070841),-0.7198500576852447,-1.2111194441238344,0.20930232558139536,0.9491836109872487,1.0,2/5,19.41%,BAG3;PRKN
prerank,GO_Biological_Process_2021__negative regulation of oligodendrocyte differentiation (GO:0048715),0.8116987142001114,1.2109931990039775,0.2545454545454545,1.0,1.0,3/5,14.63%,NOTCH1;DRD3;DAAM2
prerank,GO_Biological_Process_2021__proteoglycan biosynthetic process (GO:0030166),-0.5796928690037919,-1.2107590731501148,0.1891891891891892,0.9488717111431874,1.0,11/29,15.49%,CHST8;IGF1;B3GAT2;GAL3ST4;HS3ST3B1;EXT1;B3GAT3;EXT2;CHST9;XYLT2;CHST12
prerank,GO_Biological_Process_2021__L-ornithine transmembrane transport (GO:1903352),-0.7983730749258332,-1.210518963412902,0.3333333333333333,0.9481481092220495,1.0,3/5,11.69%,SLC25A29;SLC7A1;SLC7A2
prerank,GO_Biological_Process_2021__regulation of fertilization (GO:0080154),-0.7699476441786264,-1.2104919360532598,0.3076923076923077,0.946841219753123,1.0,1/5,3.39%,LHFPL2
prerank,GO_Biological_Process_2021__histone H4-K12 acetylation (GO:0043983),-0.7835162759046727,-1.210489289252938,0.21951219512195122,0.9454300833411343,1.0,3/6,20.15%,JADE2;MEAF6;KAT7
prerank,GO_Biological_Process_2021__negative regulation of homotypic cell-cell adhesion (GO:0034111),0.7059012261638222,1.210456719978503,0.22388059701492538,1.0,1.0,4/11,11.99%,ZNF703;ALOX12;PRKG1;ADAMTS18
prerank,GO_Biological_Process_2021__monoamine transport (GO:0015844),-0.7893340323323669,-1.2103173947701777,0.25,0.9446286127121258,1.0,4/6,10.52%,SLC6A4;SLC29A4;SLC22A3;SLC6A2
prerank,GO_Biological_Process_2021__positive regulation of regulatory T cell differentiation (GO:0045591),-0.6575254475151163,-1.2102364129123295,0.375,0.9435705639023624,1.0,3/7,11.55%,SOX12;BCL6;DUSP10
prerank,GO_Biological_Process_2021__positive regulation of chondrocyte differentiation (GO:0032332),0.7594600455543205,1.2100582962974267,0.24193548387096775,1.0,1.0,2/8,8.40%,LOXL2;SOX6
prerank,GO_Biological_Process_2021__amyloid-beta metabolic process (GO:0050435),-0.6466148620338745,-1.210025037762274,0.2857142857142857,0.9428390467657386,1.0,6/13,17.96%,NCSTN;MME;IDE;APEH;ACE;BACE2
prerank,GO_Biological_Process_2021__riboflavin metabolic process (GO:0006771),0.8127238277649642,1.210020500537399,0.1694915254237288,1.0,1.0,3/5,16.88%,SLC52A2;SLC52A1;RFK
prerank,GO_Biological_Process_2021__flavin-containing compound metabolic process (GO:0042726),0.8127238277649642,1.210020500537399,0.1694915254237288,1.0,1.0,3/5,16.88%,SLC52A2;SLC52A1;RFK
prerank,GO_Biological_Process_2021__hexose catabolic process (GO:0019320),-0.6846140818641413,-1.2100116352653623,0.2926829268292683,0.9414641583330013,1.0,2/7,12.92%,GALE;PGM2
prerank,GO_Biological_Process_2021__complement receptor mediated signaling pathway (GO:0002430),0.8209949844663305,1.209262694586115,0.15384615384615385,1.0,1.0,1/7,0.10%,C3AR1
prerank,GO_Biological_Process_2021__sno(s)RNA 3'-end processing (GO:0031126),-0.6931162906084063,-1.2089871887062245,0.25,0.9434669770609705,1.0,4/11,16.67%,FBLL1;EXOSC10;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__sodium ion export across plasma membrane (GO:0036376),0.700520158644509,1.2089785249574134,0.22727272727272727,1.0,1.0,3/8,18.43%,ATP12A;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__eye photoreceptor cell differentiation (GO:0001754),-0.6512832485870137,-1.2087263608956706,0.2894736842105263,0.9429320497389884,1.0,2/10,18.72%,STAT3;DSCAM
prerank,PanglaoDB_Augmented_2021__Enteric Neurons,-0.40512856771763334,-1.208290433875416,0.047619047619047616,0.9433413184606403,1.0,24/150,13.06%,SHC3;KCNIP1;RIMBP2;LIX1;CACNA2D1;FILIP1;RGMB;TOX;ADGRA1;FSTL5;NMU;ZNF536;KCNC1;GCNT2;MAPK4;TMEM196;VIP;STMN2;ELAVL3;IGF2BP3;PARVA;SCG2;RGS7BP;GRIA2
prerank,GO_Biological_Process_2021__phospholipid catabolic process (GO:0009395),0.6437038759167852,1.2080158671544727,0.18461538461538463,1.0,1.0,1/18,0.36%,ENPP2
prerank,GO_Biological_Process_2021__positive regulation of kinase activity (GO:0033674),-0.4671584534723898,-1.2078596478607138,0.10344827586206896,0.9433643333471179,1.0,19/93,10.21%,KIT;ALK;ROR2;KDR;FGFR4;EPHA3;RASSF2;EPHB2;EREG;DRD4;EPHA5;AZU1;MMD2;TYRO3;MAP2K3;CSF1R;PDGFRA;XRCC6;LMO4
prerank,GO_Biological_Process_2021__membrane assembly (GO:0071709),0.5915375275666754,1.2076793700671766,0.25,1.0,1.0,2/34,4.70%,LRP4;CHMP4B
prerank,GO_Biological_Process_2021__ovarian follicle development (GO:0001541),-0.68359550965485,-1.2076196978789704,0.3103448275862069,0.9428960644327155,1.0,2/11,2.39%,KIT;INHA
prerank,GO_Biological_Process_2021__negative regulation of cartilage development (GO:0061037),-0.5954655156706038,-1.207534580292013,0.225,0.941661518752739,1.0,2/11,7.52%,GREM1;PTHLH
prerank,GO_Biological_Process_2021__regulation of glomerular filtration (GO:0003093),-0.7916385982773116,-1.2075028275957904,0.2558139534883721,0.9403455323782958,1.0,1/6,1.47%,F2RL1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix constituent secretion (GO:0003330),0.7697180198734419,1.2073057211835676,0.24528301886792453,1.0,1.0,2/6,16.59%,NOTCH1;RGCC
prerank,GO_Biological_Process_2021__hydrogen peroxide metabolic process (GO:0042743),0.6870642065210133,1.2071239847238404,0.27419354838709675,1.0,1.0,3/14,13.88%,PRDX4;NOX1;ACOX1
prerank,GO_Biological_Process_2021__heart trabecula formation (GO:0060347),-0.7543741388022529,-1.2070434611573877,0.32432432432432434,0.9405855318866119,1.0,1/5,2.43%,RBP4
prerank,GO_Biological_Process_2021__tRNA processing (GO:0008033),-0.5163741927339027,-1.2067780148791731,0.1875,0.9402516396646244,1.0,12/60,13.94%,CPSF1;TRPT1;LCMT2;TRDMT1;TRMT10C;WDR4;SARS1;POP1;TRMT61A;FARS2;ADAT2;QTRT1
prerank,GO_Biological_Process_2021__transepithelial transport (GO:0070633),0.6696576162473878,1.2066569395412228,0.2878787878787879,1.0,1.0,4/15,12.89%,SLC23A1;ABCC2;ABCB1;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of macrophage chemotaxis (GO:0010759),0.6818470209633667,1.206583891543366,0.2028985507246377,1.0,1.0,3/14,8.55%,CCL5;RARRES2;CMKLR1
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte differentiation (GO:0045618),-0.6733713927895474,-1.2065818821179326,0.2631578947368421,0.9397067860993311,1.0,2/9,7.73%,NUMA1;MACROH2A2
prerank,GO_Biological_Process_2021__presynapse organization (GO:0099172),-0.6602443262900506,-1.2065701428986229,0.34285714285714286,0.9383381444018072,1.0,4/11,14.91%,C5AR1;NLGN4Y;LRRTM3;NLGN3
prerank,GO_Biological_Process_2021__low-density lipoprotein particle remodeling (GO:0034374),0.794182056788624,1.2064585212660026,0.23728813559322035,1.0,1.0,3/6,6.08%,PLA2G10;PLA2G7;AGT
prerank,GO_Biological_Process_2021__striated muscle hypertrophy (GO:0014897),0.7838689671799132,1.2063090663688139,0.2459016393442623,1.0,1.0,1/5,0.74%,CSRP3
prerank,GO_Biological_Process_2021__nucleoside metabolic process (GO:0009116),-0.5906084413731109,-1.206180823048224,0.25,0.9383895172534142,1.0,4/10,18.34%,NME4;UPP2;TYMP;MACROD2
prerank,GO_Biological_Process_2021__negative regulation of developmental growth (GO:0048640),-0.5910613280919651,-1.2061607811202903,0.225,0.9370902493217044,1.0,9/27,14.85%,OSTN;RTN4R;PTCH1;FGF13;SLC6A4;PTPRS;DUSP10;WWC3;FGFR3
prerank,GO_Biological_Process_2021__positive regulation of actin filament depolymerization (GO:0030836),-0.6656381004952565,-1.205928241442296,0.2,0.9365744488391888,1.0,1/10,1.47%,F2RL1
prerank,GO_Biological_Process_2021__zinc ion import across plasma membrane (GO:0071578),0.8075668512979433,1.2057435228528617,0.18032786885245902,1.0,1.0,1/5,6.59%,SLC39A12
prerank,GO_Biological_Process_2021__sensory organ morphogenesis (GO:0090596),0.7196032352758174,1.205330935904647,0.20588235294117646,1.0,1.0,2/8,8.52%,GLI3;TBX1
prerank,GO_Biological_Process_2021__regulation of long-chain fatty acid import across plasma membrane (GO:0010746),0.8094446342088266,1.205323328720984,0.2413793103448276,1.0,1.0,1/6,6.92%,ACSL5
prerank,GO_Biological_Process_2021__positive regulation of T-helper cell differentiation (GO:0045624),-0.7110076771843482,-1.205273354700767,0.19444444444444445,0.9377642960144039,1.0,1/10,0.81%,MYB
prerank,GO_Biological_Process_2021__renal tubule development (GO:0061326),0.8073570654555748,1.2050839426119606,0.18,1.0,1.0,1/5,9.09%,STAT1
prerank,GO_Biological_Process_2021__TOR signaling (GO:0031929),-0.5847279550331941,-1.2047257611359785,0.25806451612903225,0.9380262879937655,1.0,6/23,14.41%,PRR5L;EIF4EBP1;SYAP1;CARD11;MEAK7;RPTOR
prerank,GO_Biological_Process_2021__entrainment of circadian clock by photoperiod (GO:0043153),-0.5828808113874695,-1.2042190382898885,0.2631578947368421,0.9384553062800254,1.0,1/24,0.17%,PER2
prerank,GO_Biological_Process_2021__positive regulation of vasoconstriction (GO:0045907),0.711671514743077,1.2040232972487888,0.2463768115942029,1.0,1.0,3/9,12.31%,TBXA2R;AVPR1A;SMTNL1
prerank,GO_Biological_Process_2021__odontogenesis of dentin-containing tooth (GO:0042475),0.6957049655117119,1.203554940539199,0.2923076923076923,1.0,1.0,2/11,8.52%,MSX1;TBX1
prerank,GO_Biological_Process_2021__regulation of nervous system development (GO:0051960),-0.602483810633261,-1.203225699936278,0.20833333333333334,0.941291677251971,1.0,5/27,12.07%,PER2;ASCL1;TENM4;SIRT2;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell differentiation (GO:1905065),-0.6941619249273046,-1.2030442885393016,0.30303030303030304,0.9406270750188064,1.0,1/7,0.36%,KIT
prerank,PanglaoDB_Augmented_2021__Pinealocytes,-0.45815063746631685,-1.202721832296425,0.15,0.9404656226983059,1.0,17/77,10.75%,SV2C;PDE10A;SVOP;RNFT2;UNC13C;PMEPA1;TNR;CATSPER2;KCNJ14;DRD4;CACNA1A;SAMD7;AP3B2;SAG;ROM1;SLC2A11;TPH1
prerank,GO_Biological_Process_2021__negative regulation of autophagosome maturation (GO:1901097),0.7631905280100533,1.2025714035214785,0.23333333333333334,1.0,1.0,1/5,8.38%,PHF23
prerank,GO_Biological_Process_2021__regulation of cholesterol metabolic process (GO:0090181),0.5996030473277075,1.2023827434224685,0.2857142857142857,1.0,1.0,2/20,4.62%,LDLRAP1;LPCAT3
prerank,GO_Biological_Process_2021__selective autophagy (GO:0061912),-0.4995604881311607,-1.2023679586289262,0.1935483870967742,0.9404923127958668,1.0,4/55,8.52%,STING1;ARL13B;RAB7A;PCNT
prerank,GO_Biological_Process_2021__DNA catabolic process (GO:0006308),0.7304992306008548,1.2021759114745745,0.2459016393442623,1.0,1.0,1/10,6.11%,ISG20
prerank,GO_Biological_Process_2021__regulation of granulocyte chemotaxis (GO:0071622),0.6311780035070639,1.2019465450030355,0.22388059701492538,1.0,1.0,3/18,8.55%,CCL5;RARRES2;CMKLR1
prerank,GO_Biological_Process_2021__regulation of NMDA receptor activity (GO:2000310),-0.520477719281108,-1.2019334814472236,0.11428571428571428,0.9406438490772536,1.0,10/29,17.37%,EPHB2;CRH;SLC6A9;GRIA4;GRIA1;GRIN2A;GRIA2;RELN;OPRM1;LRRC7
prerank,GO_Biological_Process_2021__neuron remodeling (GO:0016322),0.6785244190684127,1.2011653562536615,0.19642857142857142,1.0,1.0,2/10,12.43%,RND1;C1QA
prerank,GO_Biological_Process_2021__positive regulation of cell projection organization (GO:0031346),-0.44252313449492303,-1.200981799911031,0.1,0.9428739512950164,1.0,22/109,17.37%,ROR2;EPHA3;FBXW8;AMIGO1;ITGA6;ARSB;TOX;PLXNA1;PLXNA2;APOE;STMN2;NGF;MDK;PLPPR5;P3H1;GPC2;CARMIL2;PLXNC1;RELN;CHODL;SETX;LRRC7
prerank,GO_Biological_Process_2021__negative regulation of viral life cycle (GO:1903901),0.7111277719953891,1.2008501412644166,0.27692307692307694,1.0,1.0,2/10,8.74%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__regulation of ketone biosynthetic process (GO:0010566),-0.7450248209485257,-1.200829509416148,0.17647058823529413,0.941942039100228,1.0,1/7,9.78%,AKR1C3
prerank,GO_Biological_Process_2021__regulation of macrophage chemotaxis (GO:0010758),0.6573909872926096,1.2006574828418128,0.18461538461538463,1.0,1.0,4/19,11.08%,CCL5;RARRES2;CMKLR1;STAP1
prerank,GO_Biological_Process_2021__cardiac ventricle development (GO:0003231),0.7595496091743634,1.2006498035504143,0.288135593220339,1.0,1.0,1/9,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of insulin receptor signaling pathway (GO:0046627),-0.5410992239176864,-1.200612141798004,0.15625,0.9411165127337641,1.0,6/22,18.10%,PID1;PRKCD;IRS1;PTPN1;PRKCB;PTPRE
prerank,GO_Biological_Process_2021__external encapsulating structure organization (GO:0045229),-0.4351035275636332,-1.2003869075848403,0.10344827586206896,0.9403969035355886,1.0,23/167,5.85%,ITGB5;NPNT;KDR;COL15A1;LAMB2;ADAM19;ITGA4;LAMA4;ADAMTS2;ADAMTS3;ADAM12;ADAMTS15;COL6A2;LAMB3;LOXL1;COL11A2;ADAMTS8;ITGA6;VCAN;TNR;PAPLN;COL4A3;ADAMTS5
prerank,GO_Biological_Process_2021__negative regulation of lyase activity (GO:0051350),0.6637254008409976,1.199820418662365,0.22857142857142856,1.0,1.0,4/13,21.50%,GRM3;DRD3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__regulation of morphogenesis of an epithelium (GO:1905330),-0.7744079441570798,-1.1996739925586661,0.3333333333333333,0.9417668921432724,1.0,2/5,7.25%,FGF1;FOXP1
prerank,GO_Biological_Process_2021__cilium movement involved in cell motility (GO:0060294),0.7774127922104694,1.199559330497284,0.27419354838709675,1.0,1.0,1/6,1.98%,CFAP54
prerank,GO_Biological_Process_2021__regulation of glucocorticoid receptor signaling pathway (GO:2000322),0.766842597574501,1.199452371527559,0.3050847457627119,1.0,1.0,3/5,21.34%,LMO3;CRY2;PER1
prerank,GO_Biological_Process_2021__negative regulation of glial cell apoptotic process (GO:0034351),-0.7561544494823473,-1.1994056584489565,0.3076923076923077,0.9414405586210818,1.0,1/6,6.22%,PRKCD
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell proliferation (GO:0060045),0.7448926567303619,1.1991926770876686,0.3150684931506849,1.0,1.0,4/10,21.10%,NOTCH1;FGFR2;PIM1;ZFPM2
prerank,GO_Biological_Process_2021__glucosamine-containing compound catabolic process (GO:1901072),0.7571184035771885,1.1989456743258082,0.2753623188405797,1.0,1.0,2/7,3.93%,CHIT1;CTBS
prerank,GO_Biological_Process_2021__positive regulation of acrosome reaction (GO:2000344),0.7738884159633188,1.198616207037485,0.3225806451612903,1.0,1.0,1/6,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process (GO:1902959),0.7284805421231163,1.1980797859844903,0.19696969696969696,1.0,1.0,1/9,1.74%,AGER
prerank,GO_Biological_Process_2021__homocysteine metabolic process (GO:0050667),-0.6891078860712472,-1.1980173655392912,0.34146341463414637,0.9454840243900993,1.0,1/9,0.27%,NOX4
prerank,GO_Biological_Process_2021__deoxyribonucleotide metabolic process (GO:0009262),-0.7346097192103482,-1.1979949934820855,0.38095238095238093,0.9442683771460173,1.0,2/5,8.67%,SAMHD1;RRM2
prerank,GO_Biological_Process_2021__mucosal immune response (GO:0002385),0.7974800042857227,1.1977977844336647,0.25,1.0,1.0,1/6,7.92%,IFNLR1
prerank,GO_Biological_Process_2021__depyrimidination (GO:0045008),0.776009688238669,1.1976664063531324,0.1896551724137931,1.0,1.0,1/8,1.78%,TDG
prerank,GO_Biological_Process_2021__phosphate ion transport (GO:0006817),-0.6542822100500603,-1.197484680180584,0.32653061224489793,0.9433660146211134,1.0,3/11,12.49%,SLC37A4;SLC20A2;SLC25A10
prerank,GO_Biological_Process_2021__phosphate ion transmembrane transport (GO:0035435),-0.6542822100500603,-1.197484680180584,0.32653061224489793,0.9433660146211134,1.0,3/11,12.49%,SLC37A4;SLC20A2;SLC25A10
prerank,"GO_Biological_Process_2021__regulation of wound healing, spreading of epidermal cells (GO:1903689)",0.7347631392050085,1.1971494937336435,0.2878787878787879,1.0,1.0,1/8,1.75%,RREB1
prerank,GO_Biological_Process_2021__anterior/posterior pattern specification (GO:0009952),0.6434412976847201,1.1970781282311231,0.24324324324324326,1.0,1.0,7/20,25.18%,WNT8A;TBX1;ATP6AP2;ACVR2B;PCSK5;BASP1;BHLHE41
prerank,GO_Biological_Process_2021__cellular response to steroid hormone stimulus (GO:0071383),-0.6109772580308397,-1.1970770794463852,0.3,0.9435929029812454,1.0,2/16,9.78%,BMP7;AKR1C3
prerank,GO_Biological_Process_2021__organic acid catabolic process (GO:0016054),-0.6966091565022345,-1.1969795885787524,0.2765957446808511,0.9425507236218938,1.0,1/6,0.42%,GLYATL2
prerank,GO_Biological_Process_2021__glutamine transport (GO:0006868),0.7555564785580104,1.196809102557635,0.20634920634920634,1.0,1.0,3/6,23.75%,SLC38A2;SLC38A5;SLC38A3
prerank,GO_Biological_Process_2021__triglyceride metabolic process (GO:0006641),0.5756530302100912,1.1967317486399516,0.19444444444444445,1.0,1.0,5/35,11.88%,LIPH;CAV3;FABP3;LIPI;PNPLA1
prerank,GO_Biological_Process_2021__positive regulation of neural precursor cell proliferation (GO:2000179),0.6441011472219705,1.1966523531567543,0.265625,1.0,1.0,1/19,0.79%,NES
prerank,GO_Biological_Process_2021__positive regulation of megakaryocyte differentiation (GO:0045654),-0.6538425347865643,-1.196629736153975,0.29411764705882354,0.9422674218659717,1.0,1/9,0.33%,RAB7B
prerank,GO_Biological_Process_2021__interleukin-12-mediated signaling pathway (GO:0035722),0.5845114185485266,1.1964324954048795,0.21621621621621623,1.0,1.0,4/37,7.79%,TCP1;CA1;STAT4;SOD2
prerank,GO_Biological_Process_2021__peripheral nervous system development (GO:0007422),0.6131202922664822,1.1961707085670834,0.2535211267605634,1.0,1.0,4/21,6.27%,SOX10;NTF3;ADGRB1;ARTN
prerank,GO_Biological_Process_2021__negative regulation of cellular response to insulin stimulus (GO:1900077),-0.5385665605627838,-1.196169345776443,0.15151515151515152,0.9427397030205548,1.0,6/23,18.10%,PID1;PRKCD;IRS1;PTPN1;PRKCB;PTPRE
prerank,GO_Biological_Process_2021__negative regulation of viral entry into host cell (GO:0046597),0.7255958388092908,1.1960264542105998,0.28125,1.0,1.0,2/9,8.74%,TRIM5;CIITA
prerank,GO_Biological_Process_2021__covalent chromatin modification (GO:0016569),-0.6044753988993021,-1.1957840261931356,0.25,0.9429254459220329,1.0,3/13,14.67%,HDAC1;PARP2;SIRT7
prerank,GO_Biological_Process_2021__cartilage development (GO:0051216),-0.5243198447252431,-1.1957682246649064,0.21875,0.9416665037762166,1.0,4/39,3.62%,SULF2;RUNX1;COL11A2;NFIB
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via threonine (GO:0018243),-0.6700285001220377,-1.195749412791588,0.275,0.9404111897057482,1.0,4/8,28.17%,GALNT1;GALNT16;GALNT2;EOGT
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine metabolic process (GO:0030309),0.7284491096174989,1.195722125620099,0.25757575757575757,1.0,1.0,5/10,18.95%,B3GALT1;B3GNT4;B3GNT3;B3GALNT1;B4GAT1
prerank,GO_Biological_Process_2021__regulation of calcium ion import (GO:0090279),0.6895636230480123,1.1956840323893092,0.26666666666666666,1.0,1.0,2/17,3.19%,CAV3;PDGFRB
prerank,GO_Biological_Process_2021__cardiac muscle cell development (GO:0055013),0.6680979703604739,1.195615305850702,0.22727272727272727,1.0,1.0,3/17,6.44%,CSRP3;PDGFRB;ACTC1
prerank,GO_Biological_Process_2021__regulation of protein localization to plasma membrane (GO:1903076),-0.4863652800327093,-1.1952358438663662,0.2222222222222222,0.9411673658479308,1.0,8/67,7.58%,STAC;EPHA3;PTPN9;PID1;EPHB2;ZDHHC5;NUMB;RANGRF
prerank,GO_Biological_Process_2021__glycogen catabolic process (GO:0005980),0.686601576009359,1.1949268205419483,0.2857142857142857,1.0,1.0,3/13,15.20%,PHKG1;PHKA1;AGL
prerank,GO_Biological_Process_2021__lipid droplet formation (GO:0140042),0.732132555673472,1.1948832971109211,0.27419354838709675,1.0,1.0,2/8,12.63%,SMIM22;SQLE
prerank,GO_Biological_Process_2021__cellular response to acetylcholine (GO:1905145),0.733577883095456,1.1946224844107143,0.2647058823529412,1.0,1.0,4/7,24.32%,CHRNA7;ATP2B4;LYPD1;CHRNB2
prerank,GO_Biological_Process_2021__tRNA metabolic process (GO:0006399),-0.6173090823148509,-1.194241959810902,0.3076923076923077,0.9437238374493435,1.0,4/15,12.64%,TRPT1;SARS1;POP1;FARS2
prerank,PanglaoDB_Augmented_2021__Neutrophils,0.543664836079038,1.1941894607881403,0.18421052631578946,1.0,1.0,15/51,18.39%,NR1I3;MYLK;HCK;CD300LF;ELANE;DOCK8;CD14;TAGAP;MYO1F;IGSF6;ARG2;AQP9;TBXAS1;LY86;PTAFR
prerank,GO_Biological_Process_2021__regulation of inflammatory response (GO:0050727),0.48790410240213894,1.1933625524351634,0.1511627906976744,1.0,1.0,12/126,6.08%,CASP12;PTGES;LRRC19;PTGIS;CCL5;PLA2G7;HCK;ELANE;IL15;MMP26;LPCAT3;AGT
prerank,GO_Biological_Process_2021__cell junction organization (GO:0034330),0.5178407735114906,1.1933316699073058,0.20253164556962025,1.0,1.0,8/69,14.59%,LRP4;MARVELD2;TJP3;MARVELD3;PPFIBP2;C1QA;TGFB1;MYOT
prerank,MSigDB_Hallmark_2020__Cholesterol Homeostasis,0.5345748399704704,1.1932152835845486,0.1506849315068493,1.0,1.0,19/65,20.09%,TMEM97;NSDHL;ATF5;FASN;NFIL3;AVPR1A;HMGCR;HMGCS1;SCD;SQLE;PLAUR;ANTXR2;FADS2;LGMN;GLDC;STARD4;DHCR7;PLSCR1;PNRC1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase III (GO:0045945),-0.6691131703005341,-1.1930483433445302,0.28205128205128205,0.9469403455118003,1.0,3/9,19.14%,RPTOR;ICE1;MTOR
prerank,GO_Biological_Process_2021__positive regulation of rRNA processing (GO:2000234),-0.6619937617617854,-1.1929791491997814,0.21621621621621623,0.9458058361135266,1.0,1/10,1.48%,BUD23
prerank,GO_Biological_Process_2021__regulation of glial cell apoptotic process (GO:0034350),-0.7636417585898323,-1.1928773289105594,0.32432432432432434,0.9448560626076203,1.0,1/5,6.22%,PRKCD
prerank,GO_Biological_Process_2021__regulation of regulated secretory pathway (GO:1903305),0.6064726760859128,1.1928496197467455,0.22535211267605634,1.0,1.0,8/34,20.42%,TRPV6;SYT2;SYT4;DOC2A;SYT15;SYT9;SYT13;LRRK2
prerank,GO_Biological_Process_2021__negative regulation of protein modification by small protein conjugation or removal (GO:1903321),-0.488827422395526,-1.1928162689514634,0.23076923076923078,0.9436673620356011,1.0,2/45,2.91%,PER2;SVBP
prerank,GO_Biological_Process_2021__positive regulation of gluconeogenesis (GO:0045722),0.7982213907233553,1.1925610342797794,0.2903225806451613,1.0,1.0,1/6,8.34%,PPARGC1A
prerank,GO_Biological_Process_2021__apical junction assembly (GO:0043297),0.5738215541998801,1.1922428394408697,0.25,1.0,1.0,8/39,18.42%,MARVELD2;CTNNA1;MARVELD3;F11R;CLDN10;ECT2;CLDN20;MPP7
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transport (GO:1902307),0.7206118460250255,1.1921314085327563,0.2903225806451613,1.0,1.0,2/10,15.36%,GLRX;ATP1B1
prerank,GO_Biological_Process_2021__positive regulation of osteoblast differentiation (GO:0045669),-0.5049063911792693,-1.1919001465740462,0.15,0.9454781448580296,1.0,6/37,8.62%,NPNT;BMP7;IGF1;WWTR1;BMP6;ZHX3
prerank,GO_Biological_Process_2021__negative regulation of monocyte chemotaxis (GO:0090027),-0.7461172889595385,-1.1916002025126018,0.37037037037037035,0.9450951189724262,1.0,1/5,1.73%,GREM1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway in absence of ligand (GO:2001239),-0.5724409885454087,-1.1913651831278629,0.1891891891891892,0.9446129288092973,1.0,4/19,7.26%,UNC5B;EYA4;BCL2;MAPK7
prerank,GO_Biological_Process_2021__dendritic cell chemotaxis (GO:0002407),0.804361803680438,1.191119558317197,0.2903225806451613,1.0,1.0,2/5,15.07%,CCL5;GPR183
prerank,GO_Biological_Process_2021__vacuole organization (GO:0007033),0.7844108577676715,1.1905829765146412,0.2857142857142857,1.0,1.0,1/6,2.09%,NDP
prerank,GO_Biological_Process_2021__mitochondrial RNA processing (GO:0000963),-0.6666861951903675,-1.1903166707162764,0.22857142857142856,0.9466949644635423,1.0,3/7,19.77%,TRMT10C;PNPT1;ELAC2
prerank,GO_Biological_Process_2021__negative regulation of phosphorylation (GO:0042326),-0.47704707142239,-1.1902064485498587,0.08695652173913043,0.9456320494910258,1.0,8/78,6.18%,BMP7;PID1;PRR5L;EPHB2;INHA;PRKRIP1;WWTR1;ZBED3
prerank,GO_Biological_Process_2021__cellular response to interleukin-4 (GO:0071353),-0.6973408790838195,-1.1895542205058196,0.3333333333333333,0.9468681886601304,1.0,1/5,1.33%,LEF1
prerank,GO_Biological_Process_2021__UV-damage excision repair (GO:0070914),-0.6404380853041165,-1.189543609192569,0.23684210526315788,0.9456086619874812,1.0,5/11,19.84%,ERCC1;INO80;POLD3;DDB2;XPC
prerank,GO_Biological_Process_2021__non-motile cilium assembly (GO:1905515),-0.5846694922961051,-1.1893105905071573,0.21212121212121213,0.9452087885459591,1.0,5/27,16.56%,ARL13B;PCM1;RPGRIP1L;PIBF1;TBC1D32
prerank,GO_Biological_Process_2021__lymphoid progenitor cell differentiation (GO:0002320),0.7938509082788301,1.1892268220332238,0.25396825396825395,1.0,1.0,1/5,6.28%,FLT3
prerank,GO_Biological_Process_2021__regulation of secretion (GO:0051046),-0.5867606831593478,-1.1890775397684197,0.16666666666666666,0.9445913508750527,1.0,2/13,4.02%,NRG1;SGK1
prerank,GO_Biological_Process_2021__osteoblast development (GO:0002076),-0.6637481929443437,-1.1885701806298872,0.2727272727272727,0.9452065452567455,1.0,1/6,7.52%,PTHLH
prerank,GO_Biological_Process_2021__purine-containing compound catabolic process (GO:0072523),-0.6906472453583765,-1.18831209210325,0.36363636363636365,0.944868400170186,1.0,3/11,10.85%,PNP;ITPA;DNPH1
prerank,GO_Biological_Process_2021__positive regulation of exosomal secretion (GO:1903543),-0.6330647658230478,-1.188309138655797,0.24242424242424243,0.9435413378103963,1.0,5/13,14.88%,SDC4;RAB7A;SMPD3;SNF8;TSG101
prerank,GO_Biological_Process_2021__positive regulation of cAMP-mediated signaling (GO:0043950),0.7863374358673925,1.1881705976410795,0.2833333333333333,1.0,1.0,2/6,18.68%,SCTR;CGAS
prerank,GO_Biological_Process_2021__regulation of mitochondrial depolarization (GO:0051900),-0.6964235537797343,-1.187653105632455,0.2894736842105263,0.944570577484065,1.0,3/9,10.44%,KDR;BCL2;ABCD1
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell migration (GO:0010595),-0.476385384105377,-1.1876426513449532,0.2222222222222222,0.9432871332796737,1.0,11/72,11.72%,KDR;ATOH8;FGF1;RIN2;FOXP1;HSPB1;ETS1;MAP2K3;SCARB1;NRP1;SMOC2
prerank,GO_Biological_Process_2021__neurotransmitter-gated ion channel clustering (GO:0072578),-0.7301827390610245,-1.1875443593983497,0.29411764705882354,0.9423424218313257,1.0,4/6,24.80%,APOE;LHFPL4;GPHN;SHISA7
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to mitochondrion (GO:1903955),0.6013683150292728,1.1875146635327456,0.20833333333333334,1.0,1.0,5/26,16.73%,ARIH2;HSPA1L;RHOU;UBL5;PINK1
prerank,GO_Biological_Process_2021__negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394),-0.7150105625608922,-1.1872515580137626,0.32075471698113206,0.9420106382655176,1.0,2/6,3.55%,GREM1;PMEPA1
prerank,GO_Biological_Process_2021__regulation of fibroblast apoptotic process (GO:2000269),-0.7040162235064698,-1.187036824175121,0.32558139534883723,0.9415618244632884,1.0,4/8,12.05%,BCL2L11;SFRP1;BTG1;PRDM11
prerank,GO_Biological_Process_2021__cardiac left ventricle morphogenesis (GO:0003214),0.7448225407676212,1.1864899385047367,0.19696969696969696,1.0,1.0,2/8,8.01%,NOTCH1;CPE
prerank,GO_Biological_Process_2021__cholesterol homeostasis (GO:0042632),0.5561634923621173,1.1864684164604502,0.24,1.0,1.0,5/55,4.88%,LDLRAP1;PLA2G10;CAV3;TMEM97;FABP3
prerank,GO_Biological_Process_2021__T cell homeostasis (GO:0043029),0.7483219386450736,1.1863707818685338,0.3114754098360656,1.0,1.0,3/7,20.20%,FADD;FAS;PPP2R3C
prerank,GO_Biological_Process_2021__negative regulation of extracellular matrix organization (GO:1903054),0.7507195208617607,1.1862463230108482,0.2857142857142857,1.0,1.0,3/8,22.27%,NOTCH1;TGFB1;DPP4
prerank,GO_Biological_Process_2021__regulation of mRNA 3'-end processing (GO:0031440),0.6781893072576319,1.1859930886913304,0.27941176470588236,1.0,1.0,2/11,6.96%,NCBP1;NCBP2
prerank,GO_Biological_Process_2021__negative regulation of epithelial to mesenchymal transition (GO:0010719),-0.6112497275310812,-1.1859277341605368,0.29411764705882354,0.9442161018253168,1.0,4/21,4.71%,SPRED2;SPRED3;SPRED1;SFRP1
prerank,GO_Biological_Process_2021__regulation of mRNA processing (GO:0050684),-0.5237725216366143,-1.1858602558422426,0.29411764705882354,0.943157726441784,1.0,5/33,14.40%,SRPK3;PTCD2;IWS1;SON;KHDRBS3
prerank,GO_Biological_Process_2021__negative regulation of cellular protein localization (GO:1903828),0.5956398298248843,1.1858126070732793,0.2714285714285714,1.0,1.0,2/28,2.47%,CAV3;CTNNA1
prerank,GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis (GO:0090501),-0.540236825942092,-1.1856677665232653,0.21951219512195122,0.9424546836842288,1.0,5/22,17.80%,ZC3H12B;RNASE1;POP1;ZC3H12C;LACTB2
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta clearance (GO:1900222),0.7984345557702139,1.1854368380785885,0.26865671641791045,1.0,1.0,2/5,13.23%,HMGCR;LRPAP1
prerank,GO_Biological_Process_2021__positive regulation of monocyte chemotaxis (GO:0090026),0.6818406106642116,1.1850319095261266,0.26666666666666666,1.0,1.0,2/10,3.22%,CCL5;PLA2G7
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin mediated immune response (GO:0002891),0.6677045965205269,1.184868004322155,0.2459016393442623,1.0,1.0,1/14,1.30%,C17ORF99
prerank,GO_Biological_Process_2021__ruffle organization (GO:0031529),-0.6574945790210256,-1.1847363689222934,0.29411764705882354,0.9441973684680006,1.0,2/13,9.47%,ARFIP2;CSF1R
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of cell cycle (GO:0044784),-0.6335000234453151,-1.18445849186784,0.4166666666666667,0.9426382723170654,1.0,2/6,18.40%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__metaphase/anaphase transition of mitotic cell cycle (GO:0007091),-0.6335000234453151,-1.18445849186784,0.4166666666666667,0.9426382723170654,1.0,2/6,18.40%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__negative regulation of necroptotic process (GO:0060546),0.7282937386574125,1.1844512602664896,0.3064516129032258,1.0,1.0,2/8,10.45%,YBX3;CASP8
prerank,GO_Biological_Process_2021__regulation of chromatin binding (GO:0035561),0.684452663722303,1.1841352956322433,0.234375,1.0,1.0,2/11,13.39%,GMNN;ZNF304
prerank,GO_Biological_Process_2021__regulation of microglial cell migration (GO:1904139),0.7528217224099807,1.1840535671695314,0.29508196721311475,1.0,1.0,2/5,21.40%,P2RY12;CX3CR1
prerank,GO_Biological_Process_2021__ornithine metabolic process (GO:0006591),0.6617537086003995,1.1836986082574497,0.3,1.0,1.0,2/8,16.63%,ARG1;ARG2
prerank,GO_Biological_Process_2021__regulation of B cell proliferation (GO:0030888),-0.5908963751729777,-1.183329638994466,0.22580645161290322,0.9457168579205051,1.0,2/28,2.36%,CD38;EPHB2
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin protein ligase activity (GO:1904668),-0.6483746838541568,-1.1832627341793756,0.2553191489361702,0.9447040562083581,1.0,1/10,2.02%,CDC14B
prerank,GO_Biological_Process_2021__regulation of acrosome reaction (GO:0060046),0.7500716669908835,1.1827864937278971,0.25806451612903225,1.0,1.0,5/8,22.47%,PLA2G10;SERPINA10;SPINK13;GLRA1;CACNA1H
prerank,GO_Biological_Process_2021__regulation of cell differentiation (GO:0045595),-0.4327772740597494,-1.1824520569345789,0.2,0.9461015759389545,1.0,16/124,8.40%,ALK;SINHCAF;EPHA3;RUNX1;GREM1;CEBPD;KLK6;BCL6;TRPS1;SERPINF2;ZFHX3;PTHLH;CBFB;ID2;CDK5RAP2;PDCD2
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor signaling pathway (GO:1900748),-0.7762594273690042,-1.1823289822534901,0.325,0.9451298090286703,1.0,2/6,11.72%,ADAMTS3;SMOC2
prerank,GO_Biological_Process_2021__activation of phospholipase C activity (GO:0007202),0.5913134327691839,1.1823069162715252,0.2923076923076923,1.0,1.0,3/22,9.01%,ITK;P2RY12;AVPR1A
prerank,GO_Biological_Process_2021__poly-N-acetyllactosamine biosynthetic process (GO:0030311),0.7487602870162882,1.1814783662430952,0.265625,1.0,1.0,5/9,18.95%,B3GALT1;B3GNT4;B3GNT3;B3GALNT1;B4GAT1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA gap filling (GO:0006297)",0.6061461967714453,1.1812374470595413,0.2857142857142857,1.0,1.0,3/24,13.59%,RFC5;PCNA;RPA3
prerank,GO_Biological_Process_2021__brown fat cell differentiation (GO:0050873),0.7477738548979526,1.1811268301818851,0.26865671641791045,1.0,1.0,1/6,8.34%,PPARGC1A
prerank,GO_Biological_Process_2021__RNA interference (GO:0016246),0.6225521961904107,1.1811247129104212,0.2,1.0,1.0,3/15,12.02%,HENMT1;MRPL44;CLP1
prerank,GO_Biological_Process_2021__cellular response to interleukin-12 (GO:0071349),0.5673791282311723,1.1809310983214305,0.2465753424657534,1.0,1.0,4/39,7.79%,TCP1;CA1;STAT4;SOD2
prerank,GO_Biological_Process_2021__negative regulation of circadian rhythm (GO:0042754),-0.7641302263612775,-1.1807838869726928,0.24390243902439024,0.9493110665713702,1.0,1/8,0.17%,PER2
prerank,GO_Biological_Process_2021__positive regulation of actin cytoskeleton reorganization (GO:2000251),0.6540319021752399,1.1804305069887,0.2463768115942029,1.0,1.0,3/16,11.08%,HCK;NTF3;STAP1
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell migration (GO:0014910),0.6355432390285982,1.180052159201711,0.3181818181818182,1.0,1.0,3/16,5.09%,CCL5;PDGFRB;IGFBP5
prerank,GO_Biological_Process_2021__negative regulation of autophagosome assembly (GO:1902902),0.6742416882207056,1.1800427928545396,0.24285714285714285,1.0,1.0,5/12,22.29%,CHMP4B;PHF23;PINK1;LRRK2;SEC22B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte differentiation (GO:1902107),0.7624046712734405,1.1796778244327877,0.3,1.0,1.0,1/7,1.74%,AGER
prerank,GO_Biological_Process_2021__negative regulation of interleukin-8 production (GO:0032717),0.6953867327331571,1.1795265349593032,0.2413793103448276,1.0,1.0,1/11,4.15%,ELANE
prerank,GO_Biological_Process_2021__intraciliary retrograde transport (GO:0035721),-0.6488863824799265,-1.179440781841847,0.275,0.9535195242518796,1.0,5/12,28.05%,TTC21A;WDR35;DYNC2I1;IFT43;DYNC2I2
prerank,GO_Biological_Process_2021__positive regulation of small molecule metabolic process (GO:0062013),0.6613712787655694,1.1793906124975777,0.2753623188405797,1.0,1.0,1/12,1.49%,LDLRAP1
prerank,GO_Biological_Process_2021__hydrogen peroxide catabolic process (GO:0042744),0.743818170261422,1.1792695092410235,0.29508196721311475,1.0,1.0,1/8,4.51%,PRDX4
prerank,GO_Biological_Process_2021__limb development (GO:0060173),0.6218974973092741,1.1790507877645307,0.29850746268656714,1.0,1.0,3/23,2.04%,LRP4;RSPO2;GLI3
prerank,GO_Biological_Process_2021__protein localization to cell-cell junction (GO:0150105),0.6997735027508689,1.1789933198624714,0.29310344827586204,1.0,1.0,3/13,18.42%,TJP3;F11R;MPP7
prerank,GO_Biological_Process_2021__phosphatidylglycerol metabolic process (GO:0046471),0.6874636909766305,1.1789442780089943,0.2898550724637681,1.0,1.0,1/14,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__auditory receptor cell morphogenesis (GO:0002093),0.756749486686774,1.1787247892136214,0.29508196721311475,1.0,1.0,1/5,14.34%,STRC
prerank,GO_Biological_Process_2021__auditory receptor cell stereocilium organization (GO:0060088),0.756749486686774,1.1787247892136214,0.29508196721311475,1.0,1.0,1/5,14.34%,STRC
prerank,PanglaoDB_Augmented_2021__Urothelial Cells,0.5236427951525576,1.1783089164490175,0.17142857142857143,1.0,1.0,14/58,19.28%,EPHA1;ZBTB7B;DENND1C;TNK1;TJP3;CAPN1;SYNGR2;SLC14A1;NBEAL2;TMEM79;TMEM238;TMC4;TRIM25;TMEM184A
prerank,"GO_Biological_Process_2021__base-excision repair, AP site formation (GO:0006285)",0.663058040928761,1.1783004221129025,0.22413793103448276,1.0,1.0,1/15,1.78%,TDG
prerank,GO_Biological_Process_2021__protein localization to condensed chromosome (GO:1903083),0.7149049483226122,1.1781531097836107,0.2894736842105263,1.0,1.0,1/9,4.61%,KNL1
prerank,GO_Biological_Process_2021__positive regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903071),0.8096886059936736,1.1780221682901362,0.32,1.0,1.0,2/6,9.89%,BCAP31;HERPUD1
prerank,GO_Biological_Process_2021__cellular component disassembly (GO:0022411),0.5655506436130026,1.1774298057726658,0.22388059701492538,1.0,1.0,10/41,14.61%,TLL1;MMP15;ADAMTS4;TIMP2;ELANE;BMP1;CAPN1;CTSK;A2M;KIF9
prerank,GO_Biological_Process_2021__negative regulation of lipid metabolic process (GO:0045833),-0.6093963672586789,-1.1772907584266457,0.25,0.9597052983507277,1.0,3/13,7.13%,ALK;SLC22A13;CIDEA
prerank,GO_Biological_Process_2021__alpha-amino acid metabolic process (GO:1901605),-0.5045661535753996,-1.1772362341686085,0.22857142857142856,0.9586238252931905,1.0,1/37,0.27%,NOX4
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, calcium modulating pathway (GO:0007223)",-0.5127059099342859,-1.1772322531520796,0.2222222222222222,0.9573142299034457,1.0,3/32,5.41%,LEF1;NFATC1;GNAO1
prerank,GO_Biological_Process_2021__extracellular matrix disassembly (GO:0022617),0.5650309990927433,1.1770840813518282,0.22388059701492538,1.0,1.0,10/41,14.61%,TLL1;MMP15;ADAMTS4;TIMP2;ELANE;BMP1;CAPN1;CTSK;A2M;KIF9
prerank,GO_Biological_Process_2021__regulation of ER-associated ubiquitin-dependent protein catabolic process (GO:1903069),0.748164447232184,1.1766643116023807,0.3275862068965517,1.0,1.0,3/8,13.25%,BCAP31;HERPUD1;USP14
prerank,GO_Biological_Process_2021__positive regulation of epidermis development (GO:0045684),0.8017416979153886,1.176457420302204,0.2631578947368421,1.0,1.0,2/5,13.18%,SFRP4;TMEM79
prerank,GO_Biological_Process_2021__global genome nucleotide-excision repair (GO:0070911),-0.5739675407157727,-1.1763276123314435,0.2682926829268293,0.9594888668437414,1.0,8/24,19.84%,ERCC2;GTF2H2;ERCC1;CUL4A;DDB2;GTF2H5;ERCC3;XPC
prerank,"GO_Biological_Process_2021__synaptic transmission, glutamatergic (GO:0035249)",-0.5934031164879813,-1.1760383210725402,0.28205128205128205,0.9592954910727103,1.0,3/17,3.08%,UNC13B;GRIK4;UNC13C
prerank,GO_Biological_Process_2021__positive regulation of membrane potential (GO:0045838),0.7211921042989017,1.175878802531059,0.37681159420289856,1.0,1.0,1/8,3.50%,GLRX
prerank,MSigDB_Hallmark_2020__Inflammatory Response,0.4862611489852436,1.1758440674772115,0.21052631578947367,1.0,1.0,28/131,15.95%,C3AR1;IL18R1;NDP;KCNA3;CCL5;STAB1;CD82;OPRK1;IL15;ITGA5;INHBA;PIK3R5;AHR;CD14;OSMR;NAMPT;CMKLR1;MXD1;SLC31A1;IRF1;RIPK2;PLAUR;SLC28A2;ADGRE1;RGS1;GPR183;RNF144B;PCDH7
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate metabolic process (GO:0009167),0.6148174118536905,1.1756974182140538,0.2903225806451613,1.0,1.0,7/17,28.23%,PAICS;AMPD2;AK4;IMPDH1;GMPS;PPAT;GMPR2
prerank,GO_Biological_Process_2021__PERK-mediated unfolded protein response (GO:0036499),0.756354826484373,1.1756862843663565,0.3333333333333333,1.0,1.0,2/8,9.89%,HSPA5;HERPUD1
prerank,GO_Biological_Process_2021__lipopolysaccharide-mediated signaling pathway (GO:0031663),0.6397826034408782,1.1754929893740795,0.24561403508771928,1.0,1.0,5/14,13.78%,CCL5;HCK;CD14;CD6;TGFB1
prerank,GO_Biological_Process_2021__photoperiodism (GO:0009648),-0.5821787058015213,-1.17538978454022,0.2222222222222222,0.9604834455211191,1.0,1/25,0.17%,PER2
prerank,GO_Biological_Process_2021__regulation of endopeptidase activity (GO:0052548),0.5563403353526494,1.1749666258126907,0.26153846153846155,1.0,1.0,9/45,9.68%,TIMP3;TIMP2;A2ML1;AGT;SERPINA10;SERPINF1;KNG1;SERPINI2;SPOCK3
prerank,GO_Biological_Process_2021__positive regulation of leukocyte degranulation (GO:0043302),-0.6900082921897097,-1.1746644979863847,0.2558139534883721,0.961706475386174,1.0,2/10,6.17%,F2RL1;SPHK2
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor signaling pathway (GO:1900746),-0.6350442213671728,-1.1746421096371162,0.2631578947368421,0.9605354624676309,1.0,4/16,11.72%,ADAMTS3;TSPAN12;SEMA6A;SMOC2
prerank,GO_Biological_Process_2021__positive regulation of T cell proliferation (GO:0042102),0.5834559213325013,1.1746207030030615,0.22058823529411764,1.0,1.0,9/37,11.22%,AGER;CCL5;IL15;PTPRC;HLA-DMB;FADD;HHLA2;PDCD1LG2;CD6
prerank,GO_Biological_Process_2021__monovalent inorganic cation homeostasis (GO:0055067),0.613225594808917,1.1741735394403325,0.2153846153846154,1.0,1.0,3/19,9.79%,SLC12A7;SLC26A4;CLCN3
prerank,GO_Biological_Process_2021__negative regulation of mononuclear cell migration (GO:0071676),-0.664697170705224,-1.1738332927288992,0.2413793103448276,0.9620798052804984,1.0,4/10,18.58%,GREM1;NBL1;CCN3;MIA3
prerank,"GO_Biological_Process_2021__regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043516)",-0.5811875969761895,-1.1736333733955855,0.3076923076923077,0.961464603216348,1.0,4/23,3.64%,SPRED2;SPRED3;SPRED1;SMYD2
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to hypoxia (GO:0061418),0.529922726666871,1.1734595597003956,0.21333333333333335,1.0,1.0,10/66,22.91%,NOTCH1;CA9;PSMB6;EPAS1;PSMA3;PSMB8;CUL2;HIF3A;PSMA5;ARNT
prerank,GO_Biological_Process_2021__positive regulation of axon extension involved in axon guidance (GO:0048842),-0.768370994494497,-1.173415447339392,0.2619047619047619,0.9608701121142278,1.0,2/5,18.72%,NRP1;DSCAM
prerank,GO_Biological_Process_2021__photoreceptor cell development (GO:0042461),0.6918685270554512,1.1732809611848276,0.24615384615384617,1.0,1.0,1/12,2.48%,RP1
prerank,GO_Biological_Process_2021__regulation of muscle system process (GO:0090257),-0.6909760408658209,-1.1731647502444762,0.34375,0.9606196314333505,1.0,2/8,11.64%,MYL5;TNNC2
prerank,GO_Biological_Process_2021__positive regulation of filopodium assembly (GO:0051491),-0.4977450502248248,-1.1729872468959157,0.16129032258064516,0.9598569093123878,1.0,5/24,12.53%,MIEN1;TGFB3;NRP1;RIPOR2;PLPPR5
prerank,GO_Biological_Process_2021__negative regulation of response to wounding (GO:1903035),-0.5872895743717562,-1.1724723414652982,0.2564102564102564,0.9603293775676951,1.0,6/16,16.25%,SIGLEC10;RTN4R;PTPRS;MDK;AJAP1;CASK
prerank,GO_Biological_Process_2021__cell-substrate junction assembly (GO:0007044),-0.5274270847089483,-1.1722952142629497,0.24324324324324326,0.9594364749947,1.0,4/28,10.53%,LAMB3;ITGA6;LAMA3;TRIP6
prerank,GO_Biological_Process_2021__snRNA processing (GO:0016180),-0.559511380963621,-1.1722565904188424,0.22857142857142856,0.9582243224525554,1.0,1/15,4.01%,INTS11
prerank,GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane (GO:0006614),0.5096454141789117,1.1722426749378065,0.1875,1.0,1.0,38/85,35.61%,RPL15;RPL36;RPS7;RPL9;RPS21;RPL22;SRP9;RPL21;RPL38;RPLP2;RPS5;SRP19;RPL3;SRP68;RPL35A;RPS13;RPL35;RPS20;RPL27;RPL13A;RPS27A;RPL5;RPL27A;RPL7;RPS9;RPL37;SRP14;RPS29;RPL24;RPL28;RPL32;RPL8;RPS4X;RPS12;RPL37A;RPSA;SEC61B;RPS19
prerank,GO_Biological_Process_2021__regulation of peroxisome proliferator activated receptor signaling pathway (GO:0035358),0.7241333627225872,1.1719073547742622,0.22727272727272727,1.0,1.0,2/8,8.65%,PTGIS;LMO3
prerank,GO_Biological_Process_2021__positive regulation of chromosome organization (GO:2001252),0.654124977937318,1.1716805760831874,0.2537313432835821,1.0,1.0,3/13,15.06%,SHCBP1L;MRE11;GNL3
prerank,GO_Biological_Process_2021__negative regulation of nitrogen compound metabolic process (GO:0051172),0.7215543058619216,1.1716288405632975,0.24561403508771928,1.0,1.0,3/7,22.97%,ACMSD;TGFB1;CLTC
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin protein ligase activity (GO:1904667),0.6683765653079045,1.1710699530724613,0.23333333333333334,1.0,1.0,3/9,29.86%,RPS7;MAD2L1;RPL5
prerank,GO_Biological_Process_2021__positive regulation of tissue remodeling (GO:0034105),0.7650839948595707,1.170980569639726,0.30357142857142855,1.0,1.0,3/5,23.30%,IL15;TMBIM1;IL18
prerank,PanglaoDB_Augmented_2021__Salivary Mucous Cells,-0.5212103585353742,-1.1707882149463127,0.1951219512195122,0.962419404130949,1.0,5/23,6.11%,KRT16P6;IL1RL2;MYH11;ADIRF;ANO1
prerank,GO_Biological_Process_2021__G protein-coupled acetylcholine receptor signaling pathway (GO:0007213),0.5799368116830041,1.1707567323647254,0.296875,1.0,1.0,2/18,10.75%,RGS10;CDK5R1
prerank,GO_Biological_Process_2021__cytosolic calcium ion transport (GO:0060401),-0.5327953385997279,-1.1703362993678612,0.3023255813953488,0.9630557398589851,1.0,10/28,21.75%,CACNA2D1;MCUB;SLC35G1;MICU1;MICU2;MCUR1;MCU;JPH2;JPH4;SLC25A23
prerank,GO_Biological_Process_2021__phagosome maturation (GO:0090382),-0.5320973648815996,-1.1695516684131122,0.22857142857142856,0.9646702896683118,1.0,2/28,1.09%,ATP6V0D2;RAB32
prerank,GO_Biological_Process_2021__regulation of protein secretion (GO:0050708),-0.45697206870562623,-1.169520213300753,0.2608695652173913,0.9634764422039631,1.0,14/96,11.15%,PER2;CELA2A;GLP1R;UNC13B;ITPR2;IGF1;DRD4;TGFB2;CACNA1A;BMP6;TGFB3;DNAJC1;LLGL2;APOE
prerank,GO_Biological_Process_2021__peptidyl-tyrosine modification (GO:0018212),-0.4833042739442077,-1.1693987196910047,0.24,0.9625676924883381,1.0,5/49,2.36%,KIT;KDR;FGFR4;EPHA3;EPHB2
prerank,GO_Biological_Process_2021__regulation of mast cell chemotaxis (GO:0060753),0.7739110098131639,1.1693040530433523,0.288135593220339,1.0,1.0,2/5,19.18%,VEGFC;RIN3
prerank,GO_Biological_Process_2021__positive regulation of axonogenesis (GO:0050772),-0.49533660778532684,-1.1691785457710469,0.1935483870967742,0.9619992094030297,1.0,16/40,27.09%,AMIGO1;PLXNA1;LIMK1;PLXNA2;NGF;PLXNC1;CHODL;DBNL;TIAM1;GOLGA4;SLITRK1;MAP6;MAP3K13;TIAM2;PLXND1;L1CAM
prerank,GO_Biological_Process_2021__negative regulation of response to endoplasmic reticulum stress (GO:1903573),0.5996084432593324,1.1687946183396083,0.23728813559322035,1.0,1.0,4/24,9.89%,WFS1;LPCAT3;SYVN1;HERPUD1
prerank,GO_Biological_Process_2021__sterol homeostasis (GO:0055092),0.5450084787919381,1.1685959072625616,0.26666666666666666,1.0,1.0,5/56,4.88%,LDLRAP1;PLA2G10;CAV3;TMEM97;FABP3
prerank,GO_Biological_Process_2021__extracellular structure organization (GO:0043062),-0.4334072894179072,-1.168513020073151,0.17857142857142858,0.9629317816210602,1.0,23/167,5.85%,ITGB5;NPNT;KDR;COL15A1;LAMB2;ADAM19;ITGA4;LAMA4;ADAMTS2;ADAMTS3;ADAM12;ADAMTS15;COL6A2;LAMB3;LOXL1;COL11A2;ADAMTS8;ITGA6;VCAN;TNR;PAPLN;COL4A3;ADAMTS5
prerank,GO_Biological_Process_2021__regulation of leukocyte activation (GO:0002694),0.7113602579084811,1.1683758174332592,0.2857142857142857,1.0,1.0,7/10,22.07%,PLA2G10;GPER1;PJA2;CD74;PLSCR1;CD200;GPR137B
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell differentiation (GO:1905064),-0.6644464823883862,-1.1681180208193616,0.2857142857142857,0.963150539709134,1.0,2/7,11.28%,NFATC1;DNMT1
prerank,GO_Biological_Process_2021__negative regulation of organ growth (GO:0046621),-0.7652625316343447,-1.1679282094599641,0.27906976744186046,0.9625274617680062,1.0,3/5,17.34%,SLC6A4;WWC3;WWC1
prerank,GO_Biological_Process_2021__membrane fission (GO:0090148),0.7565253650262076,1.1678944009293126,0.21052631578947367,1.0,1.0,1/7,4.70%,CHMP4B
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell migration (GO:1904752),0.6618939999609446,1.1676931218710653,0.288135593220339,1.0,1.0,3/11,13.76%,IGFBP5;PRKG1;DOCK4
prerank,GO_Biological_Process_2021__cellular biogenic amine metabolic process (GO:0006576),-0.6931090231866488,-1.1675956710125057,0.2558139534883721,0.9623727796550093,1.0,3/9,9.16%,SRM;SLC29A4;SLC22A3
prerank,GO_Biological_Process_2021__response to purine-containing compound (GO:0014074),-0.5767063378022185,-1.1673701321908503,0.20930232558139536,0.9622557969861586,1.0,3/14,5.43%,TRPC3;RYR1;VGF
prerank,GO_Biological_Process_2021__artery morphogenesis (GO:0048844),0.6255882859463222,1.1672473663442196,0.29310344827586204,1.0,1.0,5/20,11.46%,PDGFRB;ADAMTS9;NOTCH1;TBX1;SMAD7
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication (GO:0006261),0.4817244123369761,1.1672472920376245,0.2236842105263158,1.0,1.0,18/117,16.44%,MCM2;RFC5;POLE2;GMNN;POLE3;MGME1;GINS2;MCMDC2;PSMB6;GINS1;CDC6;HELB;RPA3;CDK2AP1;PSMA3;PSMB8;RECQL;ORC4
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor-activated receptor activity (GO:0045741),-0.6945000778994583,-1.167180641575241,0.3170731707317073,0.9617853341556523,1.0,2/7,3.11%,BTC;EREG
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex assembly (GO:0006294)",-0.516384544520127,-1.167093555968801,0.21052631578947367,0.961037173843678,1.0,8/26,19.84%,ERCC2;GTF2H2;CCNH;CUL4A;DDB2;GTF2H5;ERCC3;XPC
prerank,GO_Biological_Process_2021__positive regulation of cholesterol storage (GO:0010886),-0.7317991626303783,-1.1667946777108498,0.3333333333333333,0.9607366990484442,1.0,1/5,10.29%,SCARB1
prerank,GO_Biological_Process_2021__regulation of transcription regulatory region DNA binding (GO:2000677),-0.6245752464486886,-1.1665131043735162,0.30303030303030304,0.9604555619602694,1.0,2/17,3.96%,PER2;IGF1
prerank,GO_Biological_Process_2021__positive regulation of dendrite extension (GO:1903861),0.623877364447263,1.1662479284061948,0.3442622950819672,1.0,1.0,3/17,10.14%,SYT2;SYT4;CPNE5
prerank,GO_Biological_Process_2021__cellular response to hydroxyurea (GO:0072711),-0.680659955224195,-1.1658278137446783,0.275,0.9617310631470141,1.0,3/8,12.76%,TIMELESS;DDX11;SPIDR
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transporter activity (GO:1901016),0.5983055140391764,1.1653208214347028,0.22413793103448276,1.0,1.0,4/24,15.36%,CAV3;KCNE2;KCNG1;ATP1B1
prerank,GO_Biological_Process_2021__regulation of hippo signaling (GO:0035330),-0.635805515614396,-1.1652574515702685,0.28125,0.9625592572616386,1.0,10/17,19.45%,MOB3B;WTIP;SHANK2;MAP2K3;DLG5;WWC3;VGLL4;WWC1;MARK3;IQCJ-SCHIP1
prerank,GO_Biological_Process_2021__positive regulation of pathway-restricted SMAD protein phosphorylation (GO:0010862),-0.5879041928133711,-1.165201512578436,0.2413793103448276,0.9615009263681328,1.0,6/29,9.80%,BMP7;BMP3;INHA;TGFB2;BMP6;TGFB3
prerank,GO_Biological_Process_2021__intracellular cholesterol transport (GO:0032367),0.6731718762369461,1.1645876433128508,0.3108108108108108,1.0,1.0,1/14,1.49%,LDLRAP1
prerank,GO_Biological_Process_2021__regulation of DNA binding (GO:0051101),-0.5256636439504354,-1.164560322235292,0.2413793103448276,0.9626962512472007,1.0,9/35,12.07%,LEF1;IGF1;TFAP4;ZBTB7A;HMGA2;IFI16;SIRT2;NGF;HMGB2
prerank,GO_Biological_Process_2021__cellular response to nerve growth factor stimulus (GO:1990090),0.6040205238628461,1.1644228772146576,0.22535211267605634,1.0,1.0,2/21,6.03%,NTF3;WASF1
prerank,GO_Biological_Process_2021__cellular response to fluid shear stress (GO:0071498),-0.6614855899115089,-1.1643002582686959,0.3076923076923077,0.962543370482767,1.0,1/10,7.26%,MAPK7
prerank,GO_Biological_Process_2021__regulation of triglyceride biosynthetic process (GO:0010866),-0.6155608677931168,-1.1637968812502613,0.2962962962962963,0.9630717520540721,1.0,3/13,18.50%,PLIN5;SCARB1;NR1H2
prerank,GO_Biological_Process_2021__sulfur amino acid biosynthetic process (GO:0000097),-0.6886599923519474,-1.1636714057737256,0.3333333333333333,0.962477715193341,1.0,4/6,23.30%,MTR;MTHFR;CTH;MTHFD1
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter secretion (GO:0001956),0.761984383682056,1.1636503611871676,0.3235294117647059,1.0,1.0,1/6,11.81%,GPER1
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion mediated by integrin (GO:0033634),0.7568819030581757,1.1636191446871367,0.3225806451612903,1.0,1.0,4/5,23.56%,CCL5;PODXL;CXCL13;SKAP1
prerank,GO_Biological_Process_2021__negative regulation of response to DNA damage stimulus (GO:2001021),0.5904163677137649,1.1635977925777936,0.3055555555555556,1.0,1.0,9/26,22.71%,ACKR3;TRIM32;TWIST1;CDKN2D;THOC5;CD74;BCL2L1;SNAI2;KDM1A
prerank,GO_Biological_Process_2021__mesoderm morphogenesis (GO:0048332),0.7408505002692133,1.1635764026562956,0.2777777777777778,1.0,1.0,1/7,2.16%,TBX19
prerank,GO_Biological_Process_2021__mitochondrial protein processing (GO:0034982),-0.6599189208182323,-1.1634941170673934,0.3235294117647059,0.9620137018067518,1.0,3/10,19.55%,IMMP2L;MIPEP;PMPCA
prerank,GO_Biological_Process_2021__regulation of lipid transport (GO:0032368),-0.690541199047414,-1.163128770876506,0.3333333333333333,0.962174112465804,1.0,3/7,22.22%,NR1H2;PRKN;PPARA
prerank,"GO_Biological_Process_2021__negative regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043518)",0.6527548195071695,1.163043958136411,0.3125,1.0,1.0,4/12,22.71%,TWIST1;CD74;SNAI2;KDM1A
prerank,PanglaoDB_Augmented_2021__Chromaffin Cells,0.49791497054926837,1.1627527405291112,0.2328767123287671,1.0,1.0,9/117,8.01%,NPY;LRP4;P2RY1;TMEM35A;ASXL3;SLC26A4;SYT4;RGS4;CPE
prerank,GO_Biological_Process_2021__rRNA transport (GO:0051029),0.7826794675208458,1.162721824826009,0.29310344827586204,1.0,1.0,1/5,5.33%,TST
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport (GO:1903169),-0.5152647590837879,-1.1622164485607576,0.17647058823529413,0.9639267383911443,1.0,3/18,2.86%,UBASH3B;CACNA2D1;CBARP
prerank,GO_Biological_Process_2021__regulation of mammary gland epithelial cell proliferation (GO:0033599),0.7341396374306666,1.1610238236291393,0.2698412698412698,1.0,1.0,2/8,2.24%,RREB1;ZNF703
prerank,GO_Biological_Process_2021__negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067),0.7200435408246223,1.1608487293159628,0.25675675675675674,1.0,1.0,5/8,23.78%,TWIST1;TSC2;DAB2IP;NLRC3;NOP53
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor-activated receptor activity (GO:0007176),-0.5793218833052174,-1.160623243627039,0.2727272727272727,0.9685817148797219,1.0,3/21,3.11%,BTC;VPS25;EREG
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell differentiation (GO:1902036),-0.5240004336810674,-1.1603420659809778,0.2,0.9684225966822808,1.0,2/58,1.60%,MYB;RUNX1
prerank,GO_Biological_Process_2021__potassium ion homeostasis (GO:0055075),0.6244734273802994,1.1601009586802722,0.2465753424657534,1.0,1.0,4/18,18.43%,SLC12A7;ATP12A;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__response to progesterone (GO:0032570),-0.527513474969358,-1.1599616939004018,0.22857142857142856,0.968537416198952,1.0,4/15,12.82%,CATSPER2;TGFB2;TGFB3;CATSPERG
prerank,GO_Biological_Process_2021__regulation of pH (GO:0006885),0.6989949923834947,1.1598520331175841,0.3333333333333333,1.0,1.0,5/9,19.95%,SLC26A4;CLCN3;ATP6AP1;PDK4;SLC9A7
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta receptor signaling pathway (GO:0030512),-0.5023120048817945,-1.1597689375493212,0.21212121212121213,0.96812380527055,1.0,5/54,3.55%,SPRED2;SPRED3;SPRED1;LTBP1;PMEPA1
prerank,PanglaoDB_Augmented_2021__Ciliated Cells,0.5024410472718868,1.1597347821624449,0.2028985507246377,1.0,1.0,13/59,15.57%,DNAH3;C11ORF16;ECT2L;FAM81B;CCDC60;TEX26;ANKUB1;CCDC39;EFHB;TTC29;APOBEC4;CFAP126;CFAP65
prerank,MSigDB_Hallmark_2020__Reactive Oxygen Species Pathway,0.5506374532589791,1.1594829646571283,0.2972972972972973,1.0,1.0,12/41,15.40%,GLRX;MGST1;PRDX4;NQO1;JUNB;CDKN2D;SOD2;G6PD;NDUFB4;GLRX2;PRDX6;IPCEF1
prerank,GO_Biological_Process_2021__cellular response to interleukin-18 (GO:0071351),0.7871361448418667,1.1594104089801212,0.3103448275862069,1.0,1.0,1/6,1.42%,IL18R1
prerank,GO_Biological_Process_2021__interleukin-18-mediated signaling pathway (GO:0035655),0.7871361448418667,1.1594104089801212,0.3103448275862069,1.0,1.0,1/6,1.42%,IL18R1
prerank,GO_Biological_Process_2021__macropinocytosis (GO:0044351),0.7589553010818475,1.1593337855186998,0.35,1.0,1.0,1/5,4.46%,DOCK2
prerank,GO_Biological_Process_2021__regulation of spindle organization (GO:0090224),0.6462482829508248,1.159162145227233,0.29850746268656714,1.0,1.0,3/17,9.34%,BORA;PSRC1;TPX2
prerank,GO_Biological_Process_2021__cellular biogenic amine biosynthetic process (GO:0042401),-0.6320094481530556,-1.158778017663375,0.3333333333333333,0.970293959149633,1.0,3/10,10.75%,PAH;SRM;TPH1
prerank,GO_Biological_Process_2021__aspartate transmembrane transport (GO:0015810),0.7642527318430303,1.158700971591426,0.30158730158730157,1.0,1.0,2/6,11.11%,LRRC8D;SLC25A18
prerank,GO_Biological_Process_2021__amino acid transport (GO:0006865),0.5542262518259496,1.1586198793922278,0.30666666666666664,1.0,1.0,9/41,17.96%,SLC7A11;SLC38A11;SLC38A8;SLC36A1;SLC38A2;SLC7A7;SLC7A14;SLC38A5;SLC38A4
prerank,GO_Biological_Process_2021__SMAD protein complex assembly (GO:0007183),0.7501269243544566,1.1585798600190822,0.29508196721311475,1.0,1.0,3/6,16.12%,EID2;TGFB1;SMAD1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast apoptotic process (GO:2000271),-0.7051983673821539,-1.158130781210818,0.4186046511627907,0.9714413038236692,1.0,4/7,12.05%,BCL2L11;SFRP1;BTG1;PRDM11
prerank,GO_Biological_Process_2021__response to leptin (GO:0044321),-0.6225330812281205,-1.1576071959437655,0.3157894736842105,0.9719688946319748,1.0,5/9,20.75%,STAT3;NR4A3;LEP;CCND1;GCK
prerank,GO_Biological_Process_2021__inner ear receptor cell stereocilium organization (GO:0060122),0.6902168612484041,1.1574280243563522,0.2698412698412698,1.0,1.0,2/8,21.50%,STRC;ADGRV1
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate metabolic process (GO:0034035),0.7040040654050089,1.1570037380058005,0.3387096774193548,1.0,1.0,2/9,20.67%,SULT2A1;TPST2
prerank,GO_Biological_Process_2021__protein localization to kinetochore (GO:0034501),0.6849625998142335,1.1567686607679861,0.323943661971831,1.0,1.0,1/11,4.61%,KNL1
prerank,GO_Biological_Process_2021__cell part morphogenesis (GO:0032990),-0.6091624199478779,-1.1566545453941293,0.21212121212121213,0.9741257380341959,1.0,2/13,2.41%,PID1;MYH14
prerank,GO_Biological_Process_2021__positive regulation of production of molecular mediator of immune response (GO:0002702),-0.6102200039342843,-1.1566025310117667,0.22857142857142856,0.9730381072664603,1.0,4/20,6.17%,F2RL1;EPHB2;RBP4;SPHK2
prerank,GO_Biological_Process_2021__regulation of postsynaptic neurotransmitter receptor activity (GO:0098962),-0.6461145754082327,-1.1560211596713312,0.3793103448275862,0.9735796931156714,1.0,7/10,23.06%,CACNG5;NPTXR;NPTX2;DLGAP4;DLGAP2;DLGAP3;AKAP9
prerank,GO_Biological_Process_2021__positive regulation of IRE1-mediated unfolded protein response (GO:1903896),-0.7001750321047951,-1.1559934616873153,0.32432432432432434,0.9723872570467946,1.0,1/6,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__adenylate cyclase-activating G protein-coupled receptor signaling pathway (GO:0007189),0.5058010896982991,1.1558442400962439,0.2236842105263158,1.0,1.0,11/70,8.25%,CALCR;MC4R;RXFP1;GPR26;TBXA2R;CALCB;CNR2;ADGRB1;PTGER3;TSHR;ADRB1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle contraction (GO:0055117),0.5919449496309043,1.1552545524164783,0.328125,1.0,1.0,10/25,26.97%,CAV3;SMAD7;ATP1B1;PLN;KCNQ1;CALM3;HCN4;ATP2A2;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__L-alanine transport (GO:0015808),0.7515384872226447,1.1551952624213915,0.2903225806451613,1.0,1.0,3/5,23.75%,SLC36A1;SLC38A5;SLC38A3
prerank,GO_Biological_Process_2021__cellular response to glucocorticoid stimulus (GO:0071385),-0.6018629160955726,-1.1550512371899515,0.2727272727272727,0.9743883313975863,1.0,1/11,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__regulation of cilium beat frequency (GO:0003356),0.763782694318218,1.154817592305451,0.3442622950819672,1.0,1.0,2/6,10.58%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__negative regulation of macromolecule biosynthetic process (GO:0010558),0.6409735517788975,1.154678482315928,0.3064516129032258,1.0,1.0,4/10,24.35%,TGFB1;TAF7;CLTC;GSTP1
prerank,GO_Biological_Process_2021__mRNA 5'-splice site recognition (GO:0000395),-0.735246937024462,-1.154319976912519,0.3333333333333333,0.9760782573692417,1.0,1/5,3.97%,SFSWAP
prerank,MSigDB_Hallmark_2020__Apical Surface,-0.5158076937857478,-1.153936738242655,0.2926829268292683,0.9758940335188738,1.0,6/34,7.27%,MDGA1;SULF2;NTNG1;CROCC;GSTM3;HSPB1
prerank,GO_Biological_Process_2021__cellular response to prostaglandin stimulus (GO:0071379),-0.6725478203601227,-1.1538446916880436,0.42424242424242425,0.9749381574562871,1.0,2/8,9.78%,SFRP1;AKR1C3
prerank,GO_Biological_Process_2021__cellular response to interleukin-15 (GO:0071350),0.629882169037027,1.1536925130278994,0.2857142857142857,1.0,1.0,3/11,12.67%,CD4;IL15;STAT5A
prerank,GO_Biological_Process_2021__interleukin-15-mediated signaling pathway (GO:0035723),0.629882169037027,1.1536925130278994,0.2857142857142857,1.0,1.0,3/11,12.67%,CD4;IL15;STAT5A
prerank,GO_Biological_Process_2021__membrane protein proteolysis (GO:0033619),-0.48843840896195406,-1.1536497528492933,0.26666666666666666,0.9743792499982278,1.0,4/30,12.45%,ADAM19;NCSTN;RBMX;HM13
prerank,GO_Biological_Process_2021__regulation of long-term synaptic potentiation (GO:1900271),0.6006308893368233,1.1534432826152814,0.3026315789473684,1.0,1.0,2/26,1.74%,CALB1;AGER
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor-beta signaling pathway (GO:2000586),0.7696230336805108,1.1529206921635011,0.30357142857142855,1.0,1.0,1/5,7.96%,HIP1R
prerank,GO_Biological_Process_2021__adherens junction assembly (GO:0034333),0.6743827021587152,1.1521483792406109,0.3103448275862069,1.0,1.0,2/9,11.46%,ZNF703;SMAD7
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 methylation (GO:0051574),-0.7258687851714627,-1.151998104544995,0.3888888888888889,0.9790516824194551,1.0,1/5,0.81%,MYB
prerank,GO_Biological_Process_2021__positive regulation of ion transport (GO:0043270),0.5208021798011035,1.1519553674320857,0.2638888888888889,1.0,1.0,4/39,5.69%,MYLK;WFS1;CCL5;SCN4B
prerank,GO_Biological_Process_2021__response to interferon-beta (GO:0035456),0.6577655596645345,1.151795663614447,0.23076923076923078,1.0,1.0,7/16,21.79%,XAF1;STAT1;IRF1;PYHIN1;PLSCR1;IKBKE;IFITM3
prerank,GO_Biological_Process_2021__protein processing involved in protein targeting to mitochondrion (GO:0006627),-0.734182076877098,-1.1515429147000211,0.3611111111111111,0.979544362586566,1.0,3/5,19.55%,IMMP2L;MIPEP;PMPCA
prerank,GO_Biological_Process_2021__regulation of glial cell migration (GO:1903975),0.772106421371758,1.1513955783528012,0.3064516129032258,1.0,1.0,3/5,21.40%,P2RY12;GPR183;CX3CR1
prerank,GO_Biological_Process_2021__cell migration involved in heart development (GO:0060973),0.7705648133613108,1.1507973075861122,0.36923076923076925,1.0,1.0,2/5,4.13%,PDGFRB;NOTCH1
prerank,GO_Biological_Process_2021__regulation of glucan biosynthetic process (GO:0010962),-0.7449026394525698,-1.1507192332148668,0.3333333333333333,0.9809826538458203,1.0,2/7,8.64%,PPP1R3B;PPP1R3E
prerank,GO_Biological_Process_2021__ribosomal subunit export from nucleus (GO:0000054),-0.6294042960067744,-1.1507023456868852,0.2571428571428571,0.9797765889872161,1.0,3/12,18.90%,NOP9;NMD3;SDAD1
prerank,GO_Biological_Process_2021__negative regulation of adenylate cyclase activity (GO:0007194),0.6663440274131943,1.1506212951478516,0.3088235294117647,1.0,1.0,4/11,21.50%,GRM3;DRD3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__negative regulation of cyclase activity (GO:0031280),0.6663440274131943,1.1506212951478516,0.3088235294117647,1.0,1.0,4/11,21.50%,GRM3;DRD3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__regulation of cellular component biogenesis (GO:0044087),0.5720638861948553,1.1506009725043131,0.29577464788732394,1.0,1.0,8/33,16.76%,NOTCH1;AGT;SPTY2D1;GFAP;HSPA8;MSN;PINK1;DAB2IP
prerank,PanglaoDB_Augmented_2021__GABAergic Neurons,-0.43993910359422383,-1.1505700022916356,0.18181818181818182,0.9790903568153005,1.0,25/109,14.27%,KCNIP1;PTPRT;SPHKAP;NTSR2;SST;SLC6A1;ADGRA1;ZNF536;MMD2;KCNC1;UBE2QL1;MAPK4;CBLN4;TMEM196;VIP;GAD2;LRRTM3;STMN2;ELAVL3;RGS7BP;GRIA2;SYN2;BRINP2;BRINP1;GABBR2
prerank,GO_Biological_Process_2021__regulation of endothelial cell differentiation (GO:0045601),0.7140095238663906,1.1503256485846864,0.24390243902439024,1.0,1.0,1/8,0.28%,APOLD1
prerank,GO_Biological_Process_2021__regulation by virus of viral protein levels in host cell (GO:0046719),0.6986763422119051,1.1503116282438484,0.3333333333333333,1.0,1.0,3/7,24.44%,STAT1;IFIT1;HACD3
prerank,GO_Biological_Process_2021__erythrocyte development (GO:0048821),-0.5608762524956822,-1.1502835712040655,0.3333333333333333,0.9787974049910837,1.0,4/9,13.26%,ALAS1;LYAR;ZBTB7A;ABCB10
prerank,PanglaoDB_Augmented_2021__Proximal Tubule Cells,-0.4674862613957559,-1.1498552046651662,0.25,0.9791806483737647,1.0,13/74,8.85%,F11;NOX4;PAH;SLC16A9;SLC9A8;RBP4;AOAH;CACNG5;SLC22A13;NME4;SERPINF2;NR1H4;SORD
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase signaling (GO:0014068),-0.49350967370952364,-1.1498444419171527,0.21739130434782608,0.9779829289369569,1.0,9/63,5.75%,KIT;ROR2;SELP;KDR;UNC5B;F2RL1;PDGFD;IGF1;TGFB2
prerank,GO_Biological_Process_2021__gamma-aminobutyric acid metabolic process (GO:0009448),0.7922774393022968,1.1498166037063822,0.2830188679245283,1.0,1.0,2/5,12.65%,ALDH1A1;GAD1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle organization (GO:0060236),0.5786880961664076,1.1493026181534969,0.2638888888888889,1.0,1.0,9/31,18.42%,BORA;CHMP4B;PSRC1;TPX2;CHMP2B;CHMP1A;EML3;CHMP2A;GPSM2
prerank,GO_Biological_Process_2021__positive regulation of interleukin-6 production (GO:0032755),-0.4953003471513113,-1.1490562492742113,0.21428571428571427,0.9795187119355065,1.0,8/43,9.37%,RAB7B;F2RL1;IFIH1;EREG;SPHK2;TLR1;STAT3;POU2F2
prerank,GO_Biological_Process_2021__positive regulation of interferon-beta production (GO:0032728),-0.536995975265725,-1.1486939992714946,0.3,0.9797579393643101,1.0,3/28,5.48%,STING1;IFIH1;POLR3D
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host programmed cell death (GO:0052041),-0.7305126377500517,-1.1486400615204486,0.3548387096774194,0.9787231775652544,1.0,1/7,7.58%,RAB7A
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization (GO:0031115),-0.6692566786278433,-1.1485439924928744,0.3333333333333333,0.9778676470961993,1.0,5/11,21.80%,MAPRE1;STMN2;TBCD;TUBB4A;CLIP3
prerank,GO_Biological_Process_2021__sterol metabolic process (GO:0016125),0.5410837749820621,1.148263663044585,0.2898550724637681,1.0,1.0,14/46,20.71%,LDLRAP1;NSDHL;SULT2A1;CYP1B1;HMGCR;CYP19A1;SQLE;MSMO1;FAXDC2;INSIG2;DHCR7;INSIG1;ANGPTL3;SOAT1
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle cell differentiation (GO:2000727),-0.7146239032789083,-1.1477293608306474,0.3409090909090909,0.9795546610331906,1.0,1/5,1.73%,GREM1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902229),0.6594581359746515,1.1477122965716549,0.30434782608695654,1.0,1.0,3/14,6.04%,ACKR3;TRIM32;CDKN2D
prerank,GO_Biological_Process_2021__regulation of cilium movement (GO:0003352),0.7429645687526356,1.1476327853751989,0.2698412698412698,1.0,1.0,2/7,10.58%,DNAH11;CCDC39
prerank,GO_Biological_Process_2021__diterpenoid metabolic process (GO:0016101),0.5429401135389592,1.1474258138165152,0.234375,1.0,1.0,8/41,6.90%,RDH10;ALDH1A1;GPC6;RLBP1;HSPG2;GPC5;BCO1;RARRES2
prerank,GO_Biological_Process_2021__transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0007178),-0.426369377159037,-1.1472789697709602,0.16666666666666666,0.980074561543963,1.0,13/101,10.25%,ITGB5;BMP7;FOS;ZMIZ2;HIVEP1;TGFB2;RGMB;AMH;APOA1;BMP6;GCNT2;TGFB3;DLX5
prerank,GO_Biological_Process_2021__cellular response to lipoteichoic acid (GO:0071223),0.7535491417630641,1.1467029886834772,0.3333333333333333,1.0,1.0,3/6,22.83%,CD14;TLR2;LBP
prerank,GO_Biological_Process_2021__response to lipoteichoic acid (GO:0070391),0.7535491417630641,1.1467029886834772,0.3333333333333333,1.0,1.0,3/6,22.83%,CD14;TLR2;LBP
prerank,GO_Biological_Process_2021__midbody abscission (GO:0061952),0.6364365665625298,1.1465797087300296,0.36363636363636365,1.0,1.0,6/13,23.90%,CHMP4B;CHMP2B;CHMP1A;CHMP2A;MITD1;VPS4A
prerank,GO_Biological_Process_2021__innate immune response (GO:0045087),0.47577329296886284,1.1463557156599793,0.19540229885057472,1.0,1.0,38/147,22.25%,TRIM58;TRIM22;TRIM5;AGER;TRIML2;HCK;TRIM32;TNK1;ZDHHC11;RARRES2;IFNLR1;CORO1A;CIITA;PLCG2;RIPK2;MASP2;TRIM14;TRIM25;SFTPD;YES1;IFI27;PJA2;SIGLEC15;CD74;B2M;TLR2;PGLYRP1;IFIT1;SP100;SERINC3;RNF187;CX3CR1;NCF2;PPARG;IRAK4;IFITM3;STYK1;CYLD
prerank,GO_Biological_Process_2021__positive regulation of DNA repair (GO:0045739),-0.4626537327320267,-1.1461606580160255,0.2692307692307692,0.9828456615479729,1.0,11/45,17.42%,EYA4;MGMT;TIMELESS;BRCC3;ERCC8;DDX11;SPIDR;EGFR;FAM168A;HDAC10;EYA2
prerank,GO_Biological_Process_2021__neuronal ion channel clustering (GO:0045161),0.7123390217608832,1.146156187666417,0.3090909090909091,1.0,1.0,2/8,14.13%,CNTN2;MTCH1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to membrane (GO:1905477),-0.4662023351070227,-1.1456168658374668,0.20833333333333334,0.9838171301392871,1.0,8/86,7.58%,STAC;EPHA3;PTPN9;EPHB2;ZDHHC5;BCL2;TFDP1;RANGRF
prerank,GO_Biological_Process_2021__negative regulation of protein dephosphorylation (GO:0035308),0.6430236242238734,1.1455852701861968,0.328125,1.0,1.0,2/20,6.15%,PPP1R1B;FKBP1B
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via homologous recombination (GO:0010569),0.5396758841490935,1.14538668018024,0.3157894736842105,1.0,1.0,14/42,22.71%,POLQ;PPP4C;FIGNL1;WAS;KLHL15;HELB;ACTR2;CGAS;MAGEF1;RAD51AP1;RMI2;OOEP;TERF2IP;KDM1A
prerank,GO_Biological_Process_2021__regulation of mast cell activation involved in immune response (GO:0033006),-0.6870903482983813,-1.1452931958217027,0.23529411764705882,0.9837856120801464,1.0,2/7,8.37%,SPHK2;ENPP3
prerank,GO_Biological_Process_2021__phenol-containing compound biosynthetic process (GO:0046189),0.7529494983976281,1.145278187218693,0.31343283582089554,1.0,1.0,1/5,2.49%,TYR
prerank,GO_Biological_Process_2021__positive regulation of protein modification by small protein conjugation or removal (GO:1903322),0.49942469722774585,1.145027633646265,0.25,1.0,1.0,17/65,26.86%,WFS1;FANCI;PHF23;SMAD7;RIPK2;BRCA1;GNL3;DERL1;PINK1;DCUN1D1;LRRK2;RCHY1;SPHK1;UBE3A;UBE2D1;LAPTM5;UBQLN1
prerank,GO_Biological_Process_2021__positive regulation of JNK cascade (GO:0046330),-0.47968829291511744,-1.1446673957172422,0.15384615384615385,0.9844905153675692,1.0,9/57,7.17%,TPD52L1;F2RL1;RASSF2;TNFRSF19;SH3RF1;RASGRP1;TRAF3;SERPINF2;SH3RF3
prerank,GO_Biological_Process_2021__cardiac muscle hypertrophy (GO:0003300),0.7225657066902298,1.144557873451616,0.30357142857142855,1.0,1.0,4/8,18.82%,CSRP3;HTR2B;INPP5F;TTN
prerank,GO_Biological_Process_2021__response to indole-3-methanol (GO:0071680),0.7185408855195672,1.1444591204926777,0.32075471698113206,1.0,1.0,2/5,14.47%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__cellular response to indole-3-methanol (GO:0071681),0.7185408855195672,1.1444591204926777,0.32075471698113206,1.0,1.0,2/5,14.47%,CTNNA1;BRCA1
prerank,GO_Biological_Process_2021__cytochrome complex assembly (GO:0017004),-0.7274727196411799,-1.1443098003791699,0.3076923076923077,0.9846158308747122,1.0,2/5,12.79%,COX10;COA6
prerank,GO_Biological_Process_2021__positive regulation of MAP kinase activity (GO:0043406),-0.48249788000356764,-1.1436634434123447,0.2,0.9855977705132749,1.0,7/56,5.79%,KIT;TPD52L1;PDGFD;TNFRSF11A;RASGRP1;PIK3R6;FGF1
prerank,GO_Biological_Process_2021__detection of calcium ion (GO:0005513),0.6233217916733751,1.1431592229253305,0.3064516129032258,1.0,1.0,4/10,30.02%,KCNMB1;CALM3;RYR2;KCNMB2
prerank,GO_Biological_Process_2021__negative regulation of NIK/NF-kappaB signaling (GO:1901223),-0.5616259932834389,-1.1430328255795197,0.3333333333333333,0.9865598097961356,1.0,1/17,0.88%,BMP7
prerank,GO_Biological_Process_2021__positive regulation of tau-protein kinase activity (GO:1902949),-0.7537569392965644,-1.1424737619806142,0.3125,0.9869961123069746,1.0,1/5,11.39%,CLU
prerank,GO_Biological_Process_2021__regulation of Fc-gamma receptor signaling pathway involved in phagocytosis (GO:1905449),0.7549931291386185,1.1424419741094856,0.34328358208955223,1.0,1.0,1/5,5.48%,PTPRC
prerank,GO_Biological_Process_2021__regulation of mononuclear cell migration (GO:0071675),0.5914205379647015,1.1424343463738407,0.32857142857142857,1.0,1.0,3/19,8.55%,CCL5;RARRES2;CMKLR1
prerank,GO_Biological_Process_2021__epithelial cell development (GO:0002064),0.5847316212452089,1.1422526480355069,0.38461538461538464,1.0,1.0,4/17,13.18%,ACTA2;EXPH5;BFSP1;TMEM79
prerank,GO_Biological_Process_2021__cellular response to growth hormone stimulus (GO:0071378),-0.684936759292658,-1.1421310634246278,0.4117647058823529,0.9868389331498951,1.0,4/7,26.49%,STAT3;PXN;JAK2;PIK3R1
prerank,GO_Biological_Process_2021__positive regulation of intracellular transport (GO:0032388),-0.48833571141256216,-1.1420493786063692,0.3,0.9858990472131521,1.0,7/33,10.42%,PRR5L;TPR;NUMA1;PCNT;SORL1;PCM1;B3GAT3
prerank,GO_Biological_Process_2021__positive regulation of alcohol biosynthetic process (GO:1902932),-0.7297723027465162,-1.1412361372993682,0.3488372093023256,0.9877250025932773,1.0,3/8,13.23%,FGF1;BMP6;SCAP
prerank,GO_Biological_Process_2021__positive regulation of protein tyrosine kinase activity (GO:0061098),-0.48993120038026516,-1.1412303160855966,0.34615384615384615,0.9865433109836163,1.0,3/35,3.11%,NOX4;BTC;EREG
prerank,GO_Biological_Process_2021__positive regulation of collagen biosynthetic process (GO:0032967),-0.5618259652948627,-1.1409893844292938,0.3,0.9849332515775017,1.0,4/13,10.99%,RUNX1;SERPINF2;TGFB3;CREB3L1
prerank,GO_Biological_Process_2021__positive regulation of collagen metabolic process (GO:0010714),-0.5618259652948627,-1.1409893844292938,0.3,0.9849332515775017,1.0,4/13,10.99%,RUNX1;SERPINF2;TGFB3;CREB3L1
prerank,GO_Biological_Process_2021__regulation of actin filament organization (GO:0110053),0.7494363172468319,1.1408178775670883,0.3968253968253968,1.0,1.0,2/7,13.50%,WAS;BRK1
prerank,GO_Biological_Process_2021__tyrosine phosphorylation of STAT protein (GO:0007260),0.7666156489375082,1.1407797959154047,0.3,1.0,1.0,1/5,4.42%,IL15
prerank,GO_Biological_Process_2021__regulation of generation of precursor metabolites and energy (GO:0043467),-0.46651106639597556,-1.140706847091378,0.25925925925925924,0.9846241025623896,1.0,5/46,8.70%,RUBCNL;NUP210;TPR;NUP37;ZBTB7A
prerank,GO_Biological_Process_2021__epiboly involved in wound healing (GO:0090505),-0.5371199825378319,-1.140671894446358,0.2857142857142857,0.9835038261362978,1.0,4/14,20.63%,PDPN;CARMIL2;MRTFA;LCP1
prerank,GO_Biological_Process_2021__regulation of cell-matrix adhesion (GO:0001952),-0.48572595267177354,-1.1406488911414805,0.2682926829268293,0.9823862921249574,1.0,5/57,4.71%,CCL28;EPHA3;CDH13;UTRN;SFRP1
prerank,GO_Biological_Process_2021__cellular response to fatty acid (GO:0071398),-0.6665812140901113,-1.1400862966098027,0.3225806451612903,0.983132537462813,1.0,4/11,14.39%,PID1;NR1H4;AKR1C3;IRS1
prerank,GO_Biological_Process_2021__purine nucleotide metabolic process (GO:0006163),-0.5625541113058639,-1.1400746192100315,0.2413793103448276,0.9819493423105681,1.0,3/20,10.85%,PNP;ITPA;DNPH1
prerank,GO_Biological_Process_2021__cellular sodium ion homeostasis (GO:0006883),0.6677422174403559,1.1399338341061644,0.3088235294117647,1.0,1.0,5/10,28.27%,ATP12A;ATP1B1;ATP1A1;SLC9A1;SLC12A2
prerank,PanglaoDB_Augmented_2021__Kupffer Cells,0.5123249632189365,1.1398791737354654,0.2054794520547945,1.0,1.0,7/56,3.68%,C3AR1;MS4A6A;CHIT1;CD4;FGL2;HCK;CD300LF
prerank,GO_Biological_Process_2021__Golgi disassembly (GO:0090166),-0.6895286997982761,-1.1394803876763426,0.3783783783783784,0.9827802498411189,1.0,6/6,31.07%,PLK3;VRK1;PLK5;GOLGA2;GBF1;STX5
prerank,GO_Biological_Process_2021__regulation of collateral sprouting (GO:0048670),-0.6878570864643835,-1.1391859945731388,0.38095238095238093,0.9822527862033049,1.0,3/8,11.83%,FGF13;PTPRS;NGF
prerank,GO_Biological_Process_2021__protein targeting to ER (GO:0045047),0.49790044604566336,1.138724974691752,0.21518987341772153,1.0,1.0,42/97,35.61%,CHMP4B;RPL15;RPL36;RPS7;MAN1A1;RPL9;RPS21;RPL22;SRP9;RPL21;RPL38;RPLP2;RPS5;SPCS3;SRP19;RPL3;SRP68;RPL35A;RPS13;RPL35;RPS20;RPL27;RPL13A;RPS27A;RPL5;RPL27A;RPL7;RPS9;RPL37;SEC62;SRP14;RPS29;RPL24;RPL28;RPL32;RPL8;RPS4X;RPS12;RPL37A;RPSA;SGTB;RPS19
prerank,GO_Biological_Process_2021__glycosphingolipid catabolic process (GO:0046479),0.719440561935619,1.1384820564412161,0.328125,1.0,1.0,3/7,17.16%,GM2A;GBA3;NEU1
prerank,GO_Biological_Process_2021__embryonic digit morphogenesis (GO:0042733),0.6175059683580988,1.138438559135978,0.373134328358209,1.0,1.0,3/14,5.96%,MSX1;GLI3;TWIST1
prerank,GO_Biological_Process_2021__DNA strand elongation involved in DNA replication (GO:0006271),0.621151405911214,1.1384159810068903,0.288135593220339,1.0,1.0,5/18,13.33%,POLE3;GINS2;MCMDC2;GINS1;PCNA
prerank,GO_Biological_Process_2021__negative regulation of secretion (GO:0051048),-0.5815822803554594,-1.1383038428164267,0.358974358974359,0.9845217401986776,1.0,1/9,0.71%,NRG1
prerank,GO_Biological_Process_2021__collagen fibril organization (GO:0030199),-0.4547826612676788,-1.1382478516275347,0.20833333333333334,0.9834796255325411,1.0,17/77,11.20%,COL15A1;GREM1;ADAMTS2;ADAMTS3;COL6A2;LAMB3;LOXL1;COL11A2;ITGA6;COL4A3;TGFB2;SERPINF2;COL11A1;COL18A1;LAMA3;COL4A2;COL28A1
prerank,GO_Biological_Process_2021__snRNA metabolic process (GO:0016073),-0.5611900363739357,-1.1380782292101213,0.3,0.9827992755418797,1.0,1/15,4.01%,INTS11
prerank,GO_Biological_Process_2021__regulation of defense response (GO:0031347),0.5046916122124632,1.137987589123322,0.2459016393442623,1.0,1.0,4/58,3.46%,CASP12;PTGES;LRRC19;HCK
prerank,PanglaoDB_Augmented_2021__Spermatozoa,0.508064857331535,1.1379426679378433,0.2236842105263158,1.0,1.0,16/80,8.25%,MS4A6A;ADAM28;ALDH1A1;CLIC6;SLCO2B1;FGL2;CD302;CP;OMG;HLA-DMB;CD14;TEX26;ANKUB1;SOD2;FAM20A;CPM
prerank,GO_Biological_Process_2021__skeletal muscle thin filament assembly (GO:0030240),0.7149336340318168,1.1378741546702196,0.4084507042253521,1.0,1.0,2/5,18.82%,ACTC1;TTN
prerank,GO_Biological_Process_2021__regulation of hemoglobin biosynthetic process (GO:0046984),-0.7262891907069703,-1.1378034827423558,0.3684210526315789,0.9825989746635342,1.0,3/6,13.26%,SLC25A37;SLC6A9;ABCB10
prerank,GO_Biological_Process_2021__purine ribonucleoside monophosphate biosynthetic process (GO:0009168),0.6285582658466294,1.137623147952642,0.2962962962962963,1.0,1.0,5/13,26.19%,PAICS;AMPD2;IMPDH1;GMPS;PPAT
prerank,PanglaoDB_Augmented_2021__Endothelial Cells,0.44847063512355523,1.1375071920552857,0.18309859154929578,1.0,1.0,22/151,8.93%,APOLD1;MYLK;TIMP3;ELK3;SEMA3D;STAB1;HSPG2;PDGFRB;CD82;RASIP1;POSTN;F8;CYP1B1;PLAC8;CHST1;RND1;PLSCR4;SRPX;ANGPTL2;TBX1;USHBP1;SLC2A1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound biosynthetic process (GO:0072528),-0.6247258310399265,-1.137435663788428,0.3157894736842105,0.9825356789473566,1.0,4/7,27.05%,CTPS2;PRPS1;UMPS;TPK1
prerank,GO_Biological_Process_2021__phosphorylation of RNA polymerase II C-terminal domain (GO:0070816),-0.6520482680494747,-1.137398144090801,0.27906976744186046,0.981466917490854,1.0,2/8,18.19%,CCNH;GTF2H5
prerank,GO_Biological_Process_2021__G protein-coupled opioid receptor signaling pathway (GO:0038003),0.7269489799619224,1.1369780199384072,0.3103448275862069,1.0,1.0,2/5,15.90%,OPRK1;OPRD1
prerank,GO_Biological_Process_2021__cellular response to low-density lipoprotein particle stimulus (GO:0071404),-0.678191596572064,-1.1367930094128986,0.25,0.9822052605596947,1.0,1/12,1.54%,CDH13
prerank,GO_Biological_Process_2021__RNA polyadenylation (GO:0043631),-0.5178778298824975,-1.1366275802104269,0.23076923076923078,0.980466863772379,1.0,1/24,1.54%,CPSF1
prerank,GO_Biological_Process_2021__mRNA polyadenylation (GO:0006378),-0.5178778298824975,-1.1366275802104269,0.23076923076923078,0.980466863772379,1.0,1/24,1.54%,CPSF1
prerank,GO_Biological_Process_2021__mitochondrion morphogenesis (GO:0070584),-0.6184655071524884,-1.1365917755009811,0.2631578947368421,0.9793378869487331,1.0,2/11,2.41%,PID1;MYH14
prerank,GO_Biological_Process_2021__cellular response to mechanical stimulus (GO:0071260),0.5850154470760875,1.1364141223508444,0.27419354838709675,1.0,1.0,8/34,16.52%,FADD;BNIP3;F11R;CASP8;FAS;TMEM150C;IRF1;PIEZO2
prerank,GO_Biological_Process_2021__regulation of podosome assembly (GO:0071801),0.6938712531256978,1.1363063146320895,0.2903225806451613,1.0,1.0,2/7,14.61%,HCK;KIF9
prerank,GO_Biological_Process_2021__nucleosome assembly (GO:0006334),0.5831912738579744,1.1362305657590461,0.2777777777777778,1.0,1.0,8/33,22.44%,H3-3A;SPTY2D1;NAP1L2;H2BC18;GRWD1;HAT1;CHAF1A;H2BC5
prerank,GO_Biological_Process_2021__chordate embryonic development (GO:0043009),-0.49643729877650544,-1.1358611615460947,0.25,0.9804649042207887,1.0,9/43,12.83%,BMP7;SULF2;RBP4;ALDH1A2;PTCH1;TGFB3;NOG;ARNT2;TRIM71
prerank,GO_Biological_Process_2021__GPI anchor biosynthetic process (GO:0006506),0.5738204110971258,1.135591921739279,0.3287671232876712,1.0,1.0,7/27,16.11%,PIGC;PGAP4;PIGV;PIGH;PGAP3;GPAA1;MPPE1
prerank,GO_Biological_Process_2021__establishment of protein localization to peroxisome (GO:0072663),0.7146024336660897,1.1355052054917638,0.35714285714285715,1.0,1.0,1/7,7.63%,PEX16
prerank,GO_Biological_Process_2021__regulation of ruffle assembly (GO:1900027),0.6006043483373931,1.1348505023426714,0.3333333333333333,1.0,1.0,3/19,11.71%,P2RY12;STAP1;EPS8
prerank,GO_Biological_Process_2021__dicarboxylic acid biosynthetic process (GO:0043650),0.6824868305464249,1.1347217880013842,0.38333333333333336,1.0,1.0,1/7,4.01%,GOT1
prerank,GO_Biological_Process_2021__regulation of ceramide biosynthetic process (GO:2000303),-0.6390142825985735,-1.1344674245986055,0.3684210526315789,0.9840090069396318,1.0,3/13,8.84%,SPHK2;PRKCD;SMPD3
prerank,GO_Biological_Process_2021__DNA deamination (GO:0045006),-0.733416260996439,-1.1343458199950949,0.3902439024390244,0.98343758784243,1.0,3/5,16.67%,APOBEC3H;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__regulation of complement-dependent cytotoxicity (GO:1903659),-0.6402924250350835,-1.1342553755041636,0.3409090909090909,0.9824792724091638,1.0,3/6,14.28%,TGFB2;IL11;CR1L
prerank,GO_Biological_Process_2021__spliceosomal tri-snRNP complex assembly (GO:0000244),0.6498059884266698,1.1340889734579345,0.36065573770491804,1.0,1.0,1/13,3.03%,DDX20
prerank,GO_Biological_Process_2021__cotranslational protein targeting to membrane (GO:0006613),0.48854216967846176,1.134027000989976,0.2289156626506024,1.0,1.0,37/88,34.72%,RPL15;RPL36;RPS7;RPL9;RPS21;RPL22;SRP9;RPL21;RPL38;RPLP2;RPS5;SRP19;RPL3;SRP68;RPL35A;RPS13;RPL35;RPS20;RPL27;RPL13A;RPS27A;RPL5;RPL27A;RPL7;RPS9;RPL37;SEC62;SRP14;RPS29;RPL24;RPL28;RPL32;RPL8;RPS4X;RPS12;RPL37A;RPSA
prerank,GO_Biological_Process_2021__endoplasmic reticulum membrane organization (GO:0090158),0.7024512480887207,1.1334396824478918,0.3225806451612903,1.0,1.0,5/11,17.88%,LPCAT3;VAPB;ATL1;VCPIP1;TRDN
prerank,GO_Biological_Process_2021__regulation of receptor binding (GO:1900120),0.7009900884147324,1.133084624597681,0.3448275862068966,1.0,1.0,4/7,28.66%,B2M;ATP2A2;ATP2A3;PTPRF
prerank,GO_Biological_Process_2021__regulation of epidermal growth factor receptor signaling pathway (GO:0042058),-0.470495131641966,-1.132878178341119,0.19230769230769232,0.9859745257357901,1.0,6/57,6.26%,PTPN3;BTC;CDH13;RNF126;EREG;DGKD
prerank,GO_Biological_Process_2021__high-density lipoprotein particle remodeling (GO:0034375),-0.6961348001925071,-1.132525683912206,0.3103448275862069,0.9859585511965878,1.0,4/10,17.71%,APOA1;SCARB1;APOE;LCAT
prerank,GO_Biological_Process_2021__nuclear membrane disassembly (GO:0051081),-0.5816995010343484,-1.1323996938804115,0.358974358974359,0.9852529679823666,1.0,3/12,18.48%,NEK6;PRKCB;VRK1
prerank,GO_Biological_Process_2021__negative regulation of smoothened signaling pathway (GO:0045879),0.5591017064205168,1.1323897030069394,0.3230769230769231,1.0,1.0,2/23,4.49%,GLI3;HHIP
prerank,GO_Biological_Process_2021__positive regulation of myoblast differentiation (GO:0045663),-0.6280259974695905,-1.132378405853913,0.34210526315789475,0.9841626528106013,1.0,6/13,26.33%,BTG1;RIPOR2;AKIRIN1;HIF1AN;IGFBP3;BOC
prerank,GO_Biological_Process_2021__ATF6-mediated unfolded protein response (GO:0036500),0.6730238376255101,1.1323596208988738,0.3389830508474576,1.0,1.0,3/9,25.74%,HSPA5;CALR;HSP90B1
prerank,GO_Biological_Process_2021__regulation of protein kinase A signaling (GO:0010738),0.6250408709390555,1.1323524044852018,0.3235294117647059,1.0,1.0,5/14,21.50%,CALCR;AKAP5;PJA2;LRRK2;ADGRV1
prerank,GO_Biological_Process_2021__epithelial cilium movement involved in extracellular fluid movement (GO:0003351),0.619741679586324,1.132311283052899,0.3064516129032258,1.0,1.0,4/16,18.10%,ODAD4;CCDC39;CABYR;NEK10
prerank,GO_Biological_Process_2021__regulation of receptor-mediated endocytosis (GO:0048259),0.5680250882118933,1.132059195745553,0.3380281690140845,1.0,1.0,11/29,30.12%,LDLRAP1;HIP1R;LRPAP1;B2M;TF;PIK3CB;RAB21;HNRNPK;SERPINE1;FLOT1;RAC1
prerank,GO_Biological_Process_2021__positive regulation of leukocyte migration (GO:0002687),-0.555737947876622,-1.1319966860371757,0.3103448275862069,0.984316698359834,1.0,1/19,1.47%,F2RL1
prerank,GO_Biological_Process_2021__mitochondrial ribosome assembly (GO:0061668),0.7627459765179367,1.1315546022052272,0.36363636363636365,1.0,1.0,1/6,9.02%,MPV17L2
prerank,GO_Biological_Process_2021__oligosaccharide metabolic process (GO:0009311),-0.46691107198702003,-1.1314678755313226,0.19230769230769232,0.9848223512481405,1.0,4/37,5.93%,ST6GAL2;ST3GAL3;ST8SIA2;GAL3ST4
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity (GO:0006469),-0.4691814736000245,-1.131337656248206,0.25,0.9840712471425682,1.0,7/76,4.80%,UBASH3B;TRIB2;SPRED1;PTPRT;PTPRB;PRKRIP1;WWTR1
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis (GO:0006898),0.4765122613848565,1.1312816289480037,0.2894736842105263,1.0,1.0,8/110,7.96%,AMBP;LDLRAP1;STAB1;HSPG2;ACKR3;AMN;WASF1;HIP1R
prerank,GO_Biological_Process_2021__substrate adhesion-dependent cell spreading (GO:0034446),-0.4774322519609274,-1.1307501005556173,0.1875,0.9848268048494447,1.0,8/45,12.17%,LAMB2;ITGA4;LAMB3;NTNG1;TYRO3;NRP1;ITGA8;PARVA
prerank,GO_Biological_Process_2021__positive regulation of response to wounding (GO:1903036),0.5995199896576909,1.1303856683466706,0.38235294117647056,1.0,1.0,1/19,0.75%,MYLK
prerank,GO_Biological_Process_2021__polyol metabolic process (GO:0019751),0.5597576322757697,1.1295951485663829,0.3026315789473684,1.0,1.0,12/41,26.91%,PLCH1;PLCG2;PLCD3;IMPA2;INPPL1;IPMK;ITPKB;PLCD1;INPP4B;IPPK;NUDT4;NUDT11
prerank,GO_Biological_Process_2021__regulation of nervous system process (GO:0031644),-0.5560475739184317,-1.129424951114079,0.25,0.9883529506784924,1.0,10/19,23.06%,CACNG5;NPTXR;NPTX2;DLGAP4;SLC8A3;TYMP;DLGAP2;DLGAP3;HTR2C;AKAP9
prerank,GO_Biological_Process_2021__pharyngeal system development (GO:0060037),-0.6161459239153262,-1.1293718160868298,0.2972972972972973,0.9872166648381019,1.0,3/9,6.06%,BMP7;TGFB2;PTCH1
prerank,GO_Biological_Process_2021__regulation of adaptive immune response (GO:0002819),0.6772397918450972,1.129281153984127,0.34375,1.0,1.0,4/12,13.02%,AHR;FADD;IL4I1;IRF1
prerank,MSigDB_Hallmark_2020__Allograft Rejection,0.4858616624422977,1.1292121713211454,0.24096385542168675,1.0,1.0,26/125,15.32%,ITK;CD4;CCL5;STAB1;CD8A;ELANE;IL15;HLA-DMA;INHBA;PTPRC;HLA-DMB;CCND2;FYB1;STAT4;IL7;HLA-A;STAT1;WAS;GCNT1;FAS;MAP4K1;RPL9;RIPK2;TGFB1;BRCA1;IGSF6
prerank,GO_Biological_Process_2021__IMP metabolic process (GO:0046040),-0.6244969400423024,-1.1292025983249698,0.4594594594594595,0.9864496203011563,1.0,1/7,3.37%,PNP
prerank,GO_Biological_Process_2021__cellular response to gamma radiation (GO:0071480),-0.5773392811125505,-1.129125096983344,0.3333333333333333,0.9855845354364992,1.0,5/16,16.96%,MAP3K20;XRCC6;HSF1;TLK2;ATM
prerank,GO_Biological_Process_2021__protein localization to non-motile cilium (GO:0097499),-0.735127887853773,-1.1287660437587905,0.3076923076923077,0.9859681631341045,1.0,2/6,6.08%,ARL13B;ZDHHC3
prerank,GO_Biological_Process_2021__error-free translesion synthesis (GO:0070987),0.5874730201878062,1.1286445116399741,0.328125,1.0,1.0,3/22,13.59%,RFC5;PCNA;RPA3
prerank,"GO_Biological_Process_2021__positive regulation of phagocytosis, engulfment (GO:0060100)",-0.6732787460532657,-1.128620521927459,0.40540540540540543,0.9853381213032941,1.0,2/8,9.30%,F2RL1;ANO6
prerank,GO_Biological_Process_2021__TORC2 signaling (GO:0038203),-0.6923214371777017,-1.1285801286191315,0.38596491228070173,0.9842618159121976,1.0,2/6,10.99%,PRR5L;SYAP1
prerank,GO_Biological_Process_2021__regulation of mesenchymal stem cell differentiation (GO:2000739),0.6946494810400967,1.1285664434736988,0.3,1.0,1.0,2/6,9.19%,SOX6;REST
prerank,GO_Biological_Process_2021__regulation of osteoblast proliferation (GO:0033688),-0.6338169268786007,-1.128543611499504,0.35294117647058826,0.9832708585230441,1.0,2/13,4.71%,GREM1;SFRP1
prerank,GO_Biological_Process_2021__copper ion transport (GO:0006825),0.692395500166357,1.1283161576141163,0.375,1.0,1.0,1/10,0.38%,STEAP4
prerank,GO_Biological_Process_2021__alanine transport (GO:0032328),0.6989775207799486,1.1281059605137762,0.4117647058823529,1.0,1.0,2/6,23.75%,SLC36A1;SLC38A3
prerank,GO_Biological_Process_2021__phasic smooth muscle contraction (GO:0014821),0.7350434102970209,1.1278167063051967,0.3283582089552239,1.0,1.0,2/6,16.04%,PTGER3;HTR2B
prerank,GO_Biological_Process_2021__regulation of rRNA processing (GO:2000232),-0.60049536610488,-1.1275211182606664,0.35714285714285715,0.9859219640741657,1.0,1/16,1.48%,BUD23
prerank,GO_Biological_Process_2021__regulation of glucose import (GO:0046324),-0.5327293264652129,-1.1273267527292554,0.2647058823529412,0.9853775551920712,1.0,2/27,3.96%,PID1;IGF1
prerank,GO_Biological_Process_2021__response to peptide (GO:1901652),0.5750748764451519,1.127317047093692,0.3235294117647059,1.0,1.0,8/24,17.34%,CALCR;AGER;STAT4;STAT1;STAT5A;EIF2B5;STAT6;CHRNA7
prerank,GO_Biological_Process_2021__chondrocyte differentiation (GO:0002062),-0.5333849201893843,-1.1272814851751976,0.30303030303030304,0.9844052779442077,1.0,3/26,3.62%,SULF2;RUNX1;NFIB
prerank,GO_Biological_Process_2021__chemical homeostasis within a tissue (GO:0048875),0.7177025295805746,1.1271233899873974,0.29850746268656714,1.0,1.0,2/6,18.06%,RCN3;SFTPD
prerank,GO_Biological_Process_2021__surfactant homeostasis (GO:0043129),0.7177025295805746,1.1271233899873974,0.29850746268656714,1.0,1.0,2/6,18.06%,RCN3;SFTPD
prerank,GO_Biological_Process_2021__coronary artery morphogenesis (GO:0060982),0.7841003470696278,1.1270334984995547,0.25925925925925924,1.0,1.0,2/5,8.52%,NOTCH1;TBX1
prerank,GO_Biological_Process_2021__regulation of hematopoietic stem cell proliferation (GO:1902033),-0.6823121128204725,-1.126962748053986,0.42857142857142855,0.9842595854252435,1.0,4/6,22.20%,PDCD2;ACE;KAT7;EIF2AK2
prerank,GO_Biological_Process_2021__regulation of adipose tissue development (GO:1904177),-0.6602255098917691,-1.126716304471001,0.4444444444444444,0.9838178282393412,1.0,1/6,10.04%,SORL1
prerank,GO_Biological_Process_2021__cellular response to increased oxygen levels (GO:0036295),0.6520334701677581,1.126649969464054,0.3442622950819672,1.0,1.0,2/8,11.17%,ATP6AP1;FAS
prerank,GO_Biological_Process_2021__negative regulation of transcription by competitive promoter binding (GO:0010944),0.737450003728093,1.126051501797895,0.36538461538461536,1.0,1.0,3/6,25.18%,SMAD7;DACH1;BHLHE41
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030949),0.6795306381225777,1.125832936301093,0.3333333333333333,1.0,1.0,1/8,4.62%,ITGA5
prerank,GO_Biological_Process_2021__regulation of peptidyl-tyrosine phosphorylation (GO:0050730),0.4954034158003549,1.1257275068982266,0.2857142857142857,1.0,1.0,10/71,13.78%,ENPP2;IL15;ITGA5;NTF3;PTPRC;AGT;HGF;PLCG2;RIPK2;TGFB1
prerank,GO_Biological_Process_2021__oligosaccharide catabolic process (GO:0009313),0.7109962480223353,1.1256931800594372,0.3582089552238806,1.0,1.0,3/7,17.16%,GBA3;MANBA;NEU1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex disassembly (GO:0043242),0.6525506610133165,1.1256612195240907,0.35294117647058826,1.0,1.0,1/7,8.38%,PHF23
prerank,GO_Biological_Process_2021__glycosylceramide catabolic process (GO:0046477),0.7378026450640195,1.1256348442070576,0.3392857142857143,1.0,1.0,1/5,6.04%,GBA3
prerank,GO_Biological_Process_2021__regulation of protein ADP-ribosylation (GO:0010835),-0.6253249825157987,-1.1255861954380906,0.34285714285714286,0.9868640215347855,1.0,2/7,7.77%,PUM3;PNKP
prerank,GO_Biological_Process_2021__response to zinc ion (GO:0010043),0.5838170276435314,1.1252817813154294,0.3225806451612903,1.0,1.0,3/20,9.46%,ZACN;SLC30A8;KHK
prerank,GO_Biological_Process_2021__respiratory electron transport chain (GO:0022904),0.6542133519794142,1.1251519074810135,0.2857142857142857,1.0,1.0,4/13,27.00%,PPARGC1A;SLC25A18;ETFB;ETFA
prerank,GO_Biological_Process_2021__positive regulation of synapse assembly (GO:0051965),-0.48355491611324397,-1.12511442282486,0.28125,0.9873566867514414,1.0,5/27,14.91%,EPHB2;CLSTN2;DLG5;SYNDIG1;NLGN3
prerank,GO_Biological_Process_2021__retinoic acid metabolic process (GO:0042573),-0.6982625875184957,-1.1247320992506633,0.3902439024390244,0.9876677010764205,1.0,3/9,14.61%,ALDH1A2;ALDH1A3;CYP3A5
prerank,GO_Biological_Process_2021__regulation of cytoplasmic translational elongation (GO:1900247),-0.6775690443891942,-1.1245911300376439,0.32558139534883723,0.9868634477766334,1.0,4/8,25.66%,DPH5;DPH7;DPH1;DPH6
prerank,GO_Biological_Process_2021__lipid transport across blood-brain barrier (GO:1990379),-0.7074886258015273,-1.1245095955598967,0.37142857142857144,0.9859628347323095,1.0,1/5,5.12%,FABP5
prerank,GO_Biological_Process_2021__cellular response to type I interferon (GO:0071357),0.5485683662483011,1.1244101649688758,0.3,1.0,1.0,13/38,23.93%,XAF1;ISG20;HLA-A;STAT1;IFIT3;IRF1;PSMB8;IFI27;IFIT1;SP100;IFITM3;IFI35;IFI6
prerank,GO_Biological_Process_2021__type I interferon signaling pathway (GO:0060337),0.5485683662483011,1.1244101649688758,0.3,1.0,1.0,13/38,23.93%,XAF1;ISG20;HLA-A;STAT1;IFIT3;IRF1;PSMB8;IFI27;IFIT1;SP100;IFITM3;IFI35;IFI6
prerank,GO_Biological_Process_2021__removal of superoxide radicals (GO:0019430),0.7571299465466336,1.124161217789683,0.3333333333333333,1.0,1.0,1/6,7.79%,SOD2
prerank,GO_Biological_Process_2021__carboxylic acid biosynthetic process (GO:0046394),-0.6700576543426855,-1.1239491938921033,0.3333333333333333,0.9866341348810452,1.0,1/10,0.72%,PAH
prerank,GO_Biological_Process_2021__nuclear envelope organization (GO:0006998),-0.5510400330001298,-1.1236871242764637,0.38095238095238093,0.9860298755782285,1.0,7/17,22.93%,LEMD2;EMD;SUN3;DMPK;SUN2;NEMP1;TOR1B
prerank,GO_Biological_Process_2021__response to forskolin (GO:1904321),0.6954579585877848,1.1234554423227616,0.2786885245901639,1.0,1.0,1/9,5.86%,AHR
prerank,GO_Biological_Process_2021__cellular response to forskolin (GO:1904322),0.6954579585877848,1.1234554423227616,0.2786885245901639,1.0,1.0,1/9,5.86%,AHR
prerank,GO_Biological_Process_2021__negative regulation of cellular component movement (GO:0051271),0.6357690087071396,1.1232432441131708,0.3382352941176471,1.0,1.0,5/13,20.54%,SPOCK3;WAS;FBLN1;FRMD5;SP100
prerank,GO_Biological_Process_2021__regulation of histone H3-K4 methylation (GO:0051569),-0.5948438065665581,-1.1231438385243981,0.34146341463414637,0.9867484876276348,1.0,1/17,0.81%,MYB
prerank,GO_Biological_Process_2021__positive regulation of dendritic cell cytokine production (GO:0002732),-0.7176747173354501,-1.122692069725603,0.4411764705882353,0.9870580477481907,1.0,2/6,4.94%,KIT;TICAM1
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via STAT (GO:1904892),-0.6344473412522604,-1.122350048396481,0.32432432432432434,0.9870576337718047,1.0,1/9,0.93%,PTPRT
prerank,GO_Biological_Process_2021__defense response to Gram-positive bacterium (GO:0050830),0.6088090931080685,1.1222650139949482,0.3333333333333333,1.0,1.0,10/26,24.32%,RARRES2;HLA-A;LYG1;TLR2;LYG2;PGLYRP1;LBP;GBP6;ROMO1;ADAM17
prerank,GO_Biological_Process_2021__receptor clustering (GO:0043113),0.5488110376020613,1.1222562526370752,0.27692307692307694,1.0,1.0,1/25,0.45%,LRP4
prerank,"GO_Biological_Process_2021__regulation of phagocytosis, engulfment (GO:0060099)",-0.6758080357587096,-1.1213412346155356,0.4444444444444444,0.9877875769408064,1.0,2/7,9.30%,F2RL1;ANO6
prerank,GO_Biological_Process_2021__positive regulation of membrane invagination (GO:1905155),-0.6758080357587096,-1.1213412346155356,0.4444444444444444,0.9877875769408064,1.0,2/7,9.30%,F2RL1;ANO6
prerank,GO_Biological_Process_2021__myotube differentiation (GO:0014902),-0.5718347240499799,-1.1211481594393582,0.325,0.9872834860619288,1.0,4/17,5.85%,ADAM12;ADAMTS15;IGF1;ADAMTS5
prerank,GO_Biological_Process_2021__reticulophagy (GO:0061709),-0.6240399746105667,-1.1210489907372814,0.325,0.9864727167164381,1.0,1/13,0.97%,STING1
prerank,PanglaoDB_Augmented_2021__Enterochromaffin Cells,0.49895891583034546,1.120878923961142,0.2894736842105263,1.0,1.0,15/76,10.80%,ENPP2;MYLK;ANKS4B;SLC38A11;TRPA1;SSTR1;AGT;GABRA2;ANGPTL2;GIPC2;PPARGC1A;SLC17A8;CNTN3;SCGN;ALDOB
prerank,GO_Biological_Process_2021__cellular response to testosterone stimulus (GO:0071394),0.7348208808452542,1.1208543741756825,0.3114754098360656,1.0,1.0,3/5,22.28%,MSN;SPP1;NCOA4
prerank,GO_Biological_Process_2021__response to testosterone (GO:0033574),0.7348208808452542,1.1208543741756825,0.3114754098360656,1.0,1.0,3/5,22.28%,MSN;SPP1;NCOA4
prerank,GO_Biological_Process_2021__negative regulation of neuron death (GO:1901215),-0.4609704680491566,-1.120654882602826,0.21428571428571427,0.9865700773067102,1.0,2/77,1.03%,PM20D1;UNC5B
prerank,GO_Biological_Process_2021__positive regulation of RNA export from nucleus (GO:0046833),0.737409950919436,1.1196878060692212,0.39655172413793105,1.0,1.0,1/5,6.96%,NCBP2
prerank,GO_Biological_Process_2021__positive regulation of nucleobase-containing compound transport (GO:0032241),0.737409950919436,1.1196878060692212,0.39655172413793105,1.0,1.0,1/5,6.96%,NCBP2
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization to mitochondrion (GO:1903747),0.7515612237856608,1.1195635408573577,0.3076923076923077,1.0,1.0,3/7,16.73%,ATP5IF1;DNAJA1;PINK1
prerank,GO_Biological_Process_2021__sulfur amino acid catabolic process (GO:0000098),0.6778072440670185,1.1195337067084496,0.3333333333333333,1.0,1.0,1/7,5.33%,TST
prerank,GO_Biological_Process_2021__odontogenesis (GO:0042476),0.5958178476958959,1.1188555206748463,0.3382352941176471,1.0,1.0,6/22,14.08%,MSX1;SSUH2;INHBA;TBX1;FGFR2;TUFT1
prerank,GO_Biological_Process_2021__heart contraction (GO:0060047),0.5615016470596703,1.1188541970118369,0.3076923076923077,1.0,1.0,8/29,18.82%,CSRP3;SCN4B;ACTC1;MYBPC3;ATP1B1;KCNQ1;TRDN;TTN
prerank,"GO_Biological_Process_2021__positive regulation of CD8-positive, alpha-beta T cell activation (GO:2001187)",-0.6622385424598747,-1.1187903012173075,0.36585365853658536,0.991726797773314,1.0,2/6,7.73%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__regulation of system process (GO:0044057),-0.6692862910195173,-1.11872222027528,0.36585365853658536,0.9908814323004198,1.0,3/5,28.39%,HTR2C;MTG2;NOS3
prerank,GO_Biological_Process_2021__dolichol-linked oligosaccharide biosynthetic process (GO:0006488),-0.5228178051403702,-1.1182857657940901,0.36363636363636365,0.9912475872096936,1.0,3/16,10.92%,ALG8;ALG12;MPDU1
prerank,GO_Biological_Process_2021__lymphocyte chemotaxis (GO:0048247),0.6793051808421096,1.1178456972613855,0.24561403508771928,1.0,1.0,6/10,28.27%,CCL5;GPR183;CXCL13;MSMP;PIK3CD;SLC12A2
prerank,GO_Biological_Process_2021__sterol transport (GO:0015918),0.6326369226149483,1.117753744203496,0.35135135135135137,1.0,1.0,1/16,1.49%,LDLRAP1
prerank,GO_Biological_Process_2021__regulation of endothelial cell development (GO:1901550),-0.6841699093967262,-1.1176991880430713,0.2894736842105263,0.9924022648288188,1.0,2/7,24.41%,IKBKB;VCL
prerank,GO_Biological_Process_2021__melanocyte differentiation (GO:0030318),-0.6085275132876126,-1.117498302875768,0.2972972972972973,0.9920256620897333,1.0,1/9,0.36%,KIT
prerank,GO_Biological_Process_2021__substantia nigra development (GO:0021762),0.5204560882756167,1.1173909498303312,0.2857142857142857,1.0,1.0,11/38,22.52%,PLP1;ZNF430;HSPA5;G6PD;YWHAH;CKB;CNP;SUDS3;CALM3;BASP1;RAD1
prerank,GO_Biological_Process_2021__positive regulation of cholesterol efflux (GO:0010875),-0.5642519845293867,-1.117198865058588,0.2857142857142857,0.9918588625508115,1.0,4/18,12.93%,PTCH1;APOA1;APOE;EEPD1
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902043),0.6966249984383723,1.117069686321391,0.3684210526315789,1.0,1.0,1/5,0.93%,TIMP3
prerank,GO_Biological_Process_2021__acylglycerol catabolic process (GO:0046464),0.5771389860271396,1.1169815577745241,0.3380281690140845,1.0,1.0,4/24,11.88%,LIPH;FABP3;LIPI;PNPLA1
prerank,GO_Biological_Process_2021__negative regulation of TORC1 signaling (GO:1904262),0.6156294009702299,1.1167828874249348,0.3230769230769231,1.0,1.0,2/12,9.45%,SESN3;RNF152
prerank,GO_Biological_Process_2021__mesenchyme development (GO:0060485),-0.6003077500444247,-1.116535316329017,0.39473684210526316,0.9924630511351724,1.0,2/10,8.75%,BMP7;HMGA2
prerank,GO_Biological_Process_2021__regulation of establishment of endothelial barrier (GO:1903140),0.6275087314068679,1.116294086221144,0.3103448275862069,1.0,1.0,1/12,8.64%,F11R
prerank,GO_Biological_Process_2021__translesion synthesis (GO:0019985),0.5327203818643695,1.1162094248027286,0.3424657534246575,1.0,1.0,7/41,20.58%,RFC5;POLE2;PCNA;RPA3;TRIM25;POLN;RCHY1
prerank,GO_Biological_Process_2021__negative regulation of phosphatase activity (GO:0010923),0.577842609461333,1.1158348420388478,0.28169014084507044,1.0,1.0,3/24,6.15%,PPP1R1B;SH2D4A;FKBP1B
prerank,GO_Biological_Process_2021__regulation of protein deubiquitination (GO:0090085),0.7765382829999125,1.1157675523223143,0.3389830508474576,1.0,1.0,1/5,9.08%,OTUD4
prerank,GO_Biological_Process_2021__alpha-amino acid catabolic process (GO:1901606),0.5479785485948618,1.1157286633629686,0.3582089552238806,1.0,1.0,9/23,22.06%,HSD17B10;ALDH4A1;IDO1;FAH;ACMSD;IL4I1;DAO;HPD;ACAT1
prerank,GO_Biological_Process_2021__regulation of p38MAPK cascade (GO:1900744),0.5564350641561502,1.11541348453561,0.3181818181818182,1.0,1.0,2/29,1.74%,GADD45B;AGER
prerank,GO_Biological_Process_2021__chromatin-mediated maintenance of transcription (GO:0048096),-0.6418469794410644,-1.1152027639883222,0.34146341463414637,0.9956637087550969,1.0,2/10,13.16%,ZMIZ2;SERTAD2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced cell death (GO:1903201),0.6812304970070202,1.1151666369123077,0.3090909090909091,1.0,1.0,3/9,16.73%,STK26;REST;PINK1
prerank,PanglaoDB_Augmented_2021__Hematopoietic Stem Cells,0.47903744733558357,1.1150257612285823,0.2875,1.0,1.0,17/106,8.78%,C3AR1;MS4A6A;ALDH1A1;STAB1;FGL2;HCK;CD300LF;MGST1;NOTCH1;FCGRT;PTPRC;FLT3;CDCP1;CD14;ABCB1;CMKLR1;HGF
prerank,GO_Biological_Process_2021__positive regulation of mRNA metabolic process (GO:1903313),-0.6576619561674795,-1.1148717676977433,0.3783783783783784,0.9958617542511289,1.0,2/12,3.93%,PRR5L;KHSRP
prerank,GO_Biological_Process_2021__hair cell differentiation (GO:0035315),-0.691295316031006,-1.1144452067735027,0.4186046511627907,0.9962033471693813,1.0,1/6,2.73%,ERCC2
prerank,GO_Biological_Process_2021__negative regulation of transforming growth factor beta production (GO:0071635),0.6872498493882422,1.114428332886971,0.36065573770491804,1.0,1.0,2/6,18.60%,FN1;FURIN
prerank,GO_Biological_Process_2021__regulation of vasoconstriction (GO:0019229),-0.49426096759681554,-1.1143228152459246,0.2972972972972973,0.9954254585343066,1.0,3/20,7.24%,PER2;ECE1;ACE2
prerank,GO_Biological_Process_2021__regulation of endothelial cell apoptotic process (GO:2000351),-0.5311679756154813,-1.1142662467054953,0.3333333333333333,0.9944896975317662,1.0,7/26,12.23%,KDR;ITGA4;IL11;MAPK7;ANO6;AKR1C3;SCG2
prerank,GO_Biological_Process_2021__lytic vacuole organization (GO:0080171),-0.5570752199514967,-1.1141863311465756,0.30303030303030304,0.9936198351187077,1.0,7/29,19.14%,ARSB;CLN6;TPP1;GNPTAB;CLVS1;HOOK3;MTOR
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in axon guidance (GO:1902287),-0.6330461504601675,-1.1141000631491176,0.43243243243243246,0.9928156479100821,1.0,3/8,15.20%,PLXNA1;PLXNA2;PLXNC1
prerank,GO_Biological_Process_2021__nucleosome positioning (GO:0016584),-0.6193469405927099,-1.1140834318505117,0.30303030303030304,0.9918541822552656,1.0,1/9,1.16%,H1-4
prerank,GO_Biological_Process_2021__inositol phosphate metabolic process (GO:0043647),0.5597064876428036,1.1139795622003157,0.26666666666666666,1.0,1.0,12/42,26.91%,PLCH1;PLCG2;PLCD3;IMPA2;INPPL1;IPMK;ITPKB;PLCD1;INPP4B;IPPK;NUDT4;NUDT11
prerank,GO_Biological_Process_2021__metal ion export (GO:0070839),0.5888843143830074,1.1137153536335895,0.32857142857142857,1.0,1.0,10/22,26.97%,KCNE2;ATP12A;ATP1B1;SLC40A1;KCNQ1;KCNE4;ATP1A1;ATP2B4;SLC11A1;SLC9A1
prerank,GO_Biological_Process_2021__regulation of biomineral tissue development (GO:0070167),0.6055372666873753,1.1136909815187916,0.3787878787878788,1.0,1.0,4/21,13.78%,NOTCH1;NOTUM;TWIST1;TGFB1
prerank,GO_Biological_Process_2021__negative regulation of DNA replication (GO:0008156),0.6842679032969117,1.1134966093757408,0.352112676056338,1.0,1.0,2/11,11.05%,GMNN;CDC6
prerank,GO_Biological_Process_2021__tRNA threonylcarbamoyladenosine metabolic process (GO:0070525),-0.7329786953190115,-1.1134401420315672,0.35714285714285715,0.9926429429662638,1.0,2/5,21.09%,TPRKB;OSGEP
prerank,GO_Biological_Process_2021__inorganic ion transmembrane transport (GO:0098660),0.7057816685594525,1.1131984356365139,0.3387096774193548,1.0,1.0,4/7,26.14%,KCNJ11;ABCC9;CACNA1H;ASIC2
prerank,GO_Biological_Process_2021__regulation of blood-brain barrier permeability (GO:1905603),0.7531398542007703,1.1130873327716513,0.36666666666666664,1.0,1.0,1/6,6.08%,TJP3
prerank,GO_Biological_Process_2021__rhodopsin mediated signaling pathway (GO:0016056),0.6846738613724739,1.113040879159067,0.38596491228070173,1.0,1.0,3/7,15.18%,CNGB1;CNGA1;PDE6B
prerank,GO_Biological_Process_2021__regulation of Notch signaling pathway (GO:0008593),-0.4475676241951672,-1.1129222022776442,0.25,0.9931442033829391,1.0,13/66,11.30%,PRAG1;MAML3;DTX1;RITA1;MAML1;TSPEAR;TCIM;TGFB2;STAT3;ZBTB7A;JAG2;LLGL2;BEND6
prerank,GO_Biological_Process_2021__regulation of ERBB signaling pathway (GO:1901184),-0.5852551690740366,-1.1127252119434454,0.3103448275862069,0.992724706126116,1.0,3/15,12.89%,CDH13;WDR54;EGFR
prerank,GO_Biological_Process_2021__mitochondrial fragmentation involved in apoptotic process (GO:0043653),0.6778281978143336,1.1125984642333497,0.390625,1.0,1.0,3/9,20.48%,BNIP3;VPS35;ATG3
prerank,GO_Biological_Process_2021__lipid biosynthetic process (GO:0008610),0.5007053329788309,1.1124977178014688,0.28378378378378377,1.0,1.0,7/59,12.29%,LIPH;PRLR;ACSL5;HMGCR;LIPI;SCD;CYP19A1
prerank,GO_Biological_Process_2021__regulation of lipopolysaccharide-mediated signaling pathway (GO:0031664),0.6349582878027972,1.1123805654242145,0.3492063492063492,1.0,1.0,3/14,11.66%,TRIM5;CARD8;SCIMP
prerank,GO_Biological_Process_2021__heart morphogenesis (GO:0003007),0.5546634691884337,1.1121566869774704,0.30303030303030304,1.0,1.0,6/36,10.94%,TBX19;NOTCH1;ZFPM1;ACTC1;TBX1;MYBPC3
prerank,GO_Biological_Process_2021__negative regulation of T cell differentiation (GO:0045581),0.7499557587551313,1.1121199038744574,0.34375,1.0,1.0,2/5,13.02%,GLI3;IRF1
prerank,GO_Biological_Process_2021__protein methylation (GO:0006479),-0.4710614551686532,-1.1120950600971464,0.32,0.9935256678503394,1.0,13/35,20.99%,CAMKMT;EEF1AKMT1;SNRPB;PRMT5;EHMT2;PRMT8;PRMT6;ICMT;ETF1;FAM98A;EHMT1;METTL22;LCMT1
prerank,GO_Biological_Process_2021__regulation of glycogen metabolic process (GO:0070873),-0.6778157980529099,-1.1119536082081336,0.48,0.9929168429131068,1.0,3/9,8.64%,RUBCNL;PPP1R3B;PPP1R3E
prerank,GO_Biological_Process_2021__histone H3-K36 demethylation (GO:0070544),-0.6112452396801796,-1.1117992825510596,0.3684210526315789,0.9922461736023065,1.0,2/9,11.08%,KDM8;KDM4B
prerank,GO_Biological_Process_2021__positive regulation of superoxide anion generation (GO:0032930),-0.6690645998348494,-1.1117110689899417,0.358974358974359,0.9914033750116682,1.0,2/9,6.22%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__cellular response to amyloid-beta (GO:1904646),-0.4809834725584635,-1.1116090802215832,0.34615384615384615,0.9905466948655568,1.0,6/25,11.17%,ITGA4;CACNA2D1;IGF1;CACNA1A;GRIN2A;ABCC1
prerank,GO_Biological_Process_2021__positive regulation of cellular amide metabolic process (GO:0034250),-0.4512597253986049,-1.1115681747483563,0.34782608695652173,0.98959743272352,1.0,12/72,16.81%,SAMD4A;SPHK2;PRKCD;SMPD3;ELAVL1;UPF3A;LRRTM3;CLU;RBM3;CIRBP;PLD1;NSMAF
prerank,GO_Biological_Process_2021__presynaptic active zone organization (GO:1990709),-0.669073634729852,-1.111383295674656,0.358974358974359,0.9891851712384123,1.0,1/6,22.29%,BSN
prerank,GO_Biological_Process_2021__bicellular tight junction assembly (GO:0070830),0.5579347597442181,1.111360303999254,0.3582089552238806,1.0,1.0,7/33,18.42%,MARVELD2;MARVELD3;F11R;CLDN10;ECT2;CLDN20;MPP7
prerank,GO_Biological_Process_2021__response to estradiol (GO:0032355),0.5799398424650164,1.1112545190683414,0.2777777777777778,1.0,1.0,9/24,19.45%,ZNF703;SSTR1;GPER1;CYP19A1;ESR1;TGFB1;LOC400499;H2AZ1;CRHBP
prerank,GO_Biological_Process_2021__protein deacetylation (GO:0006476),-0.48062648051229473,-1.1112373216176816,0.21739130434782608,0.9884752576632931,1.0,13/43,21.41%,TBL1Y;PRDM5;HDAC5;HDAC1;SIN3B;SIRT2;SIRT7;HDAC9;HDAC10;SIN3A;HDAC7;HDAC11;HDAC4
prerank,GO_Biological_Process_2021__regulation of endothelial cell migration (GO:0010594),-0.4612707291012749,-1.111219732891147,0.22857142857142856,0.9874843831607947,1.0,13/66,11.72%,KDR;VASH1;ATOH8;SVBP;FGF1;RIN2;RHOJ;FOXP1;ETS1;SCARB1;NRP1;APOE;SMOC2
prerank,GO_Biological_Process_2021__neural crest cell migration (GO:0001755),0.5546333046676168,1.111071689877062,0.3333333333333333,1.0,1.0,7/32,16.04%,SEMA3D;SOX10;TBX1;SEMA3F;SEMA3A;FN1;HTR2B
prerank,GO_Biological_Process_2021__regulation of immunoglobulin production (GO:0002637),-0.5714099324287366,-1.1106632624443527,0.3448275862068966,0.9880636449502103,1.0,2/14,2.43%,EPHB2;RBP4
prerank,GO_Biological_Process_2021__regulation of interleukin-17 production (GO:0032660),0.6163791420474831,1.1106602272247554,0.38235294117647056,1.0,1.0,6/15,23.30%,ZBTB7B;IL15;TGFB1;SPHK1;PRNP;IL18
prerank,GO_Biological_Process_2021__negative regulation of catabolic process (GO:0009895),-0.49047458191100723,-1.1104661475379884,0.39285714285714285,0.987607934254426,1.0,3/35,7.13%,ALK;RILP;CIDEA
prerank,GO_Biological_Process_2021__regulation of macrophage migration (GO:1905521),0.6490088032577086,1.1103031721866716,0.390625,1.0,1.0,3/9,21.40%,P2RY12;CD200;CX3CR1
prerank,GO_Biological_Process_2021__regulation of transmembrane transporter activity (GO:0022898),-0.6607455007029743,-1.1100759902261348,0.36585365853658536,0.9879511053764872,1.0,2/7,7.24%,BCL2;ACE2
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase signaling (GO:0014066),-0.43830835315681765,-1.1100363046489063,0.24,0.986949578925566,1.0,10/89,6.21%,KIT;ROR2;SELP;KDR;UNC5B;F2RL1;PDGFD;IGF1;TGFB2;IER3
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell apoptotic process (GO:1905461),0.7231018208962909,1.109954963294471,0.4264705882352941,1.0,1.0,3/5,21.48%,SOD2;PDCD4;PPARG
prerank,GO_Biological_Process_2021__positive regulation of steroid metabolic process (GO:0045940),0.6905638346763328,1.109418097737569,0.45454545454545453,1.0,1.0,2/5,6.08%,LDLRAP1;AGT
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell apoptotic process (GO:0034393),0.6962763210448628,1.1093440754216288,0.36764705882352944,1.0,1.0,3/7,21.48%,SOD2;PDCD4;PPARG
prerank,GO_Biological_Process_2021__icosanoid biosynthetic process (GO:0046456),-0.6584270197582627,-1.1092043225889483,0.2978723404255319,0.9883854095795014,1.0,1/8,4.53%,LTC4S
prerank,GO_Biological_Process_2021__peptidyl-diphthamide biosynthetic process from peptidyl-histidine (GO:0017183),-0.7279787107107292,-1.1091164412027672,0.4,0.9865437905207994,1.0,4/6,25.66%,DPH5;DPH7;DPH1;DPH6
prerank,GO_Biological_Process_2021__peptidyl-diphthamide metabolic process (GO:0017182),-0.7279787107107292,-1.1091164412027672,0.4,0.9865437905207994,1.0,4/6,25.66%,DPH5;DPH7;DPH1;DPH6
prerank,GO_Biological_Process_2021__receptor signaling pathway via STAT (GO:0097696),0.6024701153517258,1.108895872513696,0.3548387096774194,1.0,1.0,4/19,14.66%,STAT4;STAT1;STAT5A;STAT6
prerank,GO_Biological_Process_2021__regulation of lipid biosynthetic process (GO:0046890),0.5446235503504943,1.1086637953755356,0.3611111111111111,1.0,1.0,7/29,17.22%,ASXL3;HSD17B13;PRKAB2;ADIPOR2;GPER1;THRSP;PDK4
prerank,GO_Biological_Process_2021__negative regulation of protein maturation (GO:1903318),0.7199907698174826,1.1086316348637606,0.373134328358209,1.0,1.0,4/8,22.72%,CHAC1;GAS1;LRRK2;PRNP
prerank,GO_Biological_Process_2021__hematopoietic progenitor cell differentiation (GO:0002244),-0.5449588199396723,-1.1086132749891688,0.3157894736842105,0.9871662894884012,1.0,3/22,4.71%,KIT;KDR;SFRP1
prerank,GO_Biological_Process_2021__mRNA modification (GO:0016556),-0.5338136787156895,-1.1085893437985423,0.32142857142857145,0.9861711494191148,1.0,3/22,11.29%,METTL8;TRMT10C;TRMT61A
prerank,GO_Biological_Process_2021__response to gamma radiation (GO:0010332),-0.514852106891244,-1.1082176355033078,0.30303030303030304,0.9864201138675363,1.0,5/21,16.96%,MAP3K20;XRCC6;HSF1;TLK2;ATM
prerank,GO_Biological_Process_2021__positive regulation of mitotic sister chromatid separation (GO:1901970),-0.5892477382172041,-1.1081535938722284,0.2962962962962963,0.9833574224862943,1.0,2/11,18.40%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of mitotic metaphase/anaphase transition (GO:0045842),-0.5892477382172041,-1.1081535938722284,0.2962962962962963,0.9833574224862943,1.0,2/11,18.40%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__positive regulation of metaphase/anaphase transition of cell cycle (GO:1902101),-0.5892477382172041,-1.1081535938722284,0.2962962962962963,0.9833574224862943,1.0,2/11,18.40%,CDC23;ANAPC7
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via tryptophan (GO:0018317),-0.6982926054839833,-1.1080607051290383,0.45,0.981496637823357,1.0,2/5,11.93%,DPY19L1;DPM3
prerank,GO_Biological_Process_2021__protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan (GO:0018406),-0.6982926054839833,-1.1080607051290383,0.45,0.981496637823357,1.0,2/5,11.93%,DPY19L1;DPM3
prerank,GO_Biological_Process_2021__cell morphogenesis involved in neuron differentiation (GO:0048667),0.4717716094316547,1.1080508115544405,0.2702702702702703,1.0,1.0,6/70,13.27%,LRP4;ADGRB1;ABITRAM;FGFR2;ATL1;RAB8A
prerank,GO_Biological_Process_2021__microtubule polymerization (GO:0046785),-0.4926334100491136,-1.107938573050906,0.23333333333333334,0.9809625602897416,1.0,4/28,11.81%,TPPP3;FGF13;MAP7D3;TUBG1
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by integrin (GO:0033632),0.657708346422805,1.1078445231564358,0.3387096774193548,1.0,1.0,5/9,23.56%,CCL5;PODXL;CXCL13;DPP4;SKAP1
prerank,PanglaoDB_Augmented_2021__Luminal Epithelial Cells,-0.43941883440354235,-1.1073017587829734,0.34782608695652173,0.9822012418261882,1.0,14/56,13.47%,FGFR4;BTC;RUNX1;LAMB3;CEBPD;CLDN4;SPDEF;ANKRD30A;BTG1;CDH1;CAPN13;MST1R;PERP;TSPAN1
prerank,GO_Biological_Process_2021__regulation of chromosome separation (GO:1905818),-0.7281924528294665,-1.1072326438022817,0.42857142857142855,0.9813290179825628,1.0,2/5,7.11%,TPR;NUMA1
prerank,GO_Biological_Process_2021__positive regulation of telomerase RNA localization to Cajal body (GO:1904874),0.6196533810456393,1.106991744375953,0.36923076923076925,1.0,1.0,3/15,14.58%,TCP1;CCT6A;CCT8
prerank,GO_Biological_Process_2021__renal absorption (GO:0070293),-0.6484930578173433,-1.1067892407240063,0.34146341463414637,0.9814117323392547,1.0,4/10,13.82%,CLDN4;SGK1;AKR1C3;HNF1A
prerank,MSigDB_Hallmark_2020__mTORC1 Signaling,0.4475963159898492,1.1067339861132757,0.2926829268292683,1.0,1.0,39/181,19.15%,SLC7A11;MCM2;TMEM97;FGL2;GLRX;GOT1;IGFBP5;UFM1;HSPA5;NFIL3;ADIPOR2;CORO1A;NAMPT;CDC25A;SLC2A1;HMGCR;DDX39A;HMGCS1;G6PD;SCD;TUBA4A;SQLE;CCT6A;POLR3G;PSMA3;UCHL5;PLOD2;FADS2;PPA1;ACTR2;LGMN;STARD4;NUFIP1;DHCR7;AK4;EPRS1;PSMG1;DHCR24;INSIG1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase biosynthetic process (GO:0019856),-0.666856860399546,-1.1063801710176167,0.40476190476190477,0.9816171049023528,1.0,1/5,8.94%,CTPS2
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway (GO:0043162),-0.5044188749794682,-1.1060303513202452,0.36363636363636365,0.9814999305575228,1.0,3/22,5.14%,RNF126;VPS25;PTPN23
prerank,GO_Biological_Process_2021__cytokine-mediated signaling pathway (GO:0019221),0.42810749844581913,1.105899187834913,0.2073170731707317,1.0,1.0,80/394,20.54%,TRIM22;TRIM5;IL18R1;IL21R;CD4;CCL5;XAF1;TCP1;HCK;CD300LF;PLP2;PRLR;CRLF1;IL15;ACKR3;JUNB;TWIST1;ISG20;FLT3;OSMR;PTPRZ1;TRAF3IP2;CA1;STAT4;SOD2;IFNLR1;PELI3;ADIPOR2;CDKN1B;CIITA;HGF;IL7;HLA-A;STAT1;IFIT3;RPS6KA4;CSF2RA;TOLLIP;PSMB6;IL20RA;CTF1;NANOG;STAT5A;TXLNA;RHOU;IRF1;RIPK2;IL17RE;IL20RB;TGFB1;PSMA3;CD27;STAT6;PSMB8;HSPA8;CAMK2D;FN1;TNFRSF11B;OPRD1;INPPL1;MSN;TXNDC17;PIM1;TRIM25;NDN;PTAFR;TNFSF13B;IL3RA;IFI27;PDCD4;CXCL13;IL18BP;TAB2;TNFSF18;BCL2L1;B2M;SHC1;MAOA;IFIT1;SP100
prerank,GO_Biological_Process_2021__negative regulation of leukocyte activation (GO:0002695),0.6820244317076241,1.105833582863173,0.3968253968253968,1.0,1.0,3/8,21.07%,CD300LF;GPER1;CD200
prerank,GO_Biological_Process_2021__positive regulation of interleukin-17 production (GO:0032740),0.6329153928698524,1.1058005873990633,0.4126984126984127,1.0,1.0,3/10,13.78%,ZBTB7B;IL15;TGFB1
prerank,GO_Biological_Process_2021__spindle assembly (GO:0051225),-0.43974858952508744,-1.105635664098162,0.20588235294117646,0.9818886178488238,1.0,10/62,9.43%,GOLGA8M;NEK6;GOLGA8H;NUMA1;SMC1A;INO80;GOLGA8A;MAPRE1;GOLGA8B;GOLGA8N
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase I (GO:0006356),-0.5680141759892519,-1.1055565812045158,0.4,0.9809908590732188,1.0,5/16,16.95%,LYAR;UBTF;POLR2L;SIRT7;WDR75
prerank,GO_Biological_Process_2021__response to molecule of bacterial origin (GO:0002237),-0.4717700920687361,-1.1051519337420894,0.3333333333333333,0.981195797127655,1.0,7/43,13.29%,SELP;TNFRSF11A;GCH1;FOXP1;SIRT2;HMGB2;OTUD5
prerank,GO_Biological_Process_2021__cellular polysaccharide biosynthetic process (GO:0033692),0.5978565864567658,1.10462260634096,0.38961038961038963,1.0,1.0,9/20,21.04%,B3GALT1;B3GNT4;CSGALNACT1;B3GNT3;NDST4;B3GALNT1;B4GAT1;HAS3;NDST3
prerank,GO_Biological_Process_2021__positive regulation of ERAD pathway (GO:1904294),0.6340250764501117,1.1044744806057396,0.3770491803278688,1.0,1.0,3/12,14.54%,BCAP31;HERPUD1;USP13
prerank,GO_Biological_Process_2021__leukocyte cell-cell adhesion (GO:0007159),-0.5532314145720373,-1.1044579093114728,0.375,0.982499847948762,1.0,2/19,1.19%,SELP;ITGA4
prerank,GO_Biological_Process_2021__regulation of superoxide anion generation (GO:0032928),-0.6519297251571091,-1.1044192488045508,0.40540540540540543,0.9815433220899644,1.0,2/10,6.22%,F2RL1;PRKCD
prerank,GO_Biological_Process_2021__synaptic vesicle budding (GO:0070142),-0.6754446918722793,-1.1042951923620008,0.3448275862068966,0.9809545908671665,1.0,4/7,22.06%,MX1;DNM2;AP3D1;SNAP91
prerank,GO_Biological_Process_2021__respiratory system development (GO:0060541),-0.48090076302398965,-1.1042302214688782,0.3333333333333333,0.9800931325628449,1.0,3/25,6.06%,RBP4;FGF1;PDPN
prerank,GO_Biological_Process_2021__synapse assembly (GO:0007416),-0.4187556843531395,-1.1040294165980198,0.17391304347826086,0.9799329962371903,1.0,16/62,19.96%,SDK1;FGF13;SHANK2;NLGN4Y;CBLN4;CDH1;DRD1;PCDHB4;LRRTM3;FARP1;DNER;NLGN3;DBNL;PCDHB13;DSCAM;NRCAM
prerank,GO_Biological_Process_2021__transforming growth factor beta receptor signaling pathway (GO:0007179),-0.43602778152292493,-1.1034120299039112,0.21875,0.9814136537825172,1.0,7/69,9.80%,ITGB5;FOS;ZMIZ2;TGFB2;APOA1;GCNT2;TGFB3
prerank,GO_Biological_Process_2021__triglyceride homeostasis (GO:0070328),-0.5343048645493922,-1.103021174465703,0.34210526315789475,0.9815710735544849,1.0,5/20,11.15%,APOA1;NR1H4;RORA;SCARB1;APOE
prerank,GO_Biological_Process_2021__activation of NF-kappaB-inducing kinase activity (GO:0007250),-0.5740273804670701,-1.1029997613031581,0.29411764705882354,0.9806368741874306,1.0,4/11,21.57%,CARD10;CHI3L1;MALT1;MAP3K7
prerank,GO_Biological_Process_2021__cell cycle G1/S phase transition (GO:0044843),0.5188546787506599,1.1029891991742773,0.34210526315789475,1.0,1.0,9/56,10.85%,SPDYA;INHBA;CDKN2D;CCNE1;CDKN1B;CDC25A;CCNE2;CRLF3;MAP3K11
prerank,PanglaoDB_Augmented_2021__Follicular Cells,0.4782022262174035,1.1027702382417497,0.3333333333333333,1.0,1.0,15/56,10.80%,C4BPB;HSD17B2;ANKS4B;TPO;SLC23A1;PRLR;ITIH2;SULT2A1;SERPINA10;UPB1;KNG1;TSHR;LECT2;SLC26A7;ALDOB
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 2 signaling pathway (GO:0034137),-0.7986178944336196,-1.102623181943982,0.34285714285714286,0.9806282457902623,1.0,2/5,6.54%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__base-excision repair (GO:0006284),0.5136662575594363,1.1024982867718736,0.34285714285714286,1.0,1.0,3/44,2.72%,TDG;RFC5;POLQ
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 methylation (GO:0051570),-0.6138242291542434,-1.1019208968280996,0.375,0.9820110577064263,1.0,1/10,0.81%,MYB
prerank,GO_Biological_Process_2021__regulation of fibroblast growth factor receptor signaling pathway (GO:0040036),-0.5706507589793175,-1.1018554355009191,0.3333333333333333,0.9812757938324206,1.0,8/19,13.63%,SULF2;SPRY4;APLN;SPRY3;CREB3L1;SMOC2;NOG;SPRY1
prerank,GO_Biological_Process_2021__cellular glucan metabolic process (GO:0006073),0.6504856850571784,1.101803827482935,0.3939393939393939,1.0,1.0,2/9,23.63%,PHKA1;PRKAG2
prerank,GO_Biological_Process_2021__generation of neurons (GO:0048699),-0.41585546453786226,-1.1017525676026798,0.2727272727272727,0.9805722879276835,1.0,11/139,6.99%,PER2;MDGA1;RUNX1;SH3RF1;ATOH8;ASCL1;NRBP2;MARK1;TGFB2;FGF13;SPOCK1
prerank,GO_Biological_Process_2021__negative regulation of ion transport (GO:0043271),0.5963498758801942,1.101618261973951,0.3484848484848485,1.0,1.0,1/18,1.71%,CAV3
prerank,GO_Biological_Process_2021__positive regulation of attachment of spindle microtubules to kinetochore (GO:0051987),-0.7146394448465729,-1.101590070849273,0.40540540540540543,0.9801265724443065,1.0,3/5,24.09%,SIRT2;RCC2;CCNB1
prerank,GO_Biological_Process_2021__iron ion homeostasis (GO:0055072),0.5051542222459922,1.101431287130026,0.3283582089552239,1.0,1.0,18/45,30.50%,CP;FRRS1;ATP6AP1;ABCG2;SLC40A1;HJV;NUBP1;B2M;TF;HEPH;TFR2;SLC11A1;SLC11A2;CUL1;CAND1;ATP6V1G1;SMAD4;ATP6V1A
prerank,GO_Biological_Process_2021__regulation of cellular response to oxidative stress (GO:1900407),-0.6064059192848205,-1.1013021013570448,0.3191489361702128,0.9800733567826149,1.0,4/9,10.44%,BMP7;GCH1;DHFR;ABCD1
prerank,GO_Biological_Process_2021__female gonad development (GO:0008585),-0.5999810388974262,-1.1012994744604432,0.34375,0.9790273873516836,1.0,2/16,2.39%,KIT;INHA
prerank,GO_Biological_Process_2021__ceramide catabolic process (GO:0046514),0.6489494869548926,1.1012330610860563,0.38028169014084506,1.0,1.0,3/13,17.16%,GM2A;GBA3;NEU1
prerank,GO_Biological_Process_2021__taurine metabolic process (GO:0019530),0.7105133027255401,1.1011127684458024,0.3559322033898305,1.0,1.0,2/6,12.67%,BAAT;STAT5A
prerank,PanglaoDB_Augmented_2021__Sebocytes,-0.48027486702016187,-1.1011042058840745,0.3076923076923077,0.978554689599093,1.0,7/40,4.12%,HRH1;F2RL1;ST6GALNAC2;LAMB3;CEBPD;CLDN4;CRH
prerank,GO_Biological_Process_2021__synaptic membrane adhesion (GO:0099560),-0.5639647179688129,-1.1008278736638217,0.375,0.9782781469014229,1.0,3/14,5.65%,GPC4;NTNG1;LRFN4
prerank,GO_Biological_Process_2021__regulation of cellular amino acid metabolic process (GO:0006521),0.5090270292899145,1.1006644552409226,0.3181818181818182,1.0,1.0,8/45,28.48%,NQO1;PSMB6;PSMA3;PSMB8;PSMA5;PPM1K;PSMC6;AZIN1
prerank,GO_Biological_Process_2021__positive regulation of transferase activity (GO:0051347),-0.3991098918723448,-1.1005156982928812,0.25,0.978287105834717,1.0,18/124,10.21%,KIT;ALK;ROR2;KDR;FGFR4;EPHA3;GREM1;EPHB2;DSCC1;DRD4;EPHA5;NVL;PNKP;TYRO3;CSF1R;PDGFRA;SORL1;LMO4
prerank,MSigDB_Hallmark_2020__Complement,0.44068367952363774,1.100341048779517,0.2962962962962963,1.0,1.0,32/147,17.86%,C4BPB;CCL5;MMP15;PLA2G7;ERAP2;TIMP2;CP;F8;PPP4C;PIK3R5;LAMP2;HSPA5;CPM;F10;RABIF;WAS;CDK5R1;L3MBTL4;C1QA;IRF1;USP14;PLAUR;VCPIP1;PRSS3;DOCK4;HPCAL4;FN1;DYRK2;LGMN;CD59;NOTCH4;PIM1
prerank,GO_Biological_Process_2021__regulation of cellular amine metabolic process (GO:0033238),0.520012465356438,1.1003097378230444,0.328125,1.0,1.0,4/43,15.17%,NQO1;PSMB6;PSMA3;PSMB8
prerank,GO_Biological_Process_2021__regulation of actin polymerization or depolymerization (GO:0008064),0.5522009236945205,1.1000496194645242,0.328125,1.0,1.0,5/24,15.39%,RASA1;ABITRAM;WAS;BRK1;ARHGAP28
prerank,GO_Biological_Process_2021__carboxylic acid transport (GO:0046942),-0.4253186416783459,-1.1000412110223552,0.2962962962962963,0.9788502871588515,1.0,7/47,7.99%,SLC16A9;SLC16A2;SLC16A12;SLC6A11;SLC25A29;SLC6A9;SLC7A1
prerank,GO_Biological_Process_2021__nerve growth factor signaling pathway (GO:0038180),0.6723834467621402,1.0997452774281933,0.3709677419354839,1.0,1.0,1/9,5.23%,NTF3
prerank,GO_Biological_Process_2021__protein localization to endosome (GO:0036010),0.6550715786766694,1.0995185327877093,0.4262295081967213,1.0,1.0,3/10,16.53%,TMEM30A;TOLLIP;VPS35
prerank,GO_Biological_Process_2021__negative regulation of chondrocyte differentiation (GO:0032331),-0.5338963960613201,-1.0994071863005923,0.2647058823529412,0.9800108166234552,1.0,2/13,7.52%,GREM1;PTHLH
prerank,GO_Biological_Process_2021__L-glutamate transmembrane transport (GO:0015813),0.6468498559730191,1.0988473196501924,0.45161290322580644,1.0,1.0,4/10,24.88%,PRAF2;SLC25A18;SLC1A3;ARL6IP5
prerank,GO_Biological_Process_2021__response to hydroxyurea (GO:0072710),-0.624562901454938,-1.098738602292598,0.3333333333333333,0.9807055051549401,1.0,3/9,12.76%,TIMELESS;DDX11;SPIDR
prerank,GO_Biological_Process_2021__regulation of PERK-mediated unfolded protein response (GO:1903897),0.6976948440500079,1.0986777312861535,0.3918918918918919,1.0,1.0,3/8,18.21%,BOK;HSPA5;TMEM33
prerank,GO_Biological_Process_2021__beta-catenin-TCF complex assembly (GO:1904837),-0.49510075274921217,-1.098571496675963,0.34146341463414637,0.9803086936391964,1.0,4/27,9.54%,LEF1;TLE2;HDAC1;SMARCA4
prerank,GO_Biological_Process_2021__T-tubule organization (GO:0033292),0.7246382802655639,1.0984161240820258,0.375,1.0,1.0,2/6,8.16%,CAV3;MYOF
prerank,GO_Biological_Process_2021__early endosome to late endosome transport (GO:0045022),-0.5792835769922928,-1.0974238153558191,0.40625,0.9831942623704027,1.0,6/20,17.62%,RILP;PTPN23;RAB7A;SNF8;STX8;HOOK3
prerank,GO_Biological_Process_2021__negative regulation of nuclear division (GO:0051784),-0.6712058784099053,-1.0972453207084143,0.4594594594594595,0.9827956589580588,1.0,1/8,0.88%,BMP7
prerank,GO_Biological_Process_2021__mitotic metaphase plate congression (GO:0007080),0.5588574631986037,1.0971500611373939,0.32894736842105265,1.0,1.0,8/40,17.32%,CHMP4B;PSRC1;KIF14;CHMP2B;CHMP1A;EML3;RAB11A;CHMP2A
prerank,GO_Biological_Process_2021__cellular response to superoxide (GO:0071451),0.7459271631246014,1.0971146794745954,0.37037037037037035,1.0,1.0,1/7,7.79%,SOD2
prerank,GO_Biological_Process_2021__regulation of exosomal secretion (GO:1903541),-0.5683913500998289,-1.0970984982349603,0.3888888888888889,0.9822341668670534,1.0,5/17,14.88%,SDC4;RAB7A;SMPD3;SNF8;TSG101
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion (GO:0022407),-0.4826339350759182,-1.0969752266077648,0.3793103448275862,0.981554908238061,1.0,1/37,0.39%,MDGA1
prerank,GO_Biological_Process_2021__protein localization to axon (GO:0099612),0.7075846789883876,1.0969245234417666,0.46551724137931033,1.0,1.0,3/5,29.13%,CNTN2;CNTNAP1;EPB41L3
prerank,GO_Biological_Process_2021__mitotic cytokinetic process (GO:1902410),0.5970986144956758,1.0966821993158737,0.36923076923076925,1.0,1.0,6/16,23.90%,CHMP4B;CHMP2B;CHMP1A;CHMP2A;MITD1;VPS4A
prerank,GO_Biological_Process_2021__atrioventricular valve morphogenesis (GO:0003181),0.6056376394289951,1.0965121305524115,0.34375,1.0,1.0,2/15,6.18%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase III promoter (GO:0006384),-0.7280709668767139,-1.0964160615775573,0.42857142857142855,0.982050485680116,1.0,1/5,14.88%,BDP1
prerank,GO_Biological_Process_2021__establishment of mitotic spindle orientation (GO:0000132),-0.5153055727773406,-1.0961080391752112,0.26666666666666666,0.9819366787288779,1.0,3/20,8.32%,NUMA1;NSFL1C;CDK5RAP2
prerank,GO_Biological_Process_2021__negative regulation of cation channel activity (GO:2001258),-0.4884805679968273,-1.0960813179108726,0.2894736842105263,0.9809486140018471,1.0,4/21,7.68%,EPHB2;CBARP;DRD4;SLC6A9
prerank,GO_Biological_Process_2021__negative regulation of organelle assembly (GO:1902116),0.5295170278018247,1.0960337901808215,0.352112676056338,1.0,1.0,10/32,22.29%,CAV3;CHMP4B;PHF23;BRCA1;MDM1;CCP110;PINK1;TCHP;LRRK2;SEC22B
prerank,GO_Biological_Process_2021__purine nucleoside monophosphate biosynthetic process (GO:0009127),0.6159549189881951,1.0959656620007108,0.35185185185185186,1.0,1.0,4/10,26.19%,PAICS;IMPDH1;GMPS;PPAT
prerank,GO_Biological_Process_2021__regulation of trans-synaptic signaling (GO:0099177),-0.49199261734628363,-1.0959325408730418,0.3225806451612903,0.9802439469399058,1.0,12/33,17.97%,GRIK4;FABP5;CACNA1A;NLGN4Y;LRP8;NGF;BTBD9;NLGN3;RELN;CACNA1B;GRIK1;GRID1
prerank,GO_Biological_Process_2021__B cell activation involved in immune response (GO:0002312),0.7112981414628144,1.0956466335254798,0.3333333333333333,1.0,1.0,5/8,24.71%,C17ORF99;GPR183;RNF168;EXOSC6;MSH6
prerank,GO_Biological_Process_2021__sulfur compound catabolic process (GO:0044273),0.5420474278241961,1.0955560272030889,0.36764705882352944,1.0,1.0,5/28,11.63%,PRELP;TST;CHAC2;OGN;CHAC1
prerank,GO_Biological_Process_2021__iron ion transmembrane transport (GO:0034755),-0.6332056050101528,-1.0954852960647286,0.4,0.9804282114630422,1.0,1/9,1.98%,SLC25A37
prerank,GO_Biological_Process_2021__histone methylation (GO:0016571),-0.5306723701342627,-1.095114896823542,0.2972972972972973,0.9806564158124642,1.0,10/23,19.55%,SMYD2;FBLL1;SUV39H2;PRMT5;EHMT2;PRMT8;SIRT7;PRMT6;CREBBP;EHMT1
prerank,GO_Biological_Process_2021__mammary gland epithelial cell differentiation (GO:0060644),0.719294827504494,1.0950480809126977,0.41935483870967744,1.0,1.0,1/6,2.24%,ZNF703
prerank,GO_Biological_Process_2021__dendritic cell differentiation (GO:0097028),-0.5283109366728618,-1.0949396801552598,0.28125,0.9803527857235911,1.0,1/11,1.47%,F2RL1
prerank,GO_Biological_Process_2021__neuromuscular junction development (GO:0007528),0.5562079559768686,1.0947724126463723,0.30158730158730157,1.0,1.0,3/23,7.72%,LRP4;DOK7;PPFIBP2
prerank,GO_Biological_Process_2021__chromatin organization involved in negative regulation of transcription (GO:0097549),0.7181391060583875,1.0945229019897809,0.40625,1.0,1.0,1/6,3.83%,POLE3
prerank,GO_Biological_Process_2021__ketone body metabolic process (GO:1902224),-0.6510245259909386,-1.0945012582475226,0.4838709677419355,0.9805805915552731,1.0,1/9,3.41%,BDH1
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, preincision complex stabilization (GO:0006293)",-0.5380175377730209,-1.094498123830915,0.35714285714285715,0.9785334504455544,1.0,7/18,19.81%,ERCC2;GTF2H2;ERCC1;CUL4A;DDB2;GTF2H5;ERCC3
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 3'-to lesion (GO:0006295)",-0.5380175377730209,-1.094498123830915,0.35714285714285715,0.9785334504455544,1.0,7/18,19.81%,ERCC2;GTF2H2;ERCC1;CUL4A;DDB2;GTF2H5;ERCC3
prerank,GO_Biological_Process_2021__negative regulation of mitotic nuclear division (GO:0045839),-0.6712183207007334,-1.0944632770735825,0.47368421052631576,0.9776306686017051,1.0,1/7,0.88%,BMP7
prerank,GO_Biological_Process_2021__protein peptidyl-prolyl isomerization (GO:0000413),0.5626565954022942,1.094348532860628,0.43333333333333335,1.0,1.0,4/19,11.67%,FKBP4;FKBP1B;FKBP5;PPID
prerank,GO_Biological_Process_2021__negative regulation of apoptotic process (GO:0043066),-0.3494151799975181,-1.0941843534124802,0.21428571428571427,0.9776547983760493,1.0,33/358,7.98%,CD38;BCL2A1;KDR;UNC5B;LEF1;HMGN5;GREM1;MIEN1;SH3RF1;FHL2;ASCL1;APIP;NTSR1;IGF1;TRIAP1;NRBP2;TCIM;SFRP1;MGMT;GRK5;AZU1;CFLAR;HDAC1;PDPN;PRKCD;IGBP1;POU3F4;BCL2;CIDEA;HSPB1;PLK2;NR1H4;TYRO3
prerank,GO_Biological_Process_2021__L-amino acid transport (GO:0015807),0.5217951760941423,1.093754004504597,0.3088235294117647,1.0,1.0,8/26,24.88%,SLC36A1;PRAF2;SLC25A18;SLC38A2;SLC38A5;SLC1A3;SLC38A3;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of potassium ion transport (GO:0043267),0.6753091713463,1.093637779202283,0.4423076923076923,1.0,1.0,1/10,1.71%,CAV3
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated autophagy (GO:1904714),0.6817471282972931,1.0935489758627503,0.38596491228070173,1.0,1.0,2/8,12.66%,EEF1A1;GFAP
prerank,PanglaoDB_Augmented_2021__Glutaminergic Neurons,-0.40578774407248214,-1.0935258253431763,0.3125,0.9789403044345111,1.0,31/105,17.48%,SPHKAP;CACNG3;TNR;SLC6A1;ADGRA1;MMD2;KCNC1;RGS8;GRIA4;GRIA1;GRIN2A;TMEM196;CTNNA2;GAD2;LRRTM3;TMEM132B;STMN2;ELAVL3;CNTNAP5;GRIA2;BRINP2;SRRM4;UNC13A;FRRS1L;CELF5;UNC79;DIRAS2;SLC1A6;CACNA1B;CELF4;SCRT1
prerank,GO_Biological_Process_2021__cellular lipid catabolic process (GO:0044242),0.5583094825336152,1.0933519616446745,0.3484848484848485,1.0,1.0,2/23,4.87%,ENPP2;CYP1B1
prerank,GO_Biological_Process_2021__cysteine metabolic process (GO:0006534),0.6995343549161644,1.0931274643107,0.4339622641509434,1.0,1.0,1/5,5.33%,TST
prerank,GO_Biological_Process_2021__negative regulation of fibroblast growth factor receptor signaling pathway (GO:0040037),-0.6066609232300079,-1.0929538617371395,0.4146341463414634,0.9796370378078516,1.0,6/13,13.63%,SULF2;SPRY4;APLN;SPRY3;CREB3L1;SPRY1
prerank,GO_Biological_Process_2021__IMP biosynthetic process (GO:0006188),0.722896725590557,1.0926632639222322,0.42,1.0,1.0,1/5,16.54%,AMPD2
prerank,GO_Biological_Process_2021__angiogenesis involved in wound healing (GO:0060055),-0.6095376501343219,-1.0926428264727248,0.3142857142857143,0.9795711852299893,1.0,1/8,0.77%,KDR
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell migration (GO:0014911),0.6011780256170345,1.0923611869523437,0.40625,1.0,1.0,3/14,5.09%,CCL5;PDGFRB;IGFBP5
prerank,PanglaoDB_Augmented_2021__Pancreatic Stellate Cells,-0.42241299408508126,-1.0918514170473654,0.25925925925925924,0.9811870111782632,1.0,9/83,3.21%,GEM;TAGLN;FBXL7;COL15A1;LAMA4;ADAMTS2;COL6A2;PCDH18;FNDC1
prerank,GO_Biological_Process_2021__regulation of protein targeting (GO:1903533),0.7361046759218474,1.0917753911538521,0.3888888888888889,1.0,1.0,2/5,16.73%,ATP5IF1;PINK1
prerank,GO_Biological_Process_2021__hemostasis (GO:0007599),0.7838750704591348,1.091572314303594,0.3620689655172414,1.0,1.0,2/5,13.44%,P2RY12;VWF
prerank,GO_Biological_Process_2021__apoptotic mitochondrial changes (GO:0008637),0.5557059974897667,1.0914265835889594,0.3939393939393939,1.0,1.0,9/30,21.12%,BIK;BOK;NAIF1;SOD2;BNIP3;VPS35;BCL2L1;ATG3;BAD
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell proliferation (GO:0046641),0.6316479961909973,1.090664771882188,0.36507936507936506,1.0,1.0,4/9,30.69%,HLA-A;IL18;SYK;TNFSF4
prerank,GO_Biological_Process_2021__regulation of hormone secretion (GO:0046883),-0.6924807093263585,-1.0904558014518457,0.4634146341463415,0.9843478250769768,1.0,2/7,6.86%,NMB;IL11
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial membrane potential (GO:0010917),0.6371690062578099,1.0901854569554477,0.37037037037037035,1.0,1.0,3/7,32.25%,RNF122;ARL6IP5;BAX
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle assembly (GO:0034379),0.6982811806987188,1.0901793316123205,0.4098360655737705,1.0,1.0,3/7,20.96%,LPCAT3;SOAT1;MTTP
prerank,GO_Biological_Process_2021__very-low-density lipoprotein particle remodeling (GO:0034372),-0.7622024567325991,-1.0898546461884941,0.475,0.984425572726525,1.0,3/5,17.71%,APOA1;APOE;LCAT
prerank,GO_Biological_Process_2021__triglyceride-rich lipoprotein particle remodeling (GO:0034370),-0.7622024567325991,-1.0898546461884941,0.475,0.984425572726525,1.0,3/5,17.71%,APOA1;APOE;LCAT
prerank,"GO_Biological_Process_2021__protein localization to chromosome, centromeric region (GO:0071459)",0.6178104938717413,1.089273564178554,0.3815789473684211,1.0,1.0,1/13,4.61%,KNL1
prerank,GO_Biological_Process_2021__regulation of stress-activated protein kinase signaling cascade (GO:0070302),-0.5910501615746537,-1.0890849184268356,0.3902439024390244,0.9858112816211795,1.0,1/10,1.73%,GREM1
prerank,GO_Biological_Process_2021__negative regulation of programmed necrotic cell death (GO:0062099),0.6782332693087165,1.0888938156423589,0.4032258064516129,1.0,1.0,2/9,10.45%,YBX3;CASP8
prerank,GO_Biological_Process_2021__oligodendrocyte development (GO:0014003),0.5867520029762096,1.0887026782712808,0.3709677419354839,1.0,1.0,6/15,23.19%,SOX10;PLP1;EIF2B5;CNTNAP1;ZNF488;B4GALT6
prerank,GO_Biological_Process_2021__regulation of superoxide metabolic process (GO:0090322),-0.644604536463397,-1.08854684484386,0.3783783783783784,0.986263144576369,1.0,3/6,8.14%,BMP7;GCH1;DHFR
prerank,GO_Biological_Process_2021__mitochondrial RNA metabolic process (GO:0000959),-0.5346784832131697,-1.0885070473188396,0.4375,0.9854062266804313,1.0,4/13,17.97%,SLC25A33;EARS2;PNPT1;TEFM
prerank,GO_Biological_Process_2021__regulation of signal transduction (GO:0009966),-0.41941010904741505,-1.0881666796196492,0.3,0.9854801420835093,1.0,25/164,11.42%,FRMPD1;GNG4;UBASH3B;PRAG1;RUNX1;DOK5;TSPAN12;RGS14;DTX1;TSPEAR;GRK5;WWTR1;PTCH1;ZDHHC3;CSK;CBFB;RGS8;RORA;UBTF;AKR1C3;LLGL2;RGS20;GIT2;CLU;RGS2
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transport via high voltage-gated calcium channel (GO:1902514),-0.5570484082522139,-1.0881024305755782,0.45161290322580644,0.984625792951239,1.0,3/10,13.41%,CACNA2D1;NOS1AP;BIN1
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090266),-0.5940062509162898,-1.088089375714983,0.42424242424242425,0.9836717919626942,1.0,3/12,13.09%,TPR;CDK5RAP2;XRCC3
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization to mitochondrion (GO:1903748),0.7322956566952196,1.0878982667282004,0.43103448275862066,1.0,1.0,4/6,25.59%,LMAN1;DNAJA1;LRRK2;BAG4
prerank,GO_Biological_Process_2021__AV node cell action potential (GO:0086016),0.7113120977099057,1.0877247857178998,0.39344262295081966,1.0,1.0,1/6,5.69%,SCN4B
prerank,GO_Biological_Process_2021__regulation of kinase activity (GO:0043549),-0.4373756049421486,-1.08767227512169,0.3333333333333333,0.9839643401225712,1.0,9/81,5.27%,KIT;ALK;ROR2;KDR;FGFR4;EPHA3;EPHB2;DRD4;EPHA5
prerank,GO_Biological_Process_2021__aminoglycan catabolic process (GO:0006026),0.562550823530016,1.0874855614257928,0.42857142857142855,1.0,1.0,5/25,3.93%,CHIT1;GPC6;HSPG2;GPC5;CTBS
prerank,GO_Biological_Process_2021__tubulin complex assembly (GO:0007021),0.7053231693272731,1.0874487957528232,0.4027777777777778,1.0,1.0,2/6,17.08%,TCP1;VBP1
prerank,GO_Biological_Process_2021__positive regulation of cartilage development (GO:0061036),0.627710533809446,1.0874459027136076,0.3548387096774194,1.0,1.0,4/14,16.56%,LOXL2;BMP1;SOX6;SCX
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue morphogenesis (GO:0055010),-0.49427866413001464,-1.0873928349991124,0.35714285714285715,0.9837647455535821,1.0,3/22,5.75%,PKP2;NRG1;TGFB2
prerank,GO_Biological_Process_2021__myeloid leukocyte differentiation (GO:0002573),-0.4762313296775388,-1.0869806802007786,0.30434782608695654,0.9841576952549645,1.0,9/47,9.95%,KIT;LEF1;F2RL1;RUNX1;TNFRSF11A;SBNO2;FOXP1;CSF1R;IFI16
prerank,GO_Biological_Process_2021__tight junction assembly (GO:0120192),0.544843884007852,1.086949338711983,0.3939393939393939,1.0,1.0,7/36,18.42%,MARVELD2;MARVELD3;F11R;CLDN10;ECT2;CLDN20;MPP7
prerank,GO_Biological_Process_2021__negative regulation of muscle cell apoptotic process (GO:0010656),-0.6860428043612146,-1.086839332527905,0.42105263157894735,0.9837851808709441,1.0,2/6,3.96%,BMP7;IGF1
prerank,GO_Biological_Process_2021__protein geranylgeranylation (GO:0018344),0.7729884413190843,1.0867580562069528,0.4426229508196721,1.0,1.0,1/5,3.39%,RABGGTB
prerank,GO_Biological_Process_2021__protein phosphorylation (GO:0006468),-0.35365644896052406,-1.086478939237557,0.16666666666666666,0.9836872712685999,1.0,37/424,9.76%,STK32B;NRK;KIT;ALK;CAMK1G;KDR;TRIB2;FGFR4;EPHA3;PRAG1;LMTK3;EPHB2;MYO3A;NEK6;PRKG2;SGK1;NRBP2;MAML1;GRK5;MAP3K20;MARK1;TGFB2;PRKCD;CDC42BPB;AURKA;PLK2;PEAK3;CSK;TYRO3;LIMK1;INCENP;CCNH;BAZ1B;CDK14;CSF1R;PDGFRA;CDKL1
prerank,GO_Biological_Process_2021__skeletal muscle contraction (GO:0003009),-0.6243044500901954,-1.0860715124856035,0.3939393939393939,0.9839351152983153,1.0,5/13,11.80%,STAC;MYH14;MYH3;TNNC2;CCDC78
prerank,GO_Biological_Process_2021__regulation of calcium ion transmembrane transporter activity (GO:1901019),0.5429822756049871,1.0858809283066593,0.3620689655172414,1.0,1.0,4/24,17.19%,CAV3;FKBP1B;CAMK2D;PLN
prerank,GO_Biological_Process_2021__positive regulation of histone methylation (GO:0031062),-0.5783478519679891,-1.0856706350630994,0.375,0.9843406706519672,1.0,5/23,12.13%,MYB;CHTOP;TET1;DNMT1;PHF1
prerank,GO_Biological_Process_2021__I-kappaB phosphorylation (GO:0007252),0.7570605747039918,1.085542411148947,0.4126984126984127,1.0,1.0,3/6,19.74%,PRDX4;DAB2IP;TLR2
prerank,GO_Biological_Process_2021__protein poly-ADP-ribosylation (GO:0070212),-0.6224873612147567,-1.0852648977475055,0.43333333333333335,0.9848316114652909,1.0,3/9,14.13%,PARP2;PARP10;ZC3HAV1
prerank,GO_Biological_Process_2021__negative regulation of IRE1-mediated unfolded protein response (GO:1903895),0.7315563070018889,1.085099459049211,0.4642857142857143,1.0,1.0,1/5,7.54%,HSPA5
prerank,GO_Biological_Process_2021__negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090101),-0.40911306122362057,-1.084989146111956,0.22580645161290322,0.9846756187435148,1.0,12/89,10.04%,SPRED2;SPRED3;SPRED1;GREM1;LEMD2;PMEPA1;CIDEA;CILP;CRIM1;ZBTB7A;VWC2;SORL1
prerank,GO_Biological_Process_2021__regulation of MAPK cascade (GO:0043408),-0.3960303902044948,-1.0847640066865347,0.2,0.984161456429762,1.0,10/136,4.53%,NRK;KIT;ROR2;KDR;SPRED1;GREM1;APIP;IGF1;PRDM15;RASGRP1
prerank,GO_Biological_Process_2021__protein deglutamylation (GO:0035608),-0.6268272787127376,-1.0847253022384902,0.3488372093023256,0.9833045414107711,1.0,1/7,3.77%,AGBL1
prerank,GO_Biological_Process_2021__DNA replication-independent nucleosome organization (GO:0034724),0.6906856242802866,1.0845519971814934,0.4603174603174603,1.0,1.0,1/10,3.54%,H3-3A
prerank,GO_Biological_Process_2021__regulation of respiratory system process (GO:0044065),0.6745677847034692,1.0844507787865199,0.3709677419354839,1.0,1.0,1/6,7.50%,TSHZ3
prerank,GO_Biological_Process_2021__embryonic hemopoiesis (GO:0035162),-0.6711229692478285,-1.0839790307555282,0.3548387096774194,0.9845673000776965,1.0,3/10,3.27%,KIT;KDR;KITLG
prerank,GO_Biological_Process_2021__ribonucleoprotein complex disassembly (GO:0032988),-0.6729969030168147,-1.083886936602287,0.4318181818181818,0.9838546701136065,1.0,2/7,18.17%,DHX8;VCP
prerank,GO_Biological_Process_2021__aromatic amino acid family catabolic process (GO:0009074),0.579398629660268,1.0838318552284751,0.3709677419354839,1.0,1.0,4/14,12.71%,IDO1;FAH;ACMSD;IL4I1
prerank,GO_Biological_Process_2021__negative regulation of T cell mediated immunity (GO:0002710),0.6769718726588225,1.083543052765176,0.43859649122807015,1.0,1.0,4/7,12.71%,PTPRC;AHR;SMAD7;IL4I1
prerank,GO_Biological_Process_2021__cellular iron ion homeostasis (GO:0006879),0.5041793485055381,1.0832334970594084,0.4696969696969697,1.0,1.0,17/42,30.50%,CP;FRRS1;ATP6AP1;ABCG2;SLC40A1;HJV;NUBP1;TF;HEPH;TFR2;SLC11A1;SLC11A2;CUL1;CAND1;ATP6V1G1;SMAD4;ATP6V1A
prerank,PanglaoDB_Augmented_2021__Plasmacytoid Dendritic Cells,0.47266278658286215,1.083172044086713,0.32,1.0,1.0,16/72,9.88%,CD4;BLNK;CLEC4C;HCK;CD300LF;CD8A;DOCK8;PTPRC;PIK3R5;SERPINF1;GMFG;CARD6;TAGAP;ARHGAP9;WAS;ARHGAP25
prerank,GO_Biological_Process_2021__cellular response to chemical stress (GO:0062197),-0.4029253472999845,-1.083129587647136,0.4090909090909091,0.98502862443131,1.0,3/81,2.01%,ETV5;NOX4;PRR5L
prerank,GO_Biological_Process_2021__collecting duct development (GO:0072044),-0.6892855809029541,-1.0830827589289678,0.43902439024390244,0.9841315002713792,1.0,1/5,6.06%,PTCH1
prerank,GO_Biological_Process_2021__blood circulation (GO:0008015),0.5090756857983704,1.083003347369658,0.352112676056338,1.0,1.0,5/36,9.09%,C3AR1;ACTC1;MYOF;AVPR1A;STAT1
prerank,GO_Biological_Process_2021__regulation of macrophage proliferation (GO:0120040),-0.7665391869326761,-1.082635157327301,0.45454545454545453,0.9836525932244381,1.0,2/5,22.28%,CSF1R;IL34
prerank,GO_Biological_Process_2021__positive regulation of macrophage proliferation (GO:0120041),-0.7665391869326761,-1.082635157327301,0.45454545454545453,0.9836525932244381,1.0,2/5,22.28%,CSF1R;IL34
prerank,GO_Biological_Process_2021__cristae formation (GO:0042407),-0.5068960121668373,-1.0826022152247528,0.3611111111111111,0.9827880208498102,1.0,1/25,1.44%,CHCHD6
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin gene segments (GO:0016447),-0.6543758588842061,-1.0823601529707956,0.40540540540540543,0.9824793574952886,1.0,1/7,3.73%,XRCC4
prerank,GO_Biological_Process_2021__glycolipid metabolic process (GO:0006664),0.5100163668168396,1.0823063620836628,0.3870967741935484,1.0,1.0,9/44,17.52%,FUT2;GM2A;GBA3;ST8SIA6;B3GNT5;PGAP3;B3GALNT1;NEU1;PSAP
prerank,GO_Biological_Process_2021__cerebral cortex cell migration (GO:0021795),-0.6283977372423126,-1.0815643003181656,0.42105263157894735,0.9838747246136971,1.0,2/6,16.42%,FGF13;RELN
prerank,GO_Biological_Process_2021__apoptotic process (GO:0006915),0.42206434719394437,1.081361587905257,0.3411764705882353,1.0,1.0,33/184,20.00%,CASP12;NOX5;MCM2;BIK;BOK;AHR;CD14;FADD;BNIP3;SIAH1;TBX1;RNF152;DAPK2;CASP8;RHOB;FAS;BCL2L14;IRF1;KREMEN1;TSC2;GLRX2;RFK;TCHP;PAWR;IFI27;PDCD4;DHCR24;FXR1;TNFAIP1;NSG1;BCL2L1;TLR2;PLSCR1
prerank,GO_Biological_Process_2021__central nervous system neuron axonogenesis (GO:0021955),-0.563325618151162,-1.0810562451864083,0.358974358974359,0.9844589789782128,1.0,1/12,2.36%,EPHB2
prerank,GO_Biological_Process_2021__steroid hormone mediated signaling pathway (GO:0043401),-0.6016547293464496,-1.080709140955623,0.39473684210526316,0.9844753973430307,1.0,1/12,0.88%,BMP7
prerank,GO_Biological_Process_2021__genetic imprinting (GO:0071514),-0.6293460121954888,-1.0804736437639353,0.45454545454545453,0.984166279447269,1.0,3/6,24.05%,DIRAS3;CTCF;DNMT3A
prerank,GO_Biological_Process_2021__positive regulation of TOR signaling (GO:0032008),-0.465182917788562,-1.0804276708144054,0.37037037037037035,0.9833488092505224,1.0,7/37,19.22%,WDR24;TELO2;RPTOR;LEP;PIP4P1;LAMTOR4;RHEB
prerank,GO_Biological_Process_2021__regulation of interleukin-6 production (GO:0032675),-0.4362606530287001,-1.0803073510741077,0.2,0.9826177210047169,1.0,8/62,9.37%,RAB7B;F2RL1;IFIH1;EREG;SPHK2;TLR1;STAT3;POU2F2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex assembly (GO:0031334),-0.42397642254872353,-1.0797898702989384,0.25806451612903225,0.9832426388878603,1.0,15/93,13.97%,NRG1;BCL2L11;TPPP3;UNC13B;ERCC2;TRABD2A;GTF2H2;ERCC1;FERMT1;EIF4G1;CLU;SPIDR;CUL4A;FAF1;SH3GLB1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, NADH to ubiquinone (GO:0006120)",0.5427057629867398,1.079697133820484,0.4090909090909091,1.0,1.0,8/30,28.93%,NDUFA2;NDUFB3;NDUFB4;NDUFB9;NDUFB2;NDUFB11;NDUFV1;NDUFB6
prerank,GO_Biological_Process_2021__positive regulation of protein transport (GO:0051222),-0.4271449318907061,-1.0795689296280433,0.3333333333333333,0.9830487558843307,1.0,11/55,10.46%,PRR5L;UNC13B;IGF1;TPR;TGFB2;BMP6;PCNT;TGFB3;PCM1;B3GAT3;CHP1
prerank,GO_Biological_Process_2021__antibacterial humoral response (GO:0019731),0.64457578313264,1.0793951373011794,0.3787878787878788,1.0,1.0,4/10,27.51%,HLA-A;SFTPD;TF;WFDC2
prerank,PanglaoDB_Augmented_2021__Fibroblasts,-0.37946652717249163,-1.0792186738672547,0.17391304347826086,0.9831228111562438,1.0,23/163,6.22%,NOX4;TAGLN;COL15A1;ABI3BP;RUNX1;GREM1;LAMA4;PENK;ADAMTS2;IL1R1;SVEP1;COL6A2;SGCD;NFATC1;PCDH18;FNDC1;IGF1;TNXB;PRRX1;COL4A3;ADAMTS5;PTCH1;PRKCD
prerank,GO_Biological_Process_2021__protein localization to site of double-strand break (GO:1990166),-0.7049737850901734,-1.0791725628205464,0.5,0.9823245291102448,1.0,1/5,3.73%,XRCC4
prerank,GO_Biological_Process_2021__atrioventricular valve development (GO:0003171),0.6474290293142947,1.0791374484711789,0.42105263157894735,1.0,1.0,2/10,6.18%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__nucleoside phosphate catabolic process (GO:1901292),-0.5174232756236363,-1.0789389487471128,0.4444444444444444,0.9820618736440203,1.0,2/13,8.37%,ITPA;ENPP3
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transport (GO:0010765),-0.637402854370443,-1.078859715788325,0.38235294117647056,0.9813223967102735,1.0,1/10,0.68%,PKP2
prerank,GO_Biological_Process_2021__purine ribonucleoside bisphosphate biosynthetic process (GO:0034036),-0.7228136665391981,-1.078814504132487,0.4358974358974359,0.9794415157415367,1.0,1/5,0.67%,PAPSS2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate biosynthetic process (GO:0050428),-0.7228136665391981,-1.078814504132487,0.4358974358974359,0.9794415157415367,1.0,1/5,0.67%,PAPSS2
prerank,GO_Biological_Process_2021__T cell mediated cytotoxicity (GO:0001913),0.7063242483228885,1.0786574622884852,0.46153846153846156,1.0,1.0,3/5,29.23%,HLA-A;EMP2;CTSH
prerank,GO_Biological_Process_2021__neural tube development (GO:0021915),-0.5612670575497738,-1.0784933113937076,0.3548387096774194,0.9795747028303396,1.0,3/15,6.06%,ARL13B;ALDH1A2;PTCH1
prerank,GO_Biological_Process_2021__regulation of cell population proliferation (GO:0042127),-0.3507155781705749,-1.0783461648944919,0.125,0.9789524984568537,1.0,68/559,9.97%,NOX4;KIT;ALK;ROR2;NRG1;KDR;TBX6;SINHCAF;MELTF;FGFR4;LEF1;HMGN5;BTC;CDH13;RUNX1;GREM1;RNF126;INHA;PDGFD;TNFRSF11A;EREG;ZBTB7C;KITLG;SMYD2;ADAMTS8;SST;IGF1;SGK1;ECRG4;SFRP1;DBF4B;GRK5;WWTR1;CDCA7;BCL6;COL4A3;SLC25A33;CHTOP;TGFB2;FGF1;HDAC1;CHRNA10;ALDH1A2;TFAP4;P3H3;TIMELESS;PDPN;BCL2;SHANK2;IL11;ACE2;ETS1;PTHLH;BMP6;ID2;GCNT2;STAT3;COL18A1;CSF1R;JAG2;BTG1;PDGFRA;DLG5;XRCC6;AKR1C3;TGFB3;VIP;PDGFC
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c (GO:0008635),0.68237990909249,1.07809197240644,0.4339622641509434,1.0,1.0,2/5,18.54%,BOK;CYCS
prerank,GO_Biological_Process_2021__positive regulation of branching involved in ureteric bud morphogenesis (GO:0090190),0.6553982041041835,1.0777714468707098,0.34545454545454546,1.0,1.0,2/8,13.02%,AGT;SIX4
prerank,GO_Biological_Process_2021__regulation of branching involved in ureteric bud morphogenesis (GO:0090189),0.6553982041041835,1.0777714468707098,0.34545454545454546,1.0,1.0,2/8,13.02%,AGT;SIX4
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-lysine acetylation (GO:2000758),0.557153206500376,1.077650500938955,0.3283582089552239,1.0,1.0,3/18,14.47%,PPARGC1A;RPS6KA4;BRCA1
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA destabilization (GO:0061158),-0.5599253059759239,-1.0764129799415063,0.36585365853658536,0.9833188095285174,1.0,2/14,12.83%,KHSRP;TRIM71
prerank,GO_Biological_Process_2021__positive regulation of amyloid precursor protein catabolic process (GO:1902993),0.5885959432690092,1.0761021264515567,0.4,1.0,1.0,1/19,1.74%,AGER
prerank,GO_Biological_Process_2021__positive regulation of heart contraction (GO:0045823),-0.5692881091661304,-1.0760984449619673,0.4473684210526316,0.9832523760590105,1.0,3/12,11.42%,APLN;TGFB2;RGS2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation in thymus (GO:0033081),-0.6319152761759506,-1.075655840334648,0.4,0.9837995370593415,1.0,1/9,6.35%,TOX
prerank,GO_Biological_Process_2021__G protein-coupled glutamate receptor signaling pathway (GO:0007216),-0.555010210407616,-1.0754711916523585,0.37037037037037035,0.9833288314692367,1.0,1/14,1.01%,HOMER2
prerank,GO_Biological_Process_2021__glycolipid biosynthetic process (GO:0009247),0.5292272658206412,1.075421008048033,0.3684210526315789,1.0,1.0,11/34,23.19%,PIGC;ST8SIA6;PGAP4;PIGV;B3GNT5;PIGH;PGAP3;MPPE1;ST6GALNAC5;PIGN;B4GALT6
prerank,MSigDB_Hallmark_2020__Angiogenesis,0.5585024320008244,1.0753795733012084,0.38571428571428573,1.0,1.0,7/24,21.91%,MSX1;POSTN;CCND2;LRPAP1;SPP1;PGLYRP1;COL5A2
prerank,GO_Biological_Process_2021__regulation of mitotic centrosome separation (GO:0046602),-0.6351766965638364,-1.075362186055645,0.35714285714285715,0.982678162611723,1.0,3/8,13.83%,NSFL1C;KIF25;CEP85
prerank,GO_Biological_Process_2021__nucleoside triphosphate catabolic process (GO:0009143),-0.6206745832460993,-1.0752765452432038,0.4418604651162791,0.9819592716623392,1.0,2/5,8.37%,ITPA;ENPP3
prerank,GO_Biological_Process_2021__negative regulation of cytosolic calcium ion concentration (GO:0051481),0.7160957230374614,1.0750777285705972,0.4426229508196721,1.0,1.0,1/6,13.12%,DRD3
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled proton transport (GO:0042776),0.5955268322637897,1.0749623540447553,0.38333333333333336,1.0,1.0,6/14,31.80%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5ME;ATP5PD;ATP5PB
prerank,GO_Biological_Process_2021__DNA replication initiation (GO:0006270),0.5236773063883492,1.0744444959165815,0.41333333333333333,1.0,1.0,4/31,3.83%,MCM2;POLE2;GMNN;POLE3
prerank,PanglaoDB_Augmented_2021__Merkel Cells,0.5356503472891007,1.074220149118108,0.3382352941176471,1.0,1.0,8/35,16.60%,HNF4G;HSD11B2;BCO1;GPX2;B3GNT3;CD99;PIEZO2;EPCAM
prerank,GO_Biological_Process_2021__Rho protein signal transduction (GO:0007266),0.5040919862513724,1.0740809655969528,0.39473684210526316,1.0,1.0,8/44,12.90%,ROPN1B;PLEKHG7;RIPOR1;WAS;RHOB;EPS8;CELSR1;RHOU
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor signaling pathway (GO:0034123),-0.5400278554844827,-1.0740006907570565,0.3333333333333333,0.9843664615317794,1.0,2/18,6.54%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__intermediate filament bundle assembly (GO:0045110),-0.7143609220022564,-1.0739806614832736,0.3829787234042553,0.9834114706324116,1.0,1/5,0.68%,PKP2
prerank,GO_Biological_Process_2021__negative regulation by symbiont of host apoptotic process (GO:0033668),0.6933494256807189,1.0738503363612286,0.35294117647058826,1.0,1.0,2/7,29.58%,BCL2L1;RNF213
prerank,GO_Biological_Process_2021__heterotypic cell-cell adhesion (GO:0034113),-0.5435930548789227,-1.0738424508317093,0.325,0.9828880204634282,1.0,2/22,1.19%,PKP2;ITGA4
prerank,GO_Biological_Process_2021__activation of Janus kinase activity (GO:0042976),0.7531591994177207,1.0737841100829009,0.4090909090909091,1.0,1.0,1/5,4.14%,PRLR
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway (GO:2001243),0.5005118401295443,1.0737693766505418,0.352112676056338,1.0,1.0,17/55,23.69%,ACKR3;TRIM32;SYVN1;CDKN2D;YBX3;SOD2;HERPUD1;BCL2L2;PLAUR;DNAJA1;PINK1;RTKN2;BCL2L1;LRRK2;SNAI2;ARMC10;CREB3
prerank,GO_Biological_Process_2021__photoreceptor cell outer segment organization (GO:0035845),0.7317601903804233,1.0732475161601067,0.46774193548387094,1.0,1.0,1/5,2.48%,RP1
prerank,GO_Biological_Process_2021__protein K63-linked ubiquitination (GO:0070534),0.5218132963209311,1.0731991690778557,0.323943661971831,1.0,1.0,5/39,9.45%,TRIM5;ARIH2;TRAF3IP2;PELI3;RNF152
prerank,GO_Biological_Process_2021__positive regulation of sequestering of triglyceride (GO:0010890),-0.6442732923223934,-1.0730796308378936,0.4318181818181818,0.9838056316980405,1.0,3/7,16.69%,PLIN5;CIDEA;OSBPL11
prerank,GO_Biological_Process_2021__plasma membrane invagination (GO:0099024),0.5730137858640755,1.0730244099371422,0.3333333333333333,1.0,1.0,2/21,9.88%,DOCK1;ARHGAP25
prerank,GO_Biological_Process_2021__cAMP metabolic process (GO:0046058),-0.5705452479721697,-1.0728688378888023,0.4444444444444444,0.9833796522785093,1.0,7/11,27.71%,PTHLH;PDE4D;ADCY7;ADCY2;ADCY5;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__antifungal innate immune response (GO:0061760),0.7064512620367055,1.07269620992476,0.4057971014492754,1.0,1.0,3/5,21.40%,RARRES2;PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of activated T cell proliferation (GO:0042104),0.6229972573191153,1.0726348654447722,0.4603174603174603,1.0,1.0,3/12,9.20%,AGER;FADD;HHLA2
prerank,GO_Biological_Process_2021__regulation of protein autophosphorylation (GO:0031952),-0.45898080566824084,-1.0724527436666775,0.34285714285714286,0.9836731128228022,1.0,4/34,10.46%,RASSF2;PDGFD;PDGFC;CHP1
prerank,GO_Biological_Process_2021__calcium-mediated signaling using intracellular calcium source (GO:0035584),-0.5426008053628528,-1.0722571335111126,0.36363636363636365,0.9834137670673313,1.0,4/17,7.76%,SELP;KDR;AZU1;ADGRL1
prerank,GO_Biological_Process_2021__acute-phase response (GO:0006953),0.7266257761112064,1.0722019956331106,0.4067796610169492,1.0,1.0,3/7,22.83%,PLSCR1;ITIH4;LBP
prerank,GO_Biological_Process_2021__glycoprotein biosynthetic process (GO:0009101),-0.41307491337621494,-1.0721562855190332,0.23333333333333334,0.9828101218961605,1.0,7/68,5.93%,B3GALT9;CHST8;ST6GALNAC2;ST3GAL3;ST8SIA2;IGF1;GAL3ST4
prerank,GO_Biological_Process_2021__negative regulation of nucleic acid-templated transcription (GO:1903507),-0.3705490015616874,-1.0721200773597945,0.3076923076923077,0.9819458597578649,1.0,39/367,9.95%,CD38;PER2;NRG1;MYB;BMP7;SOX13;LEF1;ARID5A;ATOH8;TLE2;KDM8;ASCL1;EREG;PRDM5;ZNF256;HDAC5;SFRP1;ID4;RING1;BCL6;HDAC1;TFAP4;TIMELESS;SAMD7;SBNO2;FOXP1;PHC2;SFMBT1;ID2;SAMD13;LBH;FOXK1;ZHX3;ZBTB7A;HMGA2;SUV39H2;SMARCA4;XRCC6;IFI16
prerank,GO_Biological_Process_2021__actin filament polymerization (GO:0030041),0.5380734834709027,1.0714293224652425,0.4,1.0,1.0,3/25,9.87%,PREX1;WASF1;WAS
prerank,GO_Biological_Process_2021__mesodermal cell differentiation (GO:0048333),-0.656327206073795,-1.070753840110014,0.45454545454545453,0.9853367755751566,1.0,2/7,11.17%,HMGA2;ITGA8
prerank,GO_Biological_Process_2021__cellular response to interleukin-6 (GO:0071354),-0.4555372958078222,-1.0707326689226102,0.2972972972972973,0.9844304790439584,1.0,4/23,8.50%,PTPRT;PID1;SBNO2;STAT3
prerank,GO_Biological_Process_2021__regulation of microtubule nucleation (GO:0010968),-0.631955452451555,-1.0705108187244579,0.4722222222222222,0.9840892279433712,1.0,3/9,23.62%,RANGRF;HSPA1A;CKAP5
prerank,GO_Biological_Process_2021__regulation of cellular carbohydrate metabolic process (GO:0010675),-0.5513083887972743,-1.0702818690400346,0.2571428571428571,0.9836800157554715,1.0,3/14,8.93%,MLYCD;FOXK1;RORA
prerank,GO_Biological_Process_2021__regulation of osteoclast development (GO:2001204),0.7235768122197295,1.070203045520978,0.41818181818181815,1.0,1.0,3/5,22.85%,ATP6AP1;SIGLEC15;NOTCH2
prerank,GO_Biological_Process_2021__tRNA aminoacylation (GO:0043039),-0.4935096913600467,-1.0695594305328293,0.3870967741935484,0.9849992837270384,1.0,13/35,22.17%,IARS1;VARS1;RARS1;SARS1;WARS2;FARS2;FARSB;QRSL1;RARS2;MARS1;LARS2;YARS2;HARS2
prerank,GO_Biological_Process_2021__regulation of epithelial cell migration (GO:0010632),0.4997403403119395,1.0695461793849899,0.35294117647058826,1.0,1.0,5/46,11.48%,ENPP2;RREB1;MARVELD3;DOCK1;PLCG2
prerank,GO_Biological_Process_2021__toxin transport (GO:1901998),-0.6401300575235951,-1.0693551379630961,0.45161290322580644,0.9845625855848563,1.0,4/9,12.86%,SLC22A2;SLC29A4;SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__glutamine family amino acid biosynthetic process (GO:0009084),0.6661923403537285,1.0692062145619632,0.4444444444444444,1.0,1.0,1/7,10.27%,LGSN
prerank,GO_Biological_Process_2021__GDP-mannose metabolic process (GO:0019673),-0.6831560608839171,-1.0689292733389895,0.44,0.9846741415273874,1.0,6/6,31.71%,GMDS;PMM1;GFUS;PMM2;GMPPB;MPI
prerank,GO_Biological_Process_2021__glycosaminoglycan metabolic process (GO:0030203),-0.4386158899221112,-1.0686544086492349,0.3235294117647059,0.9846214185124249,1.0,17/46,14.35%,GPC4;HS3ST3A1;SDC4;CLN6;B3GAT2;HS3ST3B1;HS3ST2;HS3ST5;GCNT2;GUSB;EXT1;B3GAT3;EXT2;GPC2;CHST9;XYLT2;SGSH
prerank,GO_Biological_Process_2021__regulation of mitotic sister chromatid segregation (GO:0033047),-0.6149537821706488,-1.0685976974051845,0.4146341463414634,0.9829197658305169,1.0,3/6,24.09%,CDK5RAP2;LCMT1;CCNB1
prerank,GO_Biological_Process_2021__regulation of mitotic spindle checkpoint (GO:1903504),-0.6149537821706488,-1.0685976974051845,0.4146341463414634,0.9829197658305169,1.0,3/6,24.09%,CDK5RAP2;LCMT1;CCNB1
prerank,GO_Biological_Process_2021__regulation of leukocyte mediated cytotoxicity (GO:0001910),0.6802179883057963,1.0685612152462052,0.3870967741935484,1.0,1.0,1/6,1.74%,AGER
prerank,GO_Biological_Process_2021__cellular response to BMP stimulus (GO:0071773),-0.4618452189997383,-1.0685117049011044,0.25,0.9822009140571432,1.0,9/50,10.25%,BMP7;SFRP1;HIVEP1;TGFB2;RGMB;AMH;BMP6;TGFB3;DLX5
prerank,GO_Biological_Process_2021__regulation of microtubule motor activity (GO:2000574),-0.6750345896114962,-1.0684250015324313,0.42857142857142855,0.9815106894519776,1.0,1/5,12.88%,CFAP100
prerank,GO_Biological_Process_2021__regulation of bone mineralization (GO:0030500),-0.4648514706984417,-1.0684175254495316,0.2857142857142857,0.980576891207115,1.0,7/41,9.80%,BMP7;GREM1;SRGN;BMP6;SGMS2;ANO6;TGFB3
prerank,GO_Biological_Process_2021__striated muscle tissue development (GO:0014706),-0.5261552713976263,-1.0682125851878002,0.3870967741935484,0.9801342338266331,1.0,6/20,7.20%,BMP7;MYH14;RBP4;SGCD;CFLAR;SVIL
prerank,GO_Biological_Process_2021__amino acid import (GO:0043090),-0.5516576079664597,-1.0679495421045102,0.4,0.9800726603887719,1.0,4/19,7.99%,SLC16A2;SLC22A2;SLC6A1;SLC7A1
prerank,GO_Biological_Process_2021__myoblast fusion (GO:0007520),-0.5728032422553,-1.0678348416351875,0.45,0.9795228075158793,1.0,3/13,5.85%,ADAM12;ADAMTS15;ADAMTS5
prerank,GO_Biological_Process_2021__positive regulation of NIK/NF-kappaB signaling (GO:1901224),0.5159525765950166,1.0678257998329306,0.36231884057971014,1.0,1.0,11/36,23.03%,LRRC19;AGER;CD14;CD27;PDCD4;RTKN2;TLR2;SPHK1;TERF2IP;C1QTNF4;IFI35
prerank,GO_Biological_Process_2021__regulation of macroautophagy (GO:0016241),-0.3783242821648629,-1.0677583148694851,0.2,0.9787707085748445,1.0,7/103,6.73%,ATP6V0D2;KDR;STING1;NRBP2;EPM2A;EXOC7;MTMR8
prerank,GO_Biological_Process_2021__regulation of amyloid-beta formation (GO:1902003),-0.4842432999846266,-1.0674301294643034,0.3793103448275862,0.97890019004035,1.0,6/31,13.41%,IGF1;SORL1;APOE;LRRTM3;CLU;BIN1
prerank,GO_Biological_Process_2021__inner ear receptor cell development (GO:0060119),0.6348287256220597,1.0673112921700145,0.4444444444444444,1.0,1.0,3/7,32.19%,ADGRV1;LRTOMT;SLC4A7
prerank,GO_Biological_Process_2021__vesicle localization (GO:0051648),0.6826271853453967,1.0671350575427614,0.390625,1.0,1.0,1/5,15.80%,RAB11A
prerank,GO_Biological_Process_2021__positive regulation of homotypic cell-cell adhesion (GO:0034112),0.653403281740016,1.0671085819753567,0.4098360655737705,1.0,1.0,3/7,13.26%,CCL5;F11R;PLAUR
prerank,GO_Biological_Process_2021__regulation of anoikis (GO:2000209),0.5762562278380192,1.0665480247599908,0.4084507042253521,1.0,1.0,5/17,21.69%,NOTCH1;ITGA5;ZNF304;PDK4;SNAI2
prerank,GO_Biological_Process_2021__positive regulation of nitrogen compound metabolic process (GO:0051173),0.5848194848821325,1.0665217607087576,0.4057971014492754,1.0,1.0,1/15,1.71%,WFS1
prerank,GO_Biological_Process_2021__cellular response to lipopolysaccharide (GO:0071222),0.47993077723258465,1.066305895863636,0.36231884057971014,1.0,1.0,23/63,29.32%,CCL5;HCK;CD14;PDCD1LG2;STAP1;CD6;TGFB1;DAB2IP;PDCD4;CXCL13;CD274;PLAA;CX3CR1;LBP;IL18;CD80;GSTP1;LYN;SERPINE1;ADAM9;TNIP2;ZFP36;NFKBIL1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-12 production (GO:0032735),0.5986130053561679,1.0652538197749624,0.42424242424242425,1.0,1.0,4/18,13.11%,AGER;PLCG2;SCIMP;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of cytokine-mediated signaling pathway (GO:0001961),0.5279449521053878,1.0652242900236406,0.4098360655737705,1.0,1.0,3/26,8.82%,CD300LF;FADD;IL7
prerank,GO_Biological_Process_2021__positive regulation of spindle checkpoint (GO:0090232),-0.6432835202837484,-1.0651581466337514,0.45454545454545453,0.9838479676490923,1.0,2/6,13.09%,TPR;XRCC3
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle spindle assembly checkpoint (GO:0090267),-0.6432835202837484,-1.0651581466337514,0.45454545454545453,0.9838479676490923,1.0,2/6,13.09%,TPR;XRCC3
prerank,GO_Biological_Process_2021__chaperone-mediated protein complex assembly (GO:0051131),0.5722159710137189,1.0650784767354993,0.4262295081967213,1.0,1.0,1/19,1.85%,TMEM35A
prerank,PanglaoDB_Augmented_2021__Cardiomyocytes,0.44778793076225376,1.0646956824039815,0.3888888888888889,1.0,1.0,14/99,11.99%,LAMA2;CSRP3;PDE1A;CAV3;TRIM54;NOTCH1;FABP3;MYOM1;ACTC1;ADIPOR2;PRKG1;CASQ1;MYBPC3;CKB
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C activity (GO:1900020),-0.7140454794597093,-1.0646446597589478,0.5,0.9834892298913819,1.0,2/5,12.89%,TCIM;EGFR
prerank,GO_Biological_Process_2021__regulation of protein kinase C activity (GO:1900019),-0.7140454794597093,-1.0646446597589478,0.5,0.9834892298913819,1.0,2/5,12.89%,TCIM;EGFR
prerank,GO_Biological_Process_2021__positive regulation of stress-activated MAPK cascade (GO:0032874),-0.4347784794083912,-1.0645378382467532,0.3181818181818182,0.9828319838429765,1.0,10/77,7.17%,TPD52L1;F2RL1;RASSF2;TNFRSF19;SH3RF1;RASGRP1;TRAF3;TGFB2;SERPINF2;SH3RF3
prerank,GO_Biological_Process_2021__negative regulation of trophoblast cell migration (GO:1901164),0.7255654350917341,1.0644333656739207,0.43859649122807015,1.0,1.0,4/5,26.75%,NODAL;CALR;ACVR1C;GJA1
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation (GO:0006635),-0.4211170716926823,-1.064082313294239,0.3333333333333333,0.9831991774153354,1.0,11/49,14.86%,DECR2;EHHADH;CROT;ACOT8;MECR;ABCD1;ACADVL;HADHA;SLC27A2;SLC25A17;ACOX3
prerank,GO_Biological_Process_2021__organic cation transport (GO:0015695),-0.5946344096549124,-1.0639138177342193,0.37142857142857144,0.9826107129351018,1.0,6/16,12.86%,SLC22A2;SLC25A29;SLC29A4;SLC22A3;SLC25A26;SLC22A1
prerank,GO_Biological_Process_2021__negative regulation of G1/S transition of mitotic cell cycle (GO:2000134),-0.48361949159357154,-1.0634592641250968,0.375,0.9829102309544502,1.0,2/30,1.56%,CDK2AP2;GFI1B
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class I (GO:0002474),0.5376179581475075,1.063373991720241,0.4225352112676056,1.0,1.0,8/27,22.38%,ERAP2;BCAP31;HLA-A;TAPBPL;B2M;ERAP1;CALR;SEC23A
prerank,GO_Biological_Process_2021__negative regulation of muscle cell differentiation (GO:0051148),-0.7228972658829059,-1.0633320220765894,0.5142857142857142,0.9822828890952631,1.0,3/5,15.37%,EREG;ID2;PTBP1
prerank,GO_Biological_Process_2021__regulation of interferon-beta production (GO:0032648),-0.5180556605070752,-1.0631292088063962,0.3793103448275862,0.9819786220888831,1.0,10/38,14.95%,STING1;IFIH1;POLR3D;TRAF3;RNF216;PTPRS;YY1;CACTIN;REL;MAVS
prerank,GO_Biological_Process_2021__rDNA heterochromatin assembly (GO:0000183),0.67875887676304,1.0631124965491041,0.43859649122807015,1.0,1.0,2/8,7.97%,H3-3A;SUV39H1
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated calcium channel activity (GO:1901386),-0.5785756699469745,-1.0628432358436828,0.3902439024390244,0.9818223221162766,1.0,3/9,12.09%,CBARP;DRD4;GPR35
prerank,GO_Biological_Process_2021__regulation of anion channel activity (GO:0010359),0.7136585357666538,1.0627034148066334,0.4426229508196721,1.0,1.0,2/6,8.34%,TCAF2;ABCB1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G1/S phase transition (GO:1902807),-0.5094394209927615,-1.062594739703903,0.41935483870967744,0.9818938850421577,1.0,2/27,1.56%,CDK2AP2;GFI1B
prerank,GO_Biological_Process_2021__response to UV-C (GO:0010225),-0.6281907743188081,-1.062467134578981,0.4473684210526316,0.9812030205781108,1.0,3/6,28.56%,YY1;WRN;POLH
prerank,GO_Biological_Process_2021__ventricular septum development (GO:0003281),0.5119898170089929,1.0623096737211064,0.34285714285714286,1.0,1.0,4/26,11.46%,NOTCH1;ZFPM1;SOX11;SMAD7
prerank,GO_Biological_Process_2021__regulation of interleukin-4 production (GO:0032673),-0.5581570826386637,-1.062274788324414,0.42424242424242425,0.9808341264605188,1.0,1/14,1.33%,LEF1
prerank,"GO_Biological_Process_2021__positive regulation of DNA damage response, signal transduction by p53 class mediator (GO:0043517)",-0.6587711246637942,-1.0621112633733851,0.47058823529411764,0.9803591453410719,1.0,3/11,0.88%,SPRED2;SPRED3;SPRED1
prerank,GO_Biological_Process_2021__negative regulation of amyloid-beta formation (GO:1902430),-0.5359263860309231,-1.0620499924747249,0.3783783783783784,0.9795916802019519,1.0,5/17,13.41%,IGF1;SORL1;APOE;CLU;BIN1
prerank,GO_Biological_Process_2021__chromosome organization (GO:0051276),-0.42452729919243704,-1.0619594470571103,0.2857142857142857,0.9789722185749252,1.0,26/86,21.41%,GEM;HDAC5;HDAC1;ZBTB7A;HMGA2;RFWD3;SMARCA4;HMGB2;PHF1;CUL4A;COPS6;LRWD1;MTHFR;HDAC10;LATS1;DDB2;PWWP3A;HMGN1;EHMT1;LDB1;XPC;HMGN2;MSH3;HDAC11;SAFB;RAE1
prerank,GO_Biological_Process_2021__positive regulation of pattern recognition receptor signaling pathway (GO:0062208),-0.5637716631756693,-1.061384523457312,0.3902439024390244,0.979951174186959,1.0,2/10,5.37%,ZDHHC5;DDX60
prerank,GO_Biological_Process_2021__dendritic spine organization (GO:0097061),-0.5108041393846046,-1.0611581724070775,0.27586206896551724,0.9797846686859643,1.0,3/24,7.61%,EPHB2;DOCK10;SHANK1
prerank,GO_Biological_Process_2021__calcium ion import (GO:0070509),-0.5124947012077024,-1.061128150786565,0.35,0.9790206383604271,1.0,8/23,18.16%,MCUB;CACNA1I;CACNA1A;MICU1;MICU2;MCUR1;CACNA1B;MCU
prerank,GO_Biological_Process_2021__glial cell development (GO:0021782),0.5336723503010146,1.0610922668964633,0.4126984126984127,1.0,1.0,6/23,21.66%,SOX10;SOX11;EIF2B5;CDK6;TLR2;ZNF488
prerank,GO_Biological_Process_2021__negative regulation of glial cell differentiation (GO:0045686),0.7110993575633568,1.0608810483020032,0.5,1.0,1.0,3/6,14.63%,NOTCH1;DRD3;DAAM2
prerank,GO_Biological_Process_2021__vasculature development (GO:0001944),0.6488604469106587,1.0608379613082324,0.43283582089552236,1.0,1.0,3/9,17.83%,PDGFRB;ACVR2B;NOTCH4
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species biosynthetic process (GO:1903427),-0.6347162935821382,-1.0607322890532023,0.42105263157894735,0.9791207785301607,1.0,6/9,22.22%,SLC30A10;ABCD1;TRAP1;ABCD2;FYN;PPARA
prerank,GO_Biological_Process_2021__mitotic nuclear membrane disassembly (GO:0007077),-0.5989776623481431,-1.0604883675555627,0.42857142857142855,0.9788892225807073,1.0,3/10,18.48%,NEK6;PRKCB;VRK1
prerank,GO_Biological_Process_2021__lactation (GO:0007595),0.6936180631745019,1.0604678122755689,0.5,1.0,1.0,2/7,4.14%,ZBTB7B;PRLR
prerank,GO_Biological_Process_2021__macrophage migration (GO:1905517),0.6349592297221857,1.0601337813939995,0.423728813559322,1.0,1.0,2/9,6.37%,CCL5;P2RY12
prerank,GO_Biological_Process_2021__histidine catabolic process (GO:0006548),0.7086056844535736,1.060042463712176,0.47619047619047616,1.0,1.0,2/5,26.05%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__histidine metabolic process (GO:0006547),0.7086056844535736,1.060042463712176,0.47619047619047616,1.0,1.0,2/5,26.05%,CARNS1;FTCD
prerank,GO_Biological_Process_2021__box C/D snoRNP assembly (GO:0000492),-0.6356134136252573,-1.0599403828108216,0.4358974358974359,0.9796649381563878,1.0,1/7,3.71%,ZNHIT6
prerank,GO_Biological_Process_2021__regulation of MDA-5 signaling pathway (GO:0039533),-0.6502082276074193,-1.0598484794977072,0.5116279069767442,0.9789965376958757,1.0,1/6,5.37%,DDX60
prerank,GO_Biological_Process_2021__stem cell development (GO:0048864),-0.5431807222610974,-1.0598029079122069,0.3235294117647059,0.9783293912699986,1.0,2/14,4.64%,NRG1;TCOF1
prerank,GO_Biological_Process_2021__negative regulation of cellular carbohydrate metabolic process (GO:0010677),-0.5626942884724088,-1.0597082818129424,0.38095238095238093,0.9776502847551592,1.0,5/14,22.22%,PGP;NUPR1;GCK;HDAC4;PPARA
prerank,GO_Biological_Process_2021__negative regulation of cell cycle phase transition (GO:1901988),0.7100364352097702,1.0595945022507594,0.5,1.0,1.0,2/6,16.59%,ATF5;RGCC
prerank,GO_Biological_Process_2021__venous blood vessel development (GO:0060841),0.7289247649019426,1.0594623363131694,0.47540983606557374,1.0,1.0,2/5,25.12%,ACVR2B;CCBE1
prerank,GO_Biological_Process_2021__regulation of cytokine production (GO:0001817),0.4468912699930371,1.0591506639269777,0.34210526315789475,1.0,1.0,12/91,10.84%,NOX5;ITK;LRRC19;BTN2A2;IL15;TRIM32;PTPRC;AGT;HHLA2;RPS6KA4;CASP8;RNF26
prerank,GO_Biological_Process_2021__regulation of mitotic metaphase/anaphase transition (GO:0030071),-0.4666758616220544,-1.0584863324114682,0.4,0.9799420513323025,1.0,3/24,10.85%,NEK6;CDK5RAP2;CDC23
prerank,GO_Biological_Process_2021__positive regulation of intrinsic apoptotic signaling pathway (GO:2001244),0.509293933301839,1.058105098841662,0.3709677419354839,1.0,1.0,5/32,10.31%,MSX1;BOK;BCAP31;SIAH1;RPS7
prerank,GO_Biological_Process_2021__cellular response to estradiol stimulus (GO:0071392),0.5873075172317085,1.0580222780258415,0.3380281690140845,1.0,1.0,6/15,19.45%,ZNF703;SSTR1;GPER1;ESR1;H2AZ1;CRHBP
prerank,GO_Biological_Process_2021__dendrite extension (GO:0097484),0.6858642097480058,1.0576556052433421,0.46153846153846156,1.0,1.0,1/5,19.08%,SLC9A6
prerank,GO_Biological_Process_2021__regulation of mast cell activation (GO:0033003),0.6857228347153992,1.0575881077017368,0.46774193548387094,1.0,1.0,5/6,29.38%,CD300LF;PLSCR1;LYN;CRLF2;CD226
prerank,GO_Biological_Process_2021__cholesterol efflux (GO:0033344),-0.5513415665830304,-1.0575412122390135,0.3125,0.9817416525953185,1.0,5/16,19.38%,APOA1;SCARB1;APOE;ABCG4;ABCG8
prerank,GO_Biological_Process_2021__negative regulation of actin nucleation (GO:0051126),0.6510960159996169,1.0574472234026056,0.453125,1.0,1.0,2/7,8.14%,GMFG;CORO1A
prerank,GO_Biological_Process_2021__ventricular septum morphogenesis (GO:0060412),0.526890595850411,1.0573697660836985,0.4090909090909091,1.0,1.0,4/22,11.46%,NOTCH1;ZFPM1;SOX11;SMAD7
prerank,GO_Biological_Process_2021__V(D)J recombination (GO:0033151),-0.6248903211119183,-1.0573615031320391,0.3888888888888889,0.9813247322615114,1.0,2/11,12.07%,XRCC4;HMGB2
prerank,GO_Biological_Process_2021__negative regulation of platelet aggregation (GO:0090331),0.6207479093322386,1.0568301946975203,0.42028985507246375,1.0,1.0,3/9,11.99%,ALOX12;PRKG1;ADAMTS18
prerank,GO_Biological_Process_2021__calcium ion import across plasma membrane (GO:0098703),0.593424551258641,1.0566691360879736,0.4594594594594595,1.0,1.0,4/13,12.27%,TRPV6;TRPV3;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__calcium ion import into cytosol (GO:1902656),0.593424551258641,1.0566691360879736,0.4594594594594595,1.0,1.0,4/13,12.27%,TRPV6;TRPV3;SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion mediated by integrin (GO:0033629),0.6203425273743919,1.0563508994060453,0.44642857142857145,1.0,1.0,5/8,26.61%,CYP1B1;PDE3B;SNAI2;JAM3;SERPINE1
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell activation (GO:0046636),0.7166880800595526,1.0562053212135936,0.45901639344262296,1.0,1.0,1/5,2.04%,GLI3
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion mediated by integrin (GO:0033630),0.5569744327143692,1.055995737917202,0.3548387096774194,1.0,1.0,8/14,28.58%,CCL5;P2RY12;PODXL;CXCL13;SKAP1;SFRP2;ADAM9;SYK
prerank,GO_Biological_Process_2021__regulation of small molecule metabolic process (GO:0062012),-0.5093576706427774,-1.0558625569934779,0.37142857142857144,0.9846069041081276,1.0,6/26,11.15%,MLYCD;NR1H4;FOXK1;RORA;ACADVL;APOE
prerank,GO_Biological_Process_2021__cell-cell junction organization (GO:0045216),-0.4101235982380147,-1.055726466076459,0.38461538461538464,0.9840303010279247,1.0,12/67,10.21%,PKP2;F2RL1;CDH13;CDH6;SDK1;TGFB2;CDHR3;CSK;CSF1R;CDH20;TGFB3;CDH1
prerank,GO_Biological_Process_2021__thiamine-containing compound metabolic process (GO:0042723),0.712762646941029,1.0555326162324348,0.43636363636363634,1.0,1.0,1/5,5.02%,SLC19A3
prerank,GO_Biological_Process_2021__mitotic DNA integrity checkpoint signaling (GO:0044774),0.6055574872621143,1.0554120359943342,0.547945205479452,1.0,1.0,2/12,11.05%,TICRR;CDC6
prerank,GO_Biological_Process_2021__regulation of toll-like receptor 2 signaling pathway (GO:0034135),-0.7522080552910682,-1.0553411890048645,0.40625,0.9844663006548776,1.0,2/6,6.54%,F2RL1;TLR1
prerank,GO_Biological_Process_2021__anterograde axonal transport (GO:0008089),-0.46909228316350376,-1.0552929409413443,0.3076923076923077,0.9837202838023732,1.0,10/33,25.03%,BLOC1S4;HSPB1;AP3B2;RAB27B;AP3S2;AP3D1;KIF1A;MGARP;KIF5C;TRAK1
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase biosynthetic process (GO:0051769),-0.6569249279749302,-1.0551390081021337,0.4782608695652174,0.983237900614232,1.0,1/7,0.77%,KDR
prerank,GO_Biological_Process_2021__exit from mitosis (GO:0010458),0.6271396807528363,1.0550640829024343,0.4393939393939394,1.0,1.0,3/11,17.32%,CHMP4B;EPS8;CHMP2A
prerank,GO_Biological_Process_2021__purine ribonucleotide biosynthetic process (GO:0009152),-0.4409289632701195,-1.0547039222965193,0.3939393939393939,0.9835424200588337,1.0,3/40,3.79%,PAPSS2;GUCY2C;DCAKD
prerank,GO_Biological_Process_2021__negative regulation of protein modification process (GO:0031400),-0.43680578641873763,-1.0544211519617002,0.38095238095238093,0.9835322635280673,1.0,11/75,13.90%,PID1;PRR5L;EPHB2;WWTR1;ZBED3;PNKP;CHP1;TRAF3IP1;PPP1R8;P3H1;CACTIN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-10 production (GO:0032733),-0.5304230226359204,-1.054128981858298,0.38235294117647056,0.9834175194749148,1.0,2/12,8.50%,F2RL1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of cellular extravasation (GO:0002693),0.6156196587687551,1.0538033352854266,0.3939393939393939,1.0,1.0,1/10,1.74%,AGER
prerank,GO_Biological_Process_2021__ESCRT complex disassembly (GO:1904896),0.6429065549966902,1.0537437237239942,0.47692307692307695,1.0,1.0,4/9,23.90%,CHMP2B;CHMP1A;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__ESCRT III complex disassembly (GO:1904903),0.6429065549966902,1.0537437237239942,0.47692307692307695,1.0,1.0,4/9,23.90%,CHMP2B;CHMP1A;CHMP2A;VPS4A
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, GABAergic (GO:0032228)",-0.5847444210688322,-1.053422459856749,0.3939393939393939,0.9844656553847048,1.0,1/11,6.08%,ZDHHC3
prerank,GO_Biological_Process_2021__brain morphogenesis (GO:0048854),-0.5711819589413779,-1.05335082504362,0.30303030303030304,0.983684628923925,1.0,2/11,10.30%,SLC6A4;CTNNA2
prerank,GO_Biological_Process_2021__polyamine metabolic process (GO:0006595),-0.6184500022068585,-1.0532827956793656,0.4166666666666667,0.9829702450087445,1.0,2/10,16.55%,SRM;HDAC10
prerank,GO_Biological_Process_2021__T cell migration (GO:0072678),0.6487861583361211,1.0532729713180418,0.5,1.0,1.0,5/6,28.27%,GPR183;CD99;MSN;PIK3CD;SLC12A2
prerank,GO_Biological_Process_2021__regulation of macrophage activation (GO:0043030),0.5909050507536288,1.0530457150938943,0.453125,1.0,1.0,7/18,22.83%,PLA2G10;PJA2;CD74;CD200;SPHK1;GPR137B;LBP
prerank,GO_Biological_Process_2021__Notch signaling involved in heart development (GO:0061314),0.6623776701055291,1.053002702573539,0.4626865671641791,1.0,1.0,3/7,22.85%,NOTCH1;SNAI2;NOTCH2
prerank,GO_Biological_Process_2021__mammary gland epithelium development (GO:0061180),0.582620064069577,1.0529415090892549,0.5079365079365079,1.0,1.0,1/13,2.24%,ZNF703
prerank,GO_Biological_Process_2021__keratan sulfate metabolic process (GO:0042339),0.5382181274355893,1.0527552805010858,0.45454545454545453,1.0,1.0,5/27,10.34%,PRELP;CHST1;B3GNT4;OGN;B3GNT3
prerank,GO_Biological_Process_2021__R-loop disassembly (GO:0062176),-0.687404526597561,-1.0523171790695691,0.5833333333333334,0.9851753318045285,1.0,2/5,14.67%,DDX21;SIRT7
prerank,GO_Biological_Process_2021__regulation of cell junction assembly (GO:1901888),-0.5012537011766092,-1.052152639622388,0.3870967741935484,0.984695168392475,1.0,2/21,7.73%,RUNX1;CBFB
prerank,MSigDB_Hallmark_2020__KRAS Signaling Dn,0.4299391712191809,1.051840497213037,0.35064935064935066,1.0,1.0,22/129,15.18%,RIBC2;CHRNG;KCNE2;CALCB;HSD11B2;SOX10;NTF3;TFCP2L1;SERPINA10;ACTC1;IRS4;NRIP2;PROP1;STAG3;TCF7L1;SNN;KCNMB1;EFHD1;SKIL;ZC2HC1C;MYOT;PDE6B
prerank,GO_Biological_Process_2021__positive regulation of histone phosphorylation (GO:0033129),0.6975141982784836,1.0517046519770423,0.42105263157894735,1.0,1.0,1/5,9.24%,RPS6KA4
prerank,GO_Biological_Process_2021__quaternary ammonium group transport (GO:0015697),-0.6499826152024257,-1.051289341287568,0.46153846153846156,0.9865304997319356,1.0,3/8,12.86%,SLC25A29;SLC22A3;SLC22A1
prerank,GO_Biological_Process_2021__regulation of mitophagy (GO:1901524),0.6706852416110689,1.0511475536498844,0.4857142857142857,1.0,1.0,4/5,29.45%,TSC2;SLC25A4;VDAC1;SLC25A5
prerank,GO_Biological_Process_2021__metanephric mesenchyme development (GO:0072075),0.6982726109757436,1.0508285909258361,0.39344262295081966,1.0,1.0,3/6,22.30%,STAT1;SIX4;BASP1
prerank,GO_Biological_Process_2021__GPI anchor metabolic process (GO:0006505),0.5621499465312938,1.0508002888059103,0.43243243243243246,1.0,1.0,6/24,16.11%,PIGC;PGAP4;PIGV;PIGH;PGAP3;MPPE1
prerank,GO_Biological_Process_2021__positive regulation of intracellular steroid hormone receptor signaling pathway (GO:0033145),0.7211157497161866,1.0506796623486732,0.5,1.0,1.0,1/5,8.65%,LMO3
prerank,GO_Biological_Process_2021__maintenance of gastrointestinal epithelium (GO:0030277),-0.583592740091812,-1.0506789776839263,0.45454545454545453,0.9872971502417484,1.0,2/8,5.58%,RBP4;VSIG1
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair (GO:2000780),0.5502485519510186,1.0505251436999559,0.3870967741935484,1.0,1.0,10/31,21.47%,POLQ;TWIST1;KLHL15;HELB;OTUB1;CGAS;MAGEF1;UBR5;RNF169;RMI2
prerank,GO_Biological_Process_2021__membrane repolarization (GO:0086009),0.6238612083075051,1.050434650771224,0.375,1.0,1.0,5/14,18.43%,KCNE2;ATP1B1;KCNQ1;KCNE4;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of biomineral tissue development (GO:0070169),-0.5279455286269374,-1.0501305384235855,0.36585365853658536,0.9880883478183465,1.0,8/29,16.26%,BMP7;BMP6;ANO6;TGFB3;ODAPH;PKDCC;ACVR1;NELL1
prerank,GO_Biological_Process_2021__inhibitory postsynaptic potential (GO:0060080),-0.6288600032196637,-1.0500636875587313,0.4166666666666667,0.9874257260151199,1.0,3/6,14.91%,DRD4;INSYN2A;NLGN3
prerank,GO_Biological_Process_2021__regulation of transferase activity (GO:0051338),-0.534244992207028,-1.0498769030884252,0.4166666666666667,0.9871529906795714,1.0,3/16,9.39%,SPTSSB;FEM1A;SMG6
prerank,GO_Biological_Process_2021__membrane repolarization during action potential (GO:0086011),0.6238977967088544,1.0495678819996108,0.46153846153846156,1.0,1.0,5/12,18.43%,KCNE2;ATP1B1;KCNQ1;KCNE4;ATP1A1
prerank,GO_Biological_Process_2021__positive regulation of macrophage cytokine production (GO:0060907),0.685361042565368,1.049443096083827,0.5084745762711864,1.0,1.0,3/7,26.27%,PLCG2;CD74;LAPTM5
prerank,GO_Biological_Process_2021__hepoxilin biosynthetic process (GO:0051122),0.6871547270733103,1.0493588581636595,0.4576271186440678,1.0,1.0,3/6,24.35%,ALOX12;ALOXE3;GSTP1
prerank,GO_Biological_Process_2021__hepoxilin metabolic process (GO:0051121),0.6871547270733103,1.0493588581636595,0.4576271186440678,1.0,1.0,3/6,24.35%,ALOX12;ALOXE3;GSTP1
prerank,GO_Biological_Process_2021__aminophospholipid transport (GO:0015917),0.7100005804464842,1.0491659797051591,0.38333333333333336,1.0,1.0,1/5,7.21%,TMEM30A
prerank,"GO_Biological_Process_2021__positive regulation of transcription, DNA-templated (GO:0045893)",-0.3304611884257524,-1.0490139030175742,0.0,0.988783482629135,1.0,89/904,10.29%,ETV1;CD38;ETV5;MYB;BMP7;STING1;H1-4;MYRFL;LEF1;HMGN5;TOX2;F2RL1;CDH13;RUNX1;GREM1;PID1;CREB5;SSBP3;CREB3L4;ZNF496;ATOH8;GABPB2;KDM8;BRCA2;MAML3;ASCL1;E2F5;NFATC1;NRL;FOS;SOX12;TEAD2;ZNF462;HDAC5;NFIB;IGF1;PRDM15;ZMIZ2;TRIAP1;ADIRF;FIZ1;ITGA6;MAML1;SFRP1;WWTR1;HIVEP1;RRP1B;LYAR;MED30;FGF1;HDAC1;WBP2NL;TFAP4;ZNF300;ZBED3;RGMB;SBNO2;IL11;ATF3;NFIX;SERPINF2;TFDP1;MAPK7;ETS1;ZFHX3;BMP6;E4F1;NR1H4;ID2;INO80;LBH;CDK5RAP2;STAT3;MAP2K3;FOXK1;HMGA2;RORA;POU2F2;SMARCA4;UBTF;RBMX;XRCC6;TGFB3;PBX4;IFI16;THOC1;CDH1;DLX5;POU3F1
prerank,GO_Biological_Process_2021__negative regulation of anion transmembrane transport (GO:1903960),0.6986113274730265,1.0488921275435263,0.4915254237288136,1.0,1.0,1/5,6.09%,TCAF2
prerank,GO_Biological_Process_2021__regulation of glycogen biosynthetic process (GO:0005979),-0.5182394465422008,-1.048817407738806,0.43243243243243246,0.9885229339191198,1.0,4/20,14.39%,IGF1;PPP1R3B;PPP1R3E;IRS1
prerank,MSigDB_Hallmark_2020__Wnt-beta Catenin Signaling,-0.4729541057113797,-1.048746988934802,0.4,0.9878752631781171,1.0,7/35,9.47%,LEF1;HDAC5;MAML1;PTCH1;NUMB;NCSTN;JAG2
prerank,GO_Biological_Process_2021__regulation of fibroblast migration (GO:0010762),-0.48047292318676943,-1.0486899602066337,0.38235294117647056,0.9871900541753554,1.0,3/21,13.84%,PRR5L;GNA12;PRKCE
prerank,GO_Biological_Process_2021__regulation of axon regeneration (GO:0048679),-0.5494193176143727,-1.04865922522937,0.4634146341463415,0.9863771355113521,1.0,2/10,10.87%,RTN4R;PTPRS
prerank,GO_Biological_Process_2021__mitochondrial calcium ion transmembrane transport (GO:0006851),-0.5566166144145643,-1.0483896032090743,0.46875,0.9862872383031863,1.0,8/19,21.75%,MCUB;MICU1;MICU2;MCUR1;SLC8A3;MCU;PMPCA;SLC25A23
prerank,PanglaoDB_Augmented_2021__Osteoclast Precursor Cells,0.4889695608890535,1.0483413837352478,0.4533333333333333,1.0,1.0,8/50,9.27%,C3AR1;MS4A6A;FGL2;HCK;PTPRC;CARD6;CIITA;CSF2RA
prerank,GO_Biological_Process_2021__regulation of protein export from nucleus (GO:0046825),-0.5116512415211516,-1.0479672717643942,0.4117647058823529,0.9866737986128871,1.0,5/22,17.64%,TPR;EMD;BAG3;SIRT7;ANP32B
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0006919),0.45903079127174184,1.047727028401298,0.4461538461538462,1.0,1.0,8/62,11.17%,CASP12;BOK;CARD8;FADD;HIP1R;CASP8;KHDC1;FAS
prerank,GO_Biological_Process_2021__cellular monovalent inorganic cation homeostasis (GO:0030004),0.5949918812214549,1.0475747072752164,0.4090909090909091,1.0,1.0,4/14,18.43%,ATP12A;ATP6AP1;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__ganglioside biosynthetic process (GO:0001574),-0.5315143475049985,-1.0475121434080945,0.43333333333333335,0.9871110977095201,1.0,3/14,10.06%,ST3GAL1;ST8SIA2;ST3GAL2
prerank,GO_Biological_Process_2021__regulation of hydrogen peroxide-induced cell death (GO:1903205),0.6474078852588092,1.04726357819798,0.44285714285714284,1.0,1.0,1/10,2.91%,STK26
prerank,GO_Biological_Process_2021__lipid droplet organization (GO:0034389),0.576999621794086,1.0472450706361984,0.45161290322580644,1.0,1.0,4/17,12.63%,SMIM22;HSD17B13;PPID;SQLE
prerank,GO_Biological_Process_2021__preassembly of GPI anchor in ER membrane (GO:0016254),0.603688913729792,1.0467139397662872,0.4142857142857143,1.0,1.0,3/15,12.09%,PIGC;PIGV;PIGH
prerank,GO_Biological_Process_2021__protein deacylation (GO:0035601),-0.4804592000108599,-1.0464139369467227,0.3,0.9898347791084539,1.0,9/23,19.09%,HDAC5;HDAC1;LYPLA2;ABHD17A;SIRT2;SIRT7;HDAC10;SIN3A;HDAC7
prerank,GO_Biological_Process_2021__regulation of cell size (GO:0008361),0.5365486865924437,1.0462795285136917,0.4117647058823529,1.0,1.0,1/21,1.71%,CAV3
prerank,GO_Biological_Process_2021__phosphatidic acid metabolic process (GO:0046473),0.49851162361290735,1.0462718552702033,0.4146341463414634,1.0,1.0,2/39,1.60%,LIPH;PLA2G10
prerank,GO_Biological_Process_2021__endodermal cell differentiation (GO:0035987),-0.47032323733545867,-1.0460221270738594,0.3333333333333333,0.9902298899518887,1.0,7/27,10.42%,ITGB5;ITGA4;LAMB3;COL11A1;HMGA2;LAMA3;COL4A2
prerank,GO_Biological_Process_2021__sarcomere organization (GO:0045214),0.5762745833479872,1.0460168582641431,0.4142857142857143,1.0,1.0,4/19,13.02%,CSRP3;CASQ1;MYPN;SIX4
prerank,GO_Biological_Process_2021__mitochondrial DNA metabolic process (GO:0032042),0.6813097538202932,1.0452966843097102,0.4915254237288136,1.0,1.0,1/7,6.49%,MGME1
prerank,GO_Biological_Process_2021__cellular protein modification process (GO:0006464),-0.3216473788624598,-1.0452308097448373,0.0,0.9914836197208814,1.0,63/864,8.54%,DUSP4;NRK;DUSP5;PTPN3;FBXL7;B3GALT9;TRIB2;LTBP1;PTPRT;LAMB2;MELTF;PRAG1;PTPRB;LMTK3;ASB9;PTPN9;PENK;FBXW8;CDC14B;ST6GALNAC2;ST3GAL3;PPP2R3B;NEK6;PRKG2;ST3GAL1;LOXL1;ST8SIA2;CCDC22;DUSP2;SGK1;FBXO27;NRBP2;VCAN;MAML1;GRK5;MAP3K20;FEM1A;MARK1;VGF;TGFB2;PORCN;PARP2;PRKCD;CD247;PPEF1;CDC42BPB;AURKA;APOA1;TGM1;ATG10;PTPRH;PLK2;PEAK3;SENP8;CSK;HS3ST5;ERCC8;FNTB;GCNT2;SEPHS1;PPM1G;DUSP12;LIMK1
prerank,GO_Biological_Process_2021__B cell receptor signaling pathway (GO:0050853),-0.4969465023183802,-1.045212891126141,0.4166666666666667,0.990659156654449,1.0,1/24,0.08%,CD38
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885),0.6259315210111408,1.0450382433678367,0.4918032786885246,1.0,1.0,4/7,21.89%,ERAP2;HLA-A;B2M;ERAP1
prerank,GO_Biological_Process_2021__regulation of membrane tubulation (GO:1903525),-0.640568102761578,-1.0446860349877207,0.45714285714285713,0.9911804685584346,1.0,3/6,17.92%,PLEKHM2;SH3GLB1;DNM2
prerank,GO_Biological_Process_2021__establishment of mitotic spindle localization (GO:0040001),-0.46575083869736267,-1.04461253198458,0.4166666666666667,0.9904856871208934,1.0,3/24,8.32%,NUMA1;NSFL1C;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of ruffle assembly (GO:1900029),0.6249969946050303,1.044552139103761,0.46875,1.0,1.0,2/11,11.71%,P2RY12;EPS8
prerank,GO_Biological_Process_2021__cilium movement (GO:0003341),0.4800786771135382,1.0445211410461195,0.3939393939393939,1.0,1.0,8/43,14.55%,CFAP54;ODAD4;DNAH11;ODAD3;CCDC39;CABYR;DNAH7;TTC29
prerank,GO_Biological_Process_2021__vascular process in circulatory system (GO:0003018),-0.5421951379961293,-1.0442506421749358,0.48717948717948717,0.9895723107279422,1.0,2/10,17.65%,ACE2;ACE
prerank,GO_Biological_Process_2021__regulation of tube diameter (GO:0035296),-0.5421951379961293,-1.0442506421749358,0.48717948717948717,0.9895723107279422,1.0,2/10,17.65%,ACE2;ACE
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization (GO:0031116),0.5490522862638392,1.0442373409988328,0.40625,1.0,1.0,3/25,10.75%,CAV3;PSRC1;CDK5R1
prerank,"GO_Biological_Process_2021__chemical synaptic transmission, postsynaptic (GO:0099565)",-0.48250427441786364,-1.0441312105669878,0.34375,0.9889701649976979,1.0,5/21,14.91%,DRD4;INSYN2A;GRIN2A;GRIN2C;NLGN3
prerank,GO_Biological_Process_2021__positive regulation of macroautophagy (GO:0016239),-0.4523122251540857,-1.044119271237352,0.34615384615384615,0.9881397024062634,1.0,4/48,8.70%,KDR;STING1;EPM2A;SPTLC1
prerank,GO_Biological_Process_2021__regulation of monooxygenase activity (GO:0032768),-0.4786286620978986,-1.0439159644576959,0.32432432432432434,0.9878073369497692,1.0,8/19,24.82%,CYGB;EGFR;NOS1AP;LEP;DNM2;DDAH1;NOSIP;VDR
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell proliferation (GO:1904707),0.5798691106917979,1.0438738655148465,0.4262295081967213,1.0,1.0,2/16,5.09%,LDLRAP1;IGFBP5
prerank,GO_Biological_Process_2021__regulation of B cell receptor signaling pathway (GO:0050855),-0.5189888445161288,-1.043515337861516,0.43333333333333335,0.9881752681164673,1.0,3/18,7.73%,RUNX1;FOXP1;CBFB
prerank,GO_Biological_Process_2021__GTP metabolic process (GO:0046039),0.5880306950217381,1.0432788982178132,0.47692307692307695,1.0,1.0,8/14,32.67%,RAB23;AK4;LRRK2;IMPDH1;RHOQ;MFN1;GTPBP1;ENTPD7
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein catabolic process (GO:1902992),-0.5277579020435703,-1.043224868126794,0.3783783783783784,0.9880722551443188,1.0,5/19,13.41%,IGF1;SORL1;APOE;CLU;BIN1
prerank,GO_Biological_Process_2021__positive regulation of type I interferon-mediated signaling pathway (GO:0060340),0.6865025507869482,1.0432106768182123,0.45901639344262296,1.0,1.0,1/5,6.92%,FADD
prerank,GO_Biological_Process_2021__cellular response to pH (GO:0071467),0.6197765826827139,1.0429040796319284,0.48333333333333334,1.0,1.0,4/13,20.19%,GPR68;PKD1L3;MCOLN1;HVCN1
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte activation (GO:0051251),-0.48916491870216444,-1.0426296731720264,0.37037037037037035,0.9890488288269055,1.0,2/19,9.75%,TICAM1;XRCC6
prerank,GO_Biological_Process_2021__phosphatidic acid biosynthetic process (GO:0006654),0.49905133700992155,1.042376254639546,0.4074074074074074,1.0,1.0,2/38,1.60%,LIPH;PLA2G10
prerank,GO_Biological_Process_2021__vitamin A metabolic process (GO:0006776),0.6930769610941747,1.0423347204362223,0.5,1.0,1.0,2/6,4.79%,RLBP1;BCO1
prerank,GO_Biological_Process_2021__response to dsRNA (GO:0043331),-0.6232056427856324,-1.0423191287634628,0.40476190476190477,0.9890467142592826,1.0,1/6,4.94%,TICAM1
prerank,GO_Biological_Process_2021__regulation of sequestering of calcium ion (GO:0051282),-0.5651372856238895,-1.0417730359558954,0.42424242424242425,0.9896023473276332,1.0,1/10,0.56%,UBASH3B
prerank,GO_Biological_Process_2021__negative regulation of gluconeogenesis (GO:0045721),-0.675140506278327,-1.041731609055835,0.5,0.9888398628086889,1.0,2/6,20.75%,PGP;GCK
prerank,GO_Biological_Process_2021__inorganic cation import across plasma membrane (GO:0098659),0.48330191004934264,1.0416473838115796,0.4594594594594595,1.0,1.0,16/63,19.95%,SLC12A7;TRPV6;KCNE2;SLC39A12;TRPV3;ATP12A;SLC24A2;SLC24A1;KCNJ9;SLC5A2;KCNJ11;ATP1B1;ATP1A1;SLC9A2;SLC9A6;SLC9A7
prerank,GO_Biological_Process_2021__folic acid-containing compound metabolic process (GO:0006760),-0.5224099935261789,-1.0415325802826372,0.3333333333333333,0.9883824249285416,1.0,7/18,15.78%,SLC19A1;MTHFD2;DHFR;MTHFS;MTHFD2L;MTHFD1L;MTHFR
prerank,GO_Biological_Process_2021__cellular response to copper ion (GO:0071280),-0.6061758463750251,-1.0413161529881154,0.3939393939393939,0.9880395845781957,1.0,1/9,2.48%,MT1E
prerank,GO_Biological_Process_2021__positive regulation of B cell differentiation (GO:0045579),0.7105520737029383,1.041300168508102,0.5172413793103449,1.0,1.0,3/5,28.58%,CD27;PPP2R3C;SYK
prerank,GO_Biological_Process_2021__cytoplasmic translation (GO:0002181),0.4559472256605245,1.0411920109375168,0.4177215189873418,1.0,1.0,42/87,37.50%,RPL15;RPL36;RPS7;RPL9;RPL26L1;RPS21;RPL22;RPL21;RPL38;RPS5;RPL3;RPL22L1;RPL35A;RPS13;RPL35;RPS20;RPL27;RPL13A;RPS27A;RPL5;FTSJ1;RPL27A;RPL7;RPS9;EIF3I;RPL37;RPS29;RPL24;RPL28;RPL32;RPL8;RPS4X;RPS12;RPL37A;EIF4A2;RPSA;RPS19;ZC3H15;RPS24;GSPT2;RPS8;RPL4
prerank,GO_Biological_Process_2021__sensory perception of taste (GO:0050909),0.6268936362384643,1.041126904573765,0.45161290322580644,1.0,1.0,1/7,2.20%,TAS1R1
prerank,GO_Biological_Process_2021__tRNA aminoacylation for protein translation (GO:0006418),-0.4795742835445085,-1.0405783320617081,0.41379310344827586,0.9892761789522967,1.0,13/39,22.17%,IARS1;VARS1;RARS1;SARS1;WARS2;EARS2;FARS2;FARSB;RARS2;MARS1;LARS2;YARS2;HARS2
prerank,GO_Biological_Process_2021__smooth muscle cell migration (GO:0014909),0.7069198508753641,1.0405516429675588,0.47619047619047616,1.0,1.0,1/6,3.19%,PDGFRB
prerank,GO_Biological_Process_2021__steroid biosynthetic process (GO:0006694),0.5019850226388206,1.040510806238486,0.4166666666666667,1.0,1.0,13/45,19.15%,BAAT;PRLR;HSD11B2;HSD17B10;HMGCR;ACOX2;CYP19A1;SQLE;MSMO1;FAXDC2;INSIG2;DHCR7;INSIG1
prerank,GO_Biological_Process_2021__protein localization to chromosome (GO:0034502),-0.4590073041970738,-1.0404137680171834,0.39285714285714285,0.9888574367935636,1.0,3/32,6.88%,LEMD2;XRCC4;TPP1
prerank,GO_Biological_Process_2021__regulation of telomerase RNA localization to Cajal body (GO:1904872),0.5643731858176673,1.039979014459272,0.4153846153846154,1.0,1.0,5/18,21.62%,TCP1;CCT6A;CCT8;DCP2;CCT7
prerank,GO_Biological_Process_2021__amino acid transmembrane transport (GO:0003333),0.5115643303818113,1.0397818796860652,0.38235294117647056,1.0,1.0,11/39,17.96%,SLC7A11;SLC38A11;SLC38A8;SLC36A1;LRRC8D;SLC25A18;SFXN3;SLC38A2;SLC7A7;SLC38A5;SLC38A4
prerank,GO_Biological_Process_2021__urea cycle (GO:0000050),0.6339567272929374,1.0396788218716537,0.45454545454545453,1.0,1.0,3/7,23.41%,ARG1;ARG2;CPS1
prerank,GO_Biological_Process_2021__positive regulation of histone modification (GO:0031058),0.5047601791046533,1.0396198642231385,0.375,1.0,1.0,5/29,14.47%,ZBTB7B;ING2;PPARGC1A;RPS6KA4;BRCA1
prerank,GO_Biological_Process_2021__protein localization to organelle (GO:0033365),0.424496283963009,1.0396022984133082,0.4024390243902439,1.0,1.0,18/121,17.73%,ROPN1B;CSRP3;MSX1;TMEM30A;LAMP2;RIPOR1;TOLLIP;FSIP2;ARL1;ARL6;SIX4;TRAM2;DNAJA1;RAB11A;TUB;VPS35;CCDC47;OTOF
prerank,GO_Biological_Process_2021__bone morphogenesis (GO:0060349),0.6394360914024888,1.0394419729448265,0.45588235294117646,1.0,1.0,2/8,11.22%,SFRP4;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of protein exit from endoplasmic reticulum (GO:0070863),0.6152849373977964,1.0391140110738235,0.47692307692307695,1.0,1.0,2/10,7.21%,BCAP31;TMEM30A
prerank,GO_Biological_Process_2021__regulation of epithelial to mesenchymal transition involved in endocardial cushion formation (GO:1905005),-0.603296905246689,-1.0390836933685679,0.4772727272727273,0.9921335782324819,1.0,5/8,16.59%,TGFB2;TGFB3;NOG;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__non-canonical Wnt signaling pathway (GO:0035567),-0.4137417781384318,-1.0390187869393408,0.32142857142857145,0.9914107101563718,1.0,5/109,5.41%,ROR2;LEF1;NFATC1;SFRP1;GNAO1
prerank,GO_Biological_Process_2021__negative regulation of macrophage activation (GO:0043031),0.6149687125751918,1.0389877016761493,0.5,1.0,1.0,1/10,5.48%,PTPRC
prerank,GO_Biological_Process_2021__benzene-containing compound metabolic process (GO:0042537),-0.6259566640594346,-1.038881287682205,0.5,0.9907772310897011,1.0,4/8,28.26%,KYNU;AADAT;ACAA1;KYAT3
prerank,GO_Biological_Process_2021__cellular response to zinc ion (GO:0071294),-0.5508525181980878,-1.0384638729950966,0.41025641025641024,0.9912136914690116,1.0,1/11,2.48%,MT1E
prerank,GO_Biological_Process_2021__DNA synthesis involved in DNA repair (GO:0000731),0.5022040139126525,1.03836479651935,0.49295774647887325,1.0,1.0,6/42,20.21%,RFC5;CDKN2D;PCNA;RPA3;TRIM25;POLN
prerank,GO_Biological_Process_2021__positive regulation of macromolecule biosynthetic process (GO:0010557),-0.3942345468587361,-1.0383527950875937,0.3333333333333333,0.9906317692721427,1.0,20/106,15.67%,KDR;FGFR4;SAMD4A;SLC25A37;EREG;IGF1;AZU1;TGFB2;SLC6A9;PPP1R3E;ELAVL1;UPF3A;SMOC2;EGFR;ABCB10;FAF1;RBM3;IRS1;CIRBP;PLD1
prerank,GO_Biological_Process_2021__protein localization to microtubule cytoskeleton (GO:0072698),-0.610480760707037,-1.0383201182147739,0.45454545454545453,0.9898249504630362,1.0,3/8,16.37%,FAM83D;MAPRE1;MID1
prerank,GO_Biological_Process_2021__regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903798),0.5939181293862613,1.0382514311034967,0.5151515151515151,1.0,1.0,3/11,17.47%,ESR1;TGFB1;MYCN
prerank,GO_Biological_Process_2021__negative regulation of protein localization to nucleus (GO:1900181),0.5889952589850814,1.038240902236075,0.4507042253521127,1.0,1.0,3/16,11.23%,CTNNA1;UFM1;RAB23
prerank,GO_Biological_Process_2021__DNA replication (GO:0006260),0.4366985671786157,1.0381717190365025,0.3950617283950617,1.0,1.0,13/94,14.47%,TICRR;MCM2;RFC5;POLE2;POLE3;RAD9B;CDC6;HELB;DONSON;MRE11;RPA3;CDK2AP1;BRCA1
prerank,GO_Biological_Process_2021__regulation of response to external stimulus (GO:0032101),0.42471356765965396,1.0381317380244337,0.39436619718309857,1.0,1.0,12/92,13.25%,CASP12;PTGES;LRRC19;TRIM5;HCK;CNGB1;P2RY12;GUCY2F;CASP8;CNGA1;IRF1;USP14
prerank,GO_Biological_Process_2021__sulfur compound biosynthetic process (GO:0044272),0.44330845909839584,1.0380590272492858,0.4027777777777778,1.0,1.0,13/87,11.63%,PRELP;HPGDS;GGTA1;MGST1;CHST1;SLC35B3;CHAC2;MAT2B;B3GNT4;OGN;CSGALNACT1;B3GNT3;CHAC1
prerank,GO_Biological_Process_2021__respiratory tube development (GO:0030323),-0.4687756887660799,-1.0377498635904732,0.391304347826087,0.9907250977526103,1.0,3/22,6.06%,RBP4;FGF1;PDPN
prerank,GO_Biological_Process_2021__extracellular matrix organization (GO:0030198),-0.36227748189170933,-1.0376144404674252,0.2608695652173913,0.990232868279943,1.0,25/232,5.85%,ITGB5;NPNT;KDR;COL15A1;LAMB2;ADAM19;ITGA4;GREM1;LAMA4;ADAMTS2;ADAMTS3;ADAM12;ADAMTS15;COL6A2;LAMB3;LOXL1;COL11A2;ADAMTS8;ITGA6;VCAN;TNR;PAPLN;COL4A3;TGFB2;ADAMTS5
prerank,GO_Biological_Process_2021__regulation of protein kinase activity (GO:0045859),-0.4079533671857769,-1.0376070684301635,0.25925925925925924,0.9893784797784052,1.0,15/91,11.16%,UBASH3B;TRIB2;SPRED1;RASSF2;EREG;PRKRIP1;C5AR1;WWTR1;AZU1;HSPB1;MMD2;MAP2K3;XRCC6;CHP1;LCP2
prerank,GO_Biological_Process_2021__potassium ion export across plasma membrane (GO:0097623),0.6244134020831751,1.0373996143583109,0.421875,1.0,1.0,3/10,17.96%,KCNE2;KCNQ1;KCNE4
prerank,GO_Biological_Process_2021__tRNA-containing ribonucleoprotein complex export from nucleus (GO:0071431),-0.46932370619710984,-1.0373888250055394,0.43478260869565216,0.9882740647471148,1.0,3/33,6.59%,NUP210;TPR;NUP37
prerank,GO_Biological_Process_2021__tRNA export from nucleus (GO:0006409),-0.46932370619710984,-1.0373888250055394,0.43478260869565216,0.9882740647471148,1.0,3/33,6.59%,NUP210;TPR;NUP37
prerank,GO_Biological_Process_2021__ketone body biosynthetic process (GO:0046951),-0.6511201288560714,-1.0371253620908139,0.5666666666666667,0.9881852742466994,1.0,1/8,3.41%,BDH1
prerank,GO_Biological_Process_2021__negative regulation of smooth muscle cell proliferation (GO:0048662),0.5447921173955887,1.0370869721046971,0.4057971014492754,1.0,1.0,6/21,11.81%,IGFBP5;SOD2;CDKN1B;PRKG1;OGN;GPER1
prerank,GO_Biological_Process_2021__nonribosomal peptide biosynthetic process (GO:0019184),0.6596487980267772,1.0368132278868145,0.4230769230769231,1.0,1.0,2/10,11.63%,CHAC2;CHAC1
prerank,GO_Biological_Process_2021__positive regulation of viral genome replication (GO:0045070),0.5363375330769966,1.0364405952984272,0.44776119402985076,1.0,1.0,4/27,11.67%,CCL5;VAPB;NR5A2;PPID
prerank,GO_Biological_Process_2021__regulation of dopamine secretion (GO:0014059),0.5488325452197238,1.0363607716025995,0.43243243243243246,1.0,1.0,6/23,19.24%,SYT2;SYT4;DRD3;SYT15;SYT9;SYT13
prerank,GO_Biological_Process_2021__modulation by symbiont of host apoptotic process (GO:0052150),0.6665535325738615,1.0362869202229517,0.4857142857142857,1.0,1.0,1/6,29.58%,RNF213
prerank,GO_Biological_Process_2021__Rap protein signal transduction (GO:0032486),-0.5914301443084505,-1.0354946817193238,0.4,0.9918762864335408,1.0,1/9,7.48%,PLK2
prerank,MSigDB_Hallmark_2020__IL-6/JAK/STAT3 Signaling,-0.4218698866355769,-1.0354132263137859,0.4375,0.9912485568747889,1.0,3/57,2.08%,CD38;ITGA4;IL1R1
prerank,GO_Biological_Process_2021__positive regulation of ossification (GO:0045778),-0.48609294748028703,-1.0352709503090167,0.46511627906976744,0.9908834291909281,1.0,8/31,16.26%,BMP7;TGFB2;BMP6;ANO6;TGFB3;PKDCC;ACVR1;NELL1
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle phase transition (GO:1901991),-0.45592110547369347,-1.0351875489267341,0.36,0.9902701250727185,1.0,3/80,1.56%,FBXL7;CDK2AP2;GFI1B
prerank,GO_Biological_Process_2021__negative regulation of macromolecule metabolic process (GO:0010605),-0.3781341364758372,-1.0351820622750967,0.34782608695652173,0.9894217311489757,1.0,20/144,11.99%,KDR;RUNX1;ATOH8;IGF1;APLN;SFRP1;TGFB2;HDAC1;AURKA;FOXP1;ID2;CILP;TAF1;TET1;CREB3L1;APOE;DNMT1;PARP10;SLC24A3;WDR54
prerank,GO_Biological_Process_2021__regulation of hyaluronan biosynthetic process (GO:1900125),0.6485483229320848,1.0349342843665095,0.5272727272727272,1.0,1.0,2/6,22.97%,TGFB1;CLTC
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transporter activity (GO:0032414),-0.508457983435231,-1.034855645464139,0.40476190476190477,0.9895435240042985,1.0,1/22,0.28%,STAC
prerank,"GO_Biological_Process_2021__regulation of Wnt signaling pathway, planar cell polarity pathway (GO:2000095)",0.6556050652202506,1.0348392973596774,0.5217391304347826,1.0,1.0,2/6,23.73%,RSPO3;MLLT3
prerank,GO_Biological_Process_2021__unsaturated fatty acid biosynthetic process (GO:0006636),-0.6380834689936894,-1.034784544668465,0.5151515151515151,0.9888337534735425,1.0,1/7,0.57%,DECR2
prerank,GO_Biological_Process_2021__synaptic vesicle budding from presynaptic endocytic zone membrane (GO:0016185),-0.6575948964158922,-1.0344657718530255,0.45161290322580644,0.9888442737008939,1.0,3/6,22.06%,MX1;DNM2;SNAP91
prerank,GO_Biological_Process_2021__embryonic skeletal system development (GO:0048706),-0.5640331729600105,-1.0342905865890633,0.4523809523809524,0.9884584110730337,1.0,5/16,11.83%,SULF2;RBP4;DSCAML1;PDGFRA;NOG
prerank,"GO_Biological_Process_2021__retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum (GO:0006890)",0.45509614761319367,1.0341772695221723,0.4375,1.0,1.0,1/78,0.22%,RAB6C
prerank,GO_Biological_Process_2021__negative regulation of stress fiber assembly (GO:0051497),0.5275743017254163,1.0338360087122105,0.37681159420289856,1.0,1.0,3/22,15.39%,F11R;WAS;ARHGAP28
prerank,GO_Biological_Process_2021__ventricular trabecula myocardium morphogenesis (GO:0003222),-0.6303516247544967,-1.0338228147965398,0.42424242424242425,0.9888528832257122,1.0,2/7,5.75%,NRG1;TGFB2
prerank,PanglaoDB_Augmented_2021__Alpha Cells,-0.3718845802023385,-1.0335731236941028,0.3125,0.9885666072451547,1.0,8/105,4.88%,CNGA3;KCNIP1;RIMBP2;PTPRT;GLP1R;CACNA2D1;SST;ID4
prerank,GO_Biological_Process_2021__pore complex assembly (GO:0046931),-0.5593254407529804,-1.0331994605482475,0.5454545454545454,0.9886390938214896,1.0,5/17,17.41%,TPR;ANO6;PLEKHA7;NUP107;TSPAN33
prerank,GO_Biological_Process_2021__positive regulation of endopeptidase activity (GO:0010950),0.5334680737233836,1.0331801315819016,0.5079365079365079,1.0,1.0,1/23,1.74%,AGER
prerank,GO_Biological_Process_2021__acid secretion (GO:0046717),0.7088124968851385,1.0329920913556994,0.5538461538461539,1.0,1.0,4/5,24.13%,ABCB4;DRD3;GHRL;SLC51A
prerank,GO_Biological_Process_2021__production of small RNA involved in gene silencing by RNA (GO:0070918),0.5387279539051552,1.0326330017646397,0.43478260869565216,1.0,1.0,2/17,11.21%,HENMT1;MRPL44
prerank,GO_Biological_Process_2021__sodium-independent organic anion transport (GO:0043252),0.621782413720374,1.0325712899649997,0.5606060606060606,1.0,1.0,2/11,1.86%,SLCO6A1;SLCO2B1
prerank,GO_Biological_Process_2021__neuroblast proliferation (GO:0007405),0.6938303289364124,1.0319043224401425,0.5161290322580645,1.0,1.0,2/6,15.73%,ARTN;RACGAP1
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle contraction (GO:0003056),0.6863407666572896,1.0318635838168173,0.5535714285714286,1.0,1.0,2/5,25.54%,DOCK4;DOCK5
prerank,GO_Biological_Process_2021__pyroptosis (GO:0070269),-0.5934369289013433,-1.031637216339222,0.4782608695652174,0.9921674938861249,1.0,3/10,9.90%,APIP;NLRP1;GSDMB
prerank,GO_Biological_Process_2021__adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway (GO:0007193),-0.41226921208648976,-1.0315588640697306,0.2857142857142857,0.9915707642948278,1.0,5/48,9.83%,HTR1F;DRD4;CHRM5;GNAT3;GPR37
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via homologous recombination (GO:2000042),0.5987686264400849,1.0313462722910505,0.4603174603174603,1.0,1.0,6/17,21.47%,POLQ;KLHL15;HELB;CGAS;MAGEF1;RMI2
prerank,GO_Biological_Process_2021__protein hexamerization (GO:0034214),0.6111966125125221,1.03064176628224,0.45901639344262296,1.0,1.0,5/8,35.41%,LRRC8D;LETM1;MAT2A;UGDH;LRRC8A
prerank,GO_Biological_Process_2021__DNA replication checkpoint signaling (GO:0000076),0.5873249643998604,1.0305597043893158,0.5757575757575758,1.0,1.0,3/14,11.05%,TICRR;RAD9B;CDC6
prerank,GO_Biological_Process_2021__water homeostasis (GO:0030104),0.6865436763892048,1.0305554042023182,0.55,1.0,1.0,2/6,17.88%,SCTR;AQP9
prerank,GO_Biological_Process_2021__actin-myosin filament sliding (GO:0033275),0.5452769885669974,1.030507252276461,0.4444444444444444,1.0,1.0,8/21,26.17%,MYBPC2;ACTC1;MYBPC3;TTN;MYL6B;MYH7;ACTN2;TMOD1
prerank,GO_Biological_Process_2021__muscle filament sliding (GO:0030049),0.5452769885669974,1.030507252276461,0.4444444444444444,1.0,1.0,8/21,26.17%,MYBPC2;ACTC1;MYBPC3;TTN;MYL6B;MYH7;ACTN2;TMOD1
prerank,GO_Biological_Process_2021__glycolytic process (GO:0006096),0.5763550803301138,1.0300588231369068,0.4714285714285714,1.0,1.0,4/24,12.38%,ENO4;HKDC1;ALDOB;PGAM1
prerank,GO_Biological_Process_2021__cellular response to purine-containing compound (GO:0071415),0.6508314916363668,1.0300009350971755,0.4642857142857143,1.0,1.0,1/7,1.55%,P2RY1
prerank,GO_Biological_Process_2021__regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307),0.5875016303765279,1.0299090901064498,0.42424242424242425,1.0,1.0,3/15,5.69%,CAV3;KCNE2;SCN4B
prerank,GO_Biological_Process_2021__regulation of ERK1 and ERK2 cascade (GO:0070372),-0.39611877260673944,-1.0297935370096212,0.4782608695652174,0.9951766831390234,1.0,15/163,4.59%,DUSP4;SPRED2;SPRED3;ROR2;NPNT;KDR;SPRED1;FGFR4;F2RL1;RGS14;EPHB2;PDGFD;APIP;RASGRP1;C5AR1
prerank,GO_Biological_Process_2021__regulation of neurogenesis (GO:0050767),-0.4484015394898369,-1.0296845509067818,0.4090909090909091,0.9946152997427067,1.0,7/42,10.23%,PER2;RGS14;ASCL1;NUMB;MME;SORL1;PCM1
prerank,GO_Biological_Process_2021__polyphosphate catabolic process (GO:0006798),-0.66706538962791,-1.029528819813378,0.4878048780487805,0.9942024951073705,1.0,3/5,30.87%,PRUNE2;PRUNE1;BNIPL
prerank,GO_Biological_Process_2021__adiponectin-activated signaling pathway (GO:0033211),0.6973368516336714,1.0294410702548382,0.46153846153846156,1.0,1.0,1/5,8.05%,ADIPOR2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron death (GO:1903203),0.6852753946101127,1.029045133766405,0.5161290322580645,1.0,1.0,4/5,28.90%,REST;PINK1;FBXO7;LANCL1
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum unfolded protein response (GO:1900101),0.6363365542243566,1.0290145883536177,0.49206349206349204,1.0,1.0,3/9,24.97%,HSPA5;ERN1;COPS5
prerank,GO_Biological_Process_2021__regulation of monocyte chemotactic protein-1 production (GO:0071637),0.6753733560092013,1.028976954059037,0.5396825396825397,1.0,1.0,1/6,5.96%,TWIST1
prerank,GO_Biological_Process_2021__keratan sulfate biosynthetic process (GO:0018146),0.5469080677300221,1.0286654766913799,0.4520547945205479,1.0,1.0,5/23,10.34%,PRELP;CHST1;B3GNT4;OGN;B3GNT3
prerank,PanglaoDB_Augmented_2021__Megakaryocytes,0.47300525795996745,1.0281000468987034,0.4126984126984127,1.0,1.0,13/64,13.78%,GNLY;IL21R;SPON2;HCK;CD300LF;GMFG;ALOX12;TAGAP;ARHGAP9;WAS;VWF;MYO1F;TGFB1
prerank,GO_Biological_Process_2021__natural killer cell mediated immunity (GO:0002228),0.662349316642684,1.0279366105774335,0.5645161290322581,1.0,1.0,2/9,9.53%,CLEC2A;TUBB
prerank,GO_Biological_Process_2021__regulation of autophagosome assembly (GO:2000785),0.48521452894627526,1.0279185843723868,0.425,1.0,1.0,6/33,22.29%,CHMP4B;PHF23;PINK1;PIP4K2C;LRRK2;SEC22B
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, enzymatic modification (GO:0015015)",-0.6094476689231951,-1.0276263960128296,0.43243243243243246,0.9987429562456138,1.0,2/6,7.75%,HS3ST3B1;HS3ST5
prerank,GO_Biological_Process_2021__glutathione biosynthetic process (GO:0006750),0.666280832896404,1.0274543838037566,0.49056603773584906,1.0,1.0,2/9,11.63%,CHAC2;CHAC1
prerank,GO_Biological_Process_2021__response to steroid hormone (GO:0048545),-0.47158432938574146,-1.0274174802981362,0.4444444444444444,0.9983886677179771,1.0,5/25,12.82%,CATSPER2;TGFB2;TGFB3;PAQR7;CATSPERG
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030947),0.5504699419742105,1.0274041634400206,0.4852941176470588,1.0,1.0,5/18,22.91%,TMEM204;ITGA5;DAB2IP;MMRN2;ARNT
prerank,GO_Biological_Process_2021__positive regulation of cardiocyte differentiation (GO:1905209),-0.5996398329379997,-1.0271775194146016,0.5111111111111111,0.9980595314902567,1.0,2/8,5.75%,GREM1;TGFB2
prerank,GO_Biological_Process_2021__ATP synthesis coupled proton transport (GO:0015986),0.572254028880944,1.0270069843150333,0.43333333333333335,1.0,1.0,6/15,31.80%,ATP5F1E;ATP5F1C;ATP5MC3;ATP5ME;ATP5PD;ATP5PB
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043370)",-0.5706945868150834,-1.026851727420782,0.4594594594594595,0.998061910377632,1.0,3/8,7.73%,RUNX1;SH3RF1;CBFB
prerank,GO_Biological_Process_2021__protein localization to presynapse (GO:1905383),-0.6653268385969082,-1.0265978980434536,0.5,0.9962107850030412,1.0,2/8,15.36%,HSPB1;RAB27B
prerank,GO_Biological_Process_2021__anterograde axonal protein transport (GO:0099641),-0.6653268385969082,-1.0265978980434536,0.5,0.9962107850030412,1.0,2/8,15.36%,HSPB1;RAB27B
prerank,GO_Biological_Process_2021__axo-dendritic protein transport (GO:0099640),-0.6653268385969082,-1.0265978980434536,0.5,0.9962107850030412,1.0,2/8,15.36%,HSPB1;RAB27B
prerank,GO_Biological_Process_2021__regulation of interferon-gamma-mediated signaling pathway (GO:0060334),0.5219859452760289,1.026300546088499,0.484375,1.0,1.0,5/18,24.86%,ARG1;STAT1;PPARG;SUMO1;IFNGR2
prerank,GO_Biological_Process_2021__positive regulation of bone mineralization (GO:0030501),-0.5162497937048717,-1.0261702923193414,0.3953488372093023,0.996630055827386,1.0,7/26,16.26%,BMP7;BMP6;ANO6;TGFB3;PKDCC;ACVR1;NELL1
prerank,GO_Biological_Process_2021__calcium ion-regulated exocytosis of neurotransmitter (GO:0048791),-0.5256546578209701,-1.0261483798582935,0.43333333333333335,0.9958892134221176,1.0,2/11,3.08%,UNC13B;UNC13C
prerank,GO_Biological_Process_2021__positive regulation of cholesterol metabolic process (GO:0090205),0.7043974330886087,1.0256998319255646,0.48333333333333334,1.0,1.0,1/5,1.49%,LDLRAP1
prerank,GO_Biological_Process_2021__membrane biogenesis (GO:0044091),0.6974987738636511,1.0254775506570102,0.509090909090909,1.0,1.0,2/6,7.63%,SERINC1;PEX16
prerank,GO_Biological_Process_2021__regulation of NLRP3 inflammasome complex assembly (GO:1900225),0.626164905565388,1.0248084306122467,0.46774193548387094,1.0,1.0,6/10,29.76%,NLRP2B;NLRC3;USP50;GBP5;CD36;DDX3X
prerank,GO_Biological_Process_2021__aerobic electron transport chain (GO:0019646),0.466196030441802,1.0245937732005517,0.43661971830985913,1.0,1.0,14/52,29.33%,NDUFA2;NDUFB3;NDUFB4;NDUFB9;NDUFB2;COX4I1;COX7A2L;UQCRB;CYCS;NDUFB11;NDUFV1;NDUFB6;UQCRHL;COX6B1
prerank,GO_Biological_Process_2021__carbohydrate transport (GO:0008643),0.6410479785873632,1.024536324383826,0.5,1.0,1.0,3/8,23.13%,SLC23A1;AQP9;SLC2A5
prerank,GO_Biological_Process_2021__positive regulation of integrin activation (GO:0033625),0.618482387576056,1.0245173384289297,0.40625,1.0,1.0,2/10,6.37%,RASIP1;P2RY12
prerank,GO_Biological_Process_2021__endosome to lysosome transport via multivesicular body sorting pathway (GO:0032510),0.6136303923513984,1.0245112474954539,0.4406779661016949,1.0,1.0,1/7,10.61%,CHMP2B
prerank,GO_Biological_Process_2021__regulation of adenylate cyclase activity (GO:0045761),0.5159954468663956,1.0242213765508397,0.42424242424242425,1.0,1.0,4/18,21.50%,GRM3;DRD3;AKAP5;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of RNA metabolic process (GO:0051254),-0.41823489977439376,-1.0242094750904838,0.3333333333333333,1.0,1.0,12/41,19.23%,BUD23;LIN28B;U2AF2;EGFR;ZC3H18;SIRT7;PNPT1;WDR75;SETX;NMD3;RIOK1;HSPA1A
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide biosynthetic process (GO:0045019),0.6688197520366267,1.0241941145597067,0.5283018867924528,1.0,1.0,1/6,1.29%,PTGIS
prerank,GO_Biological_Process_2021__negative regulation of nitric oxide metabolic process (GO:1904406),0.6688197520366267,1.0241941145597067,0.5283018867924528,1.0,1.0,1/6,1.29%,PTGIS
prerank,GO_Biological_Process_2021__sensory perception (GO:0007600),0.48791010818907826,1.0240156430594671,0.44,1.0,1.0,4/35,5.47%,PTGES;TRPA1;OPRK1;SCN9A
prerank,GO_Biological_Process_2021__ribosomal large subunit export from nucleus (GO:0000055),-0.6416649541982211,-1.0238354816273512,0.43902439024390244,1.0,1.0,2/6,18.90%,NMD3;SDAD1
prerank,GO_Biological_Process_2021__regulation of monocyte differentiation (GO:0045655),0.5827016396971451,1.0234618032110374,0.546875,1.0,1.0,3/9,19.30%,CD4;CDK6;CD74
prerank,GO_Biological_Process_2021__transition metal ion homeostasis (GO:0055076),0.5211674729712155,1.0234570518804307,0.38028169014084506,1.0,1.0,9/26,26.62%,CP;SLC40A1;HJV;B2M;TMC8;TF;HEPH;TFR2;SLC11A1
prerank,GO_Biological_Process_2021__positive regulation of cell cycle phase transition (GO:1901989),0.5910281352781738,1.0231052043342632,0.4626865671641791,1.0,1.0,5/14,21.73%,ZNF16;PLCG2;STXBP4;ATAD5;EZH2
prerank,GO_Biological_Process_2021__modification-dependent protein catabolic process (GO:0019941),-0.3339527006518818,-1.0229637015769972,0.25,1.0,1.0,11/181,7.99%,FBXL7;RNF150;MYLIP;RNF126;PTTG1;CDC26;FEM1A;AURKA;UBE2D4;TRPC4AP;UBE2R2
prerank,GO_Biological_Process_2021__positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316),0.6096752159378886,1.0229371464602233,0.4716981132075472,1.0,1.0,2/7,21.68%,TRDN;CALM3
prerank,GO_Biological_Process_2021__transcription by RNA polymerase III (GO:0006383),0.5459941678940835,1.0228767034576631,0.47058823529411764,1.0,1.0,7/28,21.43%,POLR3K;GTF3C4;TBP;POLR3G;SNAPC2;SNAPC1;POLR2K
prerank,GO_Biological_Process_2021__cellular response to fibroblast growth factor stimulus (GO:0044344),-0.42956231381595883,-1.0220973415386607,0.375,1.0,1.0,16/74,15.37%,SPRED2;SPRED1;FGFR4;SFRP1;FGF1;FIBP;FGFRL1;POLR2G;TRIM71;GTF2F1;NR4A1;POLR2C;FLRT2;POLR2L;FGFR3;PTBP1
prerank,GO_Biological_Process_2021__response to hydroperoxide (GO:0033194),-0.629211946135634,-1.0214945283815688,0.5757575757575758,1.0,1.0,1/6,6.22%,PRKCD
prerank,GO_Biological_Process_2021__acute inflammatory response (GO:0002526),0.590719709828956,1.0214055513180915,0.5076923076923077,1.0,1.0,6/14,22.83%,ELANE;CD6;PLSCR1;ITIH4;F3;LBP
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane repolarization (GO:0099623),0.5809800241097985,1.0213713235889466,0.453125,1.0,1.0,3/18,5.69%,CAV3;KCNE2;SCN4B
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902108),0.6694340154196927,1.021175070903549,0.4918032786885246,1.0,1.0,2/6,19.35%,NAIF1;ACAA2
prerank,GO_Biological_Process_2021__postsynaptic density assembly (GO:0097107),-0.6021491755882401,-1.0210767799828382,0.47368421052631576,1.0,1.0,4/5,37.13%,PTEN;SHANK3;NRXN1;NLGN2
prerank,PanglaoDB_Augmented_2021__Reticulocytes,-0.4132310582317991,-1.021000502241123,0.40625,1.0,1.0,21/96,13.83%,ITGA4;ZDHHC5;HNRNPL;ORC1;TIMELESS;URB2;GTF3C2;DDX21;INCENP;POLG;RFWD3;UCP3;EIF4G1;TTI1;NOP14;DDX11;SSRP1;MCM3;ABCB10;CUL4A;CEP85
prerank,GO_Biological_Process_2021__DNA recombination (GO:0006310),0.4887433932065424,1.0209719720828736,0.4,1.0,1.0,1/35,0.65%,RAD54L
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus (GO:1901522),0.5307818073063955,1.0202985664317514,0.4142857142857143,1.0,1.0,3/21,16.12%,NOTCH1;RUNX2;SMAD1
prerank,GO_Biological_Process_2021__cellular response to ATP (GO:0071318),0.5563481586519892,1.0199209701819414,0.39215686274509803,1.0,1.0,2/11,6.37%,P2RY1;P2RY12
prerank,GO_Biological_Process_2021__positive regulation of cell killing (GO:0031343),0.6186055819572336,1.0198851877490853,0.5074626865671642,1.0,1.0,1/9,5.17%,NOX1
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions (GO:0000375)",-0.4795037647909556,-1.0196920676687644,0.4444444444444444,1.0,1.0,8/25,17.99%,KHSRP;SF3B4;PRPF4;SRRM1;TXNL4A;SCAF11;PRPF6;PRPF3
prerank,GO_Biological_Process_2021__negative regulation of ruffle assembly (GO:1900028),0.6485357122907345,1.0196392459036374,0.45614035087719296,1.0,1.0,1/6,11.08%,STAP1
prerank,GO_Biological_Process_2021__response to DNA damage checkpoint signaling (GO:0072423),-0.6520166692475353,-1.0195233811606919,0.5,1.0,1.0,3/5,25.61%,SMC1A;MUS81;SLX4
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity (GO:0042269),-0.49748600117221237,-1.0194582821916711,0.39473684210526316,1.0,1.0,3/16,5.44%,RASGRP1;PIK3R6;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of locomotion (GO:0040017),0.5294786235925522,1.0194275697857933,0.5079365079365079,1.0,1.0,5/21,6.90%,PDGFRB;TRIM32;TWIST1;P2RY12;RARRES2
prerank,GO_Biological_Process_2021__linoleic acid metabolic process (GO:0043651),0.5608278155448762,1.0192653170617805,0.4307692307692308,1.0,1.0,4/15,16.10%,ALOX12;ELOVL2;FADS2;ALOXE3
prerank,GO_Biological_Process_2021__negative regulation of biomineral tissue development (GO:0070168),-0.5046886723132484,-1.0192226078197093,0.45714285714285713,1.0,1.0,2/16,3.63%,GREM1;SRGN
prerank,GO_Biological_Process_2021__leucine transport (GO:0015820),-0.6051435534724547,-1.0191847898705109,0.45454545454545453,1.0,1.0,1/6,10.74%,LLGL2
prerank,GO_Biological_Process_2021__regulation of T cell proliferation (GO:0042129),0.49767249339359754,1.0190974213451212,0.4931506849315068,1.0,1.0,9/38,12.71%,CCL5;IL15;PTPRC;HLA-DMB;IDO1;ARG1;PDCD1LG2;CD6;IL4I1
prerank,GO_Biological_Process_2021__embryonic cranial skeleton morphogenesis (GO:0048701),0.5957543394708461,1.0186981371080068,0.5238095238095238,1.0,1.0,3/10,11.22%,TWIST1;TBX1;FGFR2
prerank,GO_Biological_Process_2021__regulation of centriole elongation (GO:1903722),0.6628276627677696,1.0185405370817728,0.5263157894736842,1.0,1.0,2/5,17.32%,CCP110;CHMP2A
prerank,GO_Biological_Process_2021__macromolecule biosynthetic process (GO:0009059),-0.6247717524789851,-1.0184153865221757,0.45,1.0,1.0,2/5,14.56%,EIF4G1;COL5A1
prerank,GO_Biological_Process_2021__fatty-acyl-CoA biosynthetic process (GO:0046949),0.5123092880777587,1.0183120755048871,0.4605263157894737,1.0,1.0,5/25,11.91%,ACSBG1;FASN;ACSL5;ELOVL2;SCD
prerank,GO_Biological_Process_2021__negative regulation of anoikis (GO:2000811),0.5864090939281551,1.0182180553724156,0.4166666666666667,1.0,1.0,5/13,21.69%,NOTCH1;ITGA5;ZNF304;PDK4;SNAI2
prerank,GO_Biological_Process_2021__regulation of dendritic spine morphogenesis (GO:0061001),-0.41251140588979973,-1.0179374526063525,0.5,1.0,1.0,5/30,16.86%,LZTS3;LRP8;RELN;ARHGAP44;DBNL
prerank,GO_Biological_Process_2021__membrane depolarization during action potential (GO:0086010),0.517991814419402,1.01793480519591,0.4383561643835616,1.0,1.0,7/24,22.47%,SCN9A;SCN4B;SCN7A;YWHAH;CACNA1G;HCN4;CACNA1H
prerank,GO_Biological_Process_2021__regulation of cation transmembrane transport (GO:1904062),-0.4670028089739363,-1.017830698920771,0.45454545454545453,1.0,1.0,5/27,11.11%,KCNIP1;RANGRF;KCNE1;KCNN2;DPP6
prerank,GO_Biological_Process_2021__negative regulation of ossification (GO:0030279),0.5642269695520356,1.01763246032976,0.5362318840579711,1.0,1.0,2/15,4.13%,LRP4;NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell surface (GO:2000010),0.6148168921504983,1.0174844094599171,0.5079365079365079,1.0,1.0,1/10,1.85%,TMEM35A
prerank,GO_Biological_Process_2021__regulation of protein neddylation (GO:2000434),0.6309595780258591,1.017440308576854,0.5573770491803278,1.0,1.0,3/9,18.83%,COPS9;EPAS1;DCUN1D1
prerank,PanglaoDB_Augmented_2021__Pericytes,0.4335912262484609,1.0173826635992977,0.4657534246575342,1.0,1.0,15/107,7.24%,STEAP4;LAMA2;ALPL;TIMP3;MSX1;SLC38A11;ACTA2;PDGFRB;POSTN;IGFBP5;PLSCR4;MFGE8;RARRES2;ECM2;ANGPTL2
prerank,GO_Biological_Process_2021__negative regulation of cellular macromolecule biosynthetic process (GO:2000113),-0.3479769250343351,-1.017369703203939,0.2727272727272727,1.0,1.0,52/436,12.07%,CD38;PER2;NRG1;MYB;BMP7;SOX13;LEF1;SAMD4A;ARID5A;ATOH8;TLE2;KDM8;ASCL1;TYMS;EREG;PRDM5;ZNF256;HDAC5;SFRP1;ID4;RING1;BCL6;HDAC1;TFAP4;TIMELESS;SAMD7;SBNO2;FOXP1;PHC2;NCL;SFMBT1;ID2;SAMD13;DHFR;LBH;FOXK1;ZHX3;ZBTB7A;HMGA2;SUV39H2;SMARCA4;XRCC6;IFI16;SLFN11;DAP;CREB3L1;SIRT2;NACC1;DMAP1;IGF2BP3;PRDM11;HMGB2
prerank,GO_Biological_Process_2021__negative regulation of response to interferon-gamma (GO:0060331),0.6131984061387146,1.0173426243360126,0.5076923076923077,1.0,1.0,2/6,21.48%,ARG1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma-mediated signaling pathway (GO:0060336),0.6131984061387146,1.0173426243360126,0.5076923076923077,1.0,1.0,2/6,21.48%,ARG1;PPARG
prerank,GO_Biological_Process_2021__icosanoid metabolic process (GO:0006690),0.49411367559449815,1.017176792512973,0.45588235294117646,1.0,1.0,5/35,7.36%,PTGIS;PLA2G10;CYP1B1;EPHX1;ALOX12
prerank,GO_Biological_Process_2021__regulation of TOR signaling (GO:0032006),-0.4464789888538709,-1.0171147518902077,0.2962962962962963,1.0,1.0,13/61,19.22%,WDR24;EPM2A;FAM83D;GNA12;TELO2;TTI1;RPTOR;LEP;ITFG2;TBC1D7;LAMTOR4;NPRL2;RHEB
prerank,GO_Biological_Process_2021__adenylate cyclase-modulating G protein-coupled receptor signaling pathway (GO:0007188),0.4148929521677545,1.0169828525194489,0.379746835443038,1.0,1.0,14/104,8.10%,CALCR;MC4R;RXFP1;GPR26;TBXA2R;CALCB;OPRK1;GNAT2;SCTR;CNR2;ADGRB1;P2RY12;PTGER3;TSHR
prerank,GO_Biological_Process_2021__platelet-derived growth factor receptor signaling pathway (GO:0048008),-0.5320849550000157,-1.0168434145097895,0.4827586206896552,1.0,1.0,7/16,14.52%,RGS14;PDGFD;PDGFRA;PDGFC;NRP1;NR4A3;PTPN1
prerank,GO_Biological_Process_2021__regulation of intracellular protein transport (GO:0033157),-0.47288204980211107,-1.0166222009811414,0.4444444444444444,1.0,1.0,10/28,17.86%,PRR5L;TPR;PCNT;PCM1;B3GAT3;PTPN1;SIRT7;PLK3;ICE1;GCC2
prerank,GO_Biological_Process_2021__regulation of isotype switching (GO:0045191),-0.5344921339291172,-1.0164120226946654,0.4,1.0,1.0,8/13,29.04%,SHLD1;KMT5B;TP53BP1;HMCES;SUPT6H;SLC15A4;SHLD2;PARP3
prerank,GO_Biological_Process_2021__response to tumor necrosis factor (GO:0034612),-0.41581142500061846,-1.0163853834716545,0.3793103448275862,1.0,1.0,7/61,6.40%,NPNT;PID1;TNFRSF11A;GCH1;SFRP1;AFF3;IGBP1
prerank,GO_Biological_Process_2021__'de novo' posttranslational protein folding (GO:0051084),0.507500244911116,1.0161601585881226,0.5066666666666667,1.0,1.0,7/27,22.33%,HSPA1L;DNAJB1;HSPA5;HSPA8;UGGT1;ERO1A;HSPA14
prerank,GO_Biological_Process_2021__regulation of exocytosis (GO:0017157),0.47574288139275467,1.0161162056601583,0.36486486486486486,1.0,1.0,10/45,24.52%,EXPH5;RAB9A;ATP6AP1;RAB8A;STXBP6;SYTL4;SEPTIN1;LGI3;RAB21;CADPS2
prerank,GO_Biological_Process_2021__central nervous system myelination (GO:0022010),0.5833116676719796,1.0160949552171163,0.43103448275862066,1.0,1.0,2/10,5.34%,SOX10;PLP1
prerank,GO_Biological_Process_2021__cellular amino acid catabolic process (GO:0009063),0.4291795926158823,1.0160594091209327,0.4444444444444444,1.0,1.0,18/72,22.06%,SDS;GOT1;ACAD8;HSD17B10;ALDH4A1;IDO1;FAH;ARG1;ACMSD;GAD1;IL4I1;ASPA;DAO;GLDC;CARNS1;DBT;PIPOX;ACAT1
prerank,"GO_Biological_Process_2021__RNA phosphodiester bond hydrolysis, exonucleolytic (GO:0090503)",0.6725634938578788,1.0159702688572796,0.5423728813559322,1.0,1.0,1/5,24.70%,PDE12
prerank,GO_Biological_Process_2021__negative regulation of antigen receptor-mediated signaling pathway (GO:0050858),0.5411159431882121,1.0158764596331917,0.4925373134328358,1.0,1.0,4/17,26.27%,CD160;PRNP;GPS2;LAPTM5
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043280),0.43954278472637254,1.0158725713546457,0.4626865671641791,1.0,1.0,11/91,11.81%,CASP12;BOK;CARD8;BCAP31;FADD;HIP1R;REST;CASP8;KHDC1;FAS;GPER1
prerank,GO_Biological_Process_2021__negative regulation of B cell differentiation (GO:0045578),-0.5980025123175197,-1.0157874894618975,0.46153846153846156,1.0,1.0,3/5,8.01%,INHA;SFRP1;ID2
prerank,GO_Biological_Process_2021__cellular calcium ion homeostasis (GO:0006874),0.4147080820688054,1.015638141889422,0.40789473684210525,1.0,1.0,27/108,17.88%,CALB1;CSRP3;WFS1;CAV3;CCL5;GCM2;CALCB;ELANE;TMEM203;VAPB;SLC24A4;FKBP1B;SLC24A2;HERPUD1;SCGN;TMEM178A;GPER1;SLC24A1;DRD3;ATP1B1;CAMK2D;HTR2B;PLN;CHRNA7;CCDC47;NPTN;TRDN
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle cell proliferation (GO:0048661),0.510398823616032,1.015612577227214,0.47540983606557374,1.0,1.0,7/33,9.09%,LDLRAP1;CCL5;PDGFRB;ELANE;IGFBP5;NOX1;STAT1
prerank,GO_Biological_Process_2021__rescue of stalled ribosome (GO:0072344),0.6626619443663645,1.015488945384679,0.5074626865671642,1.0,1.0,2/5,32.54%,LTN1;MTRES1
prerank,GO_Biological_Process_2021__mitotic DNA replication checkpoint signaling (GO:0033314),0.6291418203365698,1.0153689641324006,0.5303030303030303,1.0,1.0,2/9,11.05%,TICRR;CDC6
prerank,GO_Biological_Process_2021__glucose homeostasis (GO:0042593),0.44127615836048784,1.0147615669840009,0.4657534246575342,1.0,1.0,7/65,10.02%,WFS1;CAV3;SLC30A8;HKDC1;ADIPOR2;PPARGC1A;LRRC8D
prerank,GO_Biological_Process_2021__dermatan sulfate metabolic process (GO:0030205),-0.5909953791358524,-1.014656500299202,0.5,1.0,1.0,4/10,22.69%,VCAN;CHST12;IDUA;DSEL
prerank,GO_Biological_Process_2021__plasma membrane bounded cell projection assembly (GO:0120031),-0.34531639450381435,-1.014536914204539,0.4,1.0,1.0,59/243,18.95%,KIT;UBXN10;CDH13;CDC14B;ARL13B;ARFIP2;RILP;CFAP221;ABCC4;B9D1;EHD4;PDE6D;PTPN23;CFAP52;EXOC7;RAB3IP;PCNT;FHDC1;SNAP29;ANO6;CEP83;PCM1;CNGA4;TRAF3IP1;NRP1;TTC39C;PTPDC1;TTC36;PARVA;FGD5;ABLIM2;MKS1;RILPL1;SCLT1;KIF24;PTPRO;ATAT1;TRAPPC14;CFAP70;PIBF1;PPP1R9B;CFAP20;CLUAP1;BBIP1;RAB11FIP3;DZIP1L;CFAP44;WDPCP;NUDCD3;TCTN1;RFX2;CYS1;WDR35;INTU;VSTM5;EXOC2;KIAA0586;DNAH5;NEK1
prerank,"GO_Biological_Process_2021__wound healing, spreading of epidermal cells (GO:0035313)",0.6469215431008528,1.0141218762275477,0.5178571428571429,1.0,1.0,1/6,4.62%,ITGA5
prerank,GO_Biological_Process_2021__protein exit from endoplasmic reticulum (GO:0032527),0.5425876876537261,1.014091397087702,0.463768115942029,1.0,1.0,4/23,16.28%,LMAN1;SYVN1;HERPUD1;DERL1
prerank,GO_Biological_Process_2021__stem cell differentiation (GO:0048863),-0.45811004464117916,-1.0140215950745899,0.38235294117647056,1.0,1.0,4/32,8.75%,KIT;SFRP1;TGFB2;HMGA2
prerank,GO_Biological_Process_2021__negative regulation of double-strand break repair via nonhomologous end joining (GO:2001033),-0.6298007668310646,-1.01397462817403,0.4594594594594595,1.0,1.0,2/7,14.83%,HMGA2;HSF1
prerank,GO_Biological_Process_2021__regulation of establishment of planar polarity (GO:0090175),-0.40164769483908863,-1.0138842708821711,0.43333333333333335,1.0,1.0,1/76,0.50%,ROR2
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell proliferation (GO:1904705),0.5012930586384176,1.0136823294056654,0.4857142857142857,1.0,1.0,6/29,11.81%,LDLRAP1;IGFBP5;SOD2;CDKN1B;PRKG1;GPER1
prerank,GO_Biological_Process_2021__protein kinase C-activating G protein-coupled receptor signaling pathway (GO:0007205),-0.5516437544757261,-1.0135681076437693,0.5,1.0,1.0,3/11,10.31%,AZU1;DGKD;DGKH
prerank,GO_Biological_Process_2021__regulation of cyclase activity (GO:0031279),-0.6447790041573654,-1.0131863136316992,0.4375,1.0,1.0,2/5,26.57%,CAP2;MAPK8
prerank,GO_Biological_Process_2021__purine ribonucleoside triphosphate metabolic process (GO:0009205),0.5833349346916202,1.0129689664683272,0.4857142857142857,1.0,1.0,7/12,32.67%,RAB23;AK4;LRRK2;RHOQ;MFN1;GTPBP1;ENTPD7
prerank,GO_Biological_Process_2021__NAD biosynthetic process (GO:0009435),-0.4724510640977326,-1.0129540127694097,0.4838709677419355,1.0,1.0,3/21,4.57%,NMNAT3;NAXE;SLC22A13
prerank,GO_Biological_Process_2021__cell communication by electrical coupling involved in cardiac conduction (GO:0086064),-0.5609843776488002,-1.012580674573657,0.47619047619047616,1.0,1.0,1/12,0.68%,PKP2
prerank,GO_Biological_Process_2021__polyadenylation-dependent snoRNA 3'-end processing (GO:0071051),-0.6209854432369806,-1.0122077416179298,0.525,1.0,1.0,3/6,16.67%,EXOSC10;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__lens fiber cell development (GO:0070307),0.6398629217582894,1.0121607625256002,0.5384615384615384,1.0,1.0,4/7,29.50%,BFSP1;WNT5B;ABI2;WNT7A
prerank,GO_Biological_Process_2021__L-phenylalanine metabolic process (GO:0006558),-0.5691408480315329,-1.012060363336874,0.5,1.0,1.0,1/9,0.72%,PAH
prerank,GO_Biological_Process_2021__T cell differentiation in thymus (GO:0033077),0.621663039304124,1.0120241097568359,0.4626865671641791,1.0,1.0,3/12,6.92%,GLI3;PTPRC;FADD
prerank,GO_Biological_Process_2021__regulation of transport (GO:0051049),0.5164636512170515,1.0118844676813974,0.5285714285714286,1.0,1.0,7/29,20.90%,SLC30A8;CLDN10;DNAJA1;RAB11A;PINK1;LRRK2;REEP5
prerank,GO_Biological_Process_2021__negative regulation of phosphate metabolic process (GO:0045936),-0.5183532102139637,-1.0117735817280225,0.43243243243243246,1.0,1.0,3/18,3.21%,BMP7;INHA;PRKRIP1
prerank,GO_Biological_Process_2021__protein kinase A signaling (GO:0010737),0.6599504989525442,1.0116737288741438,0.5423728813559322,1.0,1.0,2/7,18.82%,MYOM1;TTN
prerank,GO_Biological_Process_2021__telomere maintenance via telomere trimming (GO:0090737),-0.6121466200693535,-1.011217585073136,0.5128205128205128,1.0,1.0,3/10,13.09%,ERCC1;SMARCAL1;XRCC3
prerank,GO_Biological_Process_2021__formation of extrachromosomal circular DNA (GO:0001325),-0.6121466200693535,-1.011217585073136,0.5128205128205128,1.0,1.0,3/10,13.09%,ERCC1;SMARCAL1;XRCC3
prerank,GO_Biological_Process_2021__t-circle formation (GO:0090656),-0.6121466200693535,-1.011217585073136,0.5128205128205128,1.0,1.0,3/10,13.09%,ERCC1;SMARCAL1;XRCC3
prerank,GO_Biological_Process_2021__dolichyl diphosphate metabolic process (GO:0046465),0.6290687866743359,1.0111271032700764,0.47368421052631576,1.0,1.0,2/6,21.94%,DOLK;DOLPP1
prerank,GO_Biological_Process_2021__dolichyl diphosphate biosynthetic process (GO:0006489),0.6290687866743359,1.0111271032700764,0.47368421052631576,1.0,1.0,2/6,21.94%,DOLK;DOLPP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Stem Cells,0.473097165980345,1.0110549083274476,0.43283582089552236,1.0,1.0,13/50,18.43%,PTGES;KLRG2;SH2D4A;AP1M2;IGSF3;SERTAD4;CELSR1;SIX4;SEMA3F;TUFT1;ALOXE3;TOM1L1;SHROOM3
prerank,GO_Biological_Process_2021__regulation of DNA metabolic process (GO:0051052),0.48011007704783537,1.0109189119147959,0.5,1.0,1.0,4/39,18.07%,TICRR;HELB;SUB1;TOM1L1
prerank,GO_Biological_Process_2021__positive regulation of helicase activity (GO:0051096),-0.6631436591992665,-1.0105894018764081,0.5,1.0,1.0,2/7,7.41%,CHTOP;GTF2H2
prerank,GO_Biological_Process_2021__positive regulation of chemokine (C-X-C motif) ligand 2 production (GO:2000343),0.6840661737495938,1.010572618888205,0.5576923076923077,1.0,1.0,1/5,19.30%,CD74
prerank,GO_Biological_Process_2021__response to interferon-gamma (GO:0034341),0.5039262866123706,1.0104855277056937,0.47058823529411764,1.0,1.0,15/35,29.26%,CCL5;CIITA;STAT1;EPRS1;CD74;TLR2;SP100;IFITM3;GBP6;GBP5;PDE12;SLC11A1;RPL13A;SYNCRIP;CD47
prerank,GO_Biological_Process_2021__regulation of Ras protein signal transduction (GO:0046578),-0.4009461160797044,-1.0104685626208942,0.36363636363636365,1.0,1.0,16/74,16.69%,SPRY4;EPHB2;RABL3;IGF1;RASGRF1;RASGRP1;TGFB2;MMD2;SPRY3;RALGPS1;NGF;SPRY1;ARFGAP1;DENND1A;ARHGAP44;MYO9B
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide catabolic process (GO:0009223),0.5879296884138502,1.0103293854426176,0.5,1.0,1.0,1/13,1.78%,TDG
prerank,GO_Biological_Process_2021__imitative learning (GO:0098596),-0.60019155084906,-1.010002842853794,0.4883720930232558,1.0,1.0,3/5,35.74%,HTT;SHANK3;NRXN1
prerank,GO_Biological_Process_2021__vocal learning (GO:0042297),-0.60019155084906,-1.010002842853794,0.4883720930232558,1.0,1.0,3/5,35.74%,HTT;SHANK3;NRXN1
prerank,GO_Biological_Process_2021__regulation of catecholamine secretion (GO:0050433),0.5323107937011599,1.0099696549858066,0.4864864864864865,1.0,1.0,6/28,19.24%,SYT2;SYT4;DRD3;SYT15;SYT9;SYT13
prerank,GO_Biological_Process_2021__signal transduction in response to DNA damage (GO:0042770),-0.42832921046596373,-1.0097349877714892,0.4444444444444444,1.0,1.0,12/46,24.26%,TRIAP1;MAP3K20;HUS1;USP10;CDC5L;ATM;TP53BP1;CASP9;BRIP1;CHEK2;NDRG1;ATRIP
prerank,GO_Biological_Process_2021__lipid transport (GO:0006869),-0.37947883793826276,-1.0097035994640473,0.37037037037037035,1.0,1.0,23/94,15.27%,PRELID2;ABCC4;TRIAP1;ABCA13;PITPNC1;FABP5;CHKA;NME4;SLC27A3;APOA1;NR1H4;SCARB1;ABCD1;APOE;PITPNM1;PITPNA;GOT2;SLCO3A1;SLC25A17;ABCA9;OSBP;ABCG4;SLCO1C1
prerank,GO_Biological_Process_2021__positive regulation of RNA binding (GO:1905216),0.677931123320236,1.0095590509174757,0.48214285714285715,1.0,1.0,3/5,27.64%,NCBP1;EIF3E;FMR1
prerank,GO_Biological_Process_2021__cellular response to peptide (GO:1901653),-0.42881097259943945,-1.0094293761023139,0.32142857142857145,1.0,1.0,8/42,11.56%,ITGA4;CACNA2D1;IGF1;CACNA1A;TIMELESS;GRIN2A;ABCC1;DDX11
prerank,GO_Biological_Process_2021__positive regulation of insulin-like growth factor receptor signaling pathway (GO:0043568),-0.6396348468203219,-1.00935533396223,0.48717948717948717,1.0,1.0,1/5,3.96%,IGF1
prerank,GO_Biological_Process_2021__regulation of skeletal muscle tissue development (GO:0048641),0.6739135527907283,1.0092112670901332,0.532258064516129,1.0,1.0,2/5,28.98%,TGFB1;FLOT1
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species biosynthetic process (GO:1903428),0.6470271950967736,1.0090018876204236,0.4838709677419355,1.0,1.0,2/7,11.48%,ADGRB1;PLCG2
prerank,GO_Biological_Process_2021__BMP signaling pathway (GO:0030509),-0.4295354790094628,-1.0089843422232632,0.3125,1.0,1.0,9/47,11.83%,BMP7;HIVEP1;TGFB2;RGMB;AMH;BMP6;TGFB3;DLX5;NOG
prerank,GO_Biological_Process_2021__motor neuron axon guidance (GO:0008045),0.6254974467680731,1.0089616371842127,0.45161290322580644,1.0,1.0,7/11,30.42%,RHOH;SEMA3A;CHN1;SLIT1;NTN1;RAC1;SLIT2
prerank,GO_Biological_Process_2021__regulation of lipid storage (GO:0010883),0.5966480267696586,1.0089604264034375,0.49230769230769234,1.0,1.0,1/15,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of G1/S transition of mitotic cell cycle (GO:2000045),-0.391768616090583,-1.0088651493483016,0.4827586206896552,1.0,1.0,11/59,14.41%,CDK2AP2;GFI1B;LSM10;TFDP1;ID2;INO80;EIF4G1;SLFN11;EGFR;MYO16;RPTOR
prerank,GO_Biological_Process_2021__regulation of protein localization to membrane (GO:1905475),0.5116676001212601,1.0088081618610611,0.4931506849315068,1.0,1.0,3/26,3.49%,LDLRAP1;GPC6;GPC5
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport into cytosol (GO:0010524),-0.5090745576467914,-1.0083655911240361,0.42105263157894735,1.0,1.0,1/18,0.13%,TRPC3
prerank,GO_Biological_Process_2021__positive regulation of Arp2/3 complex-mediated actin nucleation (GO:2000601),0.6025744130249063,1.008229920981027,0.5,1.0,1.0,2/8,13.50%,WASF1;BRK1
prerank,GO_Biological_Process_2021__positive regulation of glycoprotein biosynthetic process (GO:0010560),-0.5990478315421157,-1.0081966507874993,0.4722222222222222,1.0,1.0,2/8,10.46%,IGF1;CHP1
prerank,GO_Biological_Process_2021__cellular response to cGMP (GO:0071321),-0.6651855019679038,-1.0081764231576364,0.5365853658536586,1.0,1.0,1/5,4.09%,PDE3A
prerank,GO_Biological_Process_2021__response to cGMP (GO:0070305),-0.6651855019679038,-1.0081764231576364,0.5365853658536586,1.0,1.0,1/5,4.09%,PDE3A
prerank,GO_Biological_Process_2021__ribonucleoside monophosphate biosynthetic process (GO:0009156),0.5440903423383029,1.0081548833955767,0.45901639344262296,1.0,1.0,5/12,26.19%,PAICS;RFK;IMPDH1;GMPS;PPAT
prerank,GO_Biological_Process_2021__plasma membrane phospholipid scrambling (GO:0017121),0.626741852017102,1.0078840803193116,0.5263157894736842,1.0,1.0,2/7,5.91%,PLSCR5;PLSCR4
prerank,GO_Biological_Process_2021__response to host defenses (GO:0052200),0.6131536132194241,1.007798454374343,0.5238095238095238,1.0,1.0,3/7,29.20%,B2M;TLR2;RPS27A
prerank,GO_Biological_Process_2021__modulation by symbiont of host defense response (GO:0052031),0.6131536132194241,1.007798454374343,0.5238095238095238,1.0,1.0,3/7,29.20%,B2M;TLR2;RPS27A
prerank,GO_Biological_Process_2021__peptidyl-proline modification (GO:0018208),0.4878532529581508,1.0074407747098575,0.4576271186440678,1.0,1.0,4/24,11.67%,FKBP4;FKBP1B;FKBP5;PPID
prerank,GO_Biological_Process_2021__C21-steroid hormone biosynthetic process (GO:0006700),0.6234825296839634,1.0071016949961236,0.5238095238095238,1.0,1.0,3/9,22.47%,TSPOAP1;AKR1B1;CACNA1H
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway in response to virus (GO:0039528),-0.6356050375574556,-1.0070350023567674,0.5,1.0,1.0,1/7,2.42%,IFIH1
prerank,GO_Biological_Process_2021__positive regulation of myoblast fusion (GO:1901741),0.6562791470095573,1.0067807484138303,0.5555555555555556,1.0,1.0,1/7,5.29%,ADGRB1
prerank,GO_Biological_Process_2021__interleukin-9-mediated signaling pathway (GO:0038113),0.5985595839537141,1.006734590465951,0.4838709677419355,1.0,1.0,2/6,12.67%,STAT1;STAT5A
prerank,GO_Biological_Process_2021__cellular response to interleukin-9 (GO:0071355),0.5985595839537141,1.006734590465951,0.4838709677419355,1.0,1.0,2/6,12.67%,STAT1;STAT5A
prerank,GO_Biological_Process_2021__tRNA transport (GO:0051031),-0.44821016036901784,-1.0066094108199213,0.45454545454545453,1.0,1.0,3/35,6.59%,NUP210;TPR;NUP37
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen (GO:0002483),0.5795089436735281,1.006607236075557,0.5151515151515151,1.0,1.0,4/11,21.89%,ERAP2;HLA-A;B2M;ERAP1
prerank,GO_Biological_Process_2021__sulfation (GO:0051923),0.6556946103796553,1.0064995963264247,0.5737704918032787,1.0,1.0,1/5,4.84%,SULT2A1
prerank,GO_Biological_Process_2021__glycosaminoglycan catabolic process (GO:0006027),0.46472712867623917,1.0057762176098362,0.4927536231884058,1.0,1.0,4/45,3.49%,PRELP;GPC6;HSPG2;GPC5
prerank,GO_Biological_Process_2021__phosphate-containing compound metabolic process (GO:0006796),-0.36021093386258984,-1.0057268750743324,0.5,1.0,1.0,14/168,8.53%,DUSP4;ALK;DUSP5;PTPRB;G6PC3;EPHB2;SPHK2;THNSL2;PNKP;XYLB;GDE1;ENPP3;STAT3;DUSP12
prerank,GO_Biological_Process_2021__TRIF-dependent toll-like receptor signaling pathway (GO:0035666),0.5072915960903898,1.0056354868668875,0.44285714285714284,1.0,1.0,4/25,10.45%,CD300LF;CD14;FADD;CASP8
prerank,GO_Biological_Process_2021__MyD88-independent toll-like receptor signaling pathway (GO:0002756),0.5072915960903898,1.0056354868668875,0.44285714285714284,1.0,1.0,4/25,10.45%,CD300LF;CD14;FADD;CASP8
prerank,PanglaoDB_Augmented_2021__Osteoclasts,0.43292892570983954,1.0054882436107238,0.44155844155844154,1.0,1.0,23/89,17.88%,C3AR1;AGER;OSCAR;STAB1;HCK;FCGRT;SERPINF1;CD14;CMKLR1;SLC2A1;TCN2;SIGLEC1;MAFB;C1QA;CTSK;ESR1;VWF;SLC7A7;TNFRSF11B;SPP1;PSAP;CTSZ;AQP9
prerank,"GO_Biological_Process_2021__synaptic transmission, cholinergic (GO:0007271)",0.5705838856472715,1.0053477293859538,0.5517241379310345,1.0,1.0,5/15,17.34%,CHRNB1;NQO1;CHRNE;CHRNB4;CHRNA7
prerank,GO_Biological_Process_2021__organic acid transport (GO:0015849),0.4327092337891722,1.005321518764003,0.4567901234567901,1.0,1.0,18/80,19.13%,SLC7A11;SLCO2B1;SLC23A1;ABCC2;SLC36A1;LRRC8D;SLC26A7;SLC38A2;ABCG2;SLC10A5;SLC7A7;SLC10A1;SLC7A14;SLC38A5;SLC16A1;SLC38A4;SLCO1A2;SLC16A8
prerank,"GO_Biological_Process_2021__regulation of transcription, DNA-templated (GO:0006355)",-0.3073453155891983,-1.0048698416061284,0.5,1.0,1.0,184/1686,11.19%,ETV1;CD38;ETV5;PER2;ZNF534;KIT;ZNF485;ZNF442;ZNF707;NRG1;POU6F2;MYB;BMP7;SOX13;TBX6;MYRFL;RFX8;LEF1;HMGN5;TOX2;GFI1B;RUNX1;TCF24;ARID5A;CREB5;RGS14;CREB3L4;ZNF628;ZNF572;ZNF496;ARID3B;ZNF606;ATOH8;TLE2;KDM8;BRCA2;ASCL1;E2F5;CEBPD;NFATC1;NRL;ZNF132;OR7D2;FOS;TYMS;SOX12;EREG;ZBTB7C;BACH2;TEAD2;TBL1Y;ZNF18;ZNF449;ZNF347;PRDM5;ZNF256;ZNF239;HDAC5;NFIB;BRD3;IGF1;PRDM15;ZMIZ2;ATXN1L;ZNF117;ZNF155;WTIP;ZNF48;TCIM;SFRP1;WWTR1;ID4;HIVEP1;ZNF25;RING1;PRRX1;MED30;BCL6;RFX1;ORC1;ZNF354B;ZNF608;HDAC1;ZBTB39;WBP2NL;ZNF562;AKAP17A;ZNF273;TFAP4;ZNF334;ZNF300;TIMELESS;RGMB;TOX;ZNF441;SAMD7;POU3F4;ZNF596;TRPS1;HR;ZNF846;SBNO2;HDX;ATF3;ZNF558;NFIX;TFDP1;E2F6;ARX;FOXP1;ZNF536;GTF2H2;ETS1;PHC2;ZFHX3;ZNF446;GTF2H2C;E4F1;CBFB;SPDEF;ZNF771;NR1H4;MAFK;SFMBT1;ID2;SAMD13;ZSCAN16;DHFR;ZNF397;VGLL3;LBH;CDK5RAP2;TSFM;WIZ;STAT3;MAP2K3;ZNF264;FOXK1;ZNF99;ZHX3;RRM2;ZBTB7A;CCNH;HMGA2;BAZ1B;SMARCAL1;RORA;ZNF514;ANKRD2;SUV39H2;ZNF416;ZNF429;KLF16;POU2F2;BRD9;CDK14;BTG1;SMARCA4;DACH2;XRCC6;TGFB3;ZNF184;PBX4;IFI16;ZNF215;THOC1;CDH1;DLX5;POU3F1;IKZF3;LCORL;ZNF26;ZNF275;ZBTB47;DAP;CREB3L1;MXI1;MAMLD1;ZGLP1;NFX1;SIRT2;KDM3B;APOE;ZNF66
prerank,GO_Biological_Process_2021__positive regulation of cellular metabolic process (GO:0031325),0.43691557475637005,1.0048373248129017,0.5147058823529411,1.0,1.0,9/80,9.22%,PLA2G10;CCL5;PDGFRB;INHBA;NTF3;FASN;AGT;IFNLR1;SFRP4
prerank,GO_Biological_Process_2021__activin receptor signaling pathway (GO:0032924),0.5642827223108523,1.0047804438716899,0.4857142857142857,1.0,1.0,6/12,29.16%,INHBA;ACVR2B;HJV;ACVR1C;ACVR2A;INHBB
prerank,PanglaoDB_Augmented_2021__Choroid Plexus Cells,0.42350145514547716,1.0047238984159927,0.44,1.0,1.0,15/104,12.49%,SLC13A4;GPC6;CLIC6;WFS1;MMP15;PRLR;IGFBP5;AGT;RARRES2;CPE;TMEM178A;NOTCH3;SLC31A1;CHMP1A;KIAA1217
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-threonine phosphorylation (GO:0010800),-0.525124699203493,-1.0044180661570066,0.4,1.0,1.0,2/21,5.70%,BMP7;AZU1
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type II Cells,0.45775547091746355,1.0043094334004055,0.49295774647887325,1.0,1.0,9/51,7.21%,STEAP4;ALDH1A1;CLIC6;AGER;SLCO2B1;CRLF1;TFCP2L1;CD14;SCEL
prerank,GO_Biological_Process_2021__neuron development (GO:0048666),-0.37422827103488215,-1.0042100436372097,0.4230769230769231,1.0,1.0,9/124,5.75%,ETV1;ALK;RUNX1;GPRIN2;ASCL1;RASGRF1;BLOC1S4;EPHA5;TGFB2
prerank,PanglaoDB_Augmented_2021__Pulmonary Alveolar Type I Cells,-0.3515362190791674,-1.0041311528679986,0.375,1.0,1.0,13/106,7.33%,NPNT;LAMB2;BTC;RND3;PXDC1;SDC4;CLDN4;WWTR1;COL4A3;EGFL6;PDPN;ANO1;LRIG3
prerank,GO_Biological_Process_2021__ganglion development (GO:0061548),-0.5708757140242011,-1.0041150048395866,0.4411764705882353,1.0,1.0,3/9,11.13%,ASCL1;UNC5C;NRP1
prerank,GO_Biological_Process_2021__negative regulation of sprouting angiogenesis (GO:1903671),0.6004126179262785,1.0040712420136875,0.5423728813559322,1.0,1.0,2/9,8.69%,ADAMTS9;EPN1
prerank,GO_Biological_Process_2021__regulation of MHC class I biosynthetic process (GO:0045343),0.6634117269518178,1.0038552816199566,0.5806451612903226,1.0,1.0,5/5,33.67%,CIITA;HSPH1;TAF7;NLRC5;NLRP12
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-lysine acetylation (GO:2000757),0.6043774790705398,1.0036775917865186,0.5079365079365079,1.0,1.0,4/9,26.38%,BRCA1;TAF7;KLF15;SET
prerank,GO_Biological_Process_2021__actin filament network formation (GO:0051639),-0.49347325587235935,-1.0033279742498495,0.41379310344827586,1.0,1.0,6/11,26.93%,COBL;CARMIL2;LCP1;CARMIL1;FHOD1;ACTN1
prerank,PanglaoDB_Augmented_2021__Undefined Placental Cells,0.43324108761906654,1.003287221420467,0.547945205479452,1.0,1.0,11/69,12.31%,MMP15;PRDX4;HSD11B2;FASN;FKBP4;TEAD4;MBNL3;DUSP9;AP1M2;CCDC86;SLC52A2
prerank,GO_Biological_Process_2021__neuron maturation (GO:0042551),0.5390887068284893,1.0030887770865304,0.5254237288135594,1.0,1.0,3/17,14.13%,RND1;C1QA;MTCH1
prerank,GO_Biological_Process_2021__positive regulation of heart rate (GO:0010460),0.5775615496619628,1.0029702279344082,0.4788732394366197,1.0,1.0,5/12,25.08%,ADRB1;KCNQ1;ATP2A2;ADRA1D;RYR2
prerank,GO_Biological_Process_2021__energy reserve metabolic process (GO:0006112),-0.5211299656190863,-1.0029114840392186,0.475,1.0,1.0,1/16,1.84%,PID1
prerank,GO_Biological_Process_2021__phosphorylation (GO:0016310),-0.3463311281013486,-1.0028314067375466,0.5,1.0,1.0,33/347,10.31%,NRK;ALK;TRIB2;PRAG1;LMTK3;EPHB2;NEK6;PRKG2;DGKB;SGK1;NRBP2;MAML1;FGGY;GRK5;MAP3K20;MARK1;TGFB2;SPHK2;PRKCD;DGKD;CDC42BPB;AURKA;PLK2;PEAK3;CSK;PNKP;XYLB;STAT3;LIMK1;CDK14;CDKL1;TAF1;DGKH
prerank,GO_Biological_Process_2021__negative regulation of interleukin-2 production (GO:0032703),-0.5132188871392014,-1.0027702033499128,0.4666666666666667,1.0,1.0,1/13,1.01%,HOMER2
prerank,GO_Biological_Process_2021__nitric oxide mediated signal transduction (GO:0007263),0.5400601625215784,1.0027285040757483,0.4918032786885246,1.0,1.0,2/13,9.02%,AGT;NDNF
prerank,GO_Biological_Process_2021__synapse pruning (GO:0098883),0.6325417604551897,1.0024665627363716,0.5094339622641509,1.0,1.0,2/6,21.40%,C1QA;CX3CR1
prerank,GO_Biological_Process_2021__cellular triglyceride homeostasis (GO:0035356),-0.599765881388836,-1.0021984097028755,0.53125,1.0,1.0,1/5,7.93%,NR1H4
prerank,GO_Biological_Process_2021__arginine catabolic process (GO:0006527),0.6233024840444221,1.0020661233662176,0.5079365079365079,1.0,1.0,2/7,16.63%,ARG1;ARG2
prerank,GO_Biological_Process_2021__DNA double-strand break processing (GO:0000729),0.49612693510829053,1.0019604898125467,0.5230769230769231,1.0,1.0,5/18,27.73%,MRE11;BRCA1;RNF138;RAD50;BLM
prerank,GO_Biological_Process_2021__phagosome acidification (GO:0090383),-0.49892684129006487,-1.0019507989621048,0.43902439024390244,1.0,1.0,2/20,7.58%,ATP6V0D2;RAB7A
prerank,GO_Biological_Process_2021__organelle organization (GO:0006996),-0.330165802001471,-1.0019046874781474,0.4444444444444444,1.0,1.0,39/360,11.15%,GEM;RAB32;PEX7;FBXW8;GOLGA8M;PTCD2;SPTSSB;WTIP;GOLGA8H;CFAP61;PI4K2A;ALAS1;MARK1;TMEM11;SLC25A33;TMED3;MTX1;ZMYM6;CDC42BPB;SIPA1L3;PLIN5;NUMA1;CIDEA;NSFL1C;RAB7A;ATP8B4;PLD2;GOLGA8A;KIF25;HPS6;GOLGA8B;ARAP3;GOLGA8N;ODF2;ABCD1;UBXN2A;SEMA6A;SMPD4;APOE
prerank,GO_Biological_Process_2021__negative regulation of cell population proliferation (GO:0008285),-0.34781845750159307,-1.0018840867833216,0.26666666666666666,1.0,1.0,29/284,9.84%,PER2;NOX4;ROR2;CDH13;GREM1;SLC16A2;RBP4;EREG;ZBTB7C;SMYD2;ADAMTS8;SST;SFRP1;EMD;COL4A3;TGFB2;ALDH1A2;TFAP4;P3H3;PDPN;TFDP1;ETS1;PTHLH;MCC;COL18A1;BTG1;DLG5;TGFB3;VIP
prerank,GO_Biological_Process_2021__positive regulation of NF-kappaB transcription factor activity (GO:0051092),0.42887749363377065,1.0016270381934511,0.49333333333333335,1.0,1.0,8/116,6.08%,TRIM22;TRIM5;ROR1;IL18R1;AGER;TRIML2;TRIM32;AGT
prerank,GO_Biological_Process_2021__negative regulation of neuron projection regeneration (GO:0070571),-0.5900672692758878,-1.0014592352666807,0.525,1.0,1.0,2/7,10.87%,RTN4R;PTPRS
prerank,GO_Biological_Process_2021__skeletal muscle fiber development (GO:0048741),-0.5718096086242552,-1.0014414260666558,0.4864864864864865,1.0,1.0,2/6,9.57%,RYR1;SELENON
prerank,GO_Biological_Process_2021__telomere maintenance in response to DNA damage (GO:0043247),-0.5425836281556008,-1.0011985688965446,0.5135135135135135,1.0,1.0,1/9,5.63%,DCLRE1B
prerank,GO_Biological_Process_2021__regulation of steroid metabolic process (GO:0019218),-0.49853217160083985,-1.0010555201956002,0.41025641025641024,1.0,1.0,4/19,11.15%,NR1H4;RORA;ACADVL;APOE
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity (GO:2000117),-0.4511389893755767,-1.000935741689598,0.41379310344827586,1.0,1.0,7/37,11.83%,CARD18;SH3RF1;TRIAP1;IGBP1;IFI16;XIAP;NGF
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway via JAK-STAT (GO:0060397),0.5692659909891109,1.0008279739059167,0.46551724137931033,1.0,1.0,3/10,14.66%,PRLR;STAT5A;STAT6
prerank,GO_Biological_Process_2021__positive regulation of cysteine-type endopeptidase activity (GO:2001056),0.4473129616824625,1.0008180838968472,0.5068493150684932,1.0,1.0,12/48,21.12%,CARD8;BCAP31;FADD;REST;CASP8;GPER1;RIPK2;LGMN;CYCS;NODAL;USP50;BAD
prerank,GO_Biological_Process_2021__positive regulation of calcium ion transport (GO:0051928),0.52804896729196,1.0007216411700208,0.5178571428571429,1.0,1.0,4/24,3.19%,MYLK;WFS1;CCL5;PDGFRB
prerank,GO_Biological_Process_2021__regulation of interleukin-2 production (GO:0032663),-0.436607636141291,-1.0002209764288963,0.4074074074074074,1.0,1.0,3/30,3.37%,HOMER2;RUNX1;PNP
prerank,GO_Biological_Process_2021__regulation of dendrite morphogenesis (GO:0048814),-0.45235750132899966,-1.0001850847074063,0.46153846153846156,1.0,1.0,3/30,10.65%,FBXW8;KNDC1;NSMF
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated immunity (GO:0002711),0.5118105728027215,1.0000425514813687,0.5245901639344263,1.0,1.0,2/23,8.88%,FADD;HLA-A
prerank,PanglaoDB_Augmented_2021__Myocytes,0.4404897119498525,0.999944253172602,0.44776119402985076,1.0,1.0,13/88,11.19%,LAMA2;CSRP3;CAV3;TRIM54;FABP3;NID2;ACTC1;ANGPTL2;PRKG1;CMKLR1;CASQ1;DOCK1;NOTCH3
prerank,GO_Biological_Process_2021__connective tissue development (GO:0061448),-0.44615884645208304,-0.999866487522878,0.4482758620689655,1.0,1.0,2/31,3.57%,SULF2;COL11A2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane (GO:0051204),-0.4270673717476303,-0.9989937386485663,0.42105263157894735,1.0,1.0,1/21,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__cellular response to nitrogen compound (GO:1901699),-0.52423774792774,-0.9987566237704231,0.5757575757575758,1.0,1.0,6/17,15.91%,TIMELESS;NR1H4;DDX11;SPIDR;HSF1;EPG5
prerank,GO_Biological_Process_2021__regulation of pattern recognition receptor signaling pathway (GO:0062207),-0.6321102376674905,-0.9987191383143429,0.5121951219512195,1.0,1.0,2/7,11.62%,ZDHHC5;XIAP
prerank,GO_Biological_Process_2021__regulation of G protein-coupled receptor signaling pathway (GO:0008277),-0.40304303414085607,-0.9986158611947633,0.34782608695652173,1.0,1.0,13/68,11.42%,FRMPD1;GNG4;RGS14;KLK6;GRK5;ZDHHC3;PPEF1;FNTB;SAG;CAMKMT;RGS20;GIT2;RGS2
prerank,GO_Biological_Process_2021__establishment of endothelial barrier (GO:0061028),0.5163643344867191,0.998442942712389,0.5,1.0,1.0,3/25,8.64%,MARVELD2;TJP3;F11R
prerank,GO_Biological_Process_2021__B cell activation (GO:0042113),-0.47141249207087194,-0.9982101315528307,0.44,1.0,1.0,10/50,8.70%,KIT;ITGA4;EPHB2;RABL3;HDAC5;RASGRP1;AKAP17A;BCL2;IL11;ZBTB7A
prerank,GO_Biological_Process_2021__cellular response to gonadotropin stimulus (GO:0071371),0.6809196777610543,0.9980417415032872,0.576271186440678,1.0,1.0,1/5,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase C signaling (GO:0090037),-0.6121660994033464,-0.9976764678953641,0.4186046511627907,1.0,1.0,1/6,6.17%,SPHK2
prerank,GO_Biological_Process_2021__cyclic nucleotide transport (GO:0070729),-0.63226371663564,-0.997661795441791,0.5111111111111111,1.0,1.0,2/5,5.13%,ABCC4;SLC19A1
prerank,GO_Biological_Process_2021__response to glucocorticoid (GO:0051384),0.5475727138875858,0.9975799480091616,0.45,1.0,1.0,3/16,9.19%,CALCR;GOT1;REST
prerank,GO_Biological_Process_2021__muscle cell development (GO:0055001),0.5332929390302963,0.9975051086698458,0.5454545454545454,1.0,1.0,3/24,8.16%,CHRNB1;CAV3;MYOF
prerank,GO_Biological_Process_2021__T cell activation involved in immune response (GO:0002286),-0.5618540850430127,-0.9971771157839868,0.5,1.0,1.0,1/9,1.47%,F2RL1
prerank,GO_Biological_Process_2021__positive regulation of translational initiation (GO:0045948),0.5456070939284424,0.9969826424586412,0.5483870967741935,1.0,1.0,5/17,23.78%,CCL5;EIF2B5;POLR2D;YTHDF1;RPS6KB2
prerank,GO_Biological_Process_2021__3'-phosphoadenosine 5'-phosphosulfate metabolic process (GO:0050427),-0.5107240339917472,-0.9966057806258711,0.5128205128205128,1.0,1.0,1/14,0.67%,PAPSS2
prerank,GO_Biological_Process_2021__regulation of T cell cytokine production (GO:0002724),0.5715002516775385,0.9964299563915782,0.48333333333333334,1.0,1.0,3/12,19.71%,HLA-A;SMAD7;B2M
prerank,GO_Biological_Process_2021__negative regulation of signal transduction by p53 class mediator (GO:1901797),0.5622119303464792,0.9964162177428498,0.5,1.0,1.0,5/16,23.43%,TWIST1;CD74;SNAI2;KDM1A;ARMC10
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 acetylation (GO:2000615),-0.5590294908925518,-0.9963765254237962,0.48484848484848486,1.0,1.0,2/11,6.17%,HDAC5;SPHK2
prerank,GO_Biological_Process_2021__positive regulation of stem cell proliferation (GO:2000648),0.551311639901472,0.996358025484498,0.5573770491803278,1.0,1.0,5/15,16.60%,PTPRC;CCNE1;SOX11;NANOG;EPCAM
prerank,GO_Biological_Process_2021__membrane invagination (GO:0010324),0.6278542173257031,0.9963045543684762,0.6,1.0,1.0,1/6,17.32%,CHMP2A
prerank,GO_Biological_Process_2021__transcription by RNA polymerase I (GO:0006360),-0.41871842658522906,-0.9962724091368971,0.3225806451612903,1.0,1.0,11/33,18.19%,ERCC2;TCOF1;GTF2H2;CCNH;UBTF;TAF1;POLR2L;POLR1A;TAF1D;POLR1G;GTF2H5
prerank,GO_Biological_Process_2021__protein localization to membrane (GO:0072657),-0.3612783357452441,-0.9960247287504249,0.43478260869565216,1.0,1.0,15/171,10.23%,FRMPD1;PKP2;RAB32;ITGA4;EHD4;PRAM1;PTCH1;ZDHHC3;FGF13;RAB40A;HPS6;RAB3C;TMEM150A;CDH1;ABHD17A
prerank,GO_Biological_Process_2021__neuron projection morphogenesis (GO:0048812),-0.3742876433648605,-0.995798164315592,0.4090909090909091,1.0,1.0,10/127,7.61%,NRK;BMP7;EPHB2;NTNG1;NYAP2;SGK1;DOCK10;DSCAML1;NYAP1;SHANK1
prerank,GO_Biological_Process_2021__regulation of interleukin-12 production (GO:0032655),0.5066941411995891,0.995636083302282,0.4861111111111111,1.0,1.0,5/28,13.11%,AGER;CMKLR1;PLCG2;SCIMP;RIPK2
prerank,GO_Biological_Process_2021__regulation of sequestering of triglyceride (GO:0010889),-0.5208282368516322,-0.9955920852654946,0.5609756097560976,1.0,1.0,4/12,16.69%,PLIN5;CIDEA;PNPLA2;OSBPL11
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum (GO:0070972),0.5404946487716801,0.9955450849440816,0.44285714285714284,1.0,1.0,6/14,29.39%,BCAP31;HSPA5;LRRK2;RYR2;GABARAPL2;TAPT1
prerank,GO_Biological_Process_2021__regulation of B cell activation (GO:0050864),0.5748319326653558,0.9948608417657854,0.5,1.0,1.0,4/15,17.55%,AHR;THEMIS2;IL4I1;BANK1
prerank,GO_Biological_Process_2021__regulation of autophagosome maturation (GO:1901096),0.5668790702455531,0.9946415170687684,0.5588235294117647,1.0,1.0,1/11,8.38%,PHF23
prerank,GO_Biological_Process_2021__P-body assembly (GO:0033962),0.5852767616774601,0.9944820689214963,0.5172413793103449,1.0,1.0,1/12,6.31%,PATL2
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization to mitochondrion (GO:1903749),0.4657934642161477,0.9942924509533391,0.47297297297297297,1.0,1.0,10/45,21.22%,ARIH2;HSPA1L;CASP8;YWHAH;YWHAG;RHOU;UBL5;PINK1;BAD;TP63
prerank,GO_Biological_Process_2021__regulation of histone deacetylation (GO:0031063),0.5956216670247398,0.9941786156692471,0.55,1.0,1.0,2/10,5.70%,ZBTB7B;ING2
prerank,GO_Biological_Process_2021__nucleotide transport (GO:0006862),-0.573763265079068,-0.9941272345447804,0.45454545454545453,1.0,1.0,4/6,23.42%,SLC25A33;EPG5;ABCC5;ABCC11
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell membrane repolarization (GO:0099625),0.648247832687275,0.9939237767852168,0.5161290322580645,1.0,1.0,1/7,2.82%,KCNE2
prerank,GO_Biological_Process_2021__regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901028),0.5628621709278789,0.9935266164079668,0.4918032786885246,1.0,1.0,4/13,22.76%,BOK;HIP1R;ACAA2;TMEM14A
prerank,GO_Biological_Process_2021__transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery (GO:0000972),-0.605089750498013,-0.9934508549195564,0.4634146341463415,1.0,1.0,3/6,21.41%,NUP107;LDB1;RAE1
prerank,GO_Biological_Process_2021__cell-matrix adhesion (GO:0007160),-0.4197071231160252,-0.99342111158652,0.5,1.0,1.0,4/79,1.49%,ITGB5;NPNT;ITGA4;CD96
prerank,GO_Biological_Process_2021__monoacylglycerol metabolic process (GO:0046462),0.6064432953566921,0.9929772685135191,0.5362318840579711,1.0,1.0,5/9,33.47%,FAAH;DGAT2L6;PLA2G4A;DGAT2;DGAT1
prerank,GO_Biological_Process_2021__protein localization to endoplasmic reticulum exit site (GO:0070973),0.658050457950659,0.9925746319895997,0.5344827586206896,1.0,1.0,2/5,20.42%,BCAP31;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of vascular associated smooth muscle cell migration (GO:1904754),0.5951095106673356,0.992467128353735,0.48214285714285715,1.0,1.0,2/8,13.76%,IGFBP5;DOCK4
prerank,GO_Biological_Process_2021__cellular protein-containing complex assembly (GO:0034622),0.4100898048508994,0.9923345085044499,0.475,1.0,1.0,21/136,19.54%,ANKS4B;TMEM35A;TCP1;PRLR;CHMP4B;EID2;HIP1R;CASQ1;ANLN;CCDC39;HIGD1C;ARL6;TGFB1;STXBP6;SMAD1;COX7A2L;VBP1;CHMP2A;PSMG1;RPL38;NSG1
prerank,PanglaoDB_Augmented_2021__Myoepithelial Cells,-0.38838311026508604,-0.992328495300926,0.4583333333333333,1.0,1.0,21/67,13.41%,LAMB2;CA3;FHL2;RND3;AHNAK2;LAMB3;SDC4;MYH11;WWTR1;ANO1;LRIG3;ALDH1A3;CARD10;FERMT1;LAMA3;MME;COL4A2;SH3RF2;PARVA;EGFR;PERP
prerank,GO_Biological_Process_2021__cellular response to oxidised low-density lipoprotein particle stimulus (GO:0140052),-0.6337103662076009,-0.9920565160929831,0.5,1.0,1.0,1/5,4.94%,TICAM1
prerank,GO_Biological_Process_2021__myofibril assembly (GO:0030239),0.5081995598854455,0.9917359094886281,0.5,1.0,1.0,7/32,15.38%,CSRP3;PDGFRB;ACTC1;CASQ1;MYPN;SIX4;PGM5
prerank,GO_Biological_Process_2021__outer dynein arm assembly (GO:0036158),0.5269075519099713,0.9917348640070742,0.4807692307692308,1.0,1.0,3/14,10.13%,ODAD4;ODAD3;DNAH8
prerank,GO_Biological_Process_2021__negative regulation of vascular permeability (GO:0043116),-0.6102155315429337,-0.9916679713984166,0.5945945945945946,1.0,1.0,4/10,22.15%,PDE3A;ANGPT1;PTPRJ;DDAH1
prerank,GO_Biological_Process_2021__acetylcholine receptor signaling pathway (GO:0095500),0.5248100197758266,0.9913293376613683,0.4603174603174603,1.0,1.0,5/18,24.32%,RGS10;CDK5R1;CHRNA7;LYPD1;CHRNB2
prerank,GO_Biological_Process_2021__vascular endothelial growth factor signaling pathway (GO:0038084),-0.5548881412743306,-0.9910495335142688,0.5,1.0,1.0,1/11,0.77%,KDR
prerank,GO_Biological_Process_2021__positive regulation of brown fat cell differentiation (GO:0090336),-0.5007173279427993,-0.990930949040024,0.4782608695652174,1.0,1.0,2/12,0.92%,BMP7;SOX13
prerank,GO_Biological_Process_2021__vitamin transport (GO:0051180),0.5032119019253416,0.9908741451215766,0.4861111111111111,1.0,1.0,7/22,16.22%,SLC23A1;AMN;CBLIF;TCN2;SLC52A2;ABCG2;SLC52A1
prerank,GO_Biological_Process_2021__protection from non-homologous end joining at telomere (GO:0031848),-0.5655250475075283,-0.9905778253439215,0.5476190476190477,1.0,1.0,1/7,5.63%,DCLRE1B
prerank,GO_Biological_Process_2021__regulation of mitotic spindle assembly (GO:1901673),0.5436867946505979,0.9905558566627436,0.5,1.0,1.0,5/16,17.32%,CHMP4B;CHMP2B;CHMP1A;EML3;CHMP2A
prerank,GO_Biological_Process_2021__peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine (GO:0018231),0.5183316892074196,0.9905274238410965,0.5066666666666667,1.0,1.0,3/22,9.33%,ZDHHC22;ZDHHC11;ZDHHC6
prerank,GO_Biological_Process_2021__peptidyl-L-cysteine S-palmitoylation (GO:0018230),0.5183316892074196,0.9905274238410965,0.5066666666666667,1.0,1.0,3/22,9.33%,ZDHHC22;ZDHHC11;ZDHHC6
prerank,GO_Biological_Process_2021__microtubule bundle formation (GO:0001578),-0.43664553857707106,-0.9901573453914626,0.4,1.0,1.0,7/37,10.46%,CFAP46;TPPP3;JHY;NUMA1;CDK5RAP2;RSPH1;CHP1
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation or removal (GO:0070647),-0.5143470751051301,-0.9901379588833977,0.4411764705882353,1.0,1.0,4/12,25.14%,ATG10;DESI2;DESI1;ATG7
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of NF-kappaB (GO:0007253),-0.5804894439092985,-0.9900000840936627,0.5365853658536586,1.0,1.0,3/7,18.81%,CCDC22;FAF1;NFKBIB
prerank,GO_Biological_Process_2021__icosanoid secretion (GO:0032309),-0.5718900044596029,-0.989679051998199,0.5405405405405406,1.0,1.0,2/9,4.99%,ABCC4;DRD4
prerank,GO_Biological_Process_2021__thyroid hormone generation (GO:0006590),0.5869091100349756,0.9892581606505301,0.48148148148148145,1.0,1.0,3/8,17.23%,TPO;CTSK;DIO1
prerank,GO_Biological_Process_2021__homotypic cell-cell adhesion (GO:0034109),-0.44940019041823476,-0.9889891929281214,0.47368421052631576,1.0,1.0,6/32,12.12%,UBASH3B;FIBP;HSPB1;TYRO3;PDGFRA;TLN1
prerank,"GO_Biological_Process_2021__protein alpha-1,2-demannosylation (GO:0036508)",0.4979071378973523,0.9882506749893777,0.44155844155844154,1.0,1.0,8/23,29.20%,SYVN1;RNF139;MAN1A1;UGGT1;MAN1B1;RNF185;MARCHF6;RPS27A
prerank,GO_Biological_Process_2021__receptor metabolic process (GO:0043112),0.4611779211085746,0.988208353156407,0.44594594594594594,1.0,1.0,5/46,19.54%,LDLRAP1;ACKR3;TGFB1;LGMN;NSG1
prerank,GO_Biological_Process_2021__regulation of activin receptor signaling pathway (GO:0032925),0.565486770684845,0.9876857961144325,0.5409836065573771,1.0,1.0,3/13,18.77%,SMAD7;ACVR2B;NODAL
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage (GO:1902230),0.5260448087387417,0.9869747169540851,0.5454545454545454,1.0,1.0,4/21,6.04%,ACKR3;TRIM32;ING2;CDKN2D
prerank,MSigDB_Hallmark_2020__Adipogenesis,0.3991439072597479,0.9868265761121471,0.5194805194805194,1.0,1.0,36/180,23.93%,ENPP2;MYLK;CCNG2;RREB1;NKIRAS1;CD302;LPCAT3;TST;MRAP;PTGER3;ADIPOR2;FAH;STAT5A;YWHAG;STOM;ACOX1;ALDH2;ACADL;DHCR7;MTARC2;DECR1;SPARCL1;PDCD4;G3BP2;ACAA2;IDH3A;ARL4A;REEP5;DBT;PPARG;ANGPTL4;TKT;PLIN2;RETSAT;NABP1;GHITM
prerank,GO_Biological_Process_2021__regulation of bicellular tight junction assembly (GO:2000810),-0.5257074615191408,-0.9868261589861708,0.5,1.0,1.0,2/14,7.73%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__glycerophospholipid metabolic process (GO:0006650),0.471523242862797,0.9867360056334551,0.4931506849315068,1.0,1.0,10/61,18.92%,PLA2G10;PDGFRB;PLA2G7;SERINC1;PIGC;PIGV;PIGH;PRDX6;PLCD1;ENPP6
prerank,PanglaoDB_Augmented_2021__Retinal Ganglion Cells,-0.3706818815614151,-0.9866147198431019,0.42105263157894735,1.0,1.0,32/152,16.26%,POU6F2;TOX2;NKAIN3;DTX1;CPNE4;FBLL1;ADGRA1;NYAP1;MMD2;KCNC1;IGLON5;RGS8;SLC29A4;MAPK4;CDK14;TMEM196;STMN2;ELAVL3;MTUS2;NGF;PLPPR5;GRIA2;DNER;BRINP1;FBXO44;CELF5;SRRM3;ABCG4;FXYD7;GALNT14;KCTD8;NELL1
prerank,GO_Biological_Process_2021__potassium ion import across plasma membrane (GO:1990573),0.48936800701808963,0.9863853658221796,0.4722222222222222,1.0,1.0,6/34,15.36%,SLC12A7;KCNE2;ATP12A;KCNJ9;KCNJ11;ATP1B1
prerank,"GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway, TAP-independent (GO:0002486)",0.608026179784333,0.9860468146293183,0.46296296296296297,1.0,1.0,1/6,8.88%,HLA-A
prerank,GO_Biological_Process_2021__antigen processing and presentation of endogenous peptide antigen via MHC class I via ER pathway (GO:0002484),0.608026179784333,0.9860468146293183,0.46296296296296297,1.0,1.0,1/6,8.88%,HLA-A
prerank,"GO_Biological_Process_2021__Wnt signaling pathway, planar cell polarity pathway (GO:0060071)",-0.4042862424332734,-0.9856817681149286,0.4444444444444444,1.0,1.0,1/75,0.50%,ROR2
prerank,GO_Biological_Process_2021__negative regulation of chemokine production (GO:0032682),-0.5079944896395732,-0.9854507570638391,0.4523809523809524,1.0,1.0,1/10,1.47%,F2RL1
prerank,GO_Biological_Process_2021__regulation of miRNA metabolic process (GO:2000628),-0.6148619402286849,-0.9854193481442003,0.5306122448979592,1.0,1.0,4/5,38.37%,RC3H1;NFKB1;RELA;HRAS
prerank,GO_Biological_Process_2021__cellular potassium ion homeostasis (GO:0030007),0.6075172041014048,0.9852857545885995,0.5797101449275363,1.0,1.0,3/9,18.43%,ATP12A;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__serine family amino acid catabolic process (GO:0009071),0.6355007072647227,0.9851411087581919,0.6379310344827587,1.0,1.0,3/7,17.17%,SDS;DAO;GLDC
prerank,GO_Biological_Process_2021__cardiac conduction system development (GO:0003161),0.5462604932092129,0.985071988578589,0.5441176470588235,1.0,1.0,1/12,1.11%,MSX1
prerank,GO_Biological_Process_2021__renal system development (GO:0072001),0.46813929680109617,0.9848929191274542,0.48484848484848486,1.0,1.0,4/34,9.09%,LRP4;WFS1;AGT;STAT1
prerank,GO_Biological_Process_2021__regulation of relaxation of cardiac muscle (GO:1901897),0.6691390656484661,0.9847516397544477,0.5,1.0,1.0,2/5,17.19%,CAMK2D;PLN
prerank,GO_Biological_Process_2021__response to interleukin-6 (GO:0070741),-0.5403314915867844,-0.9847316631176279,0.5135135135135135,1.0,1.0,3/9,6.79%,PTPRT;PID1;SBNO2
prerank,GO_Biological_Process_2021__response to ketone (GO:1901654),-0.41826982586639855,-0.9847064841968957,0.46875,1.0,1.0,4/17,12.82%,CATSPER2;TGFB2;TGFB3;CATSPERG
prerank,GO_Biological_Process_2021__positive regulation of protein import (GO:1904591),-0.4454471566675786,-0.984603973752444,0.4375,1.0,1.0,6/25,14.95%,TPR;PRKCD;CDH1;DMAP1;BAG3;MAVS
prerank,GO_Biological_Process_2021__protein retention in ER lumen (GO:0006621),0.6472553268897535,0.9845233358135895,0.5396825396825397,1.0,1.0,1/7,15.43%,GPAA1
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:0001844),-0.5999585005698637,-0.9843664084785795,0.5,1.0,1.0,1/5,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__retinoic acid receptor signaling pathway (GO:0048384),0.5886909207114335,0.984315895490017,0.4925373134328358,1.0,1.0,2/10,21.48%,TBX1;PPARG
prerank,GO_Biological_Process_2021__regulation of cyclic-nucleotide phosphodiesterase activity (GO:0051342),-0.6047484493964657,-0.9842623804163532,0.5531914893617021,1.0,1.0,1/5,7.26%,MAPK7
prerank,PanglaoDB_Augmented_2021__T Regulatory Cells,0.4486830811899799,0.9842309334165326,0.5142857142857142,1.0,1.0,6/47,5.48%,GNLY;ITK;CD4;CCL5;CNGB1;PTPRC
prerank,GO_Biological_Process_2021__mesenchymal cell development (GO:0014031),-0.5397093939794866,-0.9841487951456437,0.46875,1.0,1.0,2/12,4.64%,NRG1;TCOF1
prerank,PanglaoDB_Augmented_2021__Photoreceptor Cells,-0.3633819106551425,-0.9840459135755615,0.5,1.0,1.0,28/133,14.17%,SPHKAP;SVOP;PCBP3;NRL;CACNG3;NTNG1;TNR;ADAMTS5;AP3B2;ZNF536;MMD2;KCNC1;RGS8;GRIA4;RAB3C;GRIA1;SAG;ROM1;CDH20;TMEM196;CTNNA2;GAD2;STMN2;ELAVL3;CNTNAP5;GRIA2;SRRM4;FRRS1L
prerank,GO_Biological_Process_2021__methionine metabolic process (GO:0006555),-0.5665961164370779,-0.9839775476630822,0.48717948717948717,1.0,1.0,3/7,23.30%,MTR;MTHFR;MTHFD1
prerank,GO_Biological_Process_2021__regulation of Golgi to plasma membrane protein transport (GO:0042996),-0.6052798446570085,-0.9839173764441776,0.525,1.0,1.0,2/7,13.31%,CSK;PKDCC
prerank,GO_Biological_Process_2021__chaperone cofactor-dependent protein refolding (GO:0051085),0.5062200043723802,0.9839150941217247,0.4857142857142857,1.0,1.0,6/22,22.33%,HSPA1L;DNAJB1;HSPA5;HSPA8;ERO1A;HSPA14
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response (GO:0002821),0.6333285112659002,0.9837820753139245,0.59375,1.0,1.0,3/6,23.68%,FADD;SKAP1;IL6ST
prerank,GO_Biological_Process_2021__sensory perception of smell (GO:0007608),0.5663692011129753,0.9835968919778939,0.5633802816901409,1.0,1.0,1/10,5.88%,SLC24A4
prerank,GO_Biological_Process_2021__regulation of stem cell differentiation (GO:2000736),-0.40951762915531065,-0.9833918212859923,0.41379310344827586,1.0,1.0,4/71,9.66%,MYB;RUNX1;CBFB;PDGFRA
prerank,GO_Biological_Process_2021__regulation of heterotypic cell-cell adhesion (GO:0034114),-0.5104297686300643,-0.983079049338596,0.45454545454545453,1.0,1.0,4/14,8.19%,BMP7;APOA1;MAPK7;GCNT2
prerank,GO_Biological_Process_2021__response to nitric oxide (GO:0071731),-0.6032251876704512,-0.9829237492408416,0.5813953488372093,1.0,1.0,1/6,10.48%,MTR
prerank,GO_Biological_Process_2021__response to caffeine (GO:0031000),-0.6441149790569352,-0.982639985064328,0.5319148936170213,1.0,1.0,1/5,4.62%,RYR1
prerank,GO_Biological_Process_2021__cellular response to caffeine (GO:0071313),-0.6441149790569352,-0.982639985064328,0.5319148936170213,1.0,1.0,1/5,4.62%,RYR1
prerank,GO_Biological_Process_2021__O-glycan processing (GO:0016266),-0.4077132422890573,-0.9824975836741273,0.46153846153846156,1.0,1.0,5/41,4.52%,GXYLT2;ST6GALNAC2;ST3GAL3;ST3GAL1;GALNT10
prerank,GO_Biological_Process_2021__positive regulation of cellular respiration (GO:1901857),0.5960428801827666,0.9824756626650932,0.5172413793103449,1.0,1.0,2/9,16.73%,IFNLR1;PINK1
prerank,GO_Biological_Process_2021__response to endoplasmic reticulum stress (GO:0034976),0.4274739849246108,0.9824105469361997,0.4875,1.0,1.0,16/99,18.21%,ANKS4B;WFS1;ITPR1;RCN3;SYVN1;BCAP31;UFM1;HSPA5;HERPUD1;RNF139;CHAC1;EIF2B5;DERL1;DAB2IP;CCDC47;TMEM33
prerank,GO_Biological_Process_2021__regulation of axonogenesis (GO:0050770),0.4742381792621865,0.9823343711535357,0.5,1.0,1.0,2/49,5.49%,LRP4;OMG
prerank,GO_Biological_Process_2021__tongue development (GO:0043586),0.6542782440868524,0.9820661122111989,0.5606060606060606,1.0,1.0,2/5,13.02%,TBX1;SIX4
prerank,GO_Biological_Process_2021__calcium ion transmembrane transport (GO:0070588),-0.3780833945454788,-0.9819259088164559,0.4666666666666667,1.0,1.0,12/80,12.75%,TRPC3;TRPC7;CACNA2D1;MCUB;CACNA1A;TRPC4AP;GRIN2A;ANO6;GRIN2C;SLC24A3;TRPC5;SLC35G1
prerank,GO_Biological_Process_2021__response to light stimulus (GO:0009416),0.4371778805801757,0.9818905970893788,0.4925373134328358,1.0,1.0,6/48,14.12%,TYR;ELANE;TRIM32;CDKN2D;SLC24A1;OPN3
prerank,PanglaoDB_Augmented_2021__NK Cells,0.4432981649690945,0.9818665477517179,0.5223880597014925,1.0,1.0,14/64,9.88%,GNLY;ITK;IL18R1;KLRG1;SPON2;CCL5;CD8A;DOCK2;PTPRC;AHR;GMFG;TAGAP;ARHGAP9;ARHGAP25
prerank,GO_Biological_Process_2021__integrated stress response signaling (GO:0140467),0.6068808106908639,0.9814381312286651,0.5735294117647058,1.0,1.0,3/11,20.80%,HSPA5;HERPUD1;EIF2AK1
prerank,GO_Biological_Process_2021__artery development (GO:0060840),0.5468013301050723,0.9814196585649757,0.5384615384615384,1.0,1.0,4/16,20.41%,TBX1;SMAD7;ACVR2B;ANGPTL3
prerank,GO_Biological_Process_2021__histone H3 acetylation (GO:0043966),-0.4080644733130207,-0.9812932376188401,0.48484848484848486,1.0,1.0,5/38,12.81%,LEF1;BRCA2;TAF10;JADE2;TAF12
prerank,GO_Biological_Process_2021__positive regulation of cell death (GO:0010942),0.45946708545086834,0.9812805220843697,0.4861111111111111,1.0,1.0,6/49,13.11%,CALCR;CDKN1B;BNIP3;ACOX2;C1QA;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of mast cell activation (GO:0033005),-0.6285543122924224,-0.9812326376072492,0.5625,1.0,1.0,2/5,11.93%,SPHK2;NR4A3
prerank,GO_Biological_Process_2021__positive regulation of mitotic nuclear division (GO:0045840),-0.4479305457497896,-0.9808868264790265,0.43333333333333335,1.0,1.0,4/25,7.03%,BTC;EREG;IGF1;AURKA
prerank,GO_Biological_Process_2021__negative regulation of innate immune response (GO:0045824),-0.47279749607579147,-0.9807948054228904,0.4166666666666667,1.0,1.0,9/30,18.08%,LYAR;TRAFD1;SAMHD1;TYRO3;IFI16;CACTIN;SUSD4;IRAK3;FAM3A
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte proliferation (GO:0050671),-0.4392866112850762,-0.9804477405644109,0.48,1.0,1.0,3/46,3.37%,CD38;EPHB2;PNP
prerank,GO_Biological_Process_2021__fatty-acyl-CoA metabolic process (GO:0035337),0.5331024713718335,0.9802182906061255,0.5652173913043478,1.0,1.0,9/17,34.44%,FASN;SCD;ACSL4;DGAT2;CBR4;ACSL3;ACLY;DGAT1;SCD5
prerank,GO_Biological_Process_2021__receptor catabolic process (GO:0032801),-0.485733622323675,-0.9798250635946764,0.47058823529411764,1.0,1.0,2/21,6.89%,MYLIP;VLDLR
prerank,GO_Biological_Process_2021__cellular response to cAMP (GO:0071320),0.47405896393003233,0.979734175629781,0.5694444444444444,1.0,1.0,13/29,32.31%,IGFBP5;AHR;KCNQ1;AQP9;CRHBP;DMTN;HCN4;SLC5A5;PDE2A;AANAT;INPP5K;SLC26A6;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of T cell receptor signaling pathway (GO:0050860),0.5458771882498803,0.979690786569924,0.5076923076923077,1.0,1.0,3/14,26.27%,CD160;PRNP;LAPTM5
prerank,GO_Biological_Process_2021__cellular response to heat (GO:0034605),-0.4702606697457283,-0.9796552918484726,0.48717948717948717,1.0,1.0,4/31,6.11%,TPR;TCIM;FGF1;ANO1
prerank,GO_Biological_Process_2021__positive regulation of proteolysis involved in cellular protein catabolic process (GO:1903052),0.4923553254700918,0.9796351692093429,0.5,1.0,1.0,7/27,18.98%,CAV3;KCNE2;ATP5IF1;RNF139;DAB2IP;PYHIN1;MAGEF1
prerank,GO_Biological_Process_2021__negative regulation of cellular response to growth factor stimulus (GO:0090288),-0.3825837389195794,-0.979576364196752,0.47058823529411764,1.0,1.0,16/64,14.60%,SULF2;GREM1;SPRY4;LEMD2;APLN;CRIM1;SPRY3;VWC2;SORL1;CREB3L1;NOG;NBL1;SPRY1;BMPER;PTPN1;EPN2
prerank,GO_Biological_Process_2021__regulation of cell migration (GO:0030334),-0.32455879415320354,-0.9791292990819677,0.5,1.0,1.0,49/321,12.12%,KIT;ROR2;KDR;PTPRT;SRGAP1;SINHCAF;LEF1;F2RL1;CDH13;MIEN1;PRR5L;EPHB2;PDGFD;NTNG1;CLDN4;SST;IGF1;SGK1;DOCK10;ITGA6;SFRP1;ARSB;FGF1;PDPN;MCTP1;NUMB;GCNT2;PLXNA1;STAT3;PLXNA2;MAPRE1;CSF1R;PDGFRA;GNA12;DLG5;PDGFC;SORL1;CDH1;LMO4;CTNNA2;DRD1;TRIP6;SEMA6A;DUSP10;PHACTR1;SEMA4C;NOG;SH3RF2;MDK
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-serine phosphorylation (GO:0033138),0.4523787643161387,0.9790826187140927,0.5263157894736842,1.0,1.0,10/59,23.11%,CALCR;NTF3;RIPK2;TGFB1;OPRD1;PINK1;MTCP1;CREBL2;TERF2IP;ATP2B4
prerank,GO_Biological_Process_2021__negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902236),0.5423100616769483,0.9790053103892553,0.5384615384615384,1.0,1.0,5/14,23.69%,SYVN1;HERPUD1;BCL2L1;LRRK2;CREB3
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045898),0.5558809714977377,0.9789915823161617,0.5263157894736842,1.0,1.0,2/10,28.46%,ESR1;PSMC6
prerank,GO_Biological_Process_2021__cellular response to calcium ion (GO:0071277),0.44570820168031944,0.978791793014087,0.5,1.0,1.0,17/60,21.54%,NEUROD2;SYT2;SYT4;CPNE5;PLCG2;ECT2;CAMK2D;SYT15;LGMN;SYT9;ITPKB;SYT13;CRHBP;MCOLN1;DMTN;ADGRV1;MEF2A
prerank,GO_Biological_Process_2021__dicarboxylic acid metabolic process (GO:0043648),-0.41886607717609786,-0.9786408746347259,0.55,1.0,1.0,15/46,15.78%,DGLUCY;IDH2;SLC19A1;OGDH;MTHFD2;DHFR;MDH1B;ACOT8;MTHFS;NIT2;GOT2;MTHFD2L;MTHFD1L;PHYH;MTHFR
prerank,GO_Biological_Process_2021__peptide hormone secretion (GO:0030072),0.5723951238852545,0.9784256365047319,0.5483870967741935,1.0,1.0,4/14,25.20%,SLC30A8;GHRL;CDK16;RAB1A
prerank,GO_Biological_Process_2021__positive regulation of neurotransmitter transport (GO:0051590),0.667209574764799,0.9783537551549921,0.5645161290322581,1.0,1.0,1/5,11.81%,GPER1
prerank,GO_Biological_Process_2021__ceramide metabolic process (GO:0006672),-0.41559259360861667,-0.9780292675074662,0.5185185185185185,1.0,1.0,6/44,11.02%,SPTSSB;CLN6;CERS4;SGMS2;SPTLC1;SMPD4
prerank,GO_Biological_Process_2021__cellular response to leucine starvation (GO:1990253),0.5773660639826944,0.9775959793385146,0.5737704918032787,1.0,1.0,1/10,8.39%,SESN3
prerank,GO_Biological_Process_2021__regulation of cellular pH (GO:0030641),-0.44246970514309736,-0.9774615969798464,0.43333333333333335,1.0,1.0,2/26,2.19%,CA2;SLC9A8
prerank,GO_Biological_Process_2021__mitotic cytokinesis (GO:0000281),0.45540673169207535,0.9773292934612783,0.5540540540540541,1.0,1.0,6/43,15.73%,RASA1;CHMP4B;ANLN;RHOB;ECT2;RACGAP1
prerank,MSigDB_Hallmark_2020__Interferon Alpha Response,0.42801708701975394,0.9771687423721869,0.4625,1.0,1.0,22/77,21.79%,TRIM5;IL15;ISG20;IL7;IFIT3;CMPK2;CASP8;LPAR6;IRF1;RIPK2;IFI44;PSMA3;PSMB8;CNP;TRIM14;TRIM25;IFI27;CD74;B2M;PLSCR1;PROCR;IFITM3
prerank,PanglaoDB_Augmented_2021__Leydig Cells,0.41956193023577915,0.9769447611201907,0.4794520547945205,1.0,1.0,22/105,13.26%,LAMA2;ALDH1A1;TIMP3;ACSBG1;PRLR;POSTN;HSD11B2;INHBA;IGFBP5;NR5A2;PLSCR4;RARRES2;ANGPTL2;CPE;F10;EFEMP1;MAFB;CYP19A1;KIAA1217;EPAS1;ADAM21;PLAUR
prerank,GO_Biological_Process_2021__negative regulation of alpha-beta T cell differentiation (GO:0046639),0.6195247292868792,0.9766790440572223,0.576271186440678,1.0,1.0,2/5,2.52%,GLI3;ZBTB7B
prerank,GO_Biological_Process_2021__regulation of cortisol biosynthetic process (GO:2000064),0.6234810515911264,0.9762538558452821,0.5818181818181818,1.0,1.0,1/6,9.19%,REST
prerank,GO_Biological_Process_2021__positive regulation of viral release from host cell (GO:1902188),0.5718741555864338,0.9760985933103032,0.5416666666666666,1.0,1.0,4/11,23.90%,VPS37B;CHMP2B;CHMP2A;VPS4A
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion (GO:0022408),0.45067283022312166,0.9758824677281317,0.45454545454545453,1.0,1.0,7/34,17.83%,ZNF703;NOTCH1;TGFB1;RGCC;EPCAM;PODXL;NOTCH4
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation to 4-hydroxy-L-proline (GO:0018401),0.5997496716860392,0.9758152981829856,0.5652173913043478,1.0,1.0,1/6,18.08%,P4HA3
prerank,GO_Biological_Process_2021__mitral valve development (GO:0003174),-0.5874701226440974,-0.975484530084041,0.525,1.0,1.0,1/5,16.13%,ACVR1
prerank,GO_Biological_Process_2021__negative regulation of neuron apoptotic process (GO:0043524),0.4457389813840912,0.9751038064502193,0.47761194029850745,1.0,1.0,9/56,9.02%,WFS1;RASA1;CRLF1;NTF3;PTPRZ1;SOD2;PPARGC1A;KIF14;NDNF
prerank,GO_Biological_Process_2021__actin filament reorganization (GO:0090527),-0.560493964060646,-0.9750520582338367,0.5121951219512195,1.0,1.0,1/8,4.28%,EFS
prerank,GO_Biological_Process_2021__positive regulation of actin nucleation (GO:0051127),0.5679507045316725,0.9749373669995006,0.5344827586206896,1.0,1.0,2/11,13.50%,WASF1;BRK1
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling (GO:0010649),0.6106552390151263,0.9748868619194568,0.5535714285714286,1.0,1.0,3/8,21.68%,CAMK2D;TRDN;CALM3
prerank,GO_Biological_Process_2021__cardiac atrium morphogenesis (GO:0003209),0.5677695141590879,0.974340118382542,0.5692307692307692,1.0,1.0,2/10,6.18%,NOTCH1;ZFPM1
prerank,GO_Biological_Process_2021__regulation of neuroblast proliferation (GO:1902692),0.5622720025737066,0.9742746411563815,0.5172413793103449,1.0,1.0,4/15,28.20%,LRRK2;CX3CR1;KDM1A;DCT
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte mediated immunity (GO:0002888),-0.6401453944422271,-0.9742221596239705,0.6060606060606061,1.0,1.0,2/9,4.94%,F2RL1;TICAM1
prerank,GO_Biological_Process_2021__regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083),-0.41140891653147377,-0.9739968564191198,0.4074074074074074,1.0,1.0,7/28,9.46%,TYMS;ORC1;TFDP1;ID2;DHFR;RRM2;CDK14
prerank,GO_Biological_Process_2021__positive regulation of nucleic acid-templated transcription (GO:1903508),-0.32020587873552764,-0.9739031768908952,0.4166666666666667,1.0,1.0,41/394,10.29%,CD38;MYB;BMP7;MYRFL;LEF1;HMGN5;RUNX1;CREB5;ZNF496;ATOH8;KDM8;BRCA2;NFATC1;FOS;TEAD2;NFIB;IGF1;SFRP1;MED30;HDAC1;WBP2NL;TFAP4;RGMB;ETS1;ZFHX3;NR1H4;ID2;LBH;CDK5RAP2;STAT3;MAP2K3;FOXK1;HMGA2;RORA;SMARCA4;XRCC6;TGFB3;PBX4;CDH1;DLX5;POU3F1
prerank,GO_Biological_Process_2021__protein glycosylation (GO:0006486),-0.3678968500428151,-0.9738889600093558,0.45,1.0,1.0,15/115,11.93%,B3GALT9;ALG8;ST6GALNAC2;ST3GAL3;ST3GAL1;ST8SIA2;GALNT10;GAL3ST1;GCNT2;ALG12;ST3GAL2;MOGS;TET1;GCNT4;DPM3
prerank,GO_Biological_Process_2021__posttranscriptional regulation of gene expression (GO:0010608),-0.4097903647489036,-0.973585278439887,0.4864864864864865,1.0,1.0,12/42,21.58%,TCOF1;PUM3;GCNT2;TRIM71;MEX3D;RBM3;MTPN;NANOS3;RC3H1;EIF2B4;TDRD7;LARP1
prerank,PanglaoDB_Augmented_2021__Ductal Cells,-0.40853583026942175,-0.973523218141677,0.5483870967741935,1.0,1.0,15/50,13.61%,BTC;MYH14;LAMB3;SDC4;CLDN4;ANO1;ACE2;ALDH1A3;LAMA3;AKR1C3;GPR39;CDH1;PERP;TSPAN1;PDLIM3
prerank,PanglaoDB_Augmented_2021__Neurons,0.38878259064858606,0.9734649786104078,0.5888888888888889,1.0,1.0,18/265,12.65%,NPY;CALB1;PPP1R1B;PDE1A;SHISA2;ZDHHC22;GRM3;SYT4;ZCCHC12;IFIT3;SCRG1;SPOCK3;CNTN2;NEFM;KCNJ9;RIT2;C11ORF87;GAD1
prerank,GO_Biological_Process_2021__regulation of glucose metabolic process (GO:0010906),-0.4656697227840192,-0.9733326909394316,0.5333333333333333,1.0,1.0,6/30,14.67%,RUBCNL;MLYCD;FOXK1;RORA;IRS1;SIRT7
prerank,GO_Biological_Process_2021__neutrophil activation (GO:0042119),0.589124076683984,0.9732909333637549,0.5384615384615384,1.0,1.0,3/8,4.51%,CCL5;IL15;PREX1
prerank,GO_Biological_Process_2021__ribose phosphate biosynthetic process (GO:0046390),0.6152701419370802,0.9732790907855815,0.5645161290322581,1.0,1.0,2/6,23.18%,G6PD;TKT
prerank,GO_Biological_Process_2021__positive regulation of programmed cell death (GO:0043068),0.3800204922249926,0.9732141110559774,0.5584415584415584,1.0,1.0,31/235,15.13%,PNMA5;GADD45B;NLRP2B;DDX20;PREX1;BOK;CYP1B1;MOAP1;PNMA2;PXT1;FADD;KNG1;HIP1R;BNIP3;SIAH1;DUSP9;REST;SFRP4;DAPK2;CASP8;MAP3K11;RHOB;RNF122;FAS;PPID;GPER1;TFPT;MTCH1;KLF11;DNAJA1;ECT2
prerank,GO_Biological_Process_2021__acylglycerol homeostasis (GO:0055090),-0.5251795290153655,-0.973090929097094,0.475,1.0,1.0,4/15,11.15%,APOA1;RORA;SCARB1;APOE
prerank,GO_Biological_Process_2021__negative regulation of axon regeneration (GO:0048681),-0.595017767765489,-0.9728445683125405,0.5853658536585366,1.0,1.0,2/6,10.87%,RTN4R;PTPRS
prerank,GO_Biological_Process_2021__regulation of gene expression by genetic imprinting (GO:0006349),-0.5390387395681547,-0.9727504617756725,0.45714285714285713,1.0,1.0,2/7,24.05%,DIRAS3;DNMT3A
prerank,"GO_Biological_Process_2021__G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger (GO:0007187)",0.4721888053327582,0.9727142671232295,0.5972222222222222,1.0,1.0,5/33,8.10%,NPY;SSTR1;CNR2;AGT;TSHR
prerank,GO_Biological_Process_2021__positive regulation of establishment of protein localization (GO:1904951),0.5618844096830141,0.9726326409930668,0.5806451612903226,1.0,1.0,5/16,23.34%,TCP1;CCT6A;CCT8;CCT7;CORO2B
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell proliferation (GO:0046640),-0.6375293074051039,-0.9725980213418551,0.5675675675675675,1.0,1.0,1/6,2.07%,SH3RF1
prerank,GO_Biological_Process_2021__superoxide metabolic process (GO:0006801),0.5200466701242435,0.9724164786208844,0.5555555555555556,1.0,1.0,5/21,7.79%,NOX5;PREX1;NOX1;ALOX12;SOD2
prerank,GO_Biological_Process_2021__protein depalmitoylation (GO:0002084),-0.5475319974837893,-0.9722708311268952,0.4722222222222222,1.0,1.0,2/8,10.23%,LYPLA2;ABHD17A
prerank,GO_Biological_Process_2021__macromolecule depalmitoylation (GO:0098734),-0.5475319974837893,-0.9722708311268952,0.4722222222222222,1.0,1.0,2/8,10.23%,LYPLA2;ABHD17A
prerank,GO_Biological_Process_2021__positive regulation of chemotaxis (GO:0050921),-0.4541682791865489,-0.9720584508210383,0.5555555555555556,1.0,1.0,3/33,1.54%,KDR;F2RL1;CDH13
prerank,GO_Biological_Process_2021__negative regulation of microtubule polymerization or depolymerization (GO:0031111),0.4637463763922144,0.971725195259382,0.4788732394366197,1.0,1.0,3/31,9.34%,TRIM54;FKBP4;TPX2
prerank,GO_Biological_Process_2021__positive regulation of bone resorption (GO:0045780),0.6057650460231592,0.9715275220517289,0.53125,1.0,1.0,3/9,16.75%,MC4R;ATP6AP1;SPP1
prerank,GO_Biological_Process_2021__positive regulation of viral entry into host cell (GO:0046598),0.6431338632813194,0.9714566060319699,0.4827586206896552,1.0,1.0,1/5,2.19%,CD4
prerank,GO_Biological_Process_2021__positive regulation by symbiont of entry into host (GO:0075294),0.6431338632813194,0.9714566060319699,0.4827586206896552,1.0,1.0,1/5,2.19%,CD4
prerank,GO_Biological_Process_2021__response to retinoic acid (GO:0032526),0.4529765456927601,0.9714466527084691,0.5428571428571428,1.0,1.0,4/47,8.52%,HSD17B2;WNT8A;CDKN2D;TBX1
prerank,GO_Biological_Process_2021__regulation of brown fat cell differentiation (GO:0090335),-0.4894501694080944,-0.9714459361210915,0.5121951219512195,1.0,1.0,2/15,0.92%,BMP7;SOX13
prerank,GO_Biological_Process_2021__positive regulation of smoothened signaling pathway (GO:0045880),-0.48789189231036845,-0.9713811873963185,0.5428571428571428,1.0,1.0,6/18,16.82%,SFRP1;TEDC2;DLG5;TTC23;KIF7;ULK3
prerank,GO_Biological_Process_2021__negative regulation of kinase activity (GO:0033673),-0.4184884000228842,-0.9709784700453298,0.4230769230769231,1.0,1.0,5/56,4.80%,UBASH3B;TRIB2;SPRED1;PRKRIP1;WWTR1
prerank,PanglaoDB_Augmented_2021__Loop Of Henle Cells,-0.36644898479686194,-0.9708775374693603,0.4230769230769231,1.0,1.0,20/105,10.42%,GEM;KDR;LAMB2;RNF182;ARID5A;PXDC1;NEK6;CDH6;IGF1;SLC12A3;ADAMTS5;ANO1;RIN2;LRRC66;PLXNA2;SSPN;ADGRL4;PDGFRA;RNASE1;COL4A2
prerank,GO_Biological_Process_2021__regulation of chemotaxis (GO:0050920),0.5061638184889315,0.9708567423852598,0.5573770491803278,1.0,1.0,7/26,15.07%,PDGFRB;ELANE;P2RY12;RARRES2;USP14;TGFB1;GPR183
prerank,GO_Biological_Process_2021__regulation of macromolecule metabolic process (GO:0060255),0.3943903608534847,0.9707584158248164,0.4880952380952381,1.0,1.0,20/140,18.19%,TRIM58;TRIM22;TRIM5;TRIML2;RASA1;PTPRC;AHR;YBX3;REST;PCBP2;PRDM6;PRDM1;NANOG;CGGBP1;AFF1;ATP1B1;CAVIN4;TRIM14;CDK6;ATXN7L3B
prerank,GO_Biological_Process_2021__positive regulation of protein maturation (GO:1903319),0.5760205659187082,0.970474982219814,0.53125,1.0,1.0,4/9,31.58%,NKD2;CCBE1;TFR2;NLRC4
prerank,GO_Biological_Process_2021__glucosamine-containing compound metabolic process (GO:1901071),0.5645024561406529,0.9701737839578123,0.547945205479452,1.0,1.0,4/12,25.16%,CHST1;CHST6;EXTL2;OGA
prerank,GO_Biological_Process_2021__epithelial to mesenchymal transition (GO:0001837),-0.44674527442436873,-0.9700272780182565,0.4,1.0,1.0,7/39,11.83%,BMP7;LEF1;TGFB2;FAM83D;HMGA2;DLG5;NOG
prerank,GO_Biological_Process_2021__small nucleolar ribonucleoprotein complex assembly (GO:0000491),-0.5675704327533125,-0.9696745115416994,0.5263157894736842,1.0,1.0,2/9,13.65%,ZNHIT6;NAF1
prerank,GO_Biological_Process_2021__negative regulation of response to stimulus (GO:0048585),0.4449507800262613,0.96954684254715,0.5316455696202531,1.0,1.0,5/48,5.96%,AMBP;WFS1;HHIP;LPCAT3;TWIST1
prerank,GO_Biological_Process_2021__vitamin D metabolic process (GO:0042359),0.5871445817670393,0.9695020357946665,0.5757575757575758,1.0,1.0,3/7,25.62%,CYP2R1;LGMN;LRP2
prerank,GO_Biological_Process_2021__neurotrophin signaling pathway (GO:0038179),0.5359946877610714,0.969276828566718,0.5217391304347826,1.0,1.0,1/19,5.23%,NTF3
prerank,GO_Biological_Process_2021__positive regulation of macrophage differentiation (GO:0045651),0.5885269497458906,0.9689066806985341,0.5373134328358209,1.0,1.0,3/9,13.78%,FADD;CASP8;TGFB1
prerank,GO_Biological_Process_2021__ribosomal small subunit assembly (GO:0000028),0.5573946910625143,0.9689036809657082,0.532258064516129,1.0,1.0,2/15,7.93%,ABT1;ERAL1
prerank,GO_Biological_Process_2021__regulation of flagellated sperm motility (GO:1901317),0.6477009271645938,0.968684754019032,0.5333333333333333,1.0,1.0,1/6,0.48%,TEX101
prerank,GO_Biological_Process_2021__somatic recombination of immunoglobulin genes involved in immune response (GO:0002204),0.6431600205364505,0.9686670780820562,0.5681818181818182,1.0,1.0,4/6,29.18%,RNF168;EXOSC6;MSH6;MSH2
prerank,GO_Biological_Process_2021__nitrogen compound transport (GO:0071705),0.4124949174542422,0.9682447918335841,0.5540540540540541,1.0,1.0,23/111,17.96%,SLC7A11;SLC23A1;ABCC2;RCN3;AMN;TMEM30A;SLC36A1;CBLIF;TCN2;ARRDC3;LRRC8D;CHMP2B;CHMP1A;SLC38A2;SLC52A2;ABCG2;SLC7A7;SLC7A14;SLC52A1;SLC38A5;CHMP2A;AQP9;SLC38A4
prerank,GO_Biological_Process_2021__establishment of planar polarity (GO:0001736),0.6418357538133349,0.9680954772614048,0.5967741935483871,1.0,1.0,1/6,12.27%,CELSR1
prerank,GO_Biological_Process_2021__endoplasmic reticulum to cytosol transport (GO:1903513),0.577741394219611,0.9677921383948402,0.5161290322580645,1.0,1.0,3/15,16.28%,SYVN1;HERPUD1;DERL1
prerank,GO_Biological_Process_2021__midbrain dopaminergic neuron differentiation (GO:1904948),-0.5807027307689534,-0.9675152280033638,0.5510204081632653,1.0,1.0,3/8,22.33%,WNT9B;NR4A2;LRP6
prerank,"GO_Biological_Process_2021__negative regulation of transcription, DNA-templated (GO:0045892)",-0.31354770505321833,-0.9674843598448544,0.6,1.0,1.0,91/752,12.07%,CD38;ETV5;PER2;NRG1;MYB;BMP7;SOX13;TBX6;LEF1;AASS;GFI1B;RUNX1;ARID5A;FHL2;ATOH8;TLE2;KDM8;ASCL1;EREG;PRDM5;ZNF256;ZNF239;HDAC5;SMYD2;TPR;RITA1;SFRP1;ID4;HIVEP1;ZNF25;RING1;LYAR;BCL6;ZNF608;HDAC1;TFAP4;TIMELESS;PTCH1;SAMD7;IGBP1;ZNF596;TRPS1;ZNF846;SBNO2;ATF3;ZNF558;NFIX;E2F6;FOXP1;ZNF536;PHC2;ZFHX3;BMP6;E4F1;CBFB;MACROH2A2;SPDEF;NR1H4;MAFK;SFMBT1;ID2;SAMD13;LBH;STAT3;FOXK1;ZHX3;ZBTB7A;HMGA2;ANKRD2;SUV39H2;SIN3B;SMARCA4;SARS1;XRCC6;ZMYM5;IFI16;TAF1;DAP;CREB3L1;MXI1;ZGLP1;NFX1;SIRT2;NACC1;DMAP1;PCGF1;NOG;BEND3;NR4A3;PRDM11;HMGB2
prerank,GO_Biological_Process_2021__positive regulation of protein-containing complex disassembly (GO:0043243),0.5634004917660137,0.9673336354207163,0.5573770491803278,1.0,1.0,1/9,8.17%,BNIP3
prerank,GO_Biological_Process_2021__histone H3-K4 monomethylation (GO:0097692),-0.5919471374618599,-0.9664829787222204,0.5384615384615384,1.0,1.0,3/7,33.77%,KMT2B;SETD1B;SETD1A
prerank,GO_Biological_Process_2021__protein K29-linked ubiquitination (GO:0035519),-0.6543157895499416,-0.9663495125827666,0.6382978723404256,1.0,1.0,2/5,19.41%,UBE2D4;PRKN
prerank,GO_Biological_Process_2021__negative regulation of collateral sprouting (GO:0048671),-0.6536682791538759,-0.9662683372138704,0.5531914893617021,1.0,1.0,2/5,10.87%,FGF13;PTPRS
prerank,PanglaoDB_Augmented_2021__Kidney Progenitor Cells,0.4091266093547044,0.9661303542122726,0.5135135135135135,1.0,1.0,5/91,3.44%,LRP4;NES;GPC6;GLI3;FJX1
prerank,GO_Biological_Process_2021__N-acetylglucosamine metabolic process (GO:0006044),0.5734226573503556,0.9660903439435394,0.589041095890411,1.0,1.0,5/14,25.16%,CHST1;GNPDA1;CHST6;EXTL2;OGA
prerank,GO_Biological_Process_2021__regulation of hydrolase activity (GO:0051336),0.42856859465180563,0.9660677905111913,0.5492957746478874,1.0,1.0,6/64,8.71%,EPHA1;TDG;RASIP1;PRKG1;ARHGAP9;ATP5IF1
prerank,GO_Biological_Process_2021__lymphocyte activation involved in immune response (GO:0002285),-0.5919982364571185,-0.9659772289889756,0.5,1.0,1.0,1/6,1.47%,F2RL1
prerank,GO_Biological_Process_2021__regulation of megakaryocyte differentiation (GO:0045652),-0.4249419104332651,-0.9658341607061974,0.5,1.0,1.0,4/46,7.73%,RAB7B;RUNX1;HDAC1;CBFB
prerank,GO_Biological_Process_2021__negative regulation of small molecule metabolic process (GO:0062014),-0.5003236171108081,-0.965101212084653,0.4888888888888889,1.0,1.0,2/11,9.68%,SLC22A13;PGP
prerank,PanglaoDB_Augmented_2021__Mast Cells,-0.33957056161898735,-0.9650491140923899,0.6,1.0,1.0,26/162,10.99%,STK32B;KIT;PAPSS2;KDR;SPRED1;COL15A1;PID1;IL1R1;UNC13B;SGCD;HS3ST3A1;CRH;LTC4S;CPA1;RIN2;LRRC66;SLC6A4;ENPP3;EXT1;SSPN;ADGRL4;PDGFRA;RNASE1;COBL;TPH1;CREB3L1
prerank,GO_Biological_Process_2021__growth hormone receptor signaling pathway (GO:0060396),0.5265151658074204,0.9648483270937719,0.532258064516129,1.0,1.0,3/14,14.66%,PRLR;STAT5A;STAT6
prerank,GO_Biological_Process_2021__aminoglycan metabolic process (GO:0006022),-0.5800594887514636,-0.964611514191914,0.5348837209302325,1.0,1.0,5/10,14.32%,CLN6;B3GAT2;B3GAT3;CHST9;XYLT2
prerank,GO_Biological_Process_2021__modified amino acid transport (GO:0072337),-0.5681701513936135,-0.9645921133583818,0.6060606060606061,1.0,1.0,3/12,6.06%,SLC16A12;SLC19A1;PDPN
prerank,GO_Biological_Process_2021__regulation of inclusion body assembly (GO:0090083),0.6051458827434388,0.9642843542410553,0.582089552238806,1.0,1.0,1/9,7.35%,DNAJB1
prerank,GO_Biological_Process_2021__detection of stimulus involved in sensory perception of pain (GO:0062149),-0.6232317158594063,-0.9641953962393895,0.5,1.0,1.0,1/5,6.11%,ANO1
prerank,GO_Biological_Process_2021__mitotic G1/S transition checkpoint signaling (GO:0044819),-0.5217423029936621,-0.9641382581165108,0.4878048780487805,1.0,1.0,5/11,22.23%,RFWD3;PLK3;PLK5;CCND1;FBXO31
prerank,GO_Biological_Process_2021__regulation of endothelial cell proliferation (GO:0001936),-0.4020845442833746,-0.9638946147023767,0.43333333333333335,1.0,1.0,14/68,15.55%,KDR;CDH13;VASH1;ATOH8;VASH2;VIP;NRP1;APOE;HMGB2;SCG2;NR4A1;LEP;ANGPT1;EGFL7
prerank,GO_Biological_Process_2021__response to hydrogen peroxide (GO:0042542),0.47559317913601445,0.9637625990670983,0.5211267605633803,1.0,1.0,5/37,15.13%,STK26;CYP1B1;RHOB;GLRX2;ECT2
prerank,GO_Biological_Process_2021__negative regulation of cell-cell adhesion mediated by cadherin (GO:2000048),0.5526670219904283,0.9636156845021516,0.5686274509803921,1.0,1.0,4/10,17.83%,NOTCH1;RGCC;EPCAM;NOTCH4
prerank,GO_Biological_Process_2021__regulation of transmembrane transport (GO:0034762),-0.4471775560369761,-0.963422039193735,0.40625,1.0,1.0,8/27,16.89%,KCNJ16;KCNJ14;BCL2;ACE2;KCNJ6;KCNJ2;PRKCB;CTTNBP2NL
prerank,GO_Biological_Process_2021__myelin maintenance (GO:0043217),-0.5672819942450807,-0.9633940984241196,0.575,1.0,1.0,3/9,19.94%,ABCD1;CLU;ABCD2
prerank,GO_Biological_Process_2021__anoikis (GO:0043276),0.574540344131005,0.9632709719673044,0.6212121212121212,1.0,1.0,2/9,13.93%,DAPK2;TSC2
prerank,GO_Biological_Process_2021__regulation of cellular amide metabolic process (GO:0034248),-0.44014645930338986,-0.9630011887083811,0.5135135135135135,1.0,1.0,4/30,7.93%,TCOF1;PRKCD;PUM3;NR1H4
prerank,GO_Biological_Process_2021__negative regulation of T cell proliferation (GO:0042130),0.5176379492567909,0.9628898284890968,0.5217391304347826,1.0,1.0,8/20,24.05%,BTN2A2;ARG1;PDCD1LG2;IL4I1;SFTPD;CD274;PRNP;CD80
prerank,GO_Biological_Process_2021__response to ATP (GO:0033198),-0.5125481255201885,-0.9628274253185243,0.40816326530612246,1.0,1.0,3/15,6.94%,TRPC3;CIB2;P2RY11
prerank,"GO_Biological_Process_2021__nucleotide-binding domain, leucine rich repeat containing receptor signaling pathway (GO:0035872)",0.4792149093519957,0.9627765451866859,0.5294117647058824,1.0,1.0,7/21,31.13%,CASP8;RIPK2;TAB2;CYLD;NOD1;RPS27A;RNF34
prerank,GO_Biological_Process_2021__endoplasmic reticulum calcium ion homeostasis (GO:0032469),0.5223374842041688,0.9627715913564143,0.5694444444444444,1.0,1.0,5/18,17.57%,WFS1;BCAP31;HERPUD1;CAMK2D;CCDC47
prerank,GO_Biological_Process_2021__cellular response to interferon-alpha (GO:0035457),-0.5568799325909203,-0.9627481818269855,0.4857142857142857,1.0,1.0,1/7,4.10%,TPR
prerank,GO_Biological_Process_2021__anterograde dendritic transport of neurotransmitter receptor complex (GO:0098971),-0.6215143044382984,-0.9626564339007502,0.5,1.0,1.0,3/5,35.96%,KIF5C;KIF3B;KIF17
prerank,GO_Biological_Process_2021__anterograde dendritic transport (GO:0098937),-0.6215143044382984,-0.9626564339007502,0.5,1.0,1.0,3/5,35.96%,KIF5C;KIF3B;KIF17
prerank,GO_Biological_Process_2021__regulation of fatty acid metabolic process (GO:0019217),0.5347598012493795,0.9625198369714085,0.5409836065573771,1.0,1.0,8/14,28.46%,FABP3;PRKAB2;ADIPOR2;PDK4;PPARG;PRKAG2;ADIPOR1;EIF6
prerank,GO_Biological_Process_2021__regulation of oligodendrocyte differentiation (GO:0048713),0.5533994624476324,0.9624835936119014,0.5735294117647058,1.0,1.0,4/13,14.63%,NOTCH1;PTPRZ1;DRD3;DAAM2
prerank,GO_Biological_Process_2021__peptidyl-lysine methylation (GO:0018022),-0.438074737614275,-0.9624350591453762,0.4482758620689655,1.0,1.0,7/23,20.55%,SMYD2;SUV39H2;EEF1AKMT1;EHMT2;EHMT1;KMT5A;SETD2
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Aorta),-0.3454584278793885,-0.9624266123723743,0.44,1.0,1.0,13/131,6.02%,LMCD1;ITGB5;KDR;LAMB2;GXYLT2;LAMA4;SVEP1;PXDC1;FNDC1;PDE3A;WWTR1;COL4A3;P3H3
prerank,GO_Biological_Process_2021__regulation of translational termination (GO:0006449),-0.5268044411324524,-0.9623467593125246,0.45714285714285713,1.0,1.0,4/8,33.47%,ETF1;OGFOD1;JMJD4;SHFL
prerank,GO_Biological_Process_2021__metal ion transport (GO:0030001),-0.36913674383132167,-0.9622798793521101,0.4230769230769231,1.0,1.0,6/71,5.96%,TRPC3;CACNA2D1;CACNG3;RYR1;GRIN3A;CACNA1A
prerank,GO_Biological_Process_2021__pancreas development (GO:0031016),0.5964095497031164,0.9622247450869666,0.65625,1.0,1.0,1/8,10.58%,CCDC39
prerank,GO_Biological_Process_2021__regulation of cell communication by electrical coupling involved in cardiac conduction (GO:1901844),0.6121198997447987,0.9621538955614809,0.6140350877192983,1.0,1.0,3/6,21.68%,CAMK2D;TRDN;CALM3
prerank,GO_Biological_Process_2021__positive regulation of extrinsic apoptotic signaling pathway (GO:2001238),0.5456187889544243,0.9620634946109712,0.5166666666666667,1.0,1.0,4/21,11.81%,INHBA;AGT;FADD;GPER1
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte apoptotic process (GO:0070229),0.598345765430272,0.9618887623287101,0.6206896551724138,1.0,1.0,1/7,2.27%,CCL5
prerank,GO_Biological_Process_2021__dermatan sulfate biosynthetic process (GO:0030208),-0.5862617541363845,-0.9618413821914168,0.5581395348837209,1.0,1.0,2/9,15.49%,VCAN;CHST12
prerank,GO_Biological_Process_2021__cellular response to hypoxia (GO:0071456),0.4102047647102651,0.9612637952926222,0.5507246376811594,1.0,1.0,22/108,23.78%,PTGIS;CA9;TWIST1;SUV39H1;BNIP3;NDNF;PSMB6;EPAS1;PSMA3;PSMB8;OPRD1;RGCC;PINK1;TBL2;AK4;CUL2;ACAA2;HIF3A;BAD;PSMA5;ARNT;NOP53
prerank,GO_Biological_Process_2021__positive regulation of activin receptor signaling pathway (GO:0032927),0.6496063069093422,0.9610355974574816,0.5964912280701754,1.0,1.0,3/5,27.95%,ACVR2B;NODAL;ACVR2A
prerank,GO_Biological_Process_2021__detection of mechanical stimulus (GO:0050982),0.5185808937294051,0.960943383309077,0.5573770491803278,1.0,1.0,3/17,4.99%,CSRP3;CAV3;PKD2L2
prerank,GO_Biological_Process_2021__ethanolamine-containing compound metabolic process (GO:0042439),-0.5846674329485442,-0.9606441386130982,0.5833333333333334,1.0,1.0,1/5,8.27%,GDE1
prerank,GO_Biological_Process_2021__N-acylethanolamine metabolic process (GO:0070291),-0.5846674329485442,-0.9606441386130982,0.5833333333333334,1.0,1.0,1/5,8.27%,GDE1
prerank,GO_Biological_Process_2021__positive regulation of transcription by RNA polymerase II (GO:0045944),-0.31618615257775845,-0.9605224633600282,0.6666666666666666,1.0,1.0,65/684,9.95%,ETV1;ETV5;MYB;STING1;LEF1;TOX2;F2RL1;CDH13;RUNX1;GREM1;PID1;SSBP3;CREB3L4;ATOH8;GABPB2;MAML3;ASCL1;E2F5;NFATC1;NRL;FOS;SOX12;ZNF462;HDAC5;NFIB;IGF1;APLN;PRDM15;ZMIZ2;TRIAP1;ADIRF;FIZ1;ITGA6;MAML1;WWTR1;HIVEP1;RRP1B;MED30;TGFB2;FGF1;HDAC1;ZNF300;ZBED3;SBNO2;IL11;ATF3;NFIX;SERPINF2;TFDP1;MAPK7;ETS1;ZFHX3;BMP6;E4F1;NR1H4;INO80;STAT3;HMGA2;RORA;POU2F2;SMARCA4;RBMX;XRCC6;TGFB3;IFI16
prerank,GO_Biological_Process_2021__development of primary male sexual characteristics (GO:0046546),-0.4419133816024965,-0.9605108812281486,0.391304347826087,1.0,1.0,4/26,5.75%,KIT;KITLG;LHFPL2;TGFB2
prerank,PanglaoDB_Augmented_2021__Satellite Cells,0.3925667128260755,0.9602843609805335,0.5802469135802469,1.0,1.0,12/107,12.49%,CALCR;NES;TIMP3;HSPG2;TRIM32;IGFBP5;CDCP1;SRPX;DOCK1;EFEMP1;NOTCH3;KIAA1217
prerank,GO_Biological_Process_2021__vesicle cytoskeletal trafficking (GO:0099518),0.4672838407158225,0.9602701330764342,0.5915492957746479,1.0,1.0,3/35,13.63%,SYT4;MYO5B;MYO1F
prerank,GO_Biological_Process_2021__postreplication repair (GO:0006301),0.45238788432507593,0.9602203274041032,0.5571428571428572,1.0,1.0,6/43,20.21%,RFC5;PCNA;RPA3;BRCA1;TRIM25;POLN
prerank,GO_Biological_Process_2021__apoptotic cell clearance (GO:0043277),-0.41154834768668547,-0.9602193761020872,0.4666666666666667,1.0,1.0,4/20,10.29%,RHOBTB1;TYRO3;RHOBTB2;SCARB1
prerank,"GO_Biological_Process_2021__energy coupled proton transport, down electrochemical gradient (GO:0015985)",0.5900299409529507,0.9598750554929228,0.6,1.0,1.0,4/9,31.80%,ATP5F1C;ATP5MC3;ATP5PD;ATP5PB
prerank,GO_Biological_Process_2021__negative regulation of cytokine-mediated signaling pathway (GO:0001960),0.4737140993726233,0.9595537537972806,0.5,1.0,1.0,7/44,11.08%,NLRP2B;PTPRC;CARD8;PELI3;ARG1;OTUD4;STAP1
prerank,GO_Biological_Process_2021__positive regulation of transmembrane transport (GO:0034764),-0.4816555604937986,-0.9595398927652473,0.4772727272727273,1.0,1.0,3/13,11.93%,CA2;ANO6;NR4A3
prerank,MSigDB_Hallmark_2020__Fatty Acid Metabolism,0.4020588731448345,0.9595018677879266,0.5316455696202531,1.0,1.0,27/134,19.35%,ALDH1A1;NCAPH2;UROD;NSDHL;FASN;SERINC1;EPHX1;ACSL5;HSD17B10;XIST;ADIPOR2;ECI2;HMGCS1;YWHAH;IL4I1;ACOX1;MDH1;PRDX6;ACADL;HSPH1;HSD17B11;METAP1;DECR1;DHCR24;H2AZ1;CPOX;ACAA2
prerank,GO_Biological_Process_2021__long-term memory (GO:0007616),0.5417604087354414,0.9594690751858674,0.5555555555555556,1.0,1.0,1/13,0.26%,CALB1
prerank,PanglaoDB_Augmented_2021__Mller Cells,0.3931958800489064,0.9593838335725341,0.5443037974683544,1.0,1.0,15/125,8.01%,LRP4;RDH10;NES;TIMP3;RLBP1;POSTN;IGFBP5;CNR2;PLP1;DAPL1;SCN4B;PLSCR4;AGT;ANGPTL2;CPE
prerank,GO_Biological_Process_2021__intracellular lipid transport (GO:0032365),0.485445027055447,0.9593426382513618,0.5072463768115942,1.0,1.0,3/20,15.13%,FABP3;PRKAB2;THRSP
prerank,GO_Biological_Process_2021__negative regulation of cell migration involved in sprouting angiogenesis (GO:0090051),0.5603665525912458,0.9592252440210125,0.5967741935483871,1.0,1.0,2/12,4.13%,TBXA2R;NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of signaling (GO:0023057),-0.5125412534696687,-0.9592249443569789,0.36666666666666664,1.0,1.0,6/14,17.19%,UBASH3B;IL11;KIF26A;PTPN1;ACVR1;OPRM1
prerank,GO_Biological_Process_2021__regulation of toll-like receptor signaling pathway (GO:0034121),0.5076251091271708,0.9592240273441656,0.5373134328358209,1.0,1.0,9/20,29.32%,NLRP2B;OTUD4;IRF1;TLR2;GPS2;LRRC14;CD36;FLOT1;NFKBIL1
prerank,GO_Biological_Process_2021__calcium ion transport into cytosol (GO:0060402),-0.4960821656203702,-0.9590592674453821,0.5405405405405406,1.0,1.0,7/20,21.57%,CACNA2D1;GRIN2A;GRIN2C;TRPM2;JPH2;JPH4;GRIN1
prerank,GO_Biological_Process_2021__regulation of cytoskeleton organization (GO:0051493),-0.3842052693181346,-0.9589753640697067,0.46153846153846156,1.0,1.0,9/94,7.54%,IQGAP2;CDK2AP2;EPHA3;RND3;RHOBTB1;TRIM36;EPHA5;PRKCD;PEAK3
prerank,GO_Biological_Process_2021__regulation of IRE1-mediated unfolded protein response (GO:1903894),-0.5050321223875464,-0.9589506172446889,0.5,1.0,1.0,1/13,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__regulation of homophilic cell adhesion (GO:1903385),-0.5708336020131444,-0.9588795390696863,0.5142857142857142,1.0,1.0,1/5,5.14%,PTPN23
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase II (GO:0000122),-0.30223848778391804,-0.9587185780136824,0.6,1.0,1.0,65/539,11.93%,ETV5;PER2;MYB;SOX13;TBX6;AASS;GFI1B;RUNX1;ARID5A;FHL2;ASCL1;PRDM5;ZNF239;HDAC5;NFIB;SMYD2;TPR;RITA1;ID4;HIVEP1;ZNF25;LYAR;BCL6;ZNF608;HDAC1;PTCH1;IGBP1;ZNF596;TRPS1;ZNF846;ATF3;ZNF558;NFIX;E2F6;FOXP1;ZNF536;ZFHX3;BMP6;E4F1;CBFB;MACROH2A2;SPDEF;NR1H4;MAFK;ID2;STAT3;ZBTB7A;HMGA2;ANKRD2;SUV39H2;SIN3B;SMARCA4;SARS1;ZMYM5;IFI16;TAF1;MXI1;ZGLP1;NFX1;SIRT2;DMAP1;PCGF1;NOG;BEND3;NR4A3
prerank,GO_Biological_Process_2021__neuropeptide signaling pathway (GO:0007218),0.448170390922013,0.9586169582614333,0.5416666666666666,1.0,1.0,5/40,8.01%,NPY;SSTR1;OPRK1;GALR1;CPE
prerank,GO_Biological_Process_2021__leucine catabolic process (GO:0006552),-0.6070965631136023,-0.9585864401393488,0.5142857142857142,1.0,1.0,2/5,23.23%,MCCC2;HMGCL
prerank,GO_Biological_Process_2021__signal complex assembly (GO:0007172),-0.5570034504280196,-0.9583894381738978,0.48717948717948717,1.0,1.0,2/5,28.10%,PXN;SRC
prerank,MSigDB_Hallmark_2020__Notch Signaling,0.484683937243615,0.9582506740230258,0.5079365079365079,1.0,1.0,3/26,11.19%,NOTCH1;MAML2;NOTCH3
prerank,GO_Biological_Process_2021__mitochondrial ATP synthesis coupled electron transport (GO:0042775),0.43556607346902265,0.9580715337796517,0.5428571428571428,1.0,1.0,14/53,29.33%,NDUFA2;NDUFB3;NDUFB4;NDUFB9;NDUFB2;COX4I1;COX7A2L;UQCRB;CYCS;NDUFB11;NDUFV1;NDUFB6;UQCRHL;COX6B1
prerank,GO_Biological_Process_2021__histone lysine demethylation (GO:0070076),-0.4378675231921311,-0.9579854111795424,0.45454545454545453,1.0,1.0,4/24,11.13%,KDM8;HR;KDM4B;KDM3B
prerank,GO_Biological_Process_2021__positive regulation of telomerase activity (GO:0051973),-0.4235868923780004,-0.9579238977998291,0.4827586206896552,1.0,1.0,3/29,7.77%,GREM1;NVL;PNKP
prerank,GO_Biological_Process_2021__regulation of cell aging (GO:0090342),-0.567818758010967,-0.957864068921406,0.5862068965517241,1.0,1.0,2/10,2.84%,VASH1;NEK6
prerank,GO_Biological_Process_2021__gastro-intestinal system smooth muscle contraction (GO:0014831),-0.6220114187389753,-0.9576078205776727,0.5555555555555556,1.0,1.0,1/5,0.95%,SULF2
prerank,GO_Biological_Process_2021__entry of bacterium into host cell (GO:0035635),-0.5480282471077692,-0.9573529588140812,0.5142857142857142,1.0,1.0,1/7,10.21%,CDH1
prerank,GO_Biological_Process_2021__regulation of mRNA polyadenylation (GO:1900363),0.5099655660067626,0.9573221021455657,0.5692307692307692,1.0,1.0,2/18,6.96%,NCBP1;NCBP2
prerank,GO_Biological_Process_2021__regulation of epidermal cell differentiation (GO:0045604),-0.47515452446289796,-0.9567490333684155,0.48484848484848486,1.0,1.0,3/18,12.42%,RUNX1;CBFB;MAFG
prerank,PanglaoDB_Augmented_2021__Keratinocytes,-0.42841613006167073,-0.9562702495058296,0.5333333333333333,1.0,1.0,7/31,14.73%,KRT16P6;LAMB3;TGM1;MST1R;PERP;SIRT7;REL
prerank,PanglaoDB_Augmented_2021__Embryonic Stem Cells,-0.34317285866102537,-0.9562386816935562,0.4583333333333333,1.0,1.0,20/135,10.62%,KIT;ADGRA3;ITGA4;LEF1;SPRY4;RND3;TEAD2;KITLG;PRDM5;ITGA6;SFRP1;LRIG3;FRAS1;STAT3;HMGA2;FBXO15;ANO6;CDH1;COL4A2;FAT1
prerank,GO_Biological_Process_2021__negative regulation of protein-containing complex assembly (GO:0031333),0.43167102662441315,0.9561086001459019,0.5384615384615384,1.0,1.0,16/39,28.53%,NLRP2B;HSPA5;KIF14;OPRD1;NLRC3;ANKRD27;ULK1;TMC8;PPM1A;PEX5;JAM3;NOP53;AIDA;CDC42;SVIP;RPL13A
prerank,GO_Biological_Process_2021__nucleoside triphosphate biosynthetic process (GO:0009142),0.6218644725755883,0.9558527665556638,0.578125,1.0,1.0,2/8,18.00%,CMPK2;AK4
prerank,GO_Biological_Process_2021__mesoderm formation (GO:0001707),0.5487148933101424,0.9558439345342574,0.6779661016949152,1.0,1.0,1/14,2.16%,TBX19
prerank,GO_Biological_Process_2021__carboxylic acid catabolic process (GO:0046395),0.551209537045587,0.9557742866186419,0.5757575757575758,1.0,1.0,3/10,19.03%,ACOT4;IL4I1;GNPDA1
prerank,GO_Biological_Process_2021__regulation of lymphocyte proliferation (GO:0050670),0.5250757860065628,0.9555875895869547,0.5094339622641509,1.0,1.0,3/12,19.33%,AHR;SOX11;TNFSF18
prerank,GO_Biological_Process_2021__vascular wound healing (GO:0061042),-0.6198137249261668,-0.9555588080944694,0.631578947368421,1.0,1.0,1/5,0.77%,KDR
prerank,GO_Biological_Process_2021__embryo development ending in birth or egg hatching (GO:0009792),0.5326446018830756,0.9554968896172069,0.5263157894736842,1.0,1.0,3/13,14.47%,NR5A2;SCEL;BRCA1
prerank,GO_Biological_Process_2021__choline catabolic process (GO:0042426),0.6235288623902231,0.9553333370525474,0.5942028985507246,1.0,1.0,1/5,15.86%,CHDH
prerank,GO_Biological_Process_2021__embryonic digestive tract development (GO:0048566),0.5447652179482275,0.9551213998586039,0.5573770491803278,1.0,1.0,4/14,11.31%,GLI3;RARRES2;FGFR2;SOX11
prerank,PanglaoDB_Augmented_2021__Airway Epithelial Cells,0.46969235099036827,0.9551067564314981,0.5416666666666666,1.0,1.0,8/34,13.36%,VWA2;CP;FUT2;EXPH5;CLCA4;IL20RA;ZNF750;MUC4
prerank,GO_Biological_Process_2021__cellular response to corticosteroid stimulus (GO:0071384),-0.5247698349034113,-0.9550542527349377,0.5,1.0,1.0,1/11,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__relaxation of muscle (GO:0090075),0.5579883822784092,0.9548068945419101,0.6119402985074627,1.0,1.0,4/12,18.43%,ATP1B1;CAMK2D;PLN;ATP1A1
prerank,GO_Biological_Process_2021__protein autophosphorylation (GO:0046777),0.3877071737094455,0.9547980064121562,0.5662650602409639,1.0,1.0,14/142,11.36%,STK16;ITK;EPHA1;STK26;PDGFRB;HCK;MAK;TNK1;FLT3;MEX3B;DAPK2;MAP3K11;FGFR2;MAP4K1
prerank,GO_Biological_Process_2021__histone H3-K4 dimethylation (GO:0044648),-0.5926941573798423,-0.9547922635339254,0.525,1.0,1.0,3/6,33.77%,KMT2B;SETD1B;SETD1A
prerank,PanglaoDB_Augmented_2021__T Cells Naive,0.4485529775605969,0.9544724014228502,0.5362318840579711,1.0,1.0,10/37,11.22%,GNLY;CD4;PTPRC;PIK3R5;GMFG;TAGAP;ARHGAP9;WAS;ARHGAP25;CD6
prerank,GO_Biological_Process_2021__regulation of multicellular organism growth (GO:0040014),-0.5085914796935922,-0.9542258560773972,0.47058823529411764,1.0,1.0,2/13,6.06%,IGF1;PTCH1
prerank,GO_Biological_Process_2021__rRNA pseudouridine synthesis (GO:0031118),-0.5506955330100856,-0.954039446923274,0.5882352941176471,1.0,1.0,3/10,15.73%,RPUSD1;NAF1;RPUSD4
prerank,GO_Biological_Process_2021__apical protein localization (GO:0045176),0.5709747771495778,0.9537731354617456,0.5254237288135594,1.0,1.0,5/9,33.49%,CELSR1;SHROOM3;JAM3;ATP8B1;SHROOM2
prerank,GO_Biological_Process_2021__L-phenylalanine catabolic process (GO:0006559),0.5855988430879604,0.953767431016706,0.5535714285714286,1.0,1.0,2/5,12.71%,FAH;IL4I1
prerank,GO_Biological_Process_2021__erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222),0.5855988430879604,0.953767431016706,0.5535714285714286,1.0,1.0,2/5,12.71%,FAH;IL4I1
prerank,GO_Biological_Process_2021__constitutive secretory pathway (GO:0045054),0.6058045168861999,0.9537423617653797,0.6071428571428571,1.0,1.0,2/5,30.01%,TMEM167B;TRAPPC11
prerank,GO_Biological_Process_2021__regulation of osteoblast differentiation (GO:0045667),-0.3911392981674029,-0.9537377682906298,0.6071428571428571,1.0,1.0,9/70,8.68%,NPNT;BMP7;GREM1;IGF1;WWTR1;PTCH1;BMP6;ZHX3;CRIM1
prerank,GO_Biological_Process_2021__regulation of autophagy (GO:0010506),0.3741826264457573,0.9536651789159142,0.5595238095238095,1.0,1.0,39/206,22.16%,TRIM22;TRIM5;TRIML2;DEPP1;RASIP1;BOK;ITPR1;PRKAB2;DAPL1;EEF1A1;CAPN1;BNIP3;HGF;ATP6V1B2;RNF152;DAPK2;CDK5R1;GFAP;RAB8A;WDR6;USP13;HTR2B;ATP6V1C1;VPS35;PINK1;TRIM14;PSAP;TAB2;ATP6V0B;ULK1;PIP4K2C;LRRK2;ERN1;ATG101;BAD;DCN;GPR137B;ATP6V1C2;RAB39B
prerank,GO_Biological_Process_2021__nuclear pore organization (GO:0006999),-0.5184300563963818,-0.953323772530129,0.5757575757575758,1.0,1.0,1/13,4.10%,TPR
prerank,GO_Biological_Process_2021__monocyte chemotaxis (GO:0002548),0.5234399672132599,0.9532945671851624,0.576271186440678,1.0,1.0,1/10,2.27%,CCL5
prerank,GO_Biological_Process_2021__activation of protein kinase activity (GO:0032147),-0.38965814574714114,-0.9532243518977296,0.45,1.0,1.0,7/94,7.82%,NRK;NRG1;IGF1;TGFB2;FGF1;PRKCD;CARD10
prerank,GO_Biological_Process_2021__regulation of response to stress (GO:0080134),0.5512817971031703,0.9531917567426619,0.5277777777777778,1.0,1.0,5/11,23.34%,ABCB1;MLC1;SLC38A2;CRHBP;CORO2B
prerank,GO_Biological_Process_2021__axonal transport (GO:0098930),-0.41958025486085965,-0.9531612143821783,0.5,1.0,1.0,2/32,7.29%,BLOC1S4;AP3B2
prerank,GO_Biological_Process_2021__positive regulation of glucose transmembrane transport (GO:0010828),-0.43878049402422403,-0.9529727860213275,0.4117647058823529,1.0,1.0,4/23,16.87%,IGF1;NR4A3;IRS1;CLTCL1
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell proliferation (GO:2000561)",0.604185265030846,0.9527695717905079,0.5370370370370371,1.0,1.0,1/5,20.24%,CD274
prerank,PanglaoDB_Augmented_2021__Tanycytes,-0.3346127908925917,-0.9525232094791877,0.4230769230769231,1.0,1.0,15/113,5.75%,FBXL7;DOK5;PENK;VAT1L;SLC16A2;PCDH19;CACNA2D1;PCDH18;NTM;EFS;VCAN;SFRP1;ID4;MARK1;TGFB2
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization (GO:0031113),0.46974818882315844,0.9524502813072808,0.4918032786885246,1.0,1.0,3/37,10.75%,CAV3;PSRC1;CDK5R1
prerank,GO_Biological_Process_2021__defense response to bacterium (GO:0042742),0.45382681680239867,0.9523860663557344,0.5753424657534246,1.0,1.0,7/67,9.30%,GNLY;STAB1;ELANE;ADGRB1;RARRES2;HLA-A;LYG1
prerank,GO_Biological_Process_2021__nuclear transport (GO:0051169),-0.48379520114482377,-0.9522746961612185,0.475,1.0,1.0,1/14,1.98%,RGS14
prerank,GO_Biological_Process_2021__positive regulation of Golgi to plasma membrane protein transport (GO:0042998),0.642646650091593,0.9518188174883624,0.559322033898305,1.0,1.0,2/5,31.45%,CNST;ACSL3
prerank,GO_Biological_Process_2021__long-term synaptic potentiation (GO:0060291),-0.45954310972703927,-0.951239160859695,0.38095238095238093,1.0,1.0,8/18,15.57%,RGS14;CRHR2;SHANK2;PLK2;GRIN2A;GRIN2C;STX4;SLC8A3
prerank,GO_Biological_Process_2021__glutathione derivative biosynthetic process (GO:1901687),0.5162752515978237,0.9512352452296506,0.5535714285714286,1.0,1.0,2/17,3.79%,HPGDS;MGST1
prerank,GO_Biological_Process_2021__glutathione derivative metabolic process (GO:1901685),0.5162752515978237,0.9512352452296506,0.5535714285714286,1.0,1.0,2/17,3.79%,HPGDS;MGST1
prerank,GO_Biological_Process_2021__regulation of calcium-mediated signaling (GO:0050848),0.5372692618626359,0.9512263519483445,0.5507246376811594,1.0,1.0,5/16,12.40%,NEUROD2;ITPR1;CMKLR1;PLCG2;RIT2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell proliferation (GO:0050680),-0.40234586686307516,-0.9510978509611577,0.5128205128205128,1.0,1.0,11/57,12.23%,VASH1;ATOH8;BRCA2;EREG;NFIB;SFRP1;TGFB2;MCC;APOE;DUSP10;SCG2
prerank,GO_Biological_Process_2021__cellular response to organic substance (GO:0071310),-0.3573060038092628,-0.9510793797632403,0.48484848484848486,1.0,1.0,15/97,9.50%,STING1;LEF1;PTPN9;PID1;IL1RL2;KHSRP;SFRP1;EMD;PTPN23;MAPK7;NR1H4;STAT3;DCPS;CSF1R;MME
prerank,GO_Biological_Process_2021__peptide catabolic process (GO:0043171),0.49838586636253696,0.951075461508353,0.6142857142857143,1.0,1.0,6/20,14.85%,ERAP2;CHAC2;LVRN;ENPEP;CHAC1;NAALADL1
prerank,GO_Biological_Process_2021__positive regulation of antigen receptor-mediated signaling pathway (GO:0050857),0.5157662965160694,0.9510610110043572,0.5625,1.0,1.0,3/19,11.08%,KCNN4;PTPRC;STAP1
prerank,MSigDB_Hallmark_2020__DNA Repair,-0.3540090430176832,-0.9508092478023054,0.4666666666666667,1.0,1.0,21/136,13.77%,ZNF707;APRT;ERCC2;TYMS;PNP;ITPA;POLL;TAF10;NME4;ERCC1;ERCC8;DGCR8;POLR2G;NFX1;SSRP1;TAF12;POLD3;BRF2;GTF2F1;ADA;POLR2C
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (GO:0002480)",0.5662326745336046,0.9507746452987157,0.5666666666666667,1.0,1.0,2/7,19.71%,HLA-A;B2M
prerank,GO_Biological_Process_2021__epithelium development (GO:0060429),0.4202125513741649,0.9507168267200892,0.5802469135802469,1.0,1.0,13/83,13.78%,PTER;SOX10;TST;RCN3;CNN3;TBX1;STAT1;TOLLIP;FGFR2;SOX11;PPP2R3A;PCNA;TGFB1
prerank,GO_Biological_Process_2021__membrane lipid metabolic process (GO:0006643),0.5004629547672043,0.9502938248789361,0.5081967213114754,1.0,1.0,4/21,8.64%,FUT2;CYP1B1;SERINC1;CERKL
prerank,GO_Biological_Process_2021__positive regulation of heterochromatin assembly (GO:0031453),-0.5099396274781558,-0.9500757529226265,0.4857142857142857,1.0,1.0,3/13,16.74%,TPR;DNMT1;SETDB1
prerank,PanglaoDB_Augmented_2021__Cholangiocytes,0.437368613655366,0.9499997316373138,0.569620253164557,1.0,1.0,8/49,10.34%,ALPL;SMIM22;SCTR;TJP3;GPX2;AP1M2;MYO5B;B3GNT3
prerank,GO_Biological_Process_2021__phosphatidylethanolamine metabolic process (GO:0046337),0.4870967590588147,0.9498989702855336,0.5616438356164384,1.0,1.0,3/24,14.16%,PLA2G10;PLAAT5;SELENOI
prerank,GO_Biological_Process_2021__regulation of phospholipase C activity (GO:1900274),-0.49979491733491443,-0.949760796163784,0.5151515151515151,1.0,1.0,2/15,4.53%,KIT;RASGRP1
prerank,GO_Biological_Process_2021__granulocyte activation (GO:0036230),0.600697700349801,0.9496893710930372,0.609375,1.0,1.0,3/6,4.51%,CCL5;IL15;PREX1
prerank,GO_Biological_Process_2021__radial glial cell differentiation (GO:0060019),-0.5812172989410715,-0.9496299474621352,0.5853658536585366,1.0,1.0,2/5,16.99%,STAT3;GPR157
prerank,GO_Biological_Process_2021__negative regulation of intracellular estrogen receptor signaling pathway (GO:0033147),0.574790792622235,0.9495328184857033,0.47619047619047616,1.0,1.0,2/8,15.29%,BRCA1;KANK2
prerank,GO_Biological_Process_2021__creatine metabolic process (GO:0006600),0.6013818088637828,0.9494524806879607,0.6206896551724138,1.0,1.0,2/7,18.85%,CKB;CKMT1A
prerank,GO_Biological_Process_2021__negative regulation by host of viral process (GO:0044793),-0.5900310395675992,-0.949400365673679,0.627906976744186,1.0,1.0,2/5,19.41%,EIF2AK4;PRKN
prerank,GO_Biological_Process_2021__cellular response to interleukin-1 (GO:0071347),0.3874528484451577,0.9492224866805995,0.5694444444444444,1.0,1.0,10/108,16.76%,PTGIS;CCL5;PELI3;RPS6KA4;TOLLIP;PSMB6;RIPK2;PSMA3;PSMB8;DAB2IP
prerank,GO_Biological_Process_2021__positive regulation of extracellular matrix assembly (GO:1901203),0.588310480371972,0.9491247407519853,0.5645161290322581,1.0,1.0,2/8,16.59%,TGFB1;RGCC
prerank,GO_Biological_Process_2021__mitotic sister chromatid segregation (GO:0000070),0.4246569955726097,0.9489509287508777,0.5789473684210527,1.0,1.0,15/82,17.32%,NCAPH2;NCAPG;CENPK;CHMP4B;PSRC1;PHF13;KIF14;CHMP2B;TEX14;CHMP1A;SMC2;EML3;RAB11A;PDS5B;CHMP2A
prerank,GO_Biological_Process_2021__neuron projection regeneration (GO:0031102),0.5865637792275367,0.9488723282365419,0.609375,1.0,1.0,2/9,8.85%,OMG;NREP
prerank,GO_Biological_Process_2021__regulation of telomerase activity (GO:0051972),-0.40306939113601475,-0.9488145151671765,0.5806451612903226,1.0,1.0,7/40,16.96%,GREM1;NVL;PNKP;SMG6;NAF1;PARM1;ATM
prerank,GO_Biological_Process_2021__positive regulation of immune effector process (GO:0002699),-0.46473685304583756,-0.948199402356144,0.5428571428571428,1.0,1.0,2/17,5.37%,MYB;DDX60
prerank,GO_Biological_Process_2021__positive regulation of protein serine/threonine kinase activity (GO:0071902),-0.372980994010191,-0.9479251431109853,0.4666666666666667,1.0,1.0,13/88,10.99%,KIT;TPD52L1;PDGFD;RASGRP1;TCIM;PIK3R6;FGF1;INCENP;HMGA2;CSF1R;TELO2;PDGFC;SYAP1
prerank,GO_Biological_Process_2021__cellular protein complex disassembly (GO:0043624),-0.5960174873768942,-0.9476499317297447,0.5609756097560976,1.0,1.0,2/6,18.70%,APEH;ETF1
prerank,GO_Biological_Process_2021__defense response to fungus (GO:0050832),0.617337094871418,0.9472389474236453,0.639344262295082,1.0,1.0,3/7,21.40%,RARRES2;PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__purine nucleobase metabolic process (GO:0006144),0.5492558626496729,0.9470009311255195,0.578125,1.0,1.0,3/8,32.00%,PAICS;GMPS;DPYD
prerank,GO_Biological_Process_2021__negative regulation of voltage-gated potassium channel activity (GO:1903817),0.6108194116085789,0.9466891517293632,0.5909090909090909,1.0,1.0,1/7,2.82%,KCNE2
prerank,GO_Biological_Process_2021__negative regulation of delayed rectifier potassium channel activity (GO:1902260),0.6108194116085789,0.9466891517293632,0.5909090909090909,1.0,1.0,1/7,2.82%,KCNE2
prerank,GO_Biological_Process_2021__epithelial cell migration (GO:0010631),-0.41576596609778477,-0.9466768586788007,0.48,1.0,1.0,2/35,1.54%,KIT;CDH13
prerank,GO_Biological_Process_2021__dopamine metabolic process (GO:0042417),-0.4532591546026261,-0.9466156865524373,0.40625,1.0,1.0,4/15,10.32%,GCH1;DRD4;TGFB2;DRD1
prerank,GO_Biological_Process_2021__cytoskeleton organization (GO:0007010),-0.34743235052896865,-0.9462243785507736,0.47368421052631576,1.0,1.0,21/98,17.89%,RND3;RHOBTB1;WTIP;MARK1;ZMYM6;CDC42BPB;SIPA1L3;PLD2;ARAP3;RHOBTB2;SEMA6A;APOE;MDK;FGD5;BIN1;CAPZB;MAST2;ANK1;WDPCP;MAST4;KLHL20
prerank,PanglaoDB_Augmented_2021__Hepatic Stellate Cells,-0.37620055185440715,-0.9461497126724076,0.4827586206896552,1.0,1.0,12/102,5.85%,TAGLN;FBXL7;MYB;LAMB2;LAMA4;ADAMTS2;SVEP1;COL6A2;PCDH18;FNDC1;PRRX1;ADAMTS5
prerank,GO_Biological_Process_2021__regulation of potassium ion transport (GO:0043266),-0.4484766526620745,-0.9458187705387264,0.4864864864864865,1.0,1.0,6/29,11.11%,KCNIP1;KCNE1;KCNN2;VIP;DRD1;DPP6
prerank,GO_Biological_Process_2021__glycerolipid biosynthetic process (GO:0045017),-0.5410103200066654,-0.9457969954878341,0.5121951219512195,1.0,1.0,3/8,23.18%,CPNE7;CPNE6;CPNE1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell membrane potential (GO:0086036),0.6170102478702769,0.9456546856619963,0.5789473684210527,1.0,1.0,4/6,26.97%,PLN;TRDN;ATP2A2;SLC9A1
prerank,GO_Biological_Process_2021__zinc ion transport (GO:0006829),-0.4999161747541535,-0.9453945491115263,0.45714285714285713,1.0,1.0,1/16,0.88%,SLC39A11
prerank,"GO_Biological_Process_2021__base-excision repair, gap-filling (GO:0006287)",0.49452754922068637,0.9452968153522102,0.5573770491803278,1.0,1.0,2/33,2.13%,TDG;RFC5
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator (GO:0006978)",-0.4992669826640984,-0.9452875435585674,0.65,1.0,1.0,1/9,5.99%,TFAP4
prerank,GO_Biological_Process_2021__macrophage chemotaxis (GO:0048246),0.5859016802345925,0.9451155003946446,0.59375,1.0,1.0,1/7,2.27%,CCL5
prerank,GO_Biological_Process_2021__regulation of cytosolic calcium ion concentration (GO:0051480),0.4091507833138299,0.9450033366913504,0.5921052631578947,1.0,1.0,18/102,13.12%,C3AR1;CALB1;CALCR;P2RY1;CAV3;TBXA2R;CALCB;ACKR3;FKBP1B;BCAP31;PTGER3;KNG1;CMKLR1;SCGN;TMEM178A;GPER1;ESR1;DRD3
prerank,GO_Biological_Process_2021__establishment of Golgi localization (GO:0051683),0.6115257103023429,0.9444687717202004,0.5303030303030303,1.0,1.0,4/7,32.71%,RIPOR1;CDC42;PDCD10;YWHAZ
prerank,GO_Biological_Process_2021__positive regulation of microtubule polymerization or depolymerization (GO:0031112),0.5032684104577821,0.9444234765769502,0.5571428571428572,1.0,1.0,3/24,10.75%,CAV3;PSRC1;CDK5R1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-13 production (GO:0032736),-0.5859231015355801,-0.94422723949651,0.5428571428571428,1.0,1.0,1/6,6.17%,SPHK2
prerank,GO_Biological_Process_2021__B cell differentiation (GO:0030183),-0.4288173295618985,-0.9441570786901188,0.5277777777777778,1.0,1.0,6/32,8.70%,KIT;ITGA4;RABL3;HDAC5;IL11;ZBTB7A
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043123),0.3984089196178499,0.9436539777745019,0.5694444444444444,1.0,1.0,11/133,10.49%,TRIM22;TRIM5;ROR1;TRIML2;CD4;TRIM32;CXXC5;FADD;TRAF3IP2;CASP8;LITAF
prerank,GO_Biological_Process_2021__positive regulation of leukocyte chemotaxis (GO:0002690),0.43874835853457,0.9436368575065014,0.547945205479452,1.0,1.0,5/35,10.53%,CCL5;PLA2G7;RARRES2;CMKLR1;VEGFC
prerank,"GO_Biological_Process_2021__regulation of synaptic transmission, glutamatergic (GO:0051966)",-0.38261993538025424,-0.9435349372655272,0.5,1.0,1.0,3/42,3.25%,CACNG4;CACNG5;CACNG3
prerank,GO_Biological_Process_2021__carbohydrate catabolic process (GO:0016052),0.4949450200475172,0.9433478958561927,0.56,1.0,1.0,8/33,22.93%,ENO4;HKDC1;MANBA;ALDOB;PGAM1;NEU1;HK3;PKLR
prerank,GO_Biological_Process_2021__detection of bacterium (GO:0016045),0.5904773670774981,0.9431692832645963,0.5769230769230769,1.0,1.0,4/8,31.58%,HLA-A;PGLYRP1;NOD1;NLRC4
prerank,GO_Biological_Process_2021__positive regulation of RNA polymerase II transcription preinitiation complex assembly (GO:0045899),0.5937875796387094,0.9429669077360794,0.5818181818181818,1.0,1.0,2/7,28.46%,ESR1;PSMC6
prerank,GO_Biological_Process_2021__negative regulation of amino acid transport (GO:0051956),0.6166150020241267,0.9428561160454152,0.603448275862069,1.0,1.0,2/5,24.88%,GRM7;ARL6IP5
prerank,GO_Biological_Process_2021__negative regulation of cell communication (GO:0010648),-0.530319633743193,-0.9426045461971817,0.5151515151515151,1.0,1.0,6/12,17.19%,UBASH3B;IL11;KIF26A;PTPN1;ACVR1;OPRM1
prerank,GO_Biological_Process_2021__purine nucleobase transport (GO:0006863),0.6153190785598684,0.9425922142849182,0.6119402985074627,1.0,1.0,4/6,26.44%,SLC28A2;AQP9;SLC29A2;VDAC3
prerank,GO_Biological_Process_2021__central nervous system development (GO:0007417),-0.3290925150656799,-0.9425545745200292,0.5882352941176471,1.0,1.0,27/220,10.12%,MDGA1;POU6F2;KLHL17;TBX6;CHST8;PCDH18;SOX12;AMIGO1;KLK6;NFIB;CNTN6;ECRG4;VCAN;MARCKS;PTCH1;JHY;DSCAML1;TPP1;SPOCK1;ZFHX3;MACROH2A2;CDK5RAP2;STAT3;GRIN2A;PBX4;PDGFC;SMG9
prerank,GO_Biological_Process_2021__positive regulation of protein import into nucleus (GO:0042307),-0.44578327954511787,-0.9421328792138671,0.5666666666666667,1.0,1.0,6/24,14.95%,TPR;PRKCD;CDH1;DMAP1;BAG3;MAVS
prerank,PanglaoDB_Augmented_2021__Purkinje Neurons,0.37123486994609245,0.941805690639735,0.55,1.0,1.0,15/149,12.65%,CALB1;PDE1A;SYT2;ZDHHC22;ADGRB1;PLP1;GRM3;SYT4;PRKG1;SLC24A2;CNTN2;KCNJ9;RIT2;C11ORF87;GAD1
prerank,GO_Biological_Process_2021__response to fructose (GO:0009750),0.6495533655667675,0.9417248746040859,0.5737704918032787,1.0,1.0,4/5,34.99%,KHK;SLC2A5;SLC26A6;GCKR
prerank,GO_Biological_Process_2021__negative regulation of intracellular steroid hormone receptor signaling pathway (GO:0033144),-0.44938701500246353,-0.9416687303930629,0.5882352941176471,1.0,1.0,5/23,9.54%,SFRP1;HDAC1;FOXP1;ZBTB7A;SMARCA4
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic (GO:0000291)",-0.3932778043541424,-0.94154500883669,0.5666666666666667,1.0,1.0,9/30,17.70%,LSM6;DCPS;POLR2G;EXOSC7;EXOSC1;DIS3L2;EXOSC5;EXOSC4;LSM7
prerank,GO_Biological_Process_2021__mRNA 3'-end processing by stem-loop binding and cleavage (GO:0006398),0.6470369794022057,0.9414154694333444,0.6,1.0,1.0,1/5,21.65%,SLBP
prerank,GO_Biological_Process_2021__cardiac right ventricle morphogenesis (GO:0003215),-0.5525060169604596,-0.9408673976400164,0.5454545454545454,1.0,1.0,1/5,5.75%,TGFB2
prerank,GO_Biological_Process_2021__positive regulation of neurogenesis (GO:0050769),-0.3707947088840426,-0.9408057143072717,0.5909090909090909,1.0,1.0,7/64,9.50%,FBXW8;RGS14;AMIGO1;NUMB;PLXNA1;PLXNA2;MME
prerank,GO_Biological_Process_2021__L-alpha-amino acid transmembrane transport (GO:1902475),-0.40787743081314387,-0.9407335108006057,0.5714285714285714,1.0,1.0,5/26,11.69%,SLC22A2;SLC25A29;SLC6A9;SLC7A1;SLC7A2
prerank,GO_Biological_Process_2021__regulation of erythrocyte differentiation (GO:0045646),0.474465167191417,0.9407287026367086,0.5362318840579711,1.0,1.0,5/32,11.79%,INHBA;ZNF16;ZFPM1;STAT1;MAFB
prerank,MSigDB_Hallmark_2020__Hedgehog Signaling,0.4626219657521974,0.940348416121768,0.5441176470588235,1.0,1.0,6/33,12.27%,RASA1;AMOT;ETS2;TLE3;CDK5R1;CELSR1
prerank,GO_Biological_Process_2021__kynurenine metabolic process (GO:0070189),0.5856696974298272,0.9397252416356029,0.6229508196721312,1.0,1.0,1/8,8.00%,IDO1
prerank,GO_Biological_Process_2021__relaxation of cardiac muscle (GO:0055119),0.5465118425901447,0.9394789401062145,0.6470588235294118,1.0,1.0,4/13,18.43%,ATP1B1;CAMK2D;PLN;ATP1A1
prerank,GO_Biological_Process_2021__endothelial cell development (GO:0001885),-0.4514364113703407,-0.9393223392914075,0.5384615384615384,1.0,1.0,4/22,8.80%,COL15A1;F2RL1;GSTM3;COL18A1
prerank,GO_Biological_Process_2021__protein repair (GO:0030091),0.6186493181779985,0.9392576372211935,0.5857142857142857,1.0,1.0,1/5,14.82%,PCMT1
prerank,GO_Biological_Process_2021__regulation of actin nucleation (GO:0051125),-0.5061551346992627,-0.9392352619653501,0.5526315789473685,1.0,1.0,1/11,2.59%,ARFIP2
prerank,GO_Biological_Process_2021__alpha-amino acid biosynthetic process (GO:1901607),-0.5540396474436028,-0.9388524276853746,0.6363636363636364,1.0,1.0,1/6,0.72%,PAH
prerank,GO_Biological_Process_2021__regulation of calcium ion-dependent exocytosis (GO:0017158),0.48807332001473697,0.9388374565537696,0.547945205479452,1.0,1.0,11/29,23.14%,TRPV6;SYT2;SYT4;REST;DOC2A;SYT15;SYT9;SYT13;CACNA1G;CACNA1H;DOC2B
prerank,GO_Biological_Process_2021__gland development (GO:0048732),0.4415437507378933,0.9388103977124784,0.5217391304347826,1.0,1.0,9/42,17.83%,HESX1;GCM2;FADD;TBX1;IGSF3;FGFR2;GFER;MSN;NOTCH4
prerank,GO_Biological_Process_2021__carnitine biosynthetic process (GO:0045329),0.622117655657019,0.9385552286370834,0.6140350877192983,1.0,1.0,2/5,31.80%,BBOX1;ACADM
prerank,GO_Biological_Process_2021__amino-acid betaine biosynthetic process (GO:0006578),0.622117655657019,0.9385552286370834,0.6140350877192983,1.0,1.0,2/5,31.80%,BBOX1;ACADM
prerank,GO_Biological_Process_2021__positive regulation of small GTPase mediated signal transduction (GO:0051057),-0.4415596774954954,-0.9384999646437416,0.5625,1.0,1.0,5/26,11.83%,IGF1;RASGRF1;RASGRP1;MMD2;NGF
prerank,PanglaoDB_Augmented_2021__Myeloid-derived Suppressor Cells,0.4950000330113361,0.9384642761430598,0.5964912280701754,1.0,1.0,17/35,25.19%,HCK;CD300LF;PTPRC;PIK3R5;TAGAP;MYO1F;ADGRE1;IGSF6;AQP9;LY86;PTAFR;NCF2;HK3;CD80;NFAM1;IL4R;CSF3R
prerank,GO_Biological_Process_2021__negative regulation of blood pressure (GO:0045776),-0.4622804773525425,-0.9384420117412338,0.4864864864864865,1.0,1.0,1/11,3.98%,APLN
prerank,GO_Biological_Process_2021__positive regulation of apoptotic process (GO:0043065),0.3595075424534384,0.9384129477612042,0.611764705882353,1.0,1.0,28/253,11.81%,PNMA5;GADD45B;PTGIS;NLRP2B;DDX20;PREX1;BOK;CYP1B1;MOAP1;PNMA2;PXT1;FADD;KNG1;HIP1R;BNIP3;SIAH1;DUSP9;REST;SFRP4;DAPK2;CASP8;CDK5R1;MAP3K11;RHOB;RNF122;FAS;PPID;GPER1
prerank,GO_Biological_Process_2021__hemopoiesis (GO:0030097),-0.3902329686710227,-0.9383894419720527,0.41025641025641024,1.0,1.0,7/69,6.35%,KIT;KDR;RUNX1;KITLG;SFRP1;TGFB2;TOX
prerank,GO_Biological_Process_2021__positive regulation of T cell differentiation (GO:0045582),-0.4253046627742098,-0.9382583019541451,0.6,1.0,1.0,4/27,5.46%,LEF1;SOX12;PNP;BCL6
prerank,GO_Biological_Process_2021__positive regulation of cellular process (GO:0048522),-0.30582895237423263,-0.9381493221421521,0.7142857142857143,1.0,1.0,57/441,11.09%,TRPC3;NRG1;KDR;TBX6;SINHCAF;FGFR4;LEF1;HMGN5;BTC;GREM1;PDGFD;TNFRSF11A;EREG;KITLG;IGF1;SFRP1;DBF4B;GRK5;WWTR1;LYAR;SLC25A33;AZU1;CHTOP;TGFB2;FGF1;HDAC1;PDPN;PRKCD;BCL2;SHANK2;IL11;APOA1;SERPINF2;NUMA1;TGM1;TENM4;IL15RA;ETS1;ZFHX3;PTHLH;BMP6;GCNT2;INO80;HMGA2;CSF1R;PDGFRA;AKR1C3;TGFB3;VIP;PDGFC;EIF4G1;COLEC12;SLFN11;SPACA3;DNPH1;TET1;SIRT2
prerank,GO_Biological_Process_2021__regulation of RNA splicing (GO:0043484),-0.3771425081750791,-0.9380891800050633,0.5882352941176471,1.0,1.0,17/70,20.18%,AHNAK2;HNRNPL;RRP1B;AKAP17A;PTBP3;U2AF2;SON;FASTK;SRRM4;KHDRBS3;PTBP1;RPS26;PTBP2;SETX;HSPA1A;CELF1;RBM23
prerank,PanglaoDB_Augmented_2021__Interneurons,-0.3152535217406353,-0.9378173038138182,0.6363636363636364,1.0,1.0,35/274,10.37%,ETV1;GNG4;TMEM132D;PTPN3;NMB;SRGAP1;TACR1;PCBP3;NTNG1;SST;CRH;CACNA1I;VGF;TIMELESS;PRKCD;VLDLR;ARX;ADGRA1;MMD2;KCNC1;RGS8;NPTXR;GRIA4;MAPK4;RAB3C;RORA;CALN1;FAM81A;CDHR1;POU2F2;TMEM196;VIP;DLX5;CTNNA2;GAD2
prerank,GO_Biological_Process_2021__positive regulation of autophagy (GO:0010508),0.3961258478619712,0.9375353681423496,0.5657894736842105,1.0,1.0,6/76,9.45%,TRIM22;TRIM5;TRIML2;BNIP3;SESN3;RNF152
prerank,GO_Biological_Process_2021__protein import into nucleus (GO:0006606),0.42044335723298293,0.937490127839108,0.5735294117647058,1.0,1.0,5/68,8.85%,RGPD3;RGPD4;NXT1;RANBP6;RGPD1
prerank,GO_Biological_Process_2021__heterochromatin assembly (GO:0031507),0.5039294519303005,0.9373894232612893,0.5492957746478874,1.0,1.0,3/20,7.97%,H3-3A;POLE3;SUV39H1
prerank,GO_Biological_Process_2021__regulation of cell death (GO:0010941),0.4252988049157686,0.9371755664906428,0.5454545454545454,1.0,1.0,15/78,18.91%,CALCR;CCL5;CHMP4B;CDKN1B;BNIP3;ACOX2;SOX11;RIPK2;LRPAP1;HTR2B;VPS35;CHMP2A;CHRNA7;CTSZ;DHCR24
prerank,GO_Biological_Process_2021__protein sumoylation (GO:0016925),-0.3929228393215355,-0.937076052280509,0.5454545454545454,1.0,1.0,4/50,6.59%,IFIH1;NUP210;TPR;NUP37
prerank,GO_Biological_Process_2021__Golgi localization (GO:0051645),0.5490464630858196,0.9370347356907143,0.5967741935483871,1.0,1.0,2/11,11.96%,RIPOR1;ARCN1
prerank,GO_Biological_Process_2021__regulation of collagen biosynthetic process (GO:0032965),-0.46121823284048896,-0.9370299543706484,0.6052631578947368,1.0,1.0,4/14,10.99%,RUNX1;SERPINF2;TGFB3;CREB3L1
prerank,GO_Biological_Process_2021__cellular macromolecule catabolic process (GO:0044265),0.45694781014466834,0.9369411449226712,0.5915492957746479,1.0,1.0,7/41,16.76%,ADAMTS9;ISG20;NCBP1;RNASEH2C;MANBA;NGLY1;DAB2IP
prerank,GO_Biological_Process_2021__membrane depolarization during SA node cell action potential (GO:0086046),0.6138335363448634,0.9369282771364393,0.6166666666666667,1.0,1.0,2/5,22.46%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__histone deubiquitination (GO:0016578),-0.46481679855808894,-0.9367720012832856,0.5476190476190477,1.0,1.0,3/19,12.10%,TAF10;BRCC3;USP51
prerank,GO_Biological_Process_2021__negative regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902042),0.505987243051912,0.936627993558737,0.6065573770491803,1.0,1.0,6/24,19.58%,FADD;CASP8;FAS;TMBIM1;BRCA1;BCL2L1
prerank,GO_Biological_Process_2021__regulation of metaphase/anaphase transition of cell cycle (GO:1902099),-0.517417552175564,-0.9366264307783396,0.6333333333333333,1.0,1.0,2/7,10.85%,NEK6;CDC23
prerank,GO_Biological_Process_2021__fatty acid derivative biosynthetic process (GO:1901570),0.4696716709311586,0.9363247663266951,0.5522388059701493,1.0,1.0,4/26,11.91%,GGTA1;FASN;ALOX12;SCD
prerank,GO_Biological_Process_2021__regulation of purine nucleotide metabolic process (GO:1900542),-0.4124551704546181,-0.9363228479234439,0.47619047619047616,1.0,1.0,4/41,8.70%,NUP210;TPR;NUP37;ZBTB7A
prerank,GO_Biological_Process_2021__positive regulation of transcription elongation from RNA polymerase II promoter (GO:0032968),0.5657062453629189,0.9362895869465876,0.6056338028169014,1.0,1.0,1/11,11.64%,BTBD18
prerank,GO_Biological_Process_2021__mitochondrion localization (GO:0051646),-0.4239600155889562,-0.9362676494644151,0.5,1.0,1.0,2/17,6.18%,MARK1;ZBED3
prerank,GO_Biological_Process_2021__negative regulation of chromatin organization (GO:1905268),-0.5004443496384863,-0.936216214888023,0.5588235294117647,1.0,1.0,1/8,1.16%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of chromatin silencing (GO:0031936),-0.5004443496384863,-0.936216214888023,0.5588235294117647,1.0,1.0,1/8,1.16%,H1-4
prerank,GO_Biological_Process_2021__negative regulation of gene silencing (GO:0060969),-0.5004443496384863,-0.936216214888023,0.5588235294117647,1.0,1.0,1/8,1.16%,H1-4
prerank,GO_Biological_Process_2021__regulation of fatty acid beta-oxidation (GO:0031998),-0.4923387450426547,-0.9360995917659837,0.5,1.0,1.0,4/14,14.39%,TYSND1;PLIN5;ABCD1;IRS1
prerank,GO_Biological_Process_2021__phospholipid homeostasis (GO:0055091),0.5755367939154321,0.9358835159447,0.5737704918032787,1.0,1.0,2/10,5.36%,FABP3;RCN3
prerank,GO_Biological_Process_2021__negative regulation of fatty acid oxidation (GO:0046322),-0.539482593422276,-0.9354640760495677,0.5945945945945946,1.0,1.0,2/8,10.86%,PLIN5;ACADVL
prerank,GO_Biological_Process_2021__cation transport (GO:0006812),-0.3713594147485297,-0.9353854898040446,0.5714285714285714,1.0,1.0,19/138,9.55%,CNGA3;KCNJ16;SLC22A2;SGK1;SLC12A3;KCNK7;ANO1;FGF13;KCNF1;SLC25A29;SLC6A9;KCNC1;SLC7A1;SLC29A4;SLC38A7;SLC22A3;ANO6;KCNQ4;KCNN2
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator (GO:0030330)",-0.370792447075915,-0.9353163542296438,0.5757575757575758,1.0,1.0,13/65,16.96%,TRIAP1;TFAP4;AURKA;TFDP1;PLK2;CRADD;USP10;BTG2;PIDD1;PML;PLK3;PCBP4;ATM
prerank,GO_Biological_Process_2021__phosphatidylinositol dephosphorylation (GO:0046856),-0.4455056407552891,-0.9351843970194527,0.5483870967741935,1.0,1.0,8/24,23.14%,MTMR8;MTMR9;PIP4P1;MTMR7;MTM1;INPP5J;SYNJ2;INPP5B
prerank,GO_Biological_Process_2021__positive regulation of dephosphorylation (GO:0035306),-0.44978170300997083,-0.9350711158374945,0.7027027027027027,1.0,1.0,10/22,22.45%,PRKCD;MTMR9;NSMF;PTBP1;PPP1R7;SYMPK;PPP1R16B;PIN1;BMP2;PPIA
prerank,GO_Biological_Process_2021__histone-threonine phosphorylation (GO:0035405),-0.6628073864364316,-0.9348374855683658,0.6774193548387096,1.0,1.0,2/5,18.48%,PRKCB;VRK1
prerank,GO_Biological_Process_2021__nucleotide-binding oligomerization domain containing signaling pathway (GO:0070423),0.47581228875688,0.9347948156230143,0.546875,1.0,1.0,6/23,29.20%,CASP8;RIPK2;TAB2;CYLD;NOD1;RPS27A
prerank,GO_Biological_Process_2021__regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000371),0.6302472008959303,0.9347714657344374,0.631578947368421,1.0,1.0,2/5,30.82%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of DNA topoisomerase (ATP-hydrolyzing) activity (GO:2000373),0.6302472008959303,0.9347714657344374,0.631578947368421,1.0,1.0,2/5,30.82%,PLSCR1;UHRF1
prerank,GO_Biological_Process_2021__positive regulation of T cell receptor signaling pathway (GO:0050862),0.549839034038235,0.9347684849041508,0.5555555555555556,1.0,1.0,1/12,5.20%,KCNN4
prerank,GO_Biological_Process_2021__cellular response to acidic pH (GO:0071468),0.5794212527295854,0.9347411242628574,0.5909090909090909,1.0,1.0,2/8,16.24%,NOX1;PKD1L3
prerank,GO_Biological_Process_2021__negative regulation of interleukin-12 production (GO:0032695),0.5905581679218046,0.9344039539238278,0.609375,1.0,1.0,1/6,8.55%,CMKLR1
prerank,GO_Biological_Process_2021__regulation of interleukin-10 production (GO:0032653),-0.4496972085565676,-0.9341486808762678,0.5172413793103449,1.0,1.0,2/19,1.47%,TRIB2;F2RL1
prerank,GO_Biological_Process_2021__progesterone receptor signaling pathway (GO:0050847),0.5461337413127759,0.9341245563711741,0.5882352941176471,1.0,1.0,3/7,27.01%,UBR5;UBE3A;YAP1
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell differentiation (GO:0045639),-0.41092037455054514,-0.9340843192345492,0.35714285714285715,1.0,1.0,5/30,13.26%,RAB7B;ETS1;STAT3;HMGB2;ABCB10
prerank,GO_Biological_Process_2021__isotype switching (GO:0045190),0.579925676450546,0.9340366783223579,0.5833333333333334,1.0,1.0,5/7,35.95%,RNF168;EXOSC6;MSH6;MSH2;HSPD1
prerank,GO_Biological_Process_2021__histone phosphorylation (GO:0016572),-0.509570919368197,-0.9334551134035197,0.48484848484848486,1.0,1.0,3/8,8.81%,PRKCD;INCENP;BAZ1B
prerank,GO_Biological_Process_2021__regulation of biosynthetic process (GO:0009889),-0.5477319488282112,-0.9331936521799951,0.5,1.0,1.0,2/9,6.17%,SLC25A33;SPHK2
prerank,GO_Biological_Process_2021__regulation of cellular protein metabolic process (GO:0032268),0.41026485248189365,0.9331291380142315,0.5,1.0,1.0,3/44,6.08%,PLA2G10;INHBA;AGT
prerank,GO_Biological_Process_2021__positive regulation of leukocyte cell-cell adhesion (GO:1903039),-0.4466097762379958,-0.9329527857522711,0.4827586206896552,1.0,1.0,3/19,12.12%,ETS1;NR4A3;MDK
prerank,GO_Biological_Process_2021__neuron differentiation (GO:0030182),-0.3589381994654329,-0.9325357956182211,0.5384615384615384,1.0,1.0,11/115,8.01%,ALK;RUNX1;ATOH8;ERCC2;ASCL1;NRBP2;EPHA5;TGFB2;SPOCK1;TENM4;ID2
prerank,GO_Biological_Process_2021__cellular response to UV-A (GO:0071492),0.5680232014500873,0.9320771779546585,0.6,1.0,1.0,4/6,22.98%,PPID;OPN3;OPN1SW;OPN5
prerank,GO_Biological_Process_2021__regulation of carbohydrate catabolic process (GO:0043470),-0.40460788099612566,-0.9318537544904918,0.5238095238095238,1.0,1.0,4/41,8.70%,NUP210;TPR;NUP37;ZBTB7A
prerank,GO_Biological_Process_2021__membrane raft organization (GO:0031579),0.5133588229564447,0.9317860262083649,0.59375,1.0,1.0,1/14,1.71%,CAV3
prerank,GO_Biological_Process_2021__regulation of interleukin-18 production (GO:0032661),0.6441489180553138,0.9316672702314699,0.631578947368421,1.0,1.0,3/5,33.67%,TLR2;GBP5;NLRP12
prerank,PanglaoDB_Augmented_2021__Peri-islet Schwann Cells,0.3801242318359032,0.9314019561541367,0.6162790697674418,1.0,1.0,7/107,8.01%,LRP4;NES;GPC6;IGFBP5;PLP1;RUNX1T1;CPE
prerank,GO_Biological_Process_2021__positive regulation of multicellular organismal process (GO:0051240),0.36923298946075195,0.9308335281092122,0.6190476190476191,1.0,1.0,35/243,14.66%,NOX5;ITK;RREB1;ZNF703;ZBTB7B;TBXA2R;PRLR;IL15;INHBA;LOXL2;PLAC8;PRKAB2;TWIST1;AGT;KDM3A;BMP1;ADIPOR2;TSHR;ADRB1;PPARGC1A;SOX6;CMKLR1;AVPR1A;REST;HHLA2;SOX11;SCD;SMTNL1;EPAS1;SIX4;LRPAP1;TGFB1;GHRL;TLE6;STAT6
prerank,GO_Biological_Process_2021__epithelial structure maintenance (GO:0010669),-0.554519507873613,-0.9308282699184357,0.6388888888888888,1.0,1.0,2/9,5.58%,RBP4;VSIG1
prerank,PanglaoDB_Augmented_2021__Myoblasts,-0.3810437507772131,-0.9306468388493915,0.45454545454545453,1.0,1.0,9/87,5.24%,LMCD1;FBXL7;LAMB2;FGFR4;ADAM12;RND3;CACNA2D1;WWTR1;PRRX1
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction resulting in transcription (GO:0042772)",-0.4987709612301924,-0.9304548817113218,0.6486486486486487,1.0,1.0,1/10,5.99%,TFAP4
prerank,GO_Biological_Process_2021__neutrophil degranulation (GO:0043312),0.354121088622182,0.9304336725597163,0.6818181818181818,1.0,1.0,42/358,15.27%,C3AR1;CHIT1;OSCAR;FGL2;CLEC4C;MGST1;TIMP2;ELANE;DOCK2;PRDX4;PLAC8;PTPRC;GM2A;GMFG;EEF1A1;CD14;TMEM30A;LAMP2;CAPN1;ARHGAP9;ARG1;TUBB;TOLLIP;OSTF1;MANBA;C6ORF120;PGAM1;ATP6AP2;NBEAL2;STOM;GGH;TMC6;PLAUR;TMBIM1;PRSS3;CHRNB4;SLCO4C1;CCT8;TMEM63A;AGL;PRDX6;HSPA8
prerank,GO_Biological_Process_2021__regulation of apoptotic signaling pathway (GO:2001233),-0.4623816801377228,-0.9303370507286276,0.46875,1.0,1.0,3/29,8.35%,TPD52L1;BCL2;CRADD
prerank,GO_Biological_Process_2021__mitochondrial transport (GO:0006839),0.42503066247549587,0.9300241940413976,0.5735294117647058,1.0,1.0,17/52,29.45%,BCAP31;BNIP3;TOMM22;DNAJC19;SLC25A31;MTX2;BCL2L1;TMEM14C;BAD;FBXO7;SLC25A4;TMEM14A;TOMM20;TIMM8B;TOMM7;TIMM22;SLC25A5
prerank,GO_Biological_Process_2021__microtubule anchoring at centrosome (GO:0034454),-0.5362121808866431,-0.929966815682564,0.6333333333333333,1.0,1.0,4/10,18.61%,PCM1;CCDC68;HOOK3;CCDC120
prerank,GO_Biological_Process_2021__cellular response to interferon-beta (GO:0035458),0.5564736507797157,0.9296263074074572,0.671875,1.0,1.0,3/11,17.31%,STAT1;IRF1;PYHIN1
prerank,GO_Biological_Process_2021__neutrophil activation involved in immune response (GO:0002283),0.3533772958991625,0.9294861891638293,0.6741573033707865,1.0,1.0,42/360,15.27%,C3AR1;CHIT1;OSCAR;FGL2;CLEC4C;MGST1;TIMP2;ELANE;DOCK2;PRDX4;PLAC8;PTPRC;GM2A;GMFG;EEF1A1;CD14;TMEM30A;LAMP2;CAPN1;ARHGAP9;ARG1;TUBB;TOLLIP;OSTF1;MANBA;C6ORF120;PGAM1;ATP6AP2;NBEAL2;STOM;GGH;TMC6;PLAUR;TMBIM1;PRSS3;CHRNB4;SLCO4C1;CCT8;TMEM63A;AGL;PRDX6;HSPA8
prerank,GO_Biological_Process_2021__tRNA wobble base modification (GO:0002097),-0.4961267256420269,-0.9292671972120715,0.5142857142857142,1.0,1.0,5/13,27.58%,ALKBH8;ADAT2;TRMT9B;ALKBH1;CTU1
prerank,GO_Biological_Process_2021__positive regulation of translation in response to stress (GO:0032056),-0.5926710327702378,-0.9289109456991034,0.6176470588235294,1.0,1.0,2/5,18.35%,EIF4G1;EIF2AK4
prerank,GO_Biological_Process_2021__protein K11-linked ubiquitination (GO:0070979),-0.4272962124409092,-0.9288923511065365,0.5384615384615384,1.0,1.0,6/25,19.41%,CDC26;UBE2D4;CDC23;FZR1;ANAPC7;PRKN
prerank,GO_Biological_Process_2021__deadenylation-dependent decapping of nuclear-transcribed mRNA (GO:0000290),0.5574840661415728,0.9288208362339606,0.6060606060606061,1.0,1.0,2/7,16.37%,PATL2;DCP2
prerank,GO_Biological_Process_2021__phospholipid translocation (GO:0045332),0.4741800628301597,0.9286781603929529,0.546875,1.0,1.0,5/29,12.70%,PLSCR5;PLSCR4;TMEM30A;ABCB1;ABCB4
prerank,GO_Biological_Process_2021__protein-DNA complex subunit organization (GO:0071824),-0.5418484158128283,-0.928641373953653,0.5263157894736842,1.0,1.0,2/5,27.53%,SETD2;SUPT6H
prerank,GO_Biological_Process_2021__nucleobase-containing compound catabolic process (GO:0034655),0.45419457492610893,0.9286186854102549,0.5915492957746479,1.0,1.0,3/33,8.81%,ISG20;NCBP1;RNASEH2C
prerank,GO_Biological_Process_2021__regulation of protein-containing complex disassembly (GO:0043244),0.5103179464153148,0.9283756854588474,0.6268656716417911,1.0,1.0,1/15,8.17%,BNIP3
prerank,GO_Biological_Process_2021__phospholipid dephosphorylation (GO:0046839),-0.41892093214790327,-0.9283407079717703,0.42857142857142855,1.0,1.0,19/38,30.21%,MTMR8;MTMR9;PLPPR5;SGPP2;PIP4P1;PLPP4;MTMR7;MTM1;INPP5J;SYNJ2;INPP5B;EPHX2;PLPPR4;PLPPR2;PTEN;MTMR6;MTMR10;PLPP3;MTMR4
prerank,PanglaoDB_Augmented_2021__Glomus Cells,0.38482010541975004,0.9282913539421632,0.5925925925925926,1.0,1.0,7/116,8.01%,LRP4;NES;GPC6;IGFBP5;CHST1;ANGPTL2;CPE
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903377),0.5756935162746102,0.928264537285921,0.5846153846153846,1.0,1.0,2/5,21.50%,PINK1;NONO
prerank,GO_Biological_Process_2021__protein import into peroxisome matrix (GO:0016558),-0.5232036059424129,-0.9281913785462794,0.6666666666666666,1.0,1.0,2/11,10.61%,PEX7;PEX5L
prerank,GO_Biological_Process_2021__regulation of embryonic development (GO:0045995),0.4570405206070071,0.9279922009524422,0.527027027027027,1.0,1.0,3/29,15.73%,TDG;TLE6;RACGAP1
prerank,GO_Biological_Process_2021__nucleoside diphosphate metabolic process (GO:0009132),0.5208241151368111,0.9279383636722907,0.5409836065573771,1.0,1.0,2/14,18.00%,CMPK2;AK4
prerank,GO_Biological_Process_2021__regulation of neuron apoptotic process (GO:0043523),0.4110145770396182,0.9278844024710303,0.5294117647058824,1.0,1.0,11/74,13.02%,WFS1;RASA1;CRLF1;NTF3;PTPRZ1;SOD2;PPARGC1A;KIF14;NDNF;CDK5R1;SIX4
prerank,GO_Biological_Process_2021__attachment of GPI anchor to protein (GO:0016255),0.6018189329415415,0.9278768919070497,0.6724137931034483,1.0,1.0,1/5,15.43%,GPAA1
prerank,GO_Biological_Process_2021__negative regulation of MAP kinase activity (GO:0043407),-0.4286079920229237,-0.9277810142966463,0.525,1.0,1.0,9/39,11.55%,BMP7;SPRY4;RGS14;PRKCD;SPRY3;SORL1;APOE;RGS2;DUSP10
prerank,GO_Biological_Process_2021__negative regulation of T-helper cell differentiation (GO:0045623),0.611792069791232,0.9276500802797726,0.6590909090909091,1.0,1.0,1/5,11.46%,SMAD7
prerank,GO_Biological_Process_2021__spliceosomal complex assembly (GO:0000245),-0.3941618242947475,-0.9276181704580893,0.5,1.0,1.0,11/42,17.20%,SRPK3;SF3A2;TXNL4A;SMN1;ZRSR2;SF3A1;SCAF11;CELF5;CELF4;PRPF6;SETX
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair (GO:2000781),-0.3693300690148601,-0.927318395430306,0.5555555555555556,1.0,1.0,8/38,17.70%,MGMT;TIMELESS;PNKP;SHLD1;DDX11;SPIDR;KMT5B;DTX3L
prerank,GO_Biological_Process_2021__regulation of nitric oxide biosynthetic process (GO:0045428),0.4629743785785657,0.9272535331900909,0.55,1.0,1.0,1/26,1.29%,PTGIS
prerank,GO_Biological_Process_2021__cardiac muscle tissue development (GO:0048738),0.43949286351429123,0.9269335781053256,0.6212121212121212,1.0,1.0,6/32,6.44%,CSRP3;MSX1;ADAMTS9;NOTCH1;ZFPM1;ACTC1
prerank,GO_Biological_Process_2021__positive regulation of cytoskeleton organization (GO:0051495),0.4205582936887732,0.9264849368624805,0.6666666666666666,1.0,1.0,3/62,5.23%,NES;HCK;NTF3
prerank,GO_Biological_Process_2021__organelle assembly (GO:0070925),-0.31819865353749344,-0.9262349376441195,0.8,1.0,1.0,70/358,17.57%,STING1;RAB32;UBXN10;CDC14B;GOLGA8M;ARL13B;RILP;VPS25;NEK6;CFAP221;ABCC4;B9D1;EHD4;GOLGA8H;PDE6D;PTPN23;TMOD4;CFAP52;EXOC7;NSFL1C;RAB3IP;RAB7A;INO80;GOLGA8A;PCNT;MAPRE1;GOLGA8B;FHDC1;SNAP29;GOLGA8N;CEP83;PCM1;CNGA4;UBXN2A;TRAF3IP1;TTC39C;PTPDC1;TTC36;PARVA;MAP1LC3A;MKS1;RILPL1;SCLT1;ATG9B;KIF24;WDR45;SNF8;ATAT1;TRAPPC14;TSG101;EMC6;CFAP70;CIRBP;PIBF1;RCC1;TP53INP2;CFAP20;CLUAP1;PACS2;BBIP1;RAB11FIP3;DZIP1L;CFAP44;DBNL;WDPCP;NUDCD3;TCTN1;RFX2;CYS1;WDR35
prerank,GO_Biological_Process_2021__IRE1-mediated unfolded protein response (GO:0036498),0.4247763631163649,0.9256735327444061,0.5970149253731343,1.0,1.0,4/47,7.54%,WFS1;SYVN1;VAPB;HSPA5
prerank,GO_Biological_Process_2021__regulation of myotube differentiation (GO:0010830),-0.4668220741431471,-0.925634264147963,0.5,1.0,1.0,8/17,19.20%,HDAC5;MAML1;HDAC1;HDAC9;ATP11A;FBXO22;CCN3;DMPK
prerank,GO_Biological_Process_2021__organelle disassembly (GO:1903008),-0.43181824149526254,-0.9254359091208099,0.6097560975609756,1.0,1.0,1/32,0.97%,STING1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway (GO:1901030),0.4776227125875092,0.9254348568885618,0.582089552238806,1.0,1.0,5/27,12.83%,BOK;HIP1R;CASP8;YWHAH;YWHAG
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell activation (GO:0032816),-0.4819939165185493,-0.9253848021224421,0.6052631578947368,1.0,1.0,1/10,4.94%,TICAM1
prerank,GO_Biological_Process_2021__response to chemokine (GO:1990868),0.5713547092698127,0.9252365236331653,0.5967741935483871,1.0,1.0,1/11,5.30%,DOCK8
prerank,GO_Biological_Process_2021__phosphatidylethanolamine biosynthetic process (GO:0006646),-0.4665699888373862,-0.9252040797203017,0.575,1.0,1.0,4/14,15.40%,CHKA;CEPT1;PHOSPHO1;PCYT2
prerank,GO_Biological_Process_2021__pyruvate metabolic process (GO:0006090),0.4464296210377111,0.9248077228310918,0.6493506493506493,1.0,1.0,6/46,12.38%,SDS;ENO4;LDHB;HKDC1;ALDOB;PGAM1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase activity (GO:0045860),-0.3486641461826585,-0.9247845998628719,0.5185185185185185,1.0,1.0,18/125,11.39%,NRK;NOX4;RASSF2;EREG;AZU1;TGFB2;PRKCD;MMD2;MAP2K3;INCENP;HMGA2;LRP8;CSF1R;XRCC6;TELO2;SYAP1;LCP2;CLU
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell proliferation (GO:0048660),0.44214183776520133,0.9243213091973631,0.5142857142857142,1.0,1.0,7/35,10.21%,CCL5;PDGFRB;ELANE;IGFBP5;NOX1;STAT1;OGN
prerank,GO_Biological_Process_2021__proteasome assembly (GO:0043248),0.5413283646623502,0.9242684461777513,0.6031746031746031,1.0,1.0,3/10,35.21%,PSMG1;POMP;PSMD4
prerank,PanglaoDB_Augmented_2021__Foveolar Cells,0.4677862239691321,0.9242358431402371,0.5757575757575758,1.0,1.0,8/28,12.98%,LIPH;SMIM22;ANXA10;GPX2;GPRC5A;GCNT3;B3GNT3;PTGR1
prerank,GO_Biological_Process_2021__regulation of guanyl-nucleotide exchange factor activity (GO:1905097),0.6465611414605668,0.9242216978634076,0.66,1.0,1.0,1/5,13.41%,PBXIP1
prerank,GO_Biological_Process_2021__regulation of neuron differentiation (GO:0045664),-0.3766684413954682,-0.9241874426057013,0.7407407407407407,1.0,1.0,16/61,14.05%,ALK;BMP7;ASCL1;DTX1;ZFHX3;MMD2;ID2;CDK5RAP2;VWC2;BEND6;NGF;BIN1;NBL1;KCTD11;BRINP2;BRINP1
prerank,GO_Biological_Process_2021__copper ion homeostasis (GO:0055070),-0.48099659642309267,-0.9240006150155375,0.5333333333333333,1.0,1.0,5/14,17.27%,CCDC22;XIAP;COX19;ATP7B;COMMD1
prerank,GO_Biological_Process_2021__peptide biosynthetic process (GO:0043043),0.389309500239522,0.9239186255988835,0.6133333333333333,1.0,1.0,51/142,34.72%,GGTA1;EEF1A1;ASMT;RPL15;RPL36;RPS7;RHD;RPL9;RPS21;RPL22;RPL21;RSL24D1;FURIN;RPL38;PCSK5;MRPL34;MRPS14;CARNS1;RPLP2;RPS5;RPS6KB2;RPL3;COPS5;RPL35A;RPS13;RPL35;MRPS18C;RPS20;MRPL35;RPL27;RPL13A;RPS27A;RPL5;MRPL43;RPL27A;RPL7;RPS9;EIF4EBP2;MRPL42;MRPL51;MRPL28;RPL37;RPS29;RPL24;RPL28;RPL32;RPL8;RPS4X;RPS12;RPL37A;RPSA
prerank,GO_Biological_Process_2021__glycerol metabolic process (GO:0006071),0.5620196227769214,0.9238778207239557,0.639344262295082,1.0,1.0,1/9,4.01%,GOT1
prerank,GO_Biological_Process_2021__regulation of immune response (GO:0050776),0.3929598156079127,0.923803718037404,0.5584415584415584,1.0,1.0,13/88,13.02%,AMBP;C17ORF99;OSCAR;CD300LF;CD8A;IL15;AHR;PIANP;CD160;HLA-A;CASP8;IL4I1;IRF1
prerank,GO_Biological_Process_2021__negative regulation of cell cycle process (GO:0010948),-0.39492087675471027,-0.9237980440080436,0.53125,1.0,1.0,11/54,15.83%,BMP7;RING1;TFDP1;E2F6;KIF25;RRM2;EHMT2;PCGF6;TOM1L2;UXT;AURKAIP1
prerank,GO_Biological_Process_2021__peptidyl-lysine dimethylation (GO:0018027),-0.4633649172127234,-0.9237692076564581,0.5476190476190477,1.0,1.0,6/18,20.55%,SMYD2;SUV39H2;EHMT2;KMT2B;EHMT1;SETD2
prerank,GO_Biological_Process_2021__positive regulation of protein metabolic process (GO:0051247),0.4039597494035216,0.9237603767986763,0.647887323943662,1.0,1.0,7/89,8.10%,C4BPB;PLA2G10;WFS1;INHBA;TRIM32;AGT;CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of leukocyte chemotaxis (GO:0002689),-0.5103413151270757,-0.9235732041807512,0.5625,1.0,1.0,1/9,1.73%,GREM1
prerank,GO_Biological_Process_2021__mitochondrial transcription (GO:0006390),-0.5016637327982459,-0.9233265858183887,0.5757575757575758,1.0,1.0,1/10,5.68%,SLC25A33
prerank,GO_Biological_Process_2021__purine ribonucleotide catabolic process (GO:0009154),-0.444125552285733,-0.9232447196553335,0.5333333333333333,1.0,1.0,4/22,11.52%,PNP;MLYCD;NUDT7;PRTFDC1
prerank,PanglaoDB_Augmented_2021__Taste Receptor Cells,-0.3593814638680128,-0.9231379372055911,0.6666666666666666,1.0,1.0,29/105,18.34%,SVOP;UNC13C;CACNG3;RPH3A;TNR;CATSPER2;CACNA1A;FGF13;AP3B2;GNAT3;GRIA4;CTNNA2;GAD2;DPP6;CABP1;CNTNAP5;GRIA2;KCNJ6;SRRM4;FRRS1L;CPNE6;PRKCB;XKR4;CELF4;CYP46A1;SEZ6L;ST8SIA5;MYO15A;OTUD7A
prerank,GO_Biological_Process_2021__negative regulation of axon extension involved in axon guidance (GO:0048843),0.5011253110023072,0.9230474214433908,0.5714285714285714,1.0,1.0,3/19,14.43%,SEMA3D;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of interferon-gamma production (GO:0032729),0.4432924806408286,0.9229364742873573,0.5396825396825397,1.0,1.0,5/33,8.88%,IL18R1;ZFPM1;CD14;FADD;HLA-A
prerank,GO_Biological_Process_2021__regulation of interleukin-1 production (GO:0032652),-0.5450990296430812,-0.9225856413669059,0.6388888888888888,1.0,1.0,1/8,7.25%,FOXP1
prerank,GO_Biological_Process_2021__inorganic anion transport (GO:0015698),0.45616089285469574,0.9224672853827437,0.6285714285714286,1.0,1.0,6/35,18.44%,SLC13A4;SLC26A4;SLC26A7;RACGAP1;TTYH1;GLRA1
prerank,GO_Biological_Process_2021__electron transport chain (GO:0022900),0.5051134625270802,0.9223519874032391,0.6451612903225806,1.0,1.0,4/13,27.00%,PPARGC1A;CYB561;ETFB;ETFA
prerank,GO_Biological_Process_2021__positive regulation of inflammatory response (GO:0050729),0.42446191161621377,0.9222976254195315,0.581081081081081,1.0,1.0,13/51,23.68%,PLA2G7;IL15;AGT;OSMR;PDCD4;TLR2;NFKBIZ;SNX4;MAPK13;LBP;IFI35;IL18;IL6ST
prerank,GO_Biological_Process_2021__leptin-mediated signaling pathway (GO:0033210),-0.515613694414625,-0.9221023620564017,0.5384615384615384,1.0,1.0,2/9,14.61%,STAT3;LEP
prerank,GO_Biological_Process_2021__regulation of cell migration involved in sprouting angiogenesis (GO:0090049),-0.43131357593835556,-0.922001033213164,0.5757575757575758,1.0,1.0,4/25,7.82%,KDR;HDAC5;RHOJ;CARD10
prerank,GO_Biological_Process_2021__isocitrate metabolic process (GO:0006102),-0.5748832255018685,-0.9218619114084806,0.55,1.0,1.0,1/5,3.15%,IDH2
prerank,GO_Biological_Process_2021__axonemal dynein complex assembly (GO:0070286),0.47999307253268797,0.9214176527541389,0.6181818181818182,1.0,1.0,7/25,20.11%,ODAD4;ODAD3;DNAH8;CCDC39;DNAH7;DNAI1;DNAI3
prerank,PanglaoDB_Augmented_2021__Endothelial Cells (Blood Brain Barrier),-0.3412349867126089,-0.9213880521998092,0.5769230769230769,1.0,1.0,22/106,14.90%,SHC3;LEF1;TNFRSF19;ID4;SLC19A1;SEZ6L2;CDC42BPB;NYAP1;TYRO3;NCS1;GPR37;TBC1D16;FAT1;ARNT2;EGFR;FARP1;FNDC4;KAZN;CAP2;EPN2;FGFR3;SRRM3
prerank,GO_Biological_Process_2021__synaptic vesicle exocytosis (GO:0016079),-0.38693033823456385,-0.9212240066888362,0.56,1.0,1.0,8/33,18.71%,UNC13B;UNC13C;SNAP29;PIP5K1C;UNC13A;STX4;RIMS1;SNPH
prerank,GO_Biological_Process_2021__Golgi to plasma membrane protein transport (GO:0043001),0.46054004511380897,0.921190280950845,0.6031746031746031,1.0,1.0,1/25,5.93%,AMN
prerank,GO_Biological_Process_2021__N-acylphosphatidylethanolamine metabolic process (GO:0070292),0.5869563741324002,0.9211471624212798,0.6290322580645161,1.0,1.0,2/6,26.77%,PLAAT5;NAPEPLD
prerank,GO_Biological_Process_2021__positive regulation of lipid storage (GO:0010884),0.5160169479499465,0.9209032612017188,0.5909090909090909,1.0,1.0,1/16,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__regulation of trophoblast cell migration (GO:1901163),0.5107120414212711,0.9207090345545067,0.5645161290322581,1.0,1.0,7/11,38.76%,NODAL;CALR;ACVR1C;GJA1;YTHDF3;SMURF2;C1QBP
prerank,GO_Biological_Process_2021__energy derivation by oxidation of organic compounds (GO:0015980),-0.49825520972979853,-0.9206503036835616,0.6129032258064516,1.0,1.0,6/21,14.61%,PID1;COX10;ACADVL;SDHAF4;NR4A3;LEP
prerank,GO_Biological_Process_2021__receptor-mediated endocytosis of virus by host cell (GO:0019065),0.6139525180143518,0.9198022464565381,0.6896551724137931,1.0,1.0,1/6,10.18%,SIGLEC1
prerank,GO_Biological_Process_2021__positive regulation of neuroblast proliferation (GO:0002052),0.5560628608427698,0.9197496385830032,0.6140350877192983,1.0,1.0,3/11,28.20%,CX3CR1;KDM1A;DCT
prerank,GO_Biological_Process_2021__mitochondrial translation (GO:0032543),-0.33962783530454255,-0.9195858550229219,0.6060606060606061,1.0,1.0,20/94,18.71%,MRPL17;MRPL58;MRPL33;TSFM;MRPS18A;MRPL39;MRPL21;MRPL55;DAP3;MRPL48;EARS2;MRPL4;AURKAIP1;QRSL1;MRPS7;MRPL9;RARS2;MRPL40;MTRF1L;MRPS27
prerank,GO_Biological_Process_2021__endoplasmic reticulum mannose trimming (GO:1904380),0.4971751388518564,0.919537648874453,0.6,1.0,1.0,7/18,29.20%,SYVN1;RNF139;UGGT1;MAN1B1;RNF185;MARCHF6;RPS27A
prerank,PanglaoDB_Augmented_2021__B Cells Naive,0.4163298358332003,0.9195130913193827,0.5882352941176471,1.0,1.0,27/72,20.57%,ADAM28;RCSD1;DOCK8;PTPRC;GMFG;TAGAP;ARHGAP9;STAG3;LINC00926;WAS;ARHGAP25;P2RY14;STAP1;MAP4K1;ABCB4;RHOH;MITF;MYO1F;BTLA;PYHIN1;BANK1;LY86;CD72;WDFY4;CD74;TMC8;CD37
prerank,GO_Biological_Process_2021__modulation by symbiont of host process (GO:0044003),0.5443875973782817,0.9194475513240489,0.6470588235294118,1.0,1.0,3/10,29.20%,B2M;TLR2;RPS27A
prerank,PanglaoDB_Augmented_2021__Acinar Cells,-0.43708713746216454,-0.9192282789927138,0.5757575757575758,1.0,1.0,7/24,10.04%,CELA2A;CPA1;ACE2;NR1H4;AKR1C3;HGD;RNASE1
prerank,GO_Biological_Process_2021__autophagosome organization (GO:1905037),-0.37790051645886547,-0.9192106270099079,0.6206896551724138,1.0,1.0,12/50,18.10%,STING1;NSFL1C;RAB7A;UBXN2A;MAP1LC3A;ATG9B;WDR45;EMC6;TP53INP2;PACS2;ULK3;WIPI2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transport (GO:0043268),-0.41563327235757613,-0.9191345462327829,0.53125,1.0,1.0,10/37,15.05%,KCNJ16;AMIGO1;KCNN3;KCNE1;KCNN2;DRD1;NOS1AP;KCNJ6;GABBR2;KCNJ2
prerank,"GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO:0002479)",-0.41339778089580514,-0.9190668032167788,0.5185185185185185,1.0,1.0,1/60,0.33%,ITGB5
prerank,GO_Biological_Process_2021__regulation of Wnt signaling pathway (GO:0030111),0.3833209450031859,0.9190649505021692,0.5466666666666666,1.0,1.0,19/87,16.98%,RSPO2;ZNF703;SHISA2;HIC1;DEPDC1B;NOTUM;SFRP4;NKD2;TCF7L1;FGFR2;RSPO3;ATP6AP2;ESR1;KREMEN1;TSC2;DAAM2;LGR6;NLK;AMER2
prerank,PanglaoDB_Augmented_2021__Cardiac Stem And Precursor Cells,-0.3537465801437706,-0.9190570741844045,0.5555555555555556,1.0,1.0,8/90,4.80%,KIT;LAMB2;TSPAN12;ADAMTS15;RND3;CACNA2D1;KITLG;WWTR1
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA poly(A) tail shortening (GO:0000289),-0.4616487854699612,-0.9187693924547992,0.6060606060606061,1.0,1.0,1/21,1.66%,SAMD4A
prerank,GO_Biological_Process_2021__cell surface receptor signaling pathway involved in heart development (GO:0061311),0.512683792767577,0.9187184667623439,0.5909090909090909,1.0,1.0,4/12,22.85%,NOTCH1;TGFB1;SNAI2;NOTCH2
prerank,GO_Biological_Process_2021__purine ribonucleotide metabolic process (GO:0009150),0.4195429776398583,0.9184463371793342,0.6103896103896104,1.0,1.0,15/57,22.06%,ACOT4;BAAT;SULT2A1;HINT1;RAB23;ACOT13;AMPD2;ACSM4;AK4;ACOT12;LRRK2;TPST2;BAD;ACSM3;ACAT1
prerank,GO_Biological_Process_2021__positive regulation of ERBB signaling pathway (GO:1901186),0.4957170678378957,0.9184316813725053,0.6111111111111112,1.0,1.0,4/19,13.26%,AGT;HIP1R;GPER1;PLAUR
prerank,GO_Biological_Process_2021__response to cytokine (GO:0034097),-0.33472260535963766,-0.9182415439347494,0.5185185185185185,1.0,1.0,14/114,6.63%,SELP;LEF1;PTPN9;PID1;IL1RL2;IL1R1;TNFRSF11A;KHSRP;GCH1;PTPN23;AFF3;ALDH1A2;IGBP1;BCL2
prerank,PanglaoDB_Augmented_2021__Vascular Smooth Muscle Cells,0.39463147210021604,0.9181271278598061,0.5970149253731343,1.0,1.0,14/79,9.97%,LAMA2;MYLK;SEMA3D;ACTA2;PDGFRB;POSTN;IGFBP5;NID2;ECM2;RUNX1T1;ANGPTL2;PRKG1;SFRP4;ITGA11
prerank,GO_Biological_Process_2021__regulation of stem cell proliferation (GO:0072091),0.5076472381820292,0.918123998604937,0.5555555555555556,1.0,1.0,8/15,27.01%,PTPRC;SOX11;NANOG;FBLN1;EPCAM;KDM1A;GJA1;YAP1
prerank,GO_Biological_Process_2021__translational termination (GO:0006415),-0.33666093400740527,-0.9178131729463694,0.6176470588235294,1.0,1.0,18/85,18.71%,MRPL17;MRPL58;MRPL33;MRPS18A;MRPL39;MRPL21;MRPL55;DAP3;MRPL48;MRPL4;APEH;AURKAIP1;MRPS7;MRPL9;MRPL40;MTRF1L;ETF1;MRPS27
prerank,GO_Biological_Process_2021__positive regulation of BMP signaling pathway (GO:0030513),0.484166203839773,0.9178021948205358,0.5757575757575758,1.0,1.0,3/19,14.04%,NOTCH1;SOX11;ACVR2B
prerank,GO_Biological_Process_2021__organic anion transport (GO:0015711),0.4263194646386295,0.9176693461902372,0.7142857142857143,1.0,1.0,14/70,14.11%,CA12;SLCO6A1;SLCO2B1;MGST1;SLC23A1;CA9;SLC22A25;CA1;LRRC8D;SLC26A7;SLC52A2;ABCG2;CA7;SLCO4C1
prerank,GO_Biological_Process_2021__regulation of organelle organization (GO:0033043),0.41220447550763545,0.917636128024334,0.6,1.0,1.0,8/70,18.21%,LMAN1;F11R;MSN;VPS35;NEXN;PINK1;MIEF2;TMEM33
prerank,GO_Biological_Process_2021__protein K27-linked ubiquitination (GO:0044314),-0.6194386737563008,-0.9174769009441178,0.5777777777777777,1.0,1.0,2/6,19.41%,UBE2D4;PRKN
prerank,GO_Biological_Process_2021__regulation of sodium ion transport (GO:0002028),-0.4200046120888774,-0.917417317046759,0.5357142857142857,1.0,1.0,3/30,7.58%,PKP2;NKAIN3;RANGRF
prerank,GO_Biological_Process_2021__intracellular pH elevation (GO:0051454),0.5661241953846711,0.9173199452104912,0.5555555555555556,1.0,1.0,1/6,5.17%,NOX1
prerank,GO_Biological_Process_2021__sensory organ development (GO:0007423),-0.3956473850756497,-0.9172533932924326,0.5161290322580645,1.0,1.0,9/39,11.68%,RBP4;ASCL1;TGFB2;ECE1;SIPA1L3;PBX4;SMG9;CHRDL1;SMOC1
prerank,GO_Biological_Process_2021__lipid import into cell (GO:0140354),-0.5295303585619175,-0.9167043108195784,0.5581395348837209,1.0,1.0,2/8,12.67%,SPX;SLC27A2
prerank,GO_Biological_Process_2021__regulation of defense response to virus (GO:0050688),0.49767596764884664,0.9166887477497011,0.6140350877192983,1.0,1.0,3/13,10.84%,IFNLR1;PCBP2;RNF26
prerank,GO_Biological_Process_2021__positive regulation of protein localization to centrosome (GO:1904781),-0.6153777855162421,-0.9166052501349565,0.6451612903225806,1.0,1.0,5/6,35.81%,PARD6A;APC;BICD1;CEP250;MARK4
prerank,GO_Biological_Process_2021__neutrophil mediated immunity (GO:0002446),0.34988377954732697,0.9164153019309238,0.7272727272727273,1.0,1.0,42/363,15.27%,C3AR1;CHIT1;OSCAR;FGL2;CLEC4C;MGST1;TIMP2;ELANE;DOCK2;PRDX4;PLAC8;PTPRC;GM2A;GMFG;EEF1A1;CD14;TMEM30A;LAMP2;CAPN1;ARHGAP9;ARG1;TUBB;TOLLIP;OSTF1;MANBA;C6ORF120;PGAM1;ATP6AP2;NBEAL2;STOM;GGH;TMC6;PLAUR;TMBIM1;PRSS3;CHRNB4;SLCO4C1;CCT8;TMEM63A;AGL;PRDX6;HSPA8
prerank,GO_Biological_Process_2021__DNA damage induced protein phosphorylation (GO:0006975),-0.505255470862446,-0.9161401249737824,0.5555555555555556,1.0,1.0,3/8,23.04%,MAPK12;ATM;CHEK2
prerank,GO_Biological_Process_2021__apoptotic nuclear changes (GO:0030262),0.5088009123390199,0.9160643576800748,0.5806451612903226,1.0,1.0,6/19,26.55%,DNASE2;DNASE2B;GPER1;H1-0;ACVR1C;DFFB
prerank,GO_Biological_Process_2021__chromatin assembly (GO:0031497),0.44730852751475764,0.9157850790761947,0.631578947368421,1.0,1.0,7/44,12.16%,H3-3A;POLE3;SPTY2D1;H1-2;NAP1L2;H2BC18;M1AP
prerank,GO_Biological_Process_2021__regulation of keratinocyte apoptotic process (GO:1902172),0.6067144718507491,0.9157772086558911,0.6491228070175439,1.0,1.0,1/5,9.22%,SFRP4
prerank,GO_Biological_Process_2021__fatty acid homeostasis (GO:0055089),-0.4906606194929315,-0.9155473370750302,0.6060606060606061,1.0,1.0,2/9,11.15%,ABCD1;APOE
prerank,GO_Biological_Process_2021__negative regulation of lipid biosynthetic process (GO:0051055),0.5269330710797824,0.9154830242178051,0.6129032258064516,1.0,1.0,5/17,21.51%,ASXL3;GPER1;BRCA1;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell migration (GO:0010596),0.4482222454326548,0.9152941589102295,0.5,1.0,1.0,12/25,23.11%,ADAMTS9;NOTCH1;ADGRB1;ANGPT2;TGFB1;RGCC;DAB2IP;SP100;DCN;PPARG;NR2F2;ATP2B4
prerank,GO_Biological_Process_2021__positive regulation of lymphocyte differentiation (GO:0045621),0.5131073633170413,0.9152500014719557,0.625,1.0,1.0,4/14,20.20%,IL7;RHOH;CD27;PPP2R3C
prerank,GO_Biological_Process_2021__regulation of store-operated calcium entry (GO:2001256),-0.5184466617209104,-0.9149893377813098,0.5294117647058824,1.0,1.0,1/8,1.01%,HOMER2
prerank,GO_Biological_Process_2021__pyrimidine ribonucleotide metabolic process (GO:0009218),-0.5891630127156693,-0.9148278738572985,0.6585365853658537,1.0,1.0,1/5,14.34%,AK5
prerank,GO_Biological_Process_2021__regulation of dopamine uptake involved in synaptic transmission (GO:0051584),-0.5366304878409269,-0.914697080008162,0.5681818181818182,1.0,1.0,2/7,10.32%,DRD4;DRD1
prerank,GO_Biological_Process_2021__response to organic cyclic compound (GO:0014070),0.4342491331418765,0.9144764708110328,0.5882352941176471,1.0,1.0,14/37,17.17%,ALPL;CCL5;CYP1B1;IGFBP5;CDKN2D;CYP19A1;ABCB4;ESR1;DRD3;TGFB1;LOC400499;TIPARP;SPP1;GLDC
prerank,GO_Biological_Process_2021__membrane repolarization during cardiac muscle cell action potential (GO:0086013),0.5299700727128196,0.9143285902373897,0.6268656716417911,1.0,1.0,4/14,18.43%,KCNE2;ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__blood vessel morphogenesis (GO:0048514),0.4553577653760294,0.9142075778452109,0.6338028169014085,1.0,1.0,8/36,13.78%,RASA1;RASIP1;CYP1B1;LAMA1;TBX1;SMAD7;AGGF1;TGFB1
prerank,GO_Biological_Process_2021__DNA topological change (GO:0006265),-0.5128401092900214,-0.9140249335358466,0.4883720930232558,1.0,1.0,3/8,19.81%,HMGB2;TOP3B;ERCC3
prerank,GO_Biological_Process_2021__positive regulation of cell-substrate adhesion (GO:0010811),-0.3831743614780657,-0.9138596902381775,0.5454545454545454,1.0,1.0,5/56,4.71%,CCL28;NPNT;CDH13;UTRN;SFRP1
prerank,GO_Biological_Process_2021__transferrin transport (GO:0033572),-0.4216018321532866,-0.9137464157937425,0.5641025641025641,1.0,1.0,2/30,4.46%,ATP6V0D2;STEAP3
prerank,GO_Biological_Process_2021__negative regulation of protein serine/threonine kinase activity (GO:0071901),-0.3745614829791362,-0.9136955351657068,0.5714285714285714,1.0,1.0,10/68,11.42%,BMP7;SPRY4;RGS14;HEG1;TFAP4;PRKCD;SPRY3;SORL1;APOE;RGS2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor-mediated signaling pathway (GO:0010804),0.5041429690555541,0.9136942614379475,0.576271186440678,1.0,1.0,3/13,7.99%,NLRP2B;CARD8;PELI3
prerank,GO_Biological_Process_2021__positive regulation of release of sequestered calcium ion into cytosol (GO:0051281),0.4703306586423499,0.9135688798114222,0.6363636363636364,1.0,1.0,4/22,21.68%,CASQ1;GPER1;TRDN;CALM3
prerank,GO_Biological_Process_2021__embryonic skeletal system morphogenesis (GO:0048704),0.5266133845634892,0.9135335272439339,0.6721311475409836,1.0,1.0,4/13,11.31%,TWIST1;TBX1;FGFR2;SOX11
prerank,GO_Biological_Process_2021__positive regulation of nuclear division (GO:0051785),-0.44480063278780535,-0.9134791465650689,0.5675675675675675,1.0,1.0,4/17,7.03%,BTC;EREG;IGF1;AURKA
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum tubular network organization (GO:1903371),0.621727530185599,0.913447024220585,0.6885245901639344,1.0,1.0,3/5,33.73%,TMEM33;RAB3GAP1;RAB3GAP2
prerank,PanglaoDB_Augmented_2021__Purkinje Fiber Cells,0.3854482869221672,0.913377950367144,0.6790123456790124,1.0,1.0,10/100,13.56%,TMEM200C;TMEM35A;ASXL3;ZDHHC22;PLP1;PNMA2;RUNX1T1;CNTN2;NEFM;CPT1C
prerank,GO_Biological_Process_2021__positive regulation of response to cytokine stimulus (GO:0060760),-0.46624448403298663,-0.9133031426342036,0.6285714285714286,1.0,1.0,4/11,16.66%,IFIH1;TRIM44;MAVS;AGPAT2
prerank,GO_Biological_Process_2021__mature B cell differentiation involved in immune response (GO:0002313),0.6106138478819381,0.912907407011033,0.6666666666666666,1.0,1.0,3/7,15.07%,C17ORF99;DOCK11;GPR183
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell proliferation (GO:0060043),-0.4623658616419462,-0.9124366706199114,0.6875,1.0,1.0,2/15,2.43%,RUNX1;RBP4
prerank,PanglaoDB_Augmented_2021__Pluripotent Stem Cells,0.41611721658871664,0.912268121090423,0.6438356164383562,1.0,1.0,11/81,12.85%,TICRR;ALPL;TRIM32;DEPDC1B;FANCI;GINS1;PAICS;BUB1B;CDC6;NANOG;PHF6
prerank,GO_Biological_Process_2021__positive regulation of phosphorylation (GO:0042327),-0.3179360099429895,-0.9121987464040802,0.7142857142857143,1.0,1.0,15/206,5.79%,KIT;ALK;ROR2;KDR;FGFR4;EPHA3;EPHB2;EREG;IGF1;ITGA6;RASGRP1;DRD4;EPHA5;KNDC1;FGF1
prerank,GO_Biological_Process_2021__I-kappaB kinase/NF-kappaB signaling (GO:0007249),0.42830465015133984,0.9121602519196644,0.6268656716417911,1.0,1.0,8/52,19.74%,NKIRAS1;PRDX4;CD14;RIPK2;DAB2IP;NLRC3;TAB2;TLR2
prerank,GO_Biological_Process_2021__negative regulation of hormone secretion (GO:0046888),-0.6318805780905417,-0.9121277558983618,0.7317073170731707,1.0,1.0,3/5,20.21%,IL11;RAB11FIP3;RAB11FIP1
prerank,GO_Biological_Process_2021__chromosome condensation (GO:0030261),0.4623592341443837,0.911898755084623,0.6417910447761194,1.0,1.0,7/32,12.53%,NCAPH2;NCAPG;PHF13;H1-2;GPER1;CHMP1A;SMC2
prerank,GO_Biological_Process_2021__organic hydroxy compound biosynthetic process (GO:1901617),-0.3977242854174406,-0.9118339259193903,0.5517241379310345,1.0,1.0,8/39,12.92%,PER2;PNPO;OSBPL7;ACOT8;AKR1C3;PSAT1;SLC27A2;TM7SF2
prerank,GO_Biological_Process_2021__T-helper cell differentiation (GO:0042093),-0.5449100451835919,-0.9117189333374838,0.5714285714285714,1.0,1.0,2/6,7.25%,LEF1;FOXP1
prerank,GO_Biological_Process_2021__cilium assembly (GO:0060271),-0.31238870245143713,-0.9115490167027674,0.7142857142857143,1.0,1.0,61/275,18.98%,CFAP46;UBXN10;CDC14B;ARL13B;RILP;CFAP221;ABCC4;B9D1;EHD4;PDE6D;PTPN23;JHY;CFAP52;EXOC7;RAB3IP;CDK5RAP2;PCNT;NEDD1;MAPRE1;FHDC1;SNAP29;CEP83;RSPH1;ODF2;PCM1;CNGA4;TRAF3IP1;TTC39C;PTPDC1;TTC36;TUBG1;PARVA;MKS1;RILPL1;SCLT1;KIF24;RPGRIP1L;ATAT1;TRAPPC14;CFAP70;PIBF1;TUBB4A;CFAP20;CLUAP1;BBIP1;TBC1D32;RAB11FIP3;DZIP1L;CFAP44;WDPCP;NUDCD3;TCTN1;RFX2;CYS1;WDR35;INTU;EXOC2;KIAA0586;DNAH5;NEK1;HAUS8
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase II (GO:0006357),-0.3042524429350613,-0.9114589376739283,1.0,1.0,1.0,181/1645,11.15%,ETV1;ETV5;PER2;ZNF534;KIT;ZNF485;ZNF442;ZNF707;POU6F2;MYB;SOX13;STING1;TBX6;RFX8;LEF1;AASS;TOX2;F2RL1;CDH13;GFI1B;RUNX1;TCF24;GREM1;PID1;ARID5A;CREB5;SSBP3;FHL2;CREB3L4;ZNF572;ZNF496;ARID3B;ZNF606;ATOH8;GABPB2;MAML3;ASCL1;E2F5;CEBPD;NFATC1;NRL;ZNF132;FOS;SOX12;ZBTB7C;BACH2;TEAD2;TBL1Y;ZNF462;ZNF18;ZNF449;ZNF347;PRDM5;ZNF256;ZNF239;HDAC5;NFIB;SMYD2;BRD3;IGF1;PRDM15;TPR;ZMIZ2;TRIAP1;ZNF155;ADIRF;FIZ1;ITGA6;RITA1;ZNF48;MAML1;WWTR1;ID4;HIVEP1;RRP1B;ZNF25;PRRX1;LYAR;MED30;BCL6;RFX1;ZNF354B;ZNF608;FGF1;HDAC1;ZBTB39;TFAP4;ZNF334;ZNF300;PTCH1;MED15;ZBED3;TOX;ZNF441;IGBP1;POU3F4;ZNF596;TRPS1;HR;ZNF846;SBNO2;HDX;IL11;ATF3;ZNF558;NFIX;SERPINF2;TFDP1;E2F6;ARX;FOXP1;MAPK7;ZNF536;GTF2H2;ETS1;ZFHX3;ZNF446;GTF2H2C;BMP6;E4F1;CBFB;MACROH2A2;SPDEF;ZNF771;NR1H4;MAFK;ID2;ZSCAN16;ZNF397;INO80;VGLL3;WIZ;STAT3;ZNF264;FOXK1;ZNF99;ZHX3;ZBTB7A;CCNH;HMGA2;BAZ1B;SMARCAL1;RORA;ZNF514;ANKRD2;SUV39H2;ZNF416;ZNF429;KLF16;SIN3B;POU2F2;BRD9;CSF1R;SMARCA4;SARS1;RBMX;DACH2;XRCC6;TGFB3;ZNF184;PBX4;ZMYM5;IFI16;ZNF215;TAF1;DLX5;POU3F1;IKZF3;LCORL;ZNF26;ZNF275;ZBTB47;TET1;CREB3L1;MXI1;MAMLD1;ZGLP1;NFX1;SIRT2;KDM3B;APOE
prerank,GO_Biological_Process_2021__regulation of dopamine metabolic process (GO:0042053),-0.5907521525577553,-0.9113961343372978,0.6341463414634146,1.0,1.0,1/6,4.99%,DRD4
prerank,GO_Biological_Process_2021__synaptonemal complex assembly (GO:0007130),-0.49221818314891985,-0.9113912921300958,0.5714285714285714,1.0,1.0,1/12,1.84%,RAD21L1
prerank,GO_Biological_Process_2021__synaptonemal complex organization (GO:0070193),-0.49221818314891985,-0.9113912921300958,0.5714285714285714,1.0,1.0,1/12,1.84%,RAD21L1
prerank,GO_Biological_Process_2021__secondary alcohol metabolic process (GO:1902652),0.4738341162381391,0.9113268487677376,0.625,1.0,1.0,3/30,4.84%,LDLRAP1;NSDHL;SULT2A1
prerank,GO_Biological_Process_2021__regulation of microtubule polymerization or depolymerization (GO:0031110),0.4678419384399558,0.9111641531346807,0.5818181818181818,1.0,1.0,2/25,5.81%,SKA3;FKBP4
prerank,GO_Biological_Process_2021__regulation of T cell receptor signaling pathway (GO:0050856),0.4806615725969652,0.9110564139917581,0.5932203389830508,1.0,1.0,2/27,8.35%,KCNN4;CD160
prerank,GO_Biological_Process_2021__regulation of spindle assembly (GO:0090169),0.47887561876446677,0.9109645892889073,0.5882352941176471,1.0,1.0,6/21,18.42%,CHMP4B;CHMP2B;CHMP1A;EML3;CHMP2A;GPSM2
prerank,GO_Biological_Process_2021__positive regulation of muscle cell differentiation (GO:0051149),-0.44397004342415836,-0.9103424982117128,0.5806451612903226,1.0,1.0,3/22,10.30%,NRG1;OLFM2;CTNNA2
prerank,GO_Biological_Process_2021__positive regulation of blood pressure (GO:0045777),-0.5329639791035838,-0.9101760469262968,0.5384615384615384,1.0,1.0,4/6,9.35%,GLP1R;TAC3;ID2;SPX
prerank,GO_Biological_Process_2021__cytoplasmic translational initiation (GO:0002183),-0.4719678039315882,-0.9095496031704271,0.625,1.0,1.0,2/17,10.28%,EIF2B3;EIF4G1
prerank,GO_Biological_Process_2021__bone development (GO:0060348),-0.4479075064157711,-0.9094291287717154,0.41379310344827586,1.0,1.0,3/25,5.34%,SULF2;LRRC17;SLC10A7
prerank,GO_Biological_Process_2021__bicarbonate transport (GO:0015701),0.47365588537688963,0.9093715147970022,0.5974025974025974,1.0,1.0,5/25,13.83%,CA12;CA9;CA1;SLC26A7;CA7
prerank,PanglaoDB_Augmented_2021__T Follicular Helper Cells,0.4244284773592047,0.9092511720140443,0.6153846153846154,1.0,1.0,9/42,11.22%,GNLY;CD4;PTPRC;PIK3R5;GMFG;TAGAP;ARHGAP9;ARHGAP25;CD6
prerank,GO_Biological_Process_2021__chloride transmembrane transport (GO:1902476),0.4308350817153679,0.909162255328426,0.5909090909090909,1.0,1.0,9/42,22.87%,SLC12A7;GABRA2;CLCN3;GLRA3;GLRA1;GABRA4;GABRR1;GABRD;SLC1A3
prerank,PanglaoDB_Augmented_2021__Juxtaglomerular Cells,0.397061099307995,0.9091316749213236,0.5882352941176471,1.0,1.0,9/68,7.24%,LAMA2;MYLK;TIMP3;ACTA2;PDGFRB;POSTN;IGFBP5;RARRES2;ANGPTL2
prerank,GO_Biological_Process_2021__inositol phosphate biosynthetic process (GO:0032958),0.5924750997613,0.9091053712052696,0.6119402985074627,1.0,1.0,3/9,24.82%,IPMK;ITPKB;IPPK
prerank,GO_Biological_Process_2021__iron ion transport (GO:0006826),-0.4083243926246606,-0.9089574146831081,0.48148148148148145,1.0,1.0,3/43,4.46%,ATP6V0D2;MELTF;STEAP3
prerank,GO_Biological_Process_2021__positive regulation of hormone secretion (GO:0046887),-0.5383170907365444,-0.9085182242408996,0.6046511627906976,1.0,1.0,1/9,0.87%,NMB
prerank,GO_Biological_Process_2021__negative regulation of JUN kinase activity (GO:0043508),0.5320159347109776,0.9085036113414012,0.6964285714285714,1.0,1.0,5/10,25.66%,DNAJA1;PDCD4;DUSP19;GSTP1;AIDA
prerank,GO_Biological_Process_2021__stress granule assembly (GO:0034063),0.4804571184871398,0.9084841505619671,0.625,1.0,1.0,6/19,29.76%,CSDE1;UBAP2L;G3BP1;YTHDF1;DDX6;DDX3X
prerank,GO_Biological_Process_2021__negative regulation of secretion by cell (GO:1903531),0.451063338267638,0.9084767171794214,0.6086956521739131,1.0,1.0,5/27,14.27%,NOTCH1;SYT4;HMGCR;DRD3;STXBP6
prerank,GO_Biological_Process_2021__regulation of transcription initiation from RNA polymerase II promoter (GO:0060260),-0.39404092467138324,-0.9084340449937487,0.6470588235294118,1.0,1.0,8/55,15.78%,LEF1;MED30;MED15;CBFB;CSF1R;HNF1A;MED27;CDK8
prerank,GO_Biological_Process_2021__peptidyl-tyrosine autophosphorylation (GO:0038083),0.4885679590134994,0.9083626823162149,0.6290322580645161,1.0,1.0,1/14,1.02%,ITK
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell activation (GO:0046635),0.5249816834482907,0.9083515977735844,0.6323529411764706,1.0,1.0,2/12,8.88%,GLI3;HLA-A
prerank,GO_Biological_Process_2021__ceramide biosynthetic process (GO:0046513),-0.3934716481286248,-0.908244792064221,0.6176470588235294,1.0,1.0,6/36,11.02%,SPTSSB;ST8SIA2;CERS4;SGMS2;SPTLC1;SMPD4
prerank,GO_Biological_Process_2021__calcium ion transport (GO:0006816),-0.33832200388280065,-0.9080077938488625,0.6428571428571429,1.0,1.0,8/92,5.96%,TRPC3;TRPC7;CACNA2D1;CACNG3;RYR1;CACNA1I;GRIN3A;CACNA1A
prerank,GO_Biological_Process_2021__positive regulation of DNA ligation (GO:0051106),0.6069075774865039,0.9079807086433551,0.7076923076923077,1.0,1.0,1/5,15.22%,APLF
prerank,GO_Biological_Process_2021__Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation (GO:1904953),-0.5177953013362032,-0.9078896533302918,0.6,1.0,1.0,3/8,25.88%,WNT9B;LRP6;WNT3
prerank,GO_Biological_Process_2021__determination of heart left/right asymmetry (GO:0061371),-0.4023073982993141,-0.9062284897967707,0.6875,1.0,1.0,1/25,1.17%,TBX6
prerank,GO_Biological_Process_2021__regulation of apoptotic process (GO:0042981),-0.2829816548241401,-0.9060892060586214,1.0,1.0,1.0,47/572,8.75%,CD38;BCL2A1;ALK;KDR;BCL2L11;LEF1;HMGN5;RASSF2;GREM1;MIEN1;SH3RF1;FHL2;UNC13B;USP27X;ASCL1;APIP;NTSR1;IGF1;SGK1;TRIAP1;ITGA6;STEAP3;TCIM;SFRP1;MGMT;GRK5;MAP3K20;RRP1B;BCL6;AZU1;CFLAR;HDAC1;TFAP4;PDPN;SPHK2;BCL2;CIDEA;HSPB1;PLK2;SPDEF;NR1H4;CRADD;NCSTN;PDCD2;SPTLC1;ZBTB7A;HMGA2
prerank,GO_Biological_Process_2021__regulation of peptidyl-serine phosphorylation (GO:0033135),0.40718561956232885,0.9060759876524032,0.6625,1.0,1.0,13/78,23.11%,CALCR;NLRP2B;NTF3;SMAD7;RIPK2;TGFB1;OPRD1;PINK1;MTCP1;DMTN;CREBL2;TERF2IP;ATP2B4
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590),-0.41085608442091165,-0.9059715120955499,0.5555555555555556,1.0,1.0,1/62,0.33%,ITGB5
prerank,GO_Biological_Process_2021__microtubule cytoskeleton organization involved in mitosis (GO:1902850),0.38588082574578475,0.9058159392011965,0.6024096385542169,1.0,1.0,8/110,12.18%,CENPO;CENPI;CENPK;KNL1;WDR62;SPC24;BUB1B;CENPU
prerank,GO_Biological_Process_2021__regulation of response to DNA damage stimulus (GO:2001020),-0.37819489244349924,-0.9056942840352086,0.5588235294117647,1.0,1.0,7/37,14.67%,SMYD2;IER3;PRKCD;HMGA2;RFWD3;USP51;SIRT7
prerank,GO_Biological_Process_2021__positive regulation of astrocyte differentiation (GO:0048711),0.5798614374229278,0.905619364977409,0.639344262295082,1.0,1.0,1/6,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of ubiquitin protein ligase activity (GO:1904666),-0.4527058578432335,-0.90551983176128,0.631578947368421,1.0,1.0,1/19,2.02%,CDC14B
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis to fibroblast growth factor (GO:2000544),-0.5725679457517571,-0.9051491833653733,0.5294117647058824,1.0,1.0,1/5,5.79%,FGF1
prerank,GO_Biological_Process_2021__response to estrogen (GO:0043627),-0.41509024022683416,-0.904763175204859,0.6363636363636364,1.0,1.0,3/27,5.67%,ARID5A;SFRP1;GSTM3
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomerase (GO:0032212),0.45894423812295293,0.9046942697062085,0.6027397260273972,1.0,1.0,6/29,25.90%,TCP1;CCT6A;CCT8;CCT7;PKIB;TNKS2
prerank,GO_Biological_Process_2021__negative regulation of viral process (GO:0048525),0.43315179069209425,0.9046769980512656,0.6486486486486487,1.0,1.0,5/48,9.09%,TRIM5;CCL5;TRIM32;ISG20;STAT1
prerank,MSigDB_Hallmark_2020__Myogenesis,0.38035401854960066,0.9045007223881045,0.7142857142857143,1.0,1.0,25/151,11.99%,LAMA2;CSRP3;MYLK;GADD45B;CHRNB1;PTGIS;CAV3;CHRNG;NOTCH1;FABP3;MYOM1;KLF5;NQO1;FKBP1B;ACTC1;TEAD4;CNN3;SYNGR2;CASQ1;DAPK2;ATP6AP1;CTF1;MYBPC3;SCD;CKB
prerank,GO_Biological_Process_2021__regulation of smooth muscle cell differentiation (GO:0051150),-0.5776449579777434,-0.9043835200529008,0.6428571428571429,1.0,1.0,2/7,6.55%,EREG;OLFM2
prerank,GO_Biological_Process_2021__protein localization to nucleolus (GO:1902570),-0.563883231988702,-0.9043412839865236,0.6216216216216216,1.0,1.0,2/5,25.08%,NOL8;WRN
prerank,GO_Biological_Process_2021__protein alkylation (GO:0008213),-0.46171180760124725,-0.904319347670487,0.6,1.0,1.0,8/20,20.99%,CAMKMT;EEF1AKMT1;SNRPB;PRMT8;ETF1;FAM98A;METTL22;LCMT1
prerank,GO_Biological_Process_2021__regulation of nuclease activity (GO:0032069),-0.5947738814327496,-0.9042319850679733,0.6944444444444444,1.0,1.0,3/5,25.43%,HMGB2;OAS2;NEIL1
prerank,GO_Biological_Process_2021__positive regulation of peptidyl-tyrosine phosphorylation (GO:0050731),0.3894860982513804,0.9042225291891712,0.6172839506172839,1.0,1.0,15/90,13.78%,ENPP2;CCL5;DOK7;CRLF1;IL15;ITGA5;NTF3;PTPRC;AGT;FLT3;HGF;CTF1;PLCG2;RIPK2;TGFB1
prerank,GO_Biological_Process_2021__mitochondrial respirasome assembly (GO:0097250),0.574510340782127,0.9042014152163368,0.6206896551724138,1.0,1.0,2/6,16.61%,HIGD1C;COX7A2L
prerank,GO_Biological_Process_2021__heart looping (GO:0001947),-0.40708056418665284,-0.9038296538176155,0.5714285714285714,1.0,1.0,1/23,1.17%,TBX6
prerank,GO_Biological_Process_2021__cardiac muscle cell contraction (GO:0086003),-0.4349227430667589,-0.9037574912518713,0.5757575757575758,1.0,1.0,2/19,2.68%,PKP2;CACNA2D1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, ubiquinol to cytochrome c (GO:0006122)",0.5155559706210883,0.9037085660251509,0.603448275862069,1.0,1.0,6/11,40.09%,UQCRB;CYCS;UQCRHL;UQCC3;CYC1;UQCRFS1
prerank,GO_Biological_Process_2021__insulin-like growth factor receptor signaling pathway (GO:0048009),-0.5171725011569543,-0.9037046559680297,0.6097560975609756,1.0,1.0,3/11,14.39%,IGF1;GIGYF1;IRS1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance via telomere lengthening (GO:1904358),0.44879859370961456,0.9036405202260946,0.6756756756756757,1.0,1.0,6/31,25.90%,TCP1;CCT6A;CCT8;CCT7;PKIB;TNKS2
prerank,GO_Biological_Process_2021__regulation of synapse maturation (GO:0090128),0.5403553024484358,0.9036141099055456,0.6153846153846154,1.0,1.0,1/9,3.16%,NEUROD2
prerank,GO_Biological_Process_2021__C4-dicarboxylate transport (GO:0015740),0.519794864977647,0.9035978485303446,0.639344262295082,1.0,1.0,2/12,11.11%,LRRC8D;SLC25A18
prerank,PanglaoDB_Augmented_2021__Natural Killer T Cells,0.404461460668804,0.9035699718546321,0.625,1.0,1.0,9/51,11.22%,GNLY;ITK;PTPRC;PIK3R5;GMFG;TAGAP;ARHGAP9;ARHGAP25;CD6
prerank,GO_Biological_Process_2021__positive regulation of cell cycle (GO:0045787),0.4289114238602451,0.9035239756620336,0.6323529411764706,1.0,1.0,11/57,22.00%,SPDYA;TRIM32;PSRC1;CCND2;CDKN1B;FGFR2;LGMN;RGCC;CDK4;SPHK1;CALR
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway in absence of ligand (GO:0097192),-0.4485965522738952,-0.9033850879082717,0.5641025641025641,1.0,1.0,2/18,6.63%,BCL2A1;BCL2
prerank,"GO_Biological_Process_2021__fructose 1,6-bisphosphate metabolic process (GO:0030388)",0.5856874512802575,0.9031706629620717,0.6428571428571429,1.0,1.0,1/5,10.80%,ALDOB
prerank,PanglaoDB_Augmented_2021__Bergmann Glia,-0.3185891493742964,-0.903165748862713,0.7037037037037037,1.0,1.0,23/127,13.06%,KCNIP1;SPHKAP;NTSR2;FAM181B;TNR;GRIN3A;SLC6A1;PTCH1;ADGRA1;MMD2;GRIA4;GRIA1;GRIN2A;CDH20;CTNNA2;BAALC;DPP6;LRRTM3;ELAVL3;ZEB2;RGS7BP;EGFR;GRIA2
prerank,GO_Biological_Process_2021__mitotic cell cycle phase transition (GO:0044772),0.3800293720034428,0.9030898178673996,0.691358024691358,1.0,1.0,23/187,13.61%,NES;CCNG2;BORA;SPDYA;CHMP4B;INHBA;CDKN2D;CCND2;CCNE1;CCNB3;CDKN1B;ABCB1;CDC25A;CCNE2;TUBB;CEP72;CRLF3;FBXL6;FBXL3;EPS8;TUBA4A;YWHAG;CEP70
prerank,GO_Biological_Process_2021__regulation of vesicle fusion (GO:0031338),0.5572909553209375,0.9030337011705397,0.639344262295082,1.0,1.0,3/7,34.39%,SPHK1;DOC2B;C2CD5
prerank,GO_Biological_Process_2021__protein acetylation (GO:0006473),-0.42695444801183147,-0.9027612967260821,0.5757575757575758,1.0,1.0,2/25,4.62%,DSCC1;NAT9
prerank,GO_Biological_Process_2021__positive regulation of apoptotic signaling pathway (GO:2001235),-0.3818656925628492,-0.9027480462325309,0.5714285714285714,1.0,1.0,2/44,1.00%,TPD52L1;BCL2L11
prerank,GO_Biological_Process_2021__cGMP metabolic process (GO:0046068),-0.4863119081322093,-0.9026547842461611,0.53125,1.0,1.0,1/9,2.11%,GUCY2C
prerank,GO_Biological_Process_2021__methylguanosine-cap decapping (GO:0110156),0.5263967991343652,0.9024865055928681,0.6271186440677966,1.0,1.0,2/10,16.37%,PATL2;DCP2
prerank,GO_Biological_Process_2021__regulation of proteolysis involved in cellular protein catabolic process (GO:1903050),0.48903485072700614,0.9024859415114828,0.6212121212121212,1.0,1.0,5/22,16.73%,ATP5IF1;USP14;UCHL5;TMF1;PINK1
prerank,GO_Biological_Process_2021__sensory perception of sound (GO:0007605),-0.3576740263949864,-0.902369726504876,0.6333333333333333,1.0,1.0,11/72,8.48%,KIT;HOMER2;MYH14;MYO3A;COL11A2;TSPEAR;COL4A3;LHFPL3;POU3F4;COL11A1;KCNE1
prerank,GO_Biological_Process_2021__cilium organization (GO:0044782),-0.31741340784856015,-0.9022565777341458,0.6470588235294118,1.0,1.0,53/199,18.95%,UBXN10;CDC14B;ARL13B;RILP;CFAP221;ABCC4;B9D1;EHD4;CFAP61;PDE6D;PTPN23;CFAP52;EXOC7;RAB3IP;PCNT;FHDC1;SNAP29;CEP83;ODF2;PCM1;CNGA4;TRAF3IP1;TTC39C;PTPDC1;TTC36;PARVA;MKS1;RILPL1;SCLT1;KIF24;FAM161B;ATAT1;TRAPPC14;CFAP70;PIBF1;TTC17;CFAP20;CLUAP1;BBIP1;RAB11FIP3;DZIP1L;CFAP44;WDPCP;NUDCD3;TCTN1;RFX2;CYS1;WDR35;INTU;EXOC2;KIAA0586;DNAH5;NEK1
prerank,GO_Biological_Process_2021__aspartate family amino acid metabolic process (GO:0009066),0.47419920599927584,0.902198655397452,0.6615384615384615,1.0,1.0,2/16,15.90%,GOT1;ASPA
prerank,GO_Biological_Process_2021__regulation of actin filament polymerization (GO:0030833),0.39604814188856924,0.9021781723854359,0.6323529411764706,1.0,1.0,4/59,9.54%,HCK;RASA1;HIP1R;ABITRAM
prerank,GO_Biological_Process_2021__regulation of DNA repair (GO:0006282),-0.4001814596779971,-0.9019899280653304,0.5675675675675675,1.0,1.0,10/42,20.15%,EYA4;BRCC3;ERCC8;EGFR;SIRT7;PML;EYA2;RADX;BABAM2;KAT7
prerank,PanglaoDB_Augmented_2021__Smooth Muscle Cells,0.37679633126634904,0.9019354550485221,0.6338028169014085,1.0,1.0,23/129,11.19%,LAMA2;MYLK;TIMP3;VASN;SLC38A11;SPON2;ACTA2;PDGFRB;IRAG1;POSTN;HHIP;ACKR3;IGFBP5;FBLN5;NID2;PLSCR4;ACTC1;ANGPTL2;PRKG1;PRXL2C;OGN;FAS;NOTCH3
prerank,PanglaoDB_Augmented_2021__Peritubular Myoid Cells,0.3898378647848141,0.9017847730049027,0.6710526315789473,1.0,1.0,13/95,7.24%,LAMA2;MYLK;TIMP3;ACTA2;HSPG2;PDGFRB;POSTN;CYP1B1;IGFBP5;PLSCR4;EPHX1;RARRES2;ANGPTL2
prerank,GO_Biological_Process_2021__regulation of low-density lipoprotein particle clearance (GO:0010988),0.6072584610739968,0.9017528057330333,0.6774193548387096,1.0,1.0,1/5,1.49%,LDLRAP1
prerank,PanglaoDB_Augmented_2021__Trophoblast Cells,0.4311858118738835,0.9015879367851917,0.5774647887323944,1.0,1.0,13/50,14.26%,PTGES;CD4;ERVFRD-1;INHBA;KLF5;CDCP1;GPRC5A;SCEL;B3GNT3;TMEM40;FOSL2;PLAUR;MLANA
prerank,GO_Biological_Process_2021__bile acid and bile salt transport (GO:0015721),0.479410872605524,0.9014499917976209,0.6619718309859155,1.0,1.0,8/22,24.13%,SLCO2B1;ABCC2;SLC10A5;SLC10A1;SLCO1A2;STARD5;NCOA2;SLC51A
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to oxidative stress (GO:0043619),-0.490942096012285,-0.9013670421482604,0.5365853658536586,1.0,1.0,1/7,9.02%,ANKRD2
prerank,GO_Biological_Process_2021__sequestering of actin monomers (GO:0042989),0.5855204995673332,0.9012660140249664,0.6935483870967742,1.0,1.0,4/8,32.87%,PFN4;TWF1;TWF2;TMSB10
prerank,GO_Biological_Process_2021__positive regulation of phosphatase activity (GO:0010922),0.5016199927115453,0.901259777184018,0.6349206349206349,1.0,1.0,1/14,3.19%,PDGFRB
prerank,GO_Biological_Process_2021__regulation of heart contraction (GO:0008016),0.4107331179422519,0.9011733638867088,0.6231884057971014,1.0,1.0,21/64,23.12%,CAV3;ITPR1;AGT;FKBP1B;CASQ1;SMAD7;NPR2;KCNJ11;ATP1B1;CAMK2D;CORIN;PLN;KCNQ1;TRDN;ATP1A1;CALM3;ABCC9;HCN4;CACNA1H;ATP2B4;ATP2A2
prerank,GO_Biological_Process_2021__sphingolipid metabolic process (GO:0006665),0.3743358397405421,0.9010836980067595,0.6329113924050633,1.0,1.0,17/98,21.30%,ENPP2;VAPB;GM2A;GBA3;SERINC1;CERKL;ELOVL2;HACD4;B3GALNT1;ALOXE3;NEU1;DEGS2;PSAP;PRKD3;SPHK1;ALDH3A2;SPTLC3
prerank,GO_Biological_Process_2021__regulation of mitotic nuclear division (GO:0007088),-0.40469234406998955,-0.901020653371456,0.6363636363636364,1.0,1.0,6/40,8.32%,BMP7;BTC;EREG;IGF1;AURKA;CDK5RAP2
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transporter activity (GO:1901018),-0.483042302565417,-0.9007422262339619,0.631578947368421,1.0,1.0,1/9,3.58%,LRRC55
prerank,GO_Biological_Process_2021__regulation of mast cell degranulation (GO:0043304),-0.5206235035578824,-0.9006932473085058,0.6486486486486487,1.0,1.0,1/8,6.17%,SPHK2
prerank,GO_Biological_Process_2021__nucleotide-sugar metabolic process (GO:0009225),0.5265219286159127,0.9006533461800679,0.5806451612903226,1.0,1.0,4/11,27.74%,CSGALNACT1;GFPT2;EXTL2;PARG
prerank,GO_Biological_Process_2021__inner ear morphogenesis (GO:0042472),-0.4660524823594747,-0.9005965086678749,0.625,1.0,1.0,4/14,11.39%,EPHB2;MYO3A;POU3F4;TTC39C
prerank,GO_Biological_Process_2021__embryonic organ development (GO:0048568),-0.379725674732525,-0.9001753618387581,0.5357142857142857,1.0,1.0,7/44,7.36%,KIT;KDR;RBP4;TEAD2;KITLG;TGFB2;ALDH1A3
prerank,GO_Biological_Process_2021__self proteolysis (GO:0097264),0.5650495952020558,0.9001492506540034,0.676923076923077,1.0,1.0,4/6,21.50%,CAPN1;CASP8;LGMN;ADGRV1
prerank,GO_Biological_Process_2021__positive regulation of posttranscriptional gene silencing (GO:0060148),-0.48943091439742437,-0.9001420100011587,0.5476190476190477,1.0,1.0,2/10,8.50%,WTIP;STAT3
prerank,GO_Biological_Process_2021__phospholipid transport (GO:0015914),-0.3924832401685827,-0.9000255343142685,0.5263157894736842,1.0,1.0,11/51,12.08%,PRELID2;TRIAP1;PITPNC1;APOA1;ATP8B4;ATP11C;SCARB1;APOE;ABCC1;PITPNM1;PITPNA
prerank,GO_Biological_Process_2021__kidney development (GO:0001822),0.41885109077135363,0.9000048051268715,0.5942028985507246,1.0,1.0,3/43,6.08%,LRP4;WFS1;AGT
prerank,GO_Biological_Process_2021__eye photoreceptor cell development (GO:0042462),0.5281619073054575,0.8998995183249293,0.6811594202898551,1.0,1.0,1/11,2.48%,RP1
prerank,GO_Biological_Process_2021__ncRNA catabolic process (GO:0034661),-0.42669824813375534,-0.8998241509696562,0.4857142857142857,1.0,1.0,7/24,16.67%,LIN28B;POP1;EXOSC10;EXOSC7;DIS3L2;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__positive regulation of myeloid leukocyte differentiation (GO:0002763),-0.40059414448792924,-0.8995119455634993,0.5161290322580645,1.0,1.0,2/19,1.60%,LEF1;RUNX1
prerank,GO_Biological_Process_2021__TRAIL-activated apoptotic signaling pathway (GO:0036462),0.5972186646162283,0.8992382755334429,0.7192982456140351,1.0,1.0,2/5,10.45%,FADD;CASP8
prerank,GO_Biological_Process_2021__monocarboxylic acid transport (GO:0015718),-0.3743111893673353,-0.8992134587329985,0.6521739130434783,1.0,1.0,7/47,7.93%,SLC16A9;SLC16A2;SLC16A12;ABCC4;SLC22A13;SLC6A11;NR1H4
prerank,GO_Biological_Process_2021__double-strand break repair via break-induced replication (GO:0000727),0.5273880543417352,0.8990207714140396,0.640625,1.0,1.0,3/11,8.15%,MCM2;GINS2;MCMDC2
prerank,GO_Biological_Process_2021__positive regulation of syncytium formation by plasma membrane fusion (GO:0060143),0.5672905898414475,0.8990004882257722,0.671875,1.0,1.0,1/10,5.29%,ADGRB1
prerank,GO_Biological_Process_2021__positive regulation of I-kappaB phosphorylation (GO:1903721),0.6196683337134051,0.8987252799098927,0.6774193548387096,1.0,1.0,2/5,21.40%,PLCG2;CX3CR1
prerank,GO_Biological_Process_2021__positive regulation of protein kinase B signaling (GO:0051897),-0.32997412966351547,-0.8984688592508149,0.76,1.0,1.0,6/119,3.27%,KIT;NRG1;FGFR4;BTC;EREG;KITLG
prerank,PanglaoDB_Augmented_2021__Myofibroblasts,0.39076644009111355,0.8979919088873216,0.68,1.0,1.0,10/76,8.41%,LAMA2;MYLK;TIMP3;ACTA2;PDGFRB;POSTN;IGFBP5;PLSCR4;ANGPTL2;PRKG1
prerank,GO_Biological_Process_2021__negative regulation of microtubule depolymerization (GO:0007026),0.4846346224084936,0.8979259516990931,0.6716417910447762,1.0,1.0,2/21,9.34%,TRIM54;TPX2
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial fission (GO:0090141),-0.44059289299071047,-0.8978089707751784,0.6341463414634146,1.0,1.0,2/19,7.03%,KDR;AURKA
prerank,GO_Biological_Process_2021__mitochondrial translational termination (GO:0070126),-0.328917769605251,-0.8977127359679299,0.6944444444444444,1.0,1.0,16/79,18.71%,MRPL17;MRPL58;MRPL33;MRPS18A;MRPL39;MRPL21;MRPL55;DAP3;MRPL48;MRPL4;AURKAIP1;MRPS7;MRPL9;MRPL40;MTRF1L;MRPS27
prerank,GO_Biological_Process_2021__galactose catabolic process (GO:0019388),-0.5677203783047777,-0.8975472517151336,0.6086956521739131,1.0,1.0,2/6,12.92%,GALE;PGM2
prerank,"GO_Biological_Process_2021__substrate-dependent cell migration, cell extension (GO:0006930)",0.5787379956194616,0.8973698035095558,0.6666666666666666,1.0,1.0,1/7,6.37%,P2RY12
prerank,GO_Biological_Process_2021__protein homooligomerization (GO:0051260),0.37439813634731217,0.8973034965912476,0.6712328767123288,1.0,1.0,14/97,19.71%,STEAP4;TRPA1;POLQ;UPB1;HSD17B10;SOD2;ACOT13;ATL1;ECT2;GLRA3;CHMP2A;G3BP2;MCOLN1;B2M
prerank,GO_Biological_Process_2021__regulation of phosphatase activity (GO:0010921),-0.4523139934693315,-0.8966487069718776,0.6060606060606061,1.0,1.0,5/21,12.11%,PPP1R35;PPP6R1;MTMR9;CHP1;SH3RF2
prerank,GO_Biological_Process_2021__negative regulation of vascular associated smooth muscle cell proliferation (GO:1904706),0.4996410804448223,0.8965284627570662,0.6153846153846154,1.0,1.0,6/13,21.48%,SOD2;CDKN1B;PRKG1;GPER1;PDCD4;PPARG
prerank,GO_Biological_Process_2021__axon development (GO:0061564),-0.3552904904770089,-0.8964249943676796,0.7307692307692307,1.0,1.0,9/72,10.48%,EPHB2;SVBP;AMIGO1;NTNG1;DSCAML1;VASH2;DHFR;CTNNA2;MTR
prerank,GO_Biological_Process_2021__positive regulation of receptor catabolic process (GO:2000646),-0.5596224497016341,-0.8964070646536074,0.5714285714285714,1.0,1.0,3/6,17.70%,APOE;PTPN1;DTX3L
prerank,GO_Biological_Process_2021__skeletal muscle organ development (GO:0060538),0.47091020447442866,0.896292324714101,0.59375,1.0,1.0,1/17,0.74%,CSRP3
prerank,GO_Biological_Process_2021__monoacylglycerol catabolic process (GO:0052651),0.6076432345813437,0.896241528344328,0.6984126984126984,1.0,1.0,1/5,21.58%,FAAH
prerank,GO_Biological_Process_2021__microtubule anchoring at microtubule organizing center (GO:0072393),-0.47642339805434175,-0.8962321421786479,0.6060606060606061,1.0,1.0,4/12,18.61%,PCM1;CCDC68;HOOK3;CCDC120
prerank,GO_Biological_Process_2021__positive regulation of response to endoplasmic reticulum stress (GO:1905898),-0.47649363741202705,-0.8961211059334153,0.6285714285714286,1.0,1.0,1/15,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__very long-chain fatty acid metabolic process (GO:0000038),0.46239949627130733,0.8959705536437,0.6086956521739131,1.0,1.0,6/28,13.88%,ACSBG1;ACOT4;ELOVL2;ACOX2;HACD4;ACOX1
prerank,GO_Biological_Process_2021__peptidyl-tyrosine phosphorylation (GO:0018108),-0.38115588428494734,-0.8957247720927389,0.5925925925925926,1.0,1.0,5/58,2.36%,KIT;KDR;FGFR4;EPHA3;EPHB2
prerank,GO_Biological_Process_2021__negative regulation of cell development (GO:0010721),0.485650404053236,0.8955872992350041,0.631578947368421,1.0,1.0,3/18,9.19%,CAV3;NOTCH1;REST
prerank,GO_Biological_Process_2021__negative regulation of membrane protein ectodomain proteolysis (GO:0051045),0.5570598628511664,0.8955672722396789,0.59375,1.0,1.0,2/6,3.88%,TIMP3;TIMP2
prerank,GO_Biological_Process_2021__telencephalon cell migration (GO:0022029),-0.5096387470828818,-0.8953297142723936,0.5789473684210527,1.0,1.0,1/5,6.12%,FGF13
prerank,GO_Biological_Process_2021__aromatic compound biosynthetic process (GO:0019438),-0.5476983460121585,-0.8951869002912315,0.5609756097560976,1.0,1.0,2/6,4.61%,PNPO;GCH1
prerank,GO_Biological_Process_2021__induction of positive chemotaxis (GO:0050930),0.528649586827662,0.8951424712676788,0.5909090909090909,1.0,1.0,2/9,10.53%,NTF3;VEGFC
prerank,GO_Biological_Process_2021__regulation of muscle cell differentiation (GO:0051147),0.42096548520621263,0.895048389846448,0.5945945945945946,1.0,1.0,2/27,11.22%,CTNNA1;FGFR2
prerank,GO_Biological_Process_2021__retinal rod cell differentiation (GO:0060221),0.5466903325336371,0.8950340887488684,0.6388888888888888,1.0,1.0,1/8,2.48%,RP1
prerank,GO_Biological_Process_2021__actin polymerization or depolymerization (GO:0008154),0.421091167351265,0.8947373815273887,0.6438356164383562,1.0,1.0,16/44,30.77%,PREX1;WASF1;WAS;GHRL;DIAPH3;TWF1;VILL;ENAH;CFL2;TWF2;WDR1;ABI2;WASL;ARHGAP6;RAC1;CFL1
prerank,GO_Biological_Process_2021__regulation of protein catabolic process (GO:0042176),0.3886795136284819,0.8945641004513585,0.6527777777777778,1.0,1.0,12/86,18.67%,C4BPB;TRIM32;ADGRB1;EEF1A1;CDKN1B;HMGCR;GFAP;HECW1;TIPARP;DAB2IP;FURIN;PRKCG
prerank,GO_Biological_Process_2021__RNA stabilization (GO:0043489),-0.43365842615546024,-0.8942310539179862,0.5151515151515151,1.0,1.0,6/30,15.43%,TRDMT1;TENT5A;ELAVL1;VIP;NAF1;CIRBP
prerank,GO_Biological_Process_2021__positive regulation of receptor internalization (GO:0002092),-0.4712554590603999,-0.894224192176428,0.5121951219512195,1.0,1.0,2/18,3.98%,GREM1;APLN
prerank,GO_Biological_Process_2021__response to leucine (GO:0043201),0.518389492043568,0.8941047132930512,0.6,1.0,1.0,1/10,8.39%,SESN3
prerank,GO_Biological_Process_2021__cellular response to leucine (GO:0071233),0.518389492043568,0.8941047132930512,0.6,1.0,1.0,1/10,8.39%,SESN3
prerank,GO_Biological_Process_2021__regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043122),0.3693327694516905,0.8940398953954097,0.7162162162162162,1.0,1.0,28/174,19.30%,TRIM22;TRIM5;ROR1;TRIML2;CD4;TRIM32;CXXC5;CARD8;FADD;TRAF3IP2;STAT1;CASP8;LITAF;PLCG2;RHOH;ESR1;RIPK2;CARD19;ECT2;HTR2B;PINK1;DAB2IP;TRIM14;NLRC3;TRIM25;TMEM101;TAB2;CD74
prerank,GO_Biological_Process_2021__neutrophil chemotaxis (GO:0030593),0.48934326530927014,0.8938527962958615,0.6111111111111112,1.0,1.0,1/19,2.27%,CCL5
prerank,GO_Biological_Process_2021__carbohydrate biosynthetic process (GO:0016051),0.4749618657639185,0.8938263470300699,0.647887323943662,1.0,1.0,3/17,8.75%,FUT2;B3GALT1;ST8SIA6
prerank,GO_Biological_Process_2021__carbohydrate derivative biosynthetic process (GO:1901137),-0.409736752108519,-0.8937394955213156,0.5,1.0,1.0,4/24,10.06%,ALG8;GAL3ST4;RRM2;ST3GAL2
prerank,GO_Biological_Process_2021__postsynaptic density organization (GO:0097106),-0.4642075326854843,-0.8936925848041737,0.5526315789473685,1.0,1.0,4/8,37.13%,PTEN;SHANK3;NRXN1;NLGN2
prerank,GO_Biological_Process_2021__regulation of chromatin silencing (GO:0031935),-0.48240819757960895,-0.8935709732074891,0.5882352941176471,1.0,1.0,1/10,1.16%,H1-4
prerank,"GO_Biological_Process_2021__maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000463)",-0.4674509196048468,-0.8933572065947162,0.5555555555555556,1.0,1.0,1/14,3.71%,ZNHIT6
prerank,GO_Biological_Process_2021__pre-replicative complex assembly (GO:0036388),0.4149140009770507,0.8933038375472981,0.6956521739130435,1.0,1.0,7/57,16.44%,MCM2;GMNN;PSMB6;CDC6;PSMA3;PSMB8;ORC4
prerank,GO_Biological_Process_2021__negative regulation of cellular biosynthetic process (GO:0031327),0.4328951908377894,0.8932329540742037,0.6901408450704225,1.0,1.0,8/33,23.11%,PTGIS;ACMSD;OPN3;BRCA1;ACADL;ERLIN1;SNAI2;ATP2B4
prerank,GO_Biological_Process_2021__regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0061178),-0.4202686459184155,-0.8932104294392063,0.5806451612903226,1.0,1.0,3/23,7.93%,EPHA5;ANO1;NR1H4
prerank,GO_Biological_Process_2021__regulation of JNK cascade (GO:0046328),-0.35643980543936166,-0.8931574444685735,0.6521739130434783,1.0,1.0,9/88,7.17%,TPD52L1;F2RL1;RASSF2;TNFRSF19;SH3RF1;RASGRP1;TRAF3;SERPINF2;SH3RF3
prerank,GO_Biological_Process_2021__nucleoside salvage (GO:0043174),-0.43144743961199994,-0.8930136606929979,0.5,1.0,1.0,3/10,17.22%,UPP2;UCK2;TYMP
prerank,PanglaoDB_Augmented_2021__Chondrocytes,0.365571037257265,0.8930105701052709,0.65,1.0,1.0,15/109,9.43%,LAMA2;TIMP3;GADD45B;AGER;GLI3;PRG4;PDGFRB;POSTN;IGFBP5;NID2;ANGPTL2;SOX6;STAT1;RUNX2;SCRG1
prerank,GO_Biological_Process_2021__positive regulation of cell population proliferation (GO:0008284),-0.30861539361950213,-0.892942602192202,1.0,1.0,1.0,43/332,9.97%,NRG1;KDR;TBX6;SINHCAF;FGFR4;LEF1;HMGN5;BTC;CDH13;GREM1;PID1;PDGFD;TNFRSF11A;EREG;KITLG;IGF1;C5AR1;SFRP1;DBF4B;GRK5;WWTR1;SLC25A33;CHTOP;TGFB2;FGF1;HDAC1;TOX;BCL2;SHANK2;IL11;SERPINF2;FOXP1;PTHLH;BMP6;ID2;GCNT2;HMGA2;CSF1R;PDGFRA;AKR1C3;TGFB3;VIP;PDGFC
prerank,GO_Biological_Process_2021__proton-transporting ATP synthase complex assembly (GO:0043461),0.5799468294663837,0.8923390725484179,0.6307692307692307,1.0,1.0,4/6,35.51%,ATPAF2;ATPAF1;TMEM70;OXA1L
prerank,GO_Biological_Process_2021__protein localization to cytoplasmic stress granule (GO:1903608),0.5991607195039079,0.8922810490348894,0.703125,1.0,1.0,3/6,29.76%,DDX1;SSB;DDX3X
prerank,GO_Biological_Process_2021__skeletal muscle tissue regeneration (GO:0043403),-0.5668700720936115,-0.8922237929056276,0.5555555555555556,1.0,1.0,1/6,5.74%,CFLAR
prerank,GO_Biological_Process_2021__regulation of fatty acid biosynthetic process (GO:0042304),0.44891376628733043,0.8921192570779521,0.6571428571428571,1.0,1.0,9/23,28.46%,PRKAB2;ADIPOR2;BRCA1;ACADL;PDK4;ERLIN1;PRKAG2;ADIPOR1;EIF6
prerank,GO_Biological_Process_2021__ion homeostasis (GO:0050801),0.4724757465779214,0.8920670712689852,0.6,1.0,1.0,5/23,23.07%,SLC30A8;CAMK2D;SLC4A9;HCN4;SLC30A4
prerank,GO_Biological_Process_2021__epithelial cell differentiation (GO:0030855),0.4164604410456088,0.8919509738197943,0.5903614457831325,1.0,1.0,8/65,11.22%,PTER;ZNF703;OVOL3;TST;CNN3;TBX1;TOLLIP;FGFR2
prerank,GO_Biological_Process_2021__positive regulation of protein depolymerization (GO:1901881),0.5342496623376499,0.891857414484814,0.639344262295082,1.0,1.0,1/9,0.79%,NES
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced neuron death (GO:1903204),0.5463719686581275,0.8917254620358873,0.671875,1.0,1.0,4/10,22.10%,REST;PINK1;NONO;FBXO7
prerank,GO_Biological_Process_2021__tyrosine catabolic process (GO:0006572),0.5733142862181744,0.891559975506254,0.6363636363636364,1.0,1.0,3/5,20.74%,FAH;IL4I1;HPD
prerank,GO_Biological_Process_2021__epithelial tube morphogenesis (GO:0060562),0.45485731369615207,0.8914714011069504,0.6363636363636364,1.0,1.0,5/25,25.99%,RASIP1;RHOB;PODXL;RYR2;MESP1
prerank,GO_Biological_Process_2021__negative regulation of glycogen metabolic process (GO:0070874),0.5731289752034947,0.8914524673636168,0.6507936507936508,1.0,1.0,1/5,30.90%,INPP5K
prerank,GO_Biological_Process_2021__negative regulation of glycogen biosynthetic process (GO:0045719),0.5731289752034947,0.8914524673636168,0.6507936507936508,1.0,1.0,1/5,30.90%,INPP5K
prerank,GO_Biological_Process_2021__aspartate family amino acid biosynthetic process (GO:0009067),0.5961190575420139,0.8914340894920988,0.6666666666666666,1.0,1.0,2/6,15.80%,GOT1;PLOD2
prerank,GO_Biological_Process_2021__histone H3-K27 demethylation (GO:0071557),0.5982003034647471,0.8912282752195189,0.6666666666666666,1.0,1.0,3/5,36.42%,KDM7A;PHF8;UTY
prerank,GO_Biological_Process_2021__pyrimidine nucleoside transport (GO:0015864),0.5904062017247598,0.8912124225449078,0.6290322580645161,1.0,1.0,2/5,21.85%,SLC28A2;SLC29A2
prerank,GO_Biological_Process_2021__nucleoside transport (GO:0015858),0.5904062017247598,0.8912124225449078,0.6290322580645161,1.0,1.0,2/5,21.85%,SLC28A2;SLC29A2
prerank,GO_Biological_Process_2021__uridine transport (GO:0015862),0.5904062017247598,0.8912124225449078,0.6290322580645161,1.0,1.0,2/5,21.85%,SLC28A2;SLC29A2
prerank,GO_Biological_Process_2021__nucleoside diphosphate phosphorylation (GO:0006165),0.5784747543467244,0.8911901907485664,0.734375,1.0,1.0,2/8,18.00%,CMPK2;AK4
prerank,GO_Biological_Process_2021__positive regulation of cellular carbohydrate metabolic process (GO:0010676),-0.5251390895849009,-0.8909663548224497,0.6410256410256411,1.0,1.0,3/9,17.60%,PRKCE;IRS1;SLC45A3
prerank,GO_Biological_Process_2021__pentose-phosphate shunt (GO:0006098),0.4841357668433288,0.8908202633878517,0.5909090909090909,1.0,1.0,5/12,24.21%,G6PD;PGD;RPE;TKT;RBKS
prerank,GO_Biological_Process_2021__mitochondrial translational elongation (GO:0070125),-0.34083448495406243,-0.8908085394066421,0.8125,1.0,1.0,16/79,18.71%,MRPL17;MRPL58;MRPL33;TSFM;MRPS18A;MRPL39;MRPL21;MRPL55;DAP3;MRPL48;MRPL4;AURKAIP1;MRPS7;MRPL9;MRPL40;MRPS27
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane permeability involved in apoptotic process (GO:1902110),0.5706288703086394,0.8907926893418813,0.7377049180327869,1.0,1.0,1/8,8.17%,BNIP3
prerank,"GO_Biological_Process_2021__Notch receptor processing, ligand-dependent (GO:0035333)",-0.5500285864290804,-0.8907629575761902,0.5098039215686274,1.0,1.0,1/5,8.36%,NCSTN
prerank,GO_Biological_Process_2021__regulation of growth hormone secretion (GO:0060123),0.6163088600851128,0.8907452256991791,0.7727272727272727,1.0,1.0,1/5,14.00%,GHRL
prerank,GO_Biological_Process_2021__protein localization to nuclear envelope (GO:0090435),0.5928370991091201,0.8905557885178323,0.7,1.0,1.0,4/6,36.96%,NUP54;TOR1AIP2;PLK1;NUP155
prerank,GO_Biological_Process_2021__positive regulation of phospholipase C activity (GO:0010863),0.4268388970431798,0.8903550887692829,0.6470588235294118,1.0,1.0,5/33,9.01%,ITK;PDGFRB;NTF3;P2RY12;AVPR1A
prerank,GO_Biological_Process_2021__tricarboxylic acid metabolic process (GO:0072350),-0.5049673502962571,-0.8903238911600858,0.6,1.0,1.0,1/12,3.15%,IDH2
prerank,GO_Biological_Process_2021__succinyl-CoA metabolic process (GO:0006104),0.5782462230868556,0.8902494752264734,0.6379310344827587,1.0,1.0,1/5,3.28%,ACOT4
prerank,GO_Biological_Process_2021__3'-UTR-mediated mRNA stabilization (GO:0070935),0.5253822652132485,0.8901859401768444,0.6666666666666666,1.0,1.0,2/12,15.98%,YBX3;HNRNPA0
prerank,GO_Biological_Process_2021__negative regulation of interferon-beta production (GO:0032688),-0.560833888561059,-0.8898668352042839,0.6,1.0,1.0,4/7,14.73%,PTPRS;YY1;CACTIN;REL
prerank,GO_Biological_Process_2021__intracellular distribution of mitochondria (GO:0048312),0.5817904872955606,0.8895955581862643,0.640625,1.0,1.0,1/5,20.42%,LRRK2
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184)",0.3830933434093977,0.8895461110245366,0.654320987654321,1.0,1.0,41/104,34.89%,NCBP1;NCBP2;RPL15;RPL36;RPS7;RPL9;RPS21;DHX34;RPL22;RPL21;RPL38;RPLP2;RPS5;EIF3E;EIF4A3;RPL3;RPL35A;SMG7;RPS13;RPL35;RNPS1;RPS20;RPL27;RPL13A;RPS27A;RPL5;RPL27A;RPL7;RPS9;RPL37;RPS29;PPP2R2A;RPL24;RPL28;RPL32;RPL8;RPS4X;RPS12;RPL37A;RPSA;PNRC2
prerank,GO_Biological_Process_2021__regulation of protein-containing complex assembly (GO:0043254),-0.3486553626190866,-0.889539519756133,0.7241379310344828,1.0,1.0,4/93,3.89%,SELP;NRG1;BCL2L11;TRABD2A
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential (GO:0086001),-0.40175155940423213,-0.8893394104039639,0.6285714285714286,1.0,1.0,2/29,2.68%,PKP2;CACNA2D1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to synapse (GO:1902474),0.5653467660117047,0.8889832086997205,0.5964912280701754,1.0,1.0,2/5,31.67%,WNT7A;DVL1
prerank,GO_Biological_Process_2021__positive regulation of viral life cycle (GO:1903902),0.47996441773441667,0.8889033126087099,0.6615384615384615,1.0,1.0,5/17,19.30%,CD4;VPS37B;CHMP2B;CHMP2A;CD74
prerank,GO_Biological_Process_2021__mesenchymal cell differentiation (GO:0048762),-0.40166356051100305,-0.8885877444504464,0.5588235294117647,1.0,1.0,7/42,11.83%,BMP7;LEF1;TGFB2;FAM83D;HMGA2;DLG5;NOG
prerank,GO_Biological_Process_2021__regulation of RNA metabolic process (GO:0051252),-0.3677810426525817,-0.8884217599442142,0.6785714285714286,1.0,1.0,13/57,16.93%,PCBP3;AHNAK2;HNRNPL;RRP1B;AKAP17A;PTBP3;SON;IGF2BP3;FASTK;SRRM4;PTBP1;PCBP4;PTBP2
prerank,PanglaoDB_Augmented_2021__Radial Glia Cells,-0.3310854412990797,-0.8884070045194825,0.6666666666666666,1.0,1.0,12/109,5.33%,SHC3;FBXL7;KCNIP1;DOK5;PCDH19;CACNA2D1;PDGFD;NTM;EFS;ID4;MARK1;SLC6A1
prerank,PanglaoDB_Augmented_2021__Principal Cells,-0.3327989238085212,-0.8882320196355471,0.6,1.0,1.0,16/71,12.00%,NPNT;BTC;MYH14;ZBTB7C;CLDN4;SLC2A9;ANO1;ACE2;KCNE1;TMEM229A;PELI2;CDH1;COBL;CAPN13;PHACTR1;SCNN1G
prerank,GO_Biological_Process_2021__drug transport (GO:0015893),0.5879801681787071,0.8881966254185891,0.6774193548387096,1.0,1.0,1/5,4.11%,ABCC2
prerank,GO_Biological_Process_2021__regulation of cellular metabolic process (GO:0031323),0.42193177233830614,0.8880062254170522,0.6833333333333333,1.0,1.0,9/42,20.98%,BTN2A2;CYP1B1;FASN;VPS35;PINK1;PDK4;ARF4;STK17A;RNF41
prerank,GO_Biological_Process_2021__aortic valve development (GO:0003176),0.4624246026538895,0.8878949105033264,0.6065573770491803,1.0,1.0,3/21,13.78%,NOTCH1;TWIST1;TGFB1
prerank,GO_Biological_Process_2021__leukotriene biosynthetic process (GO:0019370),0.5523510498983367,0.8878565776516447,0.6296296296296297,1.0,1.0,1/8,3.44%,GGTA1
prerank,GO_Biological_Process_2021__resolution of meiotic recombination intermediates (GO:0000712),0.48833932401947305,0.8876702500117278,0.6206896551724138,1.0,1.0,3/12,15.04%,SHOC1;FANCM;MEIOB
prerank,GO_Biological_Process_2021__positive regulation of erythrocyte differentiation (GO:0045648),0.48676419224917655,0.8876189825862465,0.6231884057971014,1.0,1.0,3/23,9.09%,INHBA;ZNF16;STAT1
prerank,GO_Biological_Process_2021__positive regulation of organelle assembly (GO:1902117),-0.3669097536952404,-0.8875766358932354,0.5384615384615384,1.0,1.0,3/40,7.11%,SDC4;CROCC;NUMA1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA biosynthetic process (GO:0035338),0.48182616777026843,0.8874493539844586,0.6231884057971014,1.0,1.0,3/16,8.65%,ACSBG1;ACSL5;ELOVL2
prerank,GO_Biological_Process_2021__regulation of RNA polymerase II regulatory region sequence-specific DNA binding (GO:1903025),-0.49484580410078804,-0.8873621740850016,0.5555555555555556,1.0,1.0,1/8,10.09%,TAF1
prerank,GO_Biological_Process_2021__natural killer cell activation (GO:0030101),0.5086241086428276,0.8871379838019586,0.7,1.0,1.0,4/15,10.45%,IL21R;PTPRC;NFIL3;CASP8
prerank,GO_Biological_Process_2021__regulation of lysosomal protein catabolic process (GO:1905165),0.5549680306459269,0.8867564551037903,0.6071428571428571,1.0,1.0,2/6,34.45%,LRP2;LAPTM4B
prerank,GO_Biological_Process_2021__Fc receptor signaling pathway (GO:0038093),-0.3602069088058356,-0.8863862845160817,0.5862068965517241,1.0,1.0,3/98,2.98%,KIT;NFATC1;FOS
prerank,GO_Biological_Process_2021__regulation of microtubule depolymerization (GO:0031114),0.4567167036334981,0.8863308244619524,0.625,1.0,1.0,2/25,9.34%,TRIM54;TPX2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to stress (GO:0036003),0.48287240682982946,0.8862853459673378,0.6901408450704225,1.0,1.0,2/23,7.54%,NOTCH1;HSPA5
prerank,GO_Biological_Process_2021__cellular response to decreased oxygen levels (GO:0036294),0.40223798383943365,0.8861595973683268,0.6268656716417911,1.0,1.0,12/53,19.35%,PTGIS;TWIST1;SUV39H1;BNIP3;NDNF;EPAS1;OPRD1;RGCC;PINK1;TBL2;AK4;ACAA2
prerank,GO_Biological_Process_2021__regulation of vacuole organization (GO:0044088),0.47220662245535266,0.8861137588134231,0.6575342465753424,1.0,1.0,8/20,36.54%,ENO4;ENO2;RAB5A;SCARB2;RAB1B;LAPTM4B;PIKFYVE;TBC1D14
prerank,GO_Biological_Process_2021__dendrite self-avoidance (GO:0070593),0.49568307273668316,0.8859855038501407,0.6363636363636364,1.0,1.0,5/13,17.87%,EMB;CNTN2;MYPN;NEXN;NPTN
prerank,GO_Biological_Process_2021__negative regulation of intracellular protein transport (GO:0090317),0.5108137928814687,0.8859227036586691,0.6268656716417911,1.0,1.0,7/21,20.70%,LMAN1;UFM1;RAB23;INSIG1;LRRK2;SP100;DMTN
prerank,GO_Biological_Process_2021__chromatin organization involved in regulation of transcription (GO:0034401),-0.516439841797986,-0.8857767720383586,0.6,1.0,1.0,2/12,13.16%,ZMIZ2;SERTAD2
prerank,GO_Biological_Process_2021__determination of left/right symmetry (GO:0007368),0.43199322327142586,0.8857618662259312,0.7285714285714285,1.0,1.0,7/31,12.32%,NOTCH1;ODAD4;DNAH11;ODAD3;TBX1;CCDC39;ARL6
prerank,GO_Biological_Process_2021__regulation of mRNA catabolic process (GO:0061013),-0.33793324115301376,-0.8855111525213818,0.6666666666666666,1.0,1.0,16/112,16.67%,SAMD4A;PRR5L;KHSRP;PRKCD;HSPB1;ELAVL1;EIF4G1;IGF2BP3;EXOSC7;EXOSC1;EXOSC5;ZC3HAV1;SAMD4B;PNPT1;PCBP4;EXOSC4
prerank,PanglaoDB_Augmented_2021__Epithelial Cells,0.39181879964601646,0.885497574189341,0.6973684210526315,1.0,1.0,21/97,17.06%,LIPH;MSX1;AGER;PRG4;BOK;KNL1;ITGA5;KLF5;GPX2;SCEL;AP1M2;MYO5B;ANLN;B3GNT3;EMILIN2;BRCA1;ECT2;THRSP;PAQR5;EPCAM;TMC4
prerank,GO_Biological_Process_2021__regulation of inflammatory response to antigenic stimulus (GO:0002861),0.39188925581346584,0.8852827288659598,0.7439024390243902,1.0,1.0,8/72,8.25%,CALCR;MC4R;RXFP1;CALCB;HCK;SCTR;TSHR;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of glycogen biosynthetic process (GO:0045725),-0.46799685695315774,-0.8852325844735576,0.6666666666666666,1.0,1.0,3/11,14.39%,IGF1;PPP1R3E;IRS1
prerank,GO_Biological_Process_2021__protein localization to microtubule (GO:0035372),-0.5059545544095223,-0.8847776617697181,0.5675675675675675,1.0,1.0,3/8,22.43%,MAPRE1;MID1;MID2
prerank,GO_Biological_Process_2021__skeletal myofibril assembly (GO:0014866),-0.4678151740078843,-0.8846256826250306,0.6,1.0,1.0,2/7,5.74%,MYH11;CFLAR
prerank,GO_Biological_Process_2021__regulation of interferon-gamma production (GO:0032649),0.40372714818630584,0.8845025836197219,0.6060606060606061,1.0,1.0,7/50,9.60%,IL18R1;INHBA;ZFPM1;CD14;FADD;HLA-A;PDCD1LG2
prerank,GO_Biological_Process_2021__oxidative DNA demethylation (GO:0035511),-0.5862741486876372,-0.8843442125553013,0.7073170731707317,1.0,1.0,2/5,2.80%,ALKBH2;ALKBH3
prerank,GO_Biological_Process_2021__negative regulation of myoblast differentiation (GO:0045662),0.5459595784271088,0.8842105148072857,0.6567164179104478,1.0,1.0,4/10,24.68%,NOTCH1;TGFB1;MSTN;EID2B
prerank,GO_Biological_Process_2021__regulation of nitric oxide mediated signal transduction (GO:0010749),-0.5634433009115996,-0.8841584105574479,0.6818181818181818,1.0,1.0,2/5,13.01%,EGFR;NOS1AP
prerank,GO_Biological_Process_2021__polyol transport (GO:0015791),0.5782241243675355,0.8839916917483379,0.684931506849315,1.0,1.0,4/6,31.61%,SLC5A11;AQP9;AQP11;SLC26A6
prerank,GO_Biological_Process_2021__regulation of stress-activated MAPK cascade (GO:0032872),-0.3848768453431452,-0.8834771126819185,0.5833333333333334,1.0,1.0,5/43,6.40%,F2RL1;GREM1;RASGRP1;TGFB2;IGBP1
prerank,GO_Biological_Process_2021__histone H2A monoubiquitination (GO:0035518),-0.49187737251898245,-0.8833459310182211,0.6129032258064516,1.0,1.0,4/17,17.78%,RING1;PCGF1;PCGF6;DDB2
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase I promoter (GO:0006361),-0.37329898785102383,-0.8833425331876751,0.5714285714285714,1.0,1.0,11/31,19.81%,ERCC2;GTF2H2;CCNH;UBTF;TAF1;POLR2L;POLR1A;TAF1D;POLR1G;GTF2H5;ERCC3
prerank,GO_Biological_Process_2021__cellular response to organic cyclic compound (GO:0071407),0.3618235517711059,0.8832040789085627,0.7638888888888888,1.0,1.0,25/121,20.70%,P2RY1;ZNF703;CCL5;CTNNA1;SSTR1;CYP1B1;IGFBP5;AHR;P2RY12;GPER1;ABCB4;ESR1;TGFB1;BRCA1;MSN;TIPARP;SPP1;KCNQ1;AQP9;ATP1A1;H2AZ1;INSIG1;CRHBP;LRRK2;DMTN
prerank,GO_Biological_Process_2021__negative regulation of leukocyte apoptotic process (GO:2000107),-0.5533115907775771,-0.8831924655043778,0.5918367346938775,1.0,1.0,4/6,37.28%,MERTK;HCLS1;AXL;GAS6
prerank,GO_Biological_Process_2021__negative regulation of telomere capping (GO:1904354),-0.5237454373539058,-0.8830858961179198,0.7021276595744681,1.0,1.0,3/7,16.96%,ERCC1;SMG6;ATM
prerank,GO_Biological_Process_2021__peroxisome proliferator activated receptor signaling pathway (GO:0035357),0.5584235095654999,0.882857438472911,0.75,1.0,1.0,2/6,21.48%,ALOXE3;PPARG
prerank,GO_Biological_Process_2021__protein monoubiquitination (GO:0006513),-0.3946697493899886,-0.8827633885492691,0.6857142857142857,1.0,1.0,2/36,7.99%,RNF126;UBE2R2
prerank,GO_Biological_Process_2021__positive regulation of myeloid cell apoptotic process (GO:0033034),0.5874089349554243,0.8824505590926635,0.6885245901639344,1.0,1.0,2/5,28.04%,PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__regulation of double-strand break repair via nonhomologous end joining (GO:2001032),-0.42247276402606093,-0.8823981749624072,0.6875,1.0,1.0,8/28,17.70%,PNKP;SHLD1;HMGA2;USP51;SIRT7;HSF1;KMT5B;DTX3L
prerank,GO_Biological_Process_2021__response to increased oxygen levels (GO:0036296),0.5857876268322726,0.8822116770291883,0.7017543859649122,1.0,1.0,3/5,30.50%,ATP6AP1;ATP6V1G1;ATP6V1A
prerank,PanglaoDB_Augmented_2021__T Helper Cells,0.4184136091990421,0.882115182599061,0.676056338028169,1.0,1.0,10/46,8.19%,GNLY;ITK;IL18R1;CD4;CCL5;HPGDS;PTPRC;AHR;GMFG;TAGAP
prerank,GO_Biological_Process_2021__mRNA destabilization (GO:0061157),-0.37039269531642166,-0.8820452599856147,0.5882352941176471,1.0,1.0,5/36,13.32%,KHSRP;DCPS;TRIM71;MEX3D;DIS3L2
prerank,GO_Biological_Process_2021__DNA packaging (GO:0006323),-0.45040718600793506,-0.8815833170449519,0.6111111111111112,1.0,1.0,1/15,1.16%,H1-4
prerank,GO_Biological_Process_2021__DNA biosynthetic process (GO:0071897),-0.4391074412449207,-0.881568976803584,0.6756756756756757,1.0,1.0,2/16,5.92%,TYMS;POLL
prerank,PanglaoDB_Augmented_2021__Hepatoblasts,-0.3911357464399323,-0.8814615843643927,0.5652173913043478,1.0,1.0,6/47,7.93%,PKP2;PAH;FGFR4;CLDN4;CARD10;NR1H4
prerank,GO_Biological_Process_2021__regulation of developmental growth (GO:0048638),-0.3923250934151618,-0.8813094642283421,0.5454545454545454,1.0,1.0,9/27,19.96%,IGF1;APOE;LEP;FGFR3;LATS1;DNM2;SIN3A;LATS2;NRCAM
prerank,GO_Biological_Process_2021__nuclear body organization (GO:0030575),-0.4713820909444283,-0.8811783653504576,0.631578947368421,1.0,1.0,2/12,15.18%,ETS1;PML
prerank,GO_Biological_Process_2021__neural crest cell differentiation (GO:0014033),-0.4046669787785895,-0.8811146046108728,0.6060606060606061,1.0,1.0,2/16,4.64%,NRG1;TCOF1
prerank,GO_Biological_Process_2021__long-chain fatty-acyl-CoA metabolic process (GO:0035336),0.4596790179513191,0.8810959432805647,0.64,1.0,1.0,3/21,8.65%,ACSBG1;ACSL5;ELOVL2
prerank,GO_Biological_Process_2021__negative regulation of interleukin-17 production (GO:0032700),0.6200188110578811,0.8810102928840562,0.734375,1.0,1.0,2/5,30.69%,PRNP;TNFSF4
prerank,GO_Biological_Process_2021__chloride transport (GO:0006821),0.41006754932040296,0.8807168488275687,0.6714285714285714,1.0,1.0,11/58,22.87%,SLC12A7;GABRA2;CLCN3;SLC26A7;GLRA3;TTYH1;GLRA1;GABRA4;GABRR1;GABRD;SLC1A3
prerank,GO_Biological_Process_2021__interleukin-27-mediated signaling pathway (GO:0070106),0.5021943606154705,0.880634640995145,0.703125,1.0,1.0,2/12,9.09%,CRLF1;STAT1
prerank,PanglaoDB_Augmented_2021__Mesangial Cells,-0.33250195891684065,-0.8804538291166661,0.68,1.0,1.0,14/120,6.70%,TAGLN;FBXL7;COL15A1;ABI3BP;LEF1;LAMA4;SVEP1;PCDH18;PDE3A;MAP3K20;PRRX1;FGF1;ADAMTS5;RHOJ
prerank,GO_Biological_Process_2021__regulation of protein serine/threonine kinase activity (GO:0071900),0.3977379368033235,0.880153313665661,0.7,1.0,1.0,11/94,11.05%,CCNG2;CDKN2D;CCND2;CCNE1;CCNB3;PPEF2;CDKN1B;CDC25A;CCNE2;CDK5R1;CDC6
prerank,GO_Biological_Process_2021__histone H4 acetylation (GO:0043967),-0.3787770374834214,-0.8800952114386666,0.6153846153846154,1.0,1.0,5/46,11.89%,LEF1;BRCA2;JADE2;DMAP1;BEND3
prerank,GO_Biological_Process_2021__positive regulation of lipid catabolic process (GO:0050996),-0.4620750769362234,-0.8800150614987653,0.6756756756756757,1.0,1.0,6/15,14.45%,PRKCD;PLIN5;APOA1;ABCD1;IRS1;PNPLA2
prerank,GO_Biological_Process_2021__mitotic G1 DNA damage checkpoint signaling (GO:0031571),-0.36214444389395106,-0.8799887277007786,0.6216216216216216,1.0,1.0,12/56,16.96%,TRIAP1;AURKA;TFDP1;PLK2;CRADD;RFWD3;BTG2;PIDD1;PML;PLK3;PCBP4;ATM
prerank,GO_Biological_Process_2021__nervous system development (GO:0007399),0.33492372305999596,0.8799245666805966,0.8,1.0,1.0,28/371,12.27%,SERF1A;NES;RAPGEF5;NDP;NEUROD2;SOX10;INHBA;WDR62;NTF3;ADGRB1;IRF2BPL;NHEJ1;ARTN;PTPRZ1;PAFAH1B3;PROP1;ACTL6A;SIAH1;SOX6;SLC2A1;SCRG1;HMGCR;IL1RAPL2;NPAS1;NAB1;CHAC1;B3GNT5;CELSR1
prerank,"GO_Biological_Process_2021__DNA catabolic process, endonucleolytic (GO:0000737)",0.464853441276881,0.8798626609268293,0.609375,1.0,1.0,2/21,9.92%,DNASE2;DNASE2B
prerank,GO_Biological_Process_2021__regulation of delayed rectifier potassium channel activity (GO:1902259),0.5005143072309508,0.8797454801751605,0.6911764705882353,1.0,1.0,3/13,17.96%,KCNE2;KCNG1;KCNE4
prerank,GO_Biological_Process_2021__aortic valve morphogenesis (GO:0003180),0.47508631218947966,0.8797121565462681,0.6507936507936508,1.0,1.0,3/18,13.78%,NOTCH1;TWIST1;TGFB1
prerank,GO_Biological_Process_2021__regulation of glucokinase activity (GO:0033131),-0.554240026194052,-0.8796835558159696,0.6808510638297872,1.0,1.0,2/5,9.79%,DUSP12;MIDN
prerank,GO_Biological_Process_2021__positive regulation of alpha-beta T cell differentiation (GO:0046638),0.5083486260777554,0.8795196206403901,0.6363636363636364,1.0,1.0,2/10,2.52%,GLI3;ZBTB7B
prerank,GO_Biological_Process_2021__muscle organ development (GO:0007517),0.4328404902093631,0.8794144315959875,0.6515151515151515,1.0,1.0,8/41,10.94%,LAMA2;MKX;CAV3;TEAD4;SOX6;TBX1;ITGA11;CTF1
prerank,GO_Biological_Process_2021__regulation of secretion by cell (GO:1903530),-0.3937763601288516,-0.879368632176286,0.56,1.0,1.0,12/48,18.89%,HCRT;MCTP1;RAB3C;DNAJC1;LLGL2;P3H1;VAMP3;STX4;MCTP2;RIMS1;SNCAIP;VAMP8
prerank,GO_Biological_Process_2021__activation of adenylate cyclase activity (GO:0007190),0.45248796937726854,0.87921357098538,0.6470588235294118,1.0,1.0,4/26,8.25%,CALCR;RXFP1;TSHR;ADRB1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid metabolic process (GO:0045923),-0.42098330239983,-0.8786663567023202,0.5675675675675675,1.0,1.0,5/14,18.50%,MLYCD;APOA1;NR4A3;SLC45A3;NR1H2
prerank,PanglaoDB_Augmented_2021__Paneth Cells,0.4515584255415265,0.8784864616458946,0.6666666666666666,1.0,1.0,4/22,13.11%,KCNN4;GPX2;ACSL5;RIPK2
prerank,GO_Biological_Process_2021__positive regulation of glucose import (GO:0046326),-0.44062366860189334,-0.8784177315245204,0.5625,1.0,1.0,3/18,16.87%,IGF1;IRS1;CLTCL1
prerank,GO_Biological_Process_2021__positive regulation of protein binding (GO:0032092),-0.4073620913493131,-0.8781013425912282,0.7037037037037037,1.0,1.0,11/46,19.41%,STING1;NVL;IDE;TAF1;APOE;MARK3;DTX3L;ADD2;NMD3;TIAM1;PRKN
prerank,GO_Biological_Process_2021__macromolecule catabolic process (GO:0009057),0.45570698254727027,0.8780805228152724,0.7,1.0,1.0,5/22,16.34%,ELANE;SIAH1;CLPX;TGFB1;LGMN
prerank,GO_Biological_Process_2021__hyaluronan catabolic process (GO:0030214),-0.4582137542388824,-0.8780237210787987,0.6176470588235294,1.0,1.0,3/15,10.46%,HMMR;GUSB;CHP1
prerank,GO_Biological_Process_2021__mitochondrial outer membrane permeabilization (GO:0097345),-0.4669955936434165,-0.8778419343904785,0.5833333333333334,1.0,1.0,1/11,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__nucleotide-excision repair (GO:0006289),-0.3408020887806422,-0.8777754651706796,0.8214285714285714,1.0,1.0,25/98,20.89%,ERCC2;BRCA2;POLL;HUS1;GTF2H2;GTF2H2C;ERCC1;PNKP;ERCC8;CCNH;POLR2G;POLD3;POLR2C;CUL4A;POLR2L;COPS6;RAD23A;COMMD1;DDB2;GTF2H5;HMGN1;ERCC3;XPC;FAN1;SLC30A9
prerank,GO_Biological_Process_2021__bone marrow development (GO:0048539),-0.5130264780486897,-0.8777322610980616,0.6304347826086957,1.0,1.0,1/5,2.28%,LRRC17
prerank,GO_Biological_Process_2021__ncRNA export from nucleus (GO:0097064),-0.3785306033206966,-0.8772308840741143,0.5217391304347826,1.0,1.0,3/37,6.59%,NUP210;TPR;NUP37
prerank,GO_Biological_Process_2021__negative regulation of histone H4 acetylation (GO:0090241),0.5951758796605711,0.8770678104807097,0.7,1.0,1.0,3/5,34.22%,TAF7;CTBP1;SPI1
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response to antigenic stimulus (GO:0002862),0.3928560109543244,0.8770435718757214,0.759493670886076,1.0,1.0,8/71,8.25%,CALCR;MC4R;RXFP1;CALCB;HCK;SCTR;TSHR;ADRB1
prerank,"GO_Biological_Process_2021__phagocytosis, engulfment (GO:0006911)",0.44364742319809336,0.8769764442183575,0.7352941176470589,1.0,1.0,4/27,12.76%,ADGRB1;DOCK1;ARHGAP25;RHOH
prerank,GO_Biological_Process_2021__pentose metabolic process (GO:0019321),-0.5070499612872161,-0.8766176926263739,0.627906976744186,1.0,1.0,4/7,15.87%,FGGY;XYLB;DCXR;RPEL1
prerank,GO_Biological_Process_2021__regulation of atrial cardiac muscle cell membrane repolarization (GO:0060372),0.5756924101147018,0.8765275161595668,0.7,1.0,1.0,1/5,17.40%,KCNQ1
prerank,GO_Biological_Process_2021__regulation of histone H2B ubiquitination (GO:2001166),-0.5466035286210806,-0.8764458416730184,0.66,1.0,1.0,3/5,32.95%,WDR70;RNF20;CDK9
prerank,GO_Biological_Process_2021__activation of GTPase activity (GO:0090630),0.38873530401246637,0.875881453229363,0.72,1.0,1.0,5/75,9.88%,EPHA1;GRTP1;NTF3;RUNDC1;ARHGAP25
prerank,GO_Biological_Process_2021__cellular response to glucose stimulus (GO:0071333),0.4470483435798835,0.8756968510471306,0.7083333333333334,1.0,1.0,2/27,11.81%,AGER;GPER1
prerank,GO_Biological_Process_2021__fructose metabolic process (GO:0006000),0.5768349101167561,0.8753614649204552,0.6666666666666666,1.0,1.0,3/5,20.89%,KHK;ALDOB;AKR1B1
prerank,GO_Biological_Process_2021__positive regulation of cell motility (GO:2000147),-0.31062004249709246,-0.8753542277906328,0.8,1.0,1.0,24/170,10.79%,KIT;ROR2;KDR;LEF1;F2RL1;CDH13;MIEN1;EPHB2;PDGFD;CLDN4;IGF1;ITGA6;FGF1;PDPN;NUMB;GCNT2;STAT3;MAPRE1;CSF1R;PDGFRA;PDGFC;DRD1;TRIP6;SEMA6A
prerank,GO_Biological_Process_2021__heme biosynthetic process (GO:0006783),0.46675822950686624,0.8751465613759467,0.6438356164383562,1.0,1.0,3/17,12.89%,UROD;ATP5IF1;ABCG2
prerank,PanglaoDB_Augmented_2021__Germ Cells,0.3642947998323691,0.8751264532664752,0.6621621621621622,1.0,1.0,16/93,18.09%,TEX101;DNAH3;TSKS;PHF13;PLAAT5;ACYP1;BCL2L14;GSG1;TAF7L;MRPL14;TSSK3;BRCA1;MEIOC;MEIG1;SPATA24;SLC25A31
prerank,GO_Biological_Process_2021__purine-containing compound metabolic process (GO:0072521),-0.5170256250626126,-0.8749617067607376,0.6521739130434783,1.0,1.0,4/6,31.68%,MACROD2;PRPS1;FHIT;OARD1
prerank,GO_Biological_Process_2021__galactosylceramide metabolic process (GO:0006681),0.5480928708721894,0.8748771076847771,0.676923076923077,1.0,1.0,3/8,15.08%,B3GALT1;GBA3;B4GALT3
prerank,GO_Biological_Process_2021__negative regulation of inclusion body assembly (GO:0090084),0.5532753396254637,0.87469307311111,0.6617647058823529,1.0,1.0,1/8,7.35%,DNAJB1
prerank,GO_Biological_Process_2021__dendrite morphogenesis (GO:0048813),0.4421213570364878,0.8746017240421569,0.68,1.0,1.0,1/34,0.45%,LRP4
prerank,GO_Biological_Process_2021__regulation of neuron migration (GO:2001222),-0.41273899264250596,-0.8743613892203794,0.64,1.0,1.0,6/26,12.12%,NTNG1;CTNNA2;NSMF;SEMA6A;PHACTR1;MDK
prerank,GO_Biological_Process_2021__inositol lipid-mediated signaling (GO:0048017),0.4171595935150139,0.8743514214171523,0.6470588235294118,1.0,1.0,8/46,18.79%,PDGFRB;PLCH1;PLCD3;PLCL1;PIK3C2G;PTAFR;PLCD1;INPP5F
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule catabolic process (GO:0034656),-0.42267742391190666,-0.8742952830146857,0.6060606060606061,1.0,1.0,1/14,7.38%,ADPRM
prerank,GO_Biological_Process_2021__histone H4-K20 methylation (GO:0034770),-0.5684580019680556,-0.8741770938500725,0.6470588235294118,1.0,1.0,2/5,16.53%,BEND3;KMT5B
prerank,GO_Biological_Process_2021__histone H4-K20 trimethylation (GO:0034773),-0.5684580019680556,-0.8741770938500725,0.6470588235294118,1.0,1.0,2/5,16.53%,BEND3;KMT5B
prerank,GO_Biological_Process_2021__negative regulation of defense response to virus (GO:0050687),0.5518095617304344,0.8741179798041956,0.625,1.0,1.0,2/9,10.84%,PCBP2;RNF26
prerank,GO_Biological_Process_2021__positive regulation of heart rate by epinephrine-norepinephrine (GO:0001996),0.549089400410698,0.8741090176740479,0.6515151515151515,1.0,1.0,1/6,8.25%,ADRB1
prerank,GO_Biological_Process_2021__negative regulation of G protein-coupled receptor signaling pathway (GO:0045744),0.4484759945915192,0.873894133223838,0.6896551724137931,1.0,1.0,2/19,5.37%,CCL5;MRAP
prerank,GO_Biological_Process_2021__SA node cell to atrial cardiac muscle cell signaling (GO:0086018),0.5883088178698022,0.8738706959090995,0.6721311475409836,1.0,1.0,2/5,22.46%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__regulation of protein dephosphorylation (GO:0035304),-0.39176067432016454,-0.8735807401901892,0.7096774193548387,1.0,1.0,13/34,24.83%,PRKCD;PPP6R1;NSMF;PPP1R8;PTBP1;PPP1R7;SYMPK;ENSA;PPP1R16B;PIN1;PPIA;PPP6R2;PTPA
prerank,GO_Biological_Process_2021__DNA metabolic process (GO:0006259),0.3498963288525503,0.8735670562360468,0.7283950617283951,1.0,1.0,24/246,16.44%,RAD54L;TICRR;MCM2;TDG;RFC5;POLE2;GMNN;POLQ;POLE3;RAD9B;DNASE2;UHRF2;INIP;CDC6;HELB;PCNA;MRE11;RPA3;DCTPP1;GLRX2;BRCA1;RECQL;PDS5B;ORC4
prerank,GO_Biological_Process_2021__regulation of mitochondrial fission (GO:0090140),-0.40775262524798167,-0.8732133848031901,0.631578947368421,1.0,1.0,2/25,7.03%,KDR;AURKA
prerank,GO_Biological_Process_2021__purine ribonucleotide transport (GO:0015868),-0.4564578541255087,-0.8729376843125044,0.5405405405405406,1.0,1.0,2/12,5.13%,ABCC4;SLC19A1
prerank,GO_Biological_Process_2021__polyol biosynthetic process (GO:0046173),0.5330785229988463,0.8729170377172788,0.6567164179104478,1.0,1.0,4/13,24.82%,CYP2R1;IPMK;ITPKB;IPPK
prerank,GO_Biological_Process_2021__intracellular pH reduction (GO:0051452),-0.4003902798133205,-0.8728216900219682,0.6052631578947368,1.0,1.0,1/27,0.65%,ATP6V0D2
prerank,PanglaoDB_Augmented_2021__T Cytotoxic Cells,0.45758286430258216,0.8727456352375026,0.6376811594202898,1.0,1.0,5/25,8.19%,GNLY;ITK;CD8A;PTPRC;TAGAP
prerank,GO_Biological_Process_2021__positive regulation of synapse maturation (GO:0090129),0.5565057303203711,0.872583769141128,0.6721311475409836,1.0,1.0,1/8,3.16%,NEUROD2
prerank,GO_Biological_Process_2021__epidermis development (GO:0008544),-0.3471862717188916,-0.872480739040868,0.7142857142857143,1.0,1.0,6/39,9.10%,SVEP1;LAMB3;FABP5;HDAC1;PTHLH;LAMA3
prerank,GO_Biological_Process_2021__maintenance of DNA repeat elements (GO:0043570),0.5519401194954658,0.8723411419235108,0.6538461538461539,1.0,1.0,5/6,33.01%,RMI2;MSH6;AXIN2;MSH2;TCF7L2
prerank,GO_Biological_Process_2021__positive regulation of viral transcription (GO:0050434),-0.42356894169669446,-0.8722349111187013,0.6176470588235294,1.0,1.0,8/25,20.90%,POLR2G;GTF2F1;POLR2C;POLR2L;NELFA;MDFIC;NELFE;CCNT1
prerank,GO_Biological_Process_2021__muscle cell migration (GO:0014812),-0.5259178659864387,-0.8721251619655472,0.7435897435897436,1.0,1.0,2/8,19.54%,CCN3;PLAT
prerank,PanglaoDB_Augmented_2021__Goblet Cells,0.4427995704334021,0.871799854186956,0.6307692307692307,1.0,1.0,9/32,17.06%,PLA2G10;SMIM22;HSD11B2;TJP3;GPX2;B3GNT3;MUC4;EPCAM;TMC4
prerank,GO_Biological_Process_2021__histone H3-K36 methylation (GO:0010452),-0.5414914416791874,-0.8717913225494343,0.6111111111111112,1.0,1.0,2/5,25.92%,SETD2;ASH1L
prerank,GO_Biological_Process_2021__negative regulation of Notch signaling pathway (GO:0045746),-0.4036625854915197,-0.871634570914823,0.5714285714285714,1.0,1.0,8/22,19.66%,RITA1;TCIM;ZBTB7A;BEND6;EGFR;EGFL7;NIBAN2;NEURL1
prerank,GO_Biological_Process_2021__lymphocyte mediated immunity (GO:0002449),0.49527945191202777,0.8715384568507669,0.6451612903225806,1.0,1.0,1/11,4.03%,CD8A
prerank,GO_Biological_Process_2021__regulation of heart rate by cardiac conduction (GO:0086091),-0.3696298253813605,-0.8711895458966287,0.625,1.0,1.0,2/34,2.68%,PKP2;CACNA2D1
prerank,GO_Biological_Process_2021__negative regulation of multicellular organismal process (GO:0051241),0.36145488370375967,0.8711716806840539,0.7160493827160493,1.0,1.0,22/155,14.07%,LRP4;ALDH1A1;VASN;BTN2A2;IL18R1;AGER;NOTCH1;IL15;LOXL2;MARVELD3;TRPV3;TLE3;RPS6KA4;ARRDC3;HMGCR;ZNF750;ACOT13;SMAD7;LRPAP1;TGFB1;ACVR2B;PLCL1
prerank,GO_Biological_Process_2021__positive regulation of potassium ion transmembrane transport (GO:1901381),-0.39703615417946275,-0.8709389106817281,0.6285714285714286,1.0,1.0,10/41,15.05%,KCNJ16;AMIGO1;KCNN3;KCNE1;ANO6;KCNN2;NOS1AP;KCNJ6;GABBR2;KCNJ2
prerank,GO_Biological_Process_2021__negative regulation of phagocytosis (GO:0050765),0.513108566909552,0.8709080423060805,0.704225352112676,1.0,1.0,3/13,20.00%,CD300LF;TLR2;PLSCR1
prerank,GO_Biological_Process_2021__plasma membrane organization (GO:0007009),0.39487064607110645,0.8708370041719977,0.6891891891891891,1.0,1.0,4/53,8.16%,CAV3;PLSCR5;PLSCR4;MYOF
prerank,GO_Biological_Process_2021__sphingosine biosynthetic process (GO:0046512),-0.4773825110187112,-0.8708173026445174,0.6176470588235294,1.0,1.0,2/12,8.70%,SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__sphingoid biosynthetic process (GO:0046520),-0.4773825110187112,-0.8708173026445174,0.6176470588235294,1.0,1.0,2/12,8.70%,SPHK2;SPTLC1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-protein transferase activity (GO:0051444),0.4454701372302057,0.8707342421730792,0.6515151515151515,1.0,1.0,2/15,11.46%,RPS7;SMAD7
prerank,GO_Biological_Process_2021__DNA modification (GO:0006304),0.47260827546179324,0.8704689148179355,0.6615384615384615,1.0,1.0,1/21,1.78%,TDG
prerank,GO_Biological_Process_2021__regulation of membrane protein ectodomain proteolysis (GO:0051043),0.4821936623680345,0.8704180342953864,0.6470588235294118,1.0,1.0,2/16,3.88%,TIMP3;TIMP2
prerank,GO_Biological_Process_2021__proteolysis (GO:0006508),-0.3235643985616058,-0.8702066560018233,0.8666666666666667,1.0,1.0,31/195,12.45%,CELA2A;ADAM19;TMPRSS7;ADAMTS3;VASH1;TYSND1;CPXM2;SVBP;SRGN;TRABD2A;CPA1;AZU1;PTCH1;NLRP1;ECE1;DPP3;TPP1;VASH2;NCSTN;LRP8;MME;IDE;CAPN13;USP25;PRSS54;CPQ;LAP3;HTRA1;EEF1AKMT4-ECE2;THOP1;HM13
prerank,GO_Biological_Process_2021__calcium-ion regulated exocytosis (GO:0017156),0.4509965027357048,0.8699580915751378,0.6470588235294118,1.0,1.0,6/24,23.14%,SYT2;SYT4;SYT15;SYT9;SYT13;DOC2B
prerank,GO_Biological_Process_2021__retinal rod cell development (GO:0046548),0.5469340423900323,0.8697395165751135,0.6388888888888888,1.0,1.0,1/6,2.48%,RP1
prerank,GO_Biological_Process_2021__mitotic spindle organization (GO:0007052),0.3684881470547055,0.8696366598794778,0.7,1.0,1.0,10/135,12.18%,CENPO;CENPI;CENPK;KNL1;WDR62;SPC24;TPX2;BUB1B;MZT1;CENPU
prerank,GO_Biological_Process_2021__amide transport (GO:0042886),-0.4269296588458994,-0.8693913502084908,0.5517241379310345,1.0,1.0,3/21,6.06%,ABCA13;SLC19A1;PDPN
prerank,GO_Biological_Process_2021__elastic fiber assembly (GO:0048251),-0.5473970129265968,-0.8691359427655224,0.6428571428571429,1.0,1.0,2/5,4.47%,MYH11;TNXB
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process (GO:0006085),-0.5217480212708572,-0.869023521765797,0.65625,1.0,1.0,1/9,4.18%,MLYCD
prerank,MSigDB_Hallmark_2020__Estrogen Response Early,0.3598866183022105,0.8689388465953276,0.7532467532467533,1.0,1.0,12/152,8.93%,CA12;CALCR;PTGES;WFS1;FASN;FKBP4;NXT1;TJP3;FKBP5;MYOF;ELOVL2;SLC2A1
prerank,GO_Biological_Process_2021__negative regulation of protein polymerization (GO:0032272),-0.35445239719129723,-0.8689285352204691,0.7297297297297297,1.0,1.0,6/26,15.48%,PRKCD;MAPRE1;STMN2;SSH1;TBCD;TUBB4A
prerank,GO_Biological_Process_2021__regulation of cardiac conduction (GO:1903779),0.41896815281516575,0.8689098111283265,0.7121212121212122,1.0,1.0,15/40,25.08%,ITPR1;AGT;FKBP1B;CASQ1;NPR2;KCNJ11;ATP1B1;CORIN;TRDN;ATP1A1;ABCC9;ATP2B4;ATP2A2;RYR3;RYR2
prerank,GO_Biological_Process_2021__regulation of androgen receptor signaling pathway (GO:0060765),-0.4030631704576614,-0.8688885653404642,0.6216216216216216,1.0,1.0,6/26,11.99%,SFRP1;HDAC1;FOXP1;ZBTB7A;SMARCA4;TRIM68
prerank,GO_Biological_Process_2021__cadmium ion transmembrane transport (GO:0070574),0.5959572610027123,0.8687817991930956,0.7166666666666667,1.0,1.0,3/5,37.27%,SLC11A1;SLC11A2;SLC39A8
prerank,GO_Biological_Process_2021__cadmium ion transport (GO:0015691),0.5959572610027123,0.8687817991930956,0.7166666666666667,1.0,1.0,3/5,37.27%,SLC11A1;SLC11A2;SLC39A8
prerank,GO_Biological_Process_2021__negative regulation of fat cell differentiation (GO:0045599),-0.39565107250518705,-0.8684769751859549,0.5853658536585366,1.0,1.0,4/26,11.09%,TRIB2;WWTR1;RORA;SIRT2
prerank,GO_Biological_Process_2021__regulation of receptor signaling pathway via JAK-STAT (GO:0046425),0.4397924758057241,0.8683580344398238,0.6470588235294118,1.0,1.0,5/26,10.22%,CCL5;NOTCH1;CYP1B1;PTPRC;CRLF3
prerank,GO_Biological_Process_2021__negative regulation of endothelial cell proliferation (GO:0001937),-0.42812981060769584,-0.8683247706630902,0.675,1.0,1.0,5/25,12.23%,VASH1;ATOH8;COL4A3;APOE;SCG2
prerank,GO_Biological_Process_2021__negative regulation of G2/M transition of mitotic cell cycle (GO:0010972),-0.3910273049146561,-0.8683081825581703,0.6785714285714286,1.0,1.0,2/57,7.03%,FBXL7;AURKA
prerank,GO_Biological_Process_2021__positive regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903997),0.5871312879388522,0.8680667605509504,0.7627118644067796,1.0,1.0,1/6,11.08%,STAP1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle hypertrophy (GO:0010611),-0.4014492478787813,-0.8676479678683949,0.6451612903225806,1.0,1.0,2/22,3.96%,LMCD1;IGF1
prerank,GO_Biological_Process_2021__protein transmembrane import into intracellular organelle (GO:0044743),-0.4202612623361915,-0.8676109896775961,0.6756756756756757,1.0,1.0,4/28,11.99%,PEX7;TOMM40L;TIMM50;TOMM40
prerank,GO_Biological_Process_2021__regulation of cell adhesion mediated by integrin (GO:0033628),0.42809762023608744,0.8675582872957485,0.676923076923077,1.0,1.0,12/26,28.58%,CYP1B1;P2RY12;PDE3B;TESC;SNAI2;DPP4;JAM3;LYN;SFRP2;SERPINE1;ADAM9;SYK
prerank,GO_Biological_Process_2021__regulation of filopodium assembly (GO:0051489),-0.3791885738681408,-0.8674000587527253,0.5909090909090909,1.0,1.0,8/39,14.04%,MIEN1;PRKCD;TGFB3;NRP1;RIPOR2;PLPPR5;MYO10;CAPZB
prerank,GO_Biological_Process_2021__regulation of 3'-UTR-mediated mRNA stabilization (GO:1905868),-0.5345093795095198,-0.8673268100593491,0.6,1.0,1.0,2/6,30.83%,LARP4B;METTL16
prerank,MSigDB_Hallmark_2020__G2-M Checkpoint,0.35441842926626904,0.867136761889785,0.7534246575342466,1.0,1.0,27/174,19.81%,RAD54L;MCM2;POLQ;ATF5;KNL1;GINS2;SUV39H1;CDKN1B;CDC25A;TLE3;TPX2;DDX39A;CDC6;CHMP1A;SMC2;SQLE;DR1;TGFB1;HSPA8;RACGAP1;PDS5B;H2AZ2;G3BP1;H2AZ1;YTHDC1;PURA;CHAF1A
prerank,GO_Biological_Process_2021__negative regulation of toll-like receptor signaling pathway (GO:0034122),-0.42984646993355086,-0.8671208130668712,0.6129032258064516,1.0,1.0,5/23,7.98%,RAB7B;F2RL1;TICAM1;GRAMD4;TYRO3
prerank,PanglaoDB_Augmented_2021__Mesothelial Cells,-0.31719930189549606,-0.8671189920400576,0.8333333333333334,1.0,1.0,19/103,12.17%,DUSP5;LAMB2;SVEP1;RND3;PXDC1;ST3GAL1;SDC4;WWTR1;FGF1;ANO1;LRIG3;FRAS1;LAMA3;ADGRL4;CDH1;COL4A2;ADGRD1;HTRA1;PARVA
prerank,GO_Biological_Process_2021__presynaptic endocytosis (GO:0140238),0.44482668655138197,0.8666941206442139,0.6666666666666666,1.0,1.0,1/23,4.31%,SYT2
prerank,GO_Biological_Process_2021__regulation of transforming growth factor beta receptor signaling pathway (GO:0017015),-0.34488012444075855,-0.8664398151692546,0.7096774193548387,1.0,1.0,4/81,3.55%,SPRED2;SPRED3;SPRED1;PMEPA1
prerank,GO_Biological_Process_2021__glial cell differentiation (GO:0010001),0.44157457397177385,0.8663978721159135,0.684931506849315,1.0,1.0,4/24,13.09%,SOX10;PTPRZ1;SOX11;EIF2B5
prerank,GO_Biological_Process_2021__alpha-beta T cell activation (GO:0046631),-0.5556003436203165,-0.8662955748025304,0.6444444444444445,1.0,1.0,1/5,2.66%,CDH26
prerank,PanglaoDB_Augmented_2021__Gastric Chief Cells,0.3888127346596968,0.8661915371575605,0.7037037037037037,1.0,1.0,13/65,17.40%,PPP1R1B;VWA2;HSD11B2;TJP3;AP1M2;IL20RA;B3GNT3;FGFR2;PLEKHG3;ALDH2;PCDH1;TMC4;KCNQ1
prerank,PanglaoDB_Augmented_2021__Immature Neurons,-0.30910339040109036,-0.8660275258659391,0.75,1.0,1.0,28/126,17.84%,FEZF2;EPHA3;ASCL1;BCL2;ADGRA1;ZNF536;MMD2;KCNC1;RGS8;GRIA4;MAPK4;RAB3C;CTNNA2;GAD2;LRRTM3;STMN2;ELAVL3;GRIA2;PAX6;SRRM4;UNC13A;CELF5;UNC79;CACNA1B;CELF4;ICAM5;SCRT1;SLC35F1
prerank,GO_Biological_Process_2021__cellular response to hormone stimulus (GO:0032870),-0.3428331985028491,-0.8659864557475053,0.6923076923076923,1.0,1.0,6/62,11.93%,ARID5A;SFRP1;STAT3;AKR1C3;NSMF;NR4A3
prerank,GO_Biological_Process_2021__filopodium assembly (GO:0046847),-0.48907336854011657,-0.8657771432373534,0.7241379310344828,1.0,1.0,6/13,24.25%,FGD5;PPP1R9B;VSTM5;FGD6;SPEF1;FGD1
prerank,PanglaoDB_Augmented_2021__Neuroendocrine Cells,0.359743240968636,0.8657308587258755,0.6582278481012658,1.0,1.0,10/122,12.66%,NPY;PPP1R1B;PLP1;GRM3;SYT4;CNTN2;KCNJ9;RIT2;C11ORF87;GFAP
prerank,GO_Biological_Process_2021__positive regulation of glycogen metabolic process (GO:0070875),-0.4653093021681284,-0.8657126585740791,0.6470588235294118,1.0,1.0,3/12,14.39%,IGF1;PPP1R3E;IRS1
prerank,GO_Biological_Process_2021__positive regulation of fibroblast proliferation (GO:0048146),-0.39455729128474115,-0.8655958542562885,0.5121951219512195,1.0,1.0,4/21,9.97%,EREG;IGF1;PDGFRA;PDGFC
prerank,GO_Biological_Process_2021__positive regulation of lipid kinase activity (GO:0090218),-0.40292887424980905,-0.8653511552458719,0.6857142857142857,1.0,1.0,1/23,0.36%,KIT
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle phase transition (GO:1901990),-0.3197639268569506,-0.8651545155493418,0.7391304347826086,1.0,1.0,19/166,11.81%,CDC14B;ERCC2;NEK6;KCNH5;CDC26;HMMR;TFAP4;AURKA;ID2;INO80;CDK5RAP2;PCNT;NEDD1;MAPRE1;ODF2;PCM1;CDC23;SIRT2;TUBG1
prerank,GO_Biological_Process_2021__activation of cysteine-type endopeptidase activity (GO:0097202),0.4774336128298617,0.8651030198038369,0.6612903225806451,1.0,1.0,5/14,21.12%,FADD;CASP8;RIPK2;LGMN;BAD
prerank,GO_Biological_Process_2021__AMP metabolic process (GO:0046033),0.5397974711687117,0.8645012611346946,0.6610169491525424,1.0,1.0,4/9,31.84%,AMPD2;AK4;NT5E;NT5C1A
prerank,GO_Biological_Process_2021__cellular response to amino acid starvation (GO:0034198),-0.34317317206006537,-0.8641520472998239,0.75,1.0,1.0,2/65,1.54%,ATP6V0D2;WDR24
prerank,GO_Biological_Process_2021__negative regulation of Arp2/3 complex-mediated actin nucleation (GO:0034316),0.5610484781944508,0.8641161507009785,0.6964285714285714,1.0,1.0,2/6,20.11%,GMFG;DNAI3
prerank,GO_Biological_Process_2021__intestinal absorption (GO:0050892),0.5324177071752844,0.8640480609527661,0.6724137931034483,1.0,1.0,5/9,31.61%,F11R;KCNQ1;SLC2A5;CD36;SLC26A6
prerank,GO_Biological_Process_2021__cyclic-nucleotide-mediated signaling (GO:0019935),-0.40379492485243046,-0.8639706493863014,0.7027027027027027,1.0,1.0,7/30,13.94%,GLP1R;PDE3A;EPHA5;MAPK7;APOE;PDE7A;CAP2
prerank,GO_Biological_Process_2021__negative regulation of DNA-binding transcription factor activity (GO:0043433),0.36786165205090676,0.8638658566688632,0.7297297297297297,1.0,1.0,10/105,12.91%,PTGIS;PLA2G10;WFS1;NLRP2B;CYP1B1;CARD8;CMKLR1;SFRP4;SMAD7;ESR1
prerank,GO_Biological_Process_2021__response to fatty acid (GO:0070542),-0.45689468660203447,-0.8638230193977467,0.6756756756756757,1.0,1.0,2/14,7.93%,PID1;NR1H4
prerank,GO_Biological_Process_2021__signal transduction by p53 class mediator (GO:0072331),-0.3817647595005911,-0.8638092482803434,0.6764705882352942,1.0,1.0,4/27,11.44%,GREM1;TRIAP1;IFI16;USP10
prerank,GO_Biological_Process_2021__response to amyloid-beta (GO:1904645),0.42196246814604854,0.8635320663864635,0.6233766233766234,1.0,1.0,2/28,1.74%,CALCR;AGER
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion in response to mitochondrial depolarization (GO:1904925),0.5574084614869994,0.8634876366610471,0.6724137931034483,1.0,1.0,2/6,16.73%,ATP5IF1;PINK1
prerank,"GO_Biological_Process_2021__regulation of mRNA splicing, via spliceosome (GO:0048024)",-0.35090668862179786,-0.8626947095436724,0.5769230769230769,1.0,1.0,19/79,16.90%,SFSWAP;HNRNPL;SF3B4;NCL;ZBTB7A;RBM11;RBMX;U2AF2;SON;SRSF7;SRRM4;RBM3;KHDRBS3;CELF5;PTBP1;CIRBP;RBM25;PCBP4;CELF4
prerank,GO_Biological_Process_2021__aldehyde biosynthetic process (GO:0046184),-0.5449928983075762,-0.8626515855089909,0.627906976744186,1.0,1.0,1/5,1.63%,PNPO
prerank,GO_Biological_Process_2021__dicarboxylic acid catabolic process (GO:0043649),0.5023377298525655,0.8625807918764684,0.6557377049180327,1.0,1.0,4/12,15.90%,ACOT4;GOT1;GAD1;ASPA
prerank,GO_Biological_Process_2021__regulation of establishment of cell polarity (GO:2000114),-0.4323657758192472,-0.8625789688686236,0.7333333333333333,1.0,1.0,1/14,11.44%,RIPOR2
prerank,PanglaoDB_Augmented_2021__Satellite Glial Cells,-0.340362723568125,-0.8623313091551529,0.7714285714285715,1.0,1.0,16/92,12.49%,CNGA3;PTPRT;PID1;NTSR2;SLC6A1;MMD2;GRIN2A;CBLN4;CSF1R;CDH20;RNASE1;CDH1;BAALC;TDRD6;TMEM132C;RGS7BP
prerank,GO_Biological_Process_2021__pulmonary valve development (GO:0003177),-0.4225793499393,-0.862325227384171,0.6388888888888888,1.0,1.0,2/12,5.75%,NFATC1;TGFB2
prerank,GO_Biological_Process_2021__response to amino acid starvation (GO:1990928),-0.34076305333261736,-0.8622825611947487,0.7037037037037037,1.0,1.0,2/66,1.54%,ATP6V0D2;WDR24
prerank,GO_Biological_Process_2021__phosphatidylinositol-3-phosphate biosynthetic process (GO:0036092),0.5515057449539732,0.8622660938786492,0.7,1.0,1.0,3/7,28.04%,PIK3C2G;PIK3CB;PIK3CD
prerank,GO_Biological_Process_2021__regulation of response to interferon-gamma (GO:0060330),0.5265926692405741,0.8621611042393673,0.6981132075471698,1.0,1.0,3/11,24.86%,STAT1;SUMO1;IFNGR2
prerank,GO_Biological_Process_2021__regulation of phagocytosis (GO:0050764),0.41013000935507204,0.8619225888389411,0.6363636363636364,1.0,1.0,4/34,5.48%,HCK;IL15;DOCK2;PTPRC
prerank,GO_Biological_Process_2021__positive regulation of substrate adhesion-dependent cell spreading (GO:1900026),0.4292791308423249,0.8619184980215352,0.7162162162162162,1.0,1.0,2/30,9.58%,RREB1;DOCK1
prerank,GO_Biological_Process_2021__negative regulation of macroautophagy (GO:0016242),0.4380480124921636,0.8617334830480369,0.6973684210526315,1.0,1.0,6/25,22.29%,CHMP4B;PHF23;TSC2;PINK1;LRRK2;SEC22B
prerank,GO_Biological_Process_2021__regulation of receptor recycling (GO:0001919),-0.5038899635102511,-0.8616747863293167,0.7027027027027027,1.0,1.0,3/13,14.47%,ECE1;TBC1D16;VAMP3
prerank,GO_Biological_Process_2021__autophagosome assembly (GO:0000045),-0.3547285772355385,-0.8611042647187347,0.6666666666666666,1.0,1.0,10/52,16.39%,STING1;NSFL1C;RAB7A;UBXN2A;MAP1LC3A;ATG9B;WDR45;EMC6;TP53INP2;PACS2
prerank,GO_Biological_Process_2021__modulation of chemical synaptic transmission (GO:0050804),-0.32993341926117853,-0.8610608184884165,0.5909090909090909,1.0,1.0,24/100,17.97%,GRIK4;CACNG5;CLSTN2;HCRT;CACNA1A;MCTP1;NMU;KCTD13;NPTXR;NLGN4Y;LRP8;NGF;NPTX2;BTBD9;UNC13A;DLGAP4;NLGN3;MCTP2;SLC8A3;RELN;CACNA1B;RIMS1;GRIK1;GRID1
prerank,GO_Biological_Process_2021__DNA damage checkpoint signaling (GO:0000077),-0.3660538969376021,-0.8608250738262592,0.7096774193548387,1.0,1.0,10/28,25.70%,MAP3K20;HUS1;CDC5L;ATM;TP53BP1;BRIP1;CHEK2;ATRIP;ZNF830;ATR
prerank,GO_Biological_Process_2021__positive regulation of cytokine production (GO:0001819),0.33387933788542645,0.8607095305695369,0.7613636363636364,1.0,1.0,30/227,14.66%,NOX5;ITK;IL18R1;AGER;POLR3K;CD4;ZBTB7B;ELANE;IL15;CYP1B1;NOX1;PTPRC;TWIST1;AGT;ZFPM1;CD14;FADD;IL7;HLA-A;HHLA2;CD6;PLCG2;SCIMP;IRF1;RIPK2;MRE11;TGFB1;POLR3G;BRCA1;STAT6
prerank,GO_Biological_Process_2021__peptidyl-lysine modification (GO:0018205),-0.3352681776053519,-0.8605746261107339,0.65,1.0,1.0,14/92,17.16%,IFIH1;NUP210;LOXL1;TPR;P3H3;NUP37;SIRT2;EEF1AKMT1;SIRT7;HDAC9;NUP42;RNF113A;HDAC10;NUP107
prerank,GO_Biological_Process_2021__positive regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903800),0.5074241458421105,0.860482046168929,0.703125,1.0,1.0,2/8,17.47%,TGFB1;MYCN
prerank,GO_Biological_Process_2021__regulation of neutrophil migration (GO:1902622),0.5538440708655443,0.8604192542608623,0.7777777777777778,1.0,1.0,3/7,30.12%,RHOH;JAM3;RAC1
prerank,GO_Biological_Process_2021__sympathetic ganglion development (GO:0061549),-0.4952859507447564,-0.8602007721617088,0.7142857142857143,1.0,1.0,2/8,11.13%,ASCL1;NRP1
prerank,GO_Biological_Process_2021__cell cycle G2/M phase transition (GO:0044839),-0.3086774481668486,-0.8601653133808573,0.8076923076923077,1.0,1.0,12/116,10.23%,TPD52L1;FBXL7;KDM8;AURKA;CDK5RAP2;PCNT;NEDD1;MAPRE1;CCNH;CDK14;ODF2;PCM1
prerank,GO_Biological_Process_2021__membrane fusion (GO:0061025),-0.3500736549842648,-0.8600809532300053,0.64,1.0,1.0,10/29,17.92%,NSFL1C;SNAP29;DYSF;CHP1;UBXN2A;MX1;VAMP3;FER1L5;RIMS1;DNM2
prerank,PanglaoDB_Augmented_2021__Intercalated Cells,-0.33596441970061114,-0.8599533779666702,0.7241379310344828,1.0,1.0,8/79,4.85%,ATP6V0D2;PTPRT;KCNJ16;ZBTB7C;CFAP221;PDZD2;CYP4Z1;CFAP61
prerank,GO_Biological_Process_2021__positive regulation of GTPase activity (GO:0043547),0.3513831583205351,0.8598518085661504,0.7682926829268293,1.0,1.0,10/149,9.88%,EPHA1;RGS10;CCL5;GRTP1;NTF3;DOCK8;RUNDC1;ADRB1;F11R;ARHGAP25
prerank,GO_Biological_Process_2021__regulation of RNA export from nucleus (GO:0046831),-0.42955314642609294,-0.8597575694031003,0.631578947368421,1.0,1.0,3/12,14.49%,TPR;IWS1;NRDE2
prerank,GO_Biological_Process_2021__response to peptide hormone (GO:0043434),0.4074603127033955,0.8595232121466649,0.6527777777777778,1.0,1.0,9/40,14.66%,ZBTB7B;IGFBP5;STAT4;STAT1;KHK;GPER1;STAT5A;EIF2B5;STAT6
prerank,GO_Biological_Process_2021__membrane raft assembly (GO:0001765),0.5730663860486397,0.8594894446121831,0.7222222222222222,1.0,1.0,2/5,28.98%,EMP2;FLOT1
prerank,GO_Biological_Process_2021__cellular response to muramyl dipeptide (GO:0071225),0.53262333070888,0.8594306125727229,0.7258064516129032,1.0,1.0,6/8,41.25%,RIPK2;NOD1;CHMP5;LDOC1;VIM;ARHGEF2
prerank,GO_Biological_Process_2021__regulation of multicellular organismal development (GO:2000026),0.44810035350040545,0.8592929535931604,0.6712328767123288,1.0,1.0,4/21,16.56%,TDG;DUSP9;RACGAP1;SCX
prerank,GO_Biological_Process_2021__negative regulation of erythrocyte differentiation (GO:0045647),0.5624207107194574,0.8592669459921936,0.6724137931034483,1.0,1.0,4/5,32.31%,MAFB;ZFP36;HSPA9;ZFP36L1
prerank,GO_Biological_Process_2021__negative regulation of activin receptor signaling pathway (GO:0032926),-0.4885259192090631,-0.8589164853936287,0.6585365853658537,1.0,1.0,2/9,17.40%,ACVR1;NOMO3
prerank,GO_Biological_Process_2021__response to UV-B (GO:0010224),-0.5125142467084008,-0.8588216963645032,0.6774193548387096,1.0,1.0,2/8,21.51%,MME;STK11
prerank,GO_Biological_Process_2021__positive regulation of 3'-UTR-mediated mRNA stabilization (GO:1905870),-0.5538866781637574,-0.8586272967895194,0.6666666666666666,1.0,1.0,1/5,24.03%,LARP4B
prerank,GO_Biological_Process_2021__cellular response to potassium ion (GO:0035865),0.5634229854869864,0.858516577946391,0.6896551724137931,1.0,1.0,3/6,28.27%,CRHBP;CACNA1H;SLC12A2
prerank,GO_Biological_Process_2021__response to potassium ion (GO:0035864),0.5634229854869864,0.858516577946391,0.6896551724137931,1.0,1.0,3/6,28.27%,CRHBP;CACNA1H;SLC12A2
prerank,GO_Biological_Process_2021__positive regulation of growth (GO:0045927),0.3967251398661896,0.8582258027456389,0.7301587301587301,1.0,1.0,4/55,6.93%,WFS1;H3-3A;TRIM32;NCBP1
prerank,GO_Biological_Process_2021__skeletal system morphogenesis (GO:0048705),0.46472154128423926,0.8581945058571103,0.6956521739130435,1.0,1.0,4/22,11.31%,HHIP;SFRP4;FGFR2;SOX11
prerank,PanglaoDB_Augmented_2021__Transient Cells,-0.33967273416037647,-0.8581588334978854,0.47368421052631576,1.0,1.0,8/105,6.60%,NPNT;LAMB2;UNC5B;UNC13B;MYH14;SDC4;OGDH;CDC42BPB
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane permeability (GO:0046902),0.500021657695226,0.8579226862598094,0.7068965517241379,1.0,1.0,6/16,22.33%,NAIF1;BNIP3;SLC25A31;BCL2L1;BAD;SLC25A4
prerank,GO_Biological_Process_2021__protein localization to chromatin (GO:0071168),-0.44128906173998994,-0.8576040541921531,0.6785714285714286,1.0,1.0,6/18,22.04%,LEMD2;MACROH2A2;LRWD1;MACROH2A1;MCM9;RUVBL2
prerank,GO_Biological_Process_2021__spinal cord development (GO:0021510),-0.46425401012370965,-0.8575681550166148,0.6046511627906976,1.0,1.0,1/12,3.06%,SOX12
prerank,GO_Biological_Process_2021__regulation of gluconeogenesis (GO:0006111),0.45704640637887245,0.8575288165708428,0.6557377049180327,1.0,1.0,2/22,11.56%,PPARGC1A;SDHAF3
prerank,"GO_Biological_Process_2021__DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:0006977)",-0.3723742291956757,-0.857501709266551,0.7428571428571429,1.0,1.0,11/48,16.96%,TRIAP1;AURKA;TFDP1;PLK2;CRADD;BTG2;PIDD1;PML;PLK3;PCBP4;ATM
prerank,GO_Biological_Process_2021__positive regulation of catabolic process (GO:0009896),0.3928167574296657,0.8574948703406701,0.684931506849315,1.0,1.0,3/50,8.10%,C4BPB;TRIM32;CDKN1B
prerank,GO_Biological_Process_2021__telomere maintenance via recombination (GO:0000722),-0.470471437807498,-0.8573870037949071,0.6274509803921569,1.0,1.0,3/10,17.88%,ERCC1;XRCC3;TPRKB
prerank,"GO_Biological_Process_2021__synaptic transmission, GABAergic (GO:0051932)",0.5078070927293155,0.8570917020719723,0.7384615384615385,1.0,1.0,2/10,19.55%,GABRA2;GABRA4
prerank,PanglaoDB_Augmented_2021__Sertoli Cells,0.3576156209814478,0.8570884944973088,0.759493670886076,1.0,1.0,17/119,12.59%,TIMP3;VASN;HSPG2;PRLR;BOK;MRO;IGFBP5;PLSCR4;AGT;EPHX1;RARRES2;F10;ACOX2;FAS;EPS8;MAFB;EPAS1
prerank,GO_Biological_Process_2021__negative regulation of transcription by RNA polymerase I (GO:0016479),-0.5521665945754201,-0.8569579520337837,0.7368421052631579,1.0,1.0,2/5,19.24%,MACROH2A2;MACROH2A1
prerank,GO_Biological_Process_2021__adenine nucleotide transport (GO:0051503),-0.440592506807593,-0.8569490665844834,0.5555555555555556,1.0,1.0,2/13,5.13%,ABCC4;SLC19A1
prerank,GO_Biological_Process_2021__branched-chain amino acid catabolic process (GO:0009083),0.4389709445257932,0.856879742837182,0.625,1.0,1.0,2/19,7.00%,ACAD8;HSD17B10
prerank,GO_Biological_Process_2021__branched-chain amino acid metabolic process (GO:0009081),0.4389709445257932,0.856879742837182,0.625,1.0,1.0,2/19,7.00%,ACAD8;HSD17B10
prerank,GO_Biological_Process_2021__regulation of intracellular transport (GO:0032386),0.42105278713860866,0.8567261017216631,0.6714285714285714,1.0,1.0,11/33,28.11%,MYBPC3;RNF139;MLC1;GAS1;NEFH;INPP5F;LRRK2;REEP5;LAMP1;ANTKMT;RINT1
prerank,GO_Biological_Process_2021__positive regulation of nucleocytoplasmic transport (GO:0046824),-0.3791377013533689,-0.856718794624573,0.5333333333333333,1.0,1.0,8/41,14.95%,TPR;EMD;PRKCD;CDH1;DMAP1;BAG3;NRDE2;MAVS
prerank,GO_Biological_Process_2021__negative regulation of fibrinolysis (GO:0051918),-0.5740586404602204,-0.8566175434425598,0.6923076923076923,1.0,1.0,1/5,7.08%,SERPINF2
prerank,GO_Biological_Process_2021__negative regulation of cytoplasmic translation (GO:2000766),0.5350053016809877,0.85656920283532,0.6491228070175439,1.0,1.0,3/7,43.40%,FMR1;CPEB3;CPEB1
prerank,GO_Biological_Process_2021__peroxisomal transport (GO:0043574),0.528903696607404,0.8564670320624427,0.7,1.0,1.0,1/8,7.63%,PEX16
prerank,GO_Biological_Process_2021__negative regulation of cilium assembly (GO:1902018),0.4900892745724455,0.856462807848868,0.7058823529411765,1.0,1.0,3/11,27.01%,CCP110;TCHP;YAP1
prerank,GO_Biological_Process_2021__positive regulation of protein processing (GO:0010954),-0.44495233699561443,-0.8564425819737876,0.675,1.0,1.0,1/15,1.24%,MELTF
prerank,GO_Biological_Process_2021__protein localization to cell junction (GO:1902414),-0.37613797325242904,-0.8564362857742807,0.6521739130434783,1.0,1.0,3/21,7.61%,HEG1;NPHS1;SHANK1
prerank,GO_Biological_Process_2021__purine nucleotide catabolic process (GO:0006195),-0.4888855805547827,-0.8563349944622425,0.6,1.0,1.0,3/11,10.85%,PNP;ITPA;DNPH1
prerank,GO_Biological_Process_2021__positive regulation of phosphatidylinositol 3-kinase activity (GO:0043552),-0.4079586125448035,-0.856294700506766,0.6216216216216216,1.0,1.0,1/21,0.36%,KIT
prerank,GO_Biological_Process_2021__endoplasmic reticulum localization (GO:0051643),0.560315528929771,0.8562246644025264,0.6964285714285714,1.0,1.0,3/6,14.31%,VAPB;TLE6;GRAMD2A
prerank,GO_Biological_Process_2021__negative regulation of cation transmembrane transport (GO:1904063),0.5053734877212362,0.8561919291209708,0.7142857142857143,1.0,1.0,1/13,1.71%,CAV3
prerank,GO_Biological_Process_2021__negative regulation of release of cytochrome c from mitochondria (GO:0090201),-0.4586030400105175,-0.8561233926675887,0.6190476190476191,1.0,1.0,3/14,11.39%,IGF1;TRIAP1;CLU
prerank,GO_Biological_Process_2021__translational elongation (GO:0006414),-0.32236169462200215,-0.8560553231934851,0.8214285714285714,1.0,1.0,11/93,10.56%,EEFSEC;MRPL17;MRPL58;MRPL33;TSFM;MRPS18A;MRPL39;MRPL21;MRPL55;DAP3;MRPL48
prerank,PanglaoDB_Augmented_2021__Pulmonary Vascular Smooth Muscle Cells,-0.3672071940472433,-0.8559483723462297,0.5666666666666667,1.0,1.0,10/71,5.85%,TAGLN;COL15A1;LAMA4;ADAMTS2;SVEP1;COL6A2;SGCD;PCDH18;PRRX1;ADAMTS5
prerank,GO_Biological_Process_2021__cellular response to glucose starvation (GO:0042149),0.4319648453291542,0.8558077487154724,0.7272727272727273,1.0,1.0,4/34,17.00%,HSPA5;SESN3;NUAK2;TBL2
prerank,GO_Biological_Process_2021__pyrimidine nucleobase catabolic process (GO:0006208),0.5273590813037617,0.8554238276651925,0.6774193548387096,1.0,1.0,5/8,39.29%,DPYS;ALDH6A1;DPYD;CRMP1;DPYSL2
prerank,GO_Biological_Process_2021__positive regulation of cell differentiation (GO:0045597),-0.315474943004546,-0.855416443700761,0.7857142857142857,1.0,1.0,35/190,14.42%,NPNT;KDR;BMP7;LEF1;ASCL1;KITLG;IGF1;ADIRF;SFRP1;WWTR1;TGFB2;PDPN;RIN2;SERPINF2;MMD2;BMP6;ID2;GCNT2;ZHX3;BTG1;TGFB3;VWC2;CTNNA2;SYAP1;BEND6;RIPOR2;NGF;MDK;PKDCC;NBL1;KCTD11;BRINP2;BRINP1;DLX2;MAPK12
prerank,GO_Biological_Process_2021__response to unfolded protein (GO:0006986),0.4184268112804618,0.8553537739179529,0.7297297297297297,1.0,1.0,15/43,26.73%,HSPA1L;DNAJB1;HSPA5;HERPUD1;HSPA4L;DNAJA1;HSPA8;DERL1;DAB2IP;HSPH1;ERN1;HSPA14;HSPB3;HSPA4;PACRG
prerank,GO_Biological_Process_2021__apoptotic DNA fragmentation (GO:0006309),0.49085917244301813,0.855223972889062,0.7049180327868853,1.0,1.0,2/14,9.92%,DNASE2;DNASE2B
prerank,GO_Biological_Process_2021__regulation of interleukin-1 beta production (GO:0032651),-0.35027786516811943,-0.8552094147696241,0.7142857142857143,1.0,1.0,10/47,9.95%,F2RL1;CARD18;IGF1;AZU1;NLRP1;APOA1;FOXP1;HSPB1;STAT3;IFI16
prerank,GO_Biological_Process_2021__spermatid development (GO:0007286),0.4434421096778315,0.8550838748671132,0.703125,1.0,1.0,3/23,7.40%,ING2;SYCP3;TDRD5
prerank,GO_Biological_Process_2021__ectoderm development (GO:0007398),0.5337994263128922,0.8550710516619618,0.7377049180327869,1.0,1.0,1/7,2.52%,ZBTB7B
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transport (GO:0051926),0.5397208849979014,0.8550364568709438,0.71875,1.0,1.0,1/11,1.71%,CAV3
prerank,PanglaoDB_Augmented_2021__Decidual Cells,0.46272757249577545,0.8545319069339352,0.6621621621621622,1.0,1.0,3/16,4.03%,GNLY;CCL5;CD8A
prerank,GO_Biological_Process_2021__negative regulation of biosynthetic process (GO:0009890),0.5071901574436566,0.854473504522615,0.7833333333333333,1.0,1.0,3/13,11.81%,ASXL3;CIITA;GPER1
prerank,GO_Biological_Process_2021__regulation of double-strand break repair (GO:2000779),0.4197473407328792,0.8541181482378628,0.7205882352941176,1.0,1.0,15/39,26.24%,PPP4C;TWIST1;FIGNL1;WAS;OTUB1;ACTR2;UBR5;RNF169;RAD51AP1;OOEP;TERF2IP;KDM1A;SLF1;FOXM1;DEK
prerank,GO_Biological_Process_2021__potassium ion transmembrane transport (GO:0071805),0.3628664649168468,0.8540330734846734,0.7837837837837838,1.0,1.0,26/113,22.87%,SLC12A7;KCNA3;KCNG3;KCNE2;KCNN4;SLC24A4;ATP12A;SLC24A2;KCNG1;SLC24A1;KCNJ9;KCNK10;KCNJ11;ATP1B1;KCNQ1;KCNE4;ATP1A1;SLC9A2;SLC9A6;SLC9A7;KCNK1;LRRC38;ABCC9;KCND1;HCN4;SLC1A3
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell differentiation (GO:0030858),-0.4441895186561141,-0.8538829861419117,0.6410256410256411,1.0,1.0,2/12,9.49%,ATOH8;BTG1
prerank,GO_Biological_Process_2021__carbohydrate homeostasis (GO:0033500),0.3976350905196666,0.8538310410610399,0.7419354838709677,1.0,1.0,4/52,8.05%,WFS1;CAV3;SLC30A8;ADIPOR2
prerank,GO_Biological_Process_2021__skin development (GO:0043588),-0.33868704276062733,-0.8537980617535111,0.7391304347826086,1.0,1.0,6/51,9.78%,EREG;CLDN4;ITGA6;RYR1;TGM1;AKR1C3
prerank,GO_Biological_Process_2021__positive regulation of glial cell differentiation (GO:0045687),0.48157243145329626,0.8536670591758021,0.6567164179104478,1.0,1.0,3/12,13.78%,NOTCH1;PTPRZ1;TGFB1
prerank,GO_Biological_Process_2021__regulation of platelet aggregation (GO:0090330),-0.4285121065544878,-0.8535951678154079,0.7037037037037037,1.0,1.0,3/18,6.22%,CELA2A;PDPN;PRKCD
prerank,GO_Biological_Process_2021__regulation of ATP metabolic process (GO:1903578),-0.3679617900833868,-0.8535377596444831,0.782608695652174,1.0,1.0,8/53,11.89%,NUP210;TPR;SLC25A33;SPHK2;NUP37;ZBTB7A;ABCD1;BEND3
prerank,PanglaoDB_Augmented_2021__Cholinergic Neurons,-0.3426426125068652,-0.8530985449613496,0.72,1.0,1.0,17/88,14.90%,CACNG4;ST8SIA2;RHBDL3;VGF;FBLL1;NYAP1;RGS8;IGDCC3;LIN28B;PHF21B;STMN2;SCG2;KCNB2;PLPPR5;UNC13A;EPHA8;MSI1
prerank,GO_Biological_Process_2021__regulation of response to reactive oxygen species (GO:1901031),-0.4818313734275947,-0.8529507639797036,0.5869565217391305,1.0,1.0,3/6,8.14%,BMP7;GCH1;DHFR
prerank,GO_Biological_Process_2021__protein deneddylation (GO:0000338),0.5170963280315394,0.852948689666075,0.6911764705882353,1.0,1.0,3/10,24.97%,COPS2;COPS8;COPS5
prerank,GO_Biological_Process_2021__regulation of axon extension (GO:0030516),-0.3673485989916428,-0.8529138508136924,0.7073170731707317,1.0,1.0,8/35,19.96%,RTN4R;LIMK1;PTPRS;APOE;DBNL;DNM2;SIN3A;NRCAM
prerank,GO_Biological_Process_2021__regulation of vesicle-mediated transport (GO:0060627),0.37023572620166834,0.8528343026116045,0.6867469879518072,1.0,1.0,15/84,21.17%,HCK;SLC30A8;PTPRC;HIP1R;RNF139;RIT2;RAB8A;TSC2;GAS1;RAB11A;SNX17;INPP5F;LRRK2;SEPTIN1;SPHK1
prerank,GO_Biological_Process_2021__pyrimidine deoxyribonucleotide biosynthetic process (GO:0009221),-0.5795247135521424,-0.8528321120054487,0.6818181818181818,1.0,1.0,1/5,2.98%,TYMS
prerank,GO_Biological_Process_2021__amyloid precursor protein metabolic process (GO:0042982),-0.4094343613907231,-0.8527189294378237,0.5476190476190477,1.0,1.0,4/16,11.15%,ADAM19;KLK6;NCSTN;APOE
prerank,GO_Biological_Process_2021__regulation of Cdc42 protein signal transduction (GO:0032489),-0.523119044843747,-0.8524759241943962,0.7142857142857143,1.0,1.0,3/7,11.15%,APOA1;NRP1;APOE
prerank,GO_Biological_Process_2021__sphingosine metabolic process (GO:0006670),-0.44520258302468046,-0.8524228205732118,0.6071428571428571,1.0,1.0,3/18,14.85%,SPHK2;SPTLC1;SGPP2
prerank,GO_Biological_Process_2021__positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway (GO:0090100),-0.3778991045107821,-0.8522775233317779,0.5833333333333334,1.0,1.0,7/62,9.80%,BMP7;BMP3;INHA;TGFB2;NUMA1;BMP6;TGFB3
prerank,GO_Biological_Process_2021__positive regulation of DNA recombination (GO:0045911),-0.3898425846059008,-0.8520977113006188,0.6875,1.0,1.0,4/27,11.05%,ERCC2;TIMELESS;SHLD1;PRDM7
prerank,GO_Biological_Process_2021__porphyrin-containing compound biosynthetic process (GO:0006779),0.4487476403594508,0.8519560095284638,0.6756756756756757,1.0,1.0,3/19,12.89%,UROD;ATP5IF1;ABCG2
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via JAK-STAT (GO:0046427),0.46805550352118613,0.851953297528989,0.6363636363636364,1.0,1.0,5/17,10.22%,CCL5;NOTCH1;PRLR;CYP1B1;CRLF3
prerank,GO_Biological_Process_2021__glycoside catabolic process (GO:0016139),0.5034647062609281,0.8517054861097945,0.7222222222222222,1.0,1.0,1/8,6.04%,GBA3
prerank,GO_Biological_Process_2021__phosphatidylinositol 3-kinase signaling (GO:0014065),-0.37782952924866275,-0.8516988596834593,0.5625,1.0,1.0,8/30,14.39%,NYAP2;IGF1;NYAP1;TYRO3;SIRT2;MYO16;HTR2A;IRS1
prerank,GO_Biological_Process_2021__camera-type eye photoreceptor cell differentiation (GO:0060219),-0.5633972309497146,-0.8515688916359636,0.7,1.0,1.0,1/5,18.72%,DSCAM
prerank,GO_Biological_Process_2021__regulation of I-kappaB phosphorylation (GO:1903719),0.5749476247822715,0.8515159628311902,0.7142857142857143,1.0,1.0,2/6,21.40%,PLCG2;CX3CR1
prerank,MSigDB_Hallmark_2020__Myc Targets V2,-0.35294636303072163,-0.8514117557396493,0.6857142857142857,1.0,1.0,6/52,8.85%,MCM5;DUSP2;TCOF1;SLC19A1;SRM;SORD
prerank,GO_Biological_Process_2021__autophagosome maturation (GO:0097352),-0.41690265795850406,-0.8513716191889301,0.6153846153846154,1.0,1.0,11/29,20.01%,RUBCNL;LIX1;SNAP29;MAP1LC3A;TSG101;EPG5;WIPI2;VCP;VAMP8;UVRAG;VPS16
prerank,GO_Biological_Process_2021__inflammatory response (GO:0006954),0.36267922611080056,0.851303112014072,0.7662337662337663,1.0,1.0,14/110,8.74%,C3AR1;KLRG1;CCL5;BLNK;GPR68;TBXA2R;HSPG2;NOX1;CD14;PTGER3;TRAF3IP2;CMKLR1;F11R;CIITA
prerank,GO_Biological_Process_2021__positive regulation of fat cell differentiation (GO:0045600),-0.3661560108039406,-0.8510852850222398,0.6071428571428571,1.0,1.0,4/43,4.71%,BMP7;SOX13;ADIRF;SFRP1
prerank,GO_Biological_Process_2021__negative regulation of cellular component organization (GO:0051129),-0.3357122539549576,-0.8510315538698859,0.6956521739130435,1.0,1.0,16/64,20.99%,EPHA3;APOA1;MCTP1;BMP6;NR1H4;SORL1;TRAF3IP1;CLU;CARMIL2;HSF1;DNM2;IRAK3;HSPA1A;CRACD;SCAMP5;LCMT1
prerank,GO_Biological_Process_2021__response to cAMP (GO:0051591),0.4159173216786858,0.8508223931728381,0.7761194029850746,1.0,1.0,8/34,22.46%,IGFBP5;AHR;STAT1;KCNQ1;AQP9;CRHBP;DMTN;HCN4
prerank,PanglaoDB_Augmented_2021__Pancreatic Progenitor Cells,-0.32014166759845664,-0.8507010724408023,0.7741935483870968,1.0,1.0,17/95,12.15%,NPNT;BMP7;TSPAN12;CACNG4;MYH14;CKMT1B;ID4;SEZ6L2;MARK1;ARX;LRIG3;MAPK4;PHF21B;COBL;FAM222A;SLC7A2;DUSP15
prerank,GO_Biological_Process_2021__regulation of lymphocyte apoptotic process (GO:0070228),0.5511805241149842,0.8505558790618057,0.7936507936507936,1.0,1.0,2/5,25.83%,CD274;LYN
prerank,GO_Biological_Process_2021__lens fiber cell differentiation (GO:0070306),0.5503495206848621,0.8505159513804477,0.7,1.0,1.0,3/6,29.50%,BFSP1;WNT5B;WNT7A
prerank,GO_Biological_Process_2021__regulated exocytosis (GO:0045055),0.3440270336794752,0.8505012068643402,0.7631578947368421,1.0,1.0,31/146,19.80%,TIMP3;SYT2;F8;SYT4;RARRES2;LAMP2;FAM3C;KNG1;CDC37L1;GTPBP2;SYNGR2;HGF;VEGFC;TUBA4A;TMEM79;VWF;TGFB1;A2M;SYTL4;FN1;PCDH7;SYT15;STEAP2;PSAP;SYT9;OTOF;CD109;TTN;SYT13;CRHBP;SERPING1
prerank,GO_Biological_Process_2021__regulation of transcription by RNA polymerase III (GO:0006359),-0.41854883138653043,-0.8502432675061157,0.6060606060606061,1.0,1.0,6/20,19.14%,BRF2;ZNF76;RPTOR;ZNF345;ICE1;MTOR
prerank,GO_Biological_Process_2021__pyridine-containing compound metabolic process (GO:0072524),-0.5018629289925146,-0.8502397226065624,0.6428571428571429,1.0,1.0,1/5,1.63%,PNPO
prerank,GO_Biological_Process_2021__regulation of homotypic cell-cell adhesion (GO:0034110),0.5096870661336516,0.8501956229980794,0.6825396825396826,1.0,1.0,2/12,2.27%,ZNF703;CCL5
prerank,PanglaoDB_Augmented_2021__Neuroblasts,-0.317685801136408,-0.850101832985061,0.8571428571428571,1.0,1.0,26/127,14.98%,POU6F2;ASCL1;PROS1;ST8SIA2;NTNG1;ITGA6;RHBDL3;FBLL1;VLDLR;MAPK7;NYAP1;KCNC1;MAPK4;IGDCC3;LRP8;PHF21B;STMN2;ELAVL3;PHF1;PLPPR5;EGFR;PRR36;UNC13A;DLX2;MSI1;SEMA5B
prerank,GO_Biological_Process_2021__regulation of lamellipodium assembly (GO:0010591),0.44104970117421377,0.8498289915327351,0.6923076923076923,1.0,1.0,14/28,31.35%,WAS;BRK1;ACTR2;DMTN;ACTR3;MSTN;TWF1;TWF2;CYFIP1;CDC42;ABI2;RAC1;SLIT2;ABI3
prerank,GO_Biological_Process_2021__mitochondrial fusion (GO:0008053),0.46041147690063816,0.8495156772479027,0.625,1.0,1.0,6/18,32.25%,MIEF2;MIGA1;THG1L;MIEF1;MFN1;BAX
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transporter activity (GO:2000650),0.5260182553390884,0.8494598328202959,0.7586206896551724,1.0,1.0,2/8,15.38%,HECW1;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of cellular catabolic process (GO:0031331),0.3507952474674119,0.8494342277441284,0.7866666666666666,1.0,1.0,7/121,9.45%,TRIM22;TRIM5;TRIML2;TWIST1;BNIP3;PRXL2C;RNF152
prerank,GO_Biological_Process_2021__negative regulation of hemostasis (GO:1900047),0.4897063123424839,0.8493469684971532,0.6545454545454545,1.0,1.0,1/9,7.75%,KNG1
prerank,GO_Biological_Process_2021__bile acid biosynthetic process (GO:0006699),0.4372099644819908,0.8492444209278386,0.6617647058823529,1.0,1.0,3/21,10.78%,BAAT;HSD17B10;ACOX2
prerank,GO_Biological_Process_2021__cellular modified amino acid biosynthetic process (GO:0042398),0.465556826204428,0.8489194263563399,0.7538461538461538,1.0,1.0,4/18,20.00%,CHAC2;CHAC1;PLOD2;PLSCR1
prerank,GO_Biological_Process_2021__dicarboxylic acid transport (GO:0006835),0.44931633871384896,0.8488927162929345,0.7352941176470589,1.0,1.0,4/23,11.11%,ABCC2;PRAF2;SLC26A7;SLC25A18
prerank,GO_Biological_Process_2021__negative regulation of cAMP-mediated signaling (GO:0043951),-0.5162446045247242,-0.8486884281227242,0.7142857142857143,1.0,1.0,2/9,13.64%,PDE3A;PDE11A
prerank,GO_Biological_Process_2021__positive regulation of morphogenesis of an epithelium (GO:1905332),0.4642051899162847,0.848565598513402,0.6774193548387096,1.0,1.0,6/16,28.36%,AGT;SIX4;WNT5B;GJA1;PIK3CD;ITGAX
prerank,GO_Biological_Process_2021__multivesicular body assembly (GO:0036258),0.43597680144051265,0.8484203472224459,0.7205882352941176,1.0,1.0,6/27,17.32%,CHMP4B;VPS37B;CHMP2B;CHMP1A;RAB11A;CHMP2A
prerank,GO_Biological_Process_2021__ERAD pathway (GO:0036503),0.37380541395421163,0.8482697021586001,0.72,1.0,1.0,23/84,28.46%,WFS1;RCN3;SYVN1;HSPA5;HERPUD1;RNF139;MAN1A1;USP13;DERL1;CCDC47;TRIM25;JKAMP;UGGT1;ERLIN1;MAN1B1;HSP90B1;RNF185;UBQLN1;TMUB1;YOD1;ERLEC1;MARCHF6;PSMC6
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor-mediated signaling pathway (GO:0010803),0.3851552265058873,0.8482638886727248,0.6956521739130435,1.0,1.0,5/46,10.45%,NLRP2B;CARD8;FADD;PELI3;CASP8
prerank,GO_Biological_Process_2021__hematopoietic stem cell differentiation (GO:0060218),-0.5582245321092789,-0.8481151549830278,0.6842105263157895,1.0,1.0,1/7,4.71%,SFRP1
prerank,GO_Biological_Process_2021__regulation of extracellular matrix organization (GO:1903053),-0.4510918978796592,-0.8480995396694697,0.6428571428571429,1.0,1.0,2/13,1.60%,FGFR4;RUNX1
prerank,PanglaoDB_Augmented_2021__B Cells Memory,-0.3542711659470222,-0.8479534946578183,0.6451612903225806,1.0,1.0,2/69,0.17%,CD38;P2RY10
prerank,GO_Biological_Process_2021__regulation of substrate adhesion-dependent cell spreading (GO:1900024),-0.37324829459125897,-0.8479402018189037,0.72,1.0,1.0,6/43,12.12%,MELTF;SPRY4;PDPN;APOA1;NRP1;MDK
prerank,GO_Biological_Process_2021__adipose tissue development (GO:0060612),0.5354190405748869,0.8479155410652959,0.7241379310344828,1.0,1.0,3/11,27.50%,NAMPT;PGRMC2;DGAT2
prerank,GO_Biological_Process_2021__regulation of neurotransmitter transport (GO:0051588),-0.46297936661593553,-0.847874334474221,0.6097560975609756,1.0,1.0,5/14,18.80%,HCRT;MCTP1;MCTP2;RIMS1;SNCAIP
prerank,GO_Biological_Process_2021__cellular response to oxygen levels (GO:0071453),0.5320080717647895,0.8477927736709372,0.7017543859649122,1.0,1.0,3/8,30.50%,ATP6AP1;ATP6V1G1;ATP6V1A
prerank,GO_Biological_Process_2021__positive regulation of protein secretion (GO:0050714),-0.36137265249984846,-0.8477536903529385,0.64,1.0,1.0,8/55,9.80%,F2RL1;UNC13B;RBP4;IGF1;PTPN23;TGFB2;BMP6;TGFB3
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by miRNA (GO:0060965),0.5024186613539169,0.847334445881025,0.6774193548387096,1.0,1.0,3/8,21.48%,ESR1;TGFB1;PPARG
prerank,GO_Biological_Process_2021__cellular response to retinoic acid (GO:0071300),-0.40174056596500646,-0.8473295874628436,0.6470588235294118,1.0,1.0,6/32,17.20%,EPHA3;BRINP2;WNT9B;BRINP1;ATM;SETX
prerank,GO_Biological_Process_2021__regulation of phospholipid transport (GO:2001138),-0.5678677335649457,-0.8469892649391109,0.59375,1.0,1.0,1/5,4.24%,TRIAP1
prerank,GO_Biological_Process_2021__ubiquinone metabolic process (GO:0006743),-0.4245899179929822,-0.8469035657533222,0.6470588235294118,1.0,1.0,9/14,23.79%,COQ6;COQ9;COQ2;PDSS2;UBIAD1;COQ7;COQ10B;PDSS1;COQ10A
prerank,GO_Biological_Process_2021__protein-DNA complex assembly (GO:0065004),0.3597275783807378,0.8468685294414178,0.7466666666666667,1.0,1.0,12/110,16.44%,MCM2;GMNN;H3-3A;SPTY2D1;PSMB6;NAP1L2;CDC6;H2BC18;RPA3;PSMA3;PSMB8;ORC4
prerank,GO_Biological_Process_2021__positive regulation of cell migration (GO:0030335),0.3364795237123702,0.8468300797206832,0.8333333333333334,1.0,1.0,21/215,9.58%,ENPP2;MYLK;EPHA1;RREB1;SEMA3D;ZNF703;CCL5;SMIM22;PDGFRB;NOTCH1;TRIM32;NTF3;PTPRC;TCAF2;HSPA5;SOD2;GAB1;RIPOR1;F10;HGF;DOCK1
prerank,GO_Biological_Process_2021__regulation of endocytosis (GO:0030100),-0.35688647830007286,-0.8464396306739482,0.8636363636363636,1.0,1.0,2/53,1.54%,EPHA3;CDH13
prerank,GO_Biological_Process_2021__regulation of wound healing (GO:0061041),-0.3935839767041135,-0.8462860483013842,0.7272727272727273,1.0,1.0,3/28,3.74%,F2RL1;EPHB2;CLDN4
prerank,GO_Biological_Process_2021__regulation of mitotic cell cycle (GO:0007346),-0.30449530497302474,-0.8460234479995673,0.9354838709677419,1.0,1.0,15/147,14.83%,PTPN3;ERCC2;NEK6;CDC26;TFAP4;EIF4EBP1;BTG1;CDC23;SMOC2;PRMT5;BTG2;BRINP2;BRINP1;FZR1;HSF1
prerank,GO_Biological_Process_2021__regulation of chondrocyte differentiation (GO:0032330),-0.35661855799338316,-0.8458766339663455,0.6774193548387096,1.0,1.0,5/21,13.31%,GREM1;TRPS1;PTHLH;MDK;PKDCC
prerank,GO_Biological_Process_2021__cGMP biosynthetic process (GO:0006182),-0.5057634542991946,-0.8458241156605094,0.6666666666666666,1.0,1.0,1/7,2.11%,GUCY2C
prerank,GO_Biological_Process_2021__tRNA modification (GO:0006400),-0.3187894596886158,-0.8456846865315267,0.7692307692307693,1.0,1.0,14/61,18.04%,LCMT2;PUSL1;THADA;TRDMT1;WDR4;ALKBH8;TRMT61A;ADAT2;QTRT1;TARBP1;CDKAL1;TPRKB;TYW3;DUS2
prerank,GO_Biological_Process_2021__regulation of T-helper 17 cell differentiation (GO:2000319),0.5469705392675157,0.8454942564837096,0.6792452830188679,1.0,1.0,2/6,20.62%,SMAD7;NFKBIZ
prerank,GO_Biological_Process_2021__piecemeal microautophagy of the nucleus (GO:0034727),0.5297392871695427,0.8454450013427908,0.7592592592592593,1.0,1.0,1/7,20.25%,ULK1
prerank,GO_Biological_Process_2021__lysosomal microautophagy (GO:0016237),0.5297392871695427,0.8454450013427908,0.7592592592592593,1.0,1.0,1/7,20.25%,ULK1
prerank,GO_Biological_Process_2021__supramolecular fiber organization (GO:0097435),0.33807434888348714,0.8454342973490602,0.8352941176470589,1.0,1.0,33/282,16.09%,SERF1A;CALB1;TLL1;HSPG2;H3-3A;LOXL2;CYP1B1;FBLN5;RND1;COL8A1;ACTC1;MFGE8;FIGNL1;BMP1;HIP1R;CORO1A;SIAH1;KIF14;MYO5B;ARHGAP25;RHOB;GFAP;BFSP1;RHOH;COL9A1;COL10A1;MYO1F;TLE6;WDR73;TUBGCP4;PGM5;PLOD2;INPPL1
prerank,GO_Biological_Process_2021__negative regulation of viral-induced cytoplasmic pattern recognition receptor signaling pathway (GO:0039532),-0.5397203280084062,-0.8454134632477213,0.6756756756756757,1.0,1.0,6/9,30.42%,NPLOC4;TSPAN6;DHX58;SEC14L1;TKFC;RIOK3
prerank,GO_Biological_Process_2021__fatty acid transport (GO:0015908),-0.42748660981854775,-0.8452952827473634,0.5,1.0,1.0,6/16,14.23%,FABP5;SLC27A3;SLC22A9;APOE;GOT2;SLC25A17
prerank,GO_Biological_Process_2021__positive regulation of cardiac muscle tissue growth (GO:0055023),0.499314351828286,0.8452747983643583,0.7101449275362319,1.0,1.0,4/13,21.10%,NOTCH1;FGFR2;PIM1;ZFPM2
prerank,GO_Biological_Process_2021__negative regulation of viral transcription (GO:0032897),0.47442838700591844,0.8449671803206847,0.7419354838709677,1.0,1.0,5/12,28.84%,TRIM32;TRIM14;IFITM3;UBP1;ZFP36
prerank,GO_Biological_Process_2021__cellular response to cholesterol (GO:0071397),-0.48383801590379794,-0.8449176771354884,0.6857142857142857,1.0,1.0,2/9,6.06%,OSBPL7;PTCH1
prerank,GO_Biological_Process_2021__purine nucleobase biosynthetic process (GO:0009113),0.5275703552694382,0.8448158194497194,0.6935483870967742,1.0,1.0,2/6,26.07%,PAICS;GMPS
prerank,GO_Biological_Process_2021__protein N-linked glycosylation (GO:0006487),-0.3501815112159086,-0.8445106240753663,0.625,1.0,1.0,11/62,15.58%,ALG8;ST3GAL1;GAL3ST1;ALG12;MOGS;MPDU1;DPM3;DERL3;RPN2;UGGT2;OST4
prerank,GO_Biological_Process_2021__neutrophil migration (GO:1990266),0.46107423680131004,0.8443292822327145,0.6575342465753424,1.0,1.0,1/21,2.27%,CCL5
prerank,GO_Biological_Process_2021__ether lipid metabolic process (GO:0046485),0.47464269859810515,0.8442429174999045,0.6615384615384615,1.0,1.0,2/13,7.35%,PLA2G7;NCEH1
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell differentiation (GO:2000725),-0.5132833927109826,-0.8441368149374304,0.7058823529411765,1.0,1.0,1/8,1.73%,GREM1
prerank,GO_Biological_Process_2021__positive regulation of hemostasis (GO:1900048),0.5187645234597453,0.8438668239647527,0.6825396825396826,1.0,1.0,2/7,26.61%,DMTN;SERPINE1
prerank,GO_Biological_Process_2021__positive regulation of coagulation (GO:0050820),0.5187645234597453,0.8438668239647527,0.6825396825396826,1.0,1.0,2/7,26.61%,DMTN;SERPINE1
prerank,GO_Biological_Process_2021__brain development (GO:0007420),-0.3105391324755887,-0.8438313300150211,0.9473684210526315,1.0,1.0,19/120,11.88%,MDGA1;KLHL17;PCDH18;AMIGO1;NFIB;PTCH1;JHY;DSCAML1;ZFHX3;MACROH2A2;SLC6A4;CDK5RAP2;GRIN2A;PBX4;SMG9;CTNNA2;GRIN2C;EEF1AKMT4-ECE2;PITPNM1
prerank,GO_Biological_Process_2021__negative regulation of protein import (GO:1904590),0.5628582277645603,0.8436798107603067,0.7611940298507462,1.0,1.0,2/7,11.23%,UFM1;RAB23
prerank,GO_Biological_Process_2021__negative regulation of protein import into nucleus (GO:0042308),0.5628582277645603,0.8436798107603067,0.7611940298507462,1.0,1.0,2/7,11.23%,UFM1;RAB23
prerank,GO_Biological_Process_2021__negative regulation of immune response (GO:0050777),0.37193056374288064,0.843623696176177,0.8133333333333334,1.0,1.0,12/99,11.48%,CALCR;MC4R;AMBP;RXFP1;CALCB;HCK;SCTR;TSHR;ADRB1;PCBP2;RNF26;PLCG2
prerank,GO_Biological_Process_2021__positive regulation of ATPase activity (GO:0032781),0.40512793007076076,0.8434267378523687,0.6571428571428571,1.0,1.0,13/35,31.25%,DNAJB1;ALDOB;MYBPC3;ATP1B1;PLSCR1;MSH6;RYR2;VMP1;AHSA1;GABARAPL2;MSH2;UHRF1;TOR1AIP2
prerank,GO_Biological_Process_2021__cellular response to cold (GO:0070417),-0.5067942861913073,-0.8433589771405771,0.6388888888888888,1.0,1.0,2/6,18.35%,DNAJC3;EIF2AK4
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential (GO:0098901),-0.3844667142607256,-0.8429819920446744,0.7222222222222222,1.0,1.0,3/21,7.58%,PKP2;FGF13;RANGRF
prerank,GO_Biological_Process_2021__motile cilium assembly (GO:0044458),0.5264534076991619,0.8428318896531997,0.7096774193548387,1.0,1.0,1/8,10.58%,CCDC39
prerank,"GO_Biological_Process_2021__positive regulation of CD4-positive, alpha-beta T cell differentiation (GO:0043372)",-0.554080869792531,-0.8426184158559952,0.6842105263157895,1.0,1.0,1/5,0.81%,MYB
prerank,GO_Biological_Process_2021__negative regulation of platelet activation (GO:0010544),0.4700426634867467,0.8425979409066976,0.8153846153846154,1.0,1.0,3/14,11.99%,ALOX12;PRKG1;ADAMTS18
prerank,GO_Biological_Process_2021__regulation of animal organ morphogenesis (GO:2000027),0.5638116810937605,0.8423440506809274,0.8275862068965517,1.0,1.0,1/6,8.52%,TBX1
prerank,GO_Biological_Process_2021__negative regulation of developmental process (GO:0051093),-0.3569500005570574,-0.8421080230040063,0.8285714285714286,1.0,1.0,9/62,10.87%,SINHCAF;GREM1;VASH1;NFIB;SFRP1;GRIN3A;SFMBT1;SPRY3;PTPRS
prerank,GO_Biological_Process_2021__somatic hypermutation of immunoglobulin genes (GO:0016446),0.5047529776267249,0.8420463833756063,0.7,1.0,1.0,1/7,2.72%,POLQ
prerank,GO_Biological_Process_2021__negative regulation of binding (GO:0051100),-0.31045552452320224,-0.8420271298179471,0.9444444444444444,1.0,1.0,11/71,11.66%,LEF1;CARD18;CYP2D6;TFAP4;PRKCD;AURKA;HMGA2;IFI16;SORL1;DDX11;PPP1CA
prerank,GO_Biological_Process_2021__inner mitochondrial membrane organization (GO:0007007),-0.3724783208968122,-0.8418285871136996,0.7352941176470589,1.0,1.0,3/44,6.56%,CHCHD6;TMEM11;MTX1
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection organization (GO:0120035),0.43140368119567957,0.8416572984667283,0.6865671641791045,1.0,1.0,1/23,1.05%,FRMD7
prerank,GO_Biological_Process_2021__positive regulation of excitatory postsynaptic potential (GO:2000463),-0.3947102674425002,-0.8416275078221696,0.6,1.0,1.0,5/18,21.57%,SHANK1;NLGN3;RELN;RIMS1;GRIN1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-6 production (GO:0032715),0.4559922369818876,0.8415944970463579,0.6923076923076923,1.0,1.0,3/15,21.07%,GHRL;NLRC3;CD200
prerank,GO_Biological_Process_2021__regulation of response to biotic stimulus (GO:0002831),0.42256882130408324,0.841408063417752,0.6964285714285714,1.0,1.0,3/25,13.02%,TRIM5;CASP8;IRF1
prerank,GO_Biological_Process_2021__positive regulation of phospholipase activity (GO:0010518),0.4249784140489449,0.8412082898031762,0.6764705882352942,1.0,1.0,6/20,12.91%,CCL5;PDGFRB;NTF3;FGFR2;ARL1;ESR1
prerank,GO_Biological_Process_2021__regulation of lipid metabolic process (GO:0019216),-0.30824240370102096,-0.8411280792757087,0.9473684210526315,1.0,1.0,6/77,9.35%,FGFR4;RUBCNL;ELOVL6;ID2;RORA;SIN3B
prerank,GO_Biological_Process_2021__positive regulation of cellular biosynthetic process (GO:0031328),-0.3207211688052831,-0.8410701362249146,0.8125,1.0,1.0,25/146,15.67%,FGFR4;SAMD4A;SLC25A37;EREG;IGF1;PLIN5;APOA1;SLC6A9;PPP1R3E;ELAVL1;UPF3A;SCARB1;CHP1;CLU;SMOC2;ZEB2;EGFR;NOS1AP;ABCB10;FAF1;RBM3;IRS1;ZNF205;CIRBP;PLD1
prerank,GO_Biological_Process_2021__double-strand break repair via nonhomologous end joining (GO:0006303),-0.3567502736038857,-0.8410566370240601,0.6923076923076923,1.0,1.0,10/58,9.75%,XRCC4;DCLRE1B;POLL;BRCC3;ERCC1;ERCC8;POLM;ZBTB7A;SMARCAL1;XRCC6
prerank,GO_Biological_Process_2021__ubiquinone biosynthetic process (GO:0006744),-0.4274526353142077,-0.8408300020999928,0.65625,1.0,1.0,9/13,23.79%,COQ6;COQ9;COQ2;PDSS2;UBIAD1;COQ7;COQ10B;PDSS1;COQ10A
prerank,GO_Biological_Process_2021__quinone biosynthetic process (GO:1901663),-0.4274526353142077,-0.8408300020999928,0.65625,1.0,1.0,9/13,23.79%,COQ6;COQ9;COQ2;PDSS2;UBIAD1;COQ7;COQ10B;PDSS1;COQ10A
prerank,GO_Biological_Process_2021__multivesicular body organization (GO:0036257),0.42788419649284426,0.8406188502889823,0.7058823529411765,1.0,1.0,6/28,17.32%,CHMP4B;VPS37B;CHMP2B;CHMP1A;RAB11A;CHMP2A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate adhesion (GO:0010812),-0.38369032001286063,-0.8405498861283099,0.6410256410256411,1.0,1.0,9/34,16.25%,MELTF;SPRY4;SPOCK1;GCNT2;PTPRO;AJAP1;TBCD;NEXMIF;CASK
prerank,GO_Biological_Process_2021__peroxisome organization (GO:0007031),-0.4148095192989581,-0.8398141299298602,0.7222222222222222,1.0,1.0,3/23,10.44%,PEX7;ACOT8;ABCD1
prerank,GO_Biological_Process_2021__cellular response to misfolded protein (GO:0071218),-0.4147336385394659,-0.8396042005225491,0.6666666666666666,1.0,1.0,2/19,7.04%,RNF126;DNAJB12
prerank,GO_Biological_Process_2021__rRNA 5'-end processing (GO:0000967),-0.502824625496852,-0.8391529822925577,0.6666666666666666,1.0,1.0,3/5,11.22%,NOP9;TBL3;NOP14
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000480)",-0.502824625496852,-0.8391529822925577,0.6666666666666666,1.0,1.0,3/5,11.22%,NOP9;TBL3;NOP14
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage to generate mature 5'-end of SSU-rRNA from (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000472)",-0.502824625496852,-0.8391529822925577,0.6666666666666666,1.0,1.0,3/5,11.22%,NOP9;TBL3;NOP14
prerank,GO_Biological_Process_2021__regulation of sister chromatid cohesion (GO:0007063),-0.45277780042377397,-0.8389847620379367,0.5833333333333334,1.0,1.0,2/8,21.31%,DDX11;CTCF
prerank,GO_Biological_Process_2021__regulation of blood circulation (GO:1903522),-0.40445125301629303,-0.8389240869455787,0.6333333333333333,1.0,1.0,4/23,7.24%,PER2;ECE1;S100A1;ACE2
prerank,GO_Biological_Process_2021__ribosome assembly (GO:0042255),0.3985116240545954,0.8388771300061716,0.7162162162162162,1.0,1.0,14/42,35.61%,ERAL1;MPV17L2;RSL24D1;RPS5;NOP53;RPL3;EIF6;DDX3X;RPL5;MTERF3;MRPL20;RPL24;RPSA;RPS19
prerank,GO_Biological_Process_2021__regulation of antigen receptor-mediated signaling pathway (GO:0050854),-0.48900163397492324,-0.838863906061319,0.675,1.0,1.0,2/10,7.73%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__embryonic heart tube morphogenesis (GO:0003143),-0.3808618866937109,-0.8388085264184185,0.7586206896551724,1.0,1.0,1/26,1.17%,TBX6
prerank,PanglaoDB_Augmented_2021__Melanocytes,0.3552811445800677,0.8383910591137627,0.7468354430379747,1.0,1.0,19/112,17.16%,TIMP3;GLI3;TYR;HSPG2;POSTN;LOXL2;AHR;OSMR;SRPX;ANGPTL2;DOCK1;SYNC;EPS8;EPAS1;MITF;MLANA;FN1;FILIP1L;SRPX2
prerank,GO_Biological_Process_2021__positive regulation of nervous system development (GO:0051962),-0.3598659537218244,-0.8383497304893907,0.7037037037037037,1.0,1.0,7/40,11.32%,RGS14;EPHB2;CLSTN2;NUMB;MME;DLG5;SYNDIG1
prerank,GO_Biological_Process_2021__G2/M transition of mitotic cell cycle (GO:0000086),-0.3085467008796663,-0.8382054582802904,0.9090909090909091,1.0,1.0,12/115,10.23%,TPD52L1;FBXL7;KDM8;AURKA;CDK5RAP2;PCNT;NEDD1;MAPRE1;CCNH;CDK14;ODF2;PCM1
prerank,GO_Biological_Process_2021__monocarboxylic acid biosynthetic process (GO:0072330),-0.3415595199987833,-0.8381372339909718,0.7407407407407407,1.0,1.0,7/51,8.34%,PER2;MLYCD;OSBPL7;ALDH1A2;ALDH1A3;ACSF3;ACOT8
prerank,GO_Biological_Process_2021__mitochondrial DNA replication (GO:0006264),0.49427719839258066,0.838136806241267,0.7377049180327869,1.0,1.0,1/8,6.49%,MGME1
prerank,GO_Biological_Process_2021__regulation of angiogenesis (GO:0045765),-0.30370076385525113,-0.838115264086518,0.8076923076923077,1.0,1.0,22/146,10.79%,KDR;SPRED1;RUNX1;NAXE;TSPAN12;ADAM12;VASH1;SFRP1;PIK3R6;COL4A3;GTF2I;TGFB2;FGF1;RHOJ;HSPB1;ETS1;VASH2;HMGA2;BTG1;SARS1;COL4A2;SEMA6A
prerank,GO_Biological_Process_2021__Golgi to lysosome transport (GO:0090160),0.5034618181826158,0.8380180710606936,0.6984126984126984,1.0,1.0,5/11,31.07%,SORT1;LAMP1;LAPTM5;AP1G1;AP4M1
prerank,GO_Biological_Process_2021__negative regulation of stress-activated protein kinase signaling cascade (GO:0070303),-0.5075388411065107,-0.8379478990287538,0.6666666666666666,1.0,1.0,1/6,6.40%,IGBP1
prerank,GO_Biological_Process_2021__humoral immune response mediated by circulating immunoglobulin (GO:0002455),0.5461391409845379,0.8378111207681352,0.7636363636363637,1.0,1.0,4/6,36.55%,C1QA;C1S;C1QB;CD81
prerank,GO_Biological_Process_2021__negative regulation of protein K63-linked ubiquitination (GO:1900045),0.5240010233917777,0.8377947365578966,0.6785714285714286,1.0,1.0,4/7,23.99%,OTUB1;UBR5;PLAA;GPS2
prerank,GO_Biological_Process_2021__negative regulation of proteolysis (GO:0045861),0.4358608347000838,0.8376838384402701,0.7066666666666667,1.0,1.0,5/29,15.02%,TIMP3;TIMP2;KNG1;CHAC1;GAS1
prerank,GO_Biological_Process_2021__positive regulation of actin filament polymerization (GO:0030838),0.41399249875344757,0.837659625901111,0.746031746031746,1.0,1.0,1/36,3.46%,HCK
prerank,GO_Biological_Process_2021__internal protein amino acid acetylation (GO:0006475),0.4935904610042635,0.83758684043028,0.7321428571428571,1.0,1.0,2/7,24.88%,HAT1;KAT2B
prerank,MSigDB_Hallmark_2020__Protein Secretion,0.3430214986966209,0.8371889294655612,0.8333333333333334,1.0,1.0,21/91,30.18%,LMAN1;LAMP2;BNIP3;CLCN3;RAB9A;ARCN1;COPB1;TOM1L1;ATP1A1;SEC22B;CLTC;YIPF6;NAPA;SCAMP1;TMED10;RAB5A;AP1G1;SNAP23;ARFGEF2;SNX2;GALC
prerank,GO_Biological_Process_2021__positive regulation of protein phosphorylation (GO:0001934),0.3316845466932845,0.8370353779657949,0.8395061728395061,1.0,1.0,59/286,24.32%,ENPP2;CALCR;P2RY1;AGER;CD4;SPDYA;IL15;ITGA5;INHBA;NTF3;PTPRC;AGT;CCND2;RARRES2;FAM20A;TBX1;HGF;RPS6KA4;VEGFC;FAS;PLCG2;GPER1;RIPK2;PLAUR;MRE11;TGFB1;CDK2AP1;OPRD1;FAXDC2;PINK1;CHRNA7;BANK1;NPTN;LIMCH1;TOM1L1;NEK10;NODAL;FXR1;TAB2;CD74;MTCP1;TNIK;LRRK2;CREBL2;SPHK1;CX3CR1;CALM3;TERF2IP;MUSK;FGF5;PRNP;ATP2B4;RAD50;MSTN;PRKAG2;CD80;DUSP19;IL5;ADAM17
prerank,GO_Biological_Process_2021__protein prenylation (GO:0018342),0.5491692871474125,0.8369841893521165,0.6833333333333333,1.0,1.0,1/8,3.39%,RABGGTB
prerank,GO_Biological_Process_2021__lymphocyte differentiation (GO:0030098),-0.3642396186208289,-0.8367444780840758,0.7837837837837838,1.0,1.0,8/48,9.47%,KIT;ITGA4;RABL3;HDAC5;TOX;IL11;ZBTB7A;JAG2
prerank,GO_Biological_Process_2021__response to morphine (GO:0043278),0.565844576605184,0.8365552723794925,0.7205882352941176,1.0,1.0,2/5,18.67%,DRD3;PRKCG
prerank,GO_Biological_Process_2021__cellular response to arsenic-containing substance (GO:0071243),-0.44231406426921593,-0.8363977828805772,0.6530612244897959,1.0,1.0,5/13,24.14%,ATF3;HSF1;VCP;MKNK2;GSTO2
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transporter activity (GO:0032412),-0.36162068891537297,-0.8362921408108626,0.75,1.0,1.0,4/32,7.58%,PTPN3;UTRN;SPHK2;RANGRF
prerank,GO_Biological_Process_2021__receptor guanylyl cyclase signaling pathway (GO:0007168),-0.5023370459890442,-0.8362637449749242,0.6111111111111112,1.0,1.0,1/6,2.11%,GUCY2C
prerank,GO_Biological_Process_2021__positive regulation of cytoplasmic transport (GO:1903651),-0.46066810825445337,-0.8360045402929666,0.6363636363636364,1.0,1.0,5/10,20.79%,PTPN23;SORL1;EIPR1;PRKN;VPS11
prerank,GO_Biological_Process_2021__cellular response to vascular endothelial growth factor stimulus (GO:0035924),-0.36540628854418034,-0.8359419104622932,0.6428571428571429,1.0,1.0,6/28,13.57%,KDR;HSPB1;MAP2K3;SEMA6A;NRP1;NR4A1
prerank,GO_Biological_Process_2021__associative learning (GO:0008306),-0.5044714401122077,-0.8356839315294537,0.7272727272727273,1.0,1.0,2/9,7.61%,SLC6A1;SHANK1
prerank,GO_Biological_Process_2021__response to interleukin-1 (GO:0070555),0.3915913647796574,0.8355848462647318,0.7014925373134329,1.0,1.0,2/44,2.27%,PTGIS;CCL5
prerank,GO_Biological_Process_2021__G1/S transition of mitotic cell cycle (GO:0000082),0.3812069674197724,0.8354269160297616,0.7625,1.0,1.0,12/75,14.77%,SPDYA;INHBA;CDKN2D;CCNE1;CDKN1B;CDC25A;CCNE2;CDK18;CRLF3;CDC6;PCNA;KLF11
prerank,PanglaoDB_Augmented_2021__Retinal Progenitor Cells,0.3684543079645743,0.8351412963452783,0.7682926829268293,1.0,1.0,6/101,8.01%,LRP4;TMEM200C;NOTCH1;ZDHHC22;PTPRZ1;CPE
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of transcription factor (GO:0042994),-0.473483617096065,-0.8350950471058284,0.6666666666666666,1.0,1.0,3/12,18.81%,CCDC22;FAF1;NFKBIB
prerank,GO_Biological_Process_2021__protein modification by small protein conjugation (GO:0032446),0.33285683811861716,0.8349264741712904,0.8764044943820225,1.0,1.0,65/347,24.87%,TRIM58;TRIM22;TRIM5;TRIML2;ENC1;TRIM54;NEUROD2;ARIH2;C10ORF90;TRIM32;RNF212B;SYVN1;UFM1;KLHL21;HLA-A;UHRF2;RNF152;RNF26;FBXL3;RNF139;KIAA1586;EPAS1;EYA1;PCNA;VCPIP1;HECW1;KLHL13;BRCA1;FBXO32;RNF138;TRIM50;DERL1;PINK1;TRIM14;SPSB1;RNF220;DCUN1D1;NUP54;CUL2;MAGEF1;PJA2;TNFAIP1;ATG3;RCHY1;HIF3A;RNF187;RNF41;UBE2E1;FBXO7;RNF181;H2BC5;KCTD10;NUP188;SPSB2;RNF168;PEX5;UBA3;NUP85;SUMO1;TRIM73;KLHL8;UBE2H;BSPRY;SDE2;NUP58
prerank,GO_Biological_Process_2021__post-Golgi vesicle-mediated transport (GO:0006892),-0.3183326576802819,-0.8348404507377273,0.8,1.0,1.0,22/82,21.10%,CCDC22;BLOC1S4;SORCS1;AP4E1;ACBD3;AP1S1;SORL1;AP1S3;STX4;DOP1B;AP1S2;COMMD1;CLVS1;EXOC6B;KLHL20;DNM2;EXOC2;VAMP8;EPS15;GOPC;RABEP1;GOLGB1
prerank,PanglaoDB_Augmented_2021__Granulosa Cells,0.3609164109890612,0.8347522471421288,0.8028169014084507,1.0,1.0,6/91,7.01%,LRP4;NES;FJX1;BOK;SRPX;TEAD4
prerank,GO_Biological_Process_2021__cellular response to reactive oxygen species (GO:0034614),-0.32694222995684136,-0.8347371079406407,0.84,1.0,1.0,12/52,20.02%,FOS;PRKCD;MAPK7;PDGFRA;AKR1C3;EGFR;MPV17;ERCC6L2;SETX;PXN;PTPRK;TRPM2
prerank,GO_Biological_Process_2021__protein quality control for misfolded or incompletely synthesized proteins (GO:0006515),0.44453388888013856,0.8346882095066839,0.8,1.0,1.0,7/23,28.68%,KLHL15;NGLY1;DERL1;UGGT1;RNF185;LONP1;CLPP
prerank,GO_Biological_Process_2021__regulation of insulin receptor signaling pathway (GO:0046626),0.4000872219366642,0.8345536143656783,0.7352941176470589,1.0,1.0,2/33,3.24%,ZBTB7B;VWA2
prerank,PanglaoDB_Augmented_2021__Astrocytes,-0.304915410642524,-0.8345480143837185,0.8235294117647058,1.0,1.0,32/140,16.02%,KCNIP1;SLC16A2;SPHKAP;LUZP2;NTM;NTSR2;SLC6A11;SLC6A1;FGF1;ADGRA1;ETS1;MMD2;MAPK4;GRIN2A;CMTM5;CDH20;BAALC;APOE;LRRTM3;SYNDIG1;STMN2;HTRA1;TMEM132C;RGS7BP;GRIA2;BRINP1;HSPB6;FGFR3;OPALIN;SLCO1C1;HEPN1;RCAN2
prerank,GO_Biological_Process_2021__negative regulation of protein processing (GO:0010955),0.4975448819361767,0.8344790053216679,0.746268656716418,1.0,1.0,6/12,26.61%,CHAC1;GAS1;CTSZ;LRRK2;PRNP;SERPINE1
prerank,GO_Biological_Process_2021__antigen receptor-mediated signaling pathway (GO:0050851),0.3479863682227755,0.8342042605954804,0.88,1.0,1.0,16/142,15.17%,ITK;BTN2A2;CD4;BLNK;PTPRC;THEMIS2;FYB1;HLA-A;HHLA2;PSMB6;WAS;PLCG2;EIF2B5;RIPK2;PSMA3;PSMB8
prerank,GO_Biological_Process_2021__nucleobase-containing small molecule interconversion (GO:0015949),-0.379068540014196,-0.8341642188866968,0.71875,1.0,1.0,6/25,14.77%,TYMS;NME4;RRM2;CTPS2;AK5;AK6
prerank,GO_Biological_Process_2021__bile acid metabolic process (GO:0008206),0.4271468903772843,0.8337093424616486,0.65625,1.0,1.0,3/25,10.78%,BAAT;HSD17B10;ACOX2
prerank,PanglaoDB_Augmented_2021__Enteric Glia Cells,-0.3339193930785748,-0.8336967181035837,0.75,1.0,1.0,18/98,12.49%,KCNIP1;KDR;PTPRT;FREM1;NTM;EFS;SORCS1;ID4;SLC6A1;ALDH1A3;ZNF536;MAPK4;APOE;SYNDIG1;STMN2;SMOC2;TMEM132C;RGS7BP
prerank,GO_Biological_Process_2021__membrane organization (GO:0061024),0.3371299165123568,0.833621989075741,0.872093023255814,1.0,1.0,16/204,10.61%,CHRNB1;LDLRAP1;CAV3;CD4;SYT2;LPCAT3;CHMP4B;VAPB;TGFA;HIP1R;MYOF;SYNGR2;EPN1;CNTN2;RABIF;CHMP2B
prerank,"GO_Biological_Process_2021__fatty acid elongation, polyunsaturated fatty acid (GO:0034626)",-0.5163549342949558,-0.8333567624529488,0.7317073170731707,1.0,1.0,1/6,3.14%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, unsaturated fatty acid (GO:0019368)",-0.5163549342949558,-0.8333567624529488,0.7317073170731707,1.0,1.0,1/6,3.14%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, saturated fatty acid (GO:0019367)",-0.5163549342949558,-0.8333567624529488,0.7317073170731707,1.0,1.0,1/6,3.14%,ELOVL6
prerank,"GO_Biological_Process_2021__fatty acid elongation, monounsaturated fatty acid (GO:0034625)",-0.5163549342949558,-0.8333567624529488,0.7317073170731707,1.0,1.0,1/6,3.14%,ELOVL6
prerank,GO_Biological_Process_2021__regulation of proteasomal protein catabolic process (GO:0061136),0.3839884673773069,0.833322591331984,0.71875,1.0,1.0,7/48,18.67%,KCNE2;USP14;UCHL5;TMF1;PINK1;DAB2IP;PRKCG
prerank,GO_Biological_Process_2021__response to magnesium ion (GO:0032026),0.505211407277258,0.8332711622254952,0.6981132075471698,1.0,1.0,4/7,40.36%,RYR3;SLC41A1;SNCA;FBP1
prerank,GO_Biological_Process_2021__histone lysine methylation (GO:0034968),-0.3961922102519063,-0.8331222016010974,0.7317073170731707,1.0,1.0,7/28,17.29%,PRDM5;SMYD2;SUV39H2;EHMT2;WDR82;SETDB1;KMT2B
prerank,GO_Biological_Process_2021__glomerular epithelial cell development (GO:0072310),-0.4760828066217608,-0.8331008690068197,0.7272727272727273,1.0,1.0,1/6,5.78%,NPHS1
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell development (GO:0072015),-0.4760828066217608,-0.8331008690068197,0.7272727272727273,1.0,1.0,1/6,5.78%,NPHS1
prerank,GO_Biological_Process_2021__positive regulation of endoplasmic reticulum unfolded protein response (GO:1900103),-0.4724062131809058,-0.8330523341746627,0.6666666666666666,1.0,1.0,1/11,1.00%,BCL2L11
prerank,GO_Biological_Process_2021__negative regulation of nervous system development (GO:0051961),0.4715373943779613,0.8329780060922497,0.7142857142857143,1.0,1.0,5/14,23.24%,NOTCH1;REST;B2M;TLR2;SLIT1
prerank,GO_Biological_Process_2021__N-acetylneuraminate metabolic process (GO:0006054),-0.43266586935512685,-0.8327647811172669,0.6451612903225806,1.0,1.0,1/10,3.07%,ST3GAL1
prerank,GO_Biological_Process_2021__positive regulation of T-helper 1 type immune response (GO:0002827),0.5723352594781727,0.8327459737848925,0.7457627118644068,1.0,1.0,1/5,1.42%,IL18R1
prerank,GO_Biological_Process_2021__positive regulation of T cell mediated cytotoxicity (GO:0001916),0.4736680074734182,0.8326900458562508,0.7142857142857143,1.0,1.0,2/15,8.88%,FADD;HLA-A
prerank,GO_Biological_Process_2021__mitotic spindle midzone assembly (GO:0051256),-0.4689361087012611,-0.8326688774344766,0.5945945945945946,1.0,1.0,2/6,11.37%,KIF23;MAP10
prerank,GO_Biological_Process_2021__mitotic spindle elongation (GO:0000022),-0.4689361087012611,-0.8326688774344766,0.5945945945945946,1.0,1.0,2/6,11.37%,KIF23;MAP10
prerank,PanglaoDB_Augmented_2021__Meningeal Cells,0.3551315616038405,0.8324862829719732,0.7272727272727273,1.0,1.0,10/97,8.41%,LRP4;NES;TIMP3;ADAMTS9;POSTN;IGFBP5;RUNX1T1;ANGPTL2;CPE;PRKG1
prerank,GO_Biological_Process_2021__regulation of actin filament-based process (GO:0032970),-0.35552006610409426,-0.8324525516739673,0.7307692307692307,1.0,1.0,8/59,9.21%,IQGAP2;EPHA3;RND3;RHOBTB1;EPHA5;PRKCD;PEAK3;RHOBTB2
prerank,PanglaoDB_Augmented_2021__Epiblast Cells,-0.3256402106724245,-0.8324328445656186,0.8214285714285714,1.0,1.0,19/79,14.98%,BMP7;LEF1;MYO3A;ST8SIA2;SYT6;VASH2;IGLON5;FRAS1;IGDCC3;LIN28B;PHF21B;CDH1;SEMA6A;ERAS;TRIM71;EPHA8;VRTN;MSI1;SEMA5B
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immunity (GO:0002717),-0.4308173431883955,-0.8323747411609395,0.6756756756756757,1.0,1.0,2/13,5.44%,RASGRP1;KLRD1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity (GO:0045954),-0.4308173431883955,-0.8323747411609395,0.6756756756756757,1.0,1.0,2/13,5.44%,RASGRP1;KLRD1
prerank,GO_Biological_Process_2021__negative regulation of glycoprotein biosynthetic process (GO:0010561),-0.4616117057169621,-0.8321353857374957,0.7575757575757576,1.0,1.0,3/8,21.90%,ACOT8;BACE2;AGO2
prerank,GO_Biological_Process_2021__protein insertion into mitochondrial inner membrane (GO:0045039),0.486195867287739,0.8320463749128733,0.6716417910447762,1.0,1.0,4/10,34.46%,ROMO1;TIMM8B;TIMM22;TIMM8A
prerank,GO_Biological_Process_2021__C21-steroid hormone metabolic process (GO:0008207),0.4693656652984939,0.8320339845519499,0.7246376811594203,1.0,1.0,4/14,23.52%,HSD17B10;TSPOAP1;AKR1B1;AKR1D1
prerank,GO_Biological_Process_2021__regulation of histone H3-K9 trimethylation (GO:1900112),0.5538739618812201,0.8318140978599609,0.7272727272727273,1.0,1.0,1/5,13.39%,ZNF304
prerank,GO_Biological_Process_2021__regulation of smooth muscle contraction (GO:0006940),-0.42524897606311246,-0.8317026613689613,0.6363636363636364,1.0,1.0,2/15,12.49%,NMU;KCNB2
prerank,GO_Biological_Process_2021__positive regulation of cilium assembly (GO:0045724),-0.40190435189997425,-0.8316117883689141,0.7666666666666667,1.0,1.0,1/18,3.95%,CROCC
prerank,GO_Biological_Process_2021__positive regulation of developmental growth (GO:0048639),0.37650957093883464,0.8314291539109328,0.7391304347826086,1.0,1.0,4/46,14.00%,SYT2;SYT4;CPNE5;GHRL
prerank,GO_Biological_Process_2021__neuron apoptotic process (GO:0051402),0.43963616299690833,0.8312504153530549,0.7142857142857143,1.0,1.0,3/18,11.17%,BNIP3;SIAH1;FAS
prerank,PanglaoDB_Augmented_2021__B Cells,-0.3439930175053475,-0.8311773854452223,0.6896551724137931,1.0,1.0,2/88,0.17%,CD38;P2RY10
prerank,GO_Biological_Process_2021__mitochondrial membrane organization (GO:0007006),-0.3835679422218848,-0.8310315421236573,0.7575757575757576,1.0,1.0,4/31,6.63%,CHCHD6;TMEM11;MTX1;BCL2
prerank,GO_Biological_Process_2021__regulation of cell-cell adhesion mediated by cadherin (GO:2000047),-0.44488188760510905,-0.8309640996758741,0.6904761904761905,1.0,1.0,3/17,7.62%,ADAM19;SERPINF2;BMP6
prerank,GO_Biological_Process_2021__nitric oxide metabolic process (GO:0046209),0.4694226055807336,0.8308720403934619,0.6875,1.0,1.0,8/14,25.57%,CYP1B1;NQO1;ARG2;MTARC2;CPS1;DDAH2;CYB5B;CYB5R3
prerank,GO_Biological_Process_2021__B cell mediated immunity (GO:0019724),0.5333354983133611,0.8307402863458541,0.7313432835820896,1.0,1.0,3/6,29.18%,CD27;CD74;MSH2
prerank,GO_Biological_Process_2021__regulation of G0 to G1 transition (GO:0070316),-0.3683475511997596,-0.8306717837063369,0.6486486486486487,1.0,1.0,7/37,15.48%,RING1;TFDP1;E2F6;RRM2;EHMT2;PCGF6;UXT
prerank,GO_Biological_Process_2021__response to ethanol (GO:0045471),-0.4450306328341479,-0.8306311568845018,0.5675675675675675,1.0,1.0,4/12,13.12%,GRIN3A;SDF4;GRIN2A;GOT2
prerank,GO_Biological_Process_2021__gonad development (GO:0008406),-0.35307591496538315,-0.8305376207685375,0.64,1.0,1.0,3/31,5.75%,KIT;KITLG;TGFB2
prerank,PanglaoDB_Augmented_2021__Beta Cells,0.34490027829692144,0.8302036367251345,0.8,1.0,1.0,4/119,6.55%,NPY;SLC30A8;ASXL3;SYT4
prerank,GO_Biological_Process_2021__inositol metabolic process (GO:0006020),0.5062401146933025,0.8301999912064646,0.7288135593220338,1.0,1.0,2/7,24.82%,IMPA2;IPPK
prerank,GO_Biological_Process_2021__positive regulation of leukocyte mediated cytotoxicity (GO:0001912),0.440200425900274,0.8301824788571172,0.7704918032786885,1.0,1.0,4/25,11.08%,FADD;CD160;HLA-A;STAP1
prerank,GO_Biological_Process_2021__nucleic acid metabolic process (GO:0090304),0.35520210012175807,0.8300721451707465,0.7857142857142857,1.0,1.0,18/65,27.15%,NCBP1;NCBP2;DNASE2;PCBP2;HNRNPA0;PCBP1;POLR2D;POLR2K;ANKLE1;DDX1;RAD50;PDE12;NT5E;HNRNPK;DUSP11;METTL14;DXO;HNRNPR
prerank,GO_Biological_Process_2021__regulation of neural precursor cell proliferation (GO:2000177),0.47127326389823465,0.8299555416445185,0.7272727272727273,1.0,1.0,2/17,6.77%,NES;PTPRZ1
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial calcium ion concentration (GO:0051561),0.5389160886148635,0.8299172805987239,0.7551020408163265,1.0,1.0,1/7,6.53%,BCAP31
prerank,GO_Biological_Process_2021__neuron projection development (GO:0031175),0.34560411801405205,0.8298129640493687,0.84,1.0,1.0,6/150,5.82%,NPY;AGER;NTF3;PLP1;OMG;UNC5A
prerank,MSigDB_Hallmark_2020__Epithelial Mesenchymal Transition,0.3396250462142826,0.829656281617009,0.7529411764705882,1.0,1.0,20/159,7.74%,LAMA2;MYLK;TIMP3;GADD45B;MSX1;ACTA2;PDGFRB;CTHRC1;CRLF1;POSTN;IL15;ITGA5;INHBA;LOXL2;FBLN5;NID2;ECM2;LAMA1;BMP1;RGS4
prerank,GO_Biological_Process_2021__regulation of axon extension involved in axon guidance (GO:0048841),0.44767714628666455,0.8295703842087131,0.6612903225806451,1.0,1.0,3/23,14.43%,SEMA3D;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex I assembly (GO:0032981),0.36756466143132127,0.8291465079469019,0.7605633802816901,1.0,1.0,8/50,19.64%,NDUFA2;NDUFB3;NDUFB4;NDUFB9;NDUFB2;DMAC1;NDUFAF4;TMEM126B
prerank,GO_Biological_Process_2021__NADH dehydrogenase complex assembly (GO:0010257),0.36756466143132127,0.8291465079469019,0.7605633802816901,1.0,1.0,8/50,19.64%,NDUFA2;NDUFB3;NDUFB4;NDUFB9;NDUFB2;DMAC1;NDUFAF4;TMEM126B
prerank,GO_Biological_Process_2021__regulation of granulocyte macrophage colony-stimulating factor production (GO:0032645),-0.528677327580632,-0.8291130522089092,0.625,1.0,1.0,1/5,4.53%,RASGRP1
prerank,GO_Biological_Process_2021__positive regulation of granulocyte macrophage colony-stimulating factor production (GO:0032725),-0.528677327580632,-0.8291130522089092,0.625,1.0,1.0,1/5,4.53%,RASGRP1
prerank,GO_Biological_Process_2021__negative chemotaxis (GO:0050919),0.4000107970462239,0.8290452795073131,0.6956521739130435,1.0,1.0,13/31,30.42%,SEMA3D;SEMA3F;SEMA3A;LGR6;LRTM1;SLIT1;SEMA4A;SEMA3C;NTN1;LRTM2;SEMA4B;SEMA6C;SLIT2
prerank,PanglaoDB_Augmented_2021__Trophoblast Progenitor Cells,0.3818727715266767,0.8288973511735348,0.7285714285714285,1.0,1.0,10/64,13.10%,ZBTB7B;DENND1C;JUNB;ISG20;CTDSP1;OSTF1;LITAF;NBEAL2;IRF1;TMC6
prerank,GO_Biological_Process_2021__ribosomal large subunit assembly (GO:0000027),0.44194559958969487,0.8288602597946906,0.6865671641791045,1.0,1.0,6/20,33.16%,RSL24D1;NOP53;RPL3;RPL5;MRPL20;RPL24
prerank,PanglaoDB_Augmented_2021__Dendritic Cells,0.359376739196072,0.8288487594250171,0.8243243243243243,1.0,1.0,17/95,9.60%,MS4A6A;FGL2;GPR68;HCK;CD300LF;CD8A;HLA-DMA;PLAC8;PTPRC;PIK3R5;HLA-DMB;FLT3;CD14;TAGAP;HLA-A;ARG1;PDCD1LG2
prerank,GO_Biological_Process_2021__negative regulation of amyloid fibril formation (GO:1905907),-0.4847362980203195,-0.8287249652736591,0.7674418604651163,1.0,1.0,2/9,11.39%,APOE;CLU
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton organization (GO:0032956),-0.33675725306644866,-0.8286874307719965,0.8333333333333334,1.0,1.0,10/77,9.66%,IQGAP2;EPHA3;RND3;RHOBTB1;EPHA5;PRKCD;PEAK3;RHOBTB2;CSF1R;PDGFRA
prerank,PanglaoDB_Augmented_2021__Dopaminergic Neurons,-0.30924896842213995,-0.8284419053947785,0.8260869565217391,1.0,1.0,20/109,17.48%,RIMBP2;ADGRA1;KCNC1;MAPK4;TMEM196;PHF21B;GAD2;STMN2;ELAVL3;LHFPL4;KCNB2;GRIA2;PRR36;KCNJ6;UNC13A;CELF5;MSI1;CACNA1B;CELF4;SCRT1
prerank,GO_Biological_Process_2021__negative regulation of type I interferon-mediated signaling pathway (GO:0060339),-0.454753124493413,-0.8284106333269455,0.75,1.0,1.0,2/15,13.90%,SAMHD1;CACTIN
prerank,GO_Biological_Process_2021__water transport (GO:0006833),-0.4768824871499725,-0.8283720500809062,0.7058823529411765,1.0,1.0,2/7,14.29%,PDPN;AQP8
prerank,PanglaoDB_Augmented_2021__Gamma Delta T Cells,0.4242728277994962,0.8283601417302858,0.7066666666666667,1.0,1.0,3/25,2.27%,GNLY;SPON2;CCL5
prerank,GO_Biological_Process_2021__negative regulation of G0 to G1 transition (GO:0070317),-0.37268189601122653,-0.8283553457466677,0.6486486486486487,1.0,1.0,7/35,15.48%,RING1;TFDP1;E2F6;RRM2;EHMT2;PCGF6;UXT
prerank,GO_Biological_Process_2021__establishment of spindle localization (GO:0051293),-0.45989520783299365,-0.8281853788630735,0.7333333333333333,1.0,1.0,3/14,10.74%,ZBED3;KIF25;LLGL2
prerank,GO_Biological_Process_2021__regulation of myosin-light-chain-phosphatase activity (GO:0035507),-0.4649519159986777,-0.8277027844888255,0.625,1.0,1.0,1/6,20.51%,IKBKB
prerank,GO_Biological_Process_2021__positive regulation of release of cytochrome c from mitochondria (GO:0090200),0.4254376397708274,0.8276075393450338,0.746031746031746,1.0,1.0,6/21,16.73%,BIK;MOAP1;BNIP3;GPER1;PLAUR;PINK1
prerank,GO_Biological_Process_2021__acylglycerol metabolic process (GO:0006639),-0.380476694731683,-0.827380549107856,0.6774193548387096,1.0,1.0,6/29,11.15%,DGKB;DGKD;LMF1;LYPLA2;DGKH;APOE
prerank,PanglaoDB_Augmented_2021__Osteocytes,-0.31958220907667706,-0.827267692418946,0.75,1.0,1.0,10/79,6.06%,FBXL7;SLC16A2;ADAMTS15;RND3;PCDH18;ZNF462;LOXL1;SFRP1;WWTR1;PDPN
prerank,PanglaoDB_Augmented_2021__Microfold Cells,-0.3294014298216943,-0.8270844098821369,0.7894736842105263,1.0,1.0,10/79,6.79%,IL1R1;IFIH1;LAMB3;CEBPD;NFIB;EHD4;TICAM1;FABP5;IER3;SBNO2
prerank,GO_Biological_Process_2021__positive regulation of T cell cytokine production (GO:0002726),0.46729530109531137,0.8270213501120826,0.7741935483870968,1.0,1.0,2/17,8.88%,IL18R1;HLA-A
prerank,GO_Biological_Process_2021__positive regulation of cell-cell adhesion (GO:0022409),-0.37713026428997604,-0.8269317751976164,0.6875,1.0,1.0,5/32,8.19%,BMP7;ADAM19;PTPN23;SERPINF2;GCNT2
prerank,GO_Biological_Process_2021__epidermal cell differentiation (GO:0009913),-0.3783279789730119,-0.8269272887315912,0.7037037037037037,1.0,1.0,5/32,9.78%,ERCC2;EREG;HDAC1;TGM1;AKR1C3
prerank,GO_Biological_Process_2021__endothelin receptor signaling pathway (GO:0086100),0.549896710625901,0.8269161802903174,0.723404255319149,1.0,1.0,2/5,35.51%,PTK2B;BCAR1
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter involved in myocardial precursor cell differentiation (GO:0003256),-0.5279862903268051,-0.8268940933869111,0.6944444444444444,1.0,1.0,1/5,1.73%,GREM1
prerank,GO_Biological_Process_2021__negative regulation of skeletal muscle cell differentiation (GO:2001015),0.5791289249985253,0.8265636984395875,0.7692307692307693,1.0,1.0,3/5,24.86%,SIX4;MSTN;EPHB1
prerank,GO_Biological_Process_2021__positive regulation of dopamine receptor signaling pathway (GO:0060161),0.5661936601511552,0.8265123425506524,0.7333333333333333,1.0,1.0,3/5,20.42%,DRD3;VPS35;LRRK2
prerank,GO_Biological_Process_2021__positive regulation of endothelial cell apoptotic process (GO:2000353),-0.4755701810127887,-0.826366008042345,0.717948717948718,1.0,1.0,3/11,9.78%,ITGA4;ANO6;AKR1C3
prerank,GO_Biological_Process_2021__protein auto-ADP-ribosylation (GO:0070213),-0.4178689762172763,-0.8261952965160012,0.6363636363636364,1.0,1.0,3/12,11.38%,PARP2;PARP6;PARP10
prerank,GO_Biological_Process_2021__regulation of glycolytic process (GO:0006110),-0.3486893930812141,-0.8261945419568724,0.7666666666666667,1.0,1.0,15/65,22.22%,NUP210;IGF1;TPR;NUP37;ZBTB7A;PFKFB3;NUP42;ZBTB20;NUP107;NUP43;NUPR1;GCK;RAE1;HDAC4;PPARA
prerank,GO_Biological_Process_2021__carbohydrate derivative transport (GO:1901264),0.4667357686372028,0.8260939460179453,0.6716417910447762,1.0,1.0,1/17,1.60%,PLA2G10
prerank,GO_Biological_Process_2021__negative regulation of type I interferon production (GO:0032480),-0.37636391988664164,-0.826038576731754,0.6944444444444444,1.0,1.0,9/33,14.95%,IFIH1;RNF216;PTPRS;TRAF3IP1;OTUD5;YY1;CACTIN;REL;MAVS
prerank,GO_Biological_Process_2021__positive regulation of defense response (GO:0031349),0.37608178611039755,0.825864942651703,0.8142857142857143,1.0,1.0,4/56,6.08%,CCL5;PLA2G7;IL15;AGT
prerank,GO_Biological_Process_2021__protein ADP-ribosylation (GO:0006471),-0.36686366379884194,-0.8258563271555057,0.7407407407407407,1.0,1.0,9/26,22.38%,PARP2;PARP6;SIRT2;PARP10;ZC3HAV1;ART4;PARP16;PARP4;PARP1
prerank,GO_Biological_Process_2021__organonitrogen compound biosynthetic process (GO:1901566),-0.3171781750350974,-0.8255257472121863,0.7916666666666666,1.0,1.0,20/136,11.90%,PAH;INHA;SPTSSB;ELOVL6;GSTT2B;LCMT2;GCH1;ALAS1;GSTM3;CHKA;GAL3ST4;SPHK2;CERS4;APOA1;SGMS2;SPTLC1;ST3GAL2;CEPT1;APOE;CSNK1G2
prerank,GO_Biological_Process_2021__protein maturation by iron-sulfur cluster transfer (GO:0097428),0.48039514838673875,0.8254968257178207,0.746268656716418,1.0,1.0,4/13,36.61%,MAGEF1;GLRX5;CIAO2A;GLRX3
prerank,GO_Biological_Process_2021__calcium ion transmembrane import into cytosol (GO:0097553),0.4254652467069758,0.8253169874182616,0.7297297297297297,1.0,1.0,7/35,12.27%,TRPV6;ITPR1;PTPRC;TRPV3;SLC24A2;PLCG2;SLC24A1
prerank,GO_Biological_Process_2021__SREBP signaling pathway (GO:0032933),0.4931545771629775,0.8251309853749342,0.75,1.0,1.0,3/8,21.51%,INSIG2;INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__cellular response to sterol depletion (GO:0071501),0.4931545771629775,0.8251309853749342,0.75,1.0,1.0,3/8,21.51%,INSIG2;INSIG1;ERLIN1
prerank,GO_Biological_Process_2021__glutathione metabolic process (GO:0006749),0.4029453259969002,0.8251068133919294,0.7384615384615385,1.0,1.0,6/30,14.44%,HPGDS;CHAC2;G6PD;CHAC1;GSTT2;GLRX2
prerank,"GO_Biological_Process_2021__regulation of CD4-positive, alpha-beta T cell activation (GO:2000514)",0.5210327984316993,0.8245564656172313,0.6984126984126984,1.0,1.0,1/6,1.74%,AGER
prerank,GO_Biological_Process_2021__histone H3-K9 methylation (GO:0051567),-0.5140551878686057,-0.8244897100212999,0.7659574468085106,1.0,1.0,4/6,16.74%,PRDM5;SUV39H2;BEND3;SETDB1
prerank,GO_Biological_Process_2021__pulmonary valve morphogenesis (GO:0003184),-0.42475206807411836,-0.8244673909085646,0.631578947368421,1.0,1.0,2/10,5.75%,NFATC1;TGFB2
prerank,GO_Biological_Process_2021__response to hexose (GO:0009746),0.44823770425927245,0.824244243285002,0.7,1.0,1.0,3/19,13.09%,SLC30A8;KHK;EIF2B5
prerank,GO_Biological_Process_2021__protein hydroxylation (GO:0018126),-0.4407923399334407,-0.8239139285066949,0.6571428571428571,1.0,1.0,5/13,24.90%,P3H3;P3H1;OGFOD1;ASPH;HIF1AN
prerank,GO_Biological_Process_2021__embryonic limb morphogenesis (GO:0030326),-0.4066291268358773,-0.8238499546014308,0.7857142857142857,1.0,1.0,8/27,11.83%,MAP3K20;AFF3;TGFB2;HDAC1;PTCH1;ECE1;MYH3;NOG
prerank,GO_Biological_Process_2021__aromatic amino acid transport (GO:0015801),-0.48405846348053405,-0.8237580527914496,0.6666666666666666,1.0,1.0,1/6,7.15%,SLC25A29
prerank,GO_Biological_Process_2021__positive regulation of protein polyubiquitination (GO:1902916),-0.5067283951853927,-0.8237461734359361,0.6428571428571429,1.0,1.0,2/7,19.41%,XIAP;PRKN
prerank,GO_Biological_Process_2021__negative regulation of inflammatory response (GO:0050728),0.3479825786823901,0.8234776612920213,0.8095238095238095,1.0,1.0,10/125,4.93%,CALCR;MC4R;PTGIS;RXFP1;CALCB;HCK;ELANE;MMP26;LPCAT3;SCTR
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway (GO:0051482),0.4376810895357032,0.8234492813427337,0.7727272727272727,1.0,1.0,1/19,0.10%,C3AR1
prerank,GO_Biological_Process_2021__action potential (GO:0001508),0.38924889081530945,0.8231288963913479,0.7794117647058824,1.0,1.0,9/39,22.47%,KCNE2;SCN9A;SCN7A;YWHAH;GPER1;KCNQ1;KCNE4;CACNA1G;CACNA1H
prerank,GO_Biological_Process_2021__double-strand break repair via homologous recombination (GO:0000724),0.34827705507713413,0.8229825486223801,0.8115942028985508,1.0,1.0,19/89,20.32%,RAD54L;MCM2;POLQ;GINS2;MCMDC2;FANCM;MRE11;RPA3;BRCA1;MEIOB;RNF138;RECQL;MORF4L1;RAD51C;GINS4;POLN;RECQL4;MMS22L;RAD51AP1
prerank,GO_Biological_Process_2021__transport across blood-brain barrier (GO:0150104),-0.2932349322266793,-0.8229197320028397,0.7931034482758621,1.0,1.0,16/77,13.27%,SLC16A2;SLC16A12;SLC22A2;ABCC4;FABP5;SLC19A1;SLC6A1;SLC6A9;SLC7A1;SLC29A4;SLC22A3;ABCC1;SLC7A2;SLC24A3;SLC22A1;SLCO3A1
prerank,GO_Biological_Process_2021__positive regulation of ERK1 and ERK2 cascade (GO:0070374),0.3566342120666519,0.8229124631276111,0.7435897435897436,1.0,1.0,10/111,5.48%,CALCR;ROR1;P2RY1;AGER;CD4;CCL5;PDGFRB;NOTCH1;ACKR3;PTPRC
prerank,GO_Biological_Process_2021__lysosome organization (GO:0007040),-0.398924833451669,-0.8225506900561029,0.7741935483870968,1.0,1.0,7/32,19.14%,ARSB;CLN6;TPP1;GNPTAB;CLVS1;HOOK3;MTOR
prerank,GO_Biological_Process_2021__transcription initiation from RNA polymerase II promoter (GO:0006367),0.334066415643339,0.8225130783213666,0.7692307692307693,1.0,1.0,14/125,14.26%,NR1I3;HNF4G;NOTCH1;NR2E3;NR5A2;TEAD4;MAML2;PPARGC1A;TBP;NOTCH3;TAF7L;ESR1;DR1;MED7
prerank,GO_Biological_Process_2021__negative regulation by host of viral transcription (GO:0043922),0.5021205900716191,0.8223188879711493,0.7333333333333333,1.0,1.0,2/10,9.19%,CCL5;REST
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell to AV node cell signaling (GO:0086026),0.5222096178406894,0.8222884643448234,0.75,1.0,1.0,3/7,35.18%,KCNQ1;GJA1;SCN3B
prerank,GO_Biological_Process_2021__positive regulation of receptor-mediated endocytosis (GO:0048260),0.40137132559224414,0.822105984653112,0.8157894736842105,1.0,1.0,3/34,9.22%,LDLRAP1;NTF3;SFRP4
prerank,GO_Biological_Process_2021__acidic amino acid transport (GO:0015800),0.4542185258222985,0.8218056998827524,0.7258064516129032,1.0,1.0,3/16,11.11%,LRRC8D;PRAF2;SLC25A18
prerank,GO_Biological_Process_2021__negative regulation of actin filament bundle assembly (GO:0032232),0.40520869107760676,0.8212864956919707,0.7428571428571429,1.0,1.0,3/25,15.39%,F11R;WAS;ARHGAP28
prerank,MSigDB_Hallmark_2020__Hypoxia,0.3433673956760488,0.8212810044825598,0.8433734939759037,1.0,1.0,19/165,13.26%,CA12;CCNG2;GLRX;CP;ACKR3;PLAC8;ISG20;PHKG1;KDM3A;SRPX;HSPA5;NFIL3;CDKN1B;PPARGC1A;SLC2A1;ALDOB;LXN;FOSL2;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell proliferation (GO:0050679),-0.308810562996822,-0.8212746853525796,0.8333333333333334,1.0,1.0,17/89,13.57%,KDR;CDH13;IGF1;C5AR1;SFRP1;FGF1;TGM1;VASH2;BMP6;VIP;NRP1;NR4A3;HMGB2;MDK;SCG2;EGFR;NR4A1
prerank,GO_Biological_Process_2021__glycoprotein catabolic process (GO:0006516),0.4722995551042517,0.8212634554154848,0.7741935483870968,1.0,1.0,3/14,16.08%,ADAMTS9;MANBA;NGLY1
prerank,"GO_Biological_Process_2021__retrograde protein transport, ER to cytosol (GO:0030970)",0.49290915591704987,0.8210947199754852,0.7704918032786885,1.0,1.0,3/17,16.28%,SYVN1;HERPUD1;DERL1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound salvage (GO:0008655),-0.4374976823321156,-0.8210818671295089,0.625,1.0,1.0,3/9,17.22%,UPP2;UCK2;TYMP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside salvage (GO:0043097),-0.4374976823321156,-0.8210818671295089,0.625,1.0,1.0,3/9,17.22%,UPP2;UCK2;TYMP
prerank,GO_Biological_Process_2021__mitotic recombination (GO:0006312),-0.43793940170466544,-0.8209201734504582,0.6944444444444444,1.0,1.0,4/14,20.86%,ERCC1;XRCC3;TPRKB;MSH3
prerank,GO_Biological_Process_2021__ion transport (GO:0006811),0.34151021170955553,0.8206417961469165,0.8441558441558441,1.0,1.0,15/95,12.27%,SLC12A7;CHRNB1;TRPA1;PLP2;CNGB1;KCNN4;SLC26A4;SLC24A4;CNGB3;SLC17A8;SLC36A1;SLC24A2;SLC26A7;SLC25A18;SLC24A1
prerank,PanglaoDB_Augmented_2021__Airway Smooth Muscle Cells,0.3679448454730854,0.8205157156129371,0.7846153846153846,1.0,1.0,9/66,6.82%,TIMP3;ACTA2;PDGFRB;POSTN;LOXL2;IGFBP5;FBLN5;NID2;SRPX
prerank,GO_Biological_Process_2021__regulation of histone H3-K27 methylation (GO:0061085),-0.5440532743182273,-0.8204075155467998,0.6666666666666666,1.0,1.0,2/6,19.24%,PHF1;MACROH2A1
prerank,GO_Biological_Process_2021__post-transcriptional gene silencing by RNA (GO:0035194),-0.4214074898232243,-0.8198611444148143,0.7096774193548387,1.0,1.0,5/19,21.90%,WTIP;MOV10L1;NRDE2;CELF1;AGO2
prerank,GO_Biological_Process_2021__membrane depolarization during AV node cell action potential (GO:0086045),0.550247898929132,0.8198300626514012,0.7368421052631579,1.0,1.0,2/5,33.85%,CACNA1G;CACNA1C
prerank,GO_Biological_Process_2021__chromatin remodeling (GO:0006338),-0.3391734436569971,-0.8198073743050143,0.6923076923076923,1.0,1.0,10/92,11.08%,MYB;HDAC5;HDAC1;INO80;ZBTB7A;HMGA2;BAZ1B;SUV39H2;SMARCA4;KDM4B
prerank,GO_Biological_Process_2021__positive regulation of leukocyte apoptotic process (GO:2000108),0.5113768511770269,0.8196504015698493,0.7142857142857143,1.0,1.0,3/8,28.04%,PIK3CB;LYN;PIK3CD
prerank,PanglaoDB_Augmented_2021__Ionocytes,0.3598492210270768,0.8195294238439298,0.8055555555555556,1.0,1.0,16/67,16.35%,DNAH3;VWA2;FUT2;CCDC60;EXPH5;TFCP2L1;TEX26;ATP12A;MYO5B;IL20RA;DNAH7;MUC4;APOBEC4;ATP1B1;CFAP65;MROH9
prerank,GO_Biological_Process_2021__reelin-mediated signaling pathway (GO:0038026),-0.5059284438255461,-0.819390639942866,0.6486486486486487,1.0,1.0,3/5,16.42%,VLDLR;LRP8;RELN
prerank,GO_Biological_Process_2021__protein localization to cell surface (GO:0034394),0.42625140228925074,0.8192591070178443,0.7377049180327869,1.0,1.0,1/24,5.19%,FBLN5
prerank,GO_Biological_Process_2021__nucleosome organization (GO:0034728),0.3818348701511019,0.8191489100495122,0.7051282051282052,1.0,1.0,8/61,13.12%,H3-3A;POLE3;SMARCE1;SPTY2D1;H1-2;NAP1L2;H2BC18;ACTR6
prerank,GO_Biological_Process_2021__negative regulation of reactive oxygen species metabolic process (GO:2000378),-0.4549985940647193,-0.8191298149564703,0.6176470588235294,1.0,1.0,9/17,22.39%,PLIN5;SLC30A10;ABCD1;TRAP1;SIRT2;PRKN;ABCD2;PPARA;AATF
prerank,GO_Biological_Process_2021__glucose import (GO:0046323),0.5098287210175965,0.8190758339082879,0.6515151515151515,1.0,1.0,3/8,22.72%,SLC2A1;SLC5A2;SORT1
prerank,GO_Biological_Process_2021__negative regulation of signal transduction (GO:0009968),-0.2909312890363464,-0.8189724935205235,0.9545454545454546,1.0,1.0,35/198,14.60%,UBASH3B;PTPRT;SULF2;PID1;SPRY4;RGS14;NFATC1;TRABD2A;APLN;RITA1;TCIM;SFRP1;PTCH1;PRKCD;HMGXB4;BCL2;PLIN5;TYRO3;CILP;ZBTB7A;SPRY3;SEMA6A;CREB3L1;BEND6;RGS2;NOG;EGFR;KIF7;SPRY1;CACTIN;RPGRIP1L;KIF26A;IRS1;PTPN1;EPN2
prerank,GO_Biological_Process_2021__regulation of cell-substrate adhesion (GO:0010810),-0.3462623072053636,-0.8189491941713396,0.78125,1.0,1.0,5/37,10.63%,NPNT;PDPN;SPOCK1;GCNT2;RSU1
prerank,PanglaoDB_Augmented_2021__Enteroendocrine Cells,0.35156045175285994,0.8189451469634759,0.8045977011494253,1.0,1.0,8/114,8.01%,NPY;ENPP2;MC4R;TRPA1;ASXL3;SYT4;SOWAHA;CPE
prerank,GO_Biological_Process_2021__ventricular cardiac muscle cell action potential (GO:0086005),0.4442322221157129,0.8186655388720802,0.7,1.0,1.0,2/15,2.82%,CAV3;KCNE2
prerank,GO_Biological_Process_2021__Wnt signaling pathway (GO:0016055),-0.3354274527368412,-0.8182979318085404,0.72,1.0,1.0,4/82,5.81%,GPC4;LEF1;SFRP1;PORCN
prerank,GO_Biological_Process_2021__endothelial cell chemotaxis (GO:0035767),-0.47966085804240133,-0.8182024159024031,0.5806451612903226,1.0,1.0,3/8,18.40%,NRP1;NR4A1;CCN3
prerank,GO_Biological_Process_2021__coenzyme A metabolic process (GO:0015936),-0.4240069380902975,-0.8181312340817539,0.6470588235294118,1.0,1.0,3/14,8.04%,DCAKD;NUDT7;CROT
prerank,GO_Biological_Process_2021__enteric nervous system development (GO:0048484),0.5230098713455272,0.8178172217459755,0.7971014492753623,1.0,1.0,1/7,4.72%,SOX10
prerank,GO_Biological_Process_2021__positive regulation of receptor recycling (GO:0001921),-0.4996120404266878,-0.8177278682881481,0.6756756756756757,1.0,1.0,2/8,14.47%,ECE1;VAMP3
prerank,GO_Biological_Process_2021__carnitine shuttle (GO:0006853),0.47319105241066284,0.817726991860541,0.6833333333333333,1.0,1.0,2/10,15.13%,PRKAB2;THRSP
prerank,GO_Biological_Process_2021__negative regulation of B cell activation (GO:0050869),-0.4447124023483655,-0.8176867613245232,0.6756756756756757,1.0,1.0,3/13,8.01%,INHA;SFRP1;ID2
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide biosynthetic process (GO:1900373),-0.4862073954652327,-0.8174805545843308,0.7045454545454546,1.0,1.0,1/10,1.84%,PID1
prerank,GO_Biological_Process_2021__regulation of lipase activity (GO:0060191),-0.4624548463082111,-0.817400907563954,0.6829268292682927,1.0,1.0,2/10,7.02%,LMF1;PLIN5
prerank,GO_Biological_Process_2021__negative regulation of immune effector process (GO:0002698),-0.4357646810928727,-0.8173228123620244,0.7073170731707317,1.0,1.0,2/11,19.91%,ENPP3;RC3H1
prerank,GO_Biological_Process_2021__nucleobase catabolic process (GO:0046113),0.5084248138947566,0.8172232892873545,0.734375,1.0,1.0,4/7,39.29%,DPYS;DPYD;CRMP1;DPYSL2
prerank,GO_Biological_Process_2021__response to interferon-alpha (GO:0035455),-0.4114584788952345,-0.8172035335981299,0.7096774193548387,1.0,1.0,1/12,4.10%,TPR
prerank,GO_Biological_Process_2021__microtubule anchoring (GO:0034453),-0.4006589620049027,-0.8171704686247925,0.7368421052631579,1.0,1.0,4/12,27.50%,PCM1;GCC2;SAXO2;DAG1
prerank,GO_Biological_Process_2021__negative regulation of keratinocyte proliferation (GO:0010839),0.5371665067803042,0.8171600374876239,0.7580645161290323,1.0,1.0,3/7,21.69%,FGFR2;KLF9;SNAI2
prerank,GO_Biological_Process_2021__cardiac muscle tissue morphogenesis (GO:0055008),0.45975615186442553,0.8171497091854019,0.7619047619047619,1.0,1.0,7/17,13.78%,NOTCH1;ZFPM1;ACTC1;MYBPC3;FGFR2;SMAD7;TGFB1
prerank,GO_Biological_Process_2021__regulation of intracellular pH (GO:0051453),-0.3717851014144178,-0.8170849468163894,0.7586206896551724,1.0,1.0,2/31,2.19%,CA2;SLC9A8
prerank,GO_Biological_Process_2021__inner dynein arm assembly (GO:0036159),0.5363378371558222,0.8170487192415546,0.7962962962962963,1.0,1.0,3/8,20.11%,CCDC39;DNAH7;DNAI3
prerank,GO_Biological_Process_2021__regulation of sprouting angiogenesis (GO:1903670),0.3857966873640794,0.8170053236118312,0.7121212121212122,1.0,1.0,3/28,8.69%,ADAMTS9;ITGA5;EPN1
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway (GO:2001242),0.40838276447923105,0.8168647426962748,0.7678571428571429,1.0,1.0,12/40,22.25%,BOK;BCAP31;SIAH1;DAPK2;HERPUD1;BCL2L2;PLAUR;PINK1;RTKN2;BCL2L1;BAD;CYLD
prerank,GO_Biological_Process_2021__phosphatidylinositol-mediated signaling (GO:0048015),0.35537616586858034,0.8166285664362033,0.8356164383561644,1.0,1.0,11/64,18.79%,PDGFRB;PLCH1;PIK3R5;CD160;PLCD3;PLCL1;HTR2B;PIK3C2G;PTAFR;PLCD1;INPP5F
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell migration (GO:0010634),0.3644862079900823,0.8162875592113793,0.7361111111111112,1.0,1.0,6/77,11.48%,ENPP2;RREB1;AGT;DOCK1;RHOB;PLCG2
prerank,GO_Biological_Process_2021__double-strand break repair (GO:0006302),-0.29404919597990864,-0.8162131830098651,0.9166666666666666,1.0,1.0,23/149,13.43%,BRCA2;XRCC4;DCLRE1B;POLL;PARP2;SAMHD1;HUS1;BRCC3;ERCC1;INO80;POLM;BAZ1B;SMARCAL1;RFWD3;XRCC6;SEM1;KDM4B;RAD51B;HMGB2;PALB2;SPIDR;XRCC3;YY1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor production (GO:0032680),-0.3289442947853854,-0.8155601733428904,0.8333333333333334,1.0,1.0,12/73,8.50%,EPHB2;IFIH1;IGF1;RASGRP1;AZU1;SPHK2;TLR1;CIDEA;FOXP1;HSPB1;NR1H4;STAT3
prerank,GO_Biological_Process_2021__pre-mRNA cleavage required for polyadenylation (GO:0098789),0.46857430208006257,0.8153680396404609,0.6666666666666666,1.0,1.0,4/11,14.05%,CSTF2T;NCBP1;NCBP2;FIP1L1
prerank,GO_Biological_Process_2021__regulation of monocyte chemotaxis (GO:0090025),0.4536960078984642,0.8146010140859081,0.711864406779661,1.0,1.0,2/16,3.22%,CCL5;PLA2G7
prerank,GO_Biological_Process_2021__transcription elongation from RNA polymerase II promoter (GO:0006368),-0.3509756496791386,-0.8145845381694214,0.71875,1.0,1.0,16/62,20.90%,ERCC2;GTF2H2;IWS1;CCNH;POLR2G;SSRP1;GTF2F1;POLR2C;POLR2L;NELFA;GTF2H5;RTF1;ERCC3;SETD2;NELFE;CCNT1
prerank,GO_Biological_Process_2021__regulation of protein glycosylation (GO:0060049),-0.4737165122269896,-0.8144790256493772,0.6176470588235294,1.0,1.0,2/7,16.83%,CHP1;FKTN
prerank,GO_Biological_Process_2021__positive regulation of reproductive process (GO:2000243),-0.40252121683660347,-0.8144060725800286,0.7105263157894737,1.0,1.0,6/24,11.09%,TACR1;LHFPL2;PDE3A;ANKRD31;VIP;SIRT2
prerank,PanglaoDB_Augmented_2021__Ependymal Cells,-0.3018697508110808,-0.8143132676213642,0.8461538461538461,1.0,1.0,16/94,13.26%,MYB;PTPRT;CFAP221;CFAP47;CROCC;CFAP61;CFAP52;RSPH1;DNAH2;FAM216B;NWD1;SCGB1A1;TRIM71;CFAP100;C11ORF97;MYO16
prerank,GO_Biological_Process_2021__regulation of epithelial cell apoptotic process (GO:1904035),0.5409861921535548,0.8142082461035598,0.7966101694915254,1.0,1.0,1/8,4.57%,BOK
prerank,GO_Biological_Process_2021__protein stabilization (GO:0050821),0.3338212222182722,0.81419398521732,0.8433734939759037,1.0,1.0,20/154,17.31%,MSX1;WFS1;TCP1;C10ORF90;SYVN1;GBA3;LAMP2;HIP1R;CDC37L1;PPARGC1A;RPS7;SMAD7;STXBP4;CCT6A;USP13;CCT8;ATP1B1;NLK;PINK1;PYHIN1
prerank,GO_Biological_Process_2021__positive regulation of canonical Wnt signaling pathway (GO:0090263),0.3472302308288464,0.8139893337238826,0.7777777777777778,1.0,1.0,17/114,22.80%,GPC5;SCEL;SFRP4;PSMB6;FGFR2;ATP6AP2;TGFB1;PSMA3;DAAM2;LGR6;PSMB8;RNF220;UBR5;DKK2;LRRK2;PPM1A;PSMA5
prerank,GO_Biological_Process_2021__ribosome disassembly (GO:0032790),0.5161359052923254,0.8138583161656877,0.7868852459016393,1.0,1.0,4/7,37.85%,GFM2;MTIF2;DENR;MCTS1
prerank,GO_Biological_Process_2021__calcium-mediated signaling (GO:0019722),-0.3204893004758227,-0.8137443055019326,0.9,1.0,1.0,8/67,10.97%,SELP;KDR;AZU1;P2RY11;MCTP1;ADGRL1;ACKR2;CXCR5
prerank,GO_Biological_Process_2021__positive regulation of RIG-I signaling pathway (GO:1900246),-0.4820987762982515,-0.8137366173836517,0.6585365853658537,1.0,1.0,1/7,5.37%,DDX60
prerank,GO_Biological_Process_2021__glucose transmembrane transport (GO:1904659),-0.4008745806642753,-0.8136520627223833,0.6774193548387096,1.0,1.0,4/12,13.82%,SLC2A9;SLC2A11;SLC2A14;HNF1A
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell contraction (GO:0086004),-0.37863142669407035,-0.8136000246403173,0.7142857142857143,1.0,1.0,3/22,7.58%,PKP2;FGF13;RANGRF
prerank,GO_Biological_Process_2021__negative regulation of myeloid cell differentiation (GO:0045638),0.43711118065259097,0.8135722728378053,0.7846153846153846,1.0,1.0,7/16,36.86%,MAFB;CDK6;ZFP36;HSPA9;ZFP36L1;PTK2B;PAF1
prerank,GO_Biological_Process_2021__endodermal cell fate commitment (GO:0001711),0.5255866809499621,0.8134036832203998,0.7288135593220338,1.0,1.0,1/7,12.63%,NANOG
prerank,GO_Biological_Process_2021__body fluid secretion (GO:0007589),0.4848704057017045,0.8133881116978992,0.7,1.0,1.0,2/11,4.14%,ZBTB7B;PRLR
prerank,GO_Biological_Process_2021__regulation of miRNA mediated inhibition of translation (GO:1905616),-0.4962869400536587,-0.8130425812074094,0.7441860465116279,1.0,1.0,2/7,10.28%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__positive regulation of miRNA mediated inhibition of translation (GO:1905618),-0.4962869400536587,-0.8130425812074094,0.7441860465116279,1.0,1.0,2/7,10.28%,STAT3;EIF4G1
prerank,GO_Biological_Process_2021__axonogenesis (GO:0007409),0.32548172892680244,0.8129977702884477,0.8588235294117647,1.0,1.0,23/218,14.74%,LAMA2;EPHA1;PLA2G10;SEMA3D;EMB;NOTCH1;SPTBN5;ADGRB1;UNC5A;ARTN;LAMA1;GAB1;SIAH1;CNTN2;MYPN;CDK5R1;NOTCH3;FGFR2;ATL1;RAB8A;SEMA3F;SEMA3A;LGR6
prerank,GO_Biological_Process_2021__negative regulation of histone modification (GO:0031057),-0.4160759539934809,-0.8129474507010138,0.7906976744186046,1.0,1.0,2/13,6.17%,AASS;SPHK2
prerank,GO_Biological_Process_2021__negative regulation of epidermal growth factor-activated receptor activity (GO:0007175),-0.46006649795084187,-0.8127686205333197,0.7142857142857143,1.0,1.0,1/11,2.64%,VPS25
prerank,GO_Biological_Process_2021__negative regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902548),0.4678110336263116,0.8126873965947197,0.7611940298507462,1.0,1.0,4/9,23.47%,DAB2IP;DCN;ATP2B4;PIK3CB
prerank,GO_Biological_Process_2021__fatty acid oxidation (GO:0019395),0.3734598706971781,0.8126836027821317,0.7368421052631579,1.0,1.0,13/50,22.06%,HSD17B10;ALOX12;ADIPOR2;PPARGC1A;ECI2;PECR;ACOX1;ADH5;ACADL;DECR1;ACAA2;ALDH3A2;ACAT1
prerank,GO_Biological_Process_2021__regulation of natural killer cell activation (GO:0032814),-0.5002538407809272,-0.8124374039474965,0.696969696969697,1.0,1.0,3/7,15.47%,TICAM1;LEP;PIBF1
prerank,GO_Biological_Process_2021__depurination (GO:0045007),0.497023422006952,0.8124331134469644,0.7377049180327869,1.0,1.0,4/8,37.08%,TERF2IP;MPG;OGG1;TINF2
prerank,GO_Biological_Process_2021__RNA catabolic process (GO:0006401),0.3848864305623693,0.8124298934555536,0.8169014084507042,1.0,1.0,11/39,28.84%,ISG20;NCBP1;RNASEH2C;DCP2;ERN1;RIDA;AGO4;SIDT2;DXO;NUDT16L1;ZFP36
prerank,GO_Biological_Process_2021__positive regulation of cardiac epithelial to mesenchymal transition (GO:0062043),0.508683832124501,0.8123540122743681,0.7213114754098361,1.0,1.0,1/7,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__mismatch repair (GO:0006298),0.42443553250650007,0.8121417937117635,0.7575757575757576,1.0,1.0,3/24,13.59%,TDG;PCNA;RPA3
prerank,GO_Biological_Process_2021__anion transmembrane transport (GO:0098656),0.35943306607732634,0.8117150945692634,0.8181818181818182,1.0,1.0,6/58,11.42%,SLC13A4;SLC23A1;LRRC8D;PRAF2;SLC25A18;SFXN3
prerank,GO_Biological_Process_2021__regulation of astrocyte differentiation (GO:0048710),0.513181489204676,0.8106910884230212,0.7846153846153846,1.0,1.0,1/7,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of metallopeptidase activity (GO:1905048),-0.550162001275426,-0.8106741885156604,0.8285714285714286,1.0,1.0,2/6,3.74%,SVBP;CLDN4
prerank,GO_Biological_Process_2021__actomyosin structure organization (GO:0031032),-0.3266982217808242,-0.8105446114857258,0.9310344827586207,1.0,1.0,11/65,11.68%,ITGB5;MYH14;PDLIM1;TMOD4;CDC42BPB;KCTD13;MYH3;FHDC1;MYOM2;CSRP2;PHACTR1
prerank,MSigDB_Hallmark_2020__p53 Pathway,0.33588680507050717,0.8103007364856004,0.8441558441558441,1.0,1.0,23/168,14.35%,AEN;SLC7A11;CD82;NOTCH1;CSRNP2;GM2A;CCND2;GPX2;EPHX1;HINT1;TGFA;LDHB;MXD1;H1-2;TCN2;RPL36;CGRRF1;CDK5R1;FAS;STOM;PCNA;TGFB1;HSPA4L
prerank,GO_Biological_Process_2021__endocytic recycling (GO:0032456),-0.34613023670822496,-0.8102284093016028,0.8275862068965517,1.0,1.0,11/49,17.23%,CCDC22;VPS53;EHD4;PTPN23;RAB7A;SNF8;STX6;DENND1A;ENTR1;RAB11FIP3;EIPR1
prerank,GO_Biological_Process_2021__regulation of exit from mitosis (GO:0007096),-0.35176514937063935,-0.8101385738270961,0.8064516129032258,1.0,1.0,4/33,11.09%,CDC14B;CDC26;CDC23;SIRT2
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomere lengthening (GO:1904356),-0.39861804140292806,-0.8100156088944608,0.75,1.0,1.0,5/16,25.61%,SMG6;NAF1;ATM;PARP1;SLX4
prerank,GO_Biological_Process_2021__regulation of transmission of nerve impulse (GO:0051969),-0.5146422312045027,-0.8099967827454991,0.8108108108108109,1.0,1.0,1/5,4.71%,HCRT
prerank,GO_Biological_Process_2021__T cell activation (GO:0042110),0.3719350849630589,0.8097749447832547,0.7466666666666667,1.0,1.0,5/46,5.81%,ITK;CD4;CD8A;PTPRC;NHEJ1
prerank,GO_Biological_Process_2021__tetrapyrrole metabolic process (GO:0033013),0.43769945485410844,0.809761480864751,0.7246376811594203,1.0,1.0,4/17,13.45%,AMN;CBLIF;TCN2;PRSS3
prerank,GO_Biological_Process_2021__cobalamin metabolic process (GO:0009235),0.43769945485410844,0.809761480864751,0.7246376811594203,1.0,1.0,4/17,13.45%,AMN;CBLIF;TCN2;PRSS3
prerank,GO_Biological_Process_2021__mitochondrial protein catabolic process (GO:0035694),0.5092801596018568,0.8097001758910374,0.7272727272727273,1.0,1.0,1/6,8.17%,BNIP3
prerank,GO_Biological_Process_2021__protein palmitoylation (GO:0018345),0.41204940608213636,0.8096533075075708,0.7702702702702703,1.0,1.0,4/30,9.33%,ZDHHC22;ZDHHC11;HHAT;ZDHHC6
prerank,GO_Biological_Process_2021__integrin activation (GO:0033622),0.5061391224378724,0.8094627362277471,0.7346938775510204,1.0,1.0,1/7,15.62%,FN1
prerank,GO_Biological_Process_2021__regulation of mitochondrial gene expression (GO:0062125),-0.4567100748091925,-0.809162847797564,0.75,1.0,1.0,3/8,25.26%,TSFM;MTG2;ALKBH1
prerank,GO_Biological_Process_2021__interleukin-35-mediated signaling pathway (GO:0070757),0.48419545317297374,0.8090538061917774,0.6779661016949152,1.0,1.0,2/10,9.09%,STAT4;STAT1
prerank,GO_Biological_Process_2021__regulation of SMAD protein signal transduction (GO:0060390),-0.4259819393514689,-0.808899032173309,0.6363636363636364,1.0,1.0,7/19,18.74%,WWTR1;BMP6;CILP;TGFB3;TGFBR1;CCN3;FAM89B
prerank,GO_Biological_Process_2021__positive regulation of cytokine production involved in inflammatory response (GO:1900017),-0.42642637850344767,-0.808788871375047,0.7111111111111111,1.0,1.0,2/9,8.50%,TICAM1;STAT3
prerank,GO_Biological_Process_2021__positive regulation of macromolecule metabolic process (GO:0010604),-0.2655912830577758,-0.8087597561729434,1.0,1.0,1.0,30/268,12.18%,BMP7;ADAM19;FGFR4;LEF1;HMGN5;GREM1;PID1;EPHB2;SLC22A2;IGF1;TICAM1;AZU1;FGF1;AMH;ECE1;ANKRD31;MAPK7;ETS1;BMP6;ID2;STAT3;HMGA2;POU3F1;DRD1;DNMT1;CLU;SLC24A3;NOG;NGF;NWD1
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process (GO:0045732),0.3466916637530173,0.808533079072272,0.7654320987654321,1.0,1.0,8/70,16.76%,C4BPB;TRIM32;CDKN1B;HECW1;MSN;TIPARP;VPS35;DAB2IP
prerank,GO_Biological_Process_2021__negative regulation of cellular response to hypoxia (GO:1900038),-0.4848866657308276,-0.8084950780611955,0.6744186046511628,1.0,1.0,3/5,27.57%,DDAH1;NOL3;ENO1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, initiation (GO:2000142)",-0.33909781258083543,-0.8084115701981053,0.8484848484848485,1.0,1.0,5/54,9.47%,LEF1;MED30;MED15;CBFB;CSF1R
prerank,GO_Biological_Process_2021__limb morphogenesis (GO:0035108),0.45520415056278085,0.8083547578924901,0.7164179104477612,1.0,1.0,1/15,2.04%,GLI3
prerank,GO_Biological_Process_2021__cellular response to metal ion (GO:0071248),0.3478047491028033,0.8082124430706635,0.8125,1.0,1.0,30/102,24.65%,NEUROD2;SYT2;SYT4;CDKN1B;BNIP3;CPNE5;PLCG2;ECT2;CAMK2D;SYT15;LGMN;SYT9;GLRA1;ITPKB;SYT13;CRHBP;MCOLN1;B2M;HVCN1;LRRK2;DMTN;ADGRV1;MEF2A;CACNA1H;PRNP;TF;MT1M;SUMO1;CPNE9;RYR3
prerank,GO_Biological_Process_2021__positive regulation of Wnt signaling pathway (GO:0030177),0.3446163155758788,0.808116629723489,0.7916666666666666,1.0,1.0,22/133,22.80%,RSPO2;GPC5;DEPDC1B;SCEL;SFRP4;PSMB6;FGFR2;RSPO3;ATP6AP2;TGFB1;PSMA3;DAAM2;LGR6;PSMB8;RNF220;UBR5;TLR2;DKK2;LRRK2;PPM1A;ATP6V1C2;PSMA5
prerank,GO_Biological_Process_2021__negative regulation of DNA-dependent DNA replication (GO:2000104),0.44882752431553724,0.8080343961349353,0.7272727272727273,1.0,1.0,2/13,12.01%,GMNN;DONSON
prerank,GO_Biological_Process_2021__granulocyte chemotaxis (GO:0071621),0.45066224264330523,0.8079064222421679,0.7428571428571429,1.0,1.0,1/21,2.27%,CCL5
prerank,GO_Biological_Process_2021__negative regulation of NF-kappaB transcription factor activity (GO:0032088),0.3633023758206462,0.8078511134935358,0.7887323943661971,1.0,1.0,5/61,8.55%,PTGIS;NLRP2B;CYP1B1;CARD8;CMKLR1
prerank,GO_Biological_Process_2021__Golgi organization (GO:0007030),-0.33800004907068126,-0.8068137014193415,0.7222222222222222,1.0,1.0,25/111,19.26%,FBXW8;GOLGA8M;GOLGA8H;PI4K2A;TMED3;NSFL1C;ATP8B4;GOLGA8A;GOLGA8B;FHDC1;GOLGA8N;UBXN2A;PRMT5;PLEKHM2;STX6;ATL2;PLK3;TMED5;VTI1A;GCC2;VRK1;RAB2A;PLK5;NPLOC4;TMED4
prerank,GO_Biological_Process_2021__regulation of cell growth (GO:0001558),0.3252995938760688,0.8067927667986214,0.8433734939759037,1.0,1.0,15/170,10.22%,MSX1;TMEM97;H3-3A;INHBA;TRIM32;PSRC1;CDKN2D;AGT;OSGIN2;NCBP1;NAIF1;CDKN1B;KIF14;CGRRF1;CRLF3
prerank,GO_Biological_Process_2021__glycerolipid catabolic process (GO:0046503),-0.3801814400423738,-0.8067617738169146,0.6388888888888888,1.0,1.0,3/15,11.02%,LYPLA2;GDE1;SMPD4
prerank,GO_Biological_Process_2021__superoxide anion generation (GO:0042554),0.47277963544780627,0.8066926959417602,0.7230769230769231,1.0,1.0,3/9,7.36%,NOX5;NOX1;ALOX12
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell proliferation (GO:2000564)",-0.5136588293359199,-0.8065238889100457,0.673469387755102,1.0,1.0,1/6,2.07%,SH3RF1
prerank,GO_Biological_Process_2021__adenylate cyclase-activating adrenergic receptor signaling pathway (GO:0071880),0.47934048160426057,0.8063828971297008,0.7794117647058824,1.0,1.0,2/12,13.12%,ADRB1;DRD3
prerank,GO_Biological_Process_2021__positive regulation of histone ubiquitination (GO:0033184),0.5228574394753105,0.8063660640368863,0.7413793103448276,1.0,1.0,1/5,22.71%,KDM1A
prerank,GO_Biological_Process_2021__regulation of gene silencing by miRNA (GO:0060964),-0.3489353641476163,-0.806213330185421,0.8181818181818182,1.0,1.0,12/62,15.67%,NUP210;TPR;WTIP;NUP37;STAT3;POLR2G;ELAVL1;EIF4G1;TRIM71;POLR2C;POLR2L;NUP42
prerank,GO_Biological_Process_2021__regulation of ATP biosynthetic process (GO:2001169),-0.46616582972417375,-0.8060139923150524,0.7380952380952381,1.0,1.0,2/13,6.17%,PID1;SPHK2
prerank,GO_Biological_Process_2021__protein localization to basolateral plasma membrane (GO:1903361),0.4749910314546746,0.8059730455788645,0.7333333333333333,1.0,1.0,4/6,31.83%,LIN7C;PDZD11;AP4M1;LIN7B
prerank,GO_Biological_Process_2021__oligosaccharide biosynthetic process (GO:0009312),0.4367250789796804,0.8058513420481899,0.7272727272727273,1.0,1.0,2/16,5.51%,FUT2;B3GALT1
prerank,GO_Biological_Process_2021__positive regulation of cytosolic calcium ion concentration (GO:0007204),0.34569103969549786,0.8058095322199684,0.8289473684210527,1.0,1.0,10/93,8.55%,C3AR1;CALCR;P2RY1;CAV3;TBXA2R;ACKR3;BCAP31;PTGER3;KNG1;CMKLR1
prerank,GO_Biological_Process_2021__regulation of fat cell differentiation (GO:0045598),-0.3311848818399736,-0.8055202445114551,0.7777777777777778,1.0,1.0,8/64,11.09%,TRIB2;ADIRF;SFRP1;WWTR1;ID2;RORA;SYAP1;SIRT2
prerank,GO_Biological_Process_2021__retina homeostasis (GO:0001895),0.4657335059087903,0.805420342682626,0.803921568627451,1.0,1.0,4/18,23.13%,CNGB1;SLC28A2;B2M;TF
prerank,GO_Biological_Process_2021__amino-acid betaine metabolic process (GO:0006577),-0.49361181430390116,-0.8053903530854055,0.6388888888888888,1.0,1.0,3/5,15.07%,CROT;CPT1A;BHMT2
prerank,GO_Biological_Process_2021__interleukin-23-mediated signaling pathway (GO:0038155),0.5235480431944224,0.8052988044724365,0.75,1.0,1.0,1/6,7.76%,STAT4
prerank,PanglaoDB_Augmented_2021__Basal Cells,-0.33052341311094613,-0.805274590015956,0.76,1.0,1.0,19/67,13.60%,BMP7;SLC25A37;MT1E;LAMB3;SDC4;CLDN4;ADIRF;BCL2;HSPB1;ALDH1A3;LAMA3;DNPH1;ACADVL;SH3RF2;ALKBH7;MST1R;PERP;TSPAN1;DPP7
prerank,GO_Biological_Process_2021__negative regulation of neuron projection development (GO:0010977),0.36183226570665405,0.8049510485510344,0.7333333333333333,1.0,1.0,3/52,5.81%,LRP4;OMG;FKBP4
prerank,GO_Biological_Process_2021__peptidyl-lysine hydroxylation (GO:0017185),-0.4886103329844175,-0.8048539002915329,0.6578947368421053,1.0,1.0,1/7,6.02%,P3H3
prerank,GO_Biological_Process_2021__proteasomal protein catabolic process (GO:0010498),0.31496014224188845,0.8047371628177921,0.9358974358974359,1.0,1.0,37/189,28.99%,ENC1;RCN3;SYVN1;KBTBD6;SIAH1;KIF14;PSMB6;PCBP2;RNF122;RNF139;HECW1;PSMA3;PSMB8;DERL1;CCDC47;SPSB1;IFI27;TNFAIP1;KBTBD7;PLAA;RNF187;RNF41;KCTD10;SPSB3;PSMA5;SPSB2;FEM1C;FEM1B;RNF185;CUL4B;ERLEC1;KCTD2;CRBN;MARCHF6;PSMC6;TRIM9;PRAME
prerank,GO_Biological_Process_2021__regulation of anion transport (GO:0044070),-0.5420657137383627,-0.8042410429443345,0.7142857142857143,1.0,1.0,1/5,2.01%,CA2
prerank,GO_Biological_Process_2021__regulation of mitochondrial membrane potential (GO:0051881),-0.3411349016650198,-0.8041621476366461,0.875,1.0,1.0,4/36,10.44%,PID1;SLC25A33;BCL2;ABCD1
prerank,GO_Biological_Process_2021__regulation of protein tyrosine kinase activity (GO:0061097),-0.4028289190881231,-0.8040954385571724,0.7391304347826086,1.0,1.0,1/33,0.27%,NOX4
prerank,GO_Biological_Process_2021__transport along microtubule (GO:0010970),-0.421062585511706,-0.8040013067145421,0.625,1.0,1.0,8/13,32.70%,BAG3;APBA1;CLIP3;BORCS5;COPG1;COPG2;DYNC1I2;DYNC1I1
prerank,GO_Biological_Process_2021__histone H2A ubiquitination (GO:0033522),-0.413374790903834,-0.8039979279759137,0.7297297297297297,1.0,1.0,4/17,17.78%,RING1;PCGF1;DTX3L;DDB2
prerank,GO_Biological_Process_2021__regulation of cellular senescence (GO:2000772),-0.3675185901920768,-0.8039958295474435,0.7692307692307693,1.0,1.0,4/26,9.75%,VASH1;NEK6;HMGA2;SLC30A10
prerank,GO_Biological_Process_2021__interleukin-2-mediated signaling pathway (GO:0038110),0.4974124322457465,0.8039259189183449,0.7272727272727273,1.0,1.0,3/8,28.58%,STAT5A;SHC1;SYK
prerank,GO_Biological_Process_2021__cellular response to interleukin-2 (GO:0071352),0.4974124322457465,0.8039259189183449,0.7272727272727273,1.0,1.0,3/8,28.58%,STAT5A;SHC1;SYK
prerank,GO_Biological_Process_2021__cellular response to hexose stimulus (GO:0071331),-0.40944441597077535,-0.8034011214792222,0.7407407407407407,1.0,1.0,1/21,2.40%,UNC13B
prerank,PanglaoDB_Augmented_2021__Thymocytes,0.3772743890109303,0.803287803676071,0.8059701492537313,1.0,1.0,13/45,9.88%,GNLY;CD4;CD8A;NOTCH1;PTPRC;PIK3R5;GMFG;TSHR;CORO1A;TAGAP;ARHGAP9;WAS;ARHGAP25
prerank,GO_Biological_Process_2021__regulation of histone deacetylase activity (GO:1901725),-0.49362548726862215,-0.8030842425738327,0.7631578947368421,1.0,1.0,1/7,6.17%,SPHK2
prerank,GO_Biological_Process_2021__negative regulation of B cell proliferation (GO:0030889),-0.49512092126108304,-0.8030793643289822,0.7105263157894737,1.0,1.0,4/5,22.82%,ATM;RC3H1;TNFRSF21;BLK
prerank,GO_Biological_Process_2021__regulation of potassium ion import (GO:1903286),0.5496212514267378,0.8030576128864614,0.8269230769230769,1.0,1.0,2/7,22.94%,ATP1B1;DLG1
prerank,PanglaoDB_Augmented_2021__Trigeminal Neurons,0.3277389415033744,0.8030405564176092,0.8607594936708861,1.0,1.0,14/135,12.60%,TMEM35A;CALCB;ASXL3;PLP1;SCN9A;FKBP1B;CLGN;SYT4;NKAIN2;SCN7A;CNTN2;NEFM;C11ORF87;ATL1
prerank,GO_Biological_Process_2021__hematopoietic stem cell proliferation (GO:0071425),-0.4402727650985663,-0.8030092518802249,0.6944444444444444,1.0,1.0,1/10,1.60%,RUNX1
prerank,GO_Biological_Process_2021__peptidyl-proline hydroxylation (GO:0019511),0.46019878595792485,0.8028424360556068,0.7714285714285715,1.0,1.0,1/9,18.08%,P4HA3
prerank,GO_Biological_Process_2021__negative regulation of cellular metabolic process (GO:0031324),0.39827692750508803,0.8028155041465903,0.7384615384615385,1.0,1.0,5/29,19.18%,BTN2A2;LRPAP1;BRCA1;PINK1;RIN3
prerank,GO_Biological_Process_2021__regulation of skeletal muscle satellite cell proliferation (GO:0014842),-0.5193634863221079,-0.8027019776826457,0.7368421052631579,1.0,1.0,3/6,19.75%,CFLAR;ANGPT1;AKIRIN1
prerank,MSigDB_Hallmark_2020__Pperoxisome,0.3296511004936357,0.802699105058375,0.8375,1.0,1.0,25/95,27.18%,ALDH1A1;HSD11B2;ACSL5;SOD2;SIAH1;ABCB1;ECI2;YWHAH;ABCB4;ACOX1;PEX11B;DIO1;HSD17B11;DHCR24;PEX11A;SLC25A19;ESR2;SLC25A4;PEX5;RETSAT;MVP;SEMA3C;ACSL4;IDH1;ISOC1
prerank,GO_Biological_Process_2021__hexose metabolic process (GO:0019318),0.3935599409483105,0.8024756073445708,0.7301587301587301,1.0,1.0,5/30,15.35%,CHST1;KHK;ALDOB;GHRL;KCNJ11
prerank,GO_Biological_Process_2021__positive regulation of protein polymerization (GO:0032273),0.39000373154937945,0.8023638089065508,0.7794117647058824,1.0,1.0,4/54,10.75%,CAV3;HCK;PSRC1;CDK5R1
prerank,GO_Biological_Process_2021__regulation of canonical Wnt signaling pathway (GO:0060828),0.3150216322987412,0.80226217231823,0.8271604938271605,1.0,1.0,25/212,18.19%,LRP4;GLI3;ZNF703;GPC5;NOTUM;SCEL;TLE3;SFRP4;PSMB6;NKD2;FGFR2;ATP6AP2;BICC1;TGFB1;KREMEN1;HECW1;TLE6;PSMA3;DAAM2;LGR6;PSMB8;DAB2IP;AMER2;TMEM170B;RNF220
prerank,GO_Biological_Process_2021__negative regulation of protein kinase B signaling (GO:0051898),0.40726510147395073,0.8022518655387066,0.75,1.0,1.0,8/33,23.78%,GPER1;DRD3;TSC2;BANK1;PPP2R5B;PIK3CB;MSTN;NOP53
prerank,GO_Biological_Process_2021__positive regulation of leukocyte proliferation (GO:0070665),-0.4671039877829779,-0.8016634087187865,0.75,1.0,1.0,1/9,9.47%,CSF1R
prerank,GO_Biological_Process_2021__positive regulation of immunoglobulin production (GO:0002639),0.4202920175170689,0.8014266732514301,0.8285714285714286,1.0,1.0,2/22,5.48%,C17ORF99;PTPRC
prerank,GO_Biological_Process_2021__pigment granule transport (GO:0051904),0.4455599590730567,0.8013350964984319,0.72,1.0,1.0,4/13,29.12%,ARL6;RAB11A;MKKS;MREG
prerank,GO_Biological_Process_2021__melanosome transport (GO:0032402),0.4455599590730567,0.8013350964984319,0.72,1.0,1.0,4/13,29.12%,ARL6;RAB11A;MKKS;MREG
prerank,PanglaoDB_Augmented_2021__Nuocytes,0.4185262106934336,0.8010976846233028,0.7611940298507462,1.0,1.0,6/28,11.22%,GNLY;ITK;PTPRC;TAGAP;ARG1;CD6
prerank,PanglaoDB_Augmented_2021__Adipocyte Progenitor Cells,0.3529783400680596,0.8010693793472404,0.7972972972972973,1.0,1.0,11/75,11.19%,TIMP3;GLI3;STAB1;EGFLAM;PDGFRL;IGFBP5;TWIST1;SRPX;TCF7L1;EFEMP1;NOTCH3
prerank,GO_Biological_Process_2021__positive regulation of adenylate cyclase activity (GO:0045762),0.4802771507695216,0.8007331858154394,0.75,1.0,1.0,1/6,14.14%,AKAP5
prerank,GO_Biological_Process_2021__regulation of peptidase activity (GO:0052547),0.441836066655254,0.8006411045429263,0.7377049180327869,1.0,1.0,6/15,18.60%,A2ML1;RCN3;PSMA3;PSMB8;PINK1;FURIN
prerank,GO_Biological_Process_2021__positive regulation of DNA-directed DNA polymerase activity (GO:1900264),0.5234481480592881,0.8002115529468751,0.71875,1.0,1.0,2/8,13.33%,RFC5;PCNA
prerank,GO_Biological_Process_2021__regulation of DNA-directed DNA polymerase activity (GO:1900262),0.5234481480592881,0.8002115529468751,0.71875,1.0,1.0,2/8,13.33%,RFC5;PCNA
prerank,GO_Biological_Process_2021__leucine metabolic process (GO:0006551),-0.4644909825173136,-0.8000280841633539,0.6976744186046512,1.0,1.0,2/7,23.23%,MCCC2;HMGCL
prerank,GO_Biological_Process_2021__chromatin organization (GO:0006325),-0.3275654048389199,-0.7998060678420167,0.92,1.0,1.0,31/118,21.41%,MYB;HDAC5;HDAC1;HIRIP3;INO80;ZBTB7A;HMGA2;BAZ1B;SUV39H2;SMARCA4;KDM4B;DDX11;HMGB2;PHF1;BPTF;SMARCB1;LRWD1;HDAC10;SETDB1;PBRM1;PWWP3A;HMGN1;EHMT1;HMGN2;SETD2;BAZ2B;TADA2A;HDAC11;SAFB;NPM2;HDAC4
prerank,GO_Biological_Process_2021__positive regulation of protein modification process (GO:0031401),0.31877180706395375,0.7996967816043126,0.9113924050632911,1.0,1.0,27/170,22.50%,P2RY1;AGER;CD4;CCND2;RARRES2;FAM20A;TBX1;HGF;VEGFC;FAS;GPER1;PLAUR;TGFB1;CDK2AP1;FAXDC2;PINK1;CHRNA7;NPTN;LIMCH1;FXR1;CD74;TNIK;LRRK2;CALM3;TERF2IP;MUSK;FGF5
prerank,GO_Biological_Process_2021__negative regulation of cholesterol biosynthetic process (GO:0045541),-0.5262375600207292,-0.7993135288394326,0.7692307692307693,1.0,1.0,3/5,20.20%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of cholesterol metabolic process (GO:0090206),-0.5262375600207292,-0.7993135288394326,0.7692307692307693,1.0,1.0,3/5,20.20%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__negative regulation of sterol biosynthetic process (GO:0106119),-0.5262375600207292,-0.7993135288394326,0.7692307692307693,1.0,1.0,3/5,20.20%,APOE;SCAP;ERLIN2
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to oxidative stress (GO:0008631),0.4724722534376191,0.7991687044992771,0.711864406779661,1.0,1.0,1/10,4.87%,CYP1B1
prerank,GO_Biological_Process_2021__skeletal muscle tissue development (GO:0007519),-0.3885820526274426,-0.7988992887189886,0.8484848484848485,1.0,1.0,6/20,9.57%,MYH14;LEMD2;RYR1;CFLAR;SVIL;SELENON
prerank,GO_Biological_Process_2021__protein kinase B signaling (GO:0043491),-0.4385327050039357,-0.7983475214824527,0.7058823529411765,1.0,1.0,4/17,11.09%,KDR;IGF1;TYRO3;SIRT2
prerank,GO_Biological_Process_2021__positive regulation of mitophagy in response to mitochondrial depolarization (GO:0098779),0.48890920598413334,0.7982609143708358,0.7704918032786885,1.0,1.0,2/7,27.10%,PINK1;TOMM7
prerank,GO_Biological_Process_2021__negative regulation of autophagy (GO:0010507),-0.31400952478233574,-0.7980863317340497,0.8387096774193549,1.0,1.0,11/54,11.09%,NRBP2;BCL2;MTMR8;MTMR9;STAT3;KIF25;FOXK1;IL10RA;EIF4G1;DAP;SIRT2
prerank,GO_Biological_Process_2021__replication fork processing (GO:0031297),-0.36334198304620124,-0.7979771032223637,0.696969696969697,1.0,1.0,7/33,13.80%,BRCA2;SAMHD1;SMARCAL1;RFWD3;THOC1;DDX11;BOD1L1
prerank,GO_Biological_Process_2021__lymphocyte proliferation (GO:0046651),0.4448623257070873,0.7979428263343307,0.7540983606557377,1.0,1.0,4/14,18.09%,PTPRC;FLT3;MSN;HELLS
prerank,GO_Biological_Process_2021__molybdopterin cofactor biosynthetic process (GO:0032324),0.547720624677408,0.7978380431028997,0.8,1.0,1.0,4/6,31.36%,MOCS2;MOCOS;MOCS1;NFS1
prerank,PanglaoDB_Augmented_2021__Airway Goblet Cells,0.3758375989540909,0.7977045399877223,0.782608695652174,1.0,1.0,10/41,13.36%,LIPH;SMIM22;FUT2;KLF5;TJP3;GPX2;AP1M2;B3GNT3;GGH;MUC4
prerank,GO_Biological_Process_2021__negative regulation of histone acetylation (GO:0035067),0.47148108153581625,0.7973185922346689,0.7272727272727273,1.0,1.0,5/11,34.22%,BRCA1;TAF7;SET;CTBP1;SPI1
prerank,GO_Biological_Process_2021__negative regulation of cell growth (GO:0030308),-0.291984659210467,-0.7971823899456314,0.8333333333333334,1.0,1.0,8/97,6.17%,GNG4;OSTN;SFRP1;BCL6;TGFB2;RTN4R;FGF13;SPHK2
prerank,GO_Biological_Process_2021__regulation of T cell differentiation (GO:0045580),-0.35874611670802664,-0.7969591170438942,0.7941176470588235,1.0,1.0,3/23,12.12%,RUNX1;CBFB;MDK
prerank,GO_Biological_Process_2021__glandular epithelial cell development (GO:0002068),-0.5072705927565365,-0.7968825576689064,0.6944444444444444,1.0,1.0,2/5,13.91%,BMP6;PAX6
prerank,GO_Biological_Process_2021__aerobic respiration (GO:0009060),0.4250069442237299,0.7967944516555109,0.8305084745762712,1.0,1.0,5/19,29.31%,MTFR1L;UQCRB;SLC25A14;MTFR1;UQCRHL
prerank,GO_Biological_Process_2021__nitric oxide biosynthetic process (GO:0006809),0.4582713775241731,0.7967735660697043,0.6935483870967742,1.0,1.0,7/13,25.57%,CYP1B1;NQO1;ARG2;MTARC2;DDAH2;CYB5B;CYB5R3
prerank,GO_Biological_Process_2021__defense response to Gram-negative bacterium (GO:0050829),-0.3884995308459068,-0.7966857275292327,0.71875,1.0,1.0,2/19,5.70%,SELP;AZU1
prerank,GO_Biological_Process_2021__Ras protein signal transduction (GO:0007265),0.32701835969712567,0.7966303792266776,0.8395061728395061,1.0,1.0,13/122,13.50%,ROPN1B;RREB1;PLEKHG7;WASF1;RIPOR1;WAS;RHOB;EPS8;CELSR1;RIT2;RHOH;ZNF304;BRK1
prerank,GO_Biological_Process_2021__defense response to virus (GO:0051607),0.34270982011979423,0.7966226972421296,0.8441558441558441,1.0,1.0,11/84,9.23%,TRIM5;PLA2G10;OPRK1;PTPRC;ISG20;ZDHHC11;FADD;IFNLR1;BNIP3;STAT1;IFIT3
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress (GO:0070059),0.4359101191650182,0.7962288465297024,0.72,1.0,1.0,5/25,22.15%,ITPR1;CHAC1;DAB2IP;ERN1;ERO1A
prerank,GO_Biological_Process_2021__microglial cell activation (GO:0001774),0.43179765305007994,0.796076198207078,0.7903225806451613,1.0,1.0,1/15,1.74%,AGER
prerank,GO_Biological_Process_2021__microtubule nucleation (GO:0007020),0.41089849479306617,0.7960473832741978,0.7123287671232876,1.0,1.0,2/19,15.01%,TPX2;TUBGCP4
prerank,GO_Biological_Process_2021__heart development (GO:0007507),-0.2999079333509784,-0.7960399475932018,0.875,1.0,1.0,9/111,6.27%,PKP2;BMP7;RBP4;SGCD;HEG1;APLN;PDLIM1;TGFB2;ECE1
prerank,GO_Biological_Process_2021__cell fate commitment involved in formation of primary germ layer (GO:0060795),-0.486323152281737,-0.7958386043446454,0.6739130434782609,1.0,1.0,2/5,25.42%,RTF1;CDC73
prerank,GO_Biological_Process_2021__isopentenyl diphosphate biosynthetic process (GO:0009240),0.5379225007631107,0.7958063966817904,0.7719298245614035,1.0,1.0,4/5,40.59%,MVD;IDI1;PMVK;MVK
prerank,GO_Biological_Process_2021__negative regulation of signaling receptor activity (GO:2000272),0.421934253519959,0.7957256572208646,0.7741935483870968,1.0,1.0,2/19,7.20%,CALCR;GPRC5A
prerank,GO_Biological_Process_2021__negative regulation of lipid kinase activity (GO:0090219),0.5155870250845473,0.7955088701714019,0.7746478873239436,1.0,1.0,2/8,20.36%,DAB2IP;PIP4K2C
prerank,GO_Biological_Process_2021__L-ascorbic acid metabolic process (GO:0019852),0.48516557184592884,0.7954339985435049,0.8032786885245902,1.0,1.0,2/9,8.93%,SLC23A1;SLC2A1
prerank,GO_Biological_Process_2021__positive regulation of glucose metabolic process (GO:0010907),0.4884744421726305,0.7951533588370229,0.7384615384615385,1.0,1.0,1/12,8.34%,PPARGC1A
prerank,GO_Biological_Process_2021__positive regulation of immune response (GO:0050778),-0.3761507024145542,-0.794903447775766,0.7714285714285715,1.0,1.0,6/43,6.17%,MYB;F2RL1;EREG;POLR3D;TGFB2;SPHK2
prerank,GO_Biological_Process_2021__protein polymerization (GO:0051258),0.3722309497795378,0.7948620434304384,0.8266666666666667,1.0,1.0,6/46,12.32%,PREX1;CHMP4B;WASF1;CASQ1;WAS;ARL6
prerank,GO_Biological_Process_2021__endocardial cushion development (GO:0003197),0.4558611053462722,0.7947218297682178,0.7076923076923077,1.0,1.0,1/12,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__protein deglycosylation (GO:0006517),0.5019097061708886,0.7947041623961224,0.7763157894736842,1.0,1.0,3/8,25.16%,NGLY1;MAN2A1;OGA
prerank,MSigDB_Hallmark_2020__UV Response Up,0.3254770500475027,0.7945821564278498,0.9012345679012346,1.0,1.0,23/137,16.63%,C4BPB;MSX1;UROD;POLE3;TST;JUNB;FKBP4;CCNE1;EPHX1;DNAJB1;SOD2;GRINA;ABCB1;RHOB;SELENOW;TUBA4A;IRF1;GGH;PLCL1;DNAJA1;ATP6V1C1;EPCAM;CNP
prerank,GO_Biological_Process_2021__proteolysis involved in cellular protein catabolic process (GO:0051603),0.3603253013448765,0.7944085038529478,0.8028169014084507,1.0,1.0,15/61,29.23%,CHMP4B;CASP8;CTSK;CLPX;NGLY1;LGMN;CTSZ;RNF41;VPS4A;CUL4B;LONP1;MARCHF6;CLPP;RPS27A;CTSH
prerank,GO_Biological_Process_2021__regulation of intracellular signal transduction (GO:1902531),-0.2733644239625853,-0.7937965469180782,1.0,1.0,1.0,42/379,12.89%,NRK;SPRED1;SRGAP1;F2RL1;RASSF2;ARHGAP31;MOB3B;SMYD2;SGK1;TRAF3;FGF1;HDAC1;TAF10;SPHK2;IER3;HUS1;RHOJ;AURKA;HSPB1;FAM83D;LBH;TAF11;ARAP3;PIP5K1B;GNA12;TELO2;TAF1;ARHGAP33;TTI1;PEX5L;XIAP;SSRP1;MCF2L;WDR54;PRDM11;PIP5K1C;ARHGEF1;PRMT5;PLEKHG2;EHMT2;TAF12;EGFR
prerank,GO_Biological_Process_2021__positive regulation of sterol transport (GO:0032373),-0.46589423500692934,-0.7937294641788767,0.675,1.0,1.0,1/5,4.47%,ABCA13
prerank,GO_Biological_Process_2021__protein homotetramerization (GO:0051289),0.3508124400043589,0.7937194389273569,0.8529411764705882,1.0,1.0,5/43,11.32%,TRPA1;UPB1;HSD17B10;SOD2;ACOT13
prerank,GO_Biological_Process_2021__morphogenesis of an epithelial sheet (GO:0002011),-0.503285116811171,-0.7936169746983415,0.7105263157894737,1.0,1.0,1/7,0.88%,BMP7
prerank,PanglaoDB_Augmented_2021__Hemangioblasts,0.3773940621057936,0.7934996919964183,0.8472222222222222,1.0,1.0,2/41,6.52%,GYPB;GMFG
prerank,GO_Biological_Process_2021__positive regulation of transcription of Notch receptor target (GO:0007221),0.4442039640041235,0.7932578247560765,0.7457627118644068,1.0,1.0,4/15,11.19%,NOTCH1;MAML2;STAT1;NOTCH3
prerank,GO_Biological_Process_2021__regulation of chemokine production (GO:0032642),0.42085610862409406,0.7932114488281349,0.8405797101449275,1.0,1.0,3/22,8.82%,AGER;ELANE;IL7
prerank,GO_Biological_Process_2021__positive regulation of NLRP3 inflammasome complex assembly (GO:1900227),0.5424769036983708,0.7929206519836459,0.7346938775510204,1.0,1.0,4/6,29.76%,USP50;GBP5;CD36;DDX3X
prerank,GO_Biological_Process_2021__anterograde trans-synaptic signaling (GO:0098916),0.31820622600069415,0.7929100137845204,0.8850574712643678,1.0,1.0,10/202,7.28%,NPY;SLC12A7;ZACN;CHRNB1;CHRNG;OPRK1;PLP1;GABRA2;GRM3;HTR3E
prerank,GO_Biological_Process_2021__regulation of fibroblast proliferation (GO:0048145),-0.3643098092229933,-0.7927289306135339,0.7837837837837838,1.0,1.0,7/38,11.38%,EREG;IGF1;SFRP1;EMD;PDGFRA;PDGFC;PARP10
prerank,GO_Biological_Process_2021__regulation of excitatory synapse assembly (GO:1904889),-0.4984289326174899,-0.7925948196760692,0.7692307692307693,1.0,1.0,1/6,5.65%,LRFN4
prerank,GO_Biological_Process_2021__isoprenoid biosynthetic process (GO:0008299),0.4965371052796508,0.7925205589397312,0.8333333333333334,1.0,1.0,1/8,9.63%,HMGCR
prerank,GO_Biological_Process_2021__negative regulation of JNK cascade (GO:0046329),0.3967551191513746,0.7922912472293285,0.7586206896551724,1.0,1.0,11/30,25.66%,AMBP;MARVELD3;DNAJA1;PINK1;PDCD4;PER1;CYLD;GPS2;DUSP19;GSTP1;AIDA
prerank,GO_Biological_Process_2021__heterocycle biosynthetic process (GO:0018130),-0.457886632770803,-0.7921018624344808,0.6666666666666666,1.0,1.0,3/12,14.14%,GCH1;PYCR3;NOXRED1
prerank,GO_Biological_Process_2021__negative regulation of protein autophosphorylation (GO:0031953),-0.4480032915766266,-0.7919137479574538,0.6428571428571429,1.0,1.0,1/8,10.46%,CHP1
prerank,GO_Biological_Process_2021__toll-like receptor 3 signaling pathway (GO:0034138),0.5107891898357222,0.7915934515497749,0.8088235294117647,1.0,1.0,3/10,11.66%,FADD;CASP8;SCIMP
prerank,GO_Biological_Process_2021__positive regulation of histone acetylation (GO:0035066),0.39250476177271415,0.7912668104065245,0.7647058823529411,1.0,1.0,3/19,14.47%,PPARGC1A;RPS6KA4;BRCA1
prerank,GO_Biological_Process_2021__positive regulation of muscle contraction (GO:0045933),-0.469485579733147,-0.791199517587514,0.6842105263157895,1.0,1.0,1/7,7.34%,NMU
prerank,GO_Biological_Process_2021__cellular protein localization (GO:0034613),0.31163062333316927,0.791176513535848,0.9390243902439024,1.0,1.0,18/272,12.32%,RAB6C;CSRP3;GRTP1;AMOT;FBLN5;SLU7;RUNDC1;SEPTIN14;CPE;RABL2B;CNTN2;RAB19;RAB23;YWHAH;ARCN1;CELSR1;ARL1;ARL6
prerank,GO_Biological_Process_2021__regulation of cell division (GO:0051302),-0.32025880332559187,-0.791164373114013,0.8095238095238095,1.0,1.0,12/61,16.62%,CDK2AP2;PRDM15;FGF1;AURKA;PLK2;SIRT2;SH3GLB1;ORC6;ENTR1;PLK3;ZFYVE26;RAB11FIP3
prerank,GO_Biological_Process_2021__DNA strand elongation (GO:0022616),0.43736901063608835,0.7906915407403426,0.7796610169491526,1.0,1.0,4/17,13.43%,GINS2;MCMDC2;GINS1;MRE11
prerank,GO_Biological_Process_2021__response to metal ion (GO:0010038),0.37542340548245345,0.7906417732223329,0.8428571428571429,1.0,1.0,4/52,4.85%,ZACN;TRPV6;SLC30A8;LOXL2
prerank,GO_Biological_Process_2021__glycine transport (GO:0015816),0.4862308948780262,0.7905803352444343,0.6984126984126984,1.0,1.0,2/7,16.48%,SLC36A1;SLC38A5
prerank,GO_Biological_Process_2021__regulation of release of sequestered calcium ion into cytosol (GO:0051279),-0.36598361456502876,-0.7901796656121537,0.8387096774193549,1.0,1.0,1/36,0.56%,UBASH3B
prerank,GO_Biological_Process_2021__positive regulation of fibroblast migration (GO:0010763),0.47665711264935695,0.7901316424861892,0.7868852459016393,1.0,1.0,3/8,29.32%,TGFB1;DMTN;DDR2
prerank,GO_Biological_Process_2021__mitochondrion disassembly (GO:0061726),0.39308162044053646,0.7901008146731358,0.7164179104477612,1.0,1.0,11/34,28.76%,BNIP3;CTSK;PINK1;ULK1;ATG3;FBXO7;MAP1LC3B;WIPI1;FUNDC1;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__positive regulation of double-strand break repair via homologous recombination (GO:1905168),0.4367062521000928,0.7900472545044093,0.746268656716418,1.0,1.0,5/14,26.00%,WAS;ACTR2;RAD51AP1;OOEP;FANCB
prerank,GO_Biological_Process_2021__regulation of organelle assembly (GO:1902115),0.36250229449590143,0.7897211659004862,0.8082191780821918,1.0,1.0,9/65,22.25%,HCK;C10ORF90;ODAD3;KIF9;MSN;TBC1D13;ATG3;CEP76;CYLD
prerank,GO_Biological_Process_2021__acetyl-CoA metabolic process (GO:0006084),-0.4157878833723051,-0.7896037582539192,0.7241379310344828,1.0,1.0,2/14,6.57%,MLYCD;NUDT7
prerank,GO_Biological_Process_2021__lipid modification (GO:0030258),0.37359229783018755,0.7894294580662148,0.7727272727272727,1.0,1.0,3/36,7.36%,PLA2G7;LPCAT3;ALOX12
prerank,GO_Biological_Process_2021__small GTPase mediated signal transduction (GO:0007264),0.34028782664515017,0.789343451195661,0.8170731707317073,1.0,1.0,3/98,1.75%,RAB6C;RAPGEF5;RREB1
prerank,GO_Biological_Process_2021__NAD biosynthesis via nicotinamide riboside salvage pathway (GO:0034356),0.44304744917155264,0.7890966310499636,0.7532467532467533,1.0,1.0,2/14,8.41%,PTGIS;NAMPT
prerank,GO_Biological_Process_2021__negative regulation of apoptotic signaling pathway (GO:2001234),-0.3407655383913913,-0.788820093916076,0.7419354838709677,1.0,1.0,6/65,6.63%,SH3RF1;IGF1;TRIAP1;ITGA6;CFLAR;BCL2
prerank,GO_Biological_Process_2021__regulation of centriole replication (GO:0046599),0.4352437787922747,0.7886759102456277,0.7678571428571429,1.0,1.0,5/14,24.88%,C10ORF90;BRCA1;MDM1;CEP76;KAT2B
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell action potential involved in regulation of contraction (GO:0098909),0.5246692414707333,0.7886271981225725,0.7868852459016393,1.0,1.0,1/7,1.71%,CAV3
prerank,GO_Biological_Process_2021__visual system development (GO:0150063),-0.3456563066304154,-0.7884549813358613,0.6666666666666666,1.0,1.0,8/30,13.91%,RBP4;TGFB2;SIPA1L3;PBX4;SMG9;CHRDL1;SMOC1;PAX6
prerank,GO_Biological_Process_2021__protein-DNA covalent cross-linking repair (GO:0106300),0.5356395586840144,0.7883689624049612,0.7692307692307693,1.0,1.0,1/5,13.45%,VCPIP1
prerank,GO_Biological_Process_2021__adrenal gland development (GO:0030325),-0.4722182932405934,-0.7874663125656569,0.7446808510638298,1.0,1.0,1/6,12.12%,MDK
prerank,GO_Biological_Process_2021__regulation of cellular response to osmotic stress (GO:0106049),0.5147304043618988,0.7874622355843731,0.8166666666666667,1.0,1.0,2/5,20.77%,EFHD1;LETM1
prerank,GO_Biological_Process_2021__positive regulation of innate immune response (GO:0045089),0.3911468954682673,0.7871821639311107,0.8,1.0,1.0,7/25,23.97%,CCL5;FADD;POLR3G;PLSCR1;LBP;IFI35;GBP5
prerank,GO_Biological_Process_2021__negative regulation of mRNA polyadenylation (GO:1900364),-0.45420374326079394,-0.7871366027446987,0.775,1.0,1.0,4/8,32.95%,NELFE;CCNT1;RNF20;CDK9
prerank,GO_Biological_Process_2021__negative regulation of angiogenesis (GO:0016525),0.3461296312061553,0.7870120732384395,0.8656716417910447,1.0,1.0,9/60,9.09%,STAB1;HSPG2;ADAMTS9;AMOT;ADGRB1;SERPINF1;CD160;EPN1;STAT1
prerank,GO_Biological_Process_2021__cellular response to lipid (GO:0071396),0.32333154634843325,0.7869625650974109,0.8450704225352113,1.0,1.0,34/138,25.95%,ZNF703;MGST1;SSTR1;AHR;CD14;TBX1;PDCD1LG2;STAP1;MAP4K1;GPER1;ABCB4;ESR1;MSN;SPP1;DAB2IP;PDK4;ATP1A1;PDCD4;CXCL13;H2AZ1;INSIG1;CRHBP;CD274;PLAA;TESC;CX3CR1;NCOA4;LBP;CD80;GSTP1;WNT5B;LYN;ZNF35;TWF2
prerank,GO_Biological_Process_2021__positive regulation of metabolic process (GO:0009893),0.3434569458404588,0.7868587825988133,0.922077922077922,1.0,1.0,15/84,14.66%,ZBTB7B;PRLR;PLAC8;FASN;PRKAB2;KDM3A;ADIPOR2;TSHR;ADRB1;PPARGC1A;CMKLR1;SCD;EPAS1;GHRL;STAT6
prerank,GO_Biological_Process_2021__protein N-linked glycosylation via asparagine (GO:0018279),-0.3606532460975538,-0.7868342173172703,0.8,1.0,1.0,6/28,15.58%,ALG8;DPM3;DERL3;RPN2;UGGT2;OST4
prerank,GO_Biological_Process_2021__protein O-linked glycosylation (GO:0006493),-0.2984033726470565,-0.7866611154623236,0.8461538461538461,1.0,1.0,10/82,11.93%,GXYLT2;ST6GALNAC2;ST3GAL3;ST3GAL1;GALNT10;ST3GAL2;TET1;GALNT12;GCNT4;DPM3
prerank,GO_Biological_Process_2021__negative regulation of growth (GO:0045926),0.33871530259051186,0.7865683312586187,0.8157894736842105,1.0,1.0,10/93,10.22%,MSX1;NOTCH1;INHBA;PSRC1;CDKN2D;OSGIN2;NAIF1;CDKN1B;CGRRF1;CRLF3
prerank,GO_Biological_Process_2021__regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314),0.4023286937458809,0.7863455941467734,0.7454545454545455,1.0,1.0,5/21,25.04%,FKBP1B;CAMK2D;TRDN;CALM3;JPH1
prerank,PanglaoDB_Augmented_2021__Oligodendrocytes,0.32242819724449917,0.7862592764348691,0.8421052631578947,1.0,1.0,24/163,16.16%,ENPP2;PPP1R1B;ADAMTS4;SOX10;FASN;PLP1;OMG;GRM3;SLC39A12;SOWAHA;CNTN2;ANLN;TMEM235;TMEM178A;FGFR2;OLIG2;KCNJ9;GFAP;TMEM63A;CA10;NFE2L3;MOBP;ASPA;TTYH1
prerank,GO_Biological_Process_2021__vesicle transport along actin filament (GO:0030050),0.44667933851925845,0.785762591530533,0.765625,1.0,1.0,2/17,13.63%,MYO5B;MYO1F
prerank,GO_Biological_Process_2021__cellular copper ion homeostasis (GO:0006878),-0.43042060276099614,-0.7855724111159305,0.71875,1.0,1.0,3/11,17.08%,CCDC22;COX19;ATP7B
prerank,GO_Biological_Process_2021__mitochondrial tRNA processing (GO:0090646),0.4839723952148959,0.7854320666518445,0.75,1.0,1.0,1/7,7.00%,HSD17B10
prerank,GO_Biological_Process_2021__regulation of non-membrane spanning protein tyrosine kinase activity (GO:1903995),0.503351527828062,0.7849707633177357,0.78125,1.0,1.0,1/7,11.08%,STAP1
prerank,GO_Biological_Process_2021__acetyl-CoA biosynthetic process from pyruvate (GO:0006086),-0.4533076605693852,-0.7848806641020455,0.6111111111111112,1.0,1.0,5/5,54.68%,DLD;PDHA1;PDHX;PDHB;DLAT
prerank,GO_Biological_Process_2021__mRNA 3'-end processing (GO:0031124),0.3447958394058554,0.7848356305716392,0.8108108108108109,1.0,1.0,16/70,24.08%,CSTF2T;U2AF1;SLU7;NCBP1;NCBP2;DDX39A;CLP1;FIP1L1;THOC5;CDC40;POLR2D;SLBP;SARNP;SRSF3;EIF4A3;ALYREF
prerank,GO_Biological_Process_2021__regulation of B cell differentiation (GO:0045577),-0.4149683162916519,-0.7847263681928223,0.7,1.0,1.0,4/13,10.36%,INHA;SFRP1;ID2;IKZF3
prerank,GO_Biological_Process_2021__cellular zinc ion homeostasis (GO:0006882),0.4557494133632799,0.7847130969701455,0.803030303030303,1.0,1.0,2/18,6.59%,SLC30A8;SLC39A12
prerank,GO_Biological_Process_2021__positive regulation of secretion by cell (GO:1903532),0.36131763196759603,0.784430842176327,0.7464788732394366,1.0,1.0,10/60,14.33%,PLA2G10;MYOM1;EXPH5;RAB9A;ATP6AP1;SOX11;PPID;GPER1;TGFB1;SYTL4
prerank,GO_Biological_Process_2021__negative regulation of DNA metabolic process (GO:0051053),-0.372439426820683,-0.7842333695868703,0.7368421052631579,1.0,1.0,2/23,7.70%,H1-4;ERCC1
prerank,GO_Biological_Process_2021__axo-dendritic transport (GO:0008088),0.5064763580342361,0.784047219972136,0.711864406779661,1.0,1.0,1/6,15.27%,HSPA8
prerank,GO_Biological_Process_2021__nucleic acid-templated transcription (GO:0097659),-0.3580211792334771,-0.7839107769439513,0.7058823529411765,1.0,1.0,10/36,19.46%,DTX1;POLR2G;PTMA;POLR2C;POLR2L;FUBP3;POLR3A;PPP5C;NFKBIB;NR4A2
prerank,GO_Biological_Process_2021__positive regulation of axon extension (GO:0045773),-0.36937113642434105,-0.7836702174089195,0.8205128205128205,1.0,1.0,7/21,27.09%,LIMK1;NRP1;DBNL;DSCAM;GOLGA4;MAP3K13;L1CAM
prerank,GO_Biological_Process_2021__regulation of cholesterol efflux (GO:0010874),-0.3682141747225726,-0.7836480774064053,0.8888888888888888,1.0,1.0,5/27,12.93%,NAXE;PTCH1;APOA1;APOE;EEPD1
prerank,GO_Biological_Process_2021__sodium ion transmembrane transport (GO:0035725),0.3598567348513104,0.7835247856950824,0.9154929577464789,1.0,1.0,16/69,23.12%,SCN9A;SCN4B;SLC24A4;ATP12A;SLC24A2;SCN7A;SLC24A1;SLC5A2;ATP1B1;ATP1A1;SLC9A2;SLC9A6;SLC9A7;KCNK1;HCN4;SLC6A16
prerank,GO_Biological_Process_2021__regulation of phospholipase activity (GO:0010517),-0.4264033435089525,-0.7834267277802804,0.7631578947368421,1.0,1.0,3/9,14.85%,RASGRP1;RGS2;FGFR3
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan biosynthetic process (GO:0050650),-0.3562468475650676,-0.7832815362756658,0.7894736842105263,1.0,1.0,6/24,15.49%,VCAN;B3GAT2;B3GAT3;CHST9;XYLT2;CHST12
prerank,GO_Biological_Process_2021__fat-soluble vitamin metabolic process (GO:0006775),0.45604219244547445,0.7831505166493415,0.8548387096774194,1.0,1.0,7/16,25.62%,RLBP1;CYP2R1;LGMN;RBP2;TTPA;LRAT;LRP2
prerank,GO_Biological_Process_2021__lipoprotein transport (GO:0042953),0.480081319091965,0.7830828687423115,0.6785714285714286,1.0,1.0,5/8,28.15%,UNC119B;PPARG;ZDHHC17;VMP1;CD36
prerank,GO_Biological_Process_2021__catecholamine catabolic process (GO:0042424),0.5106203879777574,0.7828558523927136,0.7704918032786885,1.0,1.0,3/5,26.69%,MAOA;LRTOMT;MAOB
prerank,GO_Biological_Process_2021__postsynaptic density protein 95 clustering (GO:0097119),-0.4613303993031678,-0.7827884293568513,0.7906976744186046,1.0,1.0,5/5,53.88%,NRXN1;NLGN2;NLGN1;NRXN2;LRRC4
prerank,GO_Biological_Process_2021__regulation of stem cell population maintenance (GO:2000036),0.44165310699774896,0.7827740365720176,0.796875,1.0,1.0,2/18,9.19%,LOXL2;REST
prerank,GO_Biological_Process_2021__peptidyl-asparagine modification (GO:0018196),-0.3561416622583609,-0.7827166853901294,0.7666666666666667,1.0,1.0,6/29,15.58%,ALG8;DPM3;DERL3;RPN2;UGGT2;OST4
prerank,GO_Biological_Process_2021__phospholipase C-activating G protein-coupled receptor signaling pathway (GO:0007200),0.3437024380851601,0.7825410387105983,0.8289473684210527,1.0,1.0,7/58,8.55%,C3AR1;P2RY1;OPRK1;AGT;P2RY12;PTGER3;CMKLR1
prerank,GO_Biological_Process_2021__negative regulation of Wnt signaling pathway (GO:0030178),0.3118829074661827,0.7824751764865349,0.9066666666666666,1.0,1.0,20/153,17.81%,LRP4;GLI3;SHISA2;HIC1;NOTUM;TLE3;SFRP4;PSMB6;NKD2;BICC1;KREMEN1;TSC2;HECW1;TLE6;PSMA3;PSMB8;NLK;DAB2IP;AMER2;TMEM170B
prerank,MSigDB_Hallmark_2020__Myc Targets V1,0.3174463909054413,0.7823429069043434,0.9651162790697675,1.0,1.0,40/186,29.01%,MCM2;TCP1;POLE3;PRDX4;EIF1AX;U2AF1;NCBP1;NCBP2;PCNA;GNL3;DHX15;VBP1;RPL22;EPRS1;G3BP1;H2AZ1;SNRPD2;PCBP1;RPS5;CDK4;UBE2E1;CCT7;MCM6;RRM1;SRSF3;COPS5;SSB;DEK;SET;VDAC3;VDAC1;RNPS1;HNRNPR;CBX3;MAD2L1;CUL1;PSMC6;SLC25A3;SRPK1;SYNCRIP
prerank,GO_Biological_Process_2021__positive regulation of cellular component organization (GO:0051130),-0.30164589650323853,-0.7822982541384081,0.9090909090909091,1.0,1.0,7/90,5.75%,NRG1;BMP7;BCL2L11;RUNX1;TRABD2A;PTPN23;TGFB2
prerank,GO_Biological_Process_2021__regulation of membrane depolarization (GO:0003254),-0.36240732159402145,-0.7822292107095503,0.8125,1.0,1.0,1/15,0.59%,PTPN3
prerank,GO_Biological_Process_2021__negative regulation of protein catabolic process (GO:0042177),0.3891195990396093,0.7822007028599197,0.7285714285714285,1.0,1.0,4/35,9.63%,TIMP3;TIMP2;ADGRB1;HMGCR
prerank,GO_Biological_Process_2021__mitotic G2 DNA damage checkpoint signaling (GO:0007095),0.40021019905705585,0.7819096521190161,0.8253968253968254,1.0,1.0,4/27,14.47%,TICRR;DONSON;MRE11;BRCA1
prerank,GO_Biological_Process_2021__regulation of neuroinflammatory response (GO:0150077),-0.4438370269765124,-0.7819038654889497,0.8275862068965517,1.0,1.0,1/9,3.96%,IGF1
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway via death domain receptors (GO:1902041),0.4000045081390841,0.7818754825767488,0.8135593220338984,1.0,1.0,14/31,31.13%,FADD;CASP8;FAS;TMBIM1;BRCA1;BCL2L1;TMC8;SP100;MADD;FEM1B;SERPINE1;DDX3X;FAIM;RNF34
prerank,GO_Biological_Process_2021__DNA duplex unwinding (GO:0032508),0.3523732580634931,0.7817214205897866,0.7333333333333333,1.0,1.0,9/47,23.22%,MCM2;MCMDC2;MRE11;RECQL;PURA;RECQL4;MCM6;DDX1;RAD50
prerank,GO_Biological_Process_2021__fatty acid transmembrane transport (GO:1902001),0.4124850203454222,0.7816443552928977,0.7794117647058824,1.0,1.0,3/18,15.13%,PRKAB2;SLC2A1;THRSP
prerank,GO_Biological_Process_2021__replication fork protection (GO:0048478),-0.436434598287056,-0.7815188269137809,0.6341463414634146,1.0,1.0,2/8,8.91%,TIMELESS;SMARCAL1
prerank,GO_Biological_Process_2021__sarcoplasmic reticulum calcium ion transport (GO:0070296),-0.4624605543541879,-0.7814333469606638,0.7209302325581395,1.0,1.0,1/6,4.62%,RYR1
prerank,GO_Biological_Process_2021__regulation of TORC1 signaling (GO:1903432),0.3684654194533706,0.7813098733631155,0.8208955223880597,1.0,1.0,8/32,29.68%,SESN3;RNF152;GPR137B;GPR137;RRAGD;RRAGA;LAMTOR5;SPAAR
prerank,PanglaoDB_Augmented_2021__T Cells,0.3627366717131442,0.7813052478394626,0.8695652173913043,1.0,1.0,16/73,11.22%,GNLY;ITK;IL18R1;CD4;CCL5;CD8A;PTPRC;JUNB;FMNL1;GMFG;TAGAP;CD160;ARHGAP9;IFIT3;NOTCH3;CD6
prerank,GO_Biological_Process_2021__negative regulation of protein tyrosine kinase activity (GO:0061099),0.4293434997615566,0.7812444358210899,0.803030303030303,1.0,1.0,2/19,7.20%,PTPRC;GPRC5A
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell apoptotic process (GO:1904036),-0.37397608440676783,-0.781207588065032,0.75,1.0,1.0,5/23,12.23%,KDR;IL11;MAPK7;MDK;SCG2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transport (GO:1902305),-0.3584766886903285,-0.7811046580174127,0.8518518518518519,1.0,1.0,3/21,7.58%,PTPN3;UTRN;RANGRF
prerank,GO_Biological_Process_2021__termination of RNA polymerase I transcription (GO:0006363),-0.34868484183398163,-0.7810727395119151,0.8235294117647058,1.0,1.0,10/29,19.81%,ERCC2;GTF2H2;CCNH;UBTF;POLR2L;POLR1A;TAF1D;POLR1G;GTF2H5;ERCC3
prerank,GO_Biological_Process_2021__T cell differentiation (GO:0030217),0.39011226341674127,0.7807709426419508,0.75,1.0,1.0,6/31,6.92%,GLI3;CD4;CD8A;PTPRC;NHEJ1;FADD
prerank,GO_Biological_Process_2021__negative regulation of cell-matrix adhesion (GO:0001953),0.3757952267222307,0.7806883929700358,0.8208955223880597,1.0,1.0,1/28,3.82%,RASA1
prerank,GO_Biological_Process_2021__innate immune response activating cell surface receptor signaling pathway (GO:0002220),0.3426467408422019,0.780675473222864,0.8194444444444444,1.0,1.0,16/85,28.58%,CLEC4C;PSMB6;PLCG2;MUC4;MUCL1;PSMA3;PSMB8;MUC20;TAB2;PSMA5;LYN;KRAS;MUC6;CUL1;PSMC6;SYK
prerank,GO_Biological_Process_2021__cellular response to lectin (GO:1990858),0.3426467408422019,0.780675473222864,0.8194444444444444,1.0,1.0,16/85,28.58%,CLEC4C;PSMB6;PLCG2;MUC4;MUCL1;PSMA3;PSMB8;MUC20;TAB2;PSMA5;LYN;KRAS;MUC6;CUL1;PSMC6;SYK
prerank,GO_Biological_Process_2021__stimulatory C-type lectin receptor signaling pathway (GO:0002223),0.3426467408422019,0.780675473222864,0.8194444444444444,1.0,1.0,16/85,28.58%,CLEC4C;PSMB6;PLCG2;MUC4;MUCL1;PSMA3;PSMB8;MUC20;TAB2;PSMA5;LYN;KRAS;MUC6;CUL1;PSMC6;SYK
prerank,GO_Biological_Process_2021__male gonad development (GO:0008584),-0.36185631500269855,-0.7804914546212741,0.7727272727272727,1.0,1.0,3/26,5.75%,KIT;KITLG;TGFB2
prerank,GO_Biological_Process_2021__neutral amino acid transport (GO:0015804),0.39612408247469616,0.7803428088485422,0.7777777777777778,1.0,1.0,3/23,16.48%,SLC36A1;SLC38A2;SLC38A5
prerank,GO_Biological_Process_2021__ATP-dependent chromatin remodeling (GO:0043044),0.37241525584149915,0.7800054000633034,0.8115942028985508,1.0,1.0,7/40,19.29%,SMARCE1;SPTY2D1;ACTL6A;ACTR6;SRCAP;ACTR8;SMARCA1
prerank,GO_Biological_Process_2021__axon guidance (GO:0007411),0.31507135218677773,0.7798041584731554,0.8863636363636364,1.0,1.0,16/182,11.19%,LAMA2;EPHA1;PLA2G10;SEMA3D;EMB;NOTCH1;SPTBN5;UNC5A;ARTN;LAMA1;GAB1;SIAH1;CNTN2;MYPN;CDK5R1;NOTCH3
prerank,GO_Biological_Process_2021__RNA export from nucleus (GO:0006405),-0.3140939511047672,-0.7797682307292384,0.8095238095238095,1.0,1.0,11/92,11.51%,NUP62CL;CPSF1;NUP210;TPR;CHTOP;NUP37;MAGOHB;SMG6;THOC1;U2AF2;SRRM1
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-protein transferase activity (GO:0051443),-0.35435967165256843,-0.7792056917769937,0.7857142857142857,1.0,1.0,1/25,2.02%,CDC14B
prerank,GO_Biological_Process_2021__protein oxidation (GO:0018158),-0.4149376083642275,-0.7791288704106333,0.75,1.0,1.0,2/10,7.04%,LOXL1;APOA1
prerank,GO_Biological_Process_2021__cellular response to sterol (GO:0036315),-0.4009211574285327,-0.778955934533859,0.6944444444444444,1.0,1.0,3/12,8.93%,OSBPL7;PTCH1;RORA
prerank,GO_Biological_Process_2021__regulation of fatty acid oxidation (GO:0046320),-0.38594565611775766,-0.7788883328505032,0.875,1.0,1.0,5/16,11.93%,TYSND1;MLYCD;ABCD1;ACADVL;NR4A3
prerank,GO_Biological_Process_2021__immunoglobulin mediated immune response (GO:0016064),0.5340126282414993,0.7784154570370506,0.8275862068965517,1.0,1.0,2/5,19.30%,CD27;CD74
prerank,GO_Biological_Process_2021__glycosaminoglycan biosynthetic process (GO:0006024),0.34676683399108416,0.7784053002089486,0.8513513513513513,1.0,1.0,10/81,11.45%,PRELP;GPC6;HSPG2;GPC5;CHST1;B3GNT4;OGN;CSGALNACT1;B3GNT3;XYLT1
prerank,GO_Biological_Process_2021__regulation of cellular response to stress (GO:0080135),-0.285847125727064,-0.7783552327863958,0.9444444444444444,1.0,1.0,25/112,19.75%,VASH1;NEK6;NUP210;TPR;IER3;NUP37;ATF3;EIF4G1;ABCD1;USP51;BAG3;RPTOR;HSF1;NUP42;PNPT1;ATM;NUP107;OPRM1;CREBBP;NUP43;MTOR;HSPA1A;NUPR1;PRKN;CASP9
prerank,GO_Biological_Process_2021__cellular transition metal ion homeostasis (GO:0046916),0.3593757787407304,0.7782058534767137,0.8636363636363636,1.0,1.0,21/68,29.60%,SLC30A8;CP;SLC39A12;FRRS1;ATP6AP1;SLC31A1;ABCG2;SLC40A1;HJV;NUBP1;PRNP;TF;MT1M;HEPH;TFR2;SLC11A1;SLC11A2;CUL1;CAND1;ATP6V1G1;SMAD4
prerank,GO_Biological_Process_2021__positive regulation of stress-activated protein kinase signaling cascade (GO:0070304),-0.3864866353119065,-0.778181339182596,0.8,1.0,1.0,7/15,22.20%,TGFB2;SEMA4C;KLHDC10;MID1;CARD9;TAOK3;EIF2AK2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, elongation (GO:0006354)",-0.32605055848887005,-0.7781074050496231,0.8529411764705882,1.0,1.0,16/64,20.90%,ERCC2;GTF2H2;IWS1;CCNH;POLR2G;SSRP1;GTF2F1;POLR2C;POLR2L;NELFA;GTF2H5;RTF1;ERCC3;SETD2;NELFE;CCNT1
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion involved in cellular response to glucose stimulus (GO:0035774),-0.4542410398330566,-0.7779048897641152,0.7666666666666667,1.0,1.0,2/10,15.14%,ANO1;STX4
prerank,GO_Biological_Process_2021__muscle tissue development (GO:0060537),0.46948004126108966,0.777855455036182,0.8135593220338984,1.0,1.0,1/11,0.74%,CSRP3
prerank,GO_Biological_Process_2021__negative regulation of heart rate (GO:0010459),0.5316622155082891,0.7777482920902252,0.8421052631578947,1.0,1.0,2/6,17.19%,FKBP1B;PLN
prerank,GO_Biological_Process_2021__release of cytochrome c from mitochondria (GO:0001836),0.42316027782200494,0.7776563114926334,0.7580645161290323,1.0,1.0,5/16,23.93%,BOK;SOD2;BCL2L1;BAD;IFI6
prerank,GO_Biological_Process_2021__nuclear membrane reassembly (GO:0031468),-0.30748728093776045,-0.777585766312966,0.88,1.0,1.0,6/49,11.09%,LEMD2;EMD;NUP37;NSFL1C;UBXN2A;SIRT2
prerank,GO_Biological_Process_2021__endocardial cushion morphogenesis (GO:0003203),0.45621139848766307,0.7774643502626203,0.8032786885245902,1.0,1.0,1/12,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__intracellular steroid hormone receptor signaling pathway (GO:0030518),0.38000326332596057,0.7770563407560628,0.7887323943661971,1.0,1.0,10/34,27.01%,KDM3A;GPER1;ESR1;TMF1;UBR5;ESR2;NCOA4;UBE3A;RHOXF1;YAP1
prerank,GO_Biological_Process_2021__defense response to symbiont (GO:0140546),0.33728794225707875,0.7769228791632355,0.8571428571428571,1.0,1.0,23/77,21.83%,TRIM5;PLA2G10;OPRK1;PTPRC;ISG20;FADD;IFNLR1;BNIP3;STAT1;IFIT3;IRF1;AGBL5;NDUFAF4;IFI27;CGAS;G3BP1;BCL2L1;TLR2;PLSCR1;IFIT1;SERINC3;IFITM3;ABCC9
prerank,GO_Biological_Process_2021__positive regulation of potassium ion import across plasma membrane (GO:1903288),0.5474799765840048,0.7768602655461498,0.803921568627451,1.0,1.0,1/6,15.36%,ATP1B1
prerank,GO_Biological_Process_2021__Notch signaling pathway (GO:0007219),-0.3242101611297539,-0.7768176448279002,0.8823529411764706,1.0,1.0,13/46,18.94%,MAML3;ASCL1;DTX1;MAML1;NCSTN;JAG2;MDK;GMDS;WWC1;DTX3L;CREBBP;POFUT1;JAG1
prerank,GO_Biological_Process_2021__protein K48-linked ubiquitination (GO:0070936),0.36321136618057154,0.7767150490094293,0.863013698630137,1.0,1.0,13/53,25.85%,ARIH2;TRIM32;SYVN1;KBTBD6;RNF152;IFI27;UBR5;KBTBD7;RNF187;UBE2E1;UBE3A;UBE2H;UBE2D1
prerank,GO_Biological_Process_2021__peptide metabolic process (GO:0006518),0.33118485833044975,0.7766228630543661,0.8472222222222222,1.0,1.0,16/63,21.89%,HPGDS;ERAP2;CPE;CPM;LVRN;ENPEP;RHD;G6PD;GSTT2;GLRX2;NAALADL1;FURIN;PCSK5;SPCS3;TRHDE;ERAP1
prerank,GO_Biological_Process_2021__negative regulation of Rho protein signal transduction (GO:0035024),-0.3630783281034618,-0.7764804198633105,0.7666666666666667,1.0,1.0,3/16,11.44%,HEG1;KCTD13;RIPOR2
prerank,GO_Biological_Process_2021__fluid transport (GO:0042044),-0.43823484664368356,-0.7764040087869384,0.8125,1.0,1.0,2/7,14.29%,PDPN;AQP8
prerank,GO_Biological_Process_2021__pyrimidine nucleoside biosynthetic process (GO:0046134),-0.3866226249813186,-0.7761980031300233,0.8064516129032258,1.0,1.0,3/12,17.22%,UPP2;UCK2;TYMP
prerank,GO_Biological_Process_2021__prepulse inhibition (GO:0060134),-0.42893004428006687,-0.7761885771075526,0.7222222222222222,1.0,1.0,2/6,10.32%,CTNNA2;DRD1
prerank,GO_Biological_Process_2021__regulation of autophagy of mitochondrion (GO:1903146),0.4319909618024374,0.775853929967463,0.8095238095238095,1.0,1.0,3/18,26.46%,PINK1;FBXO7;VDAC1
prerank,GO_Biological_Process_2021__mRNA cleavage involved in mRNA processing (GO:0098787),0.44274418881626504,0.7758512519115498,0.7796610169491526,1.0,1.0,4/12,14.05%,CSTF2T;NCBP1;NCBP2;FIP1L1
prerank,GO_Biological_Process_2021__toll-like receptor 4 signaling pathway (GO:0034142),0.4474275665931646,0.7750818682458549,0.7666666666666667,1.0,1.0,2/13,11.66%,CD14;SCIMP
prerank,MSigDB_Hallmark_2020__Coagulation,0.3305080497881946,0.7750488418884248,0.8701298701298701,1.0,1.0,21/89,19.80%,TIMP3;P2RY1;MMP15;F8;LAMP2;BMP1;F10;RABIF;ACOX2;C1QA;CTSK;VWF;MASP2;A2M;FN1;CPB2;LGMN;ARF4;FURIN;DUSP14;SERPING1
prerank,GO_Biological_Process_2021__positive regulation of mast cell degranulation (GO:0043306),-0.46776067230425233,-0.7750430058845895,0.6530612244897959,1.0,1.0,1/6,6.17%,SPHK2
prerank,GO_Biological_Process_2021__regulation of gene expression (GO:0010468),-0.2469934511109646,-0.7747982660118935,1.0,1.0,1.0,92/800,12.18%,KDR;POU6F2;MYB;BMP7;SOX13;FEZF2;ADAM19;FGFR4;LEF1;HMGN5;RUNX1;PID1;ZNF628;EPHB2;PCBP3;ATOH8;AHNAK2;BRCA2;ASCL1;OR7D2;SOX12;TEAD2;SLC22A2;ZNF462;PRDM5;HDAC5;KHSRP;IGF1;APLN;ATXN1L;ZNF117;WTIP;HNRNPL;SFRP1;WWTR1;RRP1B;TICAM1;BCL6;TRAF3;AFF3;AZU1;TGFB2;FGF1;HDAC1;ZNF562;AKAP17A;ZNF273;AMH;SBNO2;PTBP3;AURKA;ACE2;FOXP1;ZNF536;ETS1;TRIM11;ZFHX3;PTHLH;BMP6;ID2;GCNT2;CILP;STAT3;HMGA2;RORA;BTG1;IFI16;TAF1;CDH1;POU3F1;DRD1;CREB3L1;NFX1;PRDM7;APOE;ZNF66;DNMT1;PARP10;CLU;NFIA;PCGF1;SLC24A3;NOG;NGF;SON;SPIN2B;TRIM68;TRIM4;IGF2BP3;PRDM11;PHF1;NWD1
prerank,GO_Biological_Process_2021__cellular response to hepatocyte growth factor stimulus (GO:0035729),0.453092265240714,0.7744778190944768,0.7878787878787878,1.0,1.0,2/7,16.34%,HGF;LGMN
prerank,GO_Biological_Process_2021__response to hepatocyte growth factor (GO:0035728),0.453092265240714,0.7744778190944768,0.7878787878787878,1.0,1.0,2/7,16.34%,HGF;LGMN
prerank,MSigDB_Hallmark_2020__Oxidative Phosphorylation,0.3053481578774092,0.7743810130984126,0.9487179487179487,1.0,1.0,51/180,29.45%,HSD17B10;LDHB;ATP6AP1;TOMM22;NDUFA2;NDUFB3;MDH1;NDUFB4;ATP1B1;NDUFB2;COX4I1;ATP6V1C1;COX7A2L;PDK4;UQCRB;COX11;ATP5F1E;MTX2;DECR1;CYCS;ACAA2;ATP6V0B;MRPL34;IDH3A;ACAT1;SLC25A4;ATP5F1C;RETSAT;ATP6V1D;ATP5MC3;ETFB;CYB5R3;DLST;NDUFV1;VDAC3;VDAC1;ALDH6A1;MAOB;TIMM8B;ETFA;IDH1;MRPL35;SLC25A11;IDH3B;NNT;SLC25A3;ATP6V1G1;NDUFB6;ATP5ME;COX6B1;SLC25A5
prerank,GO_Biological_Process_2021__regulation of alpha-beta T cell differentiation (GO:0046637),-0.4322743610301273,-0.77429258248631,0.7297297297297297,1.0,1.0,2/6,3.37%,SH3RF1;PNP
prerank,MSigDB_Hallmark_2020__TGF-beta Signaling,-0.3181030672784693,-0.7741236172313322,0.9411764705882353,1.0,1.0,11/49,16.59%,PMEPA1;WWTR1;HDAC1;ID2;CDH1;XIAP;PPP1CA;NOG;ID3;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__zinc ion transmembrane transport (GO:0071577),-0.42244896457708436,-0.7740475952458944,0.6857142857142857,1.0,1.0,1/16,0.88%,SLC39A11
prerank,GO_Biological_Process_2021__cellular response to molecule of bacterial origin (GO:0071219),0.34955277630565834,0.7735556975321334,0.7971014492753623,1.0,1.0,18/59,29.32%,CD14;PDCD1LG2;STAP1;DAB2IP;PDCD4;CXCL13;TLR2;CD274;PLAA;CX3CR1;LBP;CD80;GSTP1;SERPINE1;ADAM9;TNIP2;ZFP36;NFKBIL1
prerank,GO_Biological_Process_2021__pentose catabolic process (GO:0019323),-0.4733699116349045,-0.7731438855297195,0.7115384615384616,1.0,1.0,2/5,15.87%,XYLB;RPEL1
prerank,GO_Biological_Process_2021__regulation of macrophage differentiation (GO:0045649),0.46451817648947613,0.7730385254784401,0.7910447761194029,1.0,1.0,3/11,10.45%,INHBA;FADD;CASP8
prerank,GO_Biological_Process_2021__ameboidal-type cell migration (GO:0001667),0.36153002799279776,0.7728412882647583,0.7236842105263158,1.0,1.0,7/47,16.04%,SEMA3D;AMOT;SOX10;TBX1;SEMA3F;SEMA3A;HTR2B
prerank,PanglaoDB_Augmented_2021__Parietal Cells,0.34061596736891253,0.7728396634648931,0.8552631578947368,1.0,1.0,16/98,19.24%,PPP1R1B;RAPGEF5;KCNE2;CP;SOWAHA;HIP1R;MYO5B;FGFR2;PAIP2B;CHDH;PCDH1;PODXL;EBF4;KCNQ1;SPARCL1;SYT13
prerank,GO_Biological_Process_2021__mitochondrial proton-transporting ATP synthase complex assembly (GO:0033615),0.5415273888714484,0.772706892495767,0.8275862068965517,1.0,1.0,4/5,41.06%,ATPAF1;TMEM70;OXA1L;ATP23
prerank,GO_Biological_Process_2021__regulation of rhodopsin mediated signaling pathway (GO:0022400),0.40355253776435507,0.7727022209018208,0.746268656716418,1.0,1.0,5/18,18.13%,CNGB1;GUCY2F;CNGA1;PDE6B;METAP1
prerank,GO_Biological_Process_2021__positive regulation of ATP biosynthetic process (GO:2001171),-0.5140288868675367,-0.7721306467556709,0.8260869565217391,1.0,1.0,1/7,1.84%,PID1
prerank,GO_Biological_Process_2021__negative regulation of TOR signaling (GO:0032007),0.37675481875578803,0.772045628264916,0.8235294117647058,1.0,1.0,5/30,20.38%,SESN3;RNF152;TSC2;TNFAIP8L1;DEPTOR
prerank,GO_Biological_Process_2021__gene expression (GO:0010467),-0.2485979378371371,-0.772038425244606,1.0,1.0,1.0,51/322,17.89%,NOX4;CPSF1;LMF2;NUP210;ADARB2;DTX1;TPR;HNRNPL;CHTOP;LMF1;DHX8;NUP37;MAGOHB;MRPS18A;POLR2G;SMG6;RBMS2;SARS1;MRPL55;RRBP1;THOC1;SORL1;PTMA;RBMS1;EIF4G1;PRPF4;U2AF2;SRRM1;IGF2BP3;DNAJB11;POLR2C;SRSF7;RBM3;POLR2L;TASP1;CASC3;RPL12;TSPAN32;NUP42;RPS26;FARSB;ATXN1;MRPS7;MRPL9;FUBP3;NUP107;SETX;NXF5;TSPAN33;SYMPK;POLR3A
prerank,GO_Biological_Process_2021__mRNA processing (GO:0006397),-0.27459767355336234,-0.7720098311660094,1.0,1.0,1.0,64/276,19.42%,CPSF1;SNRNP27;ERCC2;HNRNPL;SF3A2;SF3B4;RBM41;CHTOP;DHX8;MAGOHB;GTF2H2;PPIH;LSM6;CCNH;POLR2G;ELAVL1;RBMX;THOC1;RBM10;RBM17;PRPF4;U2AF2;CPSF7;SRRM1;TXNL4A;SON;SNRPB;ZCRB1;GPATCH1;SNRPN;ZRSR2;RBM19;KIN;SF3A1;GTF2F1;POLR2C;SRSF7;CACTIN;SRRM4;SCAF11;CDC5L;DDX41;POLR2L;CASC3;PPIL1;RSRC1;PTBP1;AURKAIP1;SF3B6;PDCD7;DDX46;RNF113A;CWF19L2;PRPF6;SYMPK;LSM7;PRPF3;GTF2H5;WBP4;SRRT;CELF1;RNPC3;USP49;CWF19L1
prerank,GO_Biological_Process_2021__cell-cell junction assembly (GO:0007043),-0.28963622195284533,-0.7720039498579403,0.9523809523809523,1.0,1.0,6/51,12.41%,PKP2;CDH6;CDHR3;CDH20;TLN1;PIP5K1C
prerank,GO_Biological_Process_2021__SA node cell action potential (GO:0086015),0.48835989241930594,0.771739693869165,0.7288135593220338,1.0,1.0,2/7,22.46%,CACNA1G;HCN4
prerank,GO_Biological_Process_2021__actin filament depolymerization (GO:0030042),0.4669314733408556,0.7717227955441666,0.746031746031746,1.0,1.0,5/11,30.77%,TWF1;CFL2;TWF2;WDR1;CFL1
prerank,GO_Biological_Process_2021__regulation of histone H4 acetylation (GO:0090239),-0.4398990113733584,-0.7714706061828066,0.7804878048780488,1.0,1.0,3/8,20.15%,IWS1;SMARCB1;KAT7
prerank,GO_Biological_Process_2021__protein localization to nucleus (GO:0034504),-0.29952899961951573,-0.7713656573511155,0.8636363636363636,1.0,1.0,5/90,8.70%,NUP62CL;BMP7;TPR;STAT3;ZBTB7A
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte activation (GO:0051250),0.4535956172835302,0.7712459369139657,0.8070175438596491,1.0,1.0,5/13,27.19%,SOX11;IL4I1;BANK1;LAPTM5;FGL1
prerank,GO_Biological_Process_2021__amino sugar metabolic process (GO:0006040),-0.45684300833690905,-0.7712063811244251,0.8571428571428571,1.0,1.0,1/9,3.07%,ST3GAL1
prerank,GO_Biological_Process_2021__response to lipopolysaccharide (GO:0032496),-0.32622593321298055,-0.7710868091352296,0.9130434782608695,1.0,1.0,6/89,7.25%,SELP;TNFRSF11A;GCH1;TICAM1;SBNO2;FOXP1
prerank,GO_Biological_Process_2021__mitotic nuclear division (GO:0140014),0.35297547714348326,0.7709106339210098,0.859375,1.0,1.0,7/60,17.32%,CENPK;CHMP4B;TPX2;MZT1;EPS8;RAB11A;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide metabolic process (GO:1904407),-0.37559994415510356,-0.7708287103012565,0.7804878048780488,1.0,1.0,5/17,24.24%,CLU;NOS1AP;TMEM106A;DDAH1;ASS1
prerank,MSigDB_Hallmark_2020__Estrogen Response Late,0.31555214730048037,0.770661617115511,0.9047619047619048,1.0,1.0,25/153,14.83%,CA12;CALCR;PTGES;WFS1;PLAC1;PRLR;TST;FKBP4;NXT1;TJP3;ISG20;GINS2;PTGER3;FKBP5;CPE;MYOF;ACOX2;CDC6;GPER1;CKB;IMPA2;OPN3;HSPA4L;TSPAN13;AFF1
prerank,GO_Biological_Process_2021__unsaturated fatty acid metabolic process (GO:0033559),0.37594882152514214,0.7705789976228984,0.9076923076923077,1.0,1.0,10/40,16.10%,PLA2G10;CYP1B1;EPHX1;ALOX12;ELOVL2;SCD;PTGR1;ACOX1;FADS2;ALOXE3
prerank,GO_Biological_Process_2021__negative regulation of BMP signaling pathway (GO:0030514),-0.3356457559121968,-0.7705195641101324,0.8333333333333334,1.0,1.0,9/42,14.03%,GREM1;LEMD2;CRIM1;VWC2;SORL1;CHRDL1;NOG;NBL1;BMPER
prerank,GO_Biological_Process_2021__cardiac ventricle morphogenesis (GO:0003208),0.4030573621915338,0.7695442185270092,0.8,1.0,1.0,7/24,13.78%,NOTCH1;CPE;MYBPC3;FGFR2;SOX11;SMAD7;TGFB1
prerank,"GO_Biological_Process_2021__positive regulation of mRNA splicing, via spliceosome (GO:0048026)",-0.38555200412599594,-0.7694847253428732,0.7659574468085106,1.0,1.0,6/15,16.90%,SF3B4;NCL;RBMX;RBM3;CIRBP;CELF4
prerank,GO_Biological_Process_2021__diadenosine polyphosphate catabolic process (GO:0015961),0.5258896507039857,0.7692766012756123,0.8923076923076924,1.0,1.0,2/5,26.91%,NUDT4;NUDT11
prerank,GO_Biological_Process_2021__cytoskeleton-dependent intracellular transport (GO:0030705),0.3820990955221931,0.7692570992390987,0.7301587301587301,1.0,1.0,5/21,26.93%,TUBB;TUBA1A;TUBA1B;CCDC88B;HOOK2
prerank,GO_Biological_Process_2021__regulation of protein kinase B signaling (GO:0051896),-0.2879101479504883,-0.7692103685259666,0.8823529411764706,1.0,1.0,8/155,5.79%,KIT;NRG1;FGFR4;BTC;EREG;KITLG;OTUD3;FGF1
prerank,GO_Biological_Process_2021__negative regulation of pri-miRNA transcription by RNA polymerase II (GO:1902894),-0.4230510059988991,-0.7692064132671409,0.7837837837837838,1.0,1.0,1/11,3.62%,NFIB
prerank,GO_Biological_Process_2021__skeletal system development (GO:0001501),0.3328949464379703,0.7689637096154938,0.9090909090909091,1.0,1.0,18/116,13.04%,PRELP;ALPL;TLL1;ADAMTS4;HHIP;ETS2;NOTUM;TEAD4;BMP1;SOX6;CMKLR1;MEPE;LECT2;FGFR2;SOX11;XYLT1;KIAA1217;COL10A1
prerank,MSigDB_Hallmark_2020__Apoptosis,0.31554404287581195,0.7688248594340583,0.9135802469135802,1.0,1.0,19/126,13.02%,TIMP3;GADD45B;PDGFRB;BIK;TIMP2;ISG20;CCND2;BCAP31;CD14;SOD2;CDKN1B;HGF;AVPR1A;CASP8;RHOB;FAS;SMAD7;BCL2L2;IRF1
prerank,GO_Biological_Process_2021__regulation of integrin activation (GO:0033623),-0.4558417369075616,-0.7687131260542458,0.6666666666666666,1.0,1.0,1/13,0.60%,SELP
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol 3-kinase activity (GO:0043551),-0.37965221466018495,-0.768569326548324,0.8,1.0,1.0,1/28,0.36%,KIT
prerank,GO_Biological_Process_2021__positive regulation of DNA replication (GO:0045740),-0.4043749840765922,-0.7684971146027614,0.8461538461538461,1.0,1.0,3/15,13.89%,EREG;EGFR;FAF1
prerank,GO_Biological_Process_2021__marginal zone B cell differentiation (GO:0002315),-0.48408390384756805,-0.7684415444015408,0.7317073170731707,1.0,1.0,1/5,4.22%,DOCK10
prerank,GO_Biological_Process_2021__neural tube closure (GO:0001843),-0.32186687665416164,-0.7682117295364767,0.7857142857142857,1.0,1.0,7/31,17.13%,TGFB2;LMO4;COBL;SEMA4C;MTHFD1L;MTHFR;PRICKLE1
prerank,GO_Biological_Process_2021__positive regulation of catecholamine secretion (GO:0033605),-0.48033603527303914,-0.7681497071273442,0.7631578947368421,1.0,1.0,1/5,9.84%,VIP
prerank,GO_Biological_Process_2021__protein lipidation (GO:0006497),0.3703344859106652,0.768123444877877,0.8441558441558441,1.0,1.0,9/56,16.11%,ZDHHC22;PIGC;HHAT;ZDHHC6;PGAP4;PIGV;PIGH;PGAP3;MPPE1
prerank,GO_Biological_Process_2021__positive regulation of pinocytosis (GO:0048549),0.47093535354018395,0.7680948241560001,0.7931034482758621,1.0,1.0,3/7,40.54%,CDC42;ANKFY1;APPL1
prerank,GO_Biological_Process_2021__positive regulation of receptor signaling pathway via STAT (GO:1904894),0.42066029083538703,0.7677999042549546,0.7704918032786885,1.0,1.0,4/15,10.22%,CCL5;NOTCH1;CYP1B1;CRLF3
prerank,GO_Biological_Process_2021__regulation of tubulin deacetylation (GO:0090043),0.45669438630098513,0.7676691581419601,0.7777777777777778,1.0,1.0,3/7,31.72%,BEX4;FNTA;PRKAA1
prerank,GO_Biological_Process_2021__regulation of DNA replication (GO:0006275),-0.324902936186245,-0.7672135311099493,0.9142857142857143,1.0,1.0,8/43,13.89%,EREG;DSCC1;ORC3;SLFN11;EHMT2;RBBP6;EGFR;FAF1
prerank,GO_Biological_Process_2021__galactose metabolic process (GO:0006012),0.4332169748032035,0.7671691594581825,0.7777777777777778,1.0,1.0,1/9,5.67%,CHST1
prerank,GO_Biological_Process_2021__alpha-linolenic acid metabolic process (GO:0036109),0.4411979777046381,0.7669302891854605,0.7903225806451613,1.0,1.0,3/12,15.89%,ELOVL2;ACOX1;FADS2
prerank,GO_Biological_Process_2021__desensitization of G protein-coupled receptor signaling pathway (GO:0002029),0.47027175161744594,0.7665913315805669,0.7777777777777778,1.0,1.0,2/8,13.12%,ARR3;DRD3
prerank,MSigDB_Hallmark_2020__Glycolysis,-0.2616766340465465,-0.766522522196947,1.0,1.0,1.0,24/174,13.53%,GPC4;PKP2;LDHC;SLC37A4;CYB5A;VCAN;GAL3ST1;HMMR;CLN6;IER3;RARS1;VLDLR;AURKA;GALE;GUSB;EXT1;B3GAT3;MXI1;EXT2;SLC25A10;EGFR;PGM2;GOT2;HDLBP
prerank,GO_Biological_Process_2021__negative regulation of cell cycle (GO:0045786),-0.3056024292657366,-0.7664805343841851,1.0,1.0,1.0,3/62,2.39%,PTPN3;BMP7;INHA
prerank,GO_Biological_Process_2021__negative regulation of gene expression (GO:0010629),-0.2622103717868127,-0.7663079550197957,1.0,1.0,1.0,40/261,15.85%,KDR;RUNX1;SAMD4A;ATOH8;TYMS;SRGN;IGF1;APLN;SFRP1;TGFB2;HDAC1;PTBP3;AURKA;CIDEA;FOXP1;MACROH2A2;NCL;ID2;LSM6;DHFR;CILP;TAF1;CREB3L1;APOE;DNMT1;PARP10;SLC24A3;IGF2BP3;PHF1;TRIM71;DIS3L2;YY1;BTG2;SAMD4B;REL;RBMS3;PTBP1;HDAC9;RPS26;PNPT1
prerank,GO_Biological_Process_2021__type B pancreatic cell differentiation (GO:0003309),-0.46950606111332654,-0.7662036502208661,0.75,1.0,1.0,1/5,7.62%,BMP6
prerank,GO_Biological_Process_2021__regulation of cell motility (GO:2000145),-0.3039462948598056,-0.7658205794763662,0.9629629629629629,1.0,1.0,12/103,10.21%,NRG1;PRAG1;BTC;EREG;SST;SGK1;DOCK10;FGF1;PLXNA1;PLXNA2;CSF1R;LMO4
prerank,GO_Biological_Process_2021__positive regulation of epidermal cell differentiation (GO:0045606),-0.3987531565109437,-0.7657075405021333,0.7435897435897436,1.0,1.0,2/11,7.73%,NUMA1;MACROH2A2
prerank,GO_Biological_Process_2021__negative regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043154),-0.3540618809262893,-0.7654899128900452,0.84,1.0,1.0,5/40,11.83%,SH3RF1;TRIAP1;IGBP1;XIAP;NGF
prerank,GO_Biological_Process_2021__vascular endothelial growth factor receptor signaling pathway (GO:0048010),-0.32271293729507905,-0.7653002203765902,0.8275862068965517,1.0,1.0,4/55,13.37%,KDR;HSPB1;NRP1;ELMO2
prerank,GO_Biological_Process_2021__positive regulation of isomerase activity (GO:0010912),0.47513501475446096,0.7649952836977703,0.7833333333333333,1.0,1.0,3/7,36.76%,PLSCR1;UHRF1;ITGAM
prerank,GO_Biological_Process_2021__endoplasmic reticulum organization (GO:0007029),0.34891119918059466,0.7649613407559547,0.8157894736842105,1.0,1.0,14/63,21.23%,LMAN1;LPCAT3;VAPB;ATL1;TRAM2;VCPIP1;TLE6;CCDC47;OTOF;TRDN;TMEM33;LRRK2;REEP5;ALDH3A2
prerank,GO_Biological_Process_2021__response to axon injury (GO:0048678),0.43339721920841007,0.7649340554659448,0.8253968253968254,1.0,1.0,3/15,16.77%,P2RY12;NREP;FLRT3
prerank,GO_Biological_Process_2021__glutamine family amino acid metabolic process (GO:0009064),-0.3372936946907295,-0.7649098501627452,0.8,1.0,1.0,5/29,13.12%,DGLUCY;MTHFS;PYCR3;NIT2;GOT2
prerank,GO_Biological_Process_2021__negative regulation of mitochondrial fusion (GO:0010637),0.5232501012320588,0.764677640867393,0.8333333333333334,1.0,1.0,1/7,8.17%,BNIP3
prerank,GO_Biological_Process_2021__negative regulation of peptide hormone secretion (GO:0090278),-0.3992482615188559,-0.7646643892313425,0.7352941176470589,1.0,1.0,6/16,19.41%,CRH;SFRP1;MIDN;IRS1;CCN3;PRKN
prerank,GO_Biological_Process_2021__negative regulation of chromosome organization (GO:2001251),-0.4422354652159697,-0.7646570098167278,0.7272727272727273,1.0,1.0,1/7,7.70%,ERCC1
prerank,GO_Biological_Process_2021__negative regulation of intracellular signal transduction (GO:1902532),-0.3020968915540975,-0.7642027180321718,1.0,1.0,1.0,17/163,9.72%,PDE10A;BMP7;SPRED1;CCDC22;PRDM15;PDE3A;WTIP;EPM2A;OTUD3;DGKD;BCL2;SHANK2;NR1H4;MAP2K3;RORA;SPRY3;DLG5
prerank,GO_Biological_Process_2021__negative regulation of production of miRNAs involved in gene silencing by miRNA (GO:1903799),0.5022227897835212,0.764177107383035,0.84375,1.0,1.0,3/7,13.78%,ESR1;BCDIN3D;TGFB1
prerank,GO_Biological_Process_2021__lung epithelium development (GO:0060428),-0.44855666313486453,-0.7641707468893498,0.7631578947368421,1.0,1.0,1/7,2.83%,ASCL1
prerank,"GO_Biological_Process_2021__mitochondrial electron transport, cytochrome c to oxygen (GO:0006123)",0.4584992705310035,0.7641621446038768,0.8225806451612904,1.0,1.0,3/11,18.54%,COX4I1;COX7A2L;CYCS
prerank,GO_Biological_Process_2021__mammary gland development (GO:0030879),-0.4138295215021499,-0.7641185059667107,0.7894736842105263,1.0,1.0,2/17,3.98%,NRG1;APLN
prerank,GO_Biological_Process_2021__cellular biogenic amine catabolic process (GO:0042402),0.45618417863018546,0.7640059351005064,0.746268656716418,1.0,1.0,2/9,23.15%,CHDH;LRTOMT
prerank,GO_Biological_Process_2021__regulation of carbohydrate biosynthetic process (GO:0043255),0.47746875567908587,0.7639350231583003,0.8333333333333334,1.0,1.0,1/10,11.56%,SDHAF3
prerank,GO_Biological_Process_2021__COPII-coated vesicle budding (GO:0090114),0.3462621309830839,0.7637365801065601,0.9142857142857143,1.0,1.0,4/64,6.93%,LMAN1;F8;VAPB;TGFA
prerank,GO_Biological_Process_2021__regulation of transcription from RNA polymerase II promoter in response to stress (GO:0043618),0.34309999659347334,0.7637167379297133,0.8648648648648649,1.0,1.0,10/76,22.91%,CA9;DNAJB1;PSMB6;EPAS1;PSMA3;PSMB8;CUL2;HIF3A;PSMA5;ARNT
prerank,GO_Biological_Process_2021__regulation of microtubule-based movement (GO:0060632),-0.4412361659345098,-0.7636140547222033,0.7631578947368421,1.0,1.0,1/8,6.40%,IGBP1
prerank,GO_Biological_Process_2021__sister chromatid segregation (GO:0000819),-0.3490190272815963,-0.7635157365164545,0.896551724137931,1.0,1.0,6/25,13.44%,SMC1A;INO80;SGO2;KIF25;TUBG1;SMC4
prerank,GO_Biological_Process_2021__attachment of mitotic spindle microtubules to kinetochore (GO:0051315),0.4834543977423307,0.7634884640131749,0.8611111111111112,1.0,1.0,6/9,42.80%,BOD1;KIF2C;CHAMP1;SEH1L;MIS12;NUF2
prerank,GO_Biological_Process_2021__actin filament-based transport (GO:0099515),0.41636290174860335,0.7632001160691497,0.7878787878787878,1.0,1.0,5/19,29.62%,MYO5B;MYO1F;MYO1B;SYNE2;WASL
prerank,GO_Biological_Process_2021__regulation of cholesterol storage (GO:0010885),-0.3974488332502776,-0.7631758150244992,0.7428571428571429,1.0,1.0,3/13,22.22%,SCARB1;NR1H2;PPARA
prerank,PanglaoDB_Augmented_2021__Adrenergic Neurons,-0.29565566517539194,-0.7630806331427671,1.0,1.0,1.0,8/90,7.04%,RIMBP2;FGFR4;CACNG4;GAL3ST1;FAM163B;CARMIL3;FBLL1;APOA1
prerank,GO_Biological_Process_2021__positive regulation of cellular response to transforming growth factor beta stimulus (GO:1903846),0.4230369928119006,0.7628636634205317,0.7936507936507936,1.0,1.0,1/18,5.70%,ING2
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta receptor signaling pathway (GO:0030511),0.4230369928119006,0.7628636634205317,0.7936507936507936,1.0,1.0,1/18,5.70%,ING2
prerank,GO_Biological_Process_2021__muscle contraction (GO:0006936),0.3253118766258725,0.7628524938242596,0.8552631578947368,1.0,1.0,11/90,10.94%,MYLK;CHRNB1;CAV3;MYBPC2;CHRNG;ACTA2;MYOM1;ACTC1;MYOF;CHRNE;MYBPC3
prerank,GO_Biological_Process_2021__cellular polysaccharide catabolic process (GO:0044247),0.4113007943454649,0.7626528745209636,0.7454545454545455,1.0,1.0,3/14,15.20%,PHKG1;PHKA1;AGL
prerank,GO_Biological_Process_2021__protein neddylation (GO:0045116),0.4509162447905659,0.7622927898721499,0.8166666666666667,1.0,1.0,2/8,23.41%,DCUN1D1;UBA3
prerank,GO_Biological_Process_2021__negative regulation of histone methylation (GO:0031061),-0.46078899168354803,-0.7619929149162562,0.8,1.0,1.0,3/12,12.13%,AASS;DNMT1;PHF1
prerank,GO_Biological_Process_2021__negative regulation of SMAD protein signal transduction (GO:0060392),-0.47437415000635597,-0.761825352734786,0.7647058823529411,1.0,1.0,3/5,18.74%,CILP;CCN3;FAM89B
prerank,GO_Biological_Process_2021__regulation of chromatin assembly or disassembly (GO:0001672),0.500247664067073,0.7617466763384143,0.8333333333333334,1.0,1.0,1/6,6.88%,SPTY2D1
prerank,GO_Biological_Process_2021__mitochondrion distribution (GO:0048311),0.4430770647085869,0.7617094109053487,0.7538461538461538,1.0,1.0,2/12,21.54%,LRRK2;MEF2A
prerank,GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060211),-0.3955872489774261,-0.7614864595704317,0.825,1.0,1.0,2/15,13.57%,POLR2G;BTG2
prerank,GO_Biological_Process_2021__vasculogenesis (GO:0001570),0.4161754697294259,0.7614250710789486,0.782608695652174,1.0,1.0,4/20,4.13%,PDGFRB;RASA1;RASIP1;NOTCH1
prerank,GO_Biological_Process_2021__organic hydroxy compound transport (GO:0015850),0.3917935817675188,0.7613916923386804,0.8428571428571429,1.0,1.0,13/32,25.41%,SLCO2B1;ABCC2;GHRL;SLC10A5;SLC10A1;SLC16A1;AQP9;SLCO1A2;SLC16A8;STARD5;NCOA2;SLC51A;ABCG5
prerank,PanglaoDB_Augmented_2021__Cajal-Retzius Cells,-0.2784091207933349,-0.7609489880916143,0.9565217391304348,1.0,1.0,21/162,14.05%,NRG1;HOMER2;ADAM12;PCDH19;CLSTN2;CIB2;RGMB;ZNF536;KCNC1;MAPK4;INSYN2A;PHF21B;STMN2;RIPOR2;ELAVL3;SMOC2;LINGO2;PLPPR5;GRIA2;TRIM44;BRINP1
prerank,GO_Biological_Process_2021__nucleoside catabolic process (GO:0009164),0.42424332110570323,0.7608817398681427,0.7391304347826086,1.0,1.0,2/12,15.41%,UPB1;DPYS
prerank,GO_Biological_Process_2021__regulation of postsynapse organization (GO:0099175),-0.33491617703480725,-0.7607979201306891,0.88,1.0,1.0,1/26,2.04%,LZTS3
prerank,GO_Biological_Process_2021__protein import into mitochondrial matrix (GO:0030150),-0.39504544718330015,-0.7607492016744307,0.7272727272727273,1.0,1.0,4/16,16.49%,TOMM40L;TIMM50;TOMM40;TIMM44
prerank,GO_Biological_Process_2021__negative regulation of appetite (GO:0032099),-0.46208399047202425,-0.7597456172158402,0.6571428571428571,1.0,1.0,3/7,22.22%,SPX;LEP;PPARA
prerank,GO_Biological_Process_2021__import into cell (GO:0098657),0.36261113748928586,0.7596143363463301,0.835820895522388,1.0,1.0,4/35,13.42%,SLC12A7;SLC36A1;LRRC8D;NEURL1B
prerank,GO_Biological_Process_2021__embryonic organ morphogenesis (GO:0048562),-0.3652297220350611,-0.759324183443821,0.7948717948717948,1.0,1.0,5/20,9.66%,RBP4;DSCAML1;ALDH1A3;ID2;PDGFRA
prerank,GO_Biological_Process_2021__regulation of telomere maintenance via telomerase (GO:0032210),0.352196300589411,0.7593011966240978,0.8571428571428571,1.0,1.0,6/47,22.78%,TCP1;CCT6A;CCT8;DCP2;CCT7;PKIB
prerank,GO_Biological_Process_2021__amino sugar biosynthetic process (GO:0046349),0.4392960766516718,0.75921148928804,0.8135593220338984,1.0,1.0,6/12,32.23%,NANP;GNPDA1;GFPT2;UAP1;PGM3;GNPNAT1
prerank,"GO_Biological_Process_2021__regulation of DNA-templated transcription, elongation (GO:0032784)",-0.3634900047988955,-0.7590135468437675,0.8157894736842105,1.0,1.0,7/24,20.90%,TSFM;THOC1;HMGN1;LDB1;KAT7;ZMYND11;CCNT1
prerank,GO_Biological_Process_2021__protein-containing complex assembly (GO:0065003),-0.28196471772690035,-0.758809987321453,1.0,1.0,1.0,22/231,9.54%,FBXL7;STING1;LEF1;TLE2;TEAD2;ZNHIT6;TRAPPC1;HDAC1;TFAP4;PPP6R1;CD247;TRAPPC9;DNAJB12;SHANK1;CARD10;PPIH;CNIH3;GRIA1;ANO6;F5;WIPF1;SMARCA4
prerank,GO_Biological_Process_2021__gliogenesis (GO:0042063),-0.39061400187949835,-0.7586731274330852,0.8,1.0,1.0,3/13,5.75%,NFIB;AZU1;TGFB2
prerank,GO_Biological_Process_2021__negative regulation of I-kappaB kinase/NF-kappaB signaling (GO:0043124),0.3813478050774141,0.7586099513546183,0.7941176470588235,1.0,1.0,12/31,25.10%,CARD8;STAT1;CASP8;RHOH;ESR1;CARD19;DAB2IP;NLRC3;PER1;PPM1A;GSTP1;TRIM59
prerank,GO_Biological_Process_2021__positive regulation by host of viral process (GO:0044794),-0.40466999280216887,-0.7585576539122606,0.7027027027027027,1.0,1.0,6/11,31.20%,APOE;PC;PPIB;ZNF502;TBC1D20;IGF2R
prerank,"GO_Biological_Process_2021__alternative mRNA splicing, via spliceosome (GO:0000380)",0.41186172863417686,0.7584520242829502,0.8235294117647058,1.0,1.0,1/14,6.83%,SLU7
prerank,GO_Biological_Process_2021__pre-replicative complex assembly involved in nuclear cell cycle DNA replication (GO:0006267),0.44997871725006666,0.758376984720522,0.75,1.0,1.0,2/8,8.15%,MCM2;MCMDC2
prerank,GO_Biological_Process_2021__adrenergic receptor signaling pathway (GO:0071875),0.44624587615378963,0.7582702519818898,0.7878787878787878,1.0,1.0,4/15,24.50%,ADRB1;DRD3;LMBRD2;ADRA1D
prerank,GO_Biological_Process_2021__positive regulation of mitochondrion organization (GO:0010822),0.3484610290767697,0.7578339778259259,0.8507462686567164,1.0,1.0,12/52,17.11%,BIK;BOK;MOAP1;HIP1R;BNIP3;PPARGC1A;ZDHHC6;GPER1;PLAUR;VPS35;PINK1;MIEF2
prerank,GO_Biological_Process_2021__stabilization of membrane potential (GO:0030322),0.46866367538210085,0.7578145575937735,0.7313432835820896,1.0,1.0,3/11,20.74%,KCNN4;KCNK10;KCNK1
prerank,GO_Biological_Process_2021__G protein-coupled receptor internalization (GO:0002031),0.48393622089514376,0.7576628285458228,0.8070175438596491,1.0,1.0,2/6,13.12%,ARR3;DRD3
prerank,GO_Biological_Process_2021__axon extension (GO:0048675),0.39005406059781894,0.757450468514349,0.8472222222222222,1.0,1.0,8/24,31.15%,SEMA3F;SEMA3A;SLC9A6;ULK1;SLIT1;CYFIP1;SLIT2;ALCAM
prerank,GO_Biological_Process_2021__ubiquitin-dependent protein catabolic process (GO:0006511),-0.25164926663463527,-0.7574014668929961,1.0,1.0,1.0,52/319,20.38%,FBXL7;RNF150;MYLIP;RNF126;PTTG1;CDC26;FEM1A;PTPN23;AURKA;NSFL1C;UBE2D4;KCTD13;TRPC4AP;UBE2R2;ERCC8;TAF1;UBXN2A;RNF216;CDC23;SIRT2;RNF114;ZNRF1;RBBP6;TRIM71;RNF130;CUL4A;FAF1;FZR1;TSG101;PML;FBXL22;RAD23A;RBCK1;FBXO45;FBXO22;ZFAND2B;DTX3L;KLHL20;VCP;RNF215;OTUD7A;ANAPC7;KLHL25;NPLOC4;PRKN;KCTD5;RC3H1;FBXW5;SQSTM1;VPS37C;ANAPC16;MVB12B
prerank,GO_Biological_Process_2021__peptidyl-serine dephosphorylation (GO:0070262),-0.362127309800514,-0.7573456071344304,0.8076923076923077,1.0,1.0,3/13,18.59%,PPP1CA;PPM1F;PPP5C
prerank,GO_Biological_Process_2021__exonucleolytic catabolism of deadenylated mRNA (GO:0043928),-0.322335767584111,-0.7573172713799078,0.90625,1.0,1.0,7/28,17.70%,LSM6;DCPS;EXOSC7;EXOSC1;EXOSC5;EXOSC4;LSM7
prerank,GO_Biological_Process_2021__regulation of cellular component organization (GO:0051128),0.3231817306710631,0.7572717344541767,0.9240506329113924,1.0,1.0,15/120,16.76%,TMEM97;ANGPTL7;ATF5;AGT;HIP1R;KIF14;RIT2;GFAP;PAPPA2;TSC2;HSPA8;CAMK2D;SNX17;PINK1;DAB2IP
prerank,GO_Biological_Process_2021__cellular response to alkaloid (GO:0071312),-0.42690632978501136,-0.7570975080087765,0.8157894736842105,1.0,1.0,2/13,12.76%,RYR1;SPIDR
prerank,GO_Biological_Process_2021__negative regulation of heart contraction (GO:0045822),0.47808790801721185,0.7570648483071163,0.7666666666666667,1.0,1.0,2/9,17.19%,FKBP1B;PLN
prerank,GO_Biological_Process_2021__positive regulation of deoxyribonuclease activity (GO:0032077),-0.47802370453048965,-0.7570335767123096,0.8235294117647058,1.0,1.0,2/5,11.56%,PRKCD;DDX11
prerank,GO_Biological_Process_2021__endosome transport via multivesicular body sorting pathway (GO:0032509),0.402149564575005,0.7569752703457454,0.8148148148148148,1.0,1.0,4/21,17.32%,CHMP4B;CHMP2B;CHMP1A;CHMP2A
prerank,GO_Biological_Process_2021__negative regulation of cell cycle G2/M phase transition (GO:1902750),-0.3465334204207377,-0.7569420785097986,0.75,1.0,1.0,1/52,0.66%,FBXL7
prerank,GO_Biological_Process_2021__cholesterol transport (GO:0030301),0.37302503807379755,0.7569416558996633,0.8333333333333334,1.0,1.0,1/37,1.49%,LDLRAP1
prerank,GO_Biological_Process_2021__axon extension involved in axon guidance (GO:0048846),0.4880855810170926,0.7569317025083008,0.8064516129032258,1.0,1.0,5/8,31.15%,SEMA3F;SEMA3A;SLIT1;SLIT2;ALCAM
prerank,GO_Biological_Process_2021__neuron projection extension involved in neuron projection guidance (GO:1902284),0.4880855810170926,0.7569317025083008,0.8064516129032258,1.0,1.0,5/8,31.15%,SEMA3F;SEMA3A;SLIT1;SLIT2;ALCAM
prerank,GO_Biological_Process_2021__regulation of viral genome replication (GO:0045069),0.3734808663455915,0.7566545647422116,0.868421052631579,1.0,1.0,4/49,6.11%,CCL5;VAPB;NR5A2;ISG20
prerank,GO_Biological_Process_2021__regulation of potassium ion transmembrane transport (GO:1901379),-0.33222085192619244,-0.7564184587873817,0.8709677419354839,1.0,1.0,12/52,15.05%,KCNIP1;KCNJ16;AMIGO1;KCNN3;KCNE1;KCNN2;DPP6;NOS1AP;BIN1;KCNJ6;GABBR2;KCNJ2
prerank,GO_Biological_Process_2021__anaphase-promoting complex-dependent catabolic process (GO:0031145),-0.3193953374020071,-0.7562150545177861,0.8518518518518519,1.0,1.0,4/72,7.03%,PTTG1;CDC26;ECRG4;AURKA
prerank,GO_Biological_Process_2021__negative regulation of transmembrane transport (GO:0034763),-0.4440583647406224,-0.7560892097781193,0.8157894736842105,1.0,1.0,2/7,16.89%,PRKCB;CTTNBP2NL
prerank,GO_Biological_Process_2021__protein localization to mitochondrion (GO:0070585),0.42632218951241185,0.755697300426036,0.7571428571428571,1.0,1.0,3/12,20.42%,DNAJA1;PINK1;LRRK2
prerank,GO_Biological_Process_2021__regulation of neurotrophin TRK receptor signaling pathway (GO:0051386),0.4607153509986085,0.7553006795340902,0.7966101694915254,1.0,1.0,2/6,6.08%,NTF3;AGT
prerank,GO_Biological_Process_2021__short-chain fatty acid catabolic process (GO:0019626),0.4712718411344343,0.7551544496489747,0.7916666666666666,1.0,1.0,3/7,35.14%,MMUT;PCK2;MMAA
prerank,GO_Biological_Process_2021__carbohydrate derivative catabolic process (GO:1901136),-0.40040719283697523,-0.7550903165022448,0.7727272727272727,1.0,1.0,3/16,6.13%,AOAH;FBXO27;SAMHD1
prerank,"GO_Biological_Process_2021__mRNA splicing, via spliceosome (GO:0000398)",-0.2693998601923738,-0.7546705196850181,1.0,1.0,1.0,54/256,17.99%,SRPK3;CPSF1;SNRNP27;HNRNPL;SF3A2;SF3B4;RBM41;DHX8;MAGOHB;PPIH;LSM6;DCPS;POLR2G;ELAVL1;RBMX;RBM10;RBM17;PRPF4;U2AF2;CPSF7;SRRM1;TXNL4A;SMN1;SNRPB;ZCRB1;GPATCH1;PRMT5;SNRPN;ZRSR2;RBM19;SF3A1;GTF2F1;POLR2C;SRSF7;CACTIN;SCAF11;CDC5L;DDX41;POLR2L;CASC3;PPIL1;RSRC1;PTBP1;SF3B6;PDCD7;DDX46;RNF113A;CWF19L2;CELF4;PRPF6;GEMIN8;SYMPK;LSM7;PRPF3
prerank,GO_Biological_Process_2021__serine family amino acid metabolic process (GO:0009069),0.3975865783825849,0.7543357080055533,0.8064516129032258,1.0,1.0,3/15,18.10%,BAAT;DAO;SEPHS2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transporter activity (GO:1901020),-0.36660668208287406,-0.7539297070685471,0.7575757575757576,1.0,1.0,3/22,6.63%,CBARP;DRD4;THADA
prerank,GO_Biological_Process_2021__coronary vasculature morphogenesis (GO:0060977),-0.46224341066570496,-0.7537065957835063,0.8518518518518519,1.0,1.0,1/8,0.88%,SPRED1
prerank,GO_Biological_Process_2021__lipoxin metabolic process (GO:2001300),0.49037080768449176,0.7536358725297381,0.8113207547169812,1.0,1.0,2/5,12.98%,ALOX12;PTGR1
prerank,GO_Biological_Process_2021__sensory perception of mechanical stimulus (GO:0050954),0.317195148583197,0.75358868737811,0.9552238805970149,1.0,1.0,11/69,17.92%,MARVELD2;ROR1;WFS1;SLC26A4;TBX1;MYO3B;EYA1;NDUFB9;PIEZO2;KCNQ1;CDC14A
prerank,GO_Biological_Process_2021__regulation of histone H4-K16 acetylation (GO:2000618),0.5037254116277129,0.7535680333970232,0.7241379310344828,1.0,1.0,1/5,14.47%,BRCA1
prerank,GO_Biological_Process_2021__negative regulation of RIG-I signaling pathway (GO:0039536),-0.49841505262654473,-0.7532978618093159,0.7692307692307693,1.0,1.0,3/6,26.34%,NPLOC4;DHX58;SEC14L1
prerank,MSigDB_Hallmark_2020__Bile Acid Metabolism,0.32488397759430854,0.7532720528714335,0.88,1.0,1.0,17/91,21.41%,ALDH1A1;SLC23A1;TFCP2L1;ACSL5;PEX16;HSD17B6;PECR;BBOX1;FADS2;DIO1;HSD17B11;AQP9;SLCO1A2;DHCR24;PEX11A;PXMP2;PIPOX
prerank,"GO_Biological_Process_2021__regulation of CD8-positive, alpha-beta T cell activation (GO:2001185)",-0.4676682749193627,-0.7532565498953344,0.6829268292682927,1.0,1.0,1/7,2.07%,SH3RF1
prerank,GO_Biological_Process_2021__positive regulation of response to stimulus (GO:0048584),-0.32277682496782867,-0.7531410606362521,0.8787878787878788,1.0,1.0,5/31,9.57%,IFIH1;TGFB2;PRKCD;HMGA2;SELENON
prerank,GO_Biological_Process_2021__mitochondrial tRNA modification (GO:0070900),0.4457239566861022,0.7525257961922361,0.8333333333333334,1.0,1.0,1/8,7.00%,HSD17B10
prerank,"GO_Biological_Process_2021__positive regulation of gene expression, epigenetic (GO:0045815)",-0.3341209657657116,-0.7525048011428082,0.9090909090909091,1.0,1.0,11/51,17.05%,H1-4;ZMIZ2;SPHK2;DDX21;BAZ1B;ATAD2B;SERTAD2;POLR2L;POLR1A;TAF1D;POLR1G
prerank,GO_Biological_Process_2021__negative regulation of excitatory postsynaptic potential (GO:0090394),0.495462449810531,0.7524614882478469,0.8125,1.0,1.0,2/6,24.77%,LRRK2;NLGN4X
prerank,GO_Biological_Process_2021__membrane depolarization (GO:0051899),-0.31561399525125344,-0.752393413534236,0.9310344827586207,1.0,1.0,3/28,5.96%,CACNG4;CACNA1I;CACNA1A
prerank,GO_Biological_Process_2021__telomere organization (GO:0032200),0.3420430139363343,0.7522671594702207,0.8227848101265823,1.0,1.0,11/40,27.73%,H3-3A;PCNA;MRE11;RPA3;RECQL4;SP100;TERF2IP;RAD50;POLD1;ERCC4;BLM
prerank,GO_Biological_Process_2021__positive regulation of protein glycosylation (GO:0060050),-0.47071506060167584,-0.752254063891792,0.7317073170731707,1.0,1.0,1/5,10.46%,CHP1
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-tyrosine phosphorylation (GO:0050732),0.3907656591009894,0.7520391099358127,0.782608695652174,1.0,1.0,2/24,5.48%,NTF3;PTPRC
prerank,GO_Biological_Process_2021__ceramide transport (GO:0035627),0.44475348748930127,0.752021584439449,0.8181818181818182,1.0,1.0,3/13,17.52%,ABCB1;ABCB4;PSAP
prerank,GO_Biological_Process_2021__positive regulation of heterotypic cell-cell adhesion (GO:0034116),-0.44232997424196285,-0.751545508232154,0.7631578947368421,1.0,1.0,2/7,8.19%,BMP7;GCNT2
prerank,GO_Biological_Process_2021__regulation of gene silencing by RNA (GO:0060966),-0.33333204823460777,-0.7514621747081996,0.88,1.0,1.0,11/51,18.28%,NUP210;TPR;NUP37;POLR2G;EIF4G1;TRIM71;POLR2C;POLR2L;NUP42;NUP107;NUP43
prerank,GO_Biological_Process_2021__regulation of posttranscriptional gene silencing (GO:0060147),-0.33333204823460777,-0.7514621747081996,0.88,1.0,1.0,11/51,18.28%,NUP210;TPR;NUP37;POLR2G;EIF4G1;TRIM71;POLR2C;POLR2L;NUP42;NUP107;NUP43
prerank,GO_Biological_Process_2021__endoplasmic reticulum tubular network organization (GO:0071786),0.44169351659092576,0.7513287306748535,0.8166666666666667,1.0,1.0,5/12,33.46%,ATL1;TMEM33;REEP3;RAB18;RTN4
prerank,GO_Biological_Process_2021__secondary palate development (GO:0062009),0.424993570444926,0.7512195935888685,0.7538461538461538,1.0,1.0,1/11,1.38%,WNT8A
prerank,GO_Biological_Process_2021__regulation of cell cycle (GO:0051726),0.3071490876793176,0.750927603594812,0.9404761904761905,1.0,1.0,29/242,14.47%,GADD45B;NLRP2B;ZNF703;GMNN;SMIM22;NOTCH1;INHBA;TRIM32;PTPRC;JUNB;CDKN2D;FIGNL1;LIN9;CDKN1B;CDC25A;UHRF2;CRLF3;FBXL6;RHOB;FBXL3;FGFR2;GPER1;CHMP1A;SPATA22;IRF1;TGFB1;WDR6;TSC2;BRCA1
prerank,GO_Biological_Process_2021__smoothened signaling pathway (GO:0007224),-0.3191001066808751,-0.7509176532478061,0.9642857142857143,1.0,1.0,3/28,6.06%,ARL13B;B9D1;PTCH1
prerank,GO_Biological_Process_2021__zinc ion homeostasis (GO:0055069),0.416219259296155,0.7508374868843517,0.835820895522388,1.0,1.0,2/20,6.59%,SLC30A8;SLC39A12
prerank,GO_Biological_Process_2021__positive regulation of phagocytosis (GO:0050766),0.3561020861983466,0.7507338731289533,0.9,1.0,1.0,4/31,5.48%,CD300LF;IL15;DOCK2;PTPRC
prerank,GO_Biological_Process_2021__nuclear export (GO:0051168),-0.28497186709473665,-0.750731439829564,0.9615384615384616,1.0,1.0,15/73,16.19%,NUP62CL;TPR;RITA1;CHTOP;MAGOHB;RANBP3;THOC1;CHP1;U2AF2;SRRM1;SRSF7;RANBP17;CASC3;NUP42;ATXN1
prerank,GO_Biological_Process_2021__fat cell differentiation (GO:0045444),-0.32933254461567174,-0.750555261350072,0.9285714285714286,1.0,1.0,6/47,8.75%,PER2;PID1;IL11;SDF4;ZBTB7A;HMGA2
prerank,GO_Biological_Process_2021__positive regulation of proteolysis (GO:0045862),0.36097807832501244,0.7503637388344615,0.8857142857142857,1.0,1.0,6/44,10.45%,TRIM32;RCN3;FADD;ATP5IF1;NKD2;CASP8
prerank,GO_Biological_Process_2021__positive regulation of phospholipid transport (GO:2001140),-0.4234485696402748,-0.7501758629617085,0.8536585365853658,1.0,1.0,3/9,11.15%,TRIAP1;APOA1;APOE
prerank,GO_Biological_Process_2021__response to iron ion (GO:0010039),-0.465826291507175,-0.7501362630771211,0.8055555555555556,1.0,1.0,2/9,7.62%,BCL2;BMP6
prerank,GO_Biological_Process_2021__nucleic acid phosphodiester bond hydrolysis (GO:0090305),0.3274090651383967,0.7498474212832387,0.863013698630137,1.0,1.0,15/63,27.70%,RFC5;ISG20;IHO1;PCNA;MRE11;RPA3;ANKLE1;DDX1;RAD50;MEI4;POLD1;PDE12;CUL4B;DXO;ERCC4
prerank,GO_Biological_Process_2021__regulation of protein import into nucleus (GO:0042306),-0.3330938427922527,-0.7497870879605651,0.8214285714285714,1.0,1.0,8/31,14.95%,TPR;PRKCD;CDH1;CHP1;CABP1;DMAP1;BAG3;MAVS
prerank,GO_Biological_Process_2021__positive regulation of response to external stimulus (GO:0032103),0.33534750065162966,0.7497452759615246,0.9253731343283582,1.0,1.0,7/82,6.90%,CCL5;PDGFRB;PLA2G7;IL15;AGT;P2RY12;RARRES2
prerank,GO_Biological_Process_2021__regulation of interleukin-8 production (GO:0032677),0.3396625851824788,0.7497199953443108,0.9027777777777778,1.0,1.0,4/46,6.92%,ELANE;PTPRC;CD14;FADD
prerank,GO_Biological_Process_2021__5S class rRNA transcription by RNA polymerase III (GO:0042791),0.5063753564505318,0.7495364378818071,0.8095238095238095,1.0,1.0,1/6,6.35%,GTF3C4
prerank,GO_Biological_Process_2021__synapse organization (GO:0050808),-0.26294378174545563,-0.7491774840154206,1.0,1.0,1.0,14/118,11.71%,GPC4;UNC13B;UNC13C;NTNG1;C5AR1;SLC6A1;SDK1;LRFN4;SHANK2;CDH1;DRD1;PTPRS;PCDHB4;PPFIBP1
prerank,GO_Biological_Process_2021__leukotriene metabolic process (GO:0006691),-0.3936513105827024,-0.7491231986478177,0.7708333333333334,1.0,1.0,3/12,11.17%,LTC4S;CPA1;ABCC1
prerank,PanglaoDB_Augmented_2021__T Memory Cells,-0.3426841292353954,-0.7488701772673383,0.8214285714285714,1.0,1.0,4/55,1.49%,P2RY10;ITGB5;LEF1;CD96
prerank,GO_Biological_Process_2021__regulation of G2/M transition of mitotic cell cycle (GO:0010389),-0.30548990757880146,-0.7487135678577959,0.9166666666666666,1.0,1.0,13/134,11.81%,FBXL7;KCNH5;DBF4B;HMMR;AURKA;CDK5RAP2;PCNT;NEDD1;MAPRE1;ODF2;PCM1;RAD51B;TUBG1
prerank,GO_Biological_Process_2021__atrial septum development (GO:0003283),0.4733459836098788,0.748664206506012,0.8225806451612904,1.0,1.0,1/6,6.18%,ZFPM1
prerank,GO_Biological_Process_2021__maturation of LSU-rRNA (GO:0000470),-0.36366435830970945,-0.7485130468950487,0.9230769230769231,1.0,1.0,1/25,3.71%,ZNHIT6
prerank,GO_Biological_Process_2021__cellular response to unfolded protein (GO:0034620),0.39181294407828415,0.7484495473349424,0.8333333333333334,1.0,1.0,6/25,22.33%,HSPA1L;HSPA5;HSPA8;DAB2IP;ERN1;HSPA14
prerank,GO_Biological_Process_2021__positive regulation of synaptic plasticity (GO:0031915),0.48472875545752786,0.7481504842639363,0.7777777777777778,1.0,1.0,1/6,3.16%,NEUROD2
prerank,GO_Biological_Process_2021__cellular response to cytokine stimulus (GO:0071345),0.2849564947533237,0.748050063196362,0.95,1.0,1.0,56/306,20.46%,PTGIS;IL18R1;LDLRAP1;CD4;CCL5;HCK;PLP2;PRLR;CRLF1;DOCK8;JUNB;TWIST1;FLT3;OSMR;PTPRZ1;YBX3;STAT4;IFNLR1;CDKN1B;HGF;IL7;STAT1;CSF2RA;IL20RA;CTF1;PTPN20;GPER1;NANOG;STAT5A;TXLNA;RHOU;IRF1;NPR2;IL20RB;TGFB1;BRCA1;STAT6;HSPA8;FN1;OPRD1;INPPL1;DAB2IP;TCF7;PYHIN1;PIM1;NDN;EPRS1;PTAFR;IL3RA;IL18BP;CRHBP;BCL2L1;TLR2;SHC1;MAOA;IFIT1
prerank,GO_Biological_Process_2021__ear morphogenesis (GO:0042471),0.43424525590275925,0.7479443337834023,0.7419354838709677,1.0,1.0,3/11,11.22%,TWIST1;TBX1;FGFR2
prerank,GO_Biological_Process_2021__cochlea morphogenesis (GO:0090103),-0.48605147800499093,-0.747642851008464,0.725,1.0,1.0,2/6,6.46%,MYO3A;POU3F4
prerank,MSigDB_Hallmark_2020__E2F Targets,0.3006148044214236,0.7475925654700952,0.9634146341463414,1.0,1.0,40/178,23.22%,MCM2;PRDX4;CCNE1;SPC24;SUV39H1;CDKN1B;PSMC3IP;CDC25A;TUBB;CDCA3;GINS1;ATAD2;DDX39A;EXOSC8;PAICS;BUB1B;DONSON;PCNA;MRE11;RPA3;DCTPP1;BRCA1;RACGAP1;PDS5B;CCP110;NAA38;HELLS;H2AZ1;RAD51C;GINS4;MMS22L;RAD51AP1;CDK4;DIAPH3;SLBP;EZH2;MCM6;RAD1;CDKN3;RAD50
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte proliferation (GO:0050672),0.38583039180130696,0.7474148868163959,0.8285714285714286,1.0,1.0,8/18,25.83%,ARG1;PDCD1LG2;SOX11;IL4I1;SFTPD;CD274;CD80;LYN
prerank,PanglaoDB_Augmented_2021__Mammary Epithelial Cells,0.34427852094669975,0.7472504341095346,0.8840579710144928,1.0,1.0,9/55,10.34%,BTN2A2;PRLR;KLF5;KDM3A;SCEL;AP1M2;RUNX2;MYO5B;B3GNT3
prerank,GO_Biological_Process_2021__amyloid-beta formation (GO:0034205),-0.47670921932832966,-0.7472075791143259,0.8048780487804879,1.0,1.0,1/7,8.36%,NCSTN
prerank,GO_Biological_Process_2021__negative regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032435),0.38811587988920376,0.7470050162981554,0.8194444444444444,1.0,1.0,8/26,33.86%,USP14;UCHL5;CAMLG;NOP53;SVIP;BAG5;MAP1A;WAC
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway in response to DNA damage (GO:0008630),0.35421979566411804,0.7466942057044744,0.8461538461538461,1.0,1.0,4/42,5.25%,AEN;BOK;HIC1;MOAP1
prerank,GO_Biological_Process_2021__positive regulation of ATP metabolic process (GO:1903580),-0.37062245215158635,-0.7466528554783181,0.8536585365853658,1.0,1.0,2/28,3.96%,PID1;IGF1
prerank,GO_Biological_Process_2021__kinetochore organization (GO:0051383),-0.3773385913426266,-0.7463715866850685,0.7586206896551724,1.0,1.0,10/10,62.29%,POGZ;CENPE;CENPH;CENPT;CENPF;CENPC;CENPA;NUF2;MIS12;CENPW
prerank,GO_Biological_Process_2021__positive regulation of cholesterol transport (GO:0032376),-0.3550592282491867,-0.7460231824355559,0.8148148148148148,1.0,1.0,5/24,12.93%,ABCA13;PTCH1;APOA1;APOE;EEPD1
prerank,GO_Biological_Process_2021__positive regulation of protein targeting to membrane (GO:0090314),0.4056630272800601,0.7458606460468313,0.7966101694915254,1.0,1.0,7/23,30.88%,TCAF2;MIEF2;PDZK1;PRNP;MIEF1;CEMIP;TCAF1
prerank,GO_Biological_Process_2021__regulation of cellular biosynthetic process (GO:0031326),0.3778097171764324,0.745773297246918,0.7846153846153846,1.0,1.0,5/25,17.22%,CCL5;PRKAB2;ADIPOR2;MITF;PDK4
prerank,GO_Biological_Process_2021__positive regulation of blood coagulation (GO:0030194),-0.41594829354313323,-0.7454398562336119,0.725,1.0,1.0,2/12,9.30%,SERPINF2;ANO6
prerank,GO_Biological_Process_2021__regulation of protein ubiquitination (GO:0031396),-0.27476584868587456,-0.7454031662176009,1.0,1.0,1.0,2/96,2.91%,PER2;SVBP
prerank,GO_Biological_Process_2021__pyrimidine nucleoside catabolic process (GO:0046135),0.4249757535390951,0.7449348062843799,0.782608695652174,1.0,1.0,2/11,15.41%,UPB1;DPYS
prerank,GO_Biological_Process_2021__mRNA cleavage involved in gene silencing by miRNA (GO:0035279),0.46393223776622394,0.7448692193575946,0.7666666666666667,1.0,1.0,3/5,33.03%,AGO4;MOV10;AGO1
prerank,GO_Biological_Process_2021__positive regulation of cellular protein catabolic process (GO:1903364),0.3728053938348777,0.7447721389344242,0.835820895522388,1.0,1.0,3/17,16.53%,ATP5IF1;MSN;VPS35
prerank,GO_Biological_Process_2021__placenta development (GO:0001890),-0.4450353843700158,-0.7447546985605958,0.8461538461538461,1.0,1.0,1/9,1.09%,ADAM19
prerank,GO_Biological_Process_2021__negative regulation of cell migration (GO:0030336),-0.27134853082308413,-0.7446737864802317,1.0,1.0,1.0,11/112,11.83%,PTPRT;SRGAP1;SINHCAF;SFRP1;PTPN23;MCTP1;MCC;DLG5;CDH1;DUSP10;NOG
prerank,GO_Biological_Process_2021__regulation of innate immune response (GO:0045088),-0.3361864480532762,-0.744633904958036,0.8823529411764706,1.0,1.0,11/49,14.52%,EREG;LYAR;POLR3D;TRAFD1;SAMHD1;TYRO3;LRP8;IFI16;XIAP;CACTIN;PTPN1
prerank,GO_Biological_Process_2021__histone H4 deacetylation (GO:0070933),-0.3863708751324991,-0.7443731601214444,0.8205128205128205,1.0,1.0,3/9,15.39%,HDAC1;SIRT2;HDAC9
prerank,PanglaoDB_Augmented_2021__Olfactory Epithelial Cells,-0.26674265310187883,-0.7442433134713626,1.0,1.0,1.0,27/191,14.99%,NRG1;HOMER2;KLHDC9;B9D1;CLSTN2;SEZ6L2;MARK1;CFAP52;SPOCK1;FSTL5;NYAP1;MORN4;NCS1;FAM81A;RSPH1;CNGA4;TRAF3IP1;TTC21A;WDR54;NRSN2;PRR36;CAP2;DNER;EPN2;SRRM3;SPA17;ARFGEF3
prerank,GO_Biological_Process_2021__regulation of nucleic acid-templated transcription (GO:1903506),0.284090989261747,0.7442330006523825,0.9662921348314607,1.0,1.0,34/345,14.54%,TRIM22;RREB1;ZNF703;SNAI3;ATF5;NOTCH1;HIC1;ING2;NR5A2;AHR;ZNF430;HINT1;SPTY2D1;ZNF732;NFIL3;PPARGC1A;SOX6;REST;RPS6KA4;COPS2;TCF7L1;EFEMP1;CASZ1;SOX11;NAB1;MAFB;ZNF682;NANOG;RHOH;ESR1;MITF;ACVR2B;GLRX2;USP13
prerank,GO_Biological_Process_2021__positive regulation of cellular component movement (GO:0051272),0.37287943242144755,0.7441942026085282,0.8095238095238095,1.0,1.0,2/21,5.96%,TRIM32;TWIST1
prerank,GO_Biological_Process_2021__positive regulation of intracellular signal transduction (GO:1902533),0.28180189586564375,0.7440582792246591,1.0,1.0,1.0,31/419,8.78%,TRIM22;CALCR;LRRC19;TRIM5;ROR1;AGER;TRIML2;CD4;CCL5;NEUROD2;PDGFRB;BOK;SCTR;TRIM32;CXXC5;NTF3;PTPRC;PIK3R5;AGT;FLT3;P2RY12;BCAP31;CD14;FADD;TGFA;TRAF3IP2;GAB1;SIAH1;TBX1;F10;HGF
prerank,GO_Biological_Process_2021__RNA 3'-end processing (GO:0031123),0.32781115018260387,0.7439622964345359,0.8461538461538461,1.0,1.0,9/61,15.30%,CSTF2T;U2AF1;SLU7;NCBP1;NCBP2;DDX39A;CLP1;FIP1L1;THOC5
prerank,GO_Biological_Process_2021__nucleocytoplasmic transport (GO:0006913),0.36773905075060526,0.7437888285252251,0.7941176470588235,1.0,1.0,4/35,6.96%,DDX20;NXT1;NCBP1;NCBP2
prerank,GO_Biological_Process_2021__cyclic purine nucleotide metabolic process (GO:0052652),-0.3840678966828487,-0.7437690024503925,0.7741935483870968,1.0,1.0,1/17,2.11%,GUCY2C
prerank,GO_Biological_Process_2021__response to lipid (GO:0033993),0.3370539498216829,0.7437258934688878,0.9014084507042254,1.0,1.0,12/79,16.75%,HSD17B2;ALPL;WNT8A;CDKN2D;CD6;SCD;CYP19A1;ESR1;TGFB1;LOC400499;HNRNPA0;SPP1
prerank,GO_Biological_Process_2021__establishment of epithelial cell apical/basal polarity (GO:0045198),0.44144947246461097,0.7433464506982186,0.8412698412698413,1.0,1.0,2/9,26.36%,MSN;CDC42
prerank,GO_Biological_Process_2021__RNA processing (GO:0006396),-0.26532057152410254,-0.7429235348980465,1.0,1.0,1.0,37/162,17.20%,ADARB2;KHSRP;HNRNPL;SF3A2;SF3B4;DHX8;MAGOHB;LSM6;LIN28B;RBMS2;THOC1;RBMS1;PRPF4;U2AF2;SRRM1;SON;SNRPB;ZCRB1;RP9;SNRPN;ZRSR2;KIN;SF3A1;SRSF7;SRRM4;RBM3;SCAF11;NRDE2;RSRC1;IVNS1ABP;PTBP1;PPP1R9B;AURKAIP1;PDCD7;ATXN1;PRPF6;SETX
prerank,GO_Biological_Process_2021__negative regulation of platelet-derived growth factor receptor signaling pathway (GO:0010642),-0.417421468403365,-0.7427318314861547,0.7241379310344828,1.0,1.0,2/8,21.69%,PTPRJ;PTPN12
prerank,GO_Biological_Process_2021__sterol import (GO:0035376),-0.444615501642105,-0.7425726224454152,0.7272727272727273,1.0,1.0,2/6,10.29%,APOA1;SCARB1
prerank,GO_Biological_Process_2021__cholesterol import (GO:0070508),-0.444615501642105,-0.7425726224454152,0.7272727272727273,1.0,1.0,2/6,10.29%,APOA1;SCARB1
prerank,GO_Biological_Process_2021__maintenance of DNA methylation (GO:0010216),0.508077074414796,0.7423688388703021,0.8805970149253731,1.0,1.0,2/6,18.09%,UHRF2;HELLS
prerank,GO_Biological_Process_2021__transcription preinitiation complex assembly (GO:0070897),0.433848259055096,0.7418773026601061,0.8484848484848485,1.0,1.0,6/12,22.74%,TBP;TAF7L;DR1;POLR1E;GTF2A2;TAF7
prerank,GO_Biological_Process_2021__mesenchyme morphogenesis (GO:0072132),0.449219543680458,0.7417500744593578,0.7894736842105263,1.0,1.0,1/12,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__chemical synaptic transmission (GO:0007268),0.2911799150078295,0.741653088899553,0.9882352941176471,1.0,1.0,26/255,16.06%,NPY;SLC12A7;ZACN;CHRNB1;CHRNG;OPRK1;PLP1;NQO1;GABRA2;GRM3;HTR3E;SLC17A8;HTR3B;SYPL1;CHRNE;RIT2;PDLIM4;GAD1;KCNMB1;CHRNB4;AKAP5;HSPA8;TSPOAP1;GLRA3;HTR2B;DOC2A
prerank,GO_Biological_Process_2021__post-translational protein modification (GO:0043687),-0.2634904663286354,-0.7415151361862754,1.0,1.0,1.0,13/286,5.43%,FBXL7;LTBP1;LAMB2;MELTF;ASB9;PENK;FBXW8;DSCC1;CCDC22;FBXO27;VCAN;FEM1A;VGF
prerank,GO_Biological_Process_2021__establishment of melanosome localization (GO:0032401),0.41555140585463773,0.7415107257027872,0.8648648648648649,1.0,1.0,4/14,29.12%,ARL6;RAB11A;MKKS;MREG
prerank,GO_Biological_Process_2021__melanosome localization (GO:0032400),0.41555140585463773,0.7415107257027872,0.8648648648648649,1.0,1.0,4/14,29.12%,ARL6;RAB11A;MKKS;MREG
prerank,GO_Biological_Process_2021__regulation of necroptotic process (GO:0060544),0.39875055890447575,0.7413950276520653,0.828125,1.0,1.0,4/20,22.33%,YBX3;CASP8;CYLD;SLC25A4
prerank,GO_Biological_Process_2021__nuclear DNA replication (GO:0033260),0.4459692170240297,0.7413265566903217,0.8275862068965517,1.0,1.0,3/10,12.01%,MCM2;MCMDC2;DONSON
prerank,GO_Biological_Process_2021__glycosylceramide biosynthetic process (GO:0046476),0.46574766955913954,0.7412077479076942,0.8571428571428571,1.0,1.0,3/7,22.43%,B3GALT1;B4GALT3;UGT8
prerank,GO_Biological_Process_2021__positive regulation of chemokine production (GO:0032722),0.37856553335986226,0.7411476982099738,0.8309859154929577,1.0,1.0,3/28,8.82%,AGER;TWIST1;IL7
prerank,GO_Biological_Process_2021__mitochondrial respiratory chain complex assembly (GO:0033108),0.31950660041529905,0.7411342003027878,0.9041095890410958,1.0,1.0,12/76,19.64%,SCO2;SDHAF3;NDUFA2;NDUFB3;NDUFB4;NDUFB9;NDUFB2;SDHAF1;COA5;DMAC1;NDUFAF4;TMEM126B
prerank,"GO_Biological_Process_2021__DNA-templated transcription, initiation (GO:0006352)",0.3048771180893084,0.741108269896096,0.9240506329113924,1.0,1.0,27/153,22.85%,NR1I3;HNF4G;NOTCH1;NR2E3;NR5A2;TEAD4;MAML2;PPARGC1A;TBP;TBPL1;NOTCH3;POLR1H;ESR1;MED7;POLR1E;NOTCH4;GTF2A2;TBPL2;POLR2D;POLR2K;PPARG;POLR1F;ESR2;TFAM;MED17;TAF7;NOTCH2
prerank,GO_Biological_Process_2021__positive regulation of DNA metabolic process (GO:0051054),-0.3203804767470388,-0.7410615946982327,0.9375,1.0,1.0,5/57,8.08%,EYA4;FGFR4;TOX;BRCC3;ERCC8
prerank,GO_Biological_Process_2021__regulation of smoothened signaling pathway (GO:0008589),0.3465549458265195,0.7409310198679221,0.8840579710144928,1.0,1.0,7/46,19.14%,GLI3;HHIP;FGFR2;UCHL5;GAS1;STK36;TULP3
prerank,GO_Biological_Process_2021__positive regulation of epithelial to mesenchymal transition (GO:0010718),0.3723985515314287,0.7405707124194517,0.7936507936507936,1.0,1.0,4/32,5.96%,ZNF703;NOTCH1;LOXL2;TWIST1
prerank,GO_Biological_Process_2021__cellular cation homeostasis (GO:0030003),-0.43540761545653783,-0.7403878561859899,0.8055555555555556,1.0,1.0,2/6,16.01%,LETM2;TESMIN
prerank,GO_Biological_Process_2021__mRNA splice site selection (GO:0006376),-0.3593217216460321,-0.7395741188528584,0.8181818181818182,1.0,1.0,9/26,22.68%,SFSWAP;SF3A2;SF3A1;CELF5;CELF4;SETX;CELF1;LUC7L;PRPF39
prerank,GO_Biological_Process_2021__protein modification process (GO:0036211),0.3408232689560309,0.7395132121765421,0.8591549295774648,1.0,1.0,9/70,18.11%,MMP15;RABGGTB;LOXL2;CPE;MANBA;PIGH;PLOD2;UBL5;YES1
prerank,GO_Biological_Process_2021__glycosylceramide metabolic process (GO:0006677),0.4696207339152706,0.7392868326704595,0.859375,1.0,1.0,1/5,6.04%,GBA3
prerank,GO_Biological_Process_2021__N-glycan processing (GO:0006491),-0.3212002054212637,-0.7391174267161281,0.8620689655172413,1.0,1.0,2/19,3.75%,ST8SIA2;GANC
prerank,GO_Biological_Process_2021__cellular response to radiation (GO:0071478),0.3582078000114556,0.7390916084092911,0.9452054794520548,1.0,1.0,9/35,22.98%,FIGNL1;RAD9B;RHOB;OPN3;ECT2;RAD51AP1;OPN1SW;RAD1;OPN5
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway (GO:0071526),0.36676167298562673,0.7390578721099209,0.8831168831168831,1.0,1.0,3/32,14.43%,SEMA3D;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__establishment of epithelial cell polarity (GO:0090162),-0.38773157075922443,-0.7384308298604653,0.8,1.0,1.0,8/18,27.00%,SIPA1L3;FERMT1;PARD3;FBF1;MYO18A;MYO9A;CYTH1;OPHN1
prerank,GO_Biological_Process_2021__mitochondrion organization (GO:0007005),-0.26606489696728136,-0.7383788652911907,1.0,1.0,1.0,9/159,6.56%,RAB32;PID1;PTCD2;MYH14;ALAS1;IMMP2L;TMEM11;SLC25A33;MTX1
prerank,GO_Biological_Process_2021__tube closure (GO:0060606),-0.33321554253122987,-0.7382207843558956,0.9629629629629629,1.0,1.0,7/28,17.13%,TGFB2;LMO4;COBL;SEMA4C;MTHFD1L;MTHFR;PRICKLE1
prerank,GO_Biological_Process_2021__primary neural tube formation (GO:0014020),-0.33321554253122987,-0.7382207843558956,0.9629629629629629,1.0,1.0,7/28,17.13%,TGFB2;LMO4;COBL;SEMA4C;MTHFD1L;MTHFR;PRICKLE1
prerank,GO_Biological_Process_2021__glutamate metabolic process (GO:0006536),-0.37811017665714486,-0.737924588165476,0.8611111111111112,1.0,1.0,3/15,13.12%,DGLUCY;MTHFS;GOT2
prerank,GO_Biological_Process_2021__negative regulation of osteoblast differentiation (GO:0045668),-0.3522912209764136,-0.7378372846840764,0.8157894736842105,1.0,1.0,4/25,11.83%,GREM1;PTCH1;CRIM1;NOG
prerank,GO_Biological_Process_2021__chylomicron assembly (GO:0034378),0.4863342548587353,0.7378331321518359,0.8833333333333333,1.0,1.0,1/5,4.62%,LPCAT3
prerank,GO_Biological_Process_2021__positive regulation of biosynthetic process (GO:0009891),0.3771988204659274,0.7377026524018387,0.8461538461538461,1.0,1.0,7/32,16.59%,CCL5;HSD17B13;ADGRB1;PLCG2;TGFB1;SCX;RGCC
prerank,MSigDB_Hallmark_2020__Androgen Response,-0.2885986416734581,-0.7376903772296133,0.9629629629629629,1.0,1.0,10/95,9.75%,IQGAP2;HOMER2;CDC14B;ABCC4;PMEPA1;SGK1;ALDH1A3;SPDEF;SORD;XRCC6
prerank,MSigDB_Hallmark_2020__Interferon Gamma Response,0.30090331760682854,0.7367500618051005,0.9655172413793104,1.0,1.0,40/144,20.88%,CCL5;XAF1;FGL2;IL15;HLA-DMA;ISG20;STAT4;SOD2;IDO1;NAMPT;CMKLR1;CIITA;IL7;HLA-A;STAT1;IFIT3;CMPK2;CASP8;P2RY14;FAS;IRF1;RIPK2;IFI44;PSMA3;PSMB8;APOL6;TRIM14;BANK1;PIM1;TRIM25;ZNFX1;IFI27;IL18BP;CD74;B2M;SERPING1;PLSCR1;CD274;IFIT1;ARL4A
prerank,GO_Biological_Process_2021__cortical actin cytoskeleton organization (GO:0030866),0.3823277227693398,0.7364585341873261,0.855072463768116,1.0,1.0,4/17,28.38%,FMNL1;DLG1;FHOD3;RHOQ
prerank,GO_Biological_Process_2021__transmembrane receptor protein tyrosine phosphatase signaling pathway (GO:0007185),0.4772130081299889,0.7361400615211643,0.7808219178082192,1.0,1.0,1/6,28.66%,PTPRF
prerank,GO_Biological_Process_2021__negative regulation of transcription from RNA polymerase II promoter in response to stress (GO:0097201),0.441754657024061,0.7356666939413241,0.8307692307692308,1.0,1.0,1/10,7.35%,DNAJB1
prerank,GO_Biological_Process_2021__Cdc42 protein signal transduction (GO:0032488),0.46273899410180724,0.7356023698133434,0.8448275862068966,1.0,1.0,4/6,26.36%,WAS;RHOU;NTN1;CDC42
prerank,GO_Biological_Process_2021__negative regulation of calcium ion-dependent exocytosis (GO:0045955),0.49008941363314407,0.7354552660176115,0.7719298245614035,1.0,1.0,2/5,9.19%,SYT4;REST
prerank,GO_Biological_Process_2021__negative regulation of fatty acid metabolic process (GO:0045922),-0.36969301446917335,-0.7351840665071054,0.8421052631578947,1.0,1.0,2/13,10.86%,SLC22A13;ACADVL
prerank,GO_Biological_Process_2021__response to growth factor (GO:0070848),-0.3447649389327456,-0.7351032394754105,0.918918918918919,1.0,1.0,3/33,7.26%,SFRP1;EMD;MAPK7
prerank,GO_Biological_Process_2021__mitotic DNA damage checkpoint signaling (GO:0044773),0.33263628603753165,0.7349733258498503,0.8529411764705882,1.0,1.0,5/50,14.47%,TICRR;RAD9B;DONSON;MRE11;BRCA1
prerank,GO_Biological_Process_2021__kidney epithelium development (GO:0072073),-0.5011663399185267,-0.7348589936000025,0.84375,1.0,1.0,1/5,5.79%,FGF1
prerank,GO_Biological_Process_2021__negative regulation of axon extension (GO:0030517),0.36245802099132696,0.7348550803474645,0.8059701492537313,1.0,1.0,3/29,14.43%,SEMA3D;SEMA3F;SEMA3A
prerank,GO_Biological_Process_2021__positive regulation of calcium ion-dependent exocytosis (GO:0045956),0.4109182747218181,0.7345888459432259,0.8615384615384616,1.0,1.0,4/12,23.14%,SYT4;CACNA1G;CACNA1H;DOC2B
prerank,GO_Biological_Process_2021__regulation of early endosome to late endosome transport (GO:2000641),-0.36434701911004297,-0.7343387723557643,0.9166666666666666,1.0,1.0,1/17,5.14%,PTPN23
prerank,GO_Biological_Process_2021__negative regulation of transposition (GO:0010529),0.4134033703042138,0.7343309102256598,0.8070175438596491,1.0,1.0,2/16,11.64%,TDRD9;BTBD18
prerank,GO_Biological_Process_2021__regulation of nitric-oxide synthase activity (GO:0050999),-0.30599257701791005,-0.7343250168896489,0.9629629629629629,1.0,1.0,9/30,14.61%,GCH1;S100A1;DHFR;SCARB1;CYGB;APOE;EGFR;NOS1AP;LEP
prerank,GO_Biological_Process_2021__protein ubiquitination (GO:0016567),0.28271295866945806,0.7340819272125448,1.0,1.0,1.0,46/454,19.43%,TRIM58;TRIM22;TRIM5;TRIML2;ENC1;TRIM54;NEUROD2;ARIH2;C10ORF90;TRIM32;SYVN1;PELI3;SIAH1;KLHL21;HLA-A;UHRF2;RNF152;PSMB6;RNF26;FBXL3;RNF122;RNF139;EPAS1;RNF141;PCNA;VCPIP1;HECW1;KLHL13;BRCA1;PSMA3;FBXO32;RNF138;PSMB8;TRIM50;RNF144B;DERL1;PINK1;TRIM14;SPSB1;TRIM25;RNF220;CUL2;MAGEF1;PJA2;UBR5;TNFAIP1
prerank,GO_Biological_Process_2021__negative regulation of canonical Wnt signaling pathway (GO:0090090),0.2987531874103894,0.7337337226511493,0.9726027397260274,1.0,1.0,16/134,17.81%,LRP4;GLI3;NOTUM;TLE3;SFRP4;PSMB6;NKD2;BICC1;KREMEN1;HECW1;TLE6;PSMA3;PSMB8;DAB2IP;AMER2;TMEM170B
prerank,GO_Biological_Process_2021__regulation of myoblast fusion (GO:1901739),0.4533371624155368,0.7336205383315507,0.8412698412698413,1.0,1.0,1/8,5.29%,ADGRB1
prerank,GO_Biological_Process_2021__negative regulation of receptor internalization (GO:0002091),0.4386352911315635,0.7335991361210623,0.7910447761194029,1.0,1.0,2/11,19.18%,LRPAP1;RIN3
prerank,GO_Biological_Process_2021__mitotic G2/M transition checkpoint (GO:0044818),0.3476640567884802,0.7335873110681157,0.8333333333333334,1.0,1.0,5/37,14.47%,TICRR;CDC6;DONSON;MRE11;BRCA1
prerank,GO_Biological_Process_2021__B cell proliferation (GO:0042100),-0.4523537229338028,-0.7334781147702794,0.775,1.0,1.0,2/8,6.63%,RASGRP1;BCL2
prerank,GO_Biological_Process_2021__monocarboxylic acid catabolic process (GO:0072329),0.4017969634199035,0.7332075232111641,0.7647058823529411,1.0,1.0,3/14,21.58%,FAH;ACOX1;FAAH
prerank,GO_Biological_Process_2021__positive regulation of MAPK cascade (GO:0043410),0.30384819004212027,0.7331984048876318,0.9620253164556962,1.0,1.0,22/190,12.40%,CALCR;TRIM5;ROR1;P2RY1;AGER;CD4;CCL5;PDGFRB;NOTCH1;ELANE;ACKR3;PTPRC;PIK3R5;FLT3;TBX1;PRXL2C;ATP6AP1;FGFR2;PLCG2;SCIMP;GPER1;RIT2
prerank,GO_Biological_Process_2021__neuromuscular synaptic transmission (GO:0007274),0.40841221223826024,0.7331109546291409,0.819672131147541,1.0,1.0,1/13,1.26%,CHRNB1
prerank,GO_Biological_Process_2021__regulation of dendrite extension (GO:1903859),0.37600185245168194,0.732978091251983,0.796875,1.0,1.0,3/18,10.14%,SYT2;SYT4;CPNE5
prerank,GO_Biological_Process_2021__regulation of DNA methylation-dependent heterochromatin assembly (GO:0090308),-0.3864465499719074,-0.7328201777839354,0.7272727272727273,1.0,1.0,3/12,16.74%,TET1;DNMT1;SETDB1
prerank,GO_Biological_Process_2021__negative regulation of transferase activity (GO:0051348),0.37289501936244307,0.7327386841859277,0.873015873015873,1.0,1.0,2/27,11.46%,CDKN1B;SMAD7
prerank,GO_Biological_Process_2021__maintenance of protein localization in organelle (GO:0072595),0.42398421062329633,0.732650640346804,0.8679245283018868,1.0,1.0,2/17,16.73%,HSPA5;PINK1
prerank,GO_Biological_Process_2021__regulation of melanin biosynthetic process (GO:0048021),0.4419961803017234,0.7326017849117484,0.9076923076923077,1.0,1.0,1/9,14.12%,OPN3
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity (GO:2000116),-0.3719274502044569,-0.732372742212306,0.875,1.0,1.0,5/17,24.78%,IFI16;NGF;GRIN1;FYN;GRIN2B
prerank,GO_Biological_Process_2021__positive regulation of long-term synaptic potentiation (GO:1900273),-0.4099527127468926,-0.7323154523334656,0.8461538461538461,1.0,1.0,1/13,2.36%,EPHB2
prerank,GO_Biological_Process_2021__positive regulation of DNA-binding transcription factor activity (GO:0051091),0.29543127434154387,0.7323046363222372,0.927710843373494,1.0,1.0,9/190,6.08%,TRIM22;TRIM5;ROR1;IL18R1;AGER;TRIML2;NEUROD2;TRIM32;AGT
prerank,GO_Biological_Process_2021__regulation of necrotic cell death (GO:0010939),-0.4347606821932881,-0.7320931545992045,0.8,1.0,1.0,6/6,56.54%,SLC6A6;SLC6A13;MT3;ASAH1;RIPK1;HEBP2
prerank,GO_Biological_Process_2021__platelet degranulation (GO:0002576),0.30350649254280493,0.732003673162332,0.9436619718309859,1.0,1.0,20/96,18.82%,TIMP3;F8;RARRES2;LAMP2;FAM3C;KNG1;CDC37L1;GTPBP2;HGF;VEGFC;TUBA4A;VWF;TGFB1;A2M;SYTL4;FN1;PCDH7;PSAP;CD109;TTN
prerank,GO_Biological_Process_2021__negative regulation of protein transport (GO:0051224),-0.3516278912884785,-0.7318623520160056,0.875,1.0,1.0,4/20,13.31%,DRD4;CSK;APOE;PKDCC
prerank,GO_Biological_Process_2021__citrulline metabolic process (GO:0000052),0.4797380240141304,0.7318567191432542,0.8333333333333334,1.0,1.0,2/6,23.60%,CPS1;DDAH2
prerank,GO_Biological_Process_2021__negative regulation of cellular process (GO:0048523),0.2797738633762339,0.7318407030347512,0.9893617021276596,1.0,1.0,59/433,17.99%,MSX1;BTN2A2;TDRD9;WFS1;NLRP2B;GMNN;ATF5;RASA1;SSTR1;NOTCH1;LPCAT3;CHMP4B;INHBA;CYP1B1;FABP3;ADGRB1;RND1;PSRC1;CDKN2D;OSGIN2;NAIF1;KNG1;SOD2;IFNLR1;CDKN1B;BNIP3;TBX1;REST;SFRP4;IFIT3;CGRRF1;CRLF3;RHOB;CDC6;SOX11;RNF139;BTBD18;GPER1;CHMP1A;IRF1;LRPAP1;TGFB1;WDR6;TSC2;TP53TG5;KLF11;KANK2;FBLN1;HTR2B;PDS5B;VPS35;RGCC;DAB2IP;PODXL;CHMP2A;TCHP;NOTCH4;CDK6;NME6
prerank,GO_Biological_Process_2021__negative regulation of myotube differentiation (GO:0010832),-0.42510629070236855,-0.7317727359433649,0.8285714285714286,1.0,1.0,2/9,5.87%,HDAC5;HDAC1
prerank,GO_Biological_Process_2021__negative regulation of protein binding (GO:0032091),-0.2708582423601639,-0.7316375736910419,0.96875,1.0,1.0,7/58,11.66%,ITGA4;CARD18;PRKCD;AURKA;SORL1;DDX11;PPP1CA
prerank,GO_Biological_Process_2021__regulation of non-canonical Wnt signaling pathway (GO:2000050),0.4130058919795965,0.731175415419563,0.8412698412698413,1.0,1.0,3/13,14.63%,SFRP4;RSPO3;DAAM2
prerank,GO_Biological_Process_2021__regulation of GTPase activity (GO:0043087),0.2962468269821057,0.7308717227724458,0.96,1.0,1.0,9/143,8.64%,EPHA1;RGS10;CCL5;RASIP1;DOCK8;ADRB1;PRKG1;ARHGAP9;F11R
prerank,GO_Biological_Process_2021__vasodilation (GO:0042311),-0.39748971837836006,-0.730842719721948,0.8214285714285714,1.0,1.0,1/10,1.47%,F2RL1
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, initiation (GO:2000144)",0.38289023621408447,0.7307690852362617,0.7580645161290323,1.0,1.0,3/19,15.75%,TWIST1;MITF;SUB1
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle (GO:0045931),-0.36198598690298306,-0.730665967777784,0.78125,1.0,1.0,7/22,25.42%,EIF4EBP1;SMOC2;HSF1;PKN2;CCNB1;TTL;CCDC57
prerank,PanglaoDB_Augmented_2021__Pyramidal Cells,0.31005017206780344,0.730430066529553,0.9367088607594937,1.0,1.0,12/123,14.79%,CALB1;AGER;KCNN4;GRM3;SYT4;CNTN2;KCNJ9;RIT2;C11ORF87;GFAP;SPINK8;CA10
prerank,GO_Biological_Process_2021__xenobiotic transport across blood-brain barrier (GO:1990962),0.4944736779135448,0.7303702654790225,0.875,1.0,1.0,3/6,12.89%,ABCC2;ABCB1;ABCG2
prerank,GO_Biological_Process_2021__negative regulation of viral genome replication (GO:0045071),-0.318430047348143,-0.7302561471731337,0.9130434782608695,1.0,1.0,8/35,14.95%,APOBEC3H;IFIH1;HMGA2;IFI16;PARP10;MX1;ZC3HAV1;MAVS
prerank,GO_Biological_Process_2021__protein import into peroxisome membrane (GO:0045046),0.3771192666153226,0.7302275049228358,0.8125,1.0,1.0,5/20,23.27%,PEX16;PEX11B;ALDH3A2;PXMP2;PEX5
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta clearance (GO:1900223),0.4730729488040014,0.730190446848128,0.7966101694915254,1.0,1.0,1/5,13.23%,LRPAP1
prerank,GO_Biological_Process_2021__neuron projection extension (GO:1990138),0.3613156669069943,0.7301618972456756,0.875,1.0,1.0,5/31,20.25%,SEMA3F;SEMA3A;FLRT3;SLC9A6;ULK1
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transmembrane transport (GO:1902306),0.4560086207877623,0.7301432302911592,0.896551724137931,1.0,1.0,2/8,15.38%,HECW1;CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of protein catabolic process in the vacuole (GO:1904352),0.45787851735287355,0.7299976054566384,0.7777777777777778,1.0,1.0,2/5,36.55%,LRP2;CD81
prerank,GO_Biological_Process_2021__positive regulation of cell division (GO:0051781),-0.33020938271345307,-0.729925094710141,0.9583333333333334,1.0,1.0,8/31,13.84%,CDC14B;FGF1;SVIL;KIF23;CXCR5;SIRT2;MAP10;PRKCE
prerank,GO_Biological_Process_2021__protein localization to Golgi apparatus (GO:0034067),0.3758596181972198,0.7297505857143001,0.8450704225352113,1.0,1.0,8/25,35.20%,RIPOR1;ARL1;GBP5;TMED10;ARL5B;BICD2;RAB33B;ARFRP1
prerank,GO_Biological_Process_2021__glial cell migration (GO:0008347),-0.47620075148511964,-0.72916913811436,0.7567567567567568,1.0,1.0,2/5,5.75%,AZU1;TGFB2
prerank,GO_Biological_Process_2021__positive regulation of lipid biosynthetic process (GO:0046889),0.37120206503639164,0.7289852795271873,0.8441558441558441,1.0,1.0,2/28,4.88%,HSD17B13;FABP3
prerank,GO_Biological_Process_2021__positive regulation of cold-induced thermogenesis (GO:0120162),0.3304320173036046,0.7285575517563528,0.9459459459459459,1.0,1.0,14/74,14.66%,ZBTB7B;PRLR;PLAC8;PRKAB2;KDM3A;ADIPOR2;TSHR;ADRB1;PPARGC1A;CMKLR1;SCD;EPAS1;GHRL;STAT6
prerank,GO_Biological_Process_2021__actin filament bundle assembly (GO:0051017),0.370114897213899,0.7285434705819924,0.9,1.0,1.0,6/26,25.74%,EPS8;PAWR;DMTN;BAIAP2L1;MYO1B;HSP90B1
prerank,GO_Biological_Process_2021__store-operated calcium entry (GO:0002115),0.4771168774182388,0.7282609383269164,0.8181818181818182,1.0,1.0,1/5,10.23%,ORAI2
prerank,"GO_Biological_Process_2021__retrograde transport, endosome to Golgi (GO:0042147)",0.3247665617319595,0.7278687745612141,0.9487179487179487,1.0,1.0,2/82,2.79%,RAB6C;LMAN1
prerank,GO_Biological_Process_2021__regulation of mRNA stability (GO:0043488),-0.2677346979458217,-0.7277660989200297,1.0,1.0,1.0,17/135,16.67%,SAMD4A;KHSRP;PRKCD;HSPB1;TENT5A;ELAVL1;VIP;EIF4G1;IGF2BP3;EXOSC7;EXOSC1;MEX3D;EXOSC5;SAMD4B;CIRBP;PCBP4;EXOSC4
prerank,GO_Biological_Process_2021__cellular response to organonitrogen compound (GO:0071417),0.3059184573756914,0.7274184810525932,0.9722222222222222,1.0,1.0,6/92,8.10%,P2RY1;CTNNA1;IGFBP5;AHR;P2RY12;TSHR
prerank,GO_Biological_Process_2021__regulation of RNA biosynthetic process (GO:2001141),0.461192778664316,0.7273097223083258,0.7846153846153846,1.0,1.0,1/5,13.49%,MITF
prerank,GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA poly(A) tail shortening (GO:0060213),-0.3959102734039655,-0.7272114888357967,0.8421052631578947,1.0,1.0,2/13,13.57%,POLR2G;BTG2
prerank,GO_Biological_Process_2021__regulation of phospholipid metabolic process (GO:1903725),-0.3968873030242612,-0.7270976344241455,0.8,1.0,1.0,1/10,8.12%,MTMR9
prerank,GO_Biological_Process_2021__mitochondrial cytochrome c oxidase assembly (GO:0033617),0.40644550704803956,0.7269306104473618,0.8285714285714286,1.0,1.0,2/16,17.06%,SCO2;COA5
prerank,GO_Biological_Process_2021__ncRNA processing (GO:0034470),-0.26790975549451435,-0.7268490187396268,1.0,1.0,1.0,26/189,16.95%,TRPT1;INTS11;RRP1B;LYAR;NVL;RRP7A;DGCR8;TBL3;LIN28B;SARS1;POP1;EXOSC10;DDX27;NOP14;WDR46;EXOSC7;FARS2;EXOSC1;NOC4L;EXOSC5;BOP1;RPL12;TARBP2;EXOSC4;NOL8;WDR75
prerank,GO_Biological_Process_2021__proline transport (GO:0015824),0.4734478382691176,0.7267854207267461,0.8285714285714286,1.0,1.0,2/6,34.47%,SLC6A15;SLC6A7
prerank,GO_Biological_Process_2021__organic substance transport (GO:0071702),0.3038507287212191,0.7265480169135655,0.9452054794520548,1.0,1.0,12/108,12.89%,SLCO2B1;SLC23A1;RCN3;AMN;GM2A;SLC22A25;CBLIF;TCN2;ARRDC3;CHMP2B;CHMP1A;ABCG2
prerank,GO_Biological_Process_2021__negative regulation of epithelial cell migration (GO:0010633),-0.34136041856800636,-0.7265389228881527,0.925,1.0,1.0,6/24,11.55%,VASH1;SVBP;PTPN23;MCC;APOE;DUSP10
prerank,GO_Biological_Process_2021__modulation by host of symbiont process (GO:0051851),0.3751060177317186,0.7260043104083344,0.8208955223880597,1.0,1.0,2/28,2.27%,LRRC19;CCL5
prerank,GO_Biological_Process_2021__positive regulation of cytokinesis (GO:0032467),-0.3307308740495055,-0.7257676737019553,0.896551724137931,1.0,1.0,6/26,13.84%,CDC14B;SVIL;KIF23;CXCR5;MAP10;PRKCE
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557),0.3433520443062594,0.725343555492807,0.8904109589041096,1.0,1.0,5/48,6.92%,AGER;PTPRC;TWIST1;CD14;FADD
prerank,GO_Biological_Process_2021__inorganic anion transmembrane transport (GO:0098661),0.3326685540117257,0.7250100246095408,0.9354838709677419,1.0,1.0,17/56,29.26%,SLC12A7;GABRA2;CLCN3;GLRA3;GLRA1;GABRA4;GABRR1;GABRD;SLC1A3;SLC25A14;GLRB;SLC25A11;ANO2;SLC12A2;GABRA6;SLC25A3;SLC5A5
prerank,GO_Biological_Process_2021__cellular amino acid biosynthetic process (GO:0008652),0.46619886322453513,0.7245505643023725,0.7543859649122807,1.0,1.0,1/6,0.86%,ALDH1A1
prerank,GO_Biological_Process_2021__regulation of transposition (GO:0010528),0.428615166399979,0.7241423625902212,0.8307692307692308,1.0,1.0,2/11,11.64%,TDRD9;BTBD18
prerank,GO_Biological_Process_2021__negative regulation of glycolytic process (GO:0045820),-0.44454392515883956,-0.7240227613746979,0.8157894736842105,1.0,1.0,3/8,22.22%,NUPR1;HDAC4;PPARA
prerank,GO_Biological_Process_2021__negative regulation of purine nucleotide metabolic process (GO:1900543),-0.44454392515883956,-0.7240227613746979,0.8157894736842105,1.0,1.0,3/8,22.22%,NUPR1;HDAC4;PPARA
prerank,GO_Biological_Process_2021__positive regulation of vesicle fusion (GO:0031340),0.49253078195828603,0.7240041311172826,0.864406779661017,1.0,1.0,3/5,40.21%,DOC2B;C2CD5;SNCA
prerank,GO_Biological_Process_2021__positive regulation of lamellipodium assembly (GO:0010592),0.39557223212754933,0.7239976385007632,0.8260869565217391,1.0,1.0,9/21,30.12%,BRK1;ACTR2;ACTR3;MSTN;TWF2;CYFIP1;CDC42;ABI2;RAC1
prerank,GO_Biological_Process_2021__regulation of mitochondrial fusion (GO:0010635),-0.4225776121849699,-0.7239241079973618,0.8372093023255814,1.0,1.0,1/10,1.84%,PID1
prerank,GO_Biological_Process_2021__cellular response to glucagon stimulus (GO:0071377),-0.38547557165459806,-0.7238753443595025,0.8888888888888888,1.0,1.0,6/15,27.71%,CYSLTR2;ADCY7;ADCY2;ADCY5;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__astrocyte differentiation (GO:0048708),0.4629384124362692,0.7237052739973263,0.7966101694915254,1.0,1.0,2/5,17.85%,EIF2B5;CDK6
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure (GO:0003073),-0.4043820581105562,-0.7236427410901963,0.8064516129032258,1.0,1.0,4/9,26.01%,SPX;ACE;DDAH1;DRD2
prerank,GO_Biological_Process_2021__meiosis I (GO:0007127),0.3813402595353256,0.7234341091572949,0.9142857142857143,1.0,1.0,8/22,18.09%,TDRD9;ING2;SYCP3;BTBD18;MEIOB;MEIOC;HSF2BP;SLC25A31
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor production (GO:0032760),0.34367965691971636,0.7234035075349079,0.8783783783783784,1.0,1.0,5/46,6.92%,AGER;PTPRC;TWIST1;CD14;FADD
prerank,PanglaoDB_Augmented_2021__Serotonergic Neurons,0.3528108441610355,0.723265943374464,0.9705882352941176,1.0,1.0,7/40,10.80%,HSD17B2;ANKS4B;SCTR;GBA3;GIPC2;SCGN;ALDOB
prerank,GO_Biological_Process_2021__circulatory system development (GO:0072359),-0.2723677751358883,-0.7228213233622927,1.0,1.0,1.0,16/87,16.59%,PKP2;RBP4;HEG1;PDLIM1;TGFB2;ECE1;ID2;SMG9;EEF1AKMT4-ECE2;ALPK3;PDLIM3;ADAP2;TCF25;HDAC9;ACVR1;TGFBR1
prerank,GO_Biological_Process_2021__primary miRNA processing (GO:0031053),0.4317251694484712,0.7226486011718368,0.8688524590163934,1.0,1.0,2/10,16.12%,MRPL44;SMAD1
prerank,GO_Biological_Process_2021__positive regulation by host of viral genome replication (GO:0044829),-0.4567918213909136,-0.722361108179471,0.75,1.0,1.0,5/5,54.34%,PPIB;TBC1D20;VAPA;NUCKS1;YTHDC2
prerank,GO_Biological_Process_2021__regulation of protein transport (GO:0051223),-0.35405780284851684,-0.7222913548086485,0.8620689655172413,1.0,1.0,7/24,20.63%,DNAJC1;CHP1;LLGL2;P3H1;PTPN1;PPM1F;LCP1
prerank,GO_Biological_Process_2021__actin filament bundle organization (GO:0061572),0.3695965907761637,0.7222867009766457,0.8765432098765432,1.0,1.0,6/27,24.81%,EPS8;PAWR;DMTN;RFLNB;BAIAP2L1;MYO1B
prerank,GO_Biological_Process_2021__regulation of organ growth (GO:0046620),-0.4199082288624991,-0.7222694745709983,0.775,1.0,1.0,6/10,18.83%,SLC6A4;WWC3;DUSP6;WWC1;LATS1;LATS2
prerank,GO_Biological_Process_2021__glycosphingolipid metabolic process (GO:0006687),0.3434660748132563,0.7222473175621125,0.8333333333333334,1.0,1.0,8/39,23.19%,GM2A;GBA3;B3GALNT1;NEU1;PSAP;ST6GALNAC5;UGT8;B4GALT6
prerank,PanglaoDB_Augmented_2021__Motor Neurons,-0.2982746318040586,-0.722240804032216,0.9629629629629629,1.0,1.0,17/68,18.92%,CBARP;SEZ6L2;VGF;FGF1;PHF21B;KIF7;VAX2;DLX2;EPHA8;SRRM3;MSI1;ABCG4;MEX3A;MID1;FOXO6;ARHGAP39;AADAT
prerank,GO_Biological_Process_2021__regulation of cholesterol esterification (GO:0010872),0.4423715167686878,0.722188876711499,0.8615384615384616,1.0,1.0,2/7,17.20%,AGT;STARD4
prerank,MSigDB_Hallmark_2020__IL-2/STAT5 Signaling,0.3014582769865215,0.7218024818237871,0.987012987012987,1.0,1.0,20/151,13.64%,GADD45B;IL18R1;AGER;FGL2;SCN9A;AHR;CCND2;CCNE1;CDCP1;NFIL3;ABCB1;FAH;SYNGR2;MXD1;PRAF2;RHOB;CDC6;COCH;RHOH;GPR83
prerank,GO_Biological_Process_2021__regulation of tissue remodeling (GO:0034103),-0.37428414235325647,-0.7217198409226854,0.8974358974358975,1.0,1.0,1/14,1.60%,RUNX1
prerank,GO_Biological_Process_2021__positive regulation of hydrolase activity (GO:0051345),-0.28672246270730656,-0.7215881821295694,0.9629629629629629,1.0,1.0,13/105,8.12%,F2RL1;RASGRF1;DOCK10;ITGA6;RASGRP1;SFRP1;RTN4R;PLIN5;APOA1;RGS7;RGS8;ASAP3;MTMR9
prerank,GO_Biological_Process_2021__poly(A)+ mRNA export from nucleus (GO:0016973),-0.378187441004209,-0.721262320790132,0.8064516129032258,1.0,1.0,2/14,17.39%,IWS1;NXF5
prerank,GO_Biological_Process_2021__positive regulation of G protein-coupled receptor signaling pathway (GO:0045745),0.4234567374493496,0.7208741697110373,0.85,1.0,1.0,3/11,15.68%,MRAP;GPER1;KLK14
prerank,GO_Biological_Process_2021__negative regulation of striated muscle cell differentiation (GO:0051154),0.41997552556052453,0.720722813876752,0.9117647058823529,1.0,1.0,2/12,8.40%,NOTCH1;SOX6
prerank,GO_Biological_Process_2021__DNA repair (GO:0006281),0.28221075550408786,0.7206294277920814,1.0,1.0,1.0,22/266,16.05%,RAD54L;TICRR;TDG;RFC5;POLE2;POLQ;CDKN2D;MGME1;RAD9B;FAAP24;FANCI;FANCM;INIP;EYA1;PCNA;MRE11;VCPIP1;RPA3;BRCA1;APLF;RECQL;PDS5B
prerank,GO_Biological_Process_2021__glutamine metabolic process (GO:0006541),0.4438897225338264,0.7204961050542713,0.8142857142857143,1.0,1.0,2/9,23.41%,LGSN;CPS1
prerank,GO_Biological_Process_2021__positive regulation of early endosome to late endosome transport (GO:2000643),-0.4180934606287311,-0.7203527514185528,0.7027027027027027,1.0,1.0,1/7,5.14%,PTPN23
prerank,GO_Biological_Process_2021__peptidyl-lysine trimethylation (GO:0018023),-0.33231604254763936,-0.7203420030451346,0.9333333333333333,1.0,1.0,7/27,20.55%,SUV39H2;PRDM7;BEND3;WDR82;KMT5B;TET2;SETD2
prerank,GO_Biological_Process_2021__regulation of telomere capping (GO:1904353),-0.3310771736613951,-0.7202514629961304,0.8,1.0,1.0,3/19,16.96%,PNKP;SMG6;ATM
prerank,GO_Biological_Process_2021__histone H3-K4 demethylation (GO:0034720),0.4420014289520594,0.72007873701799,0.8253968253968254,1.0,1.0,1/8,22.71%,KDM1A
prerank,GO_Biological_Process_2021__neurotransmitter transport (GO:0006836),-0.29036677087779306,-0.7200683248882653,0.9393939393939394,1.0,1.0,16/65,18.71%,UNC13B;SLC22A2;SLC6A4;SLC29A4;SLC22A3;GAD2;SLC6A2;SLC22A1;SYN2;UNC13A;CASK;APBA1;SLC1A6;RIMS1;LIN7A;SNPH
prerank,MSigDB_Hallmark_2020__PI3K/AKT/mTOR  Signaling,-0.28410499717555376,-0.719920272521362,1.0,1.0,1.0,21/88,22.11%,ITPR2;ARPC3;MAP2K3;GNA14;PPP1CA;NGF;EGFR;PPP2R1B;RPTOR;PRKCB;CAB39L;FGF22;NFKBIB;TIAM1;ATF1;SQSTM1;MKNK2;MAP3K7;PFN1;PIN1;ADCY2
prerank,GO_Biological_Process_2021__regulation of leukocyte cell-cell adhesion (GO:1903037),-0.39766121627483725,-0.7197324765225649,0.7714285714285715,1.0,1.0,5/9,27.16%,MDK;MIA3;PPARA;ASS1;FUT9
prerank,GO_Biological_Process_2021__late endosome to vacuole transport via multivesicular body sorting pathway (GO:0032511),-0.38219633411239307,-0.7194581955725731,0.7352941176470589,1.0,1.0,1/13,2.64%,VPS25
prerank,GO_Biological_Process_2021__striated muscle contraction (GO:0006941),0.34529535705112524,0.7192310177400101,0.9130434782608695,1.0,1.0,3/37,5.69%,CSRP3;RCSD1;SCN4B
prerank,GO_Biological_Process_2021__fatty acid metabolic process (GO:0006631),0.3042181955470671,0.7192176118529852,0.9473684210526315,1.0,1.0,15/98,16.10%,LIPH;ACSBG1;ACOT4;BAAT;FASN;ACSL5;ALOX12;ADIPOR2;PPARGC1A;ACOX2;LIPI;CPT1C;ACOX1;MSMO1;ALOXE3
prerank,GO_Biological_Process_2021__regulation of helicase activity (GO:0051095),-0.42907855204393264,-0.7188583262187879,0.8780487804878049,1.0,1.0,1/9,5.72%,CHTOP
prerank,GO_Biological_Process_2021__negative regulation of cellular senescence (GO:2000773),0.4225261126338856,0.7188283307934835,0.875,1.0,1.0,2/12,17.85%,TWIST1;CDK6
prerank,GO_Biological_Process_2021__positive regulation of immune system process (GO:0002684),0.40670346414393593,0.7188127161872407,0.8387096774193549,1.0,1.0,1/11,4.42%,IL15
prerank,GO_Biological_Process_2021__ribosome localization (GO:0033750),0.4481741436608073,0.7187603677028768,0.8028169014084507,1.0,1.0,3/5,39.76%,EIF6;RAN;ABCE1
prerank,GO_Biological_Process_2021__histone-serine phosphorylation (GO:0035404),0.4656135666852025,0.7185669649077698,0.8805970149253731,1.0,1.0,1/5,9.24%,RPS6KA4
prerank,GO_Biological_Process_2021__serine family amino acid biosynthetic process (GO:0009070),-0.39250618652013247,-0.7184513517207983,0.7575757575757576,1.0,1.0,6/10,23.96%,SEPHS1;PSAT1;CTH;PSPH;MTHFD1;SRR
prerank,GO_Biological_Process_2021__regulation of protein localization to nucleus (GO:1900180),-0.2933586084359858,-0.7182569217892724,1.0,1.0,1.0,4/36,7.82%,TPR;WWTR1;NVL;CARD10
prerank,GO_Biological_Process_2021__negative regulation of cytokine production (GO:0001818),-0.2947429297217137,-0.7177157887539994,0.9545454545454546,1.0,1.0,14/120,11.02%,TRIB2;HOMER2;LEF1;F2RL1;INHA;IFIH1;SRGN;APOA1;CIDEA;NR1H4;SARS1;ABCD1;RNF216;TRAF3IP1
prerank,GO_Biological_Process_2021__cellular response to growth factor stimulus (GO:0071363),-0.288288397965324,-0.7175721966595213,1.0,1.0,1.0,16/137,11.37%,KDR;BMP7;PDE3A;SFRP1;EMD;MAPK7;HSPB1;BMP6;CILP;MAP2K3;DLX5;SEMA6A;SYAP1;SIRT2;NRP1;STMN2
prerank,GO_Biological_Process_2021__regulation of cell adhesion molecule production (GO:0060353),0.46649092789410945,0.7171901854040307,0.7903225806451613,1.0,1.0,1/5,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of intracellular estrogen receptor signaling pathway (GO:0033146),-0.3319871923468383,-0.7171699180072203,0.8292682926829268,1.0,1.0,2/25,7.73%,RUNX1;CBFB
prerank,GO_Biological_Process_2021__positive regulation of interleukin-2 production (GO:0032743),0.38760639924057577,0.7169522008001099,0.8333333333333334,1.0,1.0,3/18,11.48%,CD4;PTPRC;PLCG2
prerank,GO_Biological_Process_2021__negative regulation of cell adhesion (GO:0007162),0.3119148098904282,0.7169241308213689,0.9078947368421053,1.0,1.0,6/61,7.75%,RASA1;NOTCH1;CYP1B1;PTPRC;RND1;KNG1
prerank,GO_Biological_Process_2021__interleukin-1-mediated signaling pathway (GO:0070498),0.3074127129474217,0.716810570015233,0.9558823529411765,1.0,1.0,15/82,29.20%,PELI3;RPS6KA4;TOLLIP;PSMB6;RIPK2;PSMA3;PSMB8;TAB2;IRAK4;PSMA5;CUL1;PSMC6;TNIP2;NOD1;RPS27A
prerank,GO_Biological_Process_2021__negative regulation of regulated secretory pathway (GO:1903306),0.45578768652825996,0.716751134853987,0.8793103448275862,1.0,1.0,2/8,9.19%,SYT4;REST
prerank,GO_Biological_Process_2021__positive regulation of embryonic development (GO:0040019),-0.40720099509637664,-0.7161155777475875,0.90625,1.0,1.0,4/13,18.36%,ZBED3;TENM4;RBM19;NIBAN2
prerank,GO_Biological_Process_2021__negative regulation of protein localization to plasma membrane (GO:1903077),-0.3704620653654179,-0.71599936540084,0.8536585365853658,1.0,1.0,3/17,7.67%,PID1;NUMB;CSK
prerank,GO_Biological_Process_2021__regulation of ER to Golgi vesicle-mediated transport (GO:0060628),0.4301298766322458,0.7159818935555732,0.8208955223880597,1.0,1.0,3/9,20.42%,RNF139;GAS1;LRRK2
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081),0.4854257027517559,0.7155135936909586,0.8245614035087719,1.0,1.0,2/5,10.49%,AGT;ENPEP
prerank,GO_Biological_Process_2021__mesoderm development (GO:0007498),-0.3813669888983396,-0.7154908384082265,0.8095238095238095,1.0,1.0,1/12,1.17%,TBX6
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in inflammatory response (GO:1900016),0.41991180490970403,0.7154884836425787,0.8688524590163934,1.0,1.0,3/13,18.62%,CUEDC2;NLRC3;PDCD4
prerank,GO_Biological_Process_2021__acyl-CoA biosynthetic process (GO:0071616),0.4077583689390778,0.7151441061256845,0.8611111111111112,1.0,1.0,4/14,22.06%,FASN;SCD;PPCS;ACAT1
prerank,GO_Biological_Process_2021__plasma membrane repair (GO:0001778),-0.37706921805875954,-0.7151299083090766,0.9090909090909091,1.0,1.0,2/12,9.91%,AHNAK2;DYSF
prerank,GO_Biological_Process_2021__integrin-mediated signaling pathway (GO:0007229),0.307158209489688,0.7150792429231403,0.9178082191780822,1.0,1.0,9/64,15.62%,HCK;ITGA5;FYB1;DOCK1;ITGA11;ZNF304;ITGBL1;FBLN1;FN1
prerank,GO_Biological_Process_2021__bone resorption (GO:0045453),0.43960843830311475,0.7150338538763219,0.8653846153846154,1.0,1.0,1/6,8.82%,IL7
prerank,GO_Biological_Process_2021__polyphosphate metabolic process (GO:0006797),-0.4659435113641621,-0.714868260325603,0.8421052631578947,1.0,1.0,3/6,30.87%,PRUNE2;PRUNE1;BNIPL
prerank,GO_Biological_Process_2021__cardiac muscle cell action potential involved in contraction (GO:0086002),0.3700796853001166,0.714668517323809,0.8169014084507042,1.0,1.0,3/29,5.69%,CAV3;KCNE2;SCN4B
prerank,GO_Biological_Process_2021__water-soluble vitamin metabolic process (GO:0006767),0.3227768042271242,0.7144893692778055,0.971830985915493,1.0,1.0,12/64,17.55%,AOX1;SLC23A1;SLC19A3;AMN;SLC2A1;CBLIF;TCN2;SLC52A2;PRSS3;SLC52A1;RFK;ALDH1L1
prerank,GO_Biological_Process_2021__mRNA catabolic process (GO:0006402),-0.2803593038471404,-0.71442103954411,1.0,1.0,1.0,8/41,19.91%,NBDY;LSM6;EXOSC10;DIS3L2;PNPT1;EXOSC4;HSPA1A;RC3H1
prerank,GO_Biological_Process_2021__development of primary female sexual characteristics (GO:0046545),-0.4806188699190732,-0.7144210395145697,0.8181818181818182,1.0,1.0,1/6,3.39%,LHFPL2
prerank,GO_Biological_Process_2021__positive regulation of neuron differentiation (GO:0045666),0.3452509467880781,0.7143705740911477,0.8955223880597015,1.0,1.0,5/36,15.13%,NEUROD2;TRIM32;REST;SOX11;ECT2
prerank,GO_Biological_Process_2021__positive regulation of autophagy of mitochondrion (GO:1903599),0.42224736751881053,0.7143447530316165,0.8153846153846154,1.0,1.0,4/9,29.45%,FBXO7;SLC25A4;VDAC1;SLC25A5
prerank,GO_Biological_Process_2021__phosphatidylinositol metabolic process (GO:0046488),0.31170937373172053,0.7142679295739377,0.9397590361445783,1.0,1.0,11/97,20.36%,PLA2G10;PDGFRB;PIK3R5;PLCG2;PGAP3;INPPL1;PIK3C2G;PLEKHA2;PLCD1;INPP5F;PIP4K2C
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-independent decay (GO:0031086)",0.46278431776900936,0.7138039899492831,0.8620689655172413,1.0,1.0,3/7,34.89%,ZFP36;ZFP36L1;PNRC2
prerank,GO_Biological_Process_2021__positive regulation of Notch signaling pathway (GO:0045747),-0.32476751994026143,-0.7137724638175131,0.8518518518518519,1.0,1.0,5/36,9.47%,MAML3;MAML1;TGFB2;STAT3;JAG2
prerank,GO_Biological_Process_2021__negative regulation of synaptic transmission (GO:0050805),0.3741219326507477,0.7131372121018948,0.8873239436619719,1.0,1.0,6/22,24.77%,SLC24A2;SLC24A1;DRD3;LRRK2;GRIK3;NLGN4X
prerank,GO_Biological_Process_2021__chemical homeostasis (GO:0048878),0.3405427021551296,0.7130425671990603,0.9315068493150684,1.0,1.0,9/53,21.48%,EIF5A2;ACOX2;PNPLA1;ABCB4;ACOX1;AQP9;SLC4A9;ANGPTL3;PPARG
prerank,GO_Biological_Process_2021__regulation of actin filament bundle assembly (GO:0032231),-0.3368603047671084,-0.7129667384930815,0.9411764705882353,1.0,1.0,4/23,13.03%,SHANK1;ASAP3;LIMK1;SYNPO2L
prerank,GO_Biological_Process_2021__intracellular sterol transport (GO:0032366),0.4328303478498093,0.7129051420055226,0.8732394366197183,1.0,1.0,3/12,24.66%,STARD4;VPS4A;SERAC1
prerank,GO_Biological_Process_2021__tRNA methylation (GO:0030488),-0.30925218389551645,-0.7128898908573421,0.9259259259259259,1.0,1.0,6/31,11.29%,LCMT2;THADA;TRDMT1;TRMT10C;ALKBH8;TRMT61A
prerank,GO_Biological_Process_2021__negative regulation of PERK-mediated unfolded protein response (GO:1903898),-0.4540505486761596,-0.7127257371578894,0.7307692307692307,1.0,1.0,1/5,14.52%,PTPN1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte mediated cytotoxicity (GO:0001911),0.4524429718869586,0.7125605356235115,0.84375,1.0,1.0,1/7,5.48%,PTPRC
prerank,GO_Biological_Process_2021__regulation of norepinephrine secretion (GO:0014061),-0.44973181130518497,-0.712529002452419,0.8292682926829268,1.0,1.0,5/5,55.04%,ADRA2A;HRH3;STX1A;ADRA2C;KCNB1
prerank,GO_Biological_Process_2021__receptor recycling (GO:0001881),-0.39556257391879934,-0.7121618123132116,0.8571428571428571,1.0,1.0,3/9,20.01%,SORL1;PLEKHJ1;EHD3
prerank,GO_Biological_Process_2021__establishment of protein localization to extracellular region (GO:0035592),-0.34583426336977197,-0.7120640924591777,0.7647058823529411,1.0,1.0,5/35,12.23%,SVBP;STEAP3;OLFM2;RAB3C;SCG2
prerank,GO_Biological_Process_2021__response to cholesterol (GO:0070723),-0.35200755043725157,-0.7120524050484626,0.7837837837837838,1.0,1.0,2/15,6.06%,OSBPL7;PTCH1
prerank,GO_Biological_Process_2021__regulation of protein localization to chromatin (GO:1905634),0.47183988987900255,0.7119844816950441,0.8305084745762712,1.0,1.0,1/6,13.45%,VCPIP1
prerank,GO_Biological_Process_2021__tyrosine metabolic process (GO:0006570),-0.39714402859230824,-0.7119399273230081,0.9024390243902439,1.0,1.0,1/9,0.72%,PAH
prerank,GO_Biological_Process_2021__cellular macromolecule biosynthetic process (GO:0034645),0.2780560493695029,0.7118444905405585,1.0,1.0,1.0,39/276,21.54%,TICRR;MCM2;RFC5;POLE2;POLE3;INHBA;EEF1A1;RAD9B;ASMT;GTPBP2;RPL15;RPL36;RPS7;GCNT1;CDC6;HELB;DONSON;RPL9;MRE11;RPA3;BRCA1;RPS21;ORC4;SCX;RPL22;RPL21;RSL24D1;RPL38;GRWD1;MRPL34;MRPS14;RECQL4;RPLP2;RPS5;CREBL2;POLR2D;POLR2K;RMI2;MEF2A
prerank,GO_Biological_Process_2021__cellular response to topologically incorrect protein (GO:0035967),0.35535752044844776,0.7116146749343111,0.8529411764705882,1.0,1.0,6/29,22.33%,HSPA1L;HSPA5;HSPA8;DAB2IP;ERN1;HSPA14
prerank,GO_Biological_Process_2021__ciliary basal body-plasma membrane docking (GO:0097711),-0.29881714191523606,-0.711057099746184,0.9444444444444444,1.0,1.0,15/87,15.48%,B9D1;RAB3IP;CDK5RAP2;PCNT;NEDD1;MAPRE1;CEP83;ODF2;PCM1;TUBG1;MKS1;SCLT1;KIF24;RPGRIP1L;TUBB4A
prerank,GO_Biological_Process_2021__signal peptide processing (GO:0006465),0.4232469544920211,0.7109620895554194,0.8529411764705882,1.0,1.0,3/9,20.76%,FURIN;PCSK5;SPCS3
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan metabolic process (GO:0050655),0.4612051408270613,0.7109346153082984,0.8070175438596491,1.0,1.0,1/5,10.30%,CSGALNACT1
prerank,GO_Biological_Process_2021__positive regulation of necrotic cell death (GO:0010940),-0.43474075092834547,-0.7104123169515045,0.8,1.0,1.0,5/5,56.54%,SLC6A6;SLC6A13;MT3;RIPK1;HEBP2
prerank,GO_Biological_Process_2021__import into nucleus (GO:0051170),-0.28546257034134076,-0.7103341688204183,1.0,1.0,1.0,3/66,4.10%,NUP62CL;BACH2;TPR
prerank,GO_Biological_Process_2021__aspartate family amino acid catabolic process (GO:0009068),0.38950475513811594,0.7103083352883082,0.9117647058823529,1.0,1.0,2/16,4.01%,SDS;GOT1
prerank,GO_Biological_Process_2021__regulation of protein phosphorylation (GO:0001932),0.284816216671313,0.7102391310799974,0.9753086419753086,1.0,1.0,31/217,20.78%,ROPN1B;P2RY1;AGER;CD4;CCND2;RARRES2;FAM20A;TBX1;HGF;VEGFC;FAS;GPER1;FKBP8;PLAUR;TGFB1;CDK2AP1;ECT2;FBLN1;FN1;FAXDC2;PINK1;DAB2IP;CHRNA7;NPTN;LIMCH1;TTN;FXR1;CD74;TNIK;LRRK2;PPP2R5B
prerank,GO_Biological_Process_2021__stress-activated protein kinase signaling cascade (GO:0031098),-0.3007638948926459,-0.7102258008532621,0.9032258064516129,1.0,1.0,1/27,4.87%,MAP3K20
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G2/M phase transition (GO:1902751),0.37192343821478824,0.7101336336177477,0.9090909090909091,1.0,1.0,5/21,21.08%,CDC25A;ATAD5;RAB11A;RAD51C;CDK4
prerank,GO_Biological_Process_2021__pyrimidine nucleoside metabolic process (GO:0006213),0.38806589264709435,0.7100730160638732,0.8153846153846154,1.0,1.0,6/15,32.00%,UPB1;DPYS;NT5E;ERH;NT5C1A;DPYD
prerank,GO_Biological_Process_2021__clathrin coat assembly (GO:0048268),0.39057472140026095,0.7097364643508389,0.875,1.0,1.0,3/15,22.97%,HIP1R;NSG1;CLTC
prerank,GO_Biological_Process_2021__regulation of membrane repolarization (GO:0060306),0.43169001836795834,0.7096705905750268,0.85,1.0,1.0,1/10,2.82%,KCNE2
prerank,"GO_Biological_Process_2021__pentose-phosphate shunt, non-oxidative branch (GO:0009052)",0.45173163209998013,0.7093239285426487,0.8,1.0,1.0,3/5,29.95%,RPE;TKT;TALDO1
prerank,GO_Biological_Process_2021__protein polyubiquitination (GO:0000209),0.27359265038078784,0.7093078109551187,0.9882352941176471,1.0,1.0,24/286,17.58%,TRIM22;TRIM5;TRIML2;ARIH2;C10ORF90;TRIM32;SYVN1;KBTBD6;TRAF3IP2;PELI3;SIAH1;RNF152;PSMB6;RNF26;FBXL3;HECW1;BRCA1;PSMA3;FBXO32;PSMB8;RNF144B;MAGEL2;TRIM14;SPSB1
prerank,GO_Biological_Process_2021__positive regulation of epithelial cell apoptotic process (GO:1904037),-0.3896041641255641,-0.7092170957826526,0.8421052631578947,1.0,1.0,3/15,9.78%,ITGA4;ANO6;AKR1C3
prerank,GO_Biological_Process_2021__galactosylceramide biosynthetic process (GO:0006682),0.46652026946031155,0.7089369098035689,0.8823529411764706,1.0,1.0,3/6,22.43%,B3GALT1;B4GALT3;UGT8
prerank,GO_Biological_Process_2021__galactolipid biosynthetic process (GO:0019375),0.46652026946031155,0.7089369098035689,0.8823529411764706,1.0,1.0,3/6,22.43%,B3GALT1;B4GALT3;UGT8
prerank,GO_Biological_Process_2021__protein complex oligomerization (GO:0051259),-0.2834555065120482,-0.7086039734315556,1.0,1.0,1.0,23/77,20.27%,STING1;ZNHIT6;EHD4;KCNC1;ELAVL1;RBMX;CARD11;CPSF7;BEND3;PRMT8;KCNC3;MICU1;WDCP;ATL2;PNPT1;CARD9;HGSNAT;MCU;VSTM5;TP53BP1;TMEM120B;EHD3;HOMER1
prerank,GO_Biological_Process_2021__negative regulation of centrosome duplication (GO:0010826),0.40861158935174335,0.7085046635607509,0.8928571428571429,1.0,1.0,3/10,24.88%,BRCA1;MDM1;KAT2B
prerank,GO_Biological_Process_2021__positive regulation of reactive oxygen species metabolic process (GO:2000379),-0.33606146032895456,-0.7083990806038996,0.96875,1.0,1.0,6/33,12.03%,F2RL1;PID1;PRKCD;ACE2;AKR1C3;DCXR
prerank,GO_Biological_Process_2021__cellular glucose homeostasis (GO:0001678),0.3589910252875414,0.708212657206088,0.9444444444444444,1.0,1.0,4/35,11.81%,HKDC1;PPARGC1A;LRRC8D;GPER1
prerank,GO_Biological_Process_2021__monosaccharide transmembrane transport (GO:0015749),0.38444733584965196,0.7082125278049352,0.8142857142857143,1.0,1.0,3/11,19.02%,SLC23A1;SLC5A2;SLC2A12
prerank,GO_Biological_Process_2021__T cell proliferation (GO:0042098),0.4161555201667419,0.7081347303861237,0.8142857142857143,1.0,1.0,3/11,19.33%,DOCK8;MSN;TNFSF18
prerank,GO_Biological_Process_2021__negative regulation of peptidyl-serine phosphorylation (GO:0033137),0.3929142538127454,0.7077837870407441,0.8857142857142857,1.0,1.0,2/18,11.46%,NLRP2B;SMAD7
prerank,GO_Biological_Process_2021__transcription by RNA polymerase II (GO:0006366),0.28395535308144965,0.7077109293986861,0.9879518072289156,1.0,1.0,21/285,12.02%,NR1I3;HNF4G;RREB1;ZBTB7B;GCM2;NOTCH1;NR2E3;CSTF2T;NR5A2;ABT1;NCBP1;NCBP2;TEAD4;MAML2;PPARGC1A;TBP;COPS2;TBPL1;NOTCH3;GLIS3;CLP1
prerank,GO_Biological_Process_2021__ionotropic glutamate receptor signaling pathway (GO:0035235),-0.4088103353620396,-0.7076074390031077,0.8461538461538461,1.0,1.0,2/8,13.06%,GRIN3A;GRIA2
prerank,GO_Biological_Process_2021__regulation of potassium ion export across plasma membrane (GO:1903764),-0.4699460005809212,-0.707491611676353,0.8571428571428571,1.0,1.0,1/5,9.30%,ANO6
prerank,GO_Biological_Process_2021__protein acylation (GO:0043543),-0.3161676367937578,-0.7074364714988236,0.9375,1.0,1.0,4/35,6.08%,ZDHHC5;NAT9;PORCN;ZDHHC3
prerank,GO_Biological_Process_2021__positive regulation of type 2 immune response (GO:0002830),0.43936071889014366,0.707294757702942,0.835820895522388,1.0,1.0,4/9,30.69%,CD74;IL18;DENND1B;TNFSF4
prerank,GO_Biological_Process_2021__negative regulation of lipase activity (GO:0060192),-0.4382294790673631,-0.7072406750419213,0.6666666666666666,1.0,1.0,3/6,15.39%,PLIN5;RGS2;HDAC9
prerank,GO_Biological_Process_2021__histone acetylation (GO:0016573),-0.27898693499594274,-0.7072043434797854,0.9523809523809523,1.0,1.0,7/66,12.81%,LEF1;BRCA2;TAF10;JADE2;DMAP1;BEND3;TAF12
prerank,GO_Biological_Process_2021__response to UV-A (GO:0070141),0.4232913034895452,0.7071635261935668,0.8070175438596491,1.0,1.0,4/9,22.98%,PPID;OPN3;OPN1SW;OPN5
prerank,GO_Biological_Process_2021__positive regulation of peptide hormone secretion (GO:0090277),-0.30456115434911624,-0.7071119060468112,0.90625,1.0,1.0,2/29,4.12%,RBP4;CRH
prerank,GO_Biological_Process_2021__inorganic cation transmembrane transport (GO:0098662),0.2858897557289593,0.7068485218458272,0.9868421052631579,1.0,1.0,20/218,10.73%,NOX5;TRPV6;KCNA3;TRPA1;KCNG3;KCNE2;SLC30A8;KCNN4;SCN9A;SCN4B;SLC24A4;TRPM6;TRPV3;ATP12A;CACNA2D4;SLC36A1;SLC24A2;SCN7A;KCNG1;RHD
prerank,GO_Biological_Process_2021__focal adhesion assembly (GO:0048041),-0.32756510584016607,-0.7068468920041274,0.8333333333333334,1.0,1.0,9/18,31.99%,TRIP6;PTPRK;RCC2;PIP5K1A;ACTN1;SRC;CTTN;DLC1;FERMT2
prerank,GO_Biological_Process_2021__protein localization to perinuclear region of cytoplasm (GO:1905719),0.4793844191328626,0.7068201967501643,0.8833333333333333,1.0,1.0,1/6,10.84%,RNF26
prerank,GO_Biological_Process_2021__mRNA metabolic process (GO:0016071),-0.29408910889621,-0.7066482508697505,0.967741935483871,1.0,1.0,19/85,15.85%,PCBP3;EREG;LSM10;SF3A2;SF3B4;LSM6;U2AF2;SON;SNRPB;DIS3L2;KIN;SF3A1;SRSF7;SRRM4;SCAF11;HSF1;PTBP1;AURKAIP1;PNPT1
prerank,GO_Biological_Process_2021__autophagy of mitochondrion (GO:0000422),0.3364078952534527,0.7065089590610522,0.8656716417910447,1.0,1.0,11/38,28.76%,BNIP3;CTSK;PINK1;ULK1;ATG3;FBXO7;MAP1LC3B;WIPI1;FUNDC1;GABARAPL1;GABARAPL2
prerank,GO_Biological_Process_2021__glycosphingolipid biosynthetic process (GO:0006688),-0.3588797066241576,-0.7060278875989017,1.0,1.0,1.0,1/14,3.45%,ST8SIA2
prerank,GO_Biological_Process_2021__regulation of cellular protein localization (GO:1903827),-0.3020740020959021,-0.7059160597499557,0.9714285714285714,1.0,1.0,2/44,5.37%,GPC4;TRIM67
prerank,GO_Biological_Process_2021__negative regulation of centriole replication (GO:0046600),0.4438710390978193,0.7059149892291778,0.8333333333333334,1.0,1.0,3/6,24.88%,BRCA1;MDM1;KAT2B
prerank,GO_Biological_Process_2021__negative regulation of protein kinase activity by regulation of protein phosphorylation (GO:0044387),-0.44943590464313904,-0.7058749550879952,0.6976744186046512,1.0,1.0,1/6,17.82%,PPM1F
prerank,GO_Biological_Process_2021__positive regulation of developmental process (GO:0051094),0.28937527942224406,0.7057920864569851,0.975,1.0,1.0,9/149,9.33%,ENPP2;RREB1;ZNF703;NEUROD2;BMP1;BNIP3;SOX6;REST;ZDHHC6
prerank,GO_Biological_Process_2021__G-quadruplex DNA unwinding (GO:0044806),-0.4054542922803971,-0.7057313344705257,0.8260869565217391,1.0,1.0,1/7,11.56%,DDX11
prerank,GO_Biological_Process_2021__regulation of cell cycle G2/M phase transition (GO:1902749),0.3107802333345132,0.7055520118006771,0.9452054794520548,1.0,1.0,11/75,18.10%,ATF5;KIF14;TPX2;TUBB;CEP72;TUBA4A;YWHAG;CEP70;ATAD5;CCP110;NEK10
prerank,GO_Biological_Process_2021__regulation of lymphocyte differentiation (GO:0045619),0.41850856345067783,0.7051356344862042,0.8695652173913043,1.0,1.0,3/13,19.62%,PRDM1;IL4I1;SPINK5
prerank,GO_Biological_Process_2021__ephrin receptor signaling pathway (GO:0048013),-0.2768623201080088,-0.7048743039560288,1.0,1.0,1.0,4/72,5.27%,EPHA3;EPHB2;ARPC3;EPHA5
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000479)",-0.3754698294735628,-0.7045702919637149,0.8913043478260869,1.0,1.0,3/12,11.22%,NOP9;TBL3;NOP14
prerank,GO_Biological_Process_2021__nucleotide-sugar biosynthetic process (GO:0009226),0.3676631711948018,0.7044069836895974,0.8870967741935484,1.0,1.0,7/19,34.06%,NANS;GNPDA1;GFPT2;UAP1;PGM3;GNPNAT1;UGDH
prerank,GO_Biological_Process_2021__regulation of postsynaptic membrane potential (GO:0060078),-0.2996882748850931,-0.7043941649442177,0.9333333333333333,1.0,1.0,6/30,14.91%,DRD4;INSYN2A;GRIN2A;GRIN2C;GABRA3;NLGN3
prerank,GO_Biological_Process_2021__protein insertion into ER membrane (GO:0045048),-0.34637739982644145,-0.7043500137585399,0.875,1.0,1.0,4/32,11.14%,CYB5A;EMD;UBE2J2;EMC8
prerank,GO_Biological_Process_2021__regulation of protein metabolic process (GO:0051246),0.33060122087741173,0.7034913277109905,0.8714285714285714,1.0,1.0,5/38,18.60%,WFS1;PLAUR;VPS35;CHRNA7;FURIN
prerank,GO_Biological_Process_2021__response to alcohol (GO:0097305),-0.33820104986473537,-0.7031466679997599,0.78125,1.0,1.0,5/19,16.59%,GRIN3A;SDF4;GRIN2A;GOT2;TGFBR1
prerank,GO_Biological_Process_2021__regulation of ERAD pathway (GO:1904292),0.419771976421459,0.7031168953972479,0.8636363636363636,1.0,1.0,2/11,14.54%,HERPUD1;USP13
prerank,GO_Biological_Process_2021__positive regulation of mitotic cell cycle phase transition (GO:1901992),-0.28504596466188753,-0.7031145039409479,0.92,1.0,1.0,8/51,14.41%,DBF4B;LSM10;TFDP1;EIF4G1;CDC23;RAD51B;EGFR;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of defense response to virus by host (GO:0002230),-0.3694999784062123,-0.7030980194217221,0.90625,1.0,1.0,1/18,0.97%,STING1
prerank,GO_Biological_Process_2021__negative regulation of cell volume (GO:0045794),0.45205253774345905,0.703094471976187,0.8545454545454545,1.0,1.0,1/5,9.79%,CLCN3
prerank,GO_Biological_Process_2021__regulation of NIK/NF-kappaB signaling (GO:1901222),0.31307334738998943,0.7028762156338646,0.972972972972973,1.0,1.0,15/55,23.03%,LRRC19;AGER;CD14;CD27;NLRC3;PDCD4;RTKN2;TLR2;SPHK1;PPM1A;TERF2IP;CYLD;C1QTNF4;DLG1;IFI35
prerank,GO_Biological_Process_2021__epithelial cell apoptotic process (GO:1904019),-0.41669470274919174,-0.7028331489402031,0.7741935483870968,1.0,1.0,1/7,5.51%,COL4A3
prerank,PanglaoDB_Augmented_2021__Trichocytes,-0.3151661369522247,-0.7027543178893166,0.9,1.0,1.0,10/37,13.47%,LAMB3;CLDN4;HR;CARD10;FERMT1;LAMA3;GPR39;MST1R;PERP;TSPAN1
prerank,GO_Biological_Process_2021__regulation of dopamine receptor signaling pathway (GO:0060159),0.4468891988991456,0.7026960185801409,0.8450704225352113,1.0,1.0,3/8,20.42%,DRD3;VPS35;LRRK2
prerank,GO_Biological_Process_2021__regulation of myelination (GO:0031641),0.3681304727099751,0.7026254380188813,0.9365079365079365,1.0,1.0,2/21,9.01%,PTPRZ1;KIF14
prerank,GO_Biological_Process_2021__positive regulation of DNA biosynthetic process (GO:2000573),0.3297514254947862,0.7025836026211754,0.9868421052631579,1.0,1.0,8/54,16.59%,RFC5;TCP1;PDGFRB;HGF;PCNA;CCT6A;CCT8;RGCC
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species biosynthetic process (GO:1903426),-0.3590992665700822,-0.7025022946368592,0.9302325581395349,1.0,1.0,5/19,11.05%,SLC25A33;SPHK2;SLC30A10;ABCD1;TRAP1
prerank,"GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process (GO:0015014)",0.45098627119670076,0.7024285254159948,0.828125,1.0,1.0,3/7,21.04%,CSGALNACT1;NDST4;NDST3
prerank,GO_Biological_Process_2021__neural crest cell development (GO:0014032),0.33779807457320205,0.7020292789415105,0.8666666666666667,1.0,1.0,7/40,16.04%,SEMA3D;SOX10;TBX1;SOX11;SEMA3F;SEMA3A;HTR2B
prerank,GO_Biological_Process_2021__negative regulation of proteolysis involved in cellular protein catabolic process (GO:1903051),-0.34033454250853695,-0.701880031255495,0.8888888888888888,1.0,1.0,3/23,15.18%,QRICH2;TAF1;PML
prerank,"GO_Biological_Process_2021__SRP-dependent cotranslational protein targeting to membrane, translocation (GO:0006616)",-0.4358670748127181,-0.7018437596565427,0.7441860465116279,1.0,1.0,1/5,17.54%,ZFAND2B
prerank,GO_Biological_Process_2021__membrane depolarization during cardiac muscle cell action potential (GO:0086012),-0.3443951172879901,-0.7011955272009762,0.8648648648648649,1.0,1.0,1/17,2.68%,CACNA2D1
prerank,GO_Biological_Process_2021__telomeric D-loop disassembly (GO:0061820),0.4211289133711873,0.701112669077101,0.8709677419354839,1.0,1.0,2/7,27.73%,RECQL4;BLM
prerank,GO_Biological_Process_2021__hyaluronan metabolic process (GO:0030212),-0.37383835288269046,-0.7009183731123108,0.7307692307692307,1.0,1.0,3/18,10.46%,HMMR;GUSB;CHP1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-10 production (GO:0032693),-0.42182172645202193,-0.7007583022231315,0.8378378378378378,1.0,1.0,1/7,0.82%,TRIB2
prerank,GO_Biological_Process_2021__cellular response to light stimulus (GO:0071482),0.3114636378858541,0.700529348227822,0.9142857142857143,1.0,1.0,16/54,28.21%,CNGB1;CDC25A;COPS9;CNGA1;PCNA;OPN3;PDE6B;OPN1SW;MAPK13;KDM1A;OPN5;POLD1;SDE2;FMR1;ERCC4;TMEM161A
prerank,GO_Biological_Process_2021__phosphate ion homeostasis (GO:0055062),0.4592256399591886,0.7004464676586275,0.873015873015873,1.0,1.0,2/5,9.22%,GCM2;SFRP4
prerank,GO_Biological_Process_2021__pattern recognition receptor signaling pathway (GO:0002221),0.34189465528781393,0.7002965268959412,0.9868421052631579,1.0,1.0,15/39,29.20%,CD14;PLCG2;CTSK;LGMN;SFTPD;TAB2;TLR2;IRAK4;LBP;HSP90B1;MAPKAPK3;ALPK1;CD36;NOD1;RPS27A
prerank,GO_Biological_Process_2021__ubiquitin-dependent ERAD pathway (GO:0030433),0.3184726234930468,0.7000959766062574,0.918918918918919,1.0,1.0,17/71,28.46%,WFS1;SYVN1;HSPA5;HERPUD1;MAN1A1;DERL1;TRIM25;JKAMP;ERLIN1;MAN1B1;HSP90B1;RNF185;UBQLN1;TMUB1;YOD1;MARCHF6;PSMC6
prerank,GO_Biological_Process_2021__positive regulation of plasma membrane bounded cell projection assembly (GO:0120034),-0.2895522618361872,-0.7000778915105901,0.96,1.0,1.0,7/72,12.53%,F2RL1;MIEN1;CROCC;TGFB3;NRP1;RIPOR2;PLPPR5
prerank,GO_Biological_Process_2021__lipid homeostasis (GO:0055088),0.3252982270116036,0.7000700279323104,0.922077922077922,1.0,1.0,6/53,13.88%,FABP3;RCN3;ACOX2;PNPLA1;ABCB4;ACOX1
prerank,GO_Biological_Process_2021__regulation of leukocyte migration (GO:0002685),0.4180811904189634,0.6996033131709011,0.8507462686567164,1.0,1.0,2/12,19.33%,RHOH;TNFSF18
prerank,GO_Biological_Process_2021__positive regulation of viral process (GO:0048524),0.31940283019043514,0.6995242002728788,0.9473684210526315,1.0,1.0,3/59,5.86%,CCL5;VAPB;NR5A2
prerank,GO_Biological_Process_2021__rRNA 3'-end processing (GO:0031125),0.4136970610167246,0.6993658724592314,0.7808219178082192,1.0,1.0,2/9,15.56%,EXOSC8;RPS21
prerank,GO_Biological_Process_2021__mitotic intra-S DNA damage checkpoint signaling (GO:0031573),0.389721510322616,0.6991733080952403,0.855072463768116,1.0,1.0,2/13,13.43%,RAD9B;MRE11
prerank,GO_Biological_Process_2021__isoprenoid metabolic process (GO:0006720),0.451680272015503,0.698890844852246,0.8793103448275862,1.0,1.0,1/7,9.63%,HMGCR
prerank,GO_Biological_Process_2021__osteoclast differentiation (GO:0030316),0.40248406615292887,0.6988438695094424,0.8333333333333334,1.0,1.0,1/16,1.79%,OSCAR
prerank,GO_Biological_Process_2021__internal peptidyl-lysine acetylation (GO:0018393),0.34755674061180497,0.6987236440620737,0.9014084507042254,1.0,1.0,5/24,24.88%,MORF4L2;MORF4L1;MSL3;NAA50;KAT2B
prerank,GO_Biological_Process_2021__protein-DNA complex disassembly (GO:0032986),0.39516850243556834,0.6985791284146595,0.847457627118644,1.0,1.0,4/14,30.11%,SMARCE1;GRWD1;SET;SMARCD2
prerank,GO_Biological_Process_2021__regulation of cell adhesion (GO:0030155),0.3076521566365621,0.6985081273818515,0.96,1.0,1.0,6/97,9.01%,CCL5;RASA1;FUT2;RND1;KNG1;KIF14
prerank,GO_Biological_Process_2021__positive regulation of chromosome segregation (GO:0051984),-0.40357343195817746,-0.6983201951984125,0.8604651162790697,1.0,1.0,2/8,11.09%,NUMA1;SIRT2
prerank,GO_Biological_Process_2021__RNA polymerase II preinitiation complex assembly (GO:0051123),0.44068815330416,0.6978827720938512,0.9344262295081968,1.0,1.0,5/9,22.74%,TBP;TAF7L;DR1;GTF2A2;TAF7
prerank,GO_Biological_Process_2021__Notch receptor processing (GO:0007220),-0.41348674406050023,-0.6976466409356318,0.8367346938775511,1.0,1.0,1/7,8.36%,NCSTN
prerank,GO_Biological_Process_2021__calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules (GO:0016338),-0.37950169006869905,-0.69763583969914,0.8648648648648649,1.0,1.0,1/9,3.74%,CLDN4
prerank,GO_Biological_Process_2021__tRNA 5'-end processing (GO:0099116),0.41598609638655154,0.6970578862242197,0.8688524590163934,1.0,1.0,2/13,7.80%,HSD17B10;RPP38
prerank,GO_Biological_Process_2021__protein mannosylation (GO:0035268),-0.34652935189402223,-0.6969588560074083,0.9285714285714286,1.0,1.0,4/21,17.73%,DPY19L1;DPM3;FKTN;TMTC2
prerank,GO_Biological_Process_2021__modulation of excitatory postsynaptic potential (GO:0098815),-0.3255070616169673,-0.696929031152347,0.9,1.0,1.0,7/27,21.57%,SHANK1;NLGN3;SLC8A3;RELN;RIMS1;TMEM25;GRIN1
prerank,GO_Biological_Process_2021__positive regulation of interferon-alpha production (GO:0032727),-0.3713113743840659,-0.6969036532621115,0.8378378378378378,1.0,1.0,1/12,2.42%,IFIH1
prerank,GO_Biological_Process_2021__protein catabolic process (GO:0030163),0.32436102047919985,0.6968500869531982,0.9696969696969697,1.0,1.0,9/50,16.76%,ADAMTS9;ELANE;LAMP2;SIAH1;MANBA;CLPX;HSPA8;NGLY1;DAB2IP
prerank,GO_Biological_Process_2021__nucleosome disassembly (GO:0006337),0.40080219393921024,0.6967078696969947,0.8793103448275862,1.0,1.0,4/13,30.11%,SMARCE1;GRWD1;SET;SMARCD2
prerank,GO_Biological_Process_2021__chromatin disassembly (GO:0031498),0.40080219393921024,0.6967078696969947,0.8793103448275862,1.0,1.0,4/13,30.11%,SMARCE1;GRWD1;SET;SMARCD2
prerank,GO_Biological_Process_2021__response to thyroid hormone (GO:0097066),0.4263534222058105,0.6964815380703125,0.8888888888888888,1.0,1.0,3/12,29.23%,KLF9;RDX;CTSH
prerank,GO_Biological_Process_2021__pyrimidine-containing compound catabolic process (GO:0072529),0.364511157355801,0.6959753760158793,0.8260869565217391,1.0,1.0,2/17,15.41%,UPB1;DPYS
prerank,GO_Biological_Process_2021__regulation of actin cytoskeleton reorganization (GO:2000249),0.3325369969591294,0.6958771705901777,0.9154929577464789,1.0,1.0,4/33,11.08%,HCK;NTF3;F11R;STAP1
prerank,GO_Biological_Process_2021__arginine metabolic process (GO:0006525),0.41866626832170584,0.6956580320747663,0.7857142857142857,1.0,1.0,1/9,8.99%,ARG1
prerank,GO_Biological_Process_2021__negative regulation of response to biotic stimulus (GO:0002832),-0.350555809728373,-0.6954987051355258,0.96875,1.0,1.0,7/20,13.90%,LYAR;TRAFD1;TYRO3;IFI16;TRAF3IP1;SIRT2;CACTIN
prerank,GO_Biological_Process_2021__cellular response to thyroid hormone stimulus (GO:0097067),0.438785302762979,0.69539747211147,0.8620689655172413,1.0,1.0,3/11,29.23%,KLF9;RDX;CTSH
prerank,GO_Biological_Process_2021__ncRNA 3'-end processing (GO:0043628),0.39765499700064255,0.6951486279500054,0.855072463768116,1.0,1.0,7/14,37.00%,INTS6;SSB;INTS14;TRNT1;INTS5;PTCD1;INTS2
prerank,GO_Biological_Process_2021__regulation of tyrosine phosphorylation of STAT protein (GO:0042509),0.3387100047105711,0.6951187137906284,0.8676470588235294,1.0,1.0,4/35,6.28%,CCL5;CRLF1;IL15;FLT3
prerank,GO_Biological_Process_2021__ISG15-protein conjugation (GO:0032020),0.46618457793247625,0.6947980443544548,0.8823529411764706,1.0,1.0,2/5,35.36%,UBE2E1;ISG15
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor signaling pathway (GO:1900747),0.42537485008997433,0.6947792041746338,0.828125,1.0,1.0,3/7,23.47%,DAB2IP;DCN;PIK3CB
prerank,GO_Biological_Process_2021__negative regulation of blood vessel morphogenesis (GO:2000181),0.30515221270375853,0.6943407583349722,0.9710144927536232,1.0,1.0,7/53,9.09%,STAB1;HSPG2;AMOT;ADGRB1;SERPINF1;CD160;STAT1
prerank,GO_Biological_Process_2021__ventricular compact myocardium morphogenesis (GO:0003223),-0.4318609453608837,-0.6942468910175221,0.8571428571428571,1.0,1.0,2/6,16.59%,NOG;TGFBR1
prerank,GO_Biological_Process_2021__DNA integrity checkpoint signaling (GO:0031570),-0.2898257358346683,-0.6941848367470393,0.8518518518518519,1.0,1.0,3/32,6.44%,MAP3K20;TIMELESS;HUS1
prerank,GO_Biological_Process_2021__sympathetic nervous system development (GO:0048485),-0.3724286368056676,-0.6940781161905348,0.8888888888888888,1.0,1.0,2/12,11.13%,ASCL1;NRP1
prerank,GO_Biological_Process_2021__inner ear auditory receptor cell differentiation (GO:0042491),-0.4463374498730534,-0.6940019120577393,0.7804878048780488,1.0,1.0,1/5,9.47%,JAG2
prerank,GO_Biological_Process_2021__regulation of plasma membrane bounded cell projection assembly (GO:0120032),0.31721780817635503,0.6937813314991138,0.9358974358974359,1.0,1.0,18/59,31.23%,ODAD3;ABITRAM;WAS;PODXL;TBC1D13;FXR1;ATG3;DMTN;CYLD;TWF1;TWF2;CDC42;FMR1;RDX;RAB5A;RAC1;ATP8B1;TBC1D8
prerank,GO_Biological_Process_2021__histone mRNA catabolic process (GO:0071044),-0.34009982352353246,-0.6934839715288276,0.90625,1.0,1.0,3/14,16.96%,EXOSC10;EXOSC4;ATM
prerank,GO_Biological_Process_2021__neurotransmitter receptor transport to postsynaptic membrane (GO:0098969),0.42052677785874915,0.6932376718555467,0.8571428571428571,1.0,1.0,2/9,15.80%,RAB8A;RAB11A
prerank,GO_Biological_Process_2021__regulation of phosphate metabolic process (GO:0019220),-0.3658045192487402,-0.6931159031990731,0.8888888888888888,1.0,1.0,3/14,11.09%,IGBP1;SMG6;SIRT2
prerank,GO_Biological_Process_2021__response to copper ion (GO:0046688),-0.3532245709424183,-0.6922724320171777,0.9354838709677419,1.0,1.0,1/12,2.48%,MT1E
prerank,GO_Biological_Process_2021__regulation of translational initiation (GO:0006446),0.319154973351774,0.692254821169846,0.9428571428571428,1.0,1.0,7/62,13.09%,CCL5;NCBP1;NCBP2;CSDE1;C8ORF88;PAIP2B;EIF2B5
prerank,GO_Biological_Process_2021__protein localization to phagophore assembly site (GO:0034497),-0.39137119916428004,-0.692213709622274,0.7941176470588235,1.0,1.0,4/11,18.10%,ATG9B;WDR45;PACS2;WIPI2
prerank,GO_Biological_Process_2021__positive chemotaxis (GO:0050918),0.4049820251027101,0.6917240187386103,0.9692307692307692,1.0,1.0,2/15,13.93%,CORO1A;TSC2
prerank,"GO_Biological_Process_2021__RNA splicing, via transesterification reactions with bulged adenosine as nucleophile (GO:0000377)",-0.25330852767753853,-0.6916697563917601,1.0,1.0,1.0,52/233,19.42%,CPSF1;SNRNP27;HNRNPL;SF3A2;SF3B4;RBM41;DHX8;MAGOHB;PPIH;LSM6;POLR2G;ELAVL1;RBMX;RBM10;RBM17;PRPF4;U2AF2;CPSF7;SRRM1;TXNL4A;SNRPB;ZCRB1;GPATCH1;SNRPN;ZRSR2;RBM19;SF3A1;GTF2F1;POLR2C;SRSF7;CACTIN;CDC5L;DDX41;POLR2L;CASC3;PPIL1;RSRC1;PTBP1;SF3B6;PDCD7;DDX46;RNF113A;CWF19L2;PRPF6;SYMPK;LSM7;PRPF3;WBP4;SRRT;RNPC3;USP49;CWF19L1
prerank,"GO_Biological_Process_2021__regulation of gene expression, epigenetic (GO:0040029)",0.3129175460278611,0.6915808251366546,0.9206349206349206,1.0,1.0,14/74,24.88%,TDG;H3-3A;TBP;POLR1H;CGGBP1;JARID2;POLR1E;SUZ12;POLR2K;EZH2;POLR1F;SF3B1;TAF1A;KAT2B
prerank,GO_Biological_Process_2021__response to nutrient levels (GO:0031667),0.4068254077485698,0.691545279314835,0.8571428571428571,1.0,1.0,1/13,4.93%,SCTR
prerank,GO_Biological_Process_2021__lipid translocation (GO:0034204),0.3639400374089863,0.691455106671523,0.9682539682539683,1.0,1.0,3/23,12.70%,TMEM30A;ABCB1;ABCB4
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 production (GO:0032692),0.3598441204463223,0.6914214608976825,0.8428571428571429,1.0,1.0,2/18,6.38%,NLRP2B;CARD8
prerank,GO_Biological_Process_2021__small RNA loading onto RISC (GO:0070922),0.41837082062361874,0.6913598255166754,0.9130434782608695,1.0,1.0,2/9,24.83%,CLP1;AGO4
prerank,GO_Biological_Process_2021__positive regulation of translation (GO:0045727),0.2927926341085488,0.6912506402018791,0.9864864864864865,1.0,1.0,4/86,9.02%,CCL5;EIF5A2;YBX3;MPV17L2
prerank,GO_Biological_Process_2021__regulation of sodium ion transmembrane transporter activity (GO:2000649),0.33600009637241024,0.6911788886192024,0.9027777777777778,1.0,1.0,6/29,15.38%,CAV3;GLRX;SCN4B;YWHAH;HECW1;CAMK2D
prerank,GO_Biological_Process_2021__aminoglycan biosynthetic process (GO:0006023),0.32483366532144664,0.6909675477336839,0.9315068493150684,1.0,1.0,7/41,11.45%,GPC6;HSPG2;GPC5;B3GALT1;B3GNT4;B3GNT3;XYLT1
prerank,GO_Biological_Process_2021__regulation of vascular endothelial growth factor production (GO:0010574),-0.32040687751260843,-0.6908607701333421,0.9024390243902439,1.0,1.0,3/20,9.63%,SULF2;RORA;SARS1
prerank,GO_Biological_Process_2021__positive regulation of binding (GO:0051099),-0.30109552933323874,-0.6907853521864962,0.8260869565217391,1.0,1.0,10/71,12.07%,STING1;IGF1;NVL;IDE;TAF1;SIRT2;APOE;DDX11;NGF;HMGB2
prerank,GO_Biological_Process_2021__negative regulation of hydrolase activity (GO:0051346),-0.3409216736474001,-0.6906324421389403,0.8620689655172413,1.0,1.0,7/39,12.11%,PPP1R35;RRP1B;PLIN5;MAPK7;GCHFR;CHP1;SH3RF2
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to plasma membrane (GO:0099639)",0.43785265979280596,0.6904666921179361,0.8333333333333334,1.0,1.0,2/7,16.53%,RAB11A;VPS35
prerank,GO_Biological_Process_2021__mannose trimming involved in glycoprotein ERAD pathway (GO:1904382),0.4633024873239334,0.6904118209033826,0.8260869565217391,1.0,1.0,2/5,22.59%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__ubiquitin-dependent glycoprotein ERAD pathway (GO:0097466),0.4633024873239334,0.6904118209033826,0.8260869565217391,1.0,1.0,2/5,22.59%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__protein deglycosylation involved in glycoprotein catabolic process (GO:0035977),0.4633024873239334,0.6904118209033826,0.8260869565217391,1.0,1.0,2/5,22.59%,MAN1A1;MAN1B1
prerank,GO_Biological_Process_2021__regulation of response to oxidative stress (GO:1902882),-0.3750733650578879,-0.6903088362580025,0.9,1.0,1.0,5/12,19.41%,MCTP1;SELENON;ABCD1;MACROH2A1;PRKN
prerank,GO_Biological_Process_2021__positive regulation of melanin biosynthetic process (GO:0048023),0.4503915203378324,0.6902369157035181,0.8412698412698413,1.0,1.0,1/6,14.12%,OPN3
prerank,GO_Biological_Process_2021__positive regulation of secondary metabolite biosynthetic process (GO:1900378),0.4503915203378324,0.6902369157035181,0.8412698412698413,1.0,1.0,1/6,14.12%,OPN3
prerank,GO_Biological_Process_2021__striated muscle cell development (GO:0055002),-0.42572214162756616,-0.6900633889875817,0.8536585365853658,1.0,1.0,1/8,5.36%,TMOD4
prerank,GO_Biological_Process_2021__positive regulation of lipid metabolic process (GO:0045834),0.3752784351576624,0.6899672648536235,0.8823529411764706,1.0,1.0,4/17,21.48%,HSD17B13;ANGPTL3;CREBL2;PPARG
prerank,GO_Biological_Process_2021__regulation of cell cycle phase transition (GO:1901987),-0.27823934654190324,-0.6898710429111022,0.96875,1.0,1.0,7/82,10.85%,ERCC2;CDC26;TCIM;DBF4B;TFAP4;TAF1;CDC23
prerank,GO_Biological_Process_2021__long-term synaptic depression (GO:0060292),0.42691939841187476,0.6898686481932926,0.8596491228070176,1.0,1.0,2/7,12.27%,SLC24A2;SLC24A1
prerank,GO_Biological_Process_2021__regulation of defense response to virus by host (GO:0050691),0.3559552468058994,0.6898527400346525,0.9365079365079365,1.0,1.0,4/23,9.09%,ZDHHC11;TRAF3IP2;IFNLR1;STAT1
prerank,GO_Biological_Process_2021__positive regulation of cell development (GO:0010720),0.35060422207473513,0.6897570915907186,0.859375,1.0,1.0,5/23,11.81%,TRIM32;SERPINF1;ATP6AP1;SOX11;GPER1
prerank,GO_Biological_Process_2021__regulation of proteolysis (GO:0030162),0.3339908969641086,0.6895908471207556,0.9315068493150684,1.0,1.0,6/41,13.26%,TRIM32;FADD;KNG1;CASP8;RNF139;PLAUR
prerank,GO_Biological_Process_2021__positive regulation of stem cell differentiation (GO:2000738),0.3966654461291477,0.6895565678481422,0.8947368421052632,1.0,1.0,1/10,8.40%,SOX6
prerank,GO_Biological_Process_2021__response to calcium ion (GO:0051592),0.29646350835238344,0.689428069653269,0.9615384615384616,1.0,1.0,21/88,21.68%,TRPV6;NEUROD2;SYT2;SYT4;CPNE5;PLCG2;KCNMB1;ECT2;CAMK2D;SYT15;LGMN;SYT9;ITPKB;TTN;SYT13;CRHBP;MCOLN1;DMTN;ADGRV1;MEF2A;CALM3
prerank,GO_Biological_Process_2021__regulation of muscle contraction (GO:0006937),-0.35079976290329873,-0.6891169606416124,0.9032258064516129,1.0,1.0,3/16,12.49%,MYL5;TNNC2;KCNB2
prerank,GO_Biological_Process_2021__positive regulation of tyrosine phosphorylation of STAT protein (GO:0042531),0.3561567374586267,0.6890918163476594,0.921875,1.0,1.0,5/29,10.94%,CCL5;CRLF1;IL15;FLT3;CTF1
prerank,GO_Biological_Process_2021__regulation of cellular macromolecule biosynthetic process (GO:2000112),0.25982970821338525,0.6890758682352387,1.0,1.0,1.0,34/381,14.54%,TRIM22;RREB1;ZNF703;GMNN;SNAI3;ATF5;NOTCH1;HIC1;ING2;NR5A2;AHR;ZNF430;HINT1;SPTY2D1;ZNF732;NFIL3;PPARGC1A;SOX6;REST;RPS6KA4;TCF7L1;EFEMP1;CASZ1;SOX11;NAB1;MAFB;ZNF682;NANOG;RHOH;ESR1;MITF;ACVR2B;GLRX2;USP13
prerank,GO_Biological_Process_2021__negative regulation of cellular catabolic process (GO:0031330),0.3132753371280014,0.6884468678845694,0.9594594594594594,1.0,1.0,5/58,8.78%,TIMP3;TIMP2;RASIP1;DAPL1;HGF
prerank,GO_Biological_Process_2021__maintenance of synapse structure (GO:0099558),-0.39182064096098296,-0.6882466803306234,0.8372093023255814,1.0,1.0,7/7,60.84%,CHCHD10;ERC1;ERC2;RAB3A;CBLN1;CBLN2;DCTN1
prerank,GO_Biological_Process_2021__intracellular estrogen receptor signaling pathway (GO:0030520),0.3914608756036576,0.6877467128663581,0.8970588235294118,1.0,1.0,3/14,22.28%,ESR1;ESR2;NCOA4
prerank,GO_Biological_Process_2021__negative regulation of mitotic cell cycle (GO:0045930),0.3357452328444412,0.6875650891799575,0.95,1.0,1.0,1/39,0.18%,WEE2
prerank,GO_Biological_Process_2021__RNA secondary structure unwinding (GO:0010501),0.4207917009330544,0.6873281945996764,0.8529411764705882,1.0,1.0,3/7,33.03%,AGO4;DDX3X;AGO1
prerank,GO_Biological_Process_2021__protein targeting to peroxisome (GO:0006625),-0.32103453197761844,-0.6872677662124704,0.9714285714285714,1.0,1.0,1/27,1.59%,PEX7
prerank,GO_Biological_Process_2021__negative regulation of stress-activated MAPK cascade (GO:0032873),0.33243684442688454,0.6870957049628994,0.8787878787878788,1.0,1.0,11/34,25.88%,AMBP;MARVELD3;PINK1;PER1;CYLD;DLG1;GPS2;DUSP19;GSTP1;AIDA;FOXM1
prerank,GO_Biological_Process_2021__dermatan sulfate proteoglycan biosynthetic process (GO:0050651),-0.3892840402018367,-0.6870639547056748,0.875,1.0,1.0,3/12,15.49%,VCAN;B3GAT3;CHST12
prerank,GO_Biological_Process_2021__response to alkaloid (GO:0043279),-0.41469333213221704,-0.687057756658036,0.8648648648648649,1.0,1.0,1/6,4.62%,RYR1
prerank,GO_Biological_Process_2021__lung development (GO:0030324),0.3665460219091088,0.6869302150002812,0.9210526315789473,1.0,1.0,4/25,11.31%,RCN3;CCDC39;FGFR2;SOX11
prerank,GO_Biological_Process_2021__inhibitory synapse assembly (GO:1904862),0.42050245388894714,0.6868577636598078,0.819672131147541,1.0,1.0,1/10,6.24%,GABRA2
prerank,GO_Biological_Process_2021__cellular respiration (GO:0045333),0.3229530968449917,0.6859947294774639,0.9142857142857143,1.0,1.0,9/37,29.31%,PPARGC1A;MTFR1L;UQCRB;CYCS;SLC25A14;ETFB;MTFR1;ETFA;UQCRHL
prerank,GO_Biological_Process_2021__protein K63-linked deubiquitination (GO:0070536),-0.3306386831035491,-0.6859667045201597,0.9696969696969697,1.0,1.0,4/29,13.29%,USP27X;BRCC3;USP25;OTUD5
prerank,GO_Biological_Process_2021__adherens junction maintenance (GO:0034334),-0.45396667655145084,-0.6859644918996478,0.813953488372093,1.0,1.0,3/5,31.99%,PLEKHA7;KIFC3;FERMT2
prerank,GO_Biological_Process_2021__cellular protein catabolic process (GO:0044257),-0.2817345163303165,-0.6858777492365911,0.9285714285714286,1.0,1.0,5/50,9.53%,MYLIP;VLDLR;RAB7A;SPATA18;IDE
prerank,GO_Biological_Process_2021__cellular response to dopamine (GO:1903351),-0.3961932700153721,-0.6857145920731936,0.775,1.0,1.0,2/8,19.41%,DRD1;PRKN
prerank,GO_Biological_Process_2021__response to dopamine (GO:1903350),-0.3961932700153721,-0.6857145920731936,0.775,1.0,1.0,2/8,19.41%,DRD1;PRKN
prerank,GO_Biological_Process_2021__negative regulation of neuroinflammatory response (GO:0150079),0.398937826213967,0.6856055621695459,0.921875,1.0,1.0,1/9,5.48%,PTPRC
prerank,GO_Biological_Process_2021__negative regulation of neurotransmitter secretion (GO:0046929),-0.39774032092339495,-0.6855305310545552,0.8333333333333334,1.0,1.0,2/7,19.41%,PNKD;PRKN
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor production (GO:0032720),-0.33642620493238506,-0.6854788661646691,0.96875,1.0,1.0,3/24,7.93%,IGF1;CIDEA;NR1H4
prerank,GO_Biological_Process_2021__chromatin assembly or disassembly (GO:0006333),-0.3851102944957585,-0.6854418026830313,0.8604651162790697,1.0,1.0,2/11,9.11%,HIRIP3;SUV39H2
prerank,GO_Biological_Process_2021__synaptic vesicle membrane organization (GO:0048499),0.39495679853244203,0.6852794138458854,0.8805970149253731,1.0,1.0,2/15,15.07%,SYNGR2;STX19
prerank,GO_Biological_Process_2021__digestive tract morphogenesis (GO:0048546),0.42733877694981953,0.6852252496336142,0.8484848484848485,1.0,1.0,2/8,11.31%,FGFR2;SOX11
prerank,GO_Biological_Process_2021__protein autoubiquitination (GO:0051865),-0.2769223749173555,-0.6852136588798496,1.0,1.0,1.0,13/61,19.41%,SH3RF1;SH3RF3;ERCC8;NFX1;TRIM68;SH3RF2;TRIM71;MARCHF5;DTX3L;DDB2;RNFT1;RNF208;PRKN
prerank,GO_Biological_Process_2021__DNA geometric change (GO:0032392),0.3508339503089062,0.6848186853898236,0.9230769230769231,1.0,1.0,7/24,28.63%,MRE11;RECQL;RECQL4;DDX1;RAD50;BLM;MTERF1
prerank,GO_Biological_Process_2021__negative regulation of ATPase activity (GO:0032780),0.42911619143542323,0.6848136976009829,0.9076923076923077,1.0,1.0,3/12,20.46%,ATP5IF1;PLN;IFIT1
prerank,GO_Biological_Process_2021__regulation of protein acetylation (GO:1901983),0.40569141361209216,0.684636889563349,0.8095238095238095,1.0,1.0,7/11,42.78%,TERF2IP;DDX3X;CAMK1;RAPGEF3;KAT5;PARK7;TAOK1
prerank,GO_Biological_Process_2021__cellular response to epinephrine stimulus (GO:0071872),0.43516229318617905,0.684374659493265,0.8983050847457628,1.0,1.0,4/8,26.97%,KCNQ1;ATP2B4;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__response to epinephrine (GO:0071871),0.43516229318617905,0.684374659493265,0.8983050847457628,1.0,1.0,4/8,26.97%,KCNQ1;ATP2B4;RYR2;SLC9A1
prerank,GO_Biological_Process_2021__sodium ion transport (GO:0006814),0.3089502455416904,0.6841377172141394,0.9714285714285714,1.0,1.0,9/69,15.36%,SLC23A1;SCN9A;SCN4B;SLC24A4;SLC24A2;SCN7A;SLC24A1;SLC5A2;ATP1B1
prerank,GO_Biological_Process_2021__cellular response to nutrient levels (GO:0031669),0.3166429659050198,0.6840411304595414,0.9710144927536232,1.0,1.0,9/54,22.49%,STK26;LAMP2;RIPOR1;HSPA8;PDK4;ULK1;LRRK2;MAP1LC3B;WIPI1
prerank,GO_Biological_Process_2021__positive regulation of sodium ion transmembrane transporter activity (GO:2000651),0.393350520112283,0.6839815484097959,0.859375,1.0,1.0,3/12,20.84%,GLRX;ATP1B1;TESC
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 beta production (GO:0032731),-0.3052364413875557,-0.6839678756337763,0.918918918918919,1.0,1.0,6/31,9.95%,F2RL1;AZU1;NLRP1;HSPB1;STAT3;IFI16
prerank,GO_Biological_Process_2021__regulation of cell communication (GO:0010646),0.34137099129232196,0.6838051105143929,0.8888888888888888,1.0,1.0,7/28,25.08%,YWHAG;MTCH1;GLRX2;CAMK2D;TRDN;IGFBP7;RYR2
prerank,GO_Biological_Process_2021__cardiac muscle cell membrane repolarization (GO:0099622),0.4118033932999925,0.6838025687047163,0.9090909090909091,1.0,1.0,3/11,18.43%,ATP1B1;KCNQ1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cell motility (GO:2000146),0.28738235707653903,0.683732013648485,0.9850746268656716,1.0,1.0,16/88,20.98%,EPHA1;STK26;CYP1B1;IGFBP5;SPOCK3;WAS;RHOB;SMAD7;MITF;DACH1;FBLN1;LIMCH1;CD74;DNAI3;FRMD5;RNF41
prerank,GO_Biological_Process_2021__positive regulation of epidermal growth factor receptor signaling pathway (GO:0045742),-0.3535541449184083,-0.6835078573548894,0.9259259259259259,1.0,1.0,4/24,9.98%,BTC;EREG;DGKD;DOK1
prerank,GO_Biological_Process_2021__positive regulation of amyloid-beta formation (GO:1902004),-0.3642964603315769,-0.6834322040729122,0.9565217391304348,1.0,1.0,3/15,19.71%,LRRTM3;CLU;SLC2A13
prerank,GO_Biological_Process_2021__regulation of receptor catabolic process (GO:2000644),-0.43147676417831127,-0.6831524086014904,0.8157894736842105,1.0,1.0,2/5,17.70%,PTPN1;DTX3L
prerank,GO_Biological_Process_2021__autonomic nervous system development (GO:0048483),0.36929311260314046,0.6831423921366568,0.8888888888888888,1.0,1.0,4/15,15.62%,SOX10;SOX11;SEMA3A;FN1
prerank,GO_Biological_Process_2021__positive regulation of angiogenesis (GO:0045766),0.2949639012158202,0.6830797988968854,0.9493670886075949,1.0,1.0,11/87,14.47%,PTGIS;EPHA1;ITGA5;CYP1B1;TWIST1;GAB1;VEGFC;RHOB;AGGF1;ZNF304;BRCA1
prerank,GO_Biological_Process_2021__negative regulation of dephosphorylation (GO:0035305),-0.35059317331933754,-0.6829970897872789,0.8857142857142857,1.0,1.0,4/18,12.11%,PPP1R35;CHP1;PPP1R8;SH3RF2
prerank,GO_Biological_Process_2021__homologous chromosome pairing at meiosis (GO:0007129),0.35467090141024454,0.6828011863910499,0.855072463768116,1.0,1.0,5/23,15.04%,RNF212B;STAG3;IHO1;SYCP2;MEIOB
prerank,GO_Biological_Process_2021__dephosphorylation of RNA polymerase II C-terminal domain (GO:0070940),-0.4260909203380159,-0.682786767143511,0.7142857142857143,1.0,1.0,3/5,24.95%,SSU72;RPRD1B;RPRD1A
prerank,GO_Biological_Process_2021__tRNA transcription (GO:0009304),0.44631967498315156,0.682734648813788,0.890625,1.0,1.0,1/8,6.35%,GTF3C4
prerank,GO_Biological_Process_2021__negative regulation of sphingolipid biosynthetic process (GO:0090155),0.4339175387035306,0.6826633733396377,0.8518518518518519,1.0,1.0,1/5,21.17%,SPHK1
prerank,GO_Biological_Process_2021__negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244),-0.35063899362587836,-0.6822972719418015,0.9024390243902439,1.0,1.0,3/12,20.66%,NELFA;TCERG1;NELFE
prerank,GO_Biological_Process_2021__negative regulation of establishment of protein localization (GO:1904950),0.4085489527582662,0.682057882898344,0.8983050847457628,1.0,1.0,3/10,30.79%,DNAJA1;CORO2B;NDFIP2
prerank,GO_Biological_Process_2021__acyl-CoA metabolic process (GO:0006637),0.3407702801248135,0.6817813626328035,0.9545454545454546,1.0,1.0,4/31,11.32%,ACOT4;BAAT;HMGCS1;ACOT13
prerank,GO_Biological_Process_2021__positive regulation of regulated secretory pathway (GO:1903307),0.36985885293239673,0.6815962140238573,0.9344262295081968,1.0,1.0,4/16,23.14%,SYT4;CACNA1G;CACNA1H;DOC2B
prerank,"GO_Biological_Process_2021__negative regulation of gene expression, epigenetic (GO:0045814)",0.34921799625561384,0.6812635712868247,0.9206349206349206,1.0,1.0,4/27,21.73%,H3-3A;JARID2;SUZ12;EZH2
prerank,GO_Biological_Process_2021__protein secretion (GO:0009306),-0.31103731868679657,-0.6807511088130592,0.96875,1.0,1.0,7/47,12.23%,SVBP;STEAP3;PORCN;OLFM2;RAB3C;VIP;SCG2
prerank,GO_Biological_Process_2021__negative regulation of myeloid leukocyte differentiation (GO:0002762),0.37073308963525303,0.6806161450667869,0.9402985074626866,1.0,1.0,4/16,11.79%,INHBA;ZFPM1;TMEM178A;MAFB
prerank,GO_Biological_Process_2021__regulation of chromosome segregation (GO:0051983),0.395462482300652,0.6804082164233664,0.9130434782608695,1.0,1.0,4/14,26.38%,IHO1;CDC6;RMI2;PUM1
prerank,GO_Biological_Process_2021__adherens junction organization (GO:0034332),0.3247455064024555,0.6801502580570209,0.9324324324324325,1.0,1.0,2/42,2.47%,ZNF703;CTNNA1
prerank,GO_Biological_Process_2021__regulation of cholesterol biosynthetic process (GO:0045540),0.3559322121957141,0.6798807183869136,0.9655172413793104,1.0,1.0,1/17,4.62%,LPCAT3
prerank,GO_Biological_Process_2021__negative regulation of blood vessel endothelial cell migration (GO:0043537),0.3525594490917818,0.6796623106380401,0.9032258064516129,1.0,1.0,9/25,24.42%,TBXA2R;NOTCH1;ANGPT2;TGFB1;RGCC;MMRN2;PPARG;ATP2B4;MEOX2
prerank,GO_Biological_Process_2021__negative regulation of catecholamine secretion (GO:0033604),0.44189621880762536,0.6796567338758753,0.8545454545454545,1.0,1.0,1/6,6.55%,SYT4
prerank,GO_Biological_Process_2021__negative regulation of osteoclast differentiation (GO:0045671),-0.41980122206316495,-0.6795317810198784,0.8787878787878788,1.0,1.0,1/10,2.28%,LRRC17
prerank,GO_Biological_Process_2021__regulation of macrophage cytokine production (GO:0010935),0.4001783222995901,0.6790374228912038,0.8548387096774194,1.0,1.0,4/12,19.30%,CUEDC2;PLCG2;TGFB1;CD74
prerank,PanglaoDB_Augmented_2021__Distal Tubule Cells,0.2925886963860193,0.6787628499704992,0.9714285714285714,1.0,1.0,17/90,19.25%,CALB1;EXPH5;EPB41L4A;TFCP2L1;TRPM6;PPARGC1A;MYO5B;TMEM213;MUC4;ATP1B1;BBOX1;ADGRF5;ALDH1L1;PIK3C2G;MUC20;CLMN;ATP5MK
prerank,GO_Biological_Process_2021__semaphorin-plexin signaling pathway involved in neuron projection guidance (GO:1902285),-0.3721958600344998,-0.6787089063334428,0.8,1.0,1.0,4/12,15.20%,PLXNA1;PLXNA2;NRP1;PLXNC1
prerank,GO_Biological_Process_2021__7-methylguanosine RNA capping (GO:0009452),-0.32753492361096687,-0.6786969197617388,0.9444444444444444,1.0,1.0,7/30,14.66%,ERCC2;GTF2H2;CCNH;POLR2G;GTF2F1;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__7-methylguanosine mRNA capping (GO:0006370),-0.32753492361096687,-0.6786969197617388,0.9444444444444444,1.0,1.0,7/30,14.66%,ERCC2;GTF2H2;CCNH;POLR2G;GTF2F1;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__regulation of amyloid-beta clearance (GO:1900221),-0.37148835398087277,-0.6781106877881121,0.8611111111111112,1.0,1.0,3/11,11.39%,HDAC1;APOE;CLU
prerank,GO_Biological_Process_2021__negative regulation of cell division (GO:0051782),0.4517876407344198,0.6779944074230814,0.859375,1.0,1.0,4/7,30.31%,VPS4A;ZFYVE19;BLM;TXNIP
prerank,GO_Biological_Process_2021__positive regulation of gene silencing by miRNA (GO:2000637),-0.3189485904730913,-0.6779037337264153,0.8620689655172413,1.0,1.0,4/23,12.89%,WTIP;STAT3;EIF4G1;EGFR
prerank,GO_Biological_Process_2021__genitalia development (GO:0048806),0.4645515071116202,0.6778313762551169,0.9,1.0,1.0,3/6,34.70%,DNAJC19;SHH;PKD1
prerank,GO_Biological_Process_2021__peptidyl-methionine modification (GO:0018206),-0.3517108716987417,-0.6777051082872173,0.967741935483871,1.0,1.0,4/9,17.53%,APOA1;METAP2;NAA20;NAA15
prerank,GO_Biological_Process_2021__synaptic vesicle endocytosis (GO:0048488),0.3352543651734588,0.6775803540536289,0.9466666666666667,1.0,1.0,1/33,4.31%,SYT2
prerank,GO_Biological_Process_2021__positive regulation of ion transmembrane transport (GO:0034767),-0.4043064619919712,-0.6772483656059234,0.8163265306122449,1.0,1.0,1/6,9.30%,ANO6
prerank,GO_Biological_Process_2021__positive regulation of cellular senescence (GO:2000774),0.4068688363731132,0.6771711225910615,0.8571428571428571,1.0,1.0,3/9,19.71%,ARG2;CGAS;B2M
prerank,GO_Biological_Process_2021__cellular response to tumor necrosis factor (GO:0071356),-0.29122478763396503,-0.6768586721311526,1.0,1.0,1.0,6/126,6.64%,NPNT;PID1;TNFRSF11A;SFRP1;TRAF3;EDARADD
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902166),-0.39322341416023354,-0.6766829402390715,0.9,1.0,1.0,2/10,6.63%,TRIAP1;BCL2
prerank,GO_Biological_Process_2021__regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator (GO:1902165),-0.39322341416023354,-0.6766829402390715,0.9,1.0,1.0,2/10,6.63%,TRIAP1;BCL2
prerank,GO_Biological_Process_2021__positive regulation of RNA splicing (GO:0033120),-0.30697953335692446,-0.6766511301706813,0.9428571428571428,1.0,1.0,9/28,19.23%,SF3B4;NCL;RBMX;U2AF2;RBM3;CIRBP;CELF4;SETX;HSPA1A
prerank,GO_Biological_Process_2021__protein transport (GO:0015031),0.2603277608306838,0.676567399293863,1.0,1.0,1.0,60/298,26.35%,RAB6C;GRTP1;RCN3;AMN;SLU7;RUNDC1;LAMP2;RABL2B;ATP6V1B2;ARRDC3;RAB19;TVP23B;ATP6AP1;CHMP2B;RAB23;YWHAH;ARCN1;CHMP1A;ARL1;ARL6;RAB8A;NEURL1B;SNX31;STX19;ATP6V1C1;VPS35;SNX17;CHMP2A;UNC119B;TBC1D13;ARF4;STX17;CD74;ATP6V0B;MCOLN1;RAB6D;ARL4A;MTTP;SNX4;PPARG;ATP6V1C2;CLTC;TF;NAPA;LTBP2;ATP6V1D;RAB21;SCAMP1;ARL6IP5;RAB1A;ZDHHC17;LRP2;HSP90B1;RAMP1;KIF3A;VMP1;TFR2;LAPTM5;TRIM23;VPS26A
prerank,GO_Biological_Process_2021__regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900739),0.3602508636066739,0.6765217337274427,0.8307692307692308,1.0,1.0,5/20,21.22%,CASP8;YWHAH;YWHAG;BAD;TP63
prerank,GO_Biological_Process_2021__positive regulation of protein insertion into mitochondrial membrane involved in apoptotic signaling pathway (GO:1900740),0.3602508636066739,0.6765217337274427,0.8307692307692308,1.0,1.0,5/20,21.22%,CASP8;YWHAH;YWHAG;BAD;TP63
prerank,GO_Biological_Process_2021__peroxisomal membrane transport (GO:0015919),-0.32570586750428554,-0.6761070406308105,0.9428571428571428,1.0,1.0,1/25,1.59%,PEX7
prerank,GO_Biological_Process_2021__response to acidic pH (GO:0010447),0.42542245515731925,0.6760672601424546,0.8507462686567164,1.0,1.0,3/9,26.97%,PKD1L3;LGMN;SLC9A1
prerank,GO_Biological_Process_2021__sodium ion import across plasma membrane (GO:0098719),0.3885723988038395,0.6759977245688733,0.890625,1.0,1.0,7/15,28.27%,SLC5A2;SLC9A2;SLC9A6;SLC9A7;HCN4;SLC9A1;SLC12A2
prerank,"GO_Biological_Process_2021__DNA-templated transcription, termination (GO:0006353)",0.3012224535750636,0.6757826032555974,0.95,1.0,1.0,9/66,16.13%,POLR3K;CSTF2T;NCBP1;NCBP2;TBP;POLR1H;CLP1;FIP1L1;POLR1E
prerank,GO_Biological_Process_2021__kinetochore assembly (GO:0051382),-0.3773039889958734,-0.6756199942957068,0.8214285714285714,1.0,1.0,8/8,62.29%,POGZ;CENPE;CENPT;CENPF;CENPC;CENPA;MIS12;CENPW
prerank,GO_Biological_Process_2021__proton-transporting V-type ATPase complex assembly (GO:0070070),0.43941313249274744,0.675457251951258,0.9122807017543859,1.0,1.0,1/5,10.80%,ALDOB
prerank,GO_Biological_Process_2021__insulin receptor signaling pathway (GO:0008286),0.31464279668279493,0.6754290001368466,0.9852941176470589,1.0,1.0,10/61,19.99%,RARRES2;IRS4;GAB1;NAMPT;ATP6V1B2;ATP6AP1;ATP6V1C1;PDK4;ATP6V0B;SHC1
prerank,GO_Biological_Process_2021__atrial septum morphogenesis (GO:0060413),0.43357355389966035,0.6753420483640482,0.9032258064516129,1.0,1.0,1/6,6.18%,ZFPM1
prerank,GO_Biological_Process_2021__mitochondrial RNA 3'-end processing (GO:0000965),0.4680785935919767,0.6751867560731276,0.9032258064516129,1.0,1.0,1/5,7.00%,HSD17B10
prerank,GO_Biological_Process_2021__insulin secretion involved in cellular response to glucose stimulus (GO:0035773),-0.43136805428204655,-0.675123289018959,0.8444444444444444,1.0,1.0,6/6,56.88%,RAB11B;PTPRN2;PTPRN;SELENOT;RAB11FIP5;RAB11FIP2
prerank,GO_Biological_Process_2021__gland morphogenesis (GO:0022612),0.4259590532033932,0.6750025623150411,0.8727272727272727,1.0,1.0,3/6,16.18%,FGFR2;TGFB1;MSN
prerank,GO_Biological_Process_2021__positive regulation of interleukin-1 production (GO:0032732),-0.29028139240006007,-0.6747646943347528,0.9487179487179487,1.0,1.0,6/35,9.95%,F2RL1;AZU1;NLRP1;HSPB1;STAT3;IFI16
prerank,GO_Biological_Process_2021__termination of RNA polymerase II transcription (GO:0006369),0.3441291091405218,0.6747484150231953,0.9090909090909091,1.0,1.0,5/31,14.05%,CSTF2T;NCBP1;NCBP2;CLP1;FIP1L1
prerank,GO_Biological_Process_2021__positive regulation of vascular endothelial growth factor production (GO:0010575),-0.32309536235098796,-0.6747482136974682,0.8717948717948718,1.0,1.0,1/19,0.95%,SULF2
prerank,GO_Biological_Process_2021__positive regulation of supramolecular fiber organization (GO:1902905),0.31127202345462496,0.674491048662753,0.9436619718309859,1.0,1.0,3/73,5.80%,CAV3;HCK;PSRC1
prerank,GO_Biological_Process_2021__negative regulation of interleukin-1 beta production (GO:0032691),0.36481844211810244,0.674413267243957,0.8955223880597015,1.0,1.0,2/15,6.38%,NLRP2B;CARD8
prerank,GO_Biological_Process_2021__cleavage furrow formation (GO:0036089),-0.4092513638655847,-0.6742463887386102,0.8055555555555556,1.0,1.0,5/5,59.09%,SPIRE2;SNX18;RHOA;SNX9;SPIRE1
prerank,GO_Biological_Process_2021__tRNA transcription by RNA polymerase III (GO:0042797),0.4488741799926865,0.6739028706620321,0.8888888888888888,1.0,1.0,1/7,6.35%,GTF3C4
prerank,GO_Biological_Process_2021__endothelial cell migration (GO:0043542),0.3476572405008266,0.6739028407098885,0.9054054054054054,1.0,1.0,4/31,13.45%,LOXL2;CYP1B1;STAT1;PRSS3
prerank,GO_Biological_Process_2021__sphingolipid biosynthetic process (GO:0030148),-0.2670243251404966,-0.6735467878761711,1.0,1.0,1.0,8/65,11.90%,SPTSSB;ELOVL6;SPHK2;CERS4;SGMS2;SPTLC1;SMPD4;CSNK1G2
prerank,GO_Biological_Process_2021__tRNA wobble uridine modification (GO:0002098),-0.3846241898676769,-0.6734830475696801,0.90625,1.0,1.0,1/13,10.93%,ALKBH8
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination (GO:0045910),0.31331921266162754,0.6734614663723386,0.927536231884058,1.0,1.0,11/47,21.87%,POLQ;H1-2;KLHL15;HELB;CGAS;MAGEF1;H1-0;POLR2D;POLR2K;RMI2;TERF2IP
prerank,GO_Biological_Process_2021__SCF-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0031146),-0.2822645024171058,-0.6729963457546475,0.9259259259259259,1.0,1.0,2/81,4.13%,FBXL7;FBXO27
prerank,GO_Biological_Process_2021__regulation of water loss via skin (GO:0033561),0.3719229428847114,0.6729683720236703,0.8714285714285714,1.0,1.0,4/16,21.22%,ALOX12;TMEM79;ALOXE3;TP63
prerank,GO_Biological_Process_2021__establishment of skin barrier (GO:0061436),0.3719229428847114,0.6729683720236703,0.8714285714285714,1.0,1.0,4/16,21.22%,ALOX12;TMEM79;ALOXE3;TP63
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell differentiation (GO:0045630),0.4482528729112804,0.6728651465313656,0.8787878787878788,1.0,1.0,2/5,30.69%,IL18;TNFSF4
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell differentiation (GO:0045628),0.4482528729112804,0.6728651465313656,0.8787878787878788,1.0,1.0,2/5,30.69%,IL18;TNFSF4
prerank,GO_Biological_Process_2021__positive regulation of JUN kinase activity (GO:0043507),-0.3395396709530332,-0.6726157114429193,0.90625,1.0,1.0,1/17,3.08%,TNFRSF11A
prerank,GO_Biological_Process_2021__regulation of protein modification by small protein conjugation or removal (GO:1903320),0.37012733796365077,0.6723480237928567,0.8548387096774194,1.0,1.0,3/18,18.83%,EPAS1;PINK1;DCUN1D1
prerank,GO_Biological_Process_2021__oligodendrocyte differentiation (GO:0048709),0.35461334150482615,0.6720970629458218,0.8823529411764706,1.0,1.0,4/19,13.09%,SOX10;PTPRZ1;SOX6;EIF2B5
prerank,GO_Biological_Process_2021__cellular protein metabolic process (GO:0044267),0.2576371479779886,0.6720932847807845,1.0,1.0,1.0,52/338,21.07%,WFS1;MMP15;RABGGTB;RCN1;CP;ITIH2;LOXL2;IGFBP5;NOTUM;SERPINA10;EEF1A1;MFGE8;ASMT;KNG1;CPE;RPL15;PAPPA;CSF2RA;RPL36;MEPE;RPS7;MANBA;EVA1A;PIGH;MGAT4A;RPL9;PAPPA2;PCMT1;RPS21;FN1;PLOD2;UBL5;LGMN;SPP1;DAB2IP;RPL22;SFTPC;SFTPD;YES1;RPL21;RSL24D1;SPARCL1;FURIN;RPL38;PCSK5;MRPL34;MRPS14;ATG3;RPLP2;RPS5;SPCS3;SERPIND1
prerank,GO_Biological_Process_2021__eye development (GO:0001654),0.3132393696393456,0.6720596405881434,0.9315068493150684,1.0,1.0,6/39,13.23%,SALL2;SCO2;LAMA1;EFEMP1;ADAMTS18;CPAMD8
prerank,GO_Biological_Process_2021__regulation of BMP signaling pathway (GO:0030510),-0.2822227093167352,-0.671961827881938,0.967741935483871,1.0,1.0,10/57,14.03%,GREM1;LEMD2;NUMA1;CRIM1;VWC2;SORL1;XIAP;NOG;NBL1;BMPER
prerank,GO_Biological_Process_2021__peptidyl-lysine oxidation (GO:0018057),0.43425125397258,0.6719595878120843,0.8545454545454545,1.0,1.0,1/5,4.85%,LOXL2
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902175),-0.3472682006393861,-0.6719209388971379,0.8648648648648649,1.0,1.0,2/15,7.27%,MAPK7;HSPB1
prerank,GO_Biological_Process_2021__phospholipase C-activating dopamine receptor signaling pathway (GO:0060158),-0.4414457443598636,-0.6718435984260418,0.9047619047619048,1.0,1.0,2/6,10.32%,GNA14;DRD1
prerank,GO_Biological_Process_2021__hippo signaling (GO:0035329),0.3442757024402219,0.6714898638632398,0.9166666666666666,1.0,1.0,3/24,10.87%,AMOT;TEAD4;SAV1
prerank,GO_Biological_Process_2021__phosphatidylinositol phosphate biosynthetic process (GO:0046854),-0.290827645497881,-0.6713355755821878,0.9629629629629629,1.0,1.0,2/31,8.99%,PI4K2A;TMEM150A
prerank,GO_Biological_Process_2021__ATP transport (GO:0015867),0.43121544956747143,0.6713353693873648,0.875,1.0,1.0,4/9,29.45%,ABCC6;SLC25A4;CD47;SLC25A5
prerank,GO_Biological_Process_2021__morphogenesis of an epithelium (GO:0002009),0.36280798449241747,0.6712216618030672,0.8823529411764706,1.0,1.0,3/21,15.68%,SOX10;FGFR2;KLK14
prerank,GO_Biological_Process_2021__positive regulation of oligodendrocyte differentiation (GO:0048714),0.4521506882297214,0.6712198665332046,0.9354838709677419,1.0,1.0,1/5,6.77%,PTPRZ1
prerank,GO_Biological_Process_2021__high-density lipoprotein particle assembly (GO:0034380),0.4169738693776219,0.6711971349024918,0.9032258064516129,1.0,1.0,1/9,7.64%,BMP1
prerank,GO_Biological_Process_2021__response to glucagon (GO:0033762),-0.36751235851131864,-0.6709987861518777,0.96,1.0,1.0,6/17,27.71%,CYSLTR2;ADCY7;ADCY2;ADCY5;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__miRNA mediated inhibition of translation (GO:0035278),0.3713901731596643,0.6708488085933906,0.9104477611940298,1.0,1.0,5/11,33.03%,NOTCH4;AGO4;EIF6;ZFP36;AGO1
prerank,"GO_Biological_Process_2021__negative regulation of translation, ncRNA-mediated (GO:0040033)",0.3713901731596643,0.6708488085933906,0.9104477611940298,1.0,1.0,5/11,33.03%,NOTCH4;AGO4;EIF6;ZFP36;AGO1
prerank,GO_Biological_Process_2021__positive regulation of gene expression (GO:0010628),0.2532500793172956,0.6708393667796867,1.0,1.0,1.0,35/352,16.59%,NOX5;CALCR;ITK;ZBTB7B;ACTA2;NOTCH1;IL15;INHBA;MYOM1;RHOXF2;TWIST1;AGT;ACTC1;PPARGC1A;TBP;HHLA2;SFRP4;RPS7;STAP1;POLR1H;SOX11;PLCG2;GPER1;SLC38A2;MITF;TGFB1;BRCA1;FN1;HTR2B;SMAD1;POLR1E;MSN;VPS35;SCX;RGCC
prerank,GO_Biological_Process_2021__positive regulation of endocytosis (GO:0045807),-0.2821260741946311,-0.6703747059333777,0.9393939393939394,1.0,1.0,5/41,11.39%,F2RL1;ABCA13;ANO6;APOE;CLU
prerank,GO_Biological_Process_2021__synaptic vesicle recycling (GO:0036465),0.33914360935960597,0.670212240497103,0.9333333333333333,1.0,1.0,1/29,4.31%,SYT2
prerank,GO_Biological_Process_2021__response to glucose (GO:0009749),0.3214527113654687,0.6701348542455622,0.9743589743589743,1.0,1.0,4/37,13.09%,SLC30A8;KHK;GPER1;EIF2B5
prerank,GO_Biological_Process_2021__regulation of phosphorylation (GO:0042325),-0.2882179302785898,-0.6701095703554808,1.0,1.0,1.0,10/109,8.70%,BMP7;INHA;NUP210;EREG;PRKRIP1;TPR;ITGA6;NUP37;HSPB1;ZBTB7A
prerank,GO_Biological_Process_2021__potassium ion transport (GO:0006813),0.28601840615164376,0.6695694631666133,0.9866666666666667,1.0,1.0,21/102,22.87%,KCNA3;KCNG3;KCNE2;KCNN4;SLC24A4;SLC24A2;KCNG1;SLC24A1;KCNK10;KCNMB1;KCNJ11;KCNQ1;SLC9A2;SLC9A6;SLC9A7;KCNK1;LRRC38;ABCC9;KCND1;HCN4;SLC1A3
prerank,GO_Biological_Process_2021__cardiac cell development (GO:0055006),0.39731733293256616,0.6695524643819198,0.8461538461538461,1.0,1.0,1/10,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__regulation of DNA demethylation (GO:1901535),0.43069347099685684,0.6695284852591429,0.8545454545454545,1.0,1.0,2/5,19.65%,OTUD4;STPG4
prerank,GO_Biological_Process_2021__positive regulation of DNA demethylation (GO:1901537),0.43069347099685684,0.6695284852591429,0.8545454545454545,1.0,1.0,2/5,19.65%,OTUD4;STPG4
prerank,GO_Biological_Process_2021__regulation of digestive system process (GO:0044058),0.4521953789596172,0.6693925842562681,0.864406779661017,1.0,1.0,1/6,3.96%,OPRK1
prerank,"GO_Biological_Process_2021__mRNA cis splicing, via spliceosome (GO:0045292)",-0.36110819238015457,-0.6693326952037826,0.875,1.0,1.0,3/15,13.90%,SFSWAP;DCPS;CACTIN
prerank,GO_Biological_Process_2021__excitatory postsynaptic potential (GO:0060079),-0.35179780826321827,-0.6691132615612385,0.9459459459459459,1.0,1.0,2/15,11.27%,GRIN2A;GRIN2C
prerank,GO_Biological_Process_2021__negative regulation of response to cytokine stimulus (GO:0060761),0.4182341012994846,0.6688839737121703,0.9264705882352942,1.0,1.0,1/9,5.48%,PTPRC
prerank,GO_Biological_Process_2021__heparin metabolic process (GO:0030202),-0.4180041093788013,-0.6688077893997195,0.8611111111111112,1.0,1.0,3/5,18.43%,SLC10A7;ANGPT1;IDUA
prerank,PanglaoDB_Augmented_2021__Luteal Cells,0.2904704390131605,0.668739037548444,0.9863013698630136,1.0,1.0,21/114,19.29%,GPC6;WFS1;MMP15;AOX1;PRLR;BOK;ALDH4A1;FKBP5;CPE;F10;SFRP4;PGAM1;KIAA1217;CDR2L;TMEM86A;PEBP1;DAB2IP;DHCR7;PCYOX1;DHCR24;SMARCA1
prerank,GO_Biological_Process_2021__arachidonate transport (GO:1903963),-0.4131020656353345,-0.6685894977339579,0.8292682926829268,1.0,1.0,1/6,4.99%,DRD4
prerank,GO_Biological_Process_2021__arachidonic acid secretion (GO:0050482),-0.4131020656353345,-0.6685894977339579,0.8292682926829268,1.0,1.0,1/6,4.99%,DRD4
prerank,GO_Biological_Process_2021__regulation of cell cycle process (GO:0010564),0.28761508350113446,0.6684999071740645,0.96,1.0,1.0,10/88,16.36%,BORA;ATF5;KLHL21;IHO1;GPER1;KLHL13;ECT2;RACGAP1;RAB11A;CCP110
prerank,GO_Biological_Process_2021__cellular response to virus (GO:0098586),-0.3307817714671721,-0.6682941210076132,0.8285714285714286,1.0,1.0,3/24,9.37%,IFIH1;RRP1B;POU2F2
prerank,GO_Biological_Process_2021__positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress (GO:1990440),0.39445756949430394,0.6681868981726132,0.8448275862068966,1.0,1.0,1/11,7.54%,HSPA5
prerank,GO_Biological_Process_2021__spliceosomal snRNP assembly (GO:0000387),0.3153347278252775,0.6680668713517254,0.958904109589041,1.0,1.0,1/36,3.03%,DDX20
prerank,GO_Biological_Process_2021__RIG-I signaling pathway (GO:0039529),0.43705114753381014,0.6679028003738203,0.8983050847457628,1.0,1.0,2/5,32.53%,TRIM25;RNF135
prerank,GO_Biological_Process_2021__positive regulation of microtubule nucleation (GO:0090063),-0.4166627327948536,-0.6677363518944289,0.8181818181818182,1.0,1.0,2/6,23.62%,HSPA1A;CKAP5
prerank,GO_Biological_Process_2021__histone monoubiquitination (GO:0010390),-0.3134487431355991,-0.6677041405234727,0.8518518518518519,1.0,1.0,4/24,17.78%,RING1;PCGF1;DTX3L;DDB2
prerank,GO_Biological_Process_2021__monocyte differentiation (GO:0030224),-0.3818739232143642,-0.6676349174994514,0.8648648648648649,1.0,1.0,2/10,9.95%,CSF1R;IFI16
prerank,GO_Biological_Process_2021__negative regulation of cellular amide metabolic process (GO:0034249),-0.24805701610007921,-0.6673468172209864,1.0,1.0,1.0,13/80,14.52%,SAMD4A;TYMS;IGF1;NCL;DHFR;SORL1;APOE;CLU;IGF2BP3;TRIM71;BIN1;BTG2;SAMD4B
prerank,GO_Biological_Process_2021__regulation of cellular component size (GO:0032535),0.3376257127185621,0.6672681710570536,0.8904109589041096,1.0,1.0,9/30,30.12%,EPS8;PEX11B;MSN;RIN3;PEX11A;RAP1GAP2;RDX;LAMTOR5;RAC1
prerank,GO_Biological_Process_2021__protein localization to plasma membrane (GO:0072659),0.2735223115926822,0.6671168293026599,1.0,1.0,1.0,7/120,10.43%,P2RY1;CAV3;ZDHHC22;MRAP;FYB1;F11R;NKD2
prerank,GO_Biological_Process_2021__mitochondrial gene expression (GO:0140053),-0.301869215565139,-0.6670126871878598,1.0,1.0,1.0,8/35,21.07%,SLC25A33;MRPS18A;QRSL1;MRPS7;RARS2;TEFM;LARS2;MRPS21
prerank,GO_Biological_Process_2021__regulation of metal ion transport (GO:0010959),0.3836598774185032,0.6665598074756276,0.927536231884058,1.0,1.0,1/14,2.19%,CD4
prerank,GO_Biological_Process_2021__negative regulation of steroid biosynthetic process (GO:0010894),0.4431375581902648,0.6665568504917083,0.8833333333333333,1.0,1.0,1/5,21.69%,SNAI2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid acetylation (GO:0006474),0.39647948305446595,0.666403537875806,0.8840579710144928,1.0,1.0,8/13,32.78%,NAA30;NAA50;KAT2B;NAA40;NAA16;AANAT;NAA35;NAA25
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K9 acetylation (GO:2000617),-0.4373193337008989,-0.666401329606558,0.8809523809523809,1.0,1.0,2/5,14.80%,SPHK2;SMARCB1
prerank,GO_Biological_Process_2021__negative regulation of protein localization to membrane (GO:1905476),-0.33745979173437973,-0.6659462812052491,0.9487179487179487,1.0,1.0,3/21,8.48%,PID1;NUMB;KCNE1
prerank,GO_Biological_Process_2021__microtubule-based transport (GO:0099111),0.38253719657946544,0.6658306931444573,0.8888888888888888,1.0,1.0,2/11,24.79%,CABYR;ROPN1L
prerank,GO_Biological_Process_2021__positive regulation of phospholipid biosynthetic process (GO:0071073),0.4134450751782671,0.6655898900565342,0.8571428571428571,1.0,1.0,2/7,16.04%,FABP3;HTR2B
prerank,GO_Biological_Process_2021__response to manganese ion (GO:0010042),0.46594981825561443,0.6655800919531647,0.9180327868852459,1.0,1.0,2/5,27.34%,LRRK2;ADAM9
prerank,GO_Biological_Process_2021__histone H2A acetylation (GO:0043968),0.3619918000572499,0.6651654144129022,0.9076923076923077,1.0,1.0,4/16,19.03%,ACTL6A;MORF4L2;MORF4L1;MSL3
prerank,GO_Biological_Process_2021__positive regulation of smooth muscle contraction (GO:0045987),-0.3866099125627686,-0.6651101447288214,0.8461538461538461,1.0,1.0,2/8,9.35%,NMU;SPX
prerank,GO_Biological_Process_2021__positive regulation of protein localization to cell cortex (GO:1904778),-0.41591281808286296,-0.6651071942540043,0.8636363636363636,1.0,1.0,1/5,7.11%,NUMA1
prerank,GO_Biological_Process_2021__protein tetramerization (GO:0051262),0.2849676798772579,0.6650939660523657,1.0,1.0,1.0,5/58,11.32%,TRPA1;UPB1;HSD17B10;SOD2;ACOT13
prerank,GO_Biological_Process_2021__regulation of protein exit from endoplasmic reticulum (GO:0070861),0.3880840267544032,0.6648782184028078,0.8695652173913043,1.0,1.0,2/10,19.15%,TMEM30A;INSIG1
prerank,GO_Biological_Process_2021__embryonic digestive tract morphogenesis (GO:0048557),0.4385369588224377,0.6646462224420883,0.8166666666666667,1.0,1.0,2/6,11.31%,FGFR2;SOX11
prerank,GO_Biological_Process_2021__stress-activated MAPK cascade (GO:0051403),-0.26540353772928144,-0.6641315736259981,1.0,1.0,1.0,3/56,8.52%,TNFRSF19;MAP3K20;MAP2K3
prerank,GO_Biological_Process_2021__macrophage activation (GO:0042116),-0.3212621858487616,-0.6641251966694658,0.9333333333333333,1.0,1.0,10/25,16.58%,C5AR1;AZU1;TLR1;SBNO2;FOXP1;DYSF;CLU;CRTC3;FER1L5;TMEM106A
prerank,GO_Biological_Process_2021__negative regulation of cellular protein catabolic process (GO:1903363),0.41170269162154216,0.6639394079025278,0.8450704225352113,1.0,1.0,2/9,18.60%,DAB2IP;FURIN
prerank,GO_Biological_Process_2021__necroptotic process (GO:0070266),0.40642509643798685,0.6637351986432676,0.9130434782608695,1.0,1.0,3/11,22.25%,CD14;IPMK;CYLD
prerank,GO_Biological_Process_2021__regulation of cytokine-mediated signaling pathway (GO:0001959),0.2809283330616327,0.6637165138203841,0.9868421052631579,1.0,1.0,5/62,10.45%,PTPRC;FADD;IL7;STAT1;CASP8
prerank,GO_Biological_Process_2021__vesicle coating (GO:0006901),0.30385251668332014,0.6636841208733929,0.9722222222222222,1.0,1.0,3/57,6.93%,LMAN1;F8;TGFA
prerank,GO_Biological_Process_2021__COPII vesicle coating (GO:0048208),0.30385251668332014,0.6636841208733929,0.9722222222222222,1.0,1.0,3/57,6.93%,LMAN1;F8;TGFA
prerank,"GO_Biological_Process_2021__vesicle targeting, rough ER to cis-Golgi (GO:0048207)",0.30385251668332014,0.6636841208733929,0.9722222222222222,1.0,1.0,3/57,6.93%,LMAN1;F8;TGFA
prerank,GO_Biological_Process_2021__cellular response to insulin stimulus (GO:0032869),0.28121386004870985,0.6631714138316919,0.9871794871794872,1.0,1.0,19/108,22.93%,GOT1;RARRES2;IRS4;GAB1;NAMPT;ATP6V1B2;ATP6AP1;RAB8A;INSIG2;ATP6V1C1;PDK4;EPRS1;INSIG1;ATP6V0B;SHC1;PDE3B;PPARG;ATP6V1C2;PKLR
prerank,GO_Biological_Process_2021__protein localization to cell periphery (GO:1990778),0.2679000588242549,0.6631362440219799,1.0,1.0,1.0,7/123,10.43%,P2RY1;CAV3;ZDHHC22;MRAP;FYB1;F11R;NKD2
prerank,GO_Biological_Process_2021__regulation of epithelial cell proliferation (GO:0050678),-0.2781903590935317,-0.6631266897593255,0.9655172413793104,1.0,1.0,15/70,15.13%,EREG;IGF1;C5AR1;SFRP1;TGFB2;FGF1;BMP6;MCC;DUSP10;NR4A3;EGFR;NR4A1;LEP;SGPP2;ANGPT1
prerank,GO_Biological_Process_2021__negative regulation of defense response (GO:0031348),0.31082939980384444,0.6631250564742012,0.9726027397260274,1.0,1.0,8/61,14.00%,PTGIS;ELANE;MMP26;LPCAT3;PCBP2;RNF26;GPER1;GHRL
prerank,GO_Biological_Process_2021__cellular response to hydrogen peroxide (GO:0070301),0.34582478933502825,0.6630648974798453,0.9411764705882353,1.0,1.0,3/27,15.13%,CYP1B1;RHOB;ECT2
prerank,GO_Biological_Process_2021__positive regulation of protein acetylation (GO:1901985),0.3872613155200856,0.6629916340523917,0.9491525423728814,1.0,1.0,8/12,42.78%,TERF2IP;DDX3X;PRKAA1;CAMK1;RAPGEF3;KAT5;DIP2A;TAOK1
prerank,GO_Biological_Process_2021__lipoxygenase pathway (GO:0019372),0.3908125727147332,0.6628657360254101,0.8666666666666667,1.0,1.0,2/10,16.10%,ALOX12;ALOXE3
prerank,GO_Biological_Process_2021__phospholipid biosynthetic process (GO:0008654),-0.30470177713195734,-0.6626241669843865,0.9459459459459459,1.0,1.0,12/32,25.79%,SPHK2;SGMS2;CPNE7;CPNE6;PCYT2;SGMS1;GNPAT;FADS1;CPNE1;FITM2;PIP5K1A;DHDDS
prerank,GO_Biological_Process_2021__response to lead ion (GO:0010288),-0.39906180616748843,-0.6625257599765056,0.825,1.0,1.0,2/5,18.59%,PPP1CA;PPP5C
prerank,GO_Biological_Process_2021__positive regulation of phosphate metabolic process (GO:0045937),0.35166738629074074,0.6622625584172123,0.9259259259259259,1.0,1.0,1/22,2.27%,CCL5
prerank,GO_Biological_Process_2021__positive regulation of lipid transport (GO:0032370),0.3822151737301438,0.6617495889473789,0.8727272727272727,1.0,1.0,3/10,16.75%,CYP19A1;ABCB4;SPP1
prerank,GO_Biological_Process_2021__regulation of mitochondrial translation (GO:0070129),-0.27909991886873925,-0.6616932305815143,0.9117647058823529,1.0,1.0,5/20,21.93%,TRMT10C;TSFM;RPUSD4;MRPS27;MTG2
prerank,GO_Biological_Process_2021__positive regulation of myelination (GO:0031643),-0.3956259718738698,-0.6614993402626691,0.8837209302325582,1.0,1.0,1/8,7.21%,TENM4
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate metabolic process (GO:0034032),0.34200194397514977,0.661397013360836,0.9264705882352942,1.0,1.0,7/26,22.06%,ACOT4;BAAT;ACOT13;ACSM4;ACOT12;ACSM3;ACAT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate metabolic process (GO:0033875),0.34200194397514977,0.661397013360836,0.9264705882352942,1.0,1.0,7/26,22.06%,ACOT4;BAAT;ACOT13;ACSM4;ACOT12;ACSM3;ACAT1
prerank,GO_Biological_Process_2021__regulation of nucleocytoplasmic transport (GO:0046822),-0.38143507715606306,-0.6613761551207954,0.918918918918919,1.0,1.0,1/11,4.10%,TPR
prerank,GO_Biological_Process_2021__regulation of aldosterone biosynthetic process (GO:0032347),0.4163977273123026,0.6611596256716358,0.9137931034482759,1.0,1.0,1/6,9.19%,REST
prerank,GO_Biological_Process_2021__positive regulation of vasculature development (GO:1904018),0.29426081765210055,0.6611462189492995,0.9871794871794872,1.0,1.0,10/76,14.47%,PTGIS;EPHA1;CYP1B1;TWIST1;GAB1;VEGFC;RHOB;AGGF1;ZNF304;BRCA1
prerank,GO_Biological_Process_2021__regulation of microtubule binding (GO:1904526),-0.4067757759134461,-0.6606571120747183,0.8636363636363636,1.0,1.0,5/5,59.34%,MARK2;ABL1;MAP2;PPP2CB;TTBK2
prerank,GO_Biological_Process_2021__cardiolipin metabolic process (GO:0032048),-0.37979690841448965,-0.6605412224422386,0.875,1.0,1.0,4/9,24.32%,HADHA;PGS1;TAMM41;LCLAT1
prerank,GO_Biological_Process_2021__Fc-epsilon receptor signaling pathway (GO:0038095),0.28252859436133304,0.6604383169658024,1.0,1.0,1.0,5/98,15.17%,ITK;PSMB6;PLCG2;PSMA3;PSMB8
prerank,GO_Biological_Process_2021__regulation of neutrophil extravasation (GO:2000389),-0.43006488985336494,-0.6600276726154753,0.8372093023255814,1.0,1.0,3/5,20.07%,RIPOR2;MDK;XG
prerank,GO_Biological_Process_2021__positive regulation of neutrophil extravasation (GO:2000391),-0.43006488985336494,-0.6600276726154753,0.8372093023255814,1.0,1.0,3/5,20.07%,RIPOR2;MDK;XG
prerank,GO_Biological_Process_2021__regulation of programmed cell death (GO:0043067),0.2738612984740074,0.6598658614296646,0.9863013698630136,1.0,1.0,15/142,15.29%,WFS1;STK26;RABGGTB;NTF3;MOAP1;AGT;FLT3;BNIP3;STAT1;DAPK2;FAS;BCL2L14;TP53I3;GAS1;KANK2
prerank,GO_Biological_Process_2021__positive regulation of cell aging (GO:0090343),0.38649534502278216,0.6596784074649553,0.875,1.0,1.0,3/10,19.71%,ARG2;CGAS;B2M
prerank,GO_Biological_Process_2021__regulation of DNA methylation (GO:0044030),-0.39843212763031216,-0.6594979961811189,0.8,1.0,1.0,5/5,60.17%,MPHOSPH8;KDM1B;KMT2A;GRHL2;MECP2
prerank,GO_Biological_Process_2021__negative regulation of insulin secretion (GO:0046676),-0.33848617321550534,-0.6593956243767031,0.8529411764705882,1.0,1.0,5/15,19.41%,SFRP1;MIDN;IRS1;CCN3;PRKN
prerank,GO_Biological_Process_2021__negative regulation of receptor binding (GO:1900121),0.4294593797812466,0.6588889142037604,0.8524590163934426,1.0,1.0,4/6,28.66%,B2M;ATP2A2;ATP2A3;PTPRF
prerank,GO_Biological_Process_2021__regulation of cartilage development (GO:0061035),0.3619605204524318,0.6588759892205824,0.8939393939393939,1.0,1.0,3/16,16.56%,BMP1;SOX6;SCX
prerank,GO_Biological_Process_2021__actin crosslink formation (GO:0051764),-0.35282593632756903,-0.6588522577846179,0.8823529411764706,1.0,1.0,1/11,3.92%,GAS2L3
prerank,GO_Biological_Process_2021__positive regulation of nitric oxide biosynthetic process (GO:0045429),-0.3254625753156082,-0.6584815767952831,0.9302325581395349,1.0,1.0,4/16,24.24%,CLU;NOS1AP;DDAH1;ASS1
prerank,GO_Biological_Process_2021__cellular response to bacterial lipopeptide (GO:0071221),0.4390775020792964,0.6581494346363066,0.8620689655172413,1.0,1.0,2/5,19.74%,CD14;TLR2
prerank,GO_Biological_Process_2021__negative regulation of tumor necrosis factor superfamily cytokine production (GO:1903556),-0.3133622427764664,-0.6580813608089082,1.0,1.0,1.0,3/25,7.93%,IGF1;CIDEA;NR1H4
prerank,GO_Biological_Process_2021__regulation of Arp2/3 complex-mediated actin nucleation (GO:0034315),0.3644256571543229,0.6574778777883418,0.9107142857142857,1.0,1.0,3/17,13.50%,WASF1;GMFG;BRK1
prerank,GO_Biological_Process_2021__regulation of glutamate receptor signaling pathway (GO:1900449),-0.4083458782761437,-0.6574297281930122,0.9230769230769231,1.0,1.0,3/6,21.66%,FRRS1L;NECAB2;FYN
prerank,GO_Biological_Process_2021__positive regulation of protein sumoylation (GO:0033235),0.38325216655944266,0.6573953234174097,0.8870967741935484,1.0,1.0,1/9,15.06%,GNL3
prerank,GO_Biological_Process_2021__negative regulation of plasminogen activation (GO:0010757),-0.42886491902917956,-0.6572697732208895,0.8604651162790697,1.0,1.0,1/5,7.08%,SERPINF2
prerank,GO_Biological_Process_2021__cellular response to interleukin-7 (GO:0098761),0.3845225058997437,0.6567753872514608,0.9516129032258065,1.0,1.0,2/12,12.67%,IL7;STAT5A
prerank,GO_Biological_Process_2021__interleukin-7-mediated signaling pathway (GO:0038111),0.3845225058997437,0.6567753872514608,0.9516129032258065,1.0,1.0,2/12,12.67%,IL7;STAT5A
prerank,GO_Biological_Process_2021__cytoplasmic pattern recognition receptor signaling pathway (GO:0002753),-0.30687185808430906,-0.6566826645760212,1.0,1.0,1.0,1/23,2.42%,IFIH1
prerank,GO_Biological_Process_2021__chondroitin sulfate metabolic process (GO:0030204),-0.31181969982075,-0.6564496344184068,0.896551724137931,1.0,1.0,2/25,4.76%,VCAN;ARSB
prerank,GO_Biological_Process_2021__histone mRNA metabolic process (GO:0008334),0.33365181736180455,0.6557293140313306,0.9571428571428572,1.0,1.0,2/26,6.96%,NCBP1;NCBP2
prerank,GO_Biological_Process_2021__intracellular protein transmembrane transport (GO:0065002),-0.30498098305709437,-0.655419002966639,0.9428571428571428,1.0,1.0,4/40,11.99%,PEX7;TOMM40L;TIMM50;TOMM40
prerank,GO_Biological_Process_2021__toll-like receptor signaling pathway (GO:0002224),0.2983414485859461,0.6552363220297134,0.987012987012987,1.0,1.0,16/66,25.85%,CD14;FADD;CASP8;PLCG2;SCIMP;CTSK;RIPK2;LGMN;SFTPD;TAB2;TLR2;IRAK4;LBP;HSP90B1;MAPKAPK3;UBE2D1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:0000288)",-0.26113386589173015,-0.6551725940379033,1.0,1.0,1.0,9/51,17.70%,SAMD4A;LSM6;DCPS;EXOSC7;EXOSC1;EXOSC5;SAMD4B;EXOSC4;LSM7
prerank,GO_Biological_Process_2021__ventricular cardiac muscle tissue development (GO:0003229),0.3832578443127952,0.6550130225768448,0.8709677419354839,1.0,1.0,5/12,13.78%,ADAMTS9;MYBPC3;FGFR2;SMAD7;TGFB1
prerank,GO_Biological_Process_2021__regulation of lymphocyte migration (GO:2000401),0.40510358609835234,0.6549949347339747,0.8769230769230769,1.0,1.0,3/8,33.20%,MSN;WASL;AKT1
prerank,GO_Biological_Process_2021__negative regulation of tubulin deacetylation (GO:1904428),0.42188859899137876,0.654801790389142,0.8113207547169812,1.0,1.0,2/5,31.72%,BEX4;PRKAA1
prerank,GO_Biological_Process_2021__pyrimidine-containing compound metabolic process (GO:0072527),0.3727605035016064,0.6545813847908765,0.9491525423728814,1.0,1.0,1/11,5.02%,SLC19A3
prerank,GO_Biological_Process_2021__protein localization to vacuole (GO:0072665),-0.327459904959155,-0.6544634991944985,0.9032258064516129,1.0,1.0,2/13,18.46%,SH3GLB1;LAMTOR4
prerank,GO_Biological_Process_2021__somite development (GO:0061053),0.3802904077535435,0.6543686153626032,0.8461538461538461,1.0,1.0,7/10,33.05%,SOX11;PPP2R3A;MEOX2;SFRP2;MEOX1;SHH;SMO
prerank,GO_Biological_Process_2021__positive regulation of cell growth (GO:0030307),0.29044990626275813,0.6541341049465959,0.9701492537313433,1.0,1.0,6/86,10.14%,H3-3A;SYT2;TRIM32;SYT4;NCBP1;CPNE5
prerank,GO_Biological_Process_2021__regulation of protein processing (GO:0070613),-0.33904931148852185,-0.653994633719299,0.967741935483871,1.0,1.0,1/18,1.60%,RUNX1
prerank,GO_Biological_Process_2021__mononuclear cell differentiation (GO:1903131),0.34456442635414364,0.6539584212964351,0.8656716417910447,1.0,1.0,4/18,25.83%,FLT3;THOC5;PPARG;LYN
prerank,GO_Biological_Process_2021__actin-mediated cell contraction (GO:0070252),0.3998821111133856,0.6539212929801858,0.9032258064516129,1.0,1.0,2/9,15.38%,ACTC1;CAMK2D
prerank,GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process (GO:0000956),0.266415491306931,0.6537483534844174,1.0,1.0,1.0,57/160,34.89%,PATL2;NCBP1;NCBP2;RPL15;RPL36;RPS7;EXOSC8;CSDE1;CNOT11;RPL9;RPS21;DCP2;DHX34;RPL22;RPL21;RPL38;PAN3;RPLP2;RPS5;POLR2D;EIF3E;EXOSC6;EIF4A3;RPL3;PDE12;CNOT7;RPL35A;SMG7;RPS13;RPL35;PNLDC1;DXO;RNPS1;RPS20;RPL27;RPL13A;ZFP36;RPS27A;RPL5;RPL27A;RPL7;RPS9;ZFP36L1;RPL37;RPS29;PPP2R2A;AGO1;CNOT1;RPL24;RPL28;RPL32;RPL8;RPS4X;RPS12;RPL37A;RPSA;PNRC2
prerank,GO_Biological_Process_2021__positive regulation of macrophage activation (GO:0043032),0.3984060505997198,0.6537060020518296,0.9047619047619048,1.0,1.0,3/9,28.47%,STAP1;LBP;TNIP2
prerank,GO_Biological_Process_2021__mitotic spindle assembly (GO:0090307),0.3190890695106877,0.6536999567313992,0.9701492537313433,1.0,1.0,4/37,15.80%,TPX2;MZT1;RACGAP1;RAB11A
prerank,GO_Biological_Process_2021__cellular response to DNA damage stimulus (GO:0006974),0.25350347203747997,0.653523236290259,1.0,1.0,1.0,25/306,16.05%,RAD54L;TICRR;RFC5;POLE2;POLQ;SPDYA;POLE3;BOK;HIC1;MOAP1;RAD9B;SUV39H1;INIP;STXBP4;HELB;BCL2L2;SUSD6;MRE11;VCPIP1;OTUB1;BRCA1;APLF;RECQL;DYRK2;PDS5B
prerank,GO_Biological_Process_2021__regulation of protein localization to centrosome (GO:1904779),0.3965041539943094,0.6528887960565547,0.9090909090909091,1.0,1.0,1/9,10.09%,CEP72
prerank,GO_Biological_Process_2021__phosphatidylcholine biosynthetic process (GO:0006656),0.33030844908425083,0.6525868451893373,0.9692307692307692,1.0,1.0,2/28,10.67%,LPCAT3;SLC44A5
prerank,GO_Biological_Process_2021__response to organonitrogen compound (GO:0010243),0.33948484804491447,0.6525796412126688,0.9180327868852459,1.0,1.0,8/34,18.44%,RCN3;SYVN1;RNF139;DRD3;GLRA3;DERL1;CCDC47;GLRA1
prerank,GO_Biological_Process_2021__cytosolic transport (GO:0016482),0.2892403322108216,0.6524793482645027,1.0,1.0,1.0,1/109,0.22%,RAB6C
prerank,GO_Biological_Process_2021__regulation of neurotransmitter secretion (GO:0046928),-0.29870708152614667,-0.6524738371182305,0.896551724137931,1.0,1.0,6/30,18.80%,HCRT;MCTP1;MCTP2;PNKD;RIMS1;SNCAIP
prerank,GO_Biological_Process_2021__protein heterooligomerization (GO:0051291),-0.3507701970047168,-0.652355012565325,0.9,1.0,1.0,6/15,24.78%,CPSF7;FARSB;TMEM120B;GRIN1;FARSA;GRIN2B
prerank,GO_Biological_Process_2021__negative regulation of response to external stimulus (GO:0032102),0.2915537350785062,0.6523534853608096,1.0,1.0,1.0,14/83,18.79%,PTGIS;ELANE;MMP26;LPCAT3;CARD8;PCBP2;RNF26;GPER1;DRD3;GHRL;VPS35;NLRC3;CD109;INPP5F
prerank,GO_Biological_Process_2021__cellular response to epidermal growth factor stimulus (GO:0071364),0.32479911136339273,0.6523326823120694,0.9552238805970149,1.0,1.0,7/26,32.31%,EEF1A1;DAB2IP;SNAI2;DUSP22;ZFP36;INPP5K;ZFP36L1
prerank,GO_Biological_Process_2021__cGMP-mediated signaling (GO:0019934),0.39438556085281906,0.6522212357520296,0.9508196721311475,1.0,1.0,1/10,3.73%,IRAG1
prerank,GO_Biological_Process_2021__cation transmembrane transport (GO:0098655),0.3218092722069977,0.6519390358358147,0.96875,1.0,1.0,8/36,22.47%,TRPM6;SFXN3;KCNJ11;ATP1B1;SLC38A5;SLC25A19;ABCC9;CACNA1H
prerank,GO_Biological_Process_2021__regulation of JUN kinase activity (GO:0043506),0.3318909777552858,0.6519056315486177,0.9333333333333333,1.0,1.0,8/27,25.66%,PPEF2;MAP3K11;DNAJA1;DAB2IP;PDCD4;DUSP19;GSTP1;AIDA
prerank,GO_Biological_Process_2021__positive regulation of signal transduction (GO:0009967),0.26506237251384396,0.6517629721015763,1.0,1.0,1.0,31/206,18.01%,PTGIS;RSPO2;ZBTB7B;NOTCH1;ITGA5;NTF3;PTPRC;DEPDC1B;MAML2;LMO3;IL7;FAS;FGFR2;RSPO3;SCIMP;GPER1;ATP6AP2;DRD3;VWF;GHRL;LGR6;UCHL5;MYORG;KLK14;VPS35;DAB2IP;STK36;CHRNA7;NOTCH4;NPTN;LY86
prerank,GO_Biological_Process_2021__peptidyl-threonine phosphorylation (GO:0018107),0.29483182480738973,0.6508651749082285,0.958904109589041,1.0,1.0,7/54,20.42%,HIPK4;CDK5R1;CAMK2D;DYRK2;NLK;ULK1;LRRK2
prerank,GO_Biological_Process_2021__protein K48-linked deubiquitination (GO:0071108),-0.34088691198249166,-0.6506999922354403,0.875,1.0,1.0,4/22,13.29%,USP27X;OTUD3;USP25;OTUD5
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome assembly (GO:0006335),0.45451142064513106,0.6504957790050484,0.8484848484848485,1.0,1.0,3/6,29.25%,HAT1;CHAF1A;CHAF1B
prerank,GO_Biological_Process_2021__DNA replication-dependent nucleosome organization (GO:0034723),0.45451142064513106,0.6504957790050484,0.8484848484848485,1.0,1.0,3/6,29.25%,HAT1;CHAF1A;CHAF1B
prerank,GO_Biological_Process_2021__amino-acid betaine transport (GO:0015838),-0.41628806109448063,-0.6500927033940921,0.8181818181818182,1.0,1.0,1/5,7.15%,SLC25A29
prerank,"GO_Biological_Process_2021__regulation of alternative mRNA splicing, via spliceosome (GO:0000381)",-0.2839983011067317,-0.6499087635976674,1.0,1.0,1.0,10/47,16.90%,HNRNPL;ZBTB7A;RBM11;RBMX;SRRM4;KHDRBS3;CELF5;PTBP1;RBM25;CELF4
prerank,GO_Biological_Process_2021__regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235),0.33957916116907905,0.6498117573688741,0.9253731343283582,1.0,1.0,3/19,9.89%,BOK;SYVN1;HERPUD1
prerank,GO_Biological_Process_2021__positive regulation of integrin-mediated signaling pathway (GO:2001046),0.4101803447808696,0.6497212162737164,0.8928571428571429,1.0,1.0,3/7,27.67%,DMTN;LIMS2;EMP2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway (GO:0097191),0.2988858242242773,0.64971967872231,0.9436619718309859,1.0,1.0,14/59,21.12%,BOK;INHBA;MOAP1;FADD;CASP8;FAS;BCL2L2;TGFB1;CD27;DAB2IP;IFI27;BCL2L1;RNF41;BAD
prerank,GO_Biological_Process_2021__single strand break repair (GO:0000012),-0.4014890709214701,-0.6487605839616617,0.868421052631579,1.0,1.0,1/7,8.08%,ERCC8
prerank,GO_Biological_Process_2021__positive regulation of fatty acid oxidation (GO:0046321),-0.3702429583409869,-0.6487491042476838,0.8809523809523809,1.0,1.0,5/12,14.39%,MLYCD;PLIN5;ABCD1;NR4A3;IRS1
prerank,GO_Biological_Process_2021__lysosomal lumen acidification (GO:0007042),-0.420000078563989,-0.6486870301809938,0.9285714285714286,1.0,1.0,1/6,5.88%,CLN6
prerank,GO_Biological_Process_2021__morphogenesis of a polarized epithelium (GO:0001738),-0.343867583093471,-0.6486318454718738,0.8333333333333334,1.0,1.0,2/12,11.02%,LAMA3;TRAF3IP1
prerank,GO_Biological_Process_2021__protein-containing complex subunit organization (GO:0043933),0.2790511410669088,0.6485621389467401,0.9615384615384616,1.0,1.0,15/94,21.65%,WASF1;PPARGC1A;SLC2A1;WAS;FAS;PPID;MITF;TUBGCP4;GPAA1;TSPAN4;EPRS1;NUP54;CD74;DMTN;REPS2
prerank,GO_Biological_Process_2021__tRNA 3'-end processing (GO:0042780),0.43469015066648287,0.6485351294128597,0.9137931034482759,1.0,1.0,1/6,7.00%,HSD17B10
prerank,GO_Biological_Process_2021__regulation of release of cytochrome c from mitochondria (GO:0090199),0.3141935364941567,0.6485187943660905,0.9649122807017544,1.0,1.0,11/34,24.01%,BIK;MOAP1;BNIP3;HGF;GPER1;PLAUR;PINK1;BCL2L1;BAD;GHITM;HRK
prerank,GO_Biological_Process_2021__cortical cytoskeleton organization (GO:0030865),-0.2775386336612294,-0.6482087491016238,0.9642857142857143,1.0,1.0,4/35,10.74%,RND3;RHOBTB1;RHOBTB2;LLGL2
prerank,GO_Biological_Process_2021__axon choice point recognition (GO:0016198),-0.39733186631825057,-0.6477095008902122,0.8387096774193549,1.0,1.0,5/5,60.28%,GAP43;ROBO2;APP;ROBO3;ROBO1
prerank,GO_Biological_Process_2021__cell projection assembly (GO:0030031),-0.31463807591101495,-0.6476313524916737,0.925,1.0,1.0,3/19,12.17%,QRICH2;RHOJ;PARVA
prerank,GO_Biological_Process_2021__cellular response to alcohol (GO:0097306),0.30601212835963476,0.6474663383561733,0.9696969696969697,1.0,1.0,7/42,19.58%,CTNNA1;AHR;MAP4K1;MLC1;BRCA1;GLRA1;KLF9
prerank,GO_Biological_Process_2021__regulation of extrinsic apoptotic signaling pathway (GO:2001236),0.2932048612530425,0.6474589220777812,0.9859154929577465,1.0,1.0,14/52,24.45%,AGT;FADD;PELI3;CASP8;FAS;GPER1;BCL2L14;TMC8;DEPTOR;SP100;CYLD;MADD;GSTP1;FEM1B
prerank,GO_Biological_Process_2021__establishment of protein localization to organelle (GO:0072594),-0.25015321569310156,-0.6473506937842436,1.0,1.0,1.0,10/66,17.16%,NUP62CL;TPR;STAT3;IL10RA;LAMP5;RANBP17;IPO9;HK2;PRICKLE1;NUP107
prerank,GO_Biological_Process_2021__angiotensin maturation (GO:0002003),0.41232792327004814,0.6472605291598995,0.9,1.0,1.0,4/8,21.67%,ENPEP;ATP6AP2;CTSZ;REN
prerank,GO_Biological_Process_2021__regulation of angiotensin levels in blood (GO:0002002),0.41232792327004814,0.6472605291598995,0.9,1.0,1.0,4/8,21.67%,ENPEP;ATP6AP2;CTSZ;REN
prerank,GO_Biological_Process_2021__regulation of attachment of spindle microtubules to kinetochore (GO:0051988),0.3895811563791747,0.6468403984789277,0.9047619047619048,1.0,1.0,2/8,15.73%,ECT2;RACGAP1
prerank,GO_Biological_Process_2021__nucleotide phosphorylation (GO:0046939),0.4098364471544335,0.6465389002945882,0.8787878787878788,1.0,1.0,2/8,18.00%,CMPK2;AK4
prerank,GO_Biological_Process_2021__membrane repolarization during atrial cardiac muscle cell action potential (GO:0098914),-0.39981734389264956,-0.6464888112099162,0.8378378378378378,1.0,1.0,1/5,9.55%,KCNN2
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell membrane repolarization (GO:0099624),-0.39981734389264956,-0.6464888112099162,0.8378378378378378,1.0,1.0,1/5,9.55%,KCNN2
prerank,GO_Biological_Process_2021__positive regulation of histone H3-K27 methylation (GO:0061087),0.44008285414227366,0.6462506182144461,0.9375,1.0,1.0,1/5,13.39%,ZNF304
prerank,GO_Biological_Process_2021__regulation of lipid kinase activity (GO:0043550),-0.3699848686322161,-0.6461983256493372,0.9473684210526315,1.0,1.0,9/9,63.02%,WDR81;PIK3R1;WDR91;RBL2;RB1;RBL1;EEF1A2;PPP2R5A;PIK3R3
prerank,GO_Biological_Process_2021__positive regulation of non-canonical Wnt signaling pathway (GO:2000052),-0.39239579462602014,-0.6461271575842273,0.8387096774193549,1.0,1.0,1/8,4.71%,SFRP1
prerank,GO_Biological_Process_2021__regulation of epidermis development (GO:0045682),0.41942219569785194,0.6459603006415559,0.8939393939393939,1.0,1.0,1/7,13.18%,TMEM79
prerank,GO_Biological_Process_2021__release of sequestered calcium ion into cytosol (GO:0051209),0.3672314747850615,0.6459406742439481,0.9142857142857143,1.0,1.0,8/20,25.08%,ITPR1;PTPRC;PLCG2;HTR2B;LETM1;ERO1A;RYR3;RYR2
prerank,GO_Biological_Process_2021__extrinsic apoptotic signaling pathway via death domain receptors (GO:0008625),0.33855109057525073,0.645679298460758,0.9402985074626866,1.0,1.0,3/23,10.45%,MOAP1;FADD;CASP8
prerank,GO_Biological_Process_2021__regulation of aerobic respiration (GO:1903715),-0.35468938555300067,-0.6455722043547386,0.90625,1.0,1.0,5/13,18.17%,SLC25A33;IDE;ABCD1;COX7A1;VCP
prerank,GO_Biological_Process_2021__negative regulation of mRNA 3'-end processing (GO:0031441),-0.35930120592415976,-0.6455443860227533,0.926829268292683,1.0,1.0,9/9,64.09%,NELFE;CCNT1;RNF20;CDK9;ZC3H14;RNF40;CTR9;SUPT5H;BARD1
prerank,GO_Biological_Process_2021__engulfment of apoptotic cell (GO:0043652),0.3702167740997352,0.6443806192444436,0.9705882352941176,1.0,1.0,2/12,12.76%,ADGRB1;RHOH
prerank,GO_Biological_Process_2021__2-oxoglutarate metabolic process (GO:0006103),-0.37883312824237936,-0.6443084202733735,0.9772727272727273,1.0,1.0,4/11,14.68%,IDH2;OGDH;GOT2;PHYH
prerank,GO_Biological_Process_2021__second-messenger-mediated signaling (GO:0019932),-0.2618832527423904,-0.6437889597589272,0.9428571428571428,1.0,1.0,7/55,11.15%,HRH1;DGKD;P2RY11;MCTP1;ACKR2;CXCR5;APOE
prerank,GO_Biological_Process_2021__cAMP biosynthetic process (GO:0006171),-0.3770262292149704,-0.6435388770035089,0.9090909090909091,1.0,1.0,5/9,27.71%,ADCY7;ADCY2;ADCY5;ADCY9;ADCY8
prerank,GO_Biological_Process_2021__positive regulation of actin filament bundle assembly (GO:0032233),0.3168100898996272,0.6433328044404392,0.9850746268656716,1.0,1.0,1/41,1.38%,EPHA1
prerank,GO_Biological_Process_2021__inositol phosphate catabolic process (GO:0071545),0.3767068070622104,0.6426029514466471,0.8732394366197183,1.0,1.0,1/12,13.04%,IMPA2
prerank,GO_Biological_Process_2021__regulation of intracellular steroid hormone receptor signaling pathway (GO:0033143),0.29841202600899347,0.6423901978867732,0.9838709677419355,1.0,1.0,3/30,12.91%,H3-3A;UFM1;ESR1
prerank,GO_Biological_Process_2021__endomembrane system organization (GO:0010256),-0.2531916959209677,-0.6423192077990404,1.0,1.0,1.0,17/169,11.02%,FBXW8;GOLGA8M;SPTSSB;LEMD2;SRGN;GOLGA8H;PI4K2A;TMED3;NSFL1C;ATP8B4;GOLGA8A;TLCD2;GOLGA8B;GOLGA8N;DYSF;UBXN2A;SMPD4
prerank,GO_Biological_Process_2021__meiotic DNA double-strand break formation (GO:0042138),0.4386487381805822,0.6422404711437953,0.8813559322033898,1.0,1.0,2/5,13.43%,IHO1;MRE11
prerank,"GO_Biological_Process_2021__regulation of retrograde protein transport, ER to cytosol (GO:1904152)",0.37340154901199113,0.6420225347586834,0.9436619718309859,1.0,1.0,1/13,6.53%,BCAP31
prerank,GO_Biological_Process_2021__regulation of signal transduction by p53 class mediator (GO:1901796),0.2574834889160091,0.6418215784287201,1.0,1.0,1.0,12/140,15.94%,RFC5;PRKAB2;ING2;RAD9B;TBP;TPX2;CDK5R1;PRDM1;MRE11;RPA3;BRCA1;DYRK2
prerank,GO_Biological_Process_2021__positive regulation of stress fiber assembly (GO:0051496),0.3221497414234577,0.6417333320376067,0.9696969696969697,1.0,1.0,1/36,1.38%,EPHA1
prerank,GO_Biological_Process_2021__lymphatic endothelial cell differentiation (GO:0060836),-0.40146602785975016,-0.641708323084603,0.875,1.0,1.0,1/5,6.06%,PDPN
prerank,GO_Biological_Process_2021__carbohydrate phosphorylation (GO:0046835),-0.3738350927707268,-0.6412775989596803,0.868421052631579,1.0,1.0,1/8,4.56%,FGGY
prerank,GO_Biological_Process_2021__protein kinase C signaling (GO:0070528),-0.35932411896274985,-0.641207723257012,0.9444444444444444,1.0,1.0,1/8,5.70%,AZU1
prerank,GO_Biological_Process_2021__negative regulation of fatty acid biosynthetic process (GO:0045717),0.4016995252539072,0.6405688308834793,0.859375,1.0,1.0,3/10,21.51%,BRCA1;ACADL;ERLIN1
prerank,GO_Biological_Process_2021__regulation of reactive oxygen species metabolic process (GO:2000377),-0.27847639704532634,-0.6403376100982341,0.9743589743589743,1.0,1.0,10/46,14.97%,PID1;SLC25A33;SPHK2;PLIN5;ACE2;AKR1C3;SIRT2;DCXR;MPV17;NOXO1
prerank,GO_Biological_Process_2021__myelination (GO:0042552),0.3008623558128835,0.6400892482221624,0.9714285714285714,1.0,1.0,3/42,5.34%,ACSBG1;SOX10;PLP1
prerank,GO_Biological_Process_2021__protein heterotetramerization (GO:0051290),-0.3798427612407531,-0.6400066748501229,0.8913043478260869,1.0,1.0,5/11,24.78%,CPSF7;FARSB;GRIN1;FARSA;GRIN2B
prerank,GO_Biological_Process_2021__nuclear migration (GO:0007097),-0.350849518507273,-0.6398297442528942,0.926829268292683,1.0,1.0,4/13,20.62%,PCM1;TMEM201;HOOK3;SUN2
prerank,GO_Biological_Process_2021__regulation of chaperone-mediated protein folding (GO:1903644),0.414164295132865,0.6395018835790814,0.8709677419354839,1.0,1.0,1/5,35.20%,SGTB
prerank,GO_Biological_Process_2021__positive regulation of ubiquitin-dependent protein catabolic process (GO:2000060),0.2812742620552745,0.6394210985266856,0.9875,1.0,1.0,10/68,20.58%,CAV3;ARIH2;NKD2;SMAD7;RNF139;RNF144B;PYHIN1;MAGEF1;LRRK2;RCHY1
prerank,GO_Biological_Process_2021__cardiac epithelial to mesenchymal transition (GO:0060317),0.38744358504628346,0.6393182946105811,0.9384615384615385,1.0,1.0,1/12,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__plasma membrane tubulation (GO:0097320),-0.3483125458547322,-0.6392946836724266,0.8666666666666667,1.0,1.0,10/10,65.19%,PACSIN2;PACSIN3;FNBP1L;MICALL1;BIN2;EHD2;SNX9;PACSIN1;BIN3;WHAMM
prerank,GO_Biological_Process_2021__protein K11-linked deubiquitination (GO:0035871),-0.366495612869863,-0.6391177217441119,0.8461538461538461,1.0,1.0,1/8,5.56%,OTUD3
prerank,GO_Biological_Process_2021__carnitine metabolic process (GO:0009437),0.37808350959263026,0.6389971371867291,0.9,1.0,1.0,3/11,17.05%,CPT1C;BBOX1;ACADL
prerank,GO_Biological_Process_2021__negative regulation of ceramide biosynthetic process (GO:1900060),0.41523927434485985,0.6388807876848409,0.9298245614035088,1.0,1.0,2/5,31.72%,SPHK1;PRKAA1
prerank,PanglaoDB_Augmented_2021__Glycinergic Neurons,-0.2434758240533869,-0.6386173668401964,1.0,1.0,1.0,31/97,25.20%,FBLL1;ADGRA1;NYAP1;MMD2;SLC6A9;KCNC1;STMN2;ELAVL3;GRIA2;PRR36;CNIH2;DNER;BRINP1;SRRM3;ABCG4;SCRT1;TAGLN3;ARHGAP39;CASKIN1;SCAMP5;GRIN1;CLIP3;SNAP91;BSN;SLITRK1;KIF1A;PCDH8;NGB;SHISA7;GRM5;MAP6
prerank,GO_Biological_Process_2021__negative regulation of execution phase of apoptosis (GO:1900118),-0.415530023915054,-0.6385950380206877,0.9487179487179487,1.0,1.0,1/7,7.13%,CIDEA
prerank,GO_Biological_Process_2021__protein targeting (GO:0006605),0.2717739038736121,0.6383169816350099,1.0,1.0,1.0,11/111,12.32%,ZDHHC22;ZDHHC11;BCAP31;LAMP2;PEX16;VPS37B;AP1M2;ZDHHC6;TOMM22;MAN1A1;ARL6
prerank,GO_Biological_Process_2021__tRNA 5'-leader removal (GO:0001682),-0.35781530641108183,-0.6382702431780923,0.8648648648648649,1.0,1.0,3/11,12.04%,RPP14;POP1;RPP25
prerank,GO_Biological_Process_2021__RNA destabilization (GO:0050779),-0.2968705871264432,-0.6375150777552655,1.0,1.0,1.0,4/18,19.28%,LIN28B;MEX3D;ZC3H18;CELF1
prerank,GO_Biological_Process_2021__stress-induced premature senescence (GO:0090400),0.3986671075002285,0.6374419431146802,0.8627450980392157,1.0,1.0,2/6,43.33%,MAPKAPK5;PLA2R1
prerank,GO_Biological_Process_2021__positive regulation of sprouting angiogenesis (GO:1903672),0.35545133817498487,0.6369850935694706,0.9047619047619048,1.0,1.0,2/13,16.12%,ITGA5;SMAD1
prerank,GO_Biological_Process_2021__diacylglycerol biosynthetic process (GO:0006651),-0.3682726507464758,-0.6367001108823626,0.8064516129032258,1.0,1.0,2/6,14.98%,PNPLA2;MOGAT1
prerank,GO_Biological_Process_2021__regulation of DNA biosynthetic process (GO:2000278),0.3392525254427102,0.6366243001664628,0.9538461538461539,1.0,1.0,5/23,18.07%,PDGFRB;HGF;DACH1;RGCC;TOM1L1
prerank,GO_Biological_Process_2021__organophosphate biosynthetic process (GO:0090407),-0.3039122276459012,-0.6364404970846925,1.0,1.0,1.0,1/33,1.63%,PNPO
prerank,GO_Biological_Process_2021__regulation of ion transmembrane transport (GO:0034765),0.3109444475987177,0.636321531170387,0.9322033898305084,1.0,1.0,4/28,17.40%,KCNE2;KCNJ9;KCNJ11;KCNQ1
prerank,GO_Biological_Process_2021__positive regulation of fatty acid beta-oxidation (GO:0032000),0.3874298255599406,0.63630360085797,0.8983050847457628,1.0,1.0,1/9,5.96%,TWIST1
prerank,GO_Biological_Process_2021__negative regulation of calcium ion transmembrane transport (GO:1903170),-0.34731828744704646,-0.6361321591679958,0.8947368421052632,1.0,1.0,1/9,2.86%,CBARP
prerank,GO_Biological_Process_2021__glycoprotein metabolic process (GO:0009100),0.3051454671793225,0.6359122886854808,0.9493670886075949,1.0,1.0,11/49,22.59%,ADAMTS9;ST8SIA6;MANBA;GCNT1;MAN1A1;MGAT4A;NGLY1;MAN2A1;MGAT4B;GANAB;MAN1B1
prerank,"GO_Biological_Process_2021__wound healing, spreading of cells (GO:0044319)",0.3368996928629744,0.6357086504622429,0.9705882352941176,1.0,1.0,1/20,4.62%,ITGA5
prerank,GO_Biological_Process_2021__negative regulation of protein secretion (GO:0050709),-0.28819222347722395,-0.6354219900358504,1.0,1.0,1.0,12/32,22.65%,SFRP1;DRD4;MIDN;APOE;IRS1;RAB11FIP3;OPRM1;CCN3;PRKN;RAB11FIP1;RSAD2;ERP29
prerank,GO_Biological_Process_2021__natural killer cell differentiation (GO:0001779),0.39789782817160135,0.6354216601175535,0.9298245614035088,1.0,1.0,2/8,8.03%,PTPRC;NFIL3
prerank,GO_Biological_Process_2021__phosphorylated carbohydrate dephosphorylation (GO:0046838),0.3888798219897785,0.6353549932028751,0.9,1.0,1.0,1/11,13.04%,IMPA2
prerank,GO_Biological_Process_2021__inositol phosphate dephosphorylation (GO:0046855),0.3888798219897785,0.6353549932028751,0.9,1.0,1.0,1/11,13.04%,IMPA2
prerank,GO_Biological_Process_2021__negative regulation of sequestering of calcium ion (GO:0051283),0.35210495516872364,0.6352560425698383,0.8734177215189873,1.0,1.0,4/19,16.04%,ITPR1;PTPRC;PLCG2;HTR2B
prerank,GO_Biological_Process_2021__intracellular protein transport (GO:0006886),0.2521443770708212,0.6351119049747678,1.0,1.0,1.0,27/282,17.70%,RAB6C;LMAN1;GRTP1;NXT1;RANBP6;SLU7;RUNDC1;LAMP2;RABL2B;STRADA;AP1M2;RAB19;RAB23;YWHAH;ARCN1;ARL1;ARL6;TGFB1;TSC2;SNX31;STX19;STRADB;SPRN;VPS35;SNX17;TBC1D13;ARF4
prerank,GO_Biological_Process_2021__mRNA 3'-splice site recognition (GO:0000389),0.4294570064028904,0.6344215130472749,0.9,1.0,1.0,1/5,6.83%,SLU7
prerank,GO_Biological_Process_2021__regulation of protein localization to cell cortex (GO:1904776),-0.38811181842186904,-0.6344060777060183,0.8888888888888888,1.0,1.0,1/6,7.11%,NUMA1
prerank,GO_Biological_Process_2021__regulation of stress fiber assembly (GO:0051492),0.2755062758857862,0.6341712130020744,1.0,1.0,1.0,6/64,17.97%,EPHA1;F11R;WAS;ARHGAP28;RGCC;LIMCH1
prerank,GO_Biological_Process_2021__regulation of systemic arterial blood pressure by hormone (GO:0001990),0.3842566125868399,0.6340437509560317,0.9310344827586207,1.0,1.0,3/9,16.36%,AVPR1A;ENPEP;CORIN
prerank,GO_Biological_Process_2021__regulation of endothelial cell chemotaxis (GO:2001026),0.37137078188870565,0.6338720358413364,0.8888888888888888,1.0,1.0,1/13,4.13%,NOTCH1
prerank,GO_Biological_Process_2021__negative regulation of cellular protein metabolic process (GO:0032269),0.2733036546563075,0.6338316440262886,1.0,1.0,1.0,17/81,26.10%,ENC1;IGFBP5;PATL2;KNG1;RNF139;PAIP2B;DAB2IP;EPRS1;FXR1;CALR;RIDA;CAMK2N1;EIF4E2;EIF4A3;DDX6;CNOT7;PAIP2
prerank,GO_Biological_Process_2021__N-terminal protein amino acid modification (GO:0031365),0.3747449431669065,0.6333152130549591,0.9178082191780822,1.0,1.0,6/11,32.26%,METAP1;NAA50;NAA40;NAA16;AANAT;NAA35
prerank,GO_Biological_Process_2021__positive regulation of cellular protein localization (GO:1903829),-0.2543145554688006,-0.6332973703200127,1.0,1.0,1.0,15/57,20.46%,CROCC;WWTR1;NUMA1;RANGRF;CARD10;MEAK7;GPD1L;STX4;ENTR1;TM9SF4;DTX3L;NECAB2;PRKN;KAT7;PARD6A
prerank,GO_Biological_Process_2021__negative regulation of protein localization to cell periphery (GO:1904376),-0.34436365876101166,-0.6332578391710582,0.9285714285714286,1.0,1.0,2/16,7.19%,PID1;NUMB
prerank,GO_Biological_Process_2021__positive regulation of DNA binding (GO:0043388),0.33304253883228274,0.6332522511889271,0.8985507246376812,1.0,1.0,6/22,21.48%,TWIST1;PLAUR;TGFB1;PYHIN1;H1-0;PPARG
prerank,GO_Biological_Process_2021__regulation of DNA recombination (GO:0000018),0.3024144712094196,0.6332469199687873,0.9733333333333334,1.0,1.0,11/32,24.71%,PPP4C;FIGNL1;H1-2;MRE11;RAD51AP1;H1-0;TERF2IP;KDM1A;RAD50;ALYREF;MSH6
prerank,GO_Biological_Process_2021__regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032434),-0.2644011840482078,-0.6332043338604317,1.0,1.0,1.0,17/87,19.41%,TRIB2;GNA12;TAF1;SIRT2;CLU;SH3RF2;TLK2;HSPBP1;RAD23A;FBXO22;PRICKLE1;COMMD1;ZER1;VCP;N4BP1;HSPA1A;PRKN
prerank,GO_Biological_Process_2021__axoneme assembly (GO:0035082),-0.30638359975604906,-0.6326906488118111,0.9393939393939394,1.0,1.0,3/24,10.15%,CFAP46;JHY;RSPH1
prerank,GO_Biological_Process_2021__protein targeting to membrane (GO:0006612),0.27174048052630473,0.6323504941054097,1.0,1.0,1.0,13/76,21.36%,CHMP4B;ZDHHC22;ZDHHC11;PEX16;VPS37B;ZDHHC6;ARL6;PEX11B;ZDHHC24;ATG3;ALDH3A2;SRP19;PXMP2
prerank,GO_Biological_Process_2021__regulation of peptidyl-cysteine S-nitrosylation (GO:2000169),-0.38921769732666084,-0.6318773087535199,0.8461538461538461,1.0,1.0,2/6,17.65%,NOS1AP;ACE
prerank,GO_Biological_Process_2021__positive regulation of cell morphogenesis involved in differentiation (GO:0010770),0.3014263230353746,0.6317283666400312,0.9866666666666667,1.0,1.0,2/43,9.58%,RREB1;DOCK1
prerank,GO_Biological_Process_2021__regulation of interferon-alpha production (GO:0032647),-0.30486426363582503,-0.6311470610513054,0.8717948717948718,1.0,1.0,3/15,14.95%,IFIH1;PTPRS;MAVS
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in apoptotic process (GO:0043281),0.2782672605957093,0.6311101547735646,0.9743589743589743,1.0,1.0,13/63,24.88%,CDKN2D;CARD8;BCAP31;HGF;REST;GPER1;CYCS;NODAL;DHCR24;BAD;IFI6;ACVR1C;ARL6IP5
prerank,GO_Biological_Process_2021__regulation of ion transport (GO:0043269),0.2814699709843919,0.6306450157089776,0.9746835443037974,1.0,1.0,15/65,21.34%,SYT2;SYT4;NKAIN2;YWHAH;KCNJ9;CLDN10;DRD3;KCNJ11;SYT15;SYT9;ATP1A1;SYT13;B2M;PDZK1;PER1
prerank,GO_Biological_Process_2021__cardiolipin acyl-chain remodeling (GO:0035965),-0.3977241715679491,-0.6303376995037117,0.8372093023255814,1.0,1.0,2/5,24.32%,HADHA;LCLAT1
prerank,GO_Biological_Process_2021__negative regulation of intrinsic apoptotic signaling pathway by p53 class mediator (GO:1902254),-0.34354411992277367,-0.630168349841385,0.9024390243902439,1.0,1.0,2/14,6.63%,TRIAP1;BCL2
prerank,GO_Biological_Process_2021__protein deubiquitination (GO:0016579),-0.22574633630059818,-0.6299726372053609,1.0,1.0,1.0,19/223,13.67%,IFIH1;USP27X;MBD6;TRAF3;OTUD3;TAF10;INO80D;BRCC3;SENP8;INO80;FOXK1;USP35;USP25;USP10;RCE1;USP51;OTUD5;YY1;USP4
prerank,GO_Biological_Process_2021__regulation of ubiquitin-dependent protein catabolic process (GO:2000058),0.2999351241524009,0.6292664163871423,0.9375,1.0,1.0,5/38,18.98%,CAV3;RPS7;RNF139;PYHIN1;MAGEF1
prerank,GO_Biological_Process_2021__regulation of nucleobase-containing compound metabolic process (GO:0019219),0.4001855829818813,0.6291403425246759,0.9242424242424242,1.0,1.0,2/10,9.70%,RASA1;PCBP2
prerank,GO_Biological_Process_2021__membrane lipid biosynthetic process (GO:0046467),-0.28584010517265857,-0.6289093238483268,1.0,1.0,1.0,8/52,11.90%,SPTSSB;ELOVL6;SPHK2;CERS4;SGMS2;SPTLC1;ST3GAL2;CSNK1G2
prerank,GO_Biological_Process_2021__nucleobase biosynthetic process (GO:0046112),0.3769638593241436,0.6288930772210782,0.8813559322033898,1.0,1.0,1/7,10.75%,PAICS
prerank,GO_Biological_Process_2021__establishment of apical/basal cell polarity (GO:0035089),0.34616033205121655,0.628825741860228,0.9230769230769231,1.0,1.0,2/12,26.36%,MSN;CDC42
prerank,GO_Biological_Process_2021__positive regulation of lipase activity (GO:0060193),-0.3735752494518766,-0.6277290687603267,0.9024390243902439,1.0,1.0,2/6,14.85%,PLIN5;FGFR3
prerank,GO_Biological_Process_2021__clathrin-dependent endocytosis (GO:0072583),0.3025487501946465,0.6277245562822347,0.9402985074626866,1.0,1.0,4/26,23.66%,SIGLEC1;INPP5F;CLTC;DNAJC6
prerank,GO_Biological_Process_2021__positive regulation of proteasomal ubiquitin-dependent protein catabolic process (GO:0032436),-0.2531857838797509,-0.6276937080455767,1.0,1.0,1.0,15/66,19.41%,TRIB2;TAF1;SIRT2;CLU;SH3RF2;FZR1;PLK3;HSPBP1;RAD23A;FBXO22;PRICKLE1;ZER1;VCP;HSPA1A;PRKN
prerank,GO_Biological_Process_2021__negative regulation of cytokine production involved in immune response (GO:0002719),0.34667295681634214,0.6276226686695079,0.8852459016393442,1.0,1.0,3/9,13.78%,CUEDC2;SMAD7;TGFB1
prerank,GO_Biological_Process_2021__regulation of oxidoreductase activity (GO:0051341),-0.35515818431911966,-0.6275557097613593,0.9142857142857143,1.0,1.0,8/8,64.50%,MT3;ABL1;SIRT4;HDAC6;ECSIT;SZT2;ABL2;OXA1L
prerank,GO_Biological_Process_2021__B cell homeostasis (GO:0001782),-0.39058119944377867,-0.6271640031414062,0.8378378378378378,1.0,1.0,1/7,4.22%,DOCK10
prerank,GO_Biological_Process_2021__regulation of cellular response to heat (GO:1900034),0.2917442715608661,0.6267711310591924,1.0,1.0,1.0,14/75,25.59%,FKBP4;HSPA1L;DNAJB1;DNAJC2;RPA3;HSPA8;CAMK2D;HSPH1;NUP54;CHORDC1;NUP188;NUP85;NUP58;BAG4
prerank,GO_Biological_Process_2021__establishment of protein localization to mitochondrion (GO:0072655),0.30276784076663343,0.6266008076398062,0.9565217391304348,1.0,1.0,11/43,28.83%,BCAP31;TOMM22;PINK1;DNAJC19;GRPEL2;FBXO7;ROMO1;TOMM20;TIMM8B;TOMM7;TIMM22
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance (GO:0032205),-0.3299744476838678,-0.6263084544607558,0.9444444444444444,1.0,1.0,2/14,9.39%,ERCC1;SMG6
prerank,GO_Biological_Process_2021__positive regulation of type I interferon production (GO:0032481),0.2743579969445995,0.6262595125647081,1.0,1.0,1.0,11/65,19.74%,POLR3K;CD14;STAT1;IRF1;RIPK2;MRE11;POLR3G;STAT6;CGAS;G3BP1;TLR2
prerank,"GO_Biological_Process_2021__maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000462)",-0.30803749527783847,-0.6258416599243789,0.9375,1.0,1.0,4/27,11.33%,NOP9;TBL3;NOP14;WDR46
prerank,GO_Biological_Process_2021__regulation of keratinocyte proliferation (GO:0010837),0.34935356496576253,0.6256095930265535,0.9552238805970149,1.0,1.0,5/18,22.85%,FGFR2;STXBP4;KLF9;SNAI2;NOTCH2
prerank,GO_Biological_Process_2021__vascular transport (GO:0010232),0.2805612799173357,0.6250890566888809,0.9855072463768116,1.0,1.0,9/75,14.10%,AGER;SLCO2B1;ABCC2;ABCB1;SLC2A1;AVPR1A;SLC38A2;ABCG2;SLC28A2
prerank,GO_Biological_Process_2021__negative regulation of receptor-mediated endocytosis (GO:0048261),0.3329266592214923,0.6247064939852606,0.9428571428571428,1.0,1.0,2/18,19.18%,LRPAP1;RIN3
prerank,GO_Biological_Process_2021__maturation of SSU-rRNA (GO:0030490),-0.30270544715552544,-0.6246461159216659,0.9428571428571428,1.0,1.0,4/33,11.33%,LSM6;SRFBP1;NOP14;WDR46
prerank,GO_Biological_Process_2021__regulation of protein binding (GO:0043393),0.2692862482286271,0.6240374368681921,0.987012987012987,1.0,1.0,13/96,20.46%,NES;LDLRAP1;ZFPM1;HIP1R;EFHB;RIPK2;LRPAP1;DERL1;CTSZ;B2M;TMC8;LRRK2;IFIT1
prerank,GO_Biological_Process_2021__positive regulation of ligase activity (GO:0051351),0.3734905136260629,0.623950742904308,0.9117647058823529,1.0,1.0,1/9,5.81%,NHEJ1
prerank,GO_Biological_Process_2021__mature ribosome assembly (GO:0042256),0.39917656933741213,0.6237088157823487,0.9090909090909091,1.0,1.0,3/5,38.76%,EIF6;DDX3X;C1QBP
prerank,GO_Biological_Process_2021__regulation of glucose transmembrane transport (GO:0010827),0.36527673897807816,0.6236940210298025,0.9076923076923077,1.0,1.0,3/14,23.63%,SLC2A1;RTN2;PRKAG2
prerank,GO_Biological_Process_2021__histone H3-K14 acetylation (GO:0044154),-0.39787438621072174,-0.6232512963476482,0.8974358974358975,1.0,1.0,4/7,29.07%,MEAF6;KAT7;BRPF1;PHF14
prerank,GO_Biological_Process_2021__regulation of type I interferon production (GO:0032479),0.27135761476905473,0.6230319232636017,1.0,1.0,1.0,15/74,22.25%,POLR3K;TRIM32;CD14;PCBP2;RNF26;IRF1;MRE11;POLR3G;STAT6;TRIM25;CGAS;G3BP1;IKBKE;POLR2K;CYLD
prerank,GO_Biological_Process_2021__positive regulation of neutrophil migration (GO:1902624),0.32798184066047203,0.6230228713029641,0.9384615384615385,1.0,1.0,3/16,19.30%,DAPK2;CD99;CD74
prerank,GO_Biological_Process_2021__positive regulation of lipopolysaccharide-mediated signaling pathway (GO:0031666),0.4132890827930651,0.6230112581073373,0.9242424242424242,1.0,1.0,2/6,18.01%,SCIMP;LY86
prerank,GO_Biological_Process_2021__positive regulation of cellular protein metabolic process (GO:0032270),0.26814693858748145,0.6227059309348243,0.9871794871794872,1.0,1.0,5/94,6.92%,PLA2G10;INHBA;TRIM32;AGT;FADD
prerank,GO_Biological_Process_2021__regulation of mitochondrion organization (GO:0010821),-0.28550883101610186,-0.6222085308177541,0.9655172413793104,1.0,1.0,1/40,1.84%,PID1
prerank,GO_Biological_Process_2021__sphingoid metabolic process (GO:0046519),-0.3143676364373754,-0.621817204192511,0.8611111111111112,1.0,1.0,2/12,14.85%,SPHK2;SGPP2
prerank,GO_Biological_Process_2021__negative regulation of fibroblast proliferation (GO:0048147),-0.3417029576666857,-0.6214073513123861,0.9210526315789473,1.0,1.0,3/16,11.38%,SFRP1;EMD;PARP10
prerank,GO_Biological_Process_2021__peptidyl-serine autophosphorylation (GO:0036289),0.37163463201104785,0.6213336462725878,0.875,1.0,1.0,2/8,20.68%,PINK1;ERN1
prerank,GO_Biological_Process_2021__mitochondrial calcium ion homeostasis (GO:0051560),-0.3191306269674755,-0.6213030662515565,0.9285714285714286,1.0,1.0,6/19,18.16%,MCUB;MICU1;MICU2;MCUR1;SLC8A3;MCU
prerank,GO_Biological_Process_2021__heparan sulfate proteoglycan biosynthetic process (GO:0015012),-0.30051072774419063,-0.6211281808073364,0.9,1.0,1.0,6/18,14.32%,HS3ST3B1;HS3ST5;EXT1;B3GAT3;EXT2;XYLT2
prerank,GO_Biological_Process_2021__negative regulation of calcium ion import (GO:0090281),-0.3954837425763795,-0.6211021733958324,0.8787878787878788,1.0,1.0,1/5,7.82%,MRLN
prerank,GO_Biological_Process_2021__peptidyl-threonine modification (GO:0018210),0.28094316158743354,0.6208308900440365,1.0,1.0,1.0,7/60,20.42%,HIPK4;CDK5R1;CAMK2D;DYRK2;NLK;ULK1;LRRK2
prerank,GO_Biological_Process_2021__regulation of cell killing (GO:0031341),-0.31470862219623513,-0.6206525431165489,0.918918918918919,1.0,1.0,4/14,14.97%,TGFB2;IL11;CR1L;NOXO1
prerank,GO_Biological_Process_2021__keratinocyte differentiation (GO:0030216),0.3225553323353529,0.6206399437395366,0.9552238805970149,1.0,1.0,3/24,14.12%,EXPH5;SCEL;OPN3
prerank,GO_Biological_Process_2021__meiotic sister chromatid cohesion (GO:0051177),0.42161479972516375,0.6205917558612757,0.8888888888888888,1.0,1.0,1/5,10.89%,BUB1B
prerank,GO_Biological_Process_2021__defense response to protozoan (GO:0042832),0.396254198145818,0.6200409637189096,0.8947368421052632,1.0,1.0,3/8,33.50%,GBP6;SLC11A1;BATF2
prerank,GO_Biological_Process_2021__regulation of nucleotide-binding oligomerization domain containing signaling pathway (GO:0070424),-0.4257223618578977,-0.6199763732732357,0.9069767441860465,1.0,1.0,1/5,11.62%,XIAP
prerank,GO_Biological_Process_2021__canonical glycolysis (GO:0061621),0.3482468842899196,0.6199350588394713,0.9552238805970149,1.0,1.0,5/21,26.27%,ALDOB;PGAM1;HK3;PKLR;ENO2
prerank,GO_Biological_Process_2021__glucose catabolic process to pyruvate (GO:0061718),0.3482468842899196,0.6199350588394713,0.9552238805970149,1.0,1.0,5/21,26.27%,ALDOB;PGAM1;HK3;PKLR;ENO2
prerank,GO_Biological_Process_2021__RNA modification (GO:0009451),-0.2579204901844676,-0.6198338315916423,1.0,1.0,1.0,9/51,16.92%,LCMT2;TRDMT1;WDR4;TRMT61A;ADAT2;QTRT1;PUS7L;CDKAL1;NSUN4
prerank,"GO_Biological_Process_2021__transcription, DNA-templated (GO:0006351)",0.2525780177866321,0.6197430892988759,1.0,1.0,1.0,11/196,9.87%,RREB1;POLR3K;ZBTB7B;GCM2;ABT1;GTF3C4;NCBP1;NCBP2;TBP;COPS2;TBPL1
prerank,GO_Biological_Process_2021__glycerophospholipid biosynthetic process (GO:0046474),0.2600462255093435,0.6194003726913133,1.0,1.0,1.0,15/158,20.36%,LIPH;PLA2G10;LPCAT3;PIK3R5;SLC44A5;PLCG2;LIPI;SELENOI;INPPL1;DDHD2;PIK3C2G;PLEKHA2;INPP5F;PLSCR1;PIP4K2C
prerank,GO_Biological_Process_2021__intrinsic apoptotic signaling pathway (GO:0097193),0.27250881333155424,0.6191962470975066,1.0,1.0,1.0,22/82,25.82%,BOK;ITPR1;HIC1;CYP1B1;MOAP1;HINT1;BNIP3;CHAC1;BCL2L2;BRCA1;DAB2IP;CUL2;BCL2L1;ERN1;IKBKE;BAD;ERO1A;IFI6;MSH6;ARL6IP5;ZNF385B;MLLT11
prerank,GO_Biological_Process_2021__proteasome-mediated ubiquitin-dependent protein catabolic process (GO:0043161),-0.20862106836209063,-0.6190298516711394,1.0,1.0,1.0,29/296,14.34%,FBXL7;RNF126;PTTG1;CDC26;FBXO27;ECRG4;FEM1A;RNF175;AURKA;DNAJB12;NSFL1C;KCTD13;ERCC8;DMAC2;TAF1;UBXN2A;RNF216;CDC23;UBE2J2;SIRT2;ZNRF1;TRIM71;FOXRED2;CUL4A;FAF1;DERL3;UBXN8;FZR1;FBXO44
prerank,GO_Biological_Process_2021__protein localization to lysosome (GO:0061462),-0.2796227665985134,-0.618883970415507,0.9655172413793104,1.0,1.0,4/28,18.46%,RAB7A;SORL1;GCC2;LAMTOR4
prerank,GO_Biological_Process_2021__embryonic axis specification (GO:0000578),-0.34525360241563285,-0.6186678136012117,0.9230769230769231,1.0,1.0,2/11,10.64%,PTCH1;COBL
prerank,GO_Biological_Process_2021__Rac protein signal transduction (GO:0016601),0.3361030743159107,0.6185607171165468,0.9545454545454546,1.0,1.0,4/17,13.50%,WASF1;EPS8;RHOH;BRK1
prerank,GO_Biological_Process_2021__response to laminar fluid shear stress (GO:0034616),0.379350539444965,0.6181733176620396,0.8813559322033898,1.0,1.0,1/8,11.46%,SMAD7
prerank,GO_Biological_Process_2021__regulation of axon guidance (GO:1902667),-0.37252105852561296,-0.6177735023584455,0.90625,1.0,1.0,2/9,19.54%,NRP1;ZSWIM5
prerank,GO_Biological_Process_2021__positive regulation of G1/S transition of mitotic cell cycle (GO:1900087),-0.2641819886131881,-0.6173968448997326,0.9666666666666667,1.0,1.0,5/24,14.41%,LSM10;TFDP1;EIF4G1;EGFR;RPTOR
prerank,GO_Biological_Process_2021__mitotic nuclear membrane reassembly (GO:0007084),-0.24775279779747522,-0.6173896502438027,1.0,1.0,1.0,3/46,6.59%,LEMD2;EMD;NUP37
prerank,GO_Biological_Process_2021__mitotic nuclear membrane organization (GO:0101024),-0.24775279779747522,-0.6173896502438027,1.0,1.0,1.0,3/46,6.59%,LEMD2;EMD;NUP37
prerank,GO_Biological_Process_2021__negative regulation of mitotic metaphase/anaphase transition (GO:0045841),0.3374124007527236,0.6171454867741418,0.9428571428571428,1.0,1.0,2/16,11.12%,BUB1B;TEX14
prerank,GO_Biological_Process_2021__female gamete generation (GO:0007292),0.31539189519128386,0.616947519994242,0.927536231884058,1.0,1.0,2/22,12.16%,IHO1;M1AP
prerank,GO_Biological_Process_2021__positive regulation of telomere capping (GO:1904355),-0.33509054637794633,-0.6163206844775331,0.8709677419354839,1.0,1.0,1/13,7.77%,PNKP
prerank,GO_Biological_Process_2021__negative regulation of phospholipase activity (GO:0010519),-0.3715526264484725,-0.6161301372063245,0.8648648648648649,1.0,1.0,1/5,11.42%,RGS2
prerank,GO_Biological_Process_2021__lipoprotein catabolic process (GO:0042159),0.3322175338625848,0.6161282836349447,0.9193548387096774,1.0,1.0,1/10,5.90%,NOTUM
prerank,GO_Biological_Process_2021__regulation of histamine secretion by mast cell (GO:1903593),-0.393925629132545,-0.616007427928805,0.9069767441860465,1.0,1.0,3/5,20.41%,VAMP3;VAMP8;SNX6
prerank,GO_Biological_Process_2021__negative regulation of protein targeting to membrane (GO:0090315),-0.41614840742202003,-0.6158403523482938,0.925,1.0,1.0,2/5,18.15%,KCNE1;GDI1
prerank,GO_Biological_Process_2021__neuronal action potential (GO:0019228),0.34002654182469905,0.6158095451374694,0.9545454545454546,1.0,1.0,3/18,11.81%,SCN9A;SCN7A;GPER1
prerank,GO_Biological_Process_2021__neurogenesis (GO:0022008),0.29994943003727564,0.6157154063821607,0.9692307692307692,1.0,1.0,4/35,13.02%,GCM2;WDR62;CHAC1;SIX4
prerank,GO_Biological_Process_2021__regulation of myoblast differentiation (GO:0045661),0.33172888467916384,0.6155299070354341,0.9848484848484849,1.0,1.0,2/25,13.78%,NOTCH1;TGFB1
prerank,GO_Biological_Process_2021__regulation of oxidative phosphorylation (GO:0002082),-0.3164509115802766,-0.6153840605049499,0.918918918918919,1.0,1.0,5/14,19.25%,SLC25A33;ABCD1;COX7A1;VCP;NUPR1
prerank,GO_Biological_Process_2021__negative regulation of GTPase activity (GO:0034260),0.34282876308180643,0.6150769225461409,0.9365079365079365,1.0,1.0,3/17,20.42%,F11R;DAB2IP;LRRK2
prerank,GO_Biological_Process_2021__in utero embryonic development (GO:0001701),-0.30214218060399933,-0.6146605462950407,0.9166666666666666,1.0,1.0,6/19,24.92%,TGFB3;ARNT2;TGFBR1;CHD7;BMP2;PTPRR
prerank,GO_Biological_Process_2021__glycolytic process through glucose-6-phosphate (GO:0061620),0.3488303087025479,0.6142596502786339,0.9692307692307692,1.0,1.0,6/22,27.89%,ALDOB;PGAM1;HK3;PKLR;ENO2;ADPGK
prerank,GO_Biological_Process_2021__regulation of RIG-I signaling pathway (GO:0039535),-0.3393617077901607,-0.6141979922411424,1.0,1.0,1.0,1/15,5.37%,DDX60
prerank,GO_Biological_Process_2021__peptide cross-linking (GO:0018149),-0.3678583286360365,-0.6138408555135281,0.9428571428571428,1.0,1.0,2/10,7.15%,CD247;TGM1
prerank,GO_Biological_Process_2021__vesicle fusion with endoplasmic reticulum-Golgi intermediate compartment (ERGIC) membrane (GO:1990668),0.40405845441909394,0.6132414772309719,0.9436619718309859,1.0,1.0,2/5,22.29%,CALR;SEC22B
prerank,GO_Biological_Process_2021__regulation of lipoprotein lipase activity (GO:0051004),-0.32653407428129516,-0.612633502746212,0.9375,1.0,1.0,2/13,7.04%,LMF1;APOA1
prerank,GO_Biological_Process_2021__negative regulation of posttranscriptional gene silencing (GO:0060149),0.390598341876802,0.6125953039694593,0.9344262295081968,1.0,1.0,2/5,21.48%,TGFB1;PPARG
prerank,GO_Biological_Process_2021__negative regulation of gene silencing by RNA (GO:0060967),0.390598341876802,0.6125953039694593,0.9344262295081968,1.0,1.0,2/5,21.48%,TGFB1;PPARG
prerank,MSigDB_Hallmark_2020__Mitotic Spindle,0.24410523600674766,0.6121930509193563,1.0,1.0,1.0,15/187,15.73%,RAPGEF5;RASA1;DOCK2;PREX1;WASF1;TPX2;CEP72;ANLN;MAP3K11;TUBA4A;ARHGAP10;DOCK4;GEMIN4;ECT2;RACGAP1
prerank,PanglaoDB_Augmented_2021__Oxyphil Cells,0.27060283359436604,0.6119335688302697,1.0,1.0,1.0,10/66,20.69%,GCM2;DNAJC5G;CTAGE14P;COL9A1;ACVR2B;KCNJ11;TRDN;MYH7B;CTNNA3;HIF3A
prerank,GO_Biological_Process_2021__peripheral nervous system axon ensheathment (GO:0032292),-0.3769479770653802,-0.611788701293209,0.825,1.0,1.0,3/7,20.85%,SIRT2;PARD3;LGI4
prerank,GO_Biological_Process_2021__Schwann cell development (GO:0014044),-0.3769479770653802,-0.611788701293209,0.825,1.0,1.0,3/7,20.85%,SIRT2;PARD3;LGI4
prerank,GO_Biological_Process_2021__regulation of cell cycle G1/S phase transition (GO:1902806),0.3118914377195481,0.6114490884901218,1.0,1.0,1.0,4/26,11.57%,CDKN1B;KIF14;PLCG2;STXBP4
prerank,GO_Biological_Process_2021__regulation of protein targeting to membrane (GO:0090313),0.3309107105107112,0.6113856432996696,0.953125,1.0,1.0,9/27,30.90%,TCAF2;MIEF2;PDZK1;DMTN;PRNP;MIEF1;CEMIP;TCAF1;INPP5K
prerank,GO_Biological_Process_2021__camera-type eye morphogenesis (GO:0048593),0.38874722042329046,0.611106419008233,0.9016393442622951,1.0,1.0,3/9,39.93%,TENM3;SHROOM2;C12ORF57
prerank,GO_Biological_Process_2021__L-serine biosynthetic process (GO:0006564),-0.36445055980246466,-0.610803724058405,0.9210526315789473,1.0,1.0,3/6,23.96%,PSAT1;PSPH;SRR
prerank,GO_Biological_Process_2021__axon regeneration (GO:0031103),0.3761424242132019,0.6103727288851047,0.9473684210526315,1.0,1.0,1/8,8.85%,NREP
prerank,GO_Biological_Process_2021__positive regulation of exocytosis (GO:0045921),0.3074672876991806,0.6103610545220457,0.9420289855072463,1.0,1.0,5/32,17.32%,EXPH5;RAB9A;ATP6AP1;SYTL4;CHMP2A
prerank,GO_Biological_Process_2021__neuron projection organization (GO:0106027),0.3456407256945083,0.6102478679904453,0.9193548387096774,1.0,1.0,3/14,22.72%,LGMN;CHRNA7;PRNP
prerank,GO_Biological_Process_2021__renal filtration cell differentiation (GO:0061318),0.40994167194268055,0.6101900564873401,0.9016393442622951,1.0,1.0,2/5,23.42%,BASP1;KLF15
prerank,GO_Biological_Process_2021__glomerular epithelial cell differentiation (GO:0072311),0.40994167194268055,0.6101900564873401,0.9016393442622951,1.0,1.0,2/5,23.42%,BASP1;KLF15
prerank,GO_Biological_Process_2021__regulation of collagen fibril organization (GO:1904026),-0.3717049465914821,-0.6099450918113891,0.8695652173913043,1.0,1.0,5/5,62.84%,COLGALT1;RB1;CHADL;AEBP1;EFEMP2
prerank,GO_Biological_Process_2021__regulation of translation (GO:0006417),-0.22011192309966426,-0.6098955990633137,1.0,1.0,1.0,20/166,15.67%,SAMD4A;TYMS;MIF4GD;TCOF1;PUM3;HSPB1;NCL;DHFR;TSFM;ELAVL1;UPF3A;EIF4G1;TRAP1;IGF2BP3;TRIM71;BTG2;RBM3;SAMD4B;CIRBP;PLD1
prerank,GO_Biological_Process_2021__regulation of focal adhesion disassembly (GO:0120182),-0.38222079589216945,-0.6094845238246719,0.9024390243902439,1.0,1.0,6/6,61.79%,PIK3R1;MAP4K4;MAPRE2;ARF6;IQSEC1;DUSP3
prerank,GO_Biological_Process_2021__positive regulation of focal adhesion disassembly (GO:0120183),-0.38222079589216945,-0.6094845238246719,0.9024390243902439,1.0,1.0,6/6,61.79%,PIK3R1;MAP4K4;MAPRE2;ARF6;IQSEC1;DUSP3
prerank,GO_Biological_Process_2021__endosome organization (GO:0007032),-0.2665329790861374,-0.6094454411170356,0.9487179487179487,1.0,1.0,2/36,4.88%,RILP;PI4K2A
prerank,GO_Biological_Process_2021__histone H4-K8 acetylation (GO:0043982),-0.3126992872504176,-0.609433761277337,0.9230769230769231,1.0,1.0,3/15,20.15%,JADE2;MEAF6;KAT7
prerank,GO_Biological_Process_2021__histone H4-K5 acetylation (GO:0043981),-0.3126992872504176,-0.609433761277337,0.9230769230769231,1.0,1.0,3/15,20.15%,JADE2;MEAF6;KAT7
prerank,GO_Biological_Process_2021__cellular response to oxygen-containing compound (GO:1901701),0.23822018000163098,0.6094313766355284,1.0,1.0,1.0,63/227,30.90%,P2RY1;ZNF703;SSTR1;IGFBP5;AHR;P2RY12;CD14;TSHR;TBX1;PDCD1LG2;STAP1;GPER1;ABCB4;ESR1;DAB2IP;PDK4;KCNQ1;AQP9;GLRA1;PDCD4;CXCL13;H2AZ1;INSIG1;CRHBP;TLR2;CD274;PLAA;DMTN;TESC;CX3CR1;HCN4;LBP;ATP2B4;ROMO1;CD80;GSTP1;RYR3;WNT5B;HSP90B1;LYN;ZNF35;TWF2;SERPINE1;ADAM9;LAMTOR3;RRAGD;NRIP1;LAMTOR2;TNIP2;ZFP36;RRAGA;LAMTOR5;SLC5A5;NFKBIL1;SPAAR;PDE2A;P2RX7;SLIT2;FAM210B;TNFSF4;AANAT;PDK2;INPP5K
prerank,GO_Biological_Process_2021__transcription-coupled nucleotide-excision repair (GO:0006283),-0.23812546387718747,-0.6092621554267523,1.0,1.0,1.0,11/70,15.31%,ERCC2;GTF2H2;ERCC1;ERCC8;CCNH;POLR2G;POLD3;POLR2C;CUL4A;POLR2L;COPS6
prerank,GO_Biological_Process_2021__dosage compensation (GO:0007549),0.34737899133018646,0.6092404871043413,0.9661016949152542,1.0,1.0,2/10,19.18%,BRCA1;YTHDC1
prerank,GO_Biological_Process_2021__mitochondrion transport along microtubule (GO:0047497),-0.3360946543751449,-0.6091830415788093,0.926829268292683,1.0,1.0,3/13,24.84%,UXT;MAP1S;MGARP
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent rRNA catabolic process (GO:0071035),0.4077952458493524,0.6088815485947286,0.9375,1.0,1.0,1/5,10.70%,EXOSC8
prerank,GO_Biological_Process_2021__tRNA surveillance (GO:0106354),0.4077952458493524,0.6088815485947286,0.9375,1.0,1.0,1/5,10.70%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent tRNA catabolic process (GO:0071038),0.4077952458493524,0.6088815485947286,0.9375,1.0,1.0,1/5,10.70%,EXOSC8
prerank,GO_Biological_Process_2021__nuclear polyadenylation-dependent ncRNA catabolic process (GO:0071046),0.4077952458493524,0.6088815485947286,0.9375,1.0,1.0,1/5,10.70%,EXOSC8
prerank,GO_Biological_Process_2021__hyaluronan biosynthetic process (GO:0030213),0.395422093685621,0.6087881654379748,0.8970588235294118,1.0,1.0,2/5,28.41%,HAS3;CEMIP
prerank,GO_Biological_Process_2021__androgen receptor signaling pathway (GO:0030521),0.37369677183179756,0.608544479673237,0.9298245614035088,1.0,1.0,2/11,15.35%,KDM3A;TMF1
prerank,GO_Biological_Process_2021__response to insulin (GO:0032868),-0.2588936459547067,-0.6085319615989095,1.0,1.0,1.0,4/72,6.18%,CELA2A;HDAC5;SLC25A33;ZBED3
prerank,GO_Biological_Process_2021__spindle assembly checkpoint signaling (GO:0071173),0.33864557324592526,0.6081236144115725,0.8955223880597015,1.0,1.0,2/15,11.12%,BUB1B;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle checkpoint signaling (GO:0071174),0.33864557324592526,0.6081236144115725,0.8955223880597015,1.0,1.0,2/15,11.12%,BUB1B;TEX14
prerank,GO_Biological_Process_2021__mitotic spindle assembly checkpoint signaling (GO:0007094),0.33864557324592526,0.6081236144115725,0.8955223880597015,1.0,1.0,2/15,11.12%,BUB1B;TEX14
prerank,GO_Biological_Process_2021__regulation of cellular localization (GO:0060341),-0.2623100220740848,-0.6078431898603645,1.0,1.0,1.0,4/43,7.93%,EPHA5;TRIM67;NUMA1;NR1H4
prerank,MSigDB_Hallmark_2020__Apical Junction,0.24809825695384377,0.6074719440977102,1.0,1.0,1.0,31/158,24.33%,LDLRAP1;CTNNA1;RASA1;PTPRC;FYB1;ACTC1;BMP1;YWHAH;COL9A1;VWF;ITGA9;TNFRSF11B;CD99;INPPL1;MSN;TSPAN4;NEXN;PCDH1;INSIG1;SHC1;CD274;FLNC;SGCE;MAPK13;DLG1;CLDN18;PIK3CB;JAM3;ARHGEF6;EPB41L2;RHOF
prerank,GO_Biological_Process_2021__ganglioside metabolic process (GO:0001573),0.3440786442673768,0.6065069534031151,0.9178082191780822,1.0,1.0,4/16,20.63%,GM2A;ST8SIA6;NEU1;ST6GALNAC5
prerank,"GO_Biological_Process_2021__negative regulation of DNA-templated transcription, elongation (GO:0032785)",-0.30891204901849634,-0.6063917773413234,0.9761904761904762,1.0,1.0,3/13,20.66%,NELFA;TCERG1;NELFE
prerank,GO_Biological_Process_2021__interleukin-6-mediated signaling pathway (GO:0070102),0.3292505947353546,0.6063518876134324,0.9393939393939394,1.0,1.0,4/15,29.60%,STAT1;IL6ST;YAP1;SMAD4
prerank,GO_Biological_Process_2021__dendrite arborization (GO:0140059),0.39072076951702495,0.6063144016732722,0.8873239436619719,1.0,1.0,2/6,17.34%,SEMA3A;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of response to biotic stimulus (GO:0002833),0.29488492406632155,0.6062175827320317,0.9538461538461539,1.0,1.0,11/29,28.11%,CCL5;SCIMP;POLR3G;LY86;PLSCR1;IFI35;GBP5;ZCCHC3;PUM1;AKIRIN2;ANKRD17
prerank,GO_Biological_Process_2021__Fc receptor mediated stimulatory signaling pathway (GO:0002431),-0.22738488183969757,-0.6051083183957762,1.0,1.0,1.0,10/61,13.84%,ARPC3;PRKCD;CD247;PLD2;LIMK1;WIPF1;NR4A3;MYO10;ELMO2;PRKCE
prerank,GO_Biological_Process_2021__pathway-restricted SMAD protein phosphorylation (GO:0060389),0.35468137321926446,0.6049918568016796,0.9833333333333333,1.0,1.0,2/10,13.78%,SMAD7;TGFB1
prerank,GO_Biological_Process_2021__regulation of cilium assembly (GO:1902017),-0.25481163112605754,-0.6049405265771408,1.0,1.0,1.0,9/56,18.80%,CROCC;CDKL1;TBC1D16;TBC1D10B;TBC1D2B;ENTR1;TBC1D2;TBC1D7;TBC1D22A
prerank,GO_Biological_Process_2021__positive regulation of CREB transcription factor activity (GO:0032793),-0.3128397529774586,-0.6048490353523955,0.9666666666666667,1.0,1.0,4/16,16.42%,EPHA5;LRP8;CRTC3;RELN
prerank,GO_Biological_Process_2021__mRNA-containing ribonucleoprotein complex export from nucleus (GO:0071427),0.26404261429180387,0.6047534539140514,1.0,1.0,1.0,20/89,24.87%,NXT1;FYTTD1;U2AF1;SLU7;NCBP1;NCBP2;DDX39A;FIP1L1;THOC5;NUP54;CDC40;YTHDC1;SLBP;SARNP;NUP188;SRSF3;NUP85;EIF4A3;ALYREF;NUP58
prerank,GO_Biological_Process_2021__endoplasmic reticulum to Golgi vesicle-mediated transport (GO:0006888),0.24767200556350832,0.6047279381175427,1.0,1.0,1.0,14/154,19.08%,LMAN1;F8;SPTBN5;VAPB;BCAP31;TGFA;F10;ARCN1;MPPE1;CD59;ARF4;CTSZ;COPB1;STX17
prerank,GO_Biological_Process_2021__mitochondrion-endoplasmic reticulum membrane tethering (GO:1990456),0.39198639290883985,0.6046458853208008,0.88,1.0,1.0,2/6,26.13%,ATP2A2;VMP1
prerank,GO_Biological_Process_2021__peroxisome fission (GO:0016559),0.38689208437772205,0.604628576019854,0.9154929577464789,1.0,1.0,2/7,19.85%,PEX11B;PEX11A
prerank,GO_Biological_Process_2021__phosphatidylinositol biosynthetic process (GO:0006661),0.2610716753526271,0.6040703157981374,1.0,1.0,1.0,17/111,24.11%,PIK3R5;PIGC;PGAP4;PLCG2;PIGV;PIGH;PGAP3;INPPL1;MPPE1;PIK3C2G;PLEKHA2;ITPKB;INPP5F;PIP4K2C;PIGN;PIK3CB;INPP4B
prerank,GO_Biological_Process_2021__positive regulation of cyclase activity (GO:0031281),0.3348127728828433,0.6040425216799814,0.9298245614035088,1.0,1.0,1/12,14.14%,AKAP5
prerank,GO_Biological_Process_2021__nuclear membrane organization (GO:0071763),0.3250601930525003,0.6035653602105144,0.9375,1.0,1.0,3/19,17.32%,CHMP4B;GPER1;CHMP2A
prerank,GO_Biological_Process_2021__positive regulation of isotype switching (GO:0045830),-0.31418930637230436,-0.6033129610128133,0.9428571428571428,1.0,1.0,4/12,20.97%,SHLD1;KMT5B;TP53BP1;HMCES
prerank,GO_Biological_Process_2021__regulation of primary metabolic process (GO:0080090),0.251178500059094,0.603152046147282,1.0,1.0,1.0,12/114,17.68%,FASN;NQO1;PRKAB2;PSMB6;HMGCR;HMGCS1;SCD;SQLE;PSMA3;PSMB8;PSAP;DHCR7
prerank,GO_Biological_Process_2021__positive regulation of non-motile cilium assembly (GO:1902857),0.40959206939049086,0.6030025964183433,0.9365079365079365,1.0,1.0,1/5,23.08%,SEPTIN9
prerank,GO_Biological_Process_2021__carnitine transport (GO:0015879),-0.38874318459170987,-0.6029386431610065,0.8913043478260869,1.0,1.0,1/5,7.15%,SLC25A29
prerank,GO_Biological_Process_2021__regulation of type I interferon-mediated signaling pathway (GO:0060338),-0.26633793654371113,-0.6025976273154466,0.95,1.0,1.0,5/26,17.92%,SAMHD1;CACTIN;PTPN1;MAVS;CDC37
prerank,GO_Biological_Process_2021__glucose 6-phosphate metabolic process (GO:0051156),-0.3056227692741741,-0.6022556083683793,0.9411764705882353,1.0,1.0,1/20,1.60%,G6PC3
prerank,GO_Biological_Process_2021__fatty acid elongation (GO:0030497),-0.31555538141732264,-0.6020453298858434,0.875,1.0,1.0,3/12,15.28%,ELOVL6;ABCD1;HACD1
prerank,GO_Biological_Process_2021__chondroitin sulfate biosynthetic process (GO:0030206),-0.2949445020613122,-0.6019515187948881,0.9696969696969697,1.0,1.0,3/18,15.49%,VCAN;CHST9;CHST12
prerank,GO_Biological_Process_2021__positive regulation of protein dephosphorylation (GO:0035307),0.30418584899519274,0.6019503321325349,0.9841269841269841,1.0,1.0,1/27,3.19%,PDGFRB
prerank,GO_Biological_Process_2021__protein desumoylation (GO:0016926),-0.3930405281496424,-0.6016835346393102,0.9444444444444444,1.0,1.0,6/6,60.71%,SENP5;SENP1;SENP2;SENP6;SENP7;USPL1
prerank,GO_Biological_Process_2021__negative regulation of response to reactive oxygen species (GO:1901032),-0.3455519618566764,-0.6014651155855915,0.9,1.0,1.0,1/8,9.83%,GPR37
prerank,GO_Biological_Process_2021__rRNA catabolic process (GO:0016075),-0.3368188729286743,-0.6013624759140114,0.9375,1.0,1.0,4/13,16.67%,EXOSC10;EXOSC7;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen (GO:0002478),0.2589941922957305,0.6010994853699202,1.0,1.0,1.0,4/81,8.88%,HLA-DMA;HLA-DMB;HLA-A;AP1M2
prerank,GO_Biological_Process_2021__regulation of actomyosin structure organization (GO:0110020),0.36166221161431256,0.6010135528683417,0.9148936170212766,1.0,1.0,5/12,30.12%,WAS;CDC42;SLC9A1;ACTG1;RAC1
prerank,GO_Biological_Process_2021__RNA metabolic process (GO:0016070),0.24992512939917838,0.6006852064911474,1.0,1.0,1.0,9/116,12.16%,DDX20;ISG20;NCBP1;NCBP2;RNASEH2C;PCBP2;MRPL44;CLP1;M1AP
prerank,GO_Biological_Process_2021__homologous chromosome segregation (GO:0045143),-0.3143375213285748,-0.6004724169962502,0.9666666666666667,1.0,1.0,3/16,8.41%,PTTG1;ANKRD31;SGO2
prerank,GO_Biological_Process_2021__neurotrophin TRK receptor signaling pathway (GO:0048011),-0.30563350924094135,-0.6003169953218618,0.9444444444444444,1.0,1.0,1/13,11.83%,NGF
prerank,GO_Biological_Process_2021__delamination (GO:0060232),0.39951033121550966,0.599875382997018,0.9344262295081968,1.0,1.0,1/6,34.22%,SPI1
prerank,GO_Biological_Process_2021__positive regulation of interleukin-8 production (GO:0032757),0.288629235484479,0.5994678307039598,1.0,1.0,1.0,3/35,6.92%,ELANE;CD14;FADD
prerank,GO_Biological_Process_2021__adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191),0.3724958760953731,0.5990563257482152,0.8955223880597015,1.0,1.0,1/6,13.12%,DRD3
prerank,GO_Biological_Process_2021__negative regulation of protein polyubiquitination (GO:1902915),-0.36330207965179584,-0.598889762591559,0.9743589743589743,1.0,1.0,2/5,13.56%,PARP10;TRIM44
prerank,GO_Biological_Process_2021__regulation of long-term neuronal synaptic plasticity (GO:0048169),0.34476340943978534,0.5986341564038482,0.8823529411764706,1.0,1.0,3/11,31.28%,NPTN;RAB5A;NETO1
prerank,GO_Biological_Process_2021__cellular response to ionizing radiation (GO:0071479),-0.25737074112599856,-0.5984374643626869,1.0,1.0,1.0,10/44,18.28%,MAP3K20;HUS1;INO80;XRCC6;IFI16;SPIDR;HSF1;TLK2;ATM;EEF1D
prerank,GO_Biological_Process_2021__recombinational repair (GO:0000725),-0.24710090943672852,-0.5979596455327715,1.0,1.0,1.0,12/71,13.43%,BRCA2;POLL;SAMHD1;HUS1;INO80;RFWD3;SEM1;RAD51B;PALB2;SPIDR;XRCC3;YY1
prerank,GO_Biological_Process_2021__ER-associated misfolded protein catabolic process (GO:0071712),0.3493584338885763,0.5978008546217977,0.9206349206349206,1.0,1.0,3/11,25.81%,DERL1;UGGT1;RNF185
prerank,GO_Biological_Process_2021__regulation of cellular response to growth factor stimulus (GO:0090287),0.337057264471289,0.5977532817400041,0.9464285714285714,1.0,1.0,2/15,9.22%,TMEM204;SFRP4
prerank,GO_Biological_Process_2021__negative regulation of T cell migration (GO:2000405),-0.3841434944316697,-0.5976849874447465,0.8333333333333334,1.0,1.0,3/5,25.23%,RIPOR2;LRCH1;CD200R1
prerank,GO_Biological_Process_2021__regulation of cellular protein catabolic process (GO:1903362),0.32908678707648575,0.5975362262300863,0.9692307692307692,1.0,1.0,3/17,16.76%,MSN;VPS35;DAB2IP
prerank,GO_Biological_Process_2021__protein polyglutamylation (GO:0018095),0.3445809733154017,0.5972689091818514,0.9333333333333333,1.0,1.0,4/11,27.72%,TTLL4;TPGS1;TTLL7;TTLL9
prerank,GO_Biological_Process_2021__beta-catenin destruction complex assembly (GO:1904885),-0.36712052445789206,-0.5970094008833247,0.868421052631579,1.0,1.0,5/5,63.30%,APC;AMER1;GSK3B;AXIN1;CSNK1A1
prerank,GO_Biological_Process_2021__regulation of respiratory burst (GO:0060263),-0.4044744823124736,-0.5960697483220063,0.8571428571428571,1.0,1.0,2/5,26.27%,NOXO1;NOXA1
prerank,GO_Biological_Process_2021__regulation of protein K63-linked ubiquitination (GO:1900044),0.364278054969729,0.5954301605592305,0.9193548387096774,1.0,1.0,4/7,29.85%,PLAA;GPS2;DDX3X;SASH1
prerank,GO_Biological_Process_2021__ruffle assembly (GO:0097178),0.40669548134159356,0.5953318684858253,0.9375,1.0,1.0,2/5,30.90%,RAC1;INPP5K
prerank,GO_Biological_Process_2021__positive regulation of neuron death (GO:1901216),-0.27579777443981246,-0.595328225615304,0.9696969696969697,1.0,1.0,2/36,5.75%,FOS;TGFB2
prerank,GO_Biological_Process_2021__neuron projection maintenance (GO:1990535),-0.36672501714695194,-0.5945204922469922,0.8461538461538461,1.0,1.0,3/8,23.76%,ABCD1;ABCD2;PSEN1
prerank,GO_Biological_Process_2021__positive regulation of protein localization to nucleus (GO:1900182),-0.24292710279171553,-0.5944995503125579,1.0,1.0,1.0,7/57,12.34%,TPR;WWTR1;PRKCD;CARD10;CDH1;DMAP1;BAG3
prerank,GO_Biological_Process_2021__regulation of actin filament-based movement (GO:1903115),0.3624558961751059,0.5942913606213797,0.9193548387096774,1.0,1.0,2/8,17.19%,MYBPC3;PLN
prerank,GO_Biological_Process_2021__regulation of vascular wound healing (GO:0061043),-0.38077863695943615,-0.594104584406409,0.8541666666666666,1.0,1.0,1/5,11.72%,SMOC2
prerank,GO_Biological_Process_2021__negative regulation of natural killer cell mediated cytotoxicity (GO:0045953),0.37306026402221,0.5936799942611616,0.9827586206896551,1.0,1.0,1/8,8.88%,HLA-A
prerank,GO_Biological_Process_2021__positive regulation of lyase activity (GO:0051349),0.3273737819265238,0.5933038108757874,0.9473684210526315,1.0,1.0,1/11,14.14%,AKAP5
prerank,GO_Biological_Process_2021__negative regulation of interferon-gamma production (GO:0032689),0.32739933922244563,0.5928691589342698,0.9552238805970149,1.0,1.0,2/16,9.60%,INHBA;PDCD1LG2
prerank,GO_Biological_Process_2021__histone H3-K4 methylation (GO:0051568),-0.2896185158448057,-0.592724227698028,0.925,1.0,1.0,5/25,17.48%,PRDM7;BEND3;WDR82;KMT2B;TET2
prerank,GO_Biological_Process_2021__positive regulation of meiotic nuclear division (GO:0045836),-0.3762951497001964,-0.5919975772080613,0.9142857142857143,1.0,1.0,2/6,11.09%,PRDM7;SIRT2
prerank,GO_Biological_Process_2021__organelle transport along microtubule (GO:0072384),-0.2522948411969892,-0.5916598878019277,1.0,1.0,1.0,30/30,74.81%,UXT;TMEM201;MAP1S;TRAK1;BORCS5;RAB6A;COPG1;COPG2;HTT;TRAK2;BICD1;DYNC1I1;MAPT;LRPPRC;CLN3;BICDL1;HAP1;RHOT2;KIF5B;PAFAH1B1;NDE1;PEX14;UBB;ARHGAP21;RHOT1;FBXW11;BICD2;NDEL1;CDC42;RAB1A
prerank,GO_Biological_Process_2021__chromatin maintenance (GO:0070827),-0.3695678629382679,-0.5915625011459015,0.7837837837837838,1.0,1.0,2/5,27.53%,MTHFR;SUPT6H
prerank,GO_Biological_Process_2021__sodium ion homeostasis (GO:0055078),0.3330710208733498,0.5909085672974599,0.9705882352941176,1.0,1.0,3/14,18.43%,ATP12A;ATP1B1;ATP1A1
prerank,GO_Biological_Process_2021__negative regulation of cell aging (GO:0090344),0.3321537084122735,0.5908131780444006,0.9710144927536232,1.0,1.0,2/14,17.85%,TWIST1;CDK6
prerank,GO_Biological_Process_2021__polarized epithelial cell differentiation (GO:0030859),0.3456304943725518,0.5907206940402137,0.9242424242424242,1.0,1.0,2/12,26.36%,MSN;CDC42
prerank,GO_Biological_Process_2021__glomerular visceral epithelial cell differentiation (GO:0072112),-0.3396794644104781,-0.5901679620976122,0.95,1.0,1.0,3/11,18.94%,NPHS1;PTPRO;JAG1
prerank,GO_Biological_Process_2021__long-chain fatty acid transport (GO:0015909),0.29473785787858364,0.5901337034966379,0.96875,1.0,1.0,2/28,5.61%,FABP3;PRKAB2
prerank,GO_Biological_Process_2021__cell proliferation in forebrain (GO:0021846),-0.3395053620381392,-0.5900502849961893,0.9347826086956522,1.0,1.0,2/9,10.23%,NUMB;PCM1
prerank,GO_Biological_Process_2021__positive regulation of purine nucleotide metabolic process (GO:1900544),-0.3074656616678246,-0.5899164642110836,0.9230769230769231,1.0,1.0,3/19,15.86%,IGF1;PFKFB3;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of glycolytic process (GO:0045821),-0.3074656616678246,-0.5899164642110836,0.9230769230769231,1.0,1.0,3/19,15.86%,IGF1;PFKFB3;ZBTB20
prerank,GO_Biological_Process_2021__regulation of sensory perception of pain (GO:0051930),-0.33300624291319225,-0.5888935342835615,0.9166666666666666,1.0,1.0,2/9,9.84%,SPX;VIP
prerank,GO_Biological_Process_2021__pseudouridine synthesis (GO:0001522),0.34847352859372255,0.5884716394098091,1.0,1.0,1.0,1/13,6.27%,TRUB1
prerank,GO_Biological_Process_2021__regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway (GO:1903376),0.38004436899239413,0.5883271886148783,0.9393939393939394,1.0,1.0,1/6,21.50%,NONO
prerank,GO_Biological_Process_2021__RNA splicing (GO:0008380),0.2524360942966713,0.5882917810878389,1.0,1.0,1.0,6/91,8.34%,SNRNP48;U2AF1;SLU7;NCBP1;NCBP2;PPARGC1A
prerank,GO_Biological_Process_2021__mRNA export from nucleus (GO:0006406),0.2542195525612357,0.5880957604243675,1.0,1.0,1.0,24/95,27.06%,NXT1;FYTTD1;U2AF1;SLU7;NCBP1;NCBP2;DDX39A;FIP1L1;THOC5;NUP54;CDC40;YTHDC1;POLR2D;SLBP;SARNP;NUP188;SRSF3;NUP85;EIF4A3;ALYREF;NUP58;SMG7;C12ORF50;RNPS1
prerank,GO_Biological_Process_2021__negative regulation of T cell activation (GO:0050868),0.293061863664314,0.5880767199078168,0.9857142857142858,1.0,1.0,8/24,27.19%,ARG1;PDCD1LG2;IL4I1;SFTPD;CD274;CD80;LAPTM5;FGL1
prerank,GO_Biological_Process_2021__regulation of dendritic cell apoptotic process (GO:2000668),0.37048605505994714,0.5876917691959305,0.9322033898305084,1.0,1.0,1/6,25.83%,LYN
prerank,GO_Biological_Process_2021__piRNA biosynthetic process (GO:1990511),-0.3607544196882969,-0.5874994329028698,0.975,1.0,1.0,1/5,6.42%,TEX15
prerank,GO_Biological_Process_2021__regulation of cytokinesis (GO:0032465),-0.23975965918677417,-0.5874908142279337,1.0,1.0,1.0,13/66,16.62%,CDC14B;AURKA;SVIL;PLK2;KIF23;CXCR5;MAP10;PRKCE;SH3GLB1;ENTR1;PLK3;ZFYVE26;RAB11FIP3
prerank,GO_Biological_Process_2021__sensory perception of chemical stimulus (GO:0007606),0.31409727091799505,0.5874730343620713,0.9565217391304348,1.0,1.0,1/15,5.88%,SLC24A4
prerank,GO_Biological_Process_2021__regulation of myeloid leukocyte mediated immunity (GO:0002886),0.3586415374859856,0.5873283757707005,0.9295774647887324,1.0,1.0,2/7,28.58%,LYN;SYK
prerank,GO_Biological_Process_2021__positive regulation of neuron migration (GO:2001224),-0.2902688773165849,-0.586855359900576,0.9615384615384616,1.0,1.0,3/13,12.12%,NSMF;SEMA6A;MDK
prerank,GO_Biological_Process_2021__regulation of protein sumoylation (GO:0033233),0.318913186285556,0.5866440730090683,0.9841269841269841,1.0,1.0,1/14,15.06%,GNL3
prerank,GO_Biological_Process_2021__positive regulation of G2/M transition of mitotic cell cycle (GO:0010971),0.3207397461552084,0.5864336064482744,1.0,1.0,1.0,4/18,21.08%,CDC25A;RAB11A;RAD51C;CDK4
prerank,GO_Biological_Process_2021__regulation of receptor internalization (GO:0002090),0.3045781305939435,0.5864249521799506,0.9692307692307692,1.0,1.0,3/29,13.23%,NTF3;SFRP4;LRPAP1
prerank,GO_Biological_Process_2021__MyD88-dependent toll-like receptor signaling pathway (GO:0002755),0.31285456607619166,0.5862940616646536,0.9393939393939394,1.0,1.0,4/23,21.70%,CD14;TAB2;TLR2;IRAK4
prerank,GO_Biological_Process_2021__regulation of sensory perception (GO:0051931),-0.3687632596752724,-0.5859929800021837,0.918918918918919,1.0,1.0,2/7,9.84%,SPX;VIP
prerank,GO_Biological_Process_2021__negative regulation of protein metabolic process (GO:0051248),-0.2559236936395704,-0.5857069062540079,1.0,1.0,1.0,5/39,12.89%,RILP;SIRT2;APOE;CLU;EGFR
prerank,GO_Biological_Process_2021__regulation of protein polymerization (GO:0032271),-0.2832861906544188,-0.5855049183695137,0.9512195121951219,1.0,1.0,1/31,1.52%,TPPP3
prerank,GO_Biological_Process_2021__positive regulation of intracellular protein transport (GO:0090316),0.2497932144897888,0.5854798238725536,1.0,1.0,1.0,19/127,21.22%,ARIH2;TCAF2;HSPA1L;TMEM30A;RIPOR1;CASP8;YWHAH;YWHAG;RHOU;TGFB1;AKAP5;ECT2;UBL5;PINK1;MIEF2;UBR5;PDZK1;BAD;TP63
prerank,GO_Biological_Process_2021__ribosomal large subunit biogenesis (GO:0042273),0.27101189082259014,0.5848445486422587,0.9705882352941176,1.0,1.0,16/51,34.50%,RPL26L1;NIP7;RSL24D1;WDR12;NOP53;RPL3;RPL35A;EIF6;ZNF622;RPL5;RPL7;MAK16;MRPL20;RPL24;PES1;MRPL1
prerank,GO_Biological_Process_2021__negative regulation of mRNA catabolic process (GO:1902373),-0.28085549105108637,-0.5840314172818095,1.0,1.0,1.0,4/25,15.43%,TENT5A;ELAVL1;VIP;CIRBP
prerank,GO_Biological_Process_2021__positive regulation of histone H4 acetylation (GO:0090240),0.389047546211728,0.58398788779436,0.9649122807017544,1.0,1.0,1/6,14.47%,BRCA1
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein catabolic process (GO:1902991),0.33826714072352787,0.5839836011960533,1.0,1.0,1.0,4/11,33.31%,CHRNA7;PRNP;TMED10;RANBP9
prerank,GO_Biological_Process_2021__cellular response to starvation (GO:0009267),0.247777305184594,0.5838796046151756,1.0,1.0,1.0,14/129,17.22%,STK26;DAPL1;LAMP2;HSPA5;RIPOR1;SESN3;ATP6V1B2;RNF152;FAS;NUAK2;HSPA8;ATP6V1C1;TBL2;PDK4
prerank,GO_Biological_Process_2021__programmed necrotic cell death (GO:0097300),0.34534206456514777,0.5836571501536313,0.9710144927536232,1.0,1.0,3/13,22.25%,CD14;IPMK;CYLD
prerank,GO_Biological_Process_2021__chromatin silencing at telomere (GO:0006348),-0.32896203432897486,-0.5836302835487138,0.8461538461538461,1.0,1.0,1/6,11.09%,SIRT2
prerank,GO_Biological_Process_2021__negative regulation of lipid localization (GO:1905953),-0.3501001086573987,-0.5834993987705503,0.85,1.0,1.0,1/5,18.50%,NR1H2
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte proliferation (GO:0010838),-0.3621013340596321,-0.5832305019214234,0.9354838709677419,1.0,1.0,2/7,12.12%,TGM1;MDK
prerank,GO_Biological_Process_2021__protein modification by small protein removal (GO:0070646),-0.21358888199052625,-0.5832095445428653,1.0,1.0,1.0,19/231,13.67%,IFIH1;USP27X;MBD6;TRAF3;OTUD3;TAF10;INO80D;BRCC3;SENP8;INO80;FOXK1;USP35;USP25;USP10;RCE1;USP51;OTUD5;YY1;USP4
prerank,GO_Biological_Process_2021__hexose transmembrane transport (GO:0008645),-0.2794620713049163,-0.5829291831615071,1.0,1.0,1.0,3/15,12.21%,SLC2A9;SLC2A11;SLC2A14
prerank,GO_Biological_Process_2021__regulation of cellular ketone metabolic process (GO:0010565),-0.26769062977991487,-0.5820080075551677,1.0,1.0,1.0,1/53,1.27%,FGFR4
prerank,GO_Biological_Process_2021__regulation of skeletal muscle cell differentiation (GO:2001014),-0.35830544220806015,-0.5817277140697379,0.8571428571428571,1.0,1.0,7/7,64.19%,MYOCD;DDX5;MEF2C;UQCC2;DDX17;GPC1;NR1D2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision, 5'-to lesion (GO:0006296)",0.28354190359623405,0.5810946884026069,0.9710144927536232,1.0,1.0,3/34,13.59%,RFC5;PCNA;RPA3
prerank,GO_Biological_Process_2021__gene silencing by miRNA (GO:0035195),-0.26045230102491496,-0.5809605906526494,1.0,1.0,1.0,4/30,18.46%,WTIP;TRIM71;TARBP2;XPO5
prerank,GO_Biological_Process_2021__regulation of Golgi organization (GO:1903358),-0.2869593137929453,-0.5804304451051627,0.9705882352941176,1.0,1.0,17/17,71.33%,STX18;EHD3;AKAP9;MAP2K1;MYO5A;MAP2K2;STX5;ARMH3;MAPK1;RBSN;MAPK3;CAMSAP2;USP6NL;CAMSAP3;PDE4DIP;RAB33B;PDCD10
prerank,GO_Biological_Process_2021__DNA-dependent DNA replication maintenance of fidelity (GO:0045005),-0.2535919669961317,-0.5803481534863564,1.0,1.0,1.0,7/37,13.80%,TIMELESS;SMARCAL1;RFWD3;THOC1;SLFN11;DDX11;BOD1L1
prerank,GO_Biological_Process_2021__myeloid cell activation involved in immune response (GO:0002275),0.36098970631315364,0.5801606043933137,0.9565217391304348,1.0,1.0,2/11,11.48%,DOCK2;PLCG2
prerank,GO_Biological_Process_2021__nucleus organization (GO:0006997),0.2759683427139636,0.5796395832130155,1.0,1.0,1.0,7/40,19.74%,CHMP4B;CHMP2B;CHMP1A;WDR73;CHMP2A;NUP54;SPAG4
prerank,GO_Biological_Process_2021__stress granule disassembly (GO:0035617),-0.39510530379598713,-0.5793482285043347,0.9024390243902439,1.0,1.0,1/5,18.17%,VCP
prerank,GO_Biological_Process_2021__regulation of cellular catabolic process (GO:0031329),0.2660416441428244,0.5790311886181682,1.0,1.0,1.0,14/62,25.34%,DEPP1;BOK;ITPR1;DAPK2;RAB8A;USP13;PSAP;PIP4K2C;LRRK2;GPR137B;RAB39B;GPR137;DCAF12;WDR41
prerank,GO_Biological_Process_2021__myelin assembly (GO:0032288),-0.29979530998542103,-0.5787301457191121,0.9047619047619048,1.0,1.0,1/10,7.21%,TENM4
prerank,GO_Biological_Process_2021__actin filament organization (GO:0007015),0.25220200005391386,0.5782615916566342,1.0,1.0,1.0,31/131,26.36%,RND1;ACTC1;HIP1R;CORO1A;MYO5B;WAS;ARHGAP25;RHOB;EPS8;RHOH;MYO1F;GHRL;TLE6;INPPL1;SHROOM3;TTN;SHROOM4;DMTN;RFLNB;OOEP;DLG1;GAS2;ELMO3;BAIAP2L1;RHOF;MYO1B;VILL;ENAH;TMOD1;FHOD3;CDC42
prerank,GO_Biological_Process_2021__mRNA transport (GO:0051028),0.2537365243080089,0.5779901125721402,1.0,1.0,1.0,20/93,24.87%,NXT1;FYTTD1;U2AF1;SLU7;NCBP1;NCBP2;DDX39A;FIP1L1;THOC5;NUP54;CDC40;YTHDC1;SLBP;SARNP;NUP188;SRSF3;NUP85;EIF4A3;ALYREF;NUP58
prerank,GO_Biological_Process_2021__nucleus localization (GO:0051647),-0.3215248934146734,-0.5779714224025856,0.9130434782608695,1.0,1.0,3/10,20.62%,KIF25;MTOR;SUN2
prerank,GO_Biological_Process_2021__regulation of leukocyte degranulation (GO:0043300),0.37047479496414537,0.5778518936568346,0.9428571428571428,1.0,1.0,2/6,28.58%,LYN;SYK
prerank,GO_Biological_Process_2021__nuclear RNA surveillance (GO:0071027),-0.32930566927837557,-0.577611937845778,0.9117647058823529,1.0,1.0,4/9,16.67%,EXOSC10;EXOSC7;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__eye morphogenesis (GO:0048592),-0.2792980645962326,-0.5772835960245966,0.9743589743589743,1.0,1.0,3/18,14.56%,ALDH1A3;STAT3;COL5A1
prerank,GO_Biological_Process_2021__negative regulation of macrophage cytokine production (GO:0010936),-0.35393757832256845,-0.5772241726160019,0.8979591836734694,1.0,1.0,2/5,9.80%,TGFB2;TGFB3
prerank,GO_Biological_Process_2021__neuron projection arborization (GO:0140058),0.3668119406632342,0.5771791111687724,0.9206349206349206,1.0,1.0,2/6,25.62%,CHRNA7;LRP2
prerank,GO_Biological_Process_2021__negative regulation of translation (GO:0017148),0.24648426045788743,0.5771258549538398,1.0,1.0,1.0,19/83,26.38%,ENC1;IGFBP5;PATL2;RNF139;C8ORF88;PAIP2B;EPRS1;FXR1;CALR;EIF3E;RIDA;YTHDF1;EIF4E2;EIF4A3;DDX6;CNOT7;METTL14;PAIP2;PUM1
prerank,GO_Biological_Process_2021__positive regulation of DNA methylation-dependent heterochromatin assembly (GO:0090309),0.3233826520821543,0.5769924093827565,1.0,1.0,1.0,1/11,13.39%,ZNF304
prerank,GO_Biological_Process_2021__response to sterol (GO:0036314),0.3447916258814683,0.5767905628720986,0.9523809523809523,1.0,1.0,2/8,19.15%,TGFB1;INSIG1
prerank,GO_Biological_Process_2021__telomere maintenance via telomerase (GO:0007004),0.30175452957530274,0.5762631640294603,0.9516129032258065,1.0,1.0,4/26,25.65%,MRE11;TERF2IP;RAD50;GAR1
prerank,GO_Biological_Process_2021__positive regulation of telomere maintenance (GO:0032206),-0.2577881726911547,-0.5761135239914588,0.9655172413793104,1.0,1.0,5/27,16.96%,ERCC1;PNKP;NAF1;PML;ATM
prerank,GO_Biological_Process_2021__regulation of chemokine-mediated signaling pathway (GO:0070099),-0.30430994956442,-0.5760313487574659,0.9117647058823529,1.0,1.0,8/8,69.58%,RNF113A;EDN1;SLIT3;PADI2;SH2B3;HIF1A;ROBO1;SLIT2
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle exocytosis (GO:2000300),0.3147163497357691,0.5755171665806861,1.0,1.0,1.0,5/19,31.89%,LRRK2;FMR1;RAB5A;RAB3GAP1;PREPL
prerank,GO_Biological_Process_2021__axonal transport of mitochondrion (GO:0019896),-0.30247168340441144,-0.5754338892818729,0.95,1.0,1.0,11/11,69.77%,MGARP;TRAK1;TRAK2;SPAST;ACTR10;MAPT;OPA1;HAP1;HIF1A;SYBU;NEFL
prerank,GO_Biological_Process_2021__regulation of amyloid fibril formation (GO:1905906),0.31995351310038783,0.5752325449980736,0.9473684210526315,1.0,1.0,2/12,17.34%,VBP1;CHRNA7
prerank,GO_Biological_Process_2021__negative regulation of chemokine-mediated signaling pathway (GO:0070100),-0.32606927417640647,-0.5750997057707432,0.9411764705882353,1.0,1.0,1/6,16.23%,RNF113A
prerank,GO_Biological_Process_2021__canonical Wnt signaling pathway (GO:0060070),0.25755570872486055,0.5750136006845945,0.9852941176470589,1.0,1.0,3/56,10.51%,WNT8A;SFRP4;TCF7L1
prerank,GO_Biological_Process_2021__cytoplasmic sequestering of protein (GO:0051220),0.32725667190923063,0.5744596004253426,0.9571428571428572,1.0,1.0,6/11,34.70%,DBN1;KEAP1;NFKBIA;YWHAB;NFKBIE;PKD1
prerank,GO_Biological_Process_2021__rRNA processing (GO:0006364),-0.21170328293720742,-0.5741485337757216,1.0,1.0,1.0,20/163,16.95%,RRP1B;LYAR;NVL;RRP7A;LSM6;TBL3;SRFBP1;EXOSC10;DDX27;NOP14;WDR46;EXOSC7;EXOSC1;NOC4L;EXOSC5;BOP1;RPL12;EXOSC4;NOL8;WDR75
prerank,GO_Biological_Process_2021__positive regulation of mRNA processing (GO:0050685),0.31793105347004763,0.5740649017456014,0.9508196721311475,1.0,1.0,3/20,15.22%,NCBP1;NCBP2;PRDX6
prerank,GO_Biological_Process_2021__negative regulation of receptor signaling pathway via JAK-STAT (GO:0046426),0.333096512995399,0.5739755108691028,0.971830985915493,1.0,1.0,3/11,32.22%,INPP5F;ADIPOR1;NF2
prerank,GO_Biological_Process_2021__negative regulation of DNA biosynthetic process (GO:2000279),0.28040169361125966,0.5724531225428751,0.984375,1.0,1.0,2/24,16.37%,DACH1;DCP2
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced cell death (GO:1903202),0.30940794851603204,0.5718739929968545,0.9583333333333334,1.0,1.0,5/24,22.10%,SOD2;REST;PINK1;LRRK2;FBXO7
prerank,GO_Biological_Process_2021__monoubiquitinated protein deubiquitination (GO:0035520),-0.3581514762516046,-0.5714021673747847,0.9722222222222222,1.0,1.0,6/6,64.20%,USP47;USP15;BAP1;USP7;USP1;ATXN3
prerank,GO_Biological_Process_2021__positive regulation of trophoblast cell migration (GO:1901165),-0.35703479576399394,-0.5713409127149497,0.9069767441860465,1.0,1.0,5/5,64.31%,AGO2;VEGFA;ACVR1B;C1QBP;SMURF2
prerank,GO_Biological_Process_2021__cell projection organization (GO:0030030),0.291124357589854,0.5711781431115563,0.9701492537313433,1.0,1.0,4/26,17.93%,P2RY12;RHOH;RHOU;NEFH
prerank,GO_Biological_Process_2021__organic cyclic compound biosynthetic process (GO:1901362),0.31012485396963313,0.5706950466388587,0.9558823529411765,1.0,1.0,3/22,16.52%,PRLR;CYP19A1;MOCS2
prerank,GO_Biological_Process_2021__Roundabout signaling pathway (GO:0035385),-0.3587215171030202,-0.5706243517778901,0.9130434782608695,1.0,1.0,1/5,16.69%,MYO9B
prerank,GO_Biological_Process_2021__xenobiotic transport (GO:0042908),0.31987307740570886,0.5704185238759502,0.9682539682539683,1.0,1.0,3/18,12.89%,ABCC2;ABCB1;ABCG2
prerank,GO_Biological_Process_2021__nucleoside diphosphate catabolic process (GO:0009134),-0.32682255845942226,-0.5704123502790989,0.9473684210526315,1.0,1.0,8/8,67.33%,NUDT5;ENTPD2;ENTPD6;ENTPD3;ENTPD1;ENTPD5;ENTPD4;ENTPD7
prerank,GO_Biological_Process_2021__purine nucleoside bisphosphate biosynthetic process (GO:0034033),0.3432592993182194,0.5701688446812553,0.921875,1.0,1.0,3/11,22.06%,COASY;PPCS;ACAT1
prerank,GO_Biological_Process_2021__coenzyme A biosynthetic process (GO:0015937),0.3432592993182194,0.5701688446812553,0.921875,1.0,1.0,3/11,22.06%,COASY;PPCS;ACAT1
prerank,GO_Biological_Process_2021__ribonucleoside bisphosphate biosynthetic process (GO:0034030),0.3432592993182194,0.5701688446812553,0.921875,1.0,1.0,3/11,22.06%,COASY;PPCS;ACAT1
prerank,MSigDB_Hallmark_2020__Spermatogenesis,0.2541699677247376,0.5700282532983864,1.0,1.0,1.0,28/94,30.96%,CLGN;HSPA1L;MEP1B;GAD1;GSG1;ZC2HC1C;HSPA4L;PEBP1;NEFH;PSMG1;ZPBP;ARL4A;EZH2;CDKN3;SLC2A5;ACRV1;JAM3;CCNB2;VDAC3;PACRG;PCSK1N;SLC12A2;IL12RB2;TALDO1;SHE;NOS1;TOPBP1;DDX4
prerank,GO_Biological_Process_2021__positive regulation of carbohydrate metabolic process (GO:0045913),-0.2933728410397297,-0.5695869697273523,0.975,1.0,1.0,3/22,15.86%,IGF1;PFKFB3;ZBTB20
prerank,GO_Biological_Process_2021__positive regulation of neuron projection arborization (GO:0150012),-0.3167354424575883,-0.5691736216885189,0.9523809523809523,1.0,1.0,8/8,68.34%,MAP3K13;DVL2;GRIP1;FZD4;WNT5A;DVL3;DLG4;DVL1
prerank,GO_Biological_Process_2021__basic amino acid transport (GO:0015802),-0.31693491043928657,-0.5685326596553156,0.9523809523809523,1.0,1.0,1/8,7.99%,SLC7A1
prerank,GO_Biological_Process_2021__toll-like receptor 9 signaling pathway (GO:0034162),-0.2887022499403612,-0.5680621267672571,0.9473684210526315,1.0,1.0,4/9,24.51%,EPG5;IRAK2;PIK3AP1;PIK3C3
prerank,GO_Biological_Process_2021__positive regulation of transport (GO:0051050),0.26016703616585923,0.5675193426411758,1.0,1.0,1.0,5/64,11.68%,IL15;DOCK2;BOK;HIP1R;MLC1
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine biosynthetic process (GO:0006048),0.3317071757492865,0.567501087424066,0.9672131147540983,1.0,1.0,5/11,32.23%,GNPDA1;GFPT2;UAP1;PGM3;GNPNAT1
prerank,GO_Biological_Process_2021__nuclear mRNA surveillance (GO:0071028),-0.3249748528019127,-0.5674627053319433,0.9393939393939394,1.0,1.0,4/10,16.67%,EXOSC10;EXOSC7;EXOSC5;EXOSC4
prerank,GO_Biological_Process_2021__negative regulation of ERAD pathway (GO:1904293),0.3539462102399571,0.5673327787204199,0.9629629629629629,1.0,1.0,3/6,31.52%,USP14;SVIP;AQP11
prerank,GO_Biological_Process_2021__ribosomal small subunit biogenesis (GO:0042274),-0.25526218857557414,-0.5672687167311846,1.0,1.0,1.0,5/37,11.22%,RRP7A;LSM6;SRFBP1;NOM1;NOP14
prerank,GO_Biological_Process_2021__retrograde axonal transport (GO:0008090),-0.3025410512796991,-0.5666159363451081,0.9534883720930233,1.0,1.0,16/16,69.77%,KIF1A;MGARP;ACTR10;HAP1;KIF5B;PAFAH1B1;DLG2;DST;DYNC1H1;TMEM108;KIF5A;SOD1;KIF1C;FBXW11;MAP1A;NEFL
prerank,GO_Biological_Process_2021__regulation of phosphatidylinositol biosynthetic process (GO:0010511),0.35457212174297836,0.566180623832034,0.9076923076923077,1.0,1.0,1/5,16.04%,HTR2B
prerank,GO_Biological_Process_2021__UDP-N-acetylglucosamine metabolic process (GO:0006047),0.3246187219150244,0.566064606763897,0.967741935483871,1.0,1.0,5/12,32.23%,GNPDA1;GFPT2;UAP1;PGM3;GNPNAT1
prerank,GO_Biological_Process_2021__cation homeostasis (GO:0055080),0.38117766363268113,0.5660617978463985,0.9692307692307692,1.0,1.0,1/6,17.89%,COX11
prerank,GO_Biological_Process_2021__synaptic vesicle fusion to presynaptic active zone membrane (GO:0031629),-0.29694031632658324,-0.5658646184485129,0.975,1.0,1.0,2/10,15.14%,SNAP29;STX4
prerank,GO_Biological_Process_2021__regulation of vascular associated smooth muscle cell apoptotic process (GO:1905459),-0.3352768710726272,-0.5652642695238483,0.96875,1.0,1.0,2/7,11.28%,IGF1;DNMT1
prerank,GO_Biological_Process_2021__intestinal lipid absorption (GO:0098856),0.34548612936778134,0.5650887602474072,0.9622641509433962,1.0,1.0,2/8,28.15%,ABCG5;CD36
prerank,GO_Biological_Process_2021__regulation of gastrulation (GO:0010470),-0.30430970758418696,-0.5650510801900485,0.9459459459459459,1.0,1.0,1/10,7.21%,TENM4
prerank,GO_Biological_Process_2021__endochondral ossification (GO:0001958),0.3670960231053835,0.565036332537957,0.967741935483871,1.0,1.0,2/6,16.56%,INPPL1;SCX
prerank,GO_Biological_Process_2021__positive regulation of cell adhesion (GO:0045785),0.2542229659571018,0.5648984642932974,1.0,1.0,1.0,12/59,23.55%,CCL5;P2RY12;ECM2;NDNF;SMAD7;NODAL;FBLN2;TNFSF18;FRMD5;VIT;RNASE10;ADGRG1
prerank,GO_Biological_Process_2021__dopaminergic neuron differentiation (GO:0071542),-0.34468848691074994,-0.564440849495256,0.9565217391304348,1.0,1.0,3/11,22.33%,WNT9B;NR4A2;LRP6
prerank,GO_Biological_Process_2021__cellular response to amino acid stimulus (GO:0071230),0.28435406051653833,0.5640182240955143,0.9852941176470589,1.0,1.0,8/33,29.68%,SESN3;GLRA1;LAMTOR3;RRAGD;LAMTOR2;RRAGA;LAMTOR5;SPAAR
prerank,GO_Biological_Process_2021__negative regulation of alcohol biosynthetic process (GO:1902931),0.32968940948181313,0.5637032644095598,0.96,1.0,1.0,3/9,26.80%,REST;ERLIN1;DKK3
prerank,GO_Biological_Process_2021__positive regulation of insulin secretion (GO:0032024),0.28240101542992657,0.5631732722288052,1.0,1.0,1.0,6/31,23.14%,SLC30A8;GPER1;GHRL;C2CD2L;BAD;DOC2B
prerank,GO_Biological_Process_2021__establishment of centrosome localization (GO:0051660),0.37122246140875403,0.563109100231465,0.9821428571428571,1.0,1.0,2/6,27.73%,DLG1;MAD2L1
prerank,GO_Biological_Process_2021__very long-chain fatty acid biosynthetic process (GO:0042761),0.3247394078277851,0.5627626915043737,0.9710144927536232,1.0,1.0,2/11,11.55%,ELOVL2;HACD4
prerank,GO_Biological_Process_2021__response to muramyl dipeptide (GO:0032495),-0.33548433573791414,-0.5622426935388647,0.9473684210526315,1.0,1.0,1/10,6.24%,NLRP1
prerank,GO_Biological_Process_2021__calcium ion export (GO:1901660),0.35886463313619255,0.5620931898025818,0.9482758620689655,1.0,1.0,2/7,23.11%,LETM1;ATP2B4
prerank,GO_Biological_Process_2021__retinal ganglion cell axon guidance (GO:0031290),-0.3299703314164372,-0.5618613558827562,0.90625,1.0,1.0,1/6,11.13%,NRP1
prerank,GO_Biological_Process_2021__negative regulation of hydrogen peroxide-induced cell death (GO:1903206),0.3398081685774824,0.5614907387691931,0.9452054794520548,1.0,1.0,2/12,20.42%,HGF;LRRK2
prerank,GO_Biological_Process_2021__cellular component assembly (GO:0022607),0.23150753495229826,0.5612440989355413,1.0,1.0,1.0,31/219,21.65%,ANKS4B;RP1;WASF1;PPARGC1A;SLC2A1;STAG3;WAS;FAS;PPID;EPS8;M1AP;RHOH;RHOU;VCPIP1;MITF;TGFB1;SYCP2;TUBGCP4;GPAA1;TSPAN4;CFAP74;LRGUK;NEFH;PAWR;EPRS1;CD74;CHAF1A;HAS3;DMTN;FLNC;REPS2
prerank,GO_Biological_Process_2021__regulation of lysosomal lumen pH (GO:0035751),-0.3397842382687343,-0.5608862540144511,0.918918918918919,1.0,1.0,1/8,5.88%,CLN6
prerank,GO_Biological_Process_2021__embryonic heart tube development (GO:0035050),0.3555164656259712,0.5608519242293217,0.9508196721311475,1.0,1.0,4/7,36.70%,RYR2;MESP1;NDRG4;CITED2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA incision (GO:0033683)",0.27287770642408526,0.560753932586049,1.0,1.0,1.0,3/36,13.59%,RFC5;PCNA;RPA3
prerank,GO_Biological_Process_2021__peptidyl-amino acid modification (GO:0018193),-0.33348904177461053,-0.560624428787171,0.926829268292683,1.0,1.0,3/7,15.04%,APOA1;FKBP7;METAP2
prerank,GO_Biological_Process_2021__replicative senescence (GO:0090399),-0.3033192241737656,-0.5603892395579407,1.0,1.0,1.0,4/11,25.70%,MME;ATM;CHEK2;ATR
prerank,GO_Biological_Process_2021__regulation of clathrin-dependent endocytosis (GO:2000369),0.3195584563944677,0.5599531522727496,0.9705882352941176,1.0,1.0,1/13,7.96%,HIP1R
prerank,GO_Biological_Process_2021__nucleoside triphosphate metabolic process (GO:0009141),0.33756027332432487,0.5597623426437778,0.9701492537313433,1.0,1.0,3/13,18.00%,CMPK2;DCTPP1;AK4
prerank,GO_Biological_Process_2021__endochondral bone morphogenesis (GO:0060350),0.33504302542004394,0.5595219048003278,0.9402985074626866,1.0,1.0,2/9,16.56%,INPPL1;SCX
prerank,GO_Biological_Process_2021__intestinal cholesterol absorption (GO:0030299),0.3492511449864279,0.5593753066559882,0.9615384615384616,1.0,1.0,2/7,28.15%,ABCG5;CD36
prerank,GO_Biological_Process_2021__deadenylation-independent decapping of nuclear-transcribed mRNA (GO:0031087),-0.3489203685875395,-0.558673047847368,0.9230769230769231,1.0,1.0,5/5,65.12%,DCP1A;DCP1B;EDC4;EDC3;PNRC2
prerank,"GO_Biological_Process_2021__endonucleolytic cleavage in ITS1 to separate SSU-rRNA from 5.8S rRNA and LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000447)",0.3523509686952897,0.5586700018154984,0.9636363636363636,1.0,1.0,2/7,15.56%,ABT1;RPS21
prerank,GO_Biological_Process_2021__negative regulation of translational initiation (GO:0045947),-0.28021270598952697,-0.5584982653522025,0.9705882352941176,1.0,1.0,2/13,8.31%,TPR;EIF4EBP1
prerank,GO_Biological_Process_2021__adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002460),0.3108658260322082,0.5583743415607308,1.0,1.0,1.0,1/14,4.03%,CD8A
prerank,GO_Biological_Process_2021__positive regulation of cell cycle G1/S phase transition (GO:1902808),-0.2524127330167698,-0.5578405849339506,1.0,1.0,1.0,6/29,14.41%,LSM10;TFDP1;FAM83D;EIF4G1;EGFR;RPTOR
prerank,GO_Biological_Process_2021__positive regulation of vascular permeability (GO:0043117),-0.33096102400805316,-0.5577542801087126,0.925,1.0,1.0,2/11,7.62%,PDE3A;BMP6
prerank,GO_Biological_Process_2021__telomere maintenance via telomere lengthening (GO:0010833),-0.26169855977877887,-0.557154621750781,1.0,1.0,1.0,2/31,9.92%,DCLRE1B;TELO2
prerank,GO_Biological_Process_2021__establishment of protein localization to endoplasmic reticulum (GO:0072599),0.3149672323424569,0.5569626040591292,0.9846153846153847,1.0,1.0,6/17,33.73%,MAN1A1;SPCS3;RYR2;RAB3GAP1;SRP14;RAB3GAP2
prerank,GO_Biological_Process_2021__organelle fusion (GO:0048284),0.29285875351957896,0.5566937338297814,0.9545454545454546,1.0,1.0,6/21,32.25%,MIEF2;MIGA1;THG1L;MIEF1;MFN1;BAX
prerank,GO_Biological_Process_2021__cellular response to ketone (GO:1901655),-0.2504807496250428,-0.5564075631350283,1.0,1.0,1.0,4/33,9.78%,SFRP1;SPHK2;DCPS;AKR1C3
prerank,GO_Biological_Process_2021__regulation of DNA damage checkpoint (GO:2000001),-0.3192450295401843,-0.5557996657615557,0.95,1.0,1.0,2/9,10.01%,RFWD3;THOC1
prerank,GO_Biological_Process_2021__tRNA thio-modification (GO:0034227),-0.3716591023701462,-0.5554530233963167,0.9736842105263158,1.0,1.0,5/5,62.85%,CTU1;URM1;TRMU;CTU2;MOCS3
prerank,GO_Biological_Process_2021__very long-chain fatty acid catabolic process (GO:0042760),-0.3252872660810401,-0.5550885843021518,0.9333333333333333,1.0,1.0,3/7,19.94%,ABCD1;SLC27A2;ABCD2
prerank,GO_Biological_Process_2021__negative regulation of sodium ion transport (GO:0010766),0.35396816396358716,0.5539942430584804,0.9661016949152542,1.0,1.0,1/7,15.38%,CAMK2D
prerank,GO_Biological_Process_2021__positive regulation of SMAD protein signal transduction (GO:0060391),-0.3122265814589521,-0.5538545177472328,0.9714285714285714,1.0,1.0,3/11,16.59%,BMP6;TGFB3;TGFBR1
prerank,"GO_Biological_Process_2021__exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000467)",0.34036703721209466,0.5537321462670013,0.9571428571428572,1.0,1.0,1/8,10.70%,EXOSC8
prerank,GO_Biological_Process_2021__exonucleolytic trimming involved in rRNA processing (GO:0000459),0.34036703721209466,0.5537321462670013,0.9571428571428572,1.0,1.0,1/8,10.70%,EXOSC8
prerank,GO_Biological_Process_2021__vesicle tethering to Golgi (GO:0099041),-0.3337459313253564,-0.5535592899330751,0.8958333333333334,1.0,1.0,5/5,66.64%,TRIP11;TBC1D23;C17ORF75;FAM91A1;WDR11
prerank,GO_Biological_Process_2021__regulation of ubiquitin-protein transferase activity (GO:0051438),0.29791224223592744,0.5534219450650868,1.0,1.0,1.0,4/25,18.83%,ARRDC3;SMAD7;PINK1;DCUN1D1
prerank,MSigDB_Hallmark_2020__Unfolded Protein Response,-0.21400368341864393,-0.5529351854988711,1.0,1.0,1.0,21/105,18.90%,IARS1;KHSRP;MTHFD2;ATF3;EIF4EBP1;EIF4G1;EXOSC10;NOP14;SRPRB;BAG3;PSAT1;EXOSC1;EXOSC5;ARFGAP1;SEC11A;DNAJC3;EXOSC4;EXOC2;SRPRA;PDIA5;SDAD1
prerank,GO_Biological_Process_2021__ribosome biogenesis (GO:0042254),-0.19817759290247774,-0.5528216701545974,1.0,1.0,1.0,22/181,16.95%,RRP1B;LYAR;NVL;URB2;RRP7A;TBL3;EXOSC10;DDX27;NOM1;NOP14;WDR46;EXOSC7;EXOSC1;NOC4L;EXOSC5;NAF1;CUL4A;BOP1;RPL12;EXOSC4;NOL8;WDR75
prerank,GO_Biological_Process_2021__regulation of myeloid cell differentiation (GO:0045637),-0.2364266695579035,-0.552799902399767,1.0,1.0,1.0,9/53,18.24%,RUNX1;HDAC1;CBFB;NR4A3;PRKCB;PRMT6;KMT2B;SIN3A;CREBBP
prerank,GO_Biological_Process_2021__secretion (GO:0046903),0.3257478230685217,0.552682889978386,0.9571428571428572,1.0,1.0,2/11,13.12%,FBLN5;DRD3
prerank,GO_Biological_Process_2021__response to UV (GO:0009411),0.23570998754663638,0.5524794703179751,1.0,1.0,1.0,5/83,9.64%,ELANE;TRIM32;CDKN2D;CDC25A;COPS9
prerank,"GO_Biological_Process_2021__maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA) (GO:0000466)",0.2888044013125901,0.5524076561360826,1.0,1.0,1.0,3/20,15.56%,ABT1;EXOSC8;RPS21
prerank,GO_Biological_Process_2021__peptidyl-glutamic acid modification (GO:0018200),0.29444605633023857,0.551592324373918,0.9692307692307692,1.0,1.0,3/19,16.92%,TTLL4;AGBL5;TPGS1
prerank,GO_Biological_Process_2021__leukotriene transport (GO:0071716),0.3669036598532823,0.5512534692042746,0.9841269841269841,1.0,1.0,1/7,4.11%,ABCC2
prerank,GO_Biological_Process_2021__oogenesis (GO:0048477),0.3169435103375201,0.5509808235683519,0.9705882352941176,1.0,1.0,1/13,10.74%,IHO1
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated immune response to tumor cell (GO:0002857),-0.3501865571723586,-0.5506574858958071,0.9545454545454546,1.0,1.0,3/5,32.03%,PVR;NECTIN2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002860),-0.3501865571723586,-0.5506574858958071,0.9545454545454546,1.0,1.0,3/5,32.03%,PVR;NECTIN2;IL12A
prerank,GO_Biological_Process_2021__positive regulation of MHC class II biosynthetic process (GO:0045348),0.37303458208214446,0.5506508707238436,0.9523809523809523,1.0,1.0,1/6,8.74%,CIITA
prerank,GO_Biological_Process_2021__maintenance of apical/basal cell polarity (GO:0035090),0.32873625209129653,0.5504253186865351,0.9818181818181818,1.0,1.0,5/8,33.10%,LIN7C;WDR1;PDZD11;LIN7B;CRB2
prerank,GO_Biological_Process_2021__maintenance of epithelial cell apical/basal polarity (GO:0045199),0.32873625209129653,0.5504253186865351,0.9818181818181818,1.0,1.0,5/8,33.10%,LIN7C;WDR1;PDZD11;LIN7B;CRB2
prerank,GO_Biological_Process_2021__contact inhibition (GO:0060242),-0.3320567020847564,-0.5503742459493439,0.9444444444444444,1.0,1.0,2/6,20.42%,CDHR2;PTPRJ
prerank,GO_Biological_Process_2021__glycolipid transport (GO:0046836),-0.3289250354526675,-0.5498619477770548,0.9666666666666667,1.0,1.0,1/6,10.38%,RFT1
prerank,GO_Biological_Process_2021__establishment of protein localization to plasma membrane (GO:0061951),0.2756915684189645,0.5493716916757524,1.0,1.0,1.0,1/31,5.93%,AMN
prerank,GO_Biological_Process_2021__regulation of small GTPase mediated signal transduction (GO:0051056),0.23041614792171447,0.5493700863102073,1.0,1.0,1.0,15/118,17.21%,PREX1;DEPDC1B;TAGAP;ARHGAP9;ARHGAP25;RHOB;ARHGAP10;RHOH;RHOU;A2M;ECT2;ARHGAP28;RACGAP1;FAM13B;CHN1
prerank,GO_Biological_Process_2021__establishment or maintenance of epithelial cell apical/basal polarity (GO:0045197),0.2721419443405121,0.5486605759588881,1.0,1.0,1.0,13/29,39.36%,MSN;LIN7C;DLG1;CRB1;CDC42;WDR1;PDZD11;LIN7B;CRB2;CAMSAP3;PDCD6IP;ERBIN;PRKCI
prerank,GO_Biological_Process_2021__ribonucleoprotein complex biogenesis (GO:0022613),-0.23099589683781974,-0.5485897028357374,1.0,1.0,1.0,12/57,20.96%,NVL;URB2;NOM1;NOP14;NAF1;CUL4A;BOP1;BYSL;SDAD1;RIOK1;NOP16;RRP36
prerank,GO_Biological_Process_2021__peptidyl-cysteine modification (GO:0018198),0.3418706606123312,0.5479490652063334,0.9666666666666667,1.0,1.0,5/7,42.13%,NOS1;TMX3;PRDX3;PARK7;CHCHD4
prerank,GO_Biological_Process_2021__protein export from nucleus (GO:0006611),0.2846853320066276,0.5479343053512609,0.9864864864864865,1.0,1.0,6/26,22.10%,STRADA;TGFB1;STRADB;DUSP16;CALR;ANKLE1
prerank,GO_Biological_Process_2021__long-chain fatty acid import into cell (GO:0044539),0.32635600890231936,0.5479129893815876,0.96875,1.0,1.0,1/10,8.93%,SLC2A1
prerank,GO_Biological_Process_2021__regulation of non-motile cilium assembly (GO:1902855),0.3561743705765635,0.5478432355251921,0.9516129032258065,1.0,1.0,1/6,23.08%,SEPTIN9
prerank,GO_Biological_Process_2021__positive regulation by symbiont of host autophagy (GO:0075044),0.3253028353330053,0.5477050590768946,0.9622641509433962,1.0,1.0,1/6,20.25%,ULK1
prerank,GO_Biological_Process_2021__regulation of protein autoubiquitination (GO:1902498),-0.3576784059429562,-0.547503823506413,0.9512195121951219,1.0,1.0,1/6,10.09%,TAF1
prerank,GO_Biological_Process_2021__negative regulation of cell activation (GO:0050866),-0.30319767369449846,-0.5472163274171291,0.9487179487179487,1.0,1.0,2/10,11.15%,PDGFRA;APOE
prerank,"GO_Biological_Process_2021__positive regulation of DNA-templated transcription, elongation (GO:0032786)",0.2975519083806709,0.5466727760977474,0.9696969696969697,1.0,1.0,2/22,15.30%,BTBD18;THOC5
prerank,GO_Biological_Process_2021__positive regulation of toll-like receptor 9 signaling pathway (GO:0034165),-0.3346628157520744,-0.5466080122536828,0.9361702127659575,1.0,1.0,5/5,66.55%,RSAD2;SLC15A4;HMGB1;PTPN22;RTN4
prerank,GO_Biological_Process_2021__regulation of short-term neuronal synaptic plasticity (GO:0048172),0.30529348455292604,0.5465990171594903,0.9814814814814815,1.0,1.0,6/13,45.15%,SHISA8;RAB3GAP1;SHISA6;SYP;SLC4A10;SHISA9
prerank,GO_Biological_Process_2021__protein-containing complex disassembly (GO:0032984),0.26651782286115383,0.5465955327387817,1.0,1.0,1.0,3/45,8.97%,WNT8A;LAMP2;LIX1L
prerank,GO_Biological_Process_2021__negative regulation of coagulation (GO:0050819),0.30763143855693903,0.5465497949721986,0.9454545454545454,1.0,1.0,1/11,7.75%,KNG1
prerank,GO_Biological_Process_2021__cellular response to catecholamine stimulus (GO:0071870),-0.2674658276483768,-0.5465243896981297,1.0,1.0,1.0,3/21,11.93%,DRD1;SIRT2;NR4A3
prerank,GO_Biological_Process_2021__mitochondrial genome maintenance (GO:0000002),0.3147946997451959,0.5460945906887142,0.9384615384615385,1.0,1.0,4/12,27.12%,MGME1;MEF2A;SLC25A4;LONP1
prerank,GO_Biological_Process_2021__regulation of DNA recombination at telomere (GO:0072695),-0.28191188162121544,-0.5457179307229388,1.0,1.0,1.0,3/20,14.66%,POLR2G;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__negative regulation of DNA recombination at telomere (GO:0048239),-0.28191188162121544,-0.5457179307229388,1.0,1.0,1.0,3/20,14.66%,POLR2G;POLR2C;POLR2L
prerank,GO_Biological_Process_2021__translocation of molecules into host (GO:0044417),0.3495056647858007,0.5456432568084385,0.96875,1.0,1.0,2/7,24.08%,THOC5;ALYREF
prerank,GO_Biological_Process_2021__viral mRNA export from host cell nucleus (GO:0046784),0.3495056647858007,0.5456432568084385,0.96875,1.0,1.0,2/7,24.08%,THOC5;ALYREF
prerank,GO_Biological_Process_2021__regulation of striated muscle tissue development (GO:0016202),0.3584720366003425,0.5449901261853318,0.9818181818181818,1.0,1.0,1/7,13.78%,TGFB1
prerank,GO_Biological_Process_2021__positive regulation of muscle hypertrophy (GO:0014742),0.3133978974629946,0.5448973439759717,0.967741935483871,1.0,1.0,5/14,26.97%,AGT;CAMK2D;MEF2A;IL6ST;SLC9A1
prerank,GO_Biological_Process_2021__rRNA metabolic process (GO:0016072),-0.19718366351127753,-0.5446805450973656,1.0,1.0,1.0,18/150,16.95%,RRP1B;LYAR;NVL;RRP7A;TBL3;EXOSC10;DDX27;NOP14;WDR46;EXOSC7;EXOSC1;NOC4L;EXOSC5;BOP1;RPL12;EXOSC4;NOL8;WDR75
prerank,GO_Biological_Process_2021__RNA-dependent DNA biosynthetic process (GO:0006278),0.2795469935602192,0.544170304058534,0.984375,1.0,1.0,4/27,25.65%,MRE11;TERF2IP;RAD50;GAR1
prerank,GO_Biological_Process_2021__RNA biosynthetic process (GO:0032774),0.2816803299190058,0.5439109769182555,1.0,1.0,1.0,3/29,11.60%,TBP;TBPL1;HELB
prerank,GO_Biological_Process_2021__positive regulation of peptidase activity (GO:0010952),-0.28026534444840956,-0.5438122080894909,0.9375,1.0,1.0,2/16,8.36%,CLDN4;NCSTN
prerank,GO_Biological_Process_2021__pexophagy (GO:0000425),0.34484379076314675,0.543736470437703,0.9375,1.0,1.0,2/7,23.27%,MAP1LC3B;PEX5
prerank,GO_Biological_Process_2021__regulation of insulin-like growth factor receptor signaling pathway (GO:0043567),0.31541823436452787,0.5432163915874431,1.0,1.0,1.0,2/13,15.28%,IGFBP5;MYORG
prerank,GO_Biological_Process_2021__negative regulation of nucleocytoplasmic transport (GO:0046823),0.32230722668041367,0.5431510165515139,1.0,1.0,1.0,2/13,11.23%,UFM1;RAB23
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase III (GO:0042796),0.3412976413165788,0.5426486856193147,0.9104477611940298,1.0,1.0,1/8,20.67%,SNAPC1
prerank,GO_Biological_Process_2021__regulation of type B pancreatic cell development (GO:2000074),0.3382648897873203,0.542254370040689,0.9491525423728814,1.0,1.0,2/7,33.20%,BAD;AKT1
prerank,GO_Biological_Process_2021__cytoplasmic microtubule organization (GO:0031122),0.24920419296276006,0.5415142836463357,1.0,1.0,1.0,11/53,28.86%,FIGNL1;WDR73;TUBGCP4;RAB11A;TRDN;DLG1;CCDC88B;HOOK2;CRIPT;KATNA1;FIGNL2
prerank,GO_Biological_Process_2021__modification-dependent macromolecule catabolic process (GO:0043632),-0.31643460635191095,-0.540959579024486,0.9411764705882353,1.0,1.0,3/9,28.75%,DIS3L2;CHFR;TUT4
prerank,GO_Biological_Process_2021__chondroitin sulfate proteoglycan metabolic process (GO:0050654),0.3330465850451859,0.5404983481428451,0.9454545454545454,1.0,1.0,2/10,11.45%,CSGALNACT1;XYLT1
prerank,GO_Biological_Process_2021__excitatory chemical synaptic transmission (GO:0098976),-0.337050573602372,-0.5396988120348862,0.975,1.0,1.0,2/7,11.27%,GRIN2A;GRIN2C
prerank,GO_Biological_Process_2021__positive regulation of neutrophil chemotaxis (GO:0090023),-0.2719000824368813,-0.5396936678679599,0.9696969696969697,1.0,1.0,4/13,18.16%,RIPOR2;MOSPD2;MDK;MCU
prerank,GO_Biological_Process_2021__positive regulation of granulocyte chemotaxis (GO:0071624),-0.2719000824368813,-0.5396936678679599,0.9696969696969697,1.0,1.0,4/13,18.16%,RIPOR2;MOSPD2;MDK;MCU
prerank,GO_Biological_Process_2021__outflow tract septum morphogenesis (GO:0003148),0.29511687709329043,0.539681748236242,1.0,1.0,1.0,5/17,25.62%,TBX1;FGFR2;ZFPM2;SEMA3C;LRP2
prerank,GO_Biological_Process_2021__regulation of catabolic process (GO:0009894),0.28285496351003625,0.5392846862306055,0.96875,1.0,1.0,2/18,18.60%,RARRES2;FURIN
prerank,GO_Biological_Process_2021__JNK cascade (GO:0007254),-0.25918010456148527,-0.5383561914770942,1.0,1.0,1.0,1/36,1.97%,TNFRSF19
prerank,GO_Biological_Process_2021__positive regulation of protein localization to endosome (GO:1905668),-0.3002114727948527,-0.5368941157811137,0.9767441860465116,1.0,1.0,2/8,17.70%,SORL1;DTX3L
prerank,GO_Biological_Process_2021__positive regulation of protein localization to early endosome (GO:1902966),-0.3002114727948527,-0.5368941157811137,0.9767441860465116,1.0,1.0,2/8,17.70%,SORL1;DTX3L
prerank,GO_Biological_Process_2021__regulation of protein localization to early endosome (GO:1902965),-0.3002114727948527,-0.5368941157811137,0.9767441860465116,1.0,1.0,2/8,17.70%,SORL1;DTX3L
prerank,GO_Biological_Process_2021__negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway (GO:1902176),-0.2883430914725119,-0.5357971492488023,0.9655172413793104,1.0,1.0,3/17,11.05%,MAPK7;HSPB1;TRAP1
prerank,GO_Biological_Process_2021__negative regulation of oxidoreductase activity (GO:0051354),-0.341188336695397,-0.5355245750678961,0.975,1.0,1.0,6/6,65.90%,PRKN;MT3;HDAC6;SNCA;OXA1L;ETFBKMT
prerank,GO_Biological_Process_2021__autophagy of nucleus (GO:0044804),0.28377154583288033,0.5350272419586426,1.0,1.0,1.0,3/16,22.49%,ULK1;ATG3;WIPI1
prerank,GO_Biological_Process_2021__antiviral innate immune response (GO:0140374),0.31753319978034483,0.5347577060508664,0.9516129032258065,1.0,1.0,1/11,6.19%,ZDHHC11
prerank,GO_Biological_Process_2021__rRNA transcription (GO:0009303),-0.2740162726177866,-0.5343564834920924,0.9285714285714286,1.0,1.0,5/17,19.93%,TCOF1;GTF3C2;SIRT7;POLR1G;MARS1
prerank,GO_Biological_Process_2021__protein import (GO:0017038),0.22913846577298333,0.5325141662761658,1.0,1.0,1.0,14/77,23.69%,NXT1;RANBP6;LAMP2;PEX16;TOMM22;TSC2;PEX11B;SPRN;TNPO1;ALDH3A2;PXMP2;NUP188;PEX5;NUP85
prerank,GO_Biological_Process_2021__fibrinolysis (GO:0042730),0.35071671484652167,0.532411597599383,0.9821428571428571,1.0,1.0,4/7,29.42%,PLAUR;CPB2;SERPINE1;PLG
prerank,GO_Biological_Process_2021__biotin metabolic process (GO:0006768),-0.29088908248888073,-0.5321981267958528,1.0,1.0,1.0,9/9,70.93%,MCCC2;PC;HLCS;PCCB;PCCA;MCCC1;SLC5A6;BTD;PDZD11
prerank,GO_Biological_Process_2021__regulation of cytoplasmic transport (GO:1903649),0.30994994463209147,0.5318878449635785,0.9824561403508771,1.0,1.0,1/11,20.42%,LRRK2
prerank,GO_Biological_Process_2021__RNA transport (GO:0050658),0.2421086541211416,0.5317653368945042,1.0,1.0,1.0,15/64,24.08%,TST;U2AF1;SLU7;NCBP1;NCBP2;DDX39A;THOC5;CDC40;SLBP;SARNP;NUP188;SRSF3;SIDT1;EIF4A3;ALYREF
prerank,GO_Biological_Process_2021__lipoprotein localization (GO:0044872),-0.2858415991784665,-0.5311141104523363,0.9302325581395349,1.0,1.0,3/9,18.58%,ZDHHC3;PRKCB;MIA3
prerank,GO_Biological_Process_2021__ncRNA transcription (GO:0098781),-0.2707531182488725,-0.5303432654999501,0.9696969696969697,1.0,1.0,3/13,19.93%,SIRT7;POLR1G;MARS1
prerank,GO_Biological_Process_2021__negative regulation of ubiquitin-dependent protein catabolic process (GO:2000059),-0.24153931533264406,-0.530257964667974,1.0,1.0,1.0,4/33,15.56%,QRICH2;TAF1;PML;TLK2
prerank,GO_Biological_Process_2021__late endosome to lysosome transport (GO:1902774),0.34348681408521164,0.5302014254229295,1.0,1.0,1.0,2/5,31.72%,ARL8B;VPS39
prerank,GO_Biological_Process_2021__negative regulation of proteasomal protein catabolic process (GO:1901799),0.26408812614410876,0.5298728578836663,0.9857142857142858,1.0,1.0,9/32,33.86%,UCHL5;PRKCG;CAMLG;NOP53;GABARAPL2;BAG5;AQP11;MAP1A;WAC
prerank,GO_Biological_Process_2021__respiratory chain complex IV assembly (GO:0008535),0.2831971587388009,0.5296709093725099,0.9868421052631579,1.0,1.0,2/18,17.06%,SCO2;COA5
prerank,GO_Biological_Process_2021__positive regulation of proteasomal protein catabolic process (GO:1901800),0.23090651365847123,0.5295611842496649,1.0,1.0,1.0,7/74,16.76%,KCNE2;ARIH2;NKD2;SMAD7;USP13;RNF144B;DAB2IP
prerank,GO_Biological_Process_2021__fatty acid beta-oxidation using acyl-CoA dehydrogenase (GO:0033539),0.31140505320542516,0.528932907541366,0.9545454545454546,1.0,1.0,4/9,31.80%,ACADL;ETFB;ETFA;ACADM
prerank,GO_Biological_Process_2021__translation (GO:0006412),0.21300549912482308,0.5288250067714113,1.0,1.0,1.0,58/193,33.86%,EEF1A1;ASMT;GTPBP2;RPL15;RPL36;RPS7;RPL9;RPL26L1;RPS21;PPA1;RPL22;RPL21;RSL24D1;EPRS1;RPL38;MRPL34;MRPS14;IARS2;RPLP2;RPS5;GFM2;RPS6KB2;RPL3;COPS5;EEF2;MRPS34;RPL22L1;RPL35A;RPS13;RPL35;MRPS18C;RPS20;MRPL35;RPL27;RPL13A;RPS27A;RPL5;MRPL43;FTSJ1;RPL27A;RPL7;RPS9;AIMP2;EIF4EBP2;EEF2K;MRPL42;GTPBP1;MRPL51;MRPL28;RPL37;RPS29;MRPL57;RPL24;RPL28;TARS1;RPL32;RPL8;RPS4X
prerank,GO_Biological_Process_2021__negative regulation of RNA metabolic process (GO:0051253),-0.28961099715888045,-0.528556754071808,1.0,1.0,1.0,5/14,16.93%,PTBP3;NRDE2;PTBP1;RPS26;PTBP2
prerank,GO_Biological_Process_2021__negative regulation of RNA catabolic process (GO:1902369),0.33158945600681533,0.5284709245945741,1.0,1.0,1.0,4/8,30.77%,ZCCHC17;SLIRP;FMR1;PKP1
prerank,GO_Biological_Process_2021__positive regulation of neuron apoptotic process (GO:0043525),-0.27381171459199727,-0.5277077374381239,1.0,1.0,1.0,1/18,5.75%,TGFB2
prerank,"GO_Biological_Process_2021__nucleotide-excision repair, DNA damage recognition (GO:0000715)",0.2769078047778457,0.5273678479071836,1.0,1.0,1.0,8/23,36.29%,COPS2;COPS8;COPS5;CUL4B;RPS27A;GPS1;COPS7B;RAD23B
prerank,GO_Biological_Process_2021__icosanoid transport (GO:0071715),0.3390813408752637,0.5270128117081166,0.9846153846153847,1.0,1.0,1/9,4.11%,ABCC2
prerank,GO_Biological_Process_2021__regulation of supramolecular fiber organization (GO:1902903),0.27369691158879683,0.5269355349540693,0.9636363636363636,1.0,1.0,2/22,17.34%,HSPA8;CHRNA7
prerank,GO_Biological_Process_2021__positive regulation of transforming growth factor beta production (GO:0071636),0.3367874806719376,0.5269037495022111,0.9866666666666667,1.0,1.0,2/7,21.07%,ATP6AP2;CD200
prerank,GO_Biological_Process_2021__positive regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904261),-0.3239352679594737,-0.5260792707460615,0.9117647058823529,1.0,1.0,5/5,67.62%,PHLDB2;DAG1;CLASP2;PHLDB1;CLASP1
prerank,GO_Biological_Process_2021__regulation of basement membrane assembly involved in embryonic body morphogenesis (GO:1904259),-0.3239352679594737,-0.5260792707460615,0.9117647058823529,1.0,1.0,5/5,67.62%,PHLDB2;DAG1;CLASP2;PHLDB1;CLASP1
prerank,GO_Biological_Process_2021__liver development (GO:0001889),0.2730804176923551,0.5258516812556098,0.9722222222222222,1.0,1.0,2/22,14.94%,CCDC39;GFER
prerank,GO_Biological_Process_2021__extracellular transport (GO:0006858),0.30806909758048895,0.5257611163777278,0.96875,1.0,1.0,2/10,24.79%,CABYR;ROPN1L
prerank,GO_Biological_Process_2021__NIK/NF-kappaB signaling (GO:0038061),0.24040678184236716,0.5256569865098643,1.0,1.0,1.0,15/63,36.75%,PSMB6;PSMA3;PSMB8;PSMA5;COPS8;CUL1;PSMC6;AKT1;SKP1;PSMD12;PSMD4;PSME1;FBXW11;PSMC3;PSMD6
prerank,GO_Biological_Process_2021__negative regulation of intracellular transport (GO:0032387),0.3465699500290247,0.5252845296263644,0.967741935483871,1.0,1.0,2/5,19.15%,PLN;INSIG1
prerank,GO_Biological_Process_2021__fatty acid alpha-oxidation (GO:0001561),-0.3042592759211079,-0.5252257448038905,0.9722222222222222,1.0,1.0,3/7,14.68%,SLC27A2;SLC25A17;PHYH
prerank,GO_Biological_Process_2021__ribonucleoprotein complex assembly (GO:0022618),0.2216698208966167,0.525154630694549,1.0,1.0,1.0,18/120,23.98%,DDX20;ABT1;NCBP1;ERAL1;CLP1;GEMIN4;USP39;RSL24D1;RPL38;SNRPD2;YTHDC1;RPS5;POLR2D;DDX1;CRNKL1;SF3B1;NOP53;RPL3
prerank,GO_Biological_Process_2021__regulation of natural killer cell mediated cytotoxicity directed against tumor cell target (GO:0002858),-0.3325054367401345,-0.5251364490811229,0.975,1.0,1.0,3/6,32.03%,PVR;NECTIN2;IL12A
prerank,GO_Biological_Process_2021__negative regulation of lymphocyte migration (GO:2000402),-0.2953908038384726,-0.5250655692310228,1.0,1.0,1.0,4/10,25.23%,RIPOR2;MIA3;LRCH1;CD200R1
prerank,GO_Biological_Process_2021__protein K6-linked ubiquitination (GO:0085020),-0.3205312057722764,-0.5248293812737983,0.9574468085106383,1.0,1.0,1/8,7.39%,UBE2D4
prerank,GO_Biological_Process_2021__negative regulation of wound healing (GO:0061045),0.2736862418031317,0.5248118318455924,1.0,1.0,1.0,4/20,28.27%,KNG1;CD109;SERPINE1;SLC12A2
prerank,GO_Biological_Process_2021__excitatory synapse assembly (GO:1904861),-0.2950939935809262,-0.5246109430462264,0.9473684210526315,1.0,1.0,8/8,70.51%,PTEN;SHANK3;GRID2;NLGN1;WNT5A;LRRC4;PLXNB2;WNT7A
prerank,GO_Biological_Process_2021__myoblast migration (GO:0051451),0.3441024637483149,0.5239954393494487,1.0,1.0,1.0,1/6,23.49%,MSTN
prerank,"GO_Biological_Process_2021__neurotransmitter receptor transport, endosome to postsynaptic membrane (GO:0098887)",-0.31507502356464917,-0.5237008639360473,0.9555555555555556,1.0,1.0,3/6,21.24%,GRIPAP1;ARHGAP44;GRIP2
prerank,GO_Biological_Process_2021__vesicle transport along microtubule (GO:0047496),-0.2522022389429253,-0.5236556079361866,1.0,1.0,1.0,22/22,74.81%,KIFAP3;KIF13A;KIF1A;TRAK1;HTT;TRAK2;DYNC1I1;KIF3B;CLN3;BICDL1;HAP1;KIF5B;PAFAH1B1;NDE1;DYNC1H1;KIF5A;KIF1C;FBXW11;FYCO1;NDEL1;KIF3A;RAB1A
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway involved in phagocytosis (GO:0038096),0.2398943017456242,0.5236464064870523,1.0,1.0,1.0,7/59,18.11%,HCK;DOCK1;WAS;PLCG2;BRK1;ACTR2;YES1
prerank,GO_Biological_Process_2021__Fc-gamma receptor signaling pathway (GO:0038094),0.2398943017456242,0.5236464064870523,1.0,1.0,1.0,7/59,18.11%,HCK;DOCK1;WAS;PLCG2;BRK1;ACTR2;YES1
prerank,GO_Biological_Process_2021__positive regulation of mRNA binding (GO:1902416),-0.33642076801985815,-0.5234188038185206,0.9512195121951219,1.0,1.0,1/6,10.28%,EIF4G1
prerank,GO_Biological_Process_2021__negative regulation of cell junction assembly (GO:1901889),0.2805783846055878,0.5223656257897843,1.0,1.0,1.0,5/22,29.99%,TLR2;DMTN;SLIT1;DUSP22;ARHGAP6
prerank,GO_Biological_Process_2021__telomere capping (GO:0016233),-0.27388734686793476,-0.5221339307518033,0.9696969696969697,1.0,1.0,1/16,5.63%,DCLRE1B
prerank,GO_Biological_Process_2021__negative regulation of mitochondrion organization (GO:0010823),-0.25376037764035064,-0.5215411490437676,1.0,1.0,1.0,2/26,4.24%,IGF1;TRIAP1
prerank,GO_Biological_Process_2021__positive regulation of transcription regulatory region DNA binding (GO:2000679),0.30636959876561043,0.5213610654657668,0.9846153846153847,1.0,1.0,2/13,13.78%,TWIST1;TGFB1
prerank,GO_Biological_Process_2021__regulation of Rac protein signal transduction (GO:0035020),0.31525941055630124,0.521026573654301,0.984375,1.0,1.0,3/13,23.47%,KBTBD6;KBTBD7;PIK3CB
prerank,GO_Biological_Process_2021__regulation of histone acetylation (GO:0035065),0.25473514034115685,0.5207935807266323,1.0,1.0,1.0,3/29,14.47%,PPARGC1A;RPS6KA4;BRCA1
prerank,GO_Biological_Process_2021__production of miRNAs involved in gene silencing by miRNA (GO:0035196),-0.2406638076663172,-0.5206215029043936,1.0,1.0,1.0,5/27,18.79%,DGCR8;LIN28B;TRIM71;TARBP2;SRRT
prerank,GO_Biological_Process_2021__macroautophagy (GO:0016236),0.2194978760296733,0.5202259373166813,1.0,1.0,1.0,26/107,28.09%,CHMP4B;PRKAB2;LAMP2;VPS37B;LIX1L;CHMP2B;TOMM22;PINK1;CHMP2A;STX17;ULK1;ATG3;PLAA;ATG101;MAP1LC3B;WIPI1;PRKAG2;VPS4A;TOMM20;VDAC1;UBQLN1;ARL8B;TOMM7;YOD1;FUNDC1;GABARAPL1
prerank,GO_Biological_Process_2021__histone H3-K9 demethylation (GO:0033169),0.30779824948314494,0.5194292393837219,0.984375,1.0,1.0,3/10,22.71%,KDM3A;KDM7A;KDM1A
prerank,GO_Biological_Process_2021__mRNA stabilization (GO:0048255),0.2478164463930581,0.5191820307081227,1.0,1.0,1.0,3/34,15.98%,YBX3;MEIOC;HNRNPA0
prerank,GO_Biological_Process_2021__tumor necrosis factor-mediated signaling pathway (GO:0033209),0.23017406958787612,0.5188106619844636,1.0,1.0,1.0,9/89,19.33%,STAT1;PSMB6;PSMA3;CD27;PSMB8;TNFRSF11B;TXNDC17;TNFSF13B;TNFSF18
prerank,GO_Biological_Process_2021__regulation of neutrophil chemotaxis (GO:0090022),0.2716007985516098,0.5180456696918764,0.9850746268656716,1.0,1.0,6/18,30.42%,DAPK2;CD74;DPP4;JAM3;RAC1;SLIT2
prerank,GO_Biological_Process_2021__regulation of histone modification (GO:0031056),-0.27747970835052965,-0.5172969164209836,0.9117647058823529,1.0,1.0,11/11,72.27%,MTHFR;MYOCD;CDK9;AKAP8;AKAP8L;SETD5;UBE2N;NNMT;PARK7;HPF1;PARG
prerank,GO_Biological_Process_2021__negative regulation of lipid storage (GO:0010888),-0.27517075774615185,-0.5162301241224659,1.0,1.0,1.0,3/14,22.22%,PNPLA2;NR1H2;PPARA
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial translation (GO:0070131),0.29037254897286285,0.5160316279889275,0.9552238805970149,1.0,1.0,1/13,9.02%,MPV17L2
prerank,GO_Biological_Process_2021__protein mono-ADP-ribosylation (GO:0140289),-0.28826257249257237,-0.5157780005923176,0.9473684210526315,1.0,1.0,5/11,24.70%,PARP6;PARP10;PARP16;PARP4;PARP14
prerank,GO_Biological_Process_2021__interstrand cross-link repair (GO:0036297),0.2371910309966987,0.5157626530497963,1.0,1.0,1.0,12/50,29.20%,FAAP24;FANCI;FANCM;RPA3;POLN;RAD51AP1;RNF168;MSH6;FANCB;ERCC4;FANCL;RPS27A
prerank,GO_Biological_Process_2021__positive regulation of interleukin-4 production (GO:0032753),-0.28587150914843856,-0.5150284360232557,0.9705882352941176,1.0,1.0,11/11,71.43%,NLRP3;ZP3;HAVCR2;PRKCQ;PRKCZ;CEBPB;SLC7A5;RARA;HLA-E;TNFSF4;SYK
prerank,GO_Biological_Process_2021__response to type I interferon (GO:0034340),0.31399666903782775,0.5149997398076063,0.9863013698630136,1.0,1.0,2/9,20.54%,IFIT1;SP100
prerank,GO_Biological_Process_2021__positive regulation of secretion (GO:0051047),-0.31450577663671375,-0.5144941688010815,0.96875,1.0,1.0,6/6,68.56%,ALOX12B;SCIN;XBP1;ABCB11;GPLD1;ACSL3
prerank,GO_Biological_Process_2021__negative regulation of protein exit from endoplasmic reticulum (GO:0070862),0.3141142232608236,0.5143121693525682,0.9701492537313433,1.0,1.0,5/10,32.60%,INSIG1;YOD1;ERLEC1;SVIP;UBE2J1
prerank,"GO_Biological_Process_2021__nuclear-transcribed mRNA catabolic process, exonucleolytic, 3'-5' (GO:0034427)",0.3236434239484517,0.5125952465884339,0.9705882352941176,1.0,1.0,1/7,10.70%,EXOSC8
prerank,GO_Biological_Process_2021__U4 snRNA 3'-end processing (GO:0034475),0.3236434239484517,0.5125952465884339,0.9705882352941176,1.0,1.0,1/7,10.70%,EXOSC8
prerank,GO_Biological_Process_2021__triglyceride biosynthetic process (GO:0019432),-0.2570629242340855,-0.5106109072726833,0.96875,1.0,1.0,14/14,74.31%,MOGAT1;LPIN3;GPAT4;LPIN2;LPIN1;GPAT3;GK;LPGAT1;PNPLA3;DGAT1;PCK2;AGMO;DGAT2;GPAM
prerank,GO_Biological_Process_2021__formation of translation preinitiation complex (GO:0001731),-0.3057911871245816,-0.510569761090357,0.9545454545454546,1.0,1.0,9/9,69.44%,EIF2S3;EIF2S2;DHX29;EIF2D;EIF4B;EIF4H;MCTS1;DENR;EIF5
prerank,GO_Biological_Process_2021__response to reactive oxygen species (GO:0000302),0.2394708492809431,0.5095727734963065,1.0,1.0,1.0,2/50,7.79%,STK26;SOD2
prerank,GO_Biological_Process_2021__regulation of platelet-derived growth factor receptor signaling pathway (GO:0010640),0.3078521355804087,0.5092860723118888,0.9863013698630136,1.0,1.0,3/9,40.21%,F3;NDRG4;SNCA
prerank,GO_Biological_Process_2021__antigen processing and presentation of exogenous peptide antigen via MHC class II (GO:0019886),0.22196806824752216,0.5091355416398737,1.0,1.0,1.0,8/77,22.97%,HLA-DMA;HLA-DMB;AP1M2;RACGAP1;LGMN;CD74;SEC23A;CLTC
prerank,GO_Biological_Process_2021__regulation of cellular respiration (GO:0043457),0.2898191102505112,0.5086486442384807,0.9830508474576272,1.0,1.0,1/14,7.92%,IFNLR1
prerank,GO_Biological_Process_2021__negative regulation of plasma membrane bounded cell projection assembly (GO:0120033),0.25768264085379583,0.5077437595061702,1.0,1.0,1.0,3/22,17.72%,STAP1;CCP110;TCHP
prerank,GO_Biological_Process_2021__positive regulation of mitochondrial membrane potential (GO:0010918),0.31479211351016334,0.5074602615747245,0.9384615384615385,1.0,1.0,2/6,33.20%,BAD;AKT1
prerank,GO_Biological_Process_2021__acylglycerol biosynthetic process (GO:0046463),-0.24504587155963303,-0.5071797278133491,1.0,1.0,1.0,18/18,75.52%,PNPLA2;MOGAT1;LPIN3;GPAT4;LPIN2;LPIN1;GPAT3;GK;PLA2G15;LPGAT1;PNPLA3;PLCE1;DGAT1;AGMO;DGAT2;GPAM;PLA2G4A;DGAT2L6
prerank,GO_Biological_Process_2021__COPI-coated vesicle budding (GO:0035964),0.33279616543927176,0.5067444598833258,0.9666666666666667,1.0,1.0,1/6,28.15%,TMED10
prerank,GO_Biological_Process_2021__COPI coating of Golgi vesicle (GO:0048205),0.33279616543927176,0.5067444598833258,0.9666666666666667,1.0,1.0,1/6,28.15%,TMED10
prerank,GO_Biological_Process_2021__Golgi transport vesicle coating (GO:0048200),0.33279616543927176,0.5067444598833258,0.9666666666666667,1.0,1.0,1/6,28.15%,TMED10
prerank,GO_Biological_Process_2021__synaptic vesicle cycle (GO:0099504),0.2650186142462111,0.5061094863831197,1.0,1.0,1.0,6/25,29.50%,SLC17A8;OTOF;SLC32A1;SLC18A2;RAB5A;WNT7A
prerank,GO_Biological_Process_2021__activation of protein kinase A activity (GO:0034199),-0.27298995551070954,-0.5049294182604122,0.96,1.0,1.0,15/15,72.72%,ADCY7;ADCY2;ADCY5;ADCY9;ADCY8;PRKAR2B;PRKACA;ADCY6;PRKAR2A;PRKACB;PRKAR1B;ADCY1;PRKAR1A;ADCY3;PRRC1
prerank,GO_Biological_Process_2021__regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis (GO:2001270),-0.3112822628707651,-0.5047488060637437,0.9230769230769231,1.0,1.0,5/5,68.88%,RFFL;RFPL1;PAK2;RPS3;RNF34
prerank,GO_Biological_Process_2021__antigen processing and presentation of peptide antigen via MHC class II (GO:0002495),0.2214624885897068,0.504331021746457,1.0,1.0,1.0,8/79,22.97%,HLA-DMA;HLA-DMB;AP1M2;RACGAP1;LGMN;CD74;SEC23A;CLTC
prerank,GO_Biological_Process_2021__gastrulation (GO:0007369),0.30746078269373,0.5026366121412645,0.967741935483871,1.0,1.0,5/10,34.06%,MKKS;MESP1;GPC3;LRP5;UGDH
prerank,GO_Biological_Process_2021__cellular response to UV (GO:0034644),-0.22398308040804746,-0.5023013432529617,1.0,1.0,1.0,15/60,19.84%,TRIAP1;PRKCD;ERCC1;INO80;MME;TAF1;YY1;DDB2;CREBBP;EIF2AK4;PTPRK;RHBDD1;N4BP1;CASP9;XPC
prerank,GO_Biological_Process_2021__atrial cardiac muscle cell action potential (GO:0086014),-0.25053054642051575,-0.5020475556544144,1.0,1.0,1.0,1/12,9.55%,KCNN2
prerank,GO_Biological_Process_2021__negative regulation of amyloid precursor protein biosynthetic process (GO:0042985),-0.28057949752429856,-0.5015811591851568,1.0,1.0,1.0,6/6,71.95%,BACE2;AGO2;ABCA7;ITM2C;ITM2B;ITM2A
prerank,GO_Biological_Process_2021__SNARE complex assembly (GO:0035493),0.3152451724126955,0.5015177626417918,0.9827586206896551,1.0,1.0,1/8,14.27%,STXBP6
prerank,GO_Biological_Process_2021__regulation of microvillus organization (GO:0032530),0.3144150133002714,0.5007864798013753,0.984375,1.0,1.0,4/7,30.97%,PODXL;TWF2;CDHR5;ATP8B1
prerank,GO_Biological_Process_2021__regulation of tumor necrosis factor superfamily cytokine production (GO:1903555),-0.2990463228342027,-0.5004210721047487,0.9393939393939394,1.0,1.0,1/8,7.25%,FOXP1
prerank,GO_Biological_Process_2021__pre-miRNA processing (GO:0031054),0.27403273076128104,0.4995276838660887,1.0,1.0,1.0,1/13,11.21%,MRPL44
prerank,GO_Biological_Process_2021__neuron cell-cell adhesion (GO:0007158),0.2848482553472646,0.49924930474955787,0.9848484848484849,1.0,1.0,3/16,27.17%,CDK5R1;NLGN4X;NRXN3
prerank,GO_Biological_Process_2021__regulation of MHC class II biosynthetic process (GO:0045346),0.30824512815761723,0.49896591156475434,0.9705882352941176,1.0,1.0,1/8,8.74%,CIITA
prerank,GO_Biological_Process_2021__hepatocyte growth factor receptor signaling pathway (GO:0048012),0.3113349336001799,0.49887036034627436,1.0,1.0,1.0,2/11,18.52%,HGF;MUC20
prerank,GO_Biological_Process_2021__positive regulation of T-helper 17 type immune response (GO:2000318),-0.3170514471620026,-0.49875909939869695,1.0,1.0,1.0,2/6,17.32%,CARD9;MALT1
prerank,GO_Biological_Process_2021__cellular component maintenance (GO:0043954),0.2977072980743984,0.4985881034524962,0.9848484848484849,1.0,1.0,4/11,38.89%,PRNP;CLDN1;IGF1R;SUPV3L1
prerank,GO_Biological_Process_2021__regulation of cAMP-dependent protein kinase activity (GO:2000479),0.28873256903432803,0.49790113004391495,0.9859154929577465,1.0,1.0,2/12,23.11%,PKIB;ATP2B4
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in membrane fission (GO:0003373),-0.29352101110294143,-0.4978112547153246,0.9210526315789473,1.0,1.0,2/7,17.92%,MX1;DNM2
prerank,GO_Biological_Process_2021__dynamin family protein polymerization involved in mitochondrial fission (GO:0003374),-0.29352101110294143,-0.4978112547153246,0.9210526315789473,1.0,1.0,2/7,17.92%,MX1;DNM2
prerank,GO_Biological_Process_2021__valine metabolic process (GO:0006573),0.3126193070965836,0.4976842063443888,1.0,1.0,1.0,2/5,37.02%,ALDH6A1;BCAT2
prerank,GO_Biological_Process_2021__cellular response to nutrient (GO:0031670),-0.30862329803328287,-0.49666558429583435,0.9782608695652174,1.0,1.0,5/5,69.15%,CDKN2B;USF1;XBP1;LPL;PDK2
prerank,GO_Biological_Process_2021__positive regulation of B cell receptor signaling pathway (GO:0050861),-0.2755359758700186,-0.49647827633692687,1.0,1.0,1.0,2/7,15.08%,FOXP1;PRKCB
prerank,GO_Biological_Process_2021__astral microtubule organization (GO:0030953),-0.2859845639927109,-0.49556385766371236,0.9795918367346939,1.0,1.0,1/8,7.11%,NUMA1
prerank,GO_Biological_Process_2021__snRNA transcription by RNA polymerase II (GO:0042795),0.22530184283691332,0.4953089181429667,1.0,1.0,1.0,8/68,21.43%,NCBP1;NCBP2;TBP;GTF2A2;SNAPC2;SNAPC1;POLR2D;POLR2K
prerank,GO_Biological_Process_2021__negative regulation of actin filament polymerization (GO:0030837),0.2538570089925015,0.4947663071594438,1.0,1.0,1.0,4/23,25.95%,HIP1R;PFN4;TWF1;TWF2
prerank,GO_Biological_Process_2021__regulation of programmed necrotic cell death (GO:0062098),-0.23833489018388515,-0.49466860798121254,1.0,1.0,1.0,1/19,5.74%,CFLAR
prerank,GO_Biological_Process_2021__negative regulation of histone H3-K9 methylation (GO:0051573),-0.3187566057656503,-0.494327967270636,0.9302325581395349,1.0,1.0,3/6,17.25%,DNMT1;SMARCB1;DNMT3B
prerank,GO_Biological_Process_2021__regulation of chemokine (C-C motif) ligand 5 production (GO:0071649),-0.30270144423715495,-0.4941964861786072,0.9787234042553191,1.0,1.0,1/5,14.95%,MAVS
prerank,GO_Biological_Process_2021__regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis (GO:1903587),-0.2868277474668745,-0.49404225829730203,1.0,1.0,1.0,7/7,71.33%,PPP1R16B;IL12A;THBS1;VEGFA;FGF2;JCAD;PDCD10
prerank,GO_Biological_Process_2021__establishment of vesicle localization (GO:0051650),-0.24577461410669776,-0.49396491459841196,0.9722222222222222,1.0,1.0,4/17,24.86%,TMEM230;DNM2;RAB27A;KIF5C
prerank,GO_Biological_Process_2021__barbed-end actin filament capping (GO:0051016),0.26432946532351576,0.49321332938108314,0.9846153846153847,1.0,1.0,4/17,25.95%,EPS8;TWF1;VILL;TWF2
prerank,GO_Biological_Process_2021__actin filament capping (GO:0051693),0.26432946532351576,0.49321332938108314,0.9846153846153847,1.0,1.0,4/17,25.95%,EPS8;TWF1;VILL;TWF2
prerank,GO_Biological_Process_2021__endosomal vesicle fusion (GO:0034058),-0.2835574433651859,-0.49277841804489475,1.0,1.0,1.0,3/8,20.90%,SAMD9;VPS11;VPS41
prerank,GO_Biological_Process_2021__telomere maintenance (GO:0000723),-0.21176117482988904,-0.4926725152164174,1.0,1.0,1.0,8/46,19.06%,DCLRE1B;HUS1;XRCC6;POLD3;XRCC3;ATM;TPRKB;ZBTB48
prerank,GO_Biological_Process_2021__snRNA 3'-end processing (GO:0034472),0.26030227923591,0.49266485181611774,1.0,1.0,1.0,5/18,33.53%,EXOSC8;EXOSC6;INTS6;INTS14;INTS5
prerank,GO_Biological_Process_2021__regulation of peptidyl-lysine acetylation (GO:2000756),0.28574441268284895,0.4925546363471064,1.0,1.0,1.0,4/9,41.59%,KLF15;PRKAA1;DIP2A;PARK7
prerank,GO_Biological_Process_2021__regulation of establishment of protein localization (GO:0070201),0.27688276643461796,0.4922895410733512,0.9692307692307692,1.0,1.0,3/12,23.34%,DNAJA1;OOEP;CORO2B
prerank,GO_Biological_Process_2021__negative regulation of fibroblast migration (GO:0010764),-0.30125618925362185,-0.49209064432031446,0.967741935483871,1.0,1.0,6/6,69.89%,HAS1;MACIR;HYAL2;FGF2;ITGB1BP1;RAC1
prerank,GO_Biological_Process_2021__snRNA modification (GO:0040031),0.33379739032029637,0.49114365886958267,1.0,1.0,1.0,2/6,31.14%,NOP10;METTL4
prerank,GO_Biological_Process_2021__snRNA transcription (GO:0009301),0.2235694022520579,0.4909951342826689,1.0,1.0,1.0,8/69,21.43%,NCBP1;NCBP2;TBP;GTF2A2;SNAPC2;SNAPC1;POLR2D;POLR2K
prerank,GO_Biological_Process_2021__microtubule depolymerization (GO:0007019),0.2902182718214613,0.4901834547484652,1.0,1.0,1.0,2/13,17.84%,KIF14;KIF19
prerank,"GO_Biological_Process_2021__regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900151)",0.26962878407460916,0.48780100286005373,0.9827586206896551,1.0,1.0,7/14,40.79%,CNOT7;ZFP36;ZFP36L1;CNOT1;ZFP36L2;CPEB3;NANOS1
prerank,"GO_Biological_Process_2021__positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay (GO:1900153)",0.26962878407460916,0.48780100286005373,0.9827586206896551,1.0,1.0,7/14,40.79%,CNOT7;ZFP36;ZFP36L1;CNOT1;ZFP36L2;CPEB3;NANOS1
prerank,GO_Biological_Process_2021__rRNA-containing ribonucleoprotein complex export from nucleus (GO:0071428),0.30074801973221565,0.48761816657491136,0.9836065573770492,1.0,1.0,3/7,39.76%,EIF6;RAN;ABCE1
prerank,GO_Biological_Process_2021__regulation of telomere maintenance (GO:0032204),0.24071457479557243,0.48731729786717987,0.9846153846153847,1.0,1.0,5/23,27.70%,MRE11;GNL3;TERF2IP;RAD50;ERCC4
prerank,GO_Biological_Process_2021__N-terminal peptidyl-methionine acetylation (GO:0017196),0.3219081264148074,0.48712663341429585,0.9523809523809523,1.0,1.0,3/5,32.78%,NAA30;NAA16;NAA25
prerank,GO_Biological_Process_2021__embryonic eye morphogenesis (GO:0048048),0.32405439852682677,0.4850719250180358,0.9827586206896551,1.0,1.0,1/7,10.67%,EFEMP1
prerank,GO_Biological_Process_2021__negative regulation of transporter activity (GO:0032410),-0.30790390610673024,-0.4845754631872952,1.0,1.0,1.0,6/6,69.22%,CTTNBP2NL;WWP2;PPIF;SNCA;NDFIP1;NDFIP2
prerank,GO_Biological_Process_2021__regulation of cAMP-mediated signaling (GO:0043949),0.26592084345395794,0.4841979130162958,1.0,1.0,1.0,1/22,4.93%,SCTR
prerank,GO_Biological_Process_2021__regulation of keratinocyte migration (GO:0051547),-0.273431768158474,-0.4835419708296924,0.9411764705882353,1.0,1.0,10/10,72.67%,MTOR;PTEN;FGF10;MAP4K4;FGF7;MAPRE2;EPB41L4B;ARF6;IQSEC1;ADAM9
prerank,"GO_Biological_Process_2021__negative regulation of retrograde protein transport, ER to cytosol (GO:1904153)",-0.27468608599298944,-0.4823693584467123,1.0,1.0,1.0,2/9,15.24%,DERL3;UBAC2
prerank,GO_Biological_Process_2021__alditol metabolic process (GO:0019400),0.3221710485394207,0.48151868337662324,0.9682539682539683,1.0,1.0,1/5,20.41%,ANGPTL3
prerank,GO_Biological_Process_2021__positive regulation of keratinocyte migration (GO:0051549),-0.2734192305928745,-0.4806368356049447,0.972972972972973,1.0,1.0,9/9,72.67%,MTOR;FGF10;MAP4K4;FGF7;MAPRE2;EPB41L4B;ARF6;IQSEC1;ADAM9
prerank,GO_Biological_Process_2021__regulation of lamellipodium organization (GO:1902743),0.2760361763182818,0.47907202181355824,1.0,1.0,1.0,6/13,30.12%,WAS;DMTN;TWF1;TWF2;CDC42;RAC1
prerank,GO_Biological_Process_2021__neurotransmitter secretion (GO:0007269),0.21268238397483732,0.4787167930756664,1.0,1.0,1.0,9/40,32.41%,GAD1;HSPA8;OTOF;LIN7C;SLC32A1;PDZD11;DVL1;LIN7B;CPLX1
prerank,GO_Biological_Process_2021__pyrimidine nucleobase metabolic process (GO:0006206),-0.22324594552125723,-0.4786173061735415,1.0,1.0,1.0,1/11,8.94%,CTPS2
prerank,GO_Biological_Process_2021__malate metabolic process (GO:0006108),-0.3122676095788632,-0.47792865323461553,1.0,1.0,1.0,2/7,17.59%,MDH1B;ME1
prerank,GO_Biological_Process_2021__positive regulation of membrane protein ectodomain proteolysis (GO:0051044),-0.2712607217545713,-0.4777322541652832,1.0,1.0,1.0,4/10,25.86%,APOE;NRDC;PACSIN3;SH3D19
prerank,GO_Biological_Process_2021__positive regulation of deacetylase activity (GO:0090045),0.30226793127304386,0.47721625964502795,0.9846153846153847,1.0,1.0,2/6,37.66%,FNTA;C6ORF89
prerank,GO_Biological_Process_2021__protein O-linked glycosylation via serine (GO:0018242),-0.27617038837177316,-0.47670156735645924,0.9555555555555556,1.0,1.0,9/9,72.40%,GALNT1;GALNT16;GALNT2;POGLUT3;MGAT5B;GALNT13;GALNT3;POGLUT2;POGLUT1
prerank,GO_Biological_Process_2021__fructose 6-phosphate metabolic process (GO:0006002),-0.28603907004716544,-0.4755362073484596,0.9512195121951219,1.0,1.0,2/9,15.79%,PFKL;HK2
prerank,GO_Biological_Process_2021__peptidyl-lysine acetylation (GO:0018394),-0.26661263608554453,-0.4755299108737094,0.9777777777777777,1.0,1.0,2/9,20.15%,CREBBP;KAT7
prerank,MSigDB_Hallmark_2020__Pancreas Beta Cells,0.25649210298386144,0.4754010442178935,1.0,1.0,1.0,6/28,22.93%,SCGN;MAFB;SRP9;SYT13;DPP4;PKLR
prerank,GO_Biological_Process_2021__signal release from synapse (GO:0099643),0.21303720402622883,0.4752228421985614,1.0,1.0,1.0,9/39,32.41%,GAD1;HSPA8;OTOF;LIN7C;SLC32A1;PDZD11;DVL1;LIN7B;CPLX1
prerank,GO_Biological_Process_2021__negative regulation of exocytosis (GO:0045920),-0.2862318530267409,-0.4740901407623441,0.975609756097561,1.0,1.0,1/8,7.58%,RAB7A
prerank,GO_Biological_Process_2021__modulation by host of viral genome replication (GO:0044827),0.27194842414319387,0.4737411495226059,0.9855072463768116,1.0,1.0,2/11,27.64%,IFI27;FMR1
prerank,GO_Biological_Process_2021__positive regulation of skeletal muscle tissue development (GO:0048643),-0.2898271672855636,-0.4735960894152611,1.0,1.0,1.0,5/5,71.03%,NIBAN2;MEF2C;DLL1;LMOD3;FLOT1
prerank,GO_Biological_Process_2021__protein targeting to lysosome (GO:0006622),0.2511775236496714,0.4731343984544095,1.0,1.0,1.0,7/20,31.07%,LAMP2;HSPA8;NCOA4;VPS4A;LAPTM5;SCARB2;AP4M1
prerank,GO_Biological_Process_2021__regulation of T-helper 2 cell cytokine production (GO:2000551),-0.29340301654976386,-0.47281040159279636,1.0,1.0,1.0,5/5,70.67%,RSAD2;NLRP3;PRKCZ;CD81;DENND1B
prerank,GO_Biological_Process_2021__positive regulation of T-helper 2 cell cytokine production (GO:2000553),-0.29340301654976386,-0.47281040159279636,1.0,1.0,1.0,5/5,70.67%,RSAD2;NLRP3;PRKCZ;CD81;DENND1B
prerank,GO_Biological_Process_2021__positive regulation of TORC1 signaling (GO:1904263),0.2508655741736038,0.4722376547083194,1.0,1.0,1.0,5/15,29.19%,GPR137B;GPR137;RRAGD;RRAGA;LAMTOR5
prerank,GO_Biological_Process_2021__regulation of cell cycle checkpoint (GO:1901976),0.31209450842068054,0.47067500777347016,0.9811320754716981,1.0,1.0,2/6,24.45%,ETAA1;FEM1B
prerank,GO_Biological_Process_2021__regulation of transcription elongation from RNA polymerase II promoter (GO:0034243),0.24452706128195006,0.47015467406550354,1.0,1.0,1.0,2/26,23.20%,BTBD18;RNF168
prerank,GO_Biological_Process_2021__succinate transmembrane transport (GO:0071422),-0.32265570320643044,-0.47002127258629645,0.9795918367346939,1.0,1.0,1/5,12.49%,SLC25A10
prerank,GO_Biological_Process_2021__succinate transport (GO:0015744),-0.32265570320643044,-0.47002127258629645,0.9795918367346939,1.0,1.0,1/5,12.49%,SLC25A10
prerank,GO_Biological_Process_2021__cellular response to acid chemical (GO:0071229),-0.2133341010833087,-0.4696699809976012,1.0,1.0,1.0,5/28,19.66%,NSMF;RPTOR;LAMTOR4;MTOR;NEURL1
prerank,GO_Biological_Process_2021__negative regulation of p38MAPK cascade (GO:1903753),0.2966198102814626,0.4687204012409793,0.984375,1.0,1.0,2/6,22.94%,CYLD;DLG1
prerank,GO_Biological_Process_2021__organelle fission (GO:0048285),0.24620350322658996,0.4686419370258833,0.9846153846153847,1.0,1.0,5/21,26.04%,PEX11B;MTFR1L;PEX11A;MIEF1;MTFR1
prerank,GO_Biological_Process_2021__regulation of viral transcription (GO:0046782),0.21684459397426326,0.46796597657104555,1.0,1.0,1.0,5/38,21.79%,TRIM32;TRIM14;POLR2D;POLR2K;IFITM3
prerank,GO_Biological_Process_2021__vesicle organization (GO:0016050),0.22165531474127556,0.4674902642258318,1.0,1.0,1.0,11/39,29.62%,CORO1A;CHMP2B;RNF26;USP50;SORT1;WASHC4;EXOC8;HOOK2;SNX11;ARFGEF2;WASL
prerank,GO_Biological_Process_2021__positive regulation of striated muscle contraction (GO:0045989),0.30845330724894054,0.46529248336771384,1.0,1.0,1.0,1/5,17.40%,KCNQ1
prerank,GO_Biological_Process_2021__alcohol catabolic process (GO:0046164),0.28067984302911814,0.46489886155778715,0.9833333333333333,1.0,1.0,2/8,23.52%,SNX17;AKR1D1
prerank,GO_Biological_Process_2021__sterol catabolic process (GO:0016127),0.28067984302911814,0.46489886155778715,0.9833333333333333,1.0,1.0,2/8,23.52%,SNX17;AKR1D1
prerank,GO_Biological_Process_2021__cholesterol catabolic process (GO:0006707),0.28067984302911814,0.46489886155778715,0.9833333333333333,1.0,1.0,2/8,23.52%,SNX17;AKR1D1
prerank,GO_Biological_Process_2021__negative regulation of leukocyte cell-cell adhesion (GO:1903038),0.2554454934914778,0.46440964515687255,1.0,1.0,1.0,5/14,33.20%,IL4I1;LAPTM5;FGL1;GPNMB;AKT1
prerank,GO_Biological_Process_2021__regulation of cytokine production involved in inflammatory response (GO:1900015),0.23304866277890407,0.46428024024894515,1.0,1.0,1.0,6/28,23.97%,CUEDC2;CD6;NLRC3;PDCD4;PER1;GBP5
prerank,GO_Biological_Process_2021__regulation of cardiac muscle cell apoptotic process (GO:0010665),0.3022754015086525,0.4640160959985489,1.0,1.0,1.0,1/8,15.38%,CAMK2D
prerank,GO_Biological_Process_2021__DNA conformation change (GO:0071103),-0.24533419556241667,-0.46366849092332535,1.0,1.0,1.0,4/13,23.35%,HMGB2;TOP3B;ERCC3;KAT6A
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein serine/threonine kinase activity (GO:0045736),0.2545326220019248,0.46264371457630393,1.0,1.0,1.0,1/18,8.10%,CDKN1B
prerank,GO_Biological_Process_2021__negative regulation of sequestering of triglyceride (GO:0010891),-0.2876571138958915,-0.4613083762037334,0.9534883720930233,1.0,1.0,2/5,22.22%,PNPLA2;PPARA
prerank,GO_Biological_Process_2021__regulation of synaptic vesicle recycling (GO:1903421),-0.2996624862134258,-0.45981557973871967,1.0,1.0,1.0,1/5,13.59%,GRIPAP1
prerank,GO_Biological_Process_2021__myeloid leukocyte mediated immunity (GO:0002444),0.31008653396089547,0.4589549531342087,0.9830508474576272,1.0,1.0,2/6,24.32%,IRAK4;ADAM17
prerank,GO_Biological_Process_2021__maturation of 5.8S rRNA (GO:0000460),-0.22526489610568323,-0.4582580273563025,0.9655172413793104,1.0,1.0,17/17,77.50%,EXOSC10;EXOSC4;C1D;NOL9;MTREX;PRKDC;LAS1L;FTSJ3;RRP15;MPHOSPH6;RPF1;NSA2;PES1;MAK16;URB1;EIF6;WDR12
prerank,GO_Biological_Process_2021__metallo-sulfur cluster assembly (GO:0031163),-0.21626875717758026,-0.45744695348072567,1.0,1.0,1.0,3/21,17.05%,CIAO3;LYRM4;NDOR1
prerank,GO_Biological_Process_2021__autophagosome membrane docking (GO:0016240),0.2898919697385435,0.455797430760316,0.9848484848484849,1.0,1.0,3/7,26.13%,STX17;ATP2A2;VMP1
prerank,GO_Biological_Process_2021__regulation of pinocytosis (GO:0048548),-0.26364053186611647,-0.4547303531668689,0.9523809523809523,1.0,1.0,8/8,73.65%,NR1H2;CLN3;AXL;PROM2;NR1H3;PPT1;ANKFY1;CDC42
prerank,GO_Biological_Process_2021__regulation of integrin-mediated signaling pathway (GO:2001044),0.2549692572433784,0.4543898871791536,0.9655172413793104,1.0,1.0,3/12,27.67%,DMTN;LIMS2;EMP2
prerank,GO_Biological_Process_2021__regulation of acyl-CoA biosynthetic process (GO:0050812),0.28516579600375,0.45186515782349435,0.9827586206896551,1.0,1.0,3/8,31.74%,PDK4;PDK2;GSTZ1
prerank,GO_Biological_Process_2021__regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510),0.28516579600375,0.45186515782349435,0.9827586206896551,1.0,1.0,3/8,31.74%,PDK4;PDK2;GSTZ1
prerank,GO_Biological_Process_2021__negative regulation of vascular endothelial growth factor receptor signaling pathway (GO:0030948),0.2736899804576894,0.4515574056501898,1.0,1.0,1.0,3/9,28.22%,DAB2IP;MMRN2;CNMD
prerank,GO_Biological_Process_2021__regulation of dendritic spine maintenance (GO:1902950),0.2828523268274779,0.45132118310183894,1.0,1.0,1.0,2/6,22.72%,VPS35;PRNP
prerank,GO_Biological_Process_2021__positive regulation of leukocyte activation (GO:0002696),0.2656777978893452,0.4509608115966138,0.9833333333333333,1.0,1.0,4/10,29.38%,LBP;CRLF2;TNIP2;CD226
prerank,GO_Biological_Process_2021__regulation of microvillus assembly (GO:0032534),0.31620683124643556,0.4506643124879576,1.0,1.0,1.0,1/5,17.26%,PODXL
prerank,GO_Biological_Process_2021__Golgi to plasma membrane transport (GO:0006893),0.21097480140849456,0.4501517307466792,1.0,1.0,1.0,3/43,17.12%,AMN;STXBP6;STEAP2
prerank,GO_Biological_Process_2021__Golgi to endosome transport (GO:0006895),0.252456188672787,0.44982155536366186,1.0,1.0,1.0,5/15,33.60%,WIPI1;SORT1;AP1AR;AP4M1;CORO7
prerank,GO_Biological_Process_2021__membrane protein intracellular domain proteolysis (GO:0031293),-0.21926817795627895,-0.44829775799839,1.0,1.0,1.0,2/17,12.45%,NCSTN;HM13
prerank,GO_Biological_Process_2021__negative regulation of cyclin-dependent protein kinase activity (GO:1904030),0.2445502862182127,0.44823711516912396,1.0,1.0,1.0,3/19,22.98%,CDKN1B;NR2F2;CAMK2N1
prerank,GO_Biological_Process_2021__negative regulation of nervous system process (GO:0031645),0.3053922863107704,0.448172597775916,1.0,1.0,1.0,2/6,30.51%,GLRA1;TMEM98
prerank,GO_Biological_Process_2021__defense response to tumor cell (GO:0002357),-0.2750221843952677,-0.44549925284998887,0.9761904761904762,1.0,1.0,2/7,19.15%,RBMS3;PLK5
prerank,GO_Biological_Process_2021__negative regulation of telomerase activity (GO:0051974),0.28098491448484564,0.44489379520812,1.0,1.0,1.0,9/9,71.91%,ERCC4;MEN1;POT1;TP53;PINX1;PIF1;TERF1;PARP3;SRC
prerank,GO_Biological_Process_2021__regulation of triglyceride metabolic process (GO:0090207),-0.2727272727272727,-0.44454365698469905,0.9696969696969697,1.0,1.0,5/5,72.74%,GNB3;FITM2;C3;PANK2;MBOAT7
prerank,GO_Biological_Process_2021__mitochondrial fission (GO:0000266),-0.23446754114922275,-0.44364778854462344,1.0,1.0,1.0,4/15,19.41%,MX1;GDAP1;DNM2;PRKN
prerank,GO_Biological_Process_2021__negative regulation of tyrosine phosphorylation of STAT protein (GO:0042532),0.27644860234155,0.44347717633504713,0.9852941176470589,1.0,1.0,1/7,18.79%,INPP5F
prerank,GO_Biological_Process_2021__nucleic acid transport (GO:0050657),0.28062388492830725,0.4426309799975904,1.0,1.0,1.0,2/9,25.76%,SIDT1;SIDT2
prerank,GO_Biological_Process_2021__response to amino acid (GO:0043200),0.2283435072024144,0.44213196027880286,1.0,1.0,1.0,9/31,29.68%,GLRA3;GLRA1;GLRB;LAMTOR3;RRAGD;LAMTOR2;RRAGA;LAMTOR5;SPAAR
prerank,GO_Biological_Process_2021__positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains (GO:0002824),-0.2844539892988165,-0.4412399308714944,1.0,1.0,1.0,1/5,17.31%,CARD9
prerank,GO_Biological_Process_2021__protein targeting to mitochondrion (GO:0006626),0.20704137060262393,0.44107045747022755,1.0,1.0,1.0,10/49,27.10%,BCAP31;TOMM22;DNAJC19;GRPEL2;FBXO7;ROMO1;TOMM20;HSPA4;TIMM8B;TOMM7
prerank,GO_Biological_Process_2021__regulation of vesicle size (GO:0097494),0.27835914513165494,0.43982564938462027,1.0,1.0,1.0,2/7,28.79%,RIN3;RAB5A
prerank,GO_Biological_Process_2021__cranial nerve development (GO:0021545),0.30187360093216775,0.43946288658353955,1.0,1.0,1.0,1/5,24.32%,CHRNB2
prerank,GO_Biological_Process_2021__iron-sulfur cluster assembly (GO:0016226),-0.20333357715891837,-0.43861300799941993,1.0,1.0,1.0,3/22,17.05%,CIAO3;LYRM4;NDOR1
prerank,GO_Biological_Process_2021__negative regulation of cholesterol storage (GO:0010887),0.2739640238811217,0.43724169639245924,0.9838709677419355,1.0,1.0,1/8,21.48%,PPARG
prerank,GO_Biological_Process_2021__positive regulation of fibroblast growth factor receptor signaling pathway (GO:0045743),-0.304048381386245,-0.43661231930136274,0.9444444444444444,1.0,1.0,2/5,17.94%,SMOC2;FGFBP3
prerank,GO_Biological_Process_2021__regulation of amyloid precursor protein biosynthetic process (GO:0042984),0.24716027636737448,0.4360173699805063,0.9821428571428571,1.0,1.0,4/11,33.11%,SOAT1;ITM2A;ITM2B;ITM2C
prerank,GO_Biological_Process_2021__dendritic spine maintenance (GO:0097062),0.2822569883425691,0.43583423260325754,1.0,1.0,1.0,1/7,22.72%,PRNP
prerank,GO_Biological_Process_2021__protein O-linked mannosylation (GO:0035269),0.22726206314489394,0.4355066591788623,0.9859154929577465,1.0,1.0,4/17,29.52%,B4GAT1;POMGNT2;POMT1;SDF2L1
prerank,GO_Biological_Process_2021__regulation of endocytic recycling (GO:2001135),-0.25704115786290277,-0.435207031793996,1.0,1.0,1.0,2/9,17.23%,SORL1;EIPR1
prerank,GO_Biological_Process_2021__COPII-coated vesicle cargo loading (GO:0090110),-0.22390387084938543,-0.4349146392415368,0.9666666666666667,1.0,1.0,14/14,77.63%,SCAP;MIA3;SEC24C;SEC13;TBC1D20;SEC31B;SEC23B;SEC24A;SAR1A;SEC24D;SEC31A;SEC24B;RAB1A;SEC23A
prerank,GO_Biological_Process_2021__cognition (GO:0050890),0.2215630596366078,0.4345570222573478,1.0,1.0,1.0,7/38,26.15%,CHMP2B;CHRNA7;SHROOM4;LINS1;CHRNB2;GPR155;CYFIP1
prerank,GO_Biological_Process_2021__negative regulation of macrophage derived foam cell differentiation (GO:0010745),0.26657982176696304,0.43430564869738036,1.0,1.0,1.0,2/9,30.89%,PPARG;NFKBIA
prerank,GO_Biological_Process_2021__histone ubiquitination (GO:0016574),0.22502700100652043,0.4316447927180518,1.0,1.0,1.0,6/21,36.86%,UBE2E1;UHRF1;UBE2B;RAG1;WAC;PAF1
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomerase (GO:0032211),-0.2076566549271085,-0.43125400010083914,1.0,1.0,1.0,1/18,10.38%,EXOSC10
prerank,GO_Biological_Process_2021__cellular response to nitrogen levels (GO:0043562),-0.2223852537943051,-0.4311991549827308,1.0,1.0,1.0,9/9,77.78%,MAP1LC3A;NPRL2;ATG7;MAP1LC3B2;BECN1;ATG5;GABARAPL2;GABARAPL1;MAP1LC3B
prerank,GO_Biological_Process_2021__cellular response to nitrogen starvation (GO:0006995),-0.2223852537943051,-0.4311991549827308,1.0,1.0,1.0,9/9,77.78%,MAP1LC3A;NPRL2;ATG7;MAP1LC3B2;BECN1;ATG5;GABARAPL2;GABARAPL1;MAP1LC3B
prerank,GO_Biological_Process_2021__miRNA loading onto RISC involved in gene silencing by miRNA (GO:0035280),-0.24836091880243913,-0.43022864932170446,0.9354838709677419,1.0,1.0,7/7,75.18%,TARBP2;AGO2;ADAR;AGO3;DICER1;AGO1;AGO4
prerank,GO_Biological_Process_2021__positive regulation of vacuole organization (GO:0044090),0.2515915780779183,0.43005497605723075,1.0,1.0,1.0,4/11,34.36%,PIP4K2C;RAB3GAP1;RAB3GAP2;GRN
prerank,GO_Biological_Process_2021__protein insertion into ER membrane by stop-transfer membrane-anchor sequence (GO:0045050),-0.24977986687828746,-0.42964544782178593,1.0,1.0,1.0,2/10,15.23%,EMC8;EMC6
prerank,GO_Biological_Process_2021__macrophage activation involved in immune response (GO:0002281),0.2701601469447471,0.4275314007242456,0.9838709677419355,1.0,1.0,4/9,23.03%,PLCG2;CX3CR1;LBP;IFI35
prerank,GO_Biological_Process_2021__cellular response to peptide hormone stimulus (GO:0071375),0.20304122844121897,0.4264034880040895,1.0,1.0,1.0,11/85,22.93%,GOT1;TSHR;GPER1;RAB8A;INSIG2;EPRS1;INSIG1;CRHBP;PDE3B;PPARG;PKLR
prerank,GO_Biological_Process_2021__regulation of chromatin organization (GO:1902275),-0.24129436366361226,-0.4263573089740607,1.0,1.0,1.0,2/12,15.56%,SSRP1;TLK2
prerank,GO_Biological_Process_2021__regulation of nitric oxide metabolic process (GO:0080164),-0.26010939680836076,-0.4262385629743949,0.9714285714285714,1.0,1.0,3/8,22.18%,NOS1AP;TMEM106A;JAK2
prerank,GO_Biological_Process_2021__response to mitochondrial depolarisation (GO:0098780),0.2875621244696964,0.42495458142098164,1.0,1.0,1.0,2/5,36.82%,GPS2;AMBRA1
prerank,GO_Biological_Process_2021__N-acetylneuraminate catabolic process (GO:0019262),0.27306666861497353,0.42481629613797633,0.9848484848484849,1.0,1.0,2/6,30.15%,GNPDA1;NPL
prerank,GO_Biological_Process_2021__ATP synthesis coupled electron transport (GO:0042773),-0.2606821932880983,-0.42227817804526196,1.0,1.0,1.0,6/6,73.94%,COA6;NDUFA12;NDUFV3;NDUFS2;NDUFB6;NDUFV1
prerank,GO_Biological_Process_2021__hematopoietic stem cell migration (GO:0035701),-0.24368542056082665,-0.4219125595719151,1.0,1.0,1.0,1/5,15.40%,BCL11B
prerank,GO_Biological_Process_2021__positive regulation of tumor necrosis factor-mediated signaling pathway (GO:1903265),0.25965178854013005,0.42107277694144285,1.0,1.0,1.0,2/6,26.27%,ADAM17;LAPTM5
prerank,GO_Biological_Process_2021__plus-end-directed organelle transport along microtubule (GO:0072386),-0.25935264991747664,-0.4208119369606638,1.0,1.0,1.0,6/6,74.08%,KIFAP3;KIF13A;MAPT;KIF3B;FYCO1;KIF3A
prerank,GO_Biological_Process_2021__intraciliary transport involved in cilium assembly (GO:0035735),0.2031418327073059,0.42075762976308656,1.0,1.0,1.0,5/36,25.93%,SSX2IP;IFT46;TNPO1;IFT57;KIF3A
prerank,GO_Biological_Process_2021__late nucleophagy (GO:0044805),-0.26138843805885703,-0.4193637814005844,1.0,1.0,1.0,1/7,13.40%,ATG9B
prerank,GO_Biological_Process_2021__positive regulation of maintenance of sister chromatid cohesion (GO:0034093),0.27474624769650347,0.41842763781753006,1.0,1.0,1.0,1/5,24.34%,SLF1
prerank,GO_Biological_Process_2021__regulation of maintenance of mitotic sister chromatid cohesion (GO:0034182),0.27474624769650347,0.41842763781753006,1.0,1.0,1.0,1/5,24.34%,SLF1
prerank,GO_Biological_Process_2021__positive regulation of maintenance of mitotic sister chromatid cohesion (GO:0034184),0.27474624769650347,0.41842763781753006,1.0,1.0,1.0,1/5,24.34%,SLF1
prerank,GO_Biological_Process_2021__autophagy of peroxisome (GO:0030242),-0.22241584884894064,-0.4177701797743796,1.0,1.0,1.0,12/12,77.78%,ATM;ACBD5;SQSTM1;PIK3C3;NBR1;PJVK;RB1CC1;USP30;TRAPPC8;PIK3R4;PEX5;MAP1LC3B
prerank,GO_Biological_Process_2021__establishment or maintenance of apical/basal cell polarity (GO:0035088),-0.21797165267648275,-0.416392119626463,1.0,1.0,1.0,17/17,78.22%,CLIC4;LRRC7;PARD3;FSCN1;DLG3;MARK2;PARD3B;SCRIB;MTCL1;DLG2;PATJ;PRKCI;ERBIN;CRB2;CRB1;DLG1;OOEP
prerank,GO_Biological_Process_2021__maintenance of protein location in nucleus (GO:0051457),-0.20550458715596331,-0.41426052071024316,1.0,1.0,1.0,18/18,79.47%,PML;SUN2;TAF8;CHCHD10;SYNE1;MORC3;BCL3;ARL2BP;BBS4;SUPT7L;HNRNPU;SUN1;PARK7;RANGAP1;TAF3;BARD1;SKP1;SP100
prerank,GO_Biological_Process_2021__positive regulation of endocytic recycling (GO:2001137),0.2670325401345803,0.41229413510629725,1.0,1.0,1.0,2/7,26.09%,AKAP5;ACTN2
prerank,GO_Biological_Process_2021__regulation of cellular extravasation (GO:0002691),-0.23699050937600294,-0.4115340436693704,1.0,1.0,1.0,7/7,76.31%,BST1;FUT9;PLVAP;ADAM8;THY1;ICAM1;JAM3
prerank,GO_Biological_Process_2021__magnesium ion transport (GO:0015693),-0.22665324342227455,-0.41097019744694313,0.9705882352941176,1.0,1.0,3/12,22.86%,CNNM4;MAGT1;NIPAL2
prerank,GO_Biological_Process_2021__acylglycerol acyl-chain remodeling (GO:0036155),0.2651636672567532,0.40987694773163696,0.9833333333333333,1.0,1.0,3/6,33.47%,DGAT2L6;DGAT2;DGAT1
prerank,GO_Biological_Process_2021__negative regulation of cAMP-dependent protein kinase activity (GO:2000480),-0.22832042145165932,-0.40572167970560497,1.0,1.0,1.0,2/8,21.07%,PKIA;PKIG
prerank,GO_Biological_Process_2021__regulation of retinoic acid receptor signaling pathway (GO:0048385),-0.21731554088136837,-0.40567185532680816,1.0,1.0,1.0,11/11,78.28%,AKR1C3;DHRS3;TRIM16;CTBP2;SNW1;KLF2;ASXL1;CNOT1;PRAME;CALR;EZH2
prerank,GO_Biological_Process_2021__Golgi inheritance (GO:0048313),0.26105372019962314,0.4053938221888364,0.9857142857142858,1.0,1.0,1/10,13.45%,VCPIP1
prerank,GO_Biological_Process_2021__phosphatidylglycerol biosynthetic process (GO:0006655),-0.2569686411149826,-0.4049330291526629,1.0,1.0,1.0,6/6,74.31%,PGS1;TAMM41;CDS2;PLA2G6;SLC27A1;GPAM
prerank,GO_Biological_Process_2021__protein depolymerization (GO:0051261),0.21799923473527905,0.4031042441348895,1.0,1.0,1.0,9/23,34.94%,KIF14;TWF1;CFL2;TWF2;WDR1;CFL1;STMN4;KIF2C;STMN1
prerank,GO_Biological_Process_2021__positive regulation of hormone metabolic process (GO:0032352),-0.2519365084262403,-0.4027617465021109,1.0,1.0,1.0,2/6,24.75%,SLCO1C1;PAX8
prerank,GO_Biological_Process_2021__hepaticobiliary system development (GO:0061008),0.2212356771712276,0.40121791049063515,1.0,1.0,1.0,1/16,14.94%,GFER
prerank,GO_Biological_Process_2021__plus-end-directed vesicle transport along microtubule (GO:0072383),-0.25934076009718976,-0.3973879474800389,1.0,1.0,1.0,5/5,74.08%,KIFAP3;KIF13A;KIF3B;FYCO1;KIF3A
prerank,GO_Biological_Process_2021__negative regulation of cell-substrate junction organization (GO:0150118),0.2211864035366512,0.3945875883049388,1.0,1.0,1.0,3/15,29.99%,DMTN;DUSP22;ARHGAP6
prerank,GO_Biological_Process_2021__negative regulation of focal adhesion assembly (GO:0051895),0.2211864035366512,0.3945875883049388,1.0,1.0,1.0,3/15,29.99%,DMTN;DUSP22;ARHGAP6
prerank,GO_Biological_Process_2021__positive regulation of transcription initiation from RNA polymerase II promoter (GO:0060261),0.21521194796190207,0.3923662709604596,1.0,1.0,1.0,3/21,22.28%,ESR1;SUB1;MED17
prerank,GO_Biological_Process_2021__protein localization to ciliary transition zone (GO:1904491),0.2579601506936064,0.3912679142224197,0.9841269841269841,1.0,1.0,3/5,36.66%,NPHP4;TCTN2;TMEM107
prerank,GO_Biological_Process_2021__positive regulation of autophagosome assembly (GO:2000786),0.2275728128007551,0.38921950120939525,1.0,1.0,1.0,3/9,33.73%,PIP4K2C;RAB3GAP1;RAB3GAP2
prerank,GO_Biological_Process_2021__intermembrane lipid transfer (GO:0120009),0.25963283573972484,0.38816950008528045,1.0,1.0,1.0,2/6,35.90%,TTPA;CPTP
prerank,GO_Biological_Process_2021__myelination in peripheral nervous system (GO:0022011),-0.21236300270555325,-0.3859856404224233,1.0,1.0,1.0,11/11,78.78%,SIRT2;PARD3;LGI4;NF1;SOD1;SKI;DICER1;PRX;ADGRG6;CNTNAP1;NCMAP
prerank,GO_Biological_Process_2021__tail-anchored membrane protein insertion into ER membrane (GO:0071816),0.2177595842104295,0.38346448930010046,1.0,1.0,1.0,3/15,27.86%,EMC1;CAMLG;EMC3
prerank,GO_Biological_Process_2021__mitophagy (GO:0000423),-0.2223750573131591,-0.3832097021934936,1.0,1.0,1.0,8/8,77.78%,PRKN;SQSTM1;ATG14;BECN1;PHB2;ATG13;AMBRA1;MAP1LC3B
prerank,GO_Biological_Process_2021__purine nucleotide biosynthetic process (GO:0006164),0.22004500772113472,0.3820158679612785,0.9855072463768116,1.0,1.0,2/10,26.19%,AMPD2;PPAT
prerank,GO_Biological_Process_2021__histone H4-K16 acetylation (GO:0043984),-0.19046745263544199,-0.3815213319398535,1.0,1.0,1.0,19/19,80.97%,JADE2;MEAF6;KAT7;HCFC1;KAT8;PHF20;MCRS1;KANSL1;JADE1;KANSL3;ING4;JADE3;KMT2A;OGT;MSL1;MSL2;KANSL2;WDR5;MSL3
prerank,GO_Biological_Process_2021__histone H2B ubiquitination (GO:0033523),-0.2151962582538518,-0.38147773392102013,1.0,1.0,1.0,10/10,78.49%,DTX3L;CDC73;RNF8;RNF20;LEO1;RNF40;CTR9;PAF1;WAC;UBE2E1
prerank,GO_Biological_Process_2021__multi-ciliated epithelial cell differentiation (GO:1903251),0.2407117774173963,0.3778482362106803,1.0,1.0,1.0,2/5,29.57%,DEUP1;CEP152
prerank,GO_Biological_Process_2021__regulation of Rab protein signal transduction (GO:0032483),0.24136225504536224,0.3759683882259481,1.0,1.0,1.0,3/6,33.48%,MADD;DENND4C;DENND4A
prerank,GO_Biological_Process_2021__positive regulation of protein deubiquitination (GO:1903003),-0.23785072437190538,-0.37343808147579094,1.0,1.0,1.0,6/6,76.23%,VCP;TANK;TNIP1;WDR48;SART3;NOP53
prerank,"GO_Biological_Process_2021__regulation of retrograde transport, endosome to Golgi (GO:1905279)",-0.20798754657558763,-0.3645882937721138,1.0,1.0,1.0,2/6,19.41%,EIPR1;PRKN
prerank,GO_Biological_Process_2021__telomeric loop disassembly (GO:0090657),0.21400796251707915,0.3568138304549326,1.0,1.0,1.0,2/8,27.73%,RECQL4;BLM
prerank,GO_Biological_Process_2021__modulation by host of viral process (GO:0044788),-0.2032046888517714,-0.3335890807765674,1.0,0.9999573019075373,1.0,2/8,20.67%,APOE;PC
prerank,GO_Biological_Process_2021__negative regulation of telomere maintenance via telomere lengthening (GO:1904357),0.164371998486337,0.32306520329160154,1.0,0.9999972248278005,1.0,3/23,27.70%,DCP2;TNKS2;ERCC4
